Document:

EX-10.1

 Exhibit 10.1 

FACILITY AGREEMENT 

dated as of April 3, 2017 

by and among 

Endologix, Inc., 
 as the
Borrower, 
 the other Loan Parties party hereto from time to time, 

the Lenders 
 and

 Deerfield Private Design Fund IV, L.P., 

as agent for itself and the Lenders 

 Table of Contents 

 

							
	ARTICLE 1 DEFINITIONS	  	 	1	 
			
	 Section 1.1
	 	 General Definitions
	  	 	1	 
	 Section 1.2
	 	 Interpretation
	  	 	35	 
	 Section 1.3
	 	 Business Day Adjustment
	  	 	36	 
	 Section 1.4
	 	 Loan Records
	  	 	36	 
	 Section 1.5
	 	 Accounting Terms and Principles
	  	 	37	 
	 Section 1.6
	 	 [Reserved]
	  	 	37	 
	 Section 1.7
	 	 Officers
	  	 	37	 
	 Section 1.8
	 	 Joint Drafting and Negotiation
	  	 	37	 
		
	ARTICLE 2 AGREEMENT FOR THE LOAN	  	 	37	 
			
	 Section 2.1
	 	 Use of Proceeds
	  	 	37	 
	 Section 2.2
	 	 Disbursements
	  	 	37	 
	 Section 2.3
	 	 Payments; Prepayments; No Call; Non-Callable Make Whole
Amount
	  	 	38	 
	 Section 2.4
	 	 Payment Details
	  	 	39	 
	 Section 2.5
	 	 Taxes
	  	 	39	 
	 Section 2.6
	 	 Interest
	  	 	41	 
	 Section 2.7
	 	 Yield Enhancement Payment; Default Interest
	  	 	42	 
	 Section 2.8
	 	 Delivery of Warrants
	  	 	43	 
		
	ARTICLE 3 REPRESENTATIONS AND WARRANTIES	  	 	43	 
			
	 Section 3.1
	 	 Representations and Warranties of the Loan Parties
	  	 	43	 
	 Section 3.2
	 	 Borrower Acknowledgment
	  	 	56	 
	 Section 3.3
	 	 Representations and Warranties of the Lenders
	  	 	56	 
		
	ARTICLE 4 CONDITIONS OF DISBURSEMENT	  	 	57	 
			
	 Section 4.1
	 	 Conditions to the Disbursement
	  	 	57	 
		
	ARTICLE 5 PARTICULAR COVENANTS AND EVENTS OF DEFAULT	  	 	58	 
			
	 Section 5.1
	 	 Affirmative Covenants
	  	 	58	 
	 Section 5.2
	 	 Negative Covenants
	  	 	65	 
	 Section 5.3
	 	 Change in Control
	  	 	71	 
	 Section 5.4
	 	 General Acceleration Provision upon Events of Default
	  	 	72	 
	 Section 5.5
	 	 Additional Remedies
	  	 	76	 
	 Section 5.6
	 	 Recovery of Amounts Due
	  	 	77	 
	 Section 5.7
	 	 Credit Bidding
	  	 	77	 
		
	ARTICLE 6 MISCELLANEOUS	  	 	77	 
			
	 Section 6.1
	 	 Notices
	  	 	77	 
	 Section 6.2
	 	 Waiver of Notice
	  	 	78	 
	 Section 6.3
	 	 Fees, Charges, Costs and Expenses Reimbursement
	  	 	79	 
	 Section 6.4
	 	 Governing Law
	  	 	79	 
	 Section 6.5
	 	 Successors and Assigns
	  	 	80	 

  
 i 

							
	 Section 6.6
	 	 Entire Agreement; Amendments
	  	 	81	 
	 Section 6.7
	 	 Severability
	  	 	81	 
	 Section 6.8
	 	 Counterparts
	  	 	81	 
	 Section 6.9
	 	 Survival
	  	 	82	 
	 Section 6.10
	 	 No Waiver
	  	 	83	 
	 Section 6.11
	 	 Indemnity
	  	 	84	 
	 Section 6.12
	 	 No Usury
	  	 	84	 
	 Section 6.13
	 	 Specific Performance
	  	 	85	 
	 Section 6.14
	 	 Further Assurances
	  	 	85	 
	 Section 6.15
	 	 Agent
	  	 	85	 
	 Section 6.16
	 	 USA Patriot Act
	  	 	88	 
	 Section 6.17
	 	 Placement Agent
	  	 	88	 
	 Section 6.18
	 	 No Fiduciary Relationship
	  	 	88	 
	 Section 6.19
	 	 Joint and Several
	  	 	88	 
	 Section 6.20
	 	 No Third Parties Benefited
	  	 	88	 
	 Section 6.21
	 	 Binding Effect
	  	 	88	 
	 Section 6.22
	 	 Marshaling; Payments Set Aside
	  	 	89	 
	 Section 6.23
	 	 No Waiver; Cumulative Remedies
	  	 	89	 
	 Section 6.24
	 	 Right of Setoff
	  	 	89	 
	 Section 6.25
	 	 Independent Nature of Secured Parties
	  	 	89	 
	 Section 6.26
	 	 Sharing of Payments, Etc.
	  	 	90	 
	 Section 6.27
	 	 Confidentiality
	  	 	90	 
	 Section 6.28
	 	 Intercreditor Agreement
	  	 	91	 

 Annex 
  

			
	Annex A	  	Disbursement Amount and Warrants

 Schedules 
  

			
	Schedule P-1	  	Existing Investments
	Schedule 2.4	  	List of Agreement Date Lenders and Such Lenders’ Wire Instructions and Information for Notices
	Schedule 3.1(d)	  	Existing Liens
	Schedule 3.1(f)	  	Existing Indebtedness
	Schedule 3.1(h)	  	Litigation
	Schedule 3.1(m)	  	Real Estate
	Schedule 3.1(x)	  	Borrower’s Subsidiaries
	Schedule 3.1(z)	  	Borrower’s Outstanding Shares of Stock, Options and Warrants
	Schedule 3.1(aa)	  	Material Contracts
	Schedule 3.1(dd)	  	Environmental
	Schedule 3.1(ff)	  	Labor Relations
	Schedule 3.1(gg)	  	Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office
	Schedule 5.1(y)	  	Post-Closing Requirements
	Schedule 5.2(iv)	  	Contingent Obligations
	Schedule 5.2(vii)	  	Transactions with Affiliates

  
 ii 

 Exhibits 
  

			
	Exhibit A	  	Form of Loan Note
	Exhibit B	  	Form of Perfection Certificate
	Exhibit C	  	Form of Warrant
	Exhibit D	  	Closing Checklist
	Exhibit E	  	Form of Registration Rights Agreement
	Exhibit F	  	Form of Compliance Certificate

  
 iii 

 FACILITY AGREEMENT 

This FACILITY AGREEMENT (this “Agreement”), dated as of April 3, 2017, by and among Endologix, Inc., a Delaware
corporation (the “Borrower”), the other Loan Parties (as defined below) party hereto from time to time, the lenders set forth on the signature page of this Agreement (together with their successors and permitted assigns, the
“Lenders”), Deerfield Private Design Fund IV, L.P. (“Deerfield Facility Entity”), as agent for itself and the Lenders (in such capacity, together with its successors and assigns in such capacity,
“Agent,” and, together with the Lenders, the Borrower and the other Loan Parties party hereto, the “Parties”). 

W I T N E S S E T H: 

WHEREAS, the Borrower desires that the Lenders extend a term loan to the Borrower to provide funds necessary (i) to refinance certain of
the existing Indebtedness (including a certain amount of the existing 2.25% Convertible Notes), (ii) to provide funds for the Borrower’s working capital and general corporate purposes, and (iii) to pay a portion of the fees, costs and
expenses related to this Agreement; 
 WHEREAS, Borrower desires to secure all of the Obligations (other than those Obligations under the
Warrant, any Stock and the Registration Rights Agreement) by granting to Agent, for the benefit of the Secured Parties, a first priority (subject only to the prior priority of the Permitted Priority Liens) perfected Lien upon substantially all of
its personal and real property including all of the issued and outstanding Stock of its direct Subsidiaries (in each case, other than Excluded Property); and 

WHEREAS, each of the Loan Parties is willing to guaranty all of the Obligations (other than those Obligations under the Warrant, any Stock and
the Registration Rights Agreement), and to grant to Agent, for the benefit of the Secured Parties, a first priority (subject only to the prior priority of the Permitted Priority Liens) perfected Lien upon all of its respective personal and real
property, including all of the issued and outstanding Stock of its direct Subsidiaries (in each case, other than Excluded Property) which are issued to a Loan Party. 

NOW, THEREFORE, in consideration of the mutual agreements set forth herein, the Parties hereby agree as follows: 

ARTICLE 1 
 DEFINITIONS

 Section 1.1 General Definitions. Wherever used in this Agreement, the Exhibits or the Schedules attached hereto,
unless the context otherwise requires, the following terms have the following meanings: 
 “2.25% Convertible Note
Documents” means the 2.25% Convertible Notes, the 2.25% Senior Note Indenture and each other document or agreement from time to time entered into in connection with the foregoing. 

“2.25% Convertible Notes” means those certain 2.25% senior unsecured notes, governed by the terms of a base indenture, as
supplemented by the first supplemental indenture relating to the 2.25% senior notes (together, the “2.25% Senior Notes Indenture”), between the Borrower and Wells Fargo Bank, National Association, as trustee, each of which were
entered into on December 10, 2013. 

 “2.25% Senior Notes Indenture” has the meaning provided therefor in the
definition of “2.25% Convertible Notes.” 
 “3.25% Convertible Notes” means those certain 3.25% senior unsecured
notes, governed by the terms of a base indenture, as supplemented by the second supplemental indenture relating to the 3.25% senior notes (together, the “3.25% Senior Notes Indenture”), between the Borrower and Wells Fargo Bank,
National Association, as trustee, each of which were entered into on November 2, 2015, as the same may be amended, restated, refinanced, supplemented or otherwise modified in connection with a Permitted 3.25% Convertible Note Refinancing. 

“3.25% Convertible Note Documents” means the 3.25% Convertible Notes, the 3.25% Senior Note Indenture and each other document
or agreement from time to entered into in connection with the foregoing, as the same may be amended, restated, refinanced, supplemented or otherwise modified in on with a Permitted 3.25% Convertible Note Refinancing. 

“3.25% Senior Notes Indenture” has the meaning provided therefor in the definition of “3.25% Convertible Notes.”

 “10-K” means an annual report on Form
10-K (or successor form thereto), as required to be filed pursuant to the Exchange Act. 
 “10-Q” means a quarterly report on Form 10-Q (or successor form thereto), as required to be filed pursuant to the Exchange Act. 

“ABL Agent” has the meaning assigned to such term in the definition of “ABL Credit Facility” herein or the agent
for the facility referenced in clause (ii) of the definition of “ABL Credit Facility.” 
 “ABL Credit
Facility” means (i) that certain Credit and Security Agreement, dated as of the Agreement Date, by and among the Borrower, the other Persons party thereto from time to time as “Borrowers” (as defined therein) or guarantors
therein, Deerfield ELGX Revolver, LLC, in its capacity as Agent (as defined therein (including any Third Party Agent (as defined therein)), in such capacity, together with its successors and assigns in such capacity, the “ABL
Agent”) and the financial institutions or other entities from time to time parties thereto, each as a Lender (as defined therein), as amended, restated, supplemented or otherwise modified in accordance and in compliance with the
Intercreditor Agreement and (ii) any credit agreement that replaces or refinances the agreement set forth in clause (i) or in this clause (ii), provided, that any such replacement or refinancing meets the following conditions: (A) has
an aggregate commitment amount not greater than the commitments under the facility referred to in clause (i) unless otherwise agreed in writing by the Agent, (B) is secured on a senior basis to the applicable Obligations hereunder with
respect to either all assets securing the applicable Obligations or with respect to accounts receivable, inventory, equipment, cash and/or related assets, and the agent therefor enters into an intercreditor agreement reflecting the foregoing lien
priority and other provisions that are mutually acceptable to such agent and the Agent in their reasonable good faith discretion (such intercreditor agreement, the “Refinancing ICA”), (C) does not have one or more obligors that
are not obligors under this Agreement, (D) is not secured by assets and property that do not also comprise Collateral, (E) does not prohibit payments, repayments or prepayments under the Loan Documents (provided that, for the avoidance of
doubt, the foregoing shall not preclude the ability of the agent and lenders under such facility to have liens senior to those of the Agent in accordance with clause (B) above), (F) has a final maturity date equal to or later than the final
maturity date of the replaced or refinanced asset based loan facility, and (G) either (x) contains terms that are prevailing market terms at the time of the establishment of such facility for the type of financing and for the quality of
borrower, as mutually determined by Borrower and Agent in their reasonable good faith judgment (provided, that if the parties cannot mutually agree that the terms of 

  
 2 

 
the refinancing facility are then prevailing market terms for the type of financing and for the quality of borrower, then Borrower and Agent shall mutually agree in their reasonable good faith
judgment to select one third-party investment bank or debt advisory firm reasonably acceptable to each of Borrower and Agent to make such determination for both parties based on debt term sheets provided to such entity by unaffiliated potential
lenders (which determination need not be made in writing), the determination of which shall be binding on both parties; provided further, that if Borrower and Agent cannot reasonably agree in good faith upon one third-party investment
bank or debt advisory firm reasonably acceptable to each of them, then the parties shall select a retired judge or justice by mutual written consent of the parties (and if the parties do not agree within five days of a written request to do so by
any party, then upon the request of any party, the referee shall be selected by the presiding judge of the state or federal court in the county or district where venue is otherwise appropriate under applicable law), the determination of which shall
be binding on both parties or (y) contains terms (1) that are substantially identical to the ABL Credit Facility as of the Agreement Date or (2) with respect to pricing, amounts, types and timing of prepayments and payments, and
borrowing base components (including advance rates, eligibility criteria and reserves), in each case, that individually are not less favorable to the Loan Parties and, with respect to all other terms, that are not, when taken as a whole, less
favorable to the Loan Parties in any material respect. 
 “ABL Debt” means “ABL Obligations” as defined in the
Intercreditor Agreement (or similar term in the Refinancing ICA). 
 “ABL Debt Documents” means “ABL Documents”
as defined in the Intercreditor Agreement (or similar term in the Refinancing ICA). 
 “ABL Financial Covenant” has the
meaning set forth in Section 5.4(s). 
 “ABL Lenders” means the lenders under the ABL Debt Documents. 

“Accounts” means, collectively, (a) any right to payment of a monetary obligation, whether or not earned by performance,
(b) without duplication, any “account” (as defined in the UCC), any accounts receivable (whether in the form of payments for services rendered or goods sold, rents, license fees or otherwise), any “health-care-insurance
receivables” (as defined in the UCC), any “payment intangibles” (as defined in the UCC) and all other rights to payment and/or reimbursement of every kind and description, whether or not earned by performance, (c) all accounts,
“general intangibles” (as defined in the UCC), Intellectual Property, rights, remedies, Guarantees, “supporting obligations” (as defined in the UCC),
“letter-of-credit rights” (as defined in the UCC) and security interests in respect of the foregoing, all rights of enforcement and collection, all books and
records evidencing or related to the foregoing, and all rights under the Loan Documents in respect of the foregoing, (d) all information and data compiled or derived by any Loan Party or to which any Loan Party is entitled in respect of or
related to the foregoing, and (e) all proceeds of any of the foregoing. 
 “Acquisition” means any transaction or
series of related transactions for the purpose of or resulting, directly or indirectly, in (a) the acquisition of all or substantially all of the assets of a Person, or of any business or division of a Person, (b) the acquisition of in
excess of fifty percent (50%) of the Stock of any Person or otherwise causing any Person to become a Subsidiary of the Borrower, (c) a merger or consolidation or any other combination with another Person or (d) the acquisition (including
through licensing) of any Product or Intellectual Property of or from another Person if the Acquisition Consideration paid in connection with such acquisition is in excess of $5,000,000 individually or in the aggregate with respect to all such
acquisitions in any twelve (12) month period. 
 “Acquisition Consideration” has the meaning set forth in the
definition of “Permitted Acquisitions.” 

  
 3 

 “Additional Amounts” has the meaning set forth in Section 2.5(a). 

“Affiliate” means, with respect to any Person, (a) any Person that directly or indirectly controls such Person,
(b) any Person which is controlled by or is under common control with such controlling Person, and (c) each of such Person’s (other than, with respect to any Lender, any Lender’s) officers or directors (or Persons functioning in
substantially similar roles) and the spouses, parents, descendants and siblings of such officers, directors or other Persons. As used in this definition, the term “control” of a Person means the possession, directly or indirectly, of the
power to vote five percent (5%) or more of any class of voting securities of such Person or to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 “Agent” has the meaning set forth in the preamble to this Agreement. 

“Agreement” has the meaning set forth in the preamble to this Agreement. 

“Agreement Date” means the date of this Agreement. 

“All-in Yield” means the interest rate (including margins and floors), original issue
discount and fees paid to all lenders (or consenting lenders) of such debt or their Affiliates (based on the remaining life to maturity), but not including any fees not paid to all lenders (such as fees to initial purchasers (i.e., investment banks
in Rule 144A offerings), underwriters or lead agents). 
 “Amortization Payments” means the three principal payments due on
April 2, 2021, April 2, 2022 and on the Maturity Date that are set forth in the table in Section 2.3(a). 

“Announcing Form 8-K” has the meaning set forth in Section 5.1(q). 

“Anti-Corruption Laws” has the meaning set forth in Section 3.1(jj). 

“Anti-Money Laundering Laws” has the meaning set forth in Section 3.1(jj). 

“Applicable Laws” means, with respect to any Person, the common law and any federal, state, local, foreign, multinational or
international laws, statutes, codes, treaties, standards, rules and regulations, guidelines, ordinances, orders, judgments, writs, injunctions, decrees (including administrative or judicial precedents or authorities) and the interpretation or
administration thereof by, and other determinations, directives, requirements or requests of, any Governmental Authority, in each case whether or not having the force of law and that are applicable to or binding upon such Person or any of its
property or to which such Person or any of its property is subject. “Applicable Laws” includes Healthcare Laws and Environmental Laws. 

“Approved Fund” means any (a) investment company, fund, trust, securitization vehicle or conduit that is (or will be)
engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit, or (b) any Person (other than a natural person) which temporarily warehouses loans for any Lender or any entity described in the
preceding clause (a) and that, with respect to each of the preceding clauses (a) and (b), is administered or managed by (i) a Lender, (ii) an Affiliate of a Lender, or (iii) a Person (other than a natural person) or an
Affiliate of a Person (other than a natural person) that administers or manages a Lender. 
 “Authorizations” means, with
respect to any Person, any permits (including Regulatory Required Permits), approvals, authorizations, licenses, registrations, certificates, clearances, concessions, grants, franchises, variances or permissions from, and any other contractual
obligations with, any Governmental Authority, in each case whether or not having the force of law and applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject, and any supplements or
amendments with respect to the foregoing. 

  
 4 

 “Authorized Officer” means the chief executive officer, the president or the
chief financial officer of the Borrower or any other officer having substantially the same authority and responsibility. 
 “Bank of
America Cash Collateral Account” means that certain deposit account #1453234066 of Borrower at Bank of America, N.A. (or such replacement deposit account provided by Bank of America, N.A. or by another commercial bank) established and
maintained for the sole purpose of providing cash collateral in favor of Bank of America, N.A. (or such replacement commercial bank) for obligations of the Borrower in respect of certain commercial credit cards (or with respect to a replacement
commercial bank, similar commercial credit cards to those provided by Bank of America, N.A. as of the Agreement Date) provided to the Borrower by Bank of America, N.A. (or such replacement commercial bank); provided that the aggregate
amount on deposit in such deposit account (or such replacement deposit account) shall not at any time exceed $2,500,000. 

“Bankruptcy Code” means title 11 of the United States Code, as in effect from time to time. 

“Bloomberg” has the meaning set forth in the definition of “Volume Weighted Average Price.” 

“Borrower” has the meaning set forth in the preamble to this Agreement. 

“Business Day” means a day other than Saturday or Sunday on which banks are open for business in New York, New York. 

“Capital Lease” means, with respect to any Person, any lease of or other arrangement conveying the right to use, any property
by such Person as lessee that has been or should be accounted for as a capital lease on a balance sheet of such Person prepared in accordance with GAAP. 

“Capital Lease Obligations” means, at any time, with respect to any Capital Lease, any lease entered into as part of any sale
leaseback transaction of any Person or any synthetic lease, the amount of all obligations of such Person that is (or that would be, if such synthetic lease or other lease were accounted for as a Capital Lease) capitalized on a balance sheet of such
Person prepared in accordance with GAAP. 
 “Capped Call” means the capped call transactions referenced in Schedule 5.2(iv)
in respect of the 2.25% Convertible Notes and any like transactions that are economically similar to such transactions entered into in connection with any Indebtedness contemplated under clause (k) of the definition of Permitted Indebtedness.

 “Cash Equivalents” means (a) any readily-marketable securities (i) issued by, or directly, unconditionally and
fully guaranteed or insured by the United States federal government or (ii) issued by any agency of the United States federal government the obligations of which are fully backed by the full faith and credit of the United States federal
government, (b) any readily-marketable direct obligations issued by any other agency of the United States federal government, any state of the United States or any political subdivision of any such state or any public instrumentality thereof,
in each case having a rating of at least “A-1” from S&P or at least “P-1” from Moody’s, (c) any commercial paper rated at least “A-1” by S&P or “P-1” by Moody’s and issued by any Person organized under the laws of any state of the United States, (d) any United States
dollar-denominated time deposit, insured certificate of deposit, overnight bank deposit or bankers’ acceptance issued or accepted by any commercial bank that is (A) organized under the laws of the United States, any state thereof or the
District of Columbia, (B) “adequately capitalized” (as 

  
 5 

 
defined in the regulations of its primary federal banking regulators) and (C) has Tier 1 capital (as defined in such regulations) in excess of $250,000,000, (e) shares of any United States
money market fund that (i) has substantially all of its assets invested continuously in the types of investments referred to in clause (a), (b), (c) or (d) above with maturities as set forth in the proviso below, (ii) has net assets
in excess of $500,000,000 and (iii) has obtained from either S&P or Moody’s the highest rating obtainable for money market funds in the United States; provided, however, that the maturities of all obligations specified in
any of clauses (a), (b), (c) or (d) above shall not exceed one year and (f) investments made in accordance with the Borrower’s investment policy in effect as of the Agreement Date that was provided to the Agent’s counsel on
March 14, 2017 at 12:15 p.m. New York time, and any amendments thereto that do not, when taken as a whole, materially increase the risk of the investments made by the Borrower from time to time from such Borrower’s investment policy in
effect as of the Agreement Date. 
 “Change in Control” means any of the following events: (a) any Person or two or
more Persons acting in concert shall have acquired beneficial ownership, directly or indirectly, of, or shall have acquired by contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation, will result in its or
their acquisition of or control over, voting Stock of the Borrower (or other securities convertible into such voting Stock) representing more than 50% of the combined voting power of all voting Stock of the Borrower; (b) the Borrower shall have
ceased to own, directly or indirectly, 100% of the Stock of any of its Subsidiaries (with the exception of any Subsidiaries permitted to be dissolved or merged to the extent otherwise permitted by this Agreement and other than, solely with respect
to Foreign Subsidiaries, directors qualifying shares as necessary to comply with foreign law); (c) the occurrence of a “Change of Control”, “Change in Control”, “Fundamental Change” or terms of similar import under the
2.25% Convertible Note Documents, the 3.25% Convertible Note Documents or the ABL Debt Documents; or (d) the occurrence of any “Major Transaction” (as defined in any Warrant). As used herein, “beneficial ownership” shall
have the meaning provided in Rule 13d-3 of the SEC under the Exchange Act. 
 “CMS”
means the federal Centers for Medicare and Medicaid Services (formerly the federal Health Care Financing Administration), and any successor Governmental Authority. 

“CoC Fee” means: 

(a) if both (1) principal on the Loans are (or are obligated or required to be) prepaid, repaid, redeemed or paid (in each case, for the
avoidance of doubt, other than any Amortization Payments) in full (or in part) prior to the Maturity Date and (2) a Change in Control is consummated (or a first public announcement of a potential Change in Control is made) prior to the Maturity
Date (and, for the avoidance of doubt, with respect to any such public announcement, where a Change in Control is ultimately consummated (whether before, on the date of or after the Maturity Date)), $4,200,000 (or, if such amount is prepaid, repaid,
redeemed or paid in connection with a partial (as opposed to full) prepayment, repayment, redemption or payment of the Loans (in each case, for the avoidance of doubt, other than any Amortization Payments), then such ratable portion of such amount
based on the principal amount of such Loans prepaid, repaid, redeemed or repaid (in each case, for the avoidance of doubt, other than any Amortization Payments)); 

(b) if both (1) principal on the Loans are (or are obligated or required to be) prepaid, repaid, redeemed or paid (in each case, for the
avoidance of doubt, other than any Amortization Payments) in full (or in part) prior to the Maturity Date and (2) a potential Change in Control is first publicly announced (or a Change in Control is consummated) both (A) on or after the
Maturity Date and (B) within 150 days after such prepayment, repayment, redemption or payment in full (or in part) of principal on the Loans (in each case, for the avoidance of doubt, other than any Amortization Payments) prior to the Maturity
Date, an amount in cash equal to all interest payments that would have been required on the prepaid, repaid, redeemed or paid Loans (or the Loans obligated or required to be prepaid, repaid, redeemed

  
 6 

 
or paid) from the date of such prepayment, repayment, redemption or payment (or the date such prepayment, repayment, redemption or payment was obligated or required to be made) through and
including the Maturity Date (in each case, for the avoidance of doubt, other than any Amortization Payments); or 
 (c) if both
(1) principal on the Loans are (or are obligated or required to be) prepaid, repaid, redeemed or paid (in each case, for the avoidance of doubt, other than any Amortization Payments) in full prior to the Maturity Date and (2) a potential
Change in Control is first publicly announced (or a Change in Control is consummated) both (A) on or after the Maturity Date and (B) more than 150 days after such prepayment, repayment, redemption or payment (in each case, for the
avoidance of doubt, other than any Amortization Payments) in full of the Loans prior to the Maturity Date, $0. 
 “Code”
means the Internal Revenue Code of 1986, as amended, and any Treasury Regulations promulgated thereunder. 
 “Collateral”
has the meaning given to it in the Security Agreement. 
 “Common Stock” means the “Common Stock” of the
Borrower, with a $0.001 par value per share. 
 “Compliance Certificate” means a certificate, duly executed by an
Authorized Officer of the Borrower, appropriately completed and substantially in the form of Exhibit F hereto. 
 “Contingent
Obligation” means, with respect to any Person, any direct or indirect liability of such Person: (a) with respect to any Indebtedness of another Person (a “Third Party Obligation”) if the purpose or intent of such
Person incurring such liability, or the effect thereof, is to provide assurance to the obligee of such Third Party Obligation that such Third Party Obligation will be paid or discharged, or that any agreement relating thereto will be complied with,
or that any holder of such Third Party Obligation will be protected, in whole or in part, against loss with respect thereto; (b) with respect to any undrawn portion of any letter of credit issued for the account of such Person or as to which
such Person is otherwise liable for the reimbursement of any drawing; (c) under any Swap Contract, to the extent not yet due and payable; (d) to make
take-or-pay or similar payments if required regardless of nonperformance by any other party or parties to an agreement; or (e) for any obligations of another Person
pursuant to any Guarantee or pursuant to any agreement to purchase, repurchase or otherwise acquire any obligation or any property constituting security therefor, to provide funds for the payment or discharge of such obligation or to preserve the
solvency, financial condition or level of income of another Person. The amount of any Contingent Obligation shall be equal to the amount of the obligation so Guaranteed or otherwise supported or, if not a fixed and determinable amount, the maximum
amount so Guaranteed or otherwise supported. 
 “Control Agreement” means, with respect to any deposit account, securities
account, commodity account, securities entitlement or commodity contract, an agreement, in form and substance reasonably satisfactory to Agent, among Agent, the financial institution or other Person at which such account is maintained or with which
such entitlement or contract is carried and the Loan Party maintaining such account or owning such entitlement or contract, effective to grant “control” (within the meaning of Articles 8 and 9 under the applicable UCC) over such account to
Agent. 
 “Convertible Note Documents” means, collectively, the 2.25% Convertible Note Documents and the 3.25% Convertible
Note Documents (which, for the avoidance of doubt, shall include the indenture and each other document or agreement from time to time entered into in connection with any Permitted 3.25% Convertible Note Refinancing, in each case, to the extent such
indenture, documents or agreements are permitted pursuant to the terms of the definition of “Permitted 3.25% Convertible Note Refinancing). 

  
 7 

 “Convertible Securities” means any Stock or securities (other than Options)
directly or indirectly convertible into or exchangeable or exercisable for shares of Common Stock. 
 “Correction” means
repair, modification, adjustment, relabeling, destruction or inspection (including patient monitoring) of a product without its physical removal to some other location. 

“Current Balance Sheet” has the meaning set forth in the definition of “Enterprise Value.” 

“DEA” means the Drug Enforcement Administration of the United States of America, any comparable state or local Governmental
Authority, any comparable Governmental Authority in any non-United States jurisdiction, and any successor agency of any of the foregoing. 

“Deerfield Facility Entity” has the meaning set forth in the preamble to this Agreement. 

“Default” means any event which, with the giving of notice, lapse of time or fulfillment of any other applicable condition
(or any combination of the foregoing), would constitute an Event of Default. 
 “Disbursement” has the meaning set forth in
Section 2.2(a). 
 “Dispose” and “Disposition” mean (a) the sale, lease, license, transfer,
assignment, conveyance or other disposition of any assets or property and (b) the sale or transfer by the Borrower or any Subsidiary of the Borrower of any Stock issued by any Subsidiary of the Borrower. 

“Disqualified Stock” means any Stock which, by its terms (or by the terms of any security or other Stock into which it is
convertible or for which it is exchangeable), or upon the happening of any event or condition, (a) matures or is mandatorily redeemable (other than solely for Stock that does not constitute Disqualified Stock) , pursuant to a sinking fund
obligation or otherwise, or is redeemable (in each case, other than solely for Stock that does not constitute Disqualified Stock) at the option of the holder thereof, in whole or in part, on or prior to the date that is ninety-one (91) days following the Maturity Date (excluding any provisions requiring redemption upon a “change in control” or similar event, provided that such “change in control” or similar
event results in the occurrence of the payment in full of the Obligations (other than unasserted contingent indemnification obligations and other than Obligations under the Warrant and the Registration Rights Agreement)), (b) is convertible into or
exchangeable for (i) debt securities or (ii) any Stock referred to in (a) above, in each case, at any time on or prior to the date that is ninety-one (91) days following the Maturity
Date at the time such Stock was issued, or (c) is entitled to receive scheduled dividends or distributions in cash prior to the date that is ninety-one (91) days following the Maturity Date.

 “Dollars” and the “$” sign mean the lawful currency of the United States of America. 

“Domestic Subsidiary” means any Subsidiary incorporated, organized or otherwise formed under the laws of the United
States, any state thereof or the District of Columbia. 
 “Drug Application” means a new drug application, an abbreviated
drug application, or a product license application for any Product, as appropriate, as those terms are defined in the FDCA. 

“DTC” has the meaning set forth in Section 3.1(qq). 

“EBITDA” means, at any date of determination, an amount equal to (a) Net Income of the Successor Entity for the most
recently completed trailing four quarter measurement period, plus (b) in each case, to the extent deducted in determining Net Income (whether in cash, paid in-kind or otherwise) for such period,
without duplication, (i) Interest Expense of the Successor Entity for such trailing four quarter 

  
 8 

 
period, (ii) income taxes of the Successor Entity for such trailing four quarter period, (iii) depreciation and amortization of the Successor Entity for such trailing four quarter
period; provided that, with respect of all components of the foregoing clause (a) and clause (b) of this definition, such amounts shall be limited to those of Successor Entity only (and not any of its Subsidiaries) unless such
Subsidiaries (other than any Excluded Subsidiaries) become Guarantors under the Loan Documents and provide a Lien on all of their assets and property that would constitute Collateral under the Loan Documents and take such other actions that would be
required by Section 5.1(l) (such actions of such Subsidiaries in such instance, the “Successor Entity Subsidiary Joinder Actions”). 

“Eligible Assignee” means (a) a Lender, (b) an Affiliate of a Lender, (c) an Approved Fund, and (d) any
other Person (other than a natural person) approved by Agent; provided, however, that with respect to clause (d) above, no such Person shall include (i) Borrower or any of Borrower’s Affiliates or (ii) unless an Event of
Default has occurred and is continuing, (A) any direct competitor of Loan Parties, in each case, as determined by Agent in its reasonable discretion, (B) any investor or fund that has publicly announced in writing its intention to obtain
control of the Borrower publicly or otherwise to the knowledge of the assigning Lender, or (D) any Person listed in the email delivered by counsel to the Borrower to counsel to the Agent on March 16, 2017 at 5:00 p.m. (Pacific time) and any
Affiliates or Approved Funds of any such Person actually known to the assigning Lender and to the Agent to be Affiliates or Approved Funds of any such Person. 

“Employee” means any employee of any Loan Party or any Subsidiary of any Loan Party. 

“Employee Benefit Plan” means any “employee benefit plan” within the meaning of Section 3(3) of ERISA, under
which (A) any current or former employee, director or independent contractor of the Borrower or any of its Subsidiaries has any present or future right to benefits or compensation and which is contributed to, sponsored by or maintained by the
Borrower or any of its Subsidiaries or (B) the Borrower or any of its Subsidiaries has had or has or could reasonably be expected to have any present or future obligation or liability. 

“Enterprise Value” means (a) the Market Cap, minus (b) the amount of the Indebtedness of the Successor
Entity and its Subsidiaries as shown on a consolidated basis on the latest balance sheet publicly filed under the Exchange Act prior to the announcement date of the Successor Entity Transaction (the “Current Balance Sheet”),
plus (c) the amount of cash and Cash Equivalents (without giving effect to clause (f) of the definition of “Cash Equivalents) of the Successor Entity and its Subsidiaries as shown on a consolidated basis on the Current Balance
Sheet. 
 “Environmental Laws” means all Applicable Laws, Authorizations and permits imposing liability or standards of
conduct for or relating to the regulation and protection of human health, safety, the workplace, the environment and natural resources, and including public notification requirements and environmental transfer of ownership, notification or approval
statutes. 
 “Environmental Liabilities” means all Liabilities (including costs of removal and remedial actions, natural
resource damages and costs and expenses of investigation and feasibility studies, including the cost of environmental consultants and attorneys’ costs) that may be imposed on, incurred by or asserted against any Loan Party or any Subsidiary of
any Loan Party as a result of, or related to, any claim, suit, action, investigation, proceeding or demand by any Person, whether based in contract, tort, implied or express warranty, strict liability, criminal or civil statute or common law or
otherwise, arising under any Environmental Law resulting from the ownership, lease, sublease or other operation or occupation of property by any Loan Party or any Subsidiary of any Loan Party, whether on, prior or after the date hereof. 

  
 9 

 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended
and applicable published guidance thereunder. 
 “ERISA Affiliate” means collectively the Borrower, any Subsidiary of
Borrower and any Person under common control or treated as a single employer with, Borrower or any Subsidiary of Borrower within the meaning of Code Section 414 (b), (c), (m) or (o) or under ERISA. 

“ERISA Event” means any of the following: (a) a reportable event described in Section 4043(b) or (c) of ERISA
(other than an event for which the 30-day notice period is waived) with respect to a Title IV Plan; (b) the withdrawal of any ERISA Affiliate from a Title IV Plan subject to Section 4063 of ERISA
during a plan year in which it was a substantial employer, as defined in Section 4001(a)(2) of ERISA; (c) the complete or partial withdrawal of any ERISA Affiliate from any Multiemployer Plan; (d) with respect to any Multiemployer Plan,
the filing of a notice of insolvency or termination, or treatment of a plan amendment as termination, under Section 4041A of ERISA; (e) the filing of a notice of intent to terminate a Title IV Plan, or treatment of a plan amendment as
termination, under Section 4041 of ERISA; (f) the institution of proceedings to terminate a Title IV Plan or Multiemployer Plan by the PBGC; (g) the failure to make any required contribution to any Title IV Plan or Multiemployer Plan
when due; (h) the imposition of a Lien under Section 412 or 430(k) of the Code or Section 303 or 4068 of ERISA on any property (or rights to property, whether real or personal) of any ERISA Affiliate; (i) the failure of an
Employee Benefit Plan or any trust thereunder intended to qualify for tax exempt status under Section 401 or 501 of the Code or other Applicable Law to qualify thereunder; (j) a Title IV plan is in “at risk” status within the
meaning of Code Section 430(i); (k) a Multiemployer Plan is in “endangered status” or “critical status” within the meaning of Section 432(b) of the Code; and (l) any other event or condition that constitutes grounds under
Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Title IV Plan or Multiemployer Plan or for the imposition of any Liability upon any ERISA Affiliate under Title IV of ERISA other than for
contributions to Title IV Plans and Multiemployer Plans in the ordinary course and PBGC premiums due but not delinquent. 

“Exercise Price” has the meaning provided therefor in the Warrants. 

“Event of Default” has the meaning set forth in Section 5.4. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated
thereunder. 
 “Excluded Accounts” has the meaning set forth in Section 5.1(k). 

“Excluded Domestic Holdco” means a wholly-owned Domestic Subsidiary of the Borrower substantially all of the assets of
which consist of Stock of Excluded Foreign Subsidiaries held directly or indirectly by such Subsidiary and which does not engage in any business, operations or activity other than that of a holding company, excluding for purposes of such
determination, Indebtedness of such Excluded Foreign Subsidiaries. 
 “Excluded Foreign Subsidiary” means any Foreign
Subsidiary which is a controlled foreign corporation (as defined in the Code) that has not guaranteed or pledged any of its assets to secure, or with respect to which there shall not have been pledged
two-thirds or more of the voting Stock to secure, any Indebtedness (other than the Obligations) of a Loan Party. 

“Excluded Property” means, collectively: 

  
 10 

 (a) voting shares of any (A) Excluded Foreign Subsidiary of Borrower or (B) Excluded
Domestic Holdco, in each case, in excess of 65% of all of the issued and outstanding voting shares of capital stock of such subsidiary; 

(b) any lease, license, contract, property right or agreement as to which, if and to the extent that, and only for so long as, the grant of a
security interest therein shall (1) constitute or result in a breach, termination or default under any such lease, license, contract, property right or agreement or render it unenforceable, (2) be prohibited by any applicable law or
(3) require the consent of any third party (in each case of clauses (1), (2) and (3), other than to the extent that any such breach, termination, default, prohibition or requirement for consent would be rendered ineffective pursuant to Sections
9-406, 9-407, 9-408 or 9-409 of the UCC of any relevant jurisdiction or any other
applicable Law), provided that such security interest shall attach immediately to each portion of such lease, license, contract, property rights or agreement that does not result in any of the consequences specified above; 

(c) any “intent to use” trademark applications for which a statement of use has not been filed (but only until such statement is
filed); 
 (d) motor vehicles and other assets, in each instance, in which perfection of a security requires notation on certificates of
title with a value, individually, of less than $250,000; 
 (e) without in any way limiting clause (a) above, equity interests in any
Person (other than wholly owned Subsidiaries) to the extent not permitted by the terms of such Person’s organizational or joint venture documents (so long as such joint venture was not entered into (or such Subsidiary was not formed) in
contravention of the terms of the Loan Documents and such prohibition did not arise in anticipation of the restrictions under the Loan Documents); 

(f) any assets financed by purchase money Indebtedness or Capital Leases, to the extent such purchase money Indebtedness or Capital Lease is
permitted hereunder, if the documentation governing such purchase money Indebtedness or Capital Leases securing such purchase money Indebtedness or Capital Leases prohibits the creation of a security interest or lien thereon or requires the consent
of any Person as a condition to the creation of any other security interest or lien on such property or if such contract or other agreement would be breached or give any party the right to terminate it as a result of creation of such security
interest or lien; 
 (g) those assets as to which Agent determines (in its sole discretion) that the cost of obtaining such a security
interest or perfection thereof are excessive in relation to the benefit to Agent and the Lenders of the security to be afforded thereby; and 

(h) the Bank of America Cash Collateral Account; 

provided, however, notwithstanding anything to the contrary herein or under the other Loan Documents, “Excluded
Property” shall not include (a) any proceeds, products, substitutions, receivables or replacements of Excluded Property (unless such proceeds, products, substitutions, receivables or replacements would otherwise constitute Excluded
Property) or (b) any assets or property provided as security or collateral for the ABL Debt or for which a Lien has been granted in favor of ABL Agent, any ABL Lender or any other Person party to the ABL Debt Documents. 

“Excluded Subsidiary” means (a) any Excluded Domestic Holdco and (b) any Excluded Foreign Subsidiary. 

  
 11 

 “Excluded Taxes” means with respect to any Lender, (a) Taxes imposed on (or
measured by) such Lender’s net income, franchise Taxes and branch profits Taxes, or Taxes measured by capital or net worth, in each case (i) imposed as a result of such Lender being organized under the laws of, or having its principal
office, or applicable lending office located in the jurisdiction imposing such Tax (or any political subdivision thereof), or (ii) that are Other Connection Taxes, (b) any United States federal withholding Tax imposed on amounts payable to
such Lender under the laws in effect at the time such Lender becomes a party to this Agreement or such Lender changes its lending office, except to the extent such Lender acquired its interest in the Loan from a transferor that was entitled,
immediately before such transfer, to receive Additional Amounts with respect to such withholding Tax pursuant to Section 2.5(a) or was itself so entitled immediately before changing its lending office, (c) any Tax imposed on amounts payable to
such Lender directly as a result of such Lender’s failure to comply with Section 2.5(d) other than as a result of a change in Applicable Law occurring subsequent to the date such Lender became a party to this Agreement, or (d) any United
States federal withholding Tax imposed on amounts payable to such Lender under FATCA. 
 “Existing ABL Agent” has the
meaning assigned to such term in the definition of “Existing ABL Credit Facility” herein. 
 “Existing ABL Credit
Facility” means that certain Credit and Security Agreement, dated as of July 29, 2016, by and among the Borrower, the other Persons party thereto from time to time as “Borrowers” (as defined therein), Midcap Financial Trust,
a Delaware statutory trust, as Agent (as defined therein, in such capacity, the “Existing ABL Agent”) and the financial institutions or other entities from time to time parties thereto, each as a Lender (as defined therein) (in such
capacity, the “Existing ABL Lenders”), as amended, restated, supplemented or otherwise modified prior to the Agreement Date. 

“Existing ABL Debt Documents” shall have the meaning of “Financing Documents” (as defined in the Existing ABL
Credit Facility). 
 “Existing ABL Lenders” has the meaning assigned to such term in the definition of “Existing ABL
Credit Facility” herein. 
 “FATCA” means Sections 1471 through 1474 of the Code as of the date of this Agreement (or
any amended or successor version that is substantively comparable and not materially more onerous to comply with), any regulations or official interpretations thereof and any agreements entered into pursuant to Section 1471(b)(1) of the Code and any
applicable intergovernmental agreements entered into with respect to the foregoing. 
 “FCPA” has the meaning set forth in
Section 3.1(jj). 
 “FDA” means the Food and Drug Administration of the United States of America, any comparable state or
local Governmental Authority, any comparable Governmental Authority in any non- United States jurisdiction, and any successor agency of any of the foregoing. 

“FDCA” means the Federal Food, Drug and Cosmetic Act, as amended, 21 U.S.C. Section 301 et seq., and all regulations
promulgated thereunder. 
 “Federal Reserve Board” means the Board of Governors of the Federal Reserve System or any entity
succeeding to any of its principal functions. 

  
 12 

 “Final Payment” means such cash amount as may be necessary to repay the
outstanding principal amount of the Loans and any other Obligations (including, for the avoidance of doubt, for any applicable Non-Callable Make Whole Amount payable hereunder and the CoC Fee payable
hereunder, but excluding (A) unasserted contingent indemnification obligations and (B) those Obligations under the Warrant, any Stock and the Registration Rights Agreement), owing by the Borrower and the other Loan Parties to the Secured
Parties pursuant to the Loan Documents. 
 “First Amortization Date” has the meaning set forth in Section 2.3(a). 

“Foreign Benefit Plan” means any employee benefit plan that is subject to the laws of a jurisdiction outside the United
States, including those mandated by a government other than that of the United States of America. 
 “Foreign Lender” has
the meaning set forth in Section 2.5(d). 
 “Foreign Subsidiary” means, with respect to any Person, a Subsidiary of such
Person, which Subsidiary is not a Domestic Subsidiary. 
 “GAAP” means generally accepted accounting principles in the
United States applied on a consistent basis, subject to the provisions of Section 1.5. 
 “General Intangible” means
any “general intangible” as defined in Article 9 of the UCC, and any personal property, including things in action, other than accounts, chattel paper, commercial tort claims, deposit accounts, documents, goods, instruments, investment
property, letter-of-credit rights, letters of credit, money, and oil, gas or other minerals before extraction, but including payment intangibles and software. 

“Good Manufacturing Practices” means current good manufacturing practices, as set forth in 21 C.F.R. Parts 210 and 211. 

“Governmental Authority” means any nation, sovereign, government, quasi-governmental agency, governmental department,
ministry, cabinet, commission, board, bureau, agency, court, tribunal, regulatory authority, instrumentality, judicial, legislative, fiscal or administrative or public body or entity, whether domestic or foreign, federal, state, local or other
political subdivision thereof, having jurisdiction over the matter or matters and Person or Persons in question or having the authority to exercise executive, legislative, taxing, judicial, regulatory or administrative functions of or pertaining to
government, including any central bank, securities exchange, regulatory body, arbitrator, public sector entity, supra-national entity and any self-regulatory organization. 

“Guarantee” by any Person means any obligation, contingent or otherwise, of such Person directly or indirectly guaranteeing
any Indebtedness or other obligation of any other Person and, without limiting the generality of the foregoing, any obligation, direct or indirect, contingent or otherwise, of such Person (a) to purchase or pay (or advance or supply funds for
the purchase or payment of) such Indebtedness or other obligation (whether arising by virtue of partnership arrangements, by agreement to keep-well, to purchase assets, goods, securities or services, to take-or-pay, or to maintain financial statement conditions or otherwise), or (b) entered into for the purpose of assuring in any other manner the obligee of such Indebtedness or other obligation of the
payment thereof or to protect such obligee against loss in respect thereof (in whole or in part), provided, however, that the term Guarantee shall not include endorsements for collection or deposit in the Ordinary Course of Business.
The term “Guarantee” used as a verb has a corresponding meaning. 
 “Guarantor” means each Subsidiary of
the Borrower (other than any Excluded Subsidiary) or other Person who provides a guaranty of the Obligations (other than unasserted contingent indemnification obligations and other than those Obligations under the Warrant, any Stock and the
Registration Rights Agreement) under the Security Agreement or other Loan Document. 

  
 13 

 “Hazardous Material” means any substance, material or waste that is classified,
regulated or otherwise characterized under any Environmental Law as hazardous, toxic, a contaminant or a pollutant or by other words of similar meaning or regulatory effect, including petroleum or any fraction thereof, asbestos, polychlorinated
biphenyls and radioactive substances. 
 “Healthcare Laws” means all applicable Laws relating to the procurement,
development, provision, clinical and non-clinical evaluation or investigation, product approval or clearance, manufacture, production, analysis, distribution, dispensing, importation, exportation, use,
handling, quality, reimbursement, sale, labeling, advertising, promotion, or post-market requirements of any drug, medical device, clinical laboratory service, food, dietary supplement or other product (including, without limitation, any ingredient
or component of, or accessory to, the foregoing products) subject to regulation under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. et seq.), Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. §263a et seq) and its implementing
regulations (42 C.F.R. Part 493) and similar state or foreign laws, controlled substances laws, pharmacy laws, consumer product safety laws, Medicare, Medicaid, and all laws, policies, procedures, requirements and regulations pursuant to which
Regulatory Required Permits are issued, in each case, as the same may be amended from time to time. 
 “Immaterial
Subsidiaries” shall mean, as of any date of determination, any Subsidiary of the Borrower that is not a Loan Party that, when measured as of the most recent fiscal quarter end or fiscal year end for which the Borrower has filed its 10-K or 10-Q, when taken together with all other Immaterial Subsidiaries as of such date, (i) did not have assets with a value in excess of 5.0% of the total property and
assets of the Loan Parties and their Subsidiaries on a consolidated basis set forth in the balance sheet included in such 10-K or 10-Q in accordance with GAAP and on a
pro forma basis and (ii) did not have revenues representing in excess of 5.0% of total revenues of the Loan Parties and their Subsidiaries on a consolidated basis. 

“In Connection with a Change in Control” means any prepayment, repayment, redemption or other payment (in each case, whether
in full or in part) of the Obligations (other than unasserted contingent indemnification obligations and any Obligations under the Warrants, the Registration Rights Agreement or Stock) that is both (1) made, or that is obligated or required to
be made (including as a result of the Lenders’ exercise of the Put Right), hereunder prior to (but not including) the Maturity Date and (2) either: (a) such prepayment, repayment, redemption or other payment is made (or is obligated or
required to be made) at any time during the period that commences 150 days prior to the earlier to occur of (i) the first public announcement of a potential Change in Control (and, for the avoidance of doubt, where a Change in Control is
ultimately consummated before, on the date of or after the Maturity Date) or (ii) the consummation of a Change in Control, and ends on the consummation of a Change in Control, (b) such prepayment, repayment, redemption or other payment is
otherwise made (or is obligated or required to be made) as a result of a Change in Control, or (c) such prepayment, repayment, redemption or other payment is made (or is obligated or required to be made, whether through acceleration or
otherwise) at any time on or after a Successor Entity Transaction. 
 “Indebtedness” means the following with respect to
any Person: 
 (i) all indebtedness for borrowed money of such Person; 

(ii) the deferred purchase price of assets or services (other than trade payables entered into in the Ordinary Course of
Business and which are not more than 120 days past due and other than items covered by clause (xiv) of this definition) of such Person, which in accordance with GAAP should be shown to be a liability on the balance sheet; 

  
 14 

 (iii) all guarantees of Indebtedness by such Person; 

(iv) the face amount of all letters of credit issued or acceptance facilities established for the account of such Person (or
for which such Person is liable), including without duplication, all drafts drawn thereunder; 
 (v) all Capital Lease
Obligations of such Person; 
 (vi) all indebtedness (including indebtedness of other types covered by the other clauses of
this definition) of such Person or another Person secured by any Lien on any assets or property of such Person, whether or not such indebtedness has been assumed or is recourse (with the amount thereof, in the case of any such indebtedness that has
not been assumed by such Person, being measured as the lower of (y) fair market value of such property and (z) the amount of the indebtedness secured); 

(vii) all indebtedness created or arising under any conditional sale or title retention agreement, or incurred as financing, in
either case with respect to assets or property acquired by such Person (even if the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such assets or property); 

(viii) all obligations of such Persons evidenced by notes, bonds, debentures or similar instruments, including obligations so
evidenced incurred in connection with the acquisition of property, assets or businesses; 
 (ix) all obligations of such
Person, whether or not contingent, in respect of Disqualified Stock, valued at, in the case of redeemable preferred Stock, the greater of the voluntary liquidation preference and the involuntary liquidation preference of such Stock plus accrued and
unpaid dividends; 
 (x) all direct or indirect liability, contingent or otherwise, of such Person with respect to any other
Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability
will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto; 

(xi) all direct or indirect liability, contingent or otherwise, of such Person under Swap Contracts; 

(xii) all direct or indirect liability, contingent or otherwise, of such Person to make take-or-pay or similar payments if required regardless of nonperformance by any other party or parties to an agreement; 

(xiii) all direct or indirect liability, contingent or otherwise, of such Person for the obligations of another Person through
any agreement to purchase, repurchase or otherwise acquire such obligation or any assets or property constituting security therefor, to provide funds for the payment or discharge of such obligation or to maintain the solvency, financial condition or
any balance sheet item or level of income of another Person; 

  
 15 

 (xiv) earn-outs, all purchase price adjustments, profit sharing arrangements,
deferred purchase money amounts and similar payment obligations (or continuing obligations of any nature of such Person arising out of purchase and sale contracts) (including in connection with Permitted Acquisitions), but only to the extent the
same (x) have become due and payable and are recorded as a liability on the balance sheet of such Person and (y) are payable in cash; 

(xv) all off-balance sheet liabilities of such Person; or 

(xvi) all obligations arising under non-compete agreements, bonus, deferred
compensation, incentive compensation or similar arrangements, other than those arising in the Ordinary Course of Business. 

“Indemnified Person” has the meaning set forth in Section 6.11(a). 

“Indemnified Taxes” means (a) any Tax imposed on or with respect to any payments made by or on account of any Obligation
of any Loan Party under any Loan Document, other than an Excluded Tax, and (b) to the extent not otherwise described in clause (a) above in this definition, Other Taxes. 

“Indemnity” has the meaning set forth in Section 6.11(a). 

“Intellectual Property” means all copyright rights, copyright applications, copyright registrations and like protections in
each work of authorship and derivative work, whether published or unpublished, any patents, patent applications and like protections, including improvements, divisions, continuations, renewals, reissues, extensions, and continuations-in-part of the same, trademarks, trade names, service marks, mask works, rights of use of any name, domain names, or any other similar rights, any applications
therefor, whether registered or not, know-how, operating manuals, trade secret rights, clinical and non-clinical data, rights to unpatented inventions, and any claims
for damage by way of any past, present, or future infringement of any of the foregoing. 
 “Intercreditor Agreement” means
(a) the Intercreditor Agreement dated as of the Agreement Date by and among Agent and ABL Agent and acknowledged and agreed by the Loan Parties, as amended, restated, supplemented or otherwise modified from time to time in accordance with the
terms thereof and (b) the Refinancing ICA, as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof. 

“Interest Expense” means, for any period, interest expense for the Successor Entity set forth in the Successor Entity’s
most recent publicly reported income statement; provided that such amounts shall be limited to those incurred by the Successor Entity only (and not any of its Subsidiaries) unless such Subsidiaries (other than any Excluded Subsidiaries) have
completed and consummated the Successor Entity Subsidiary Joinder Actions. 
 “Interest Payment Date” has the meaning set
forth in Section 2.6(a). 
 “Interest Rate” means 6.87% per annum for the principal amount of the Loans and any overdue
interest thereon, plus any additional amounts set forth in Section 2.7(b). 

  
 16 

 “Internal Controls” has the meaning set forth in Section 3.1(u). 

“Investment” has the meaning set forth in Section 5.2(v). 

“Investment Company Act” means the Investment Company Act of 1940, as amended, including the rules and regulations
promulgated thereunder. 
 “IP” has the meaning set forth in Section 3.1(n). 

“IRS” means the United States Internal Revenue Service. 

“L/C Cash Collateral Accounts” means, collectively, each segregated deposit account of Borrower from time to time established
and maintained with the issuers of letters of credit for the sole purpose of securing Borrower’s obligations under such letters of credit to the extent such obligations constitute “Permitted Contingent Obligations” for purposes of
clause (i) of the definition of thereof; provided, that (a) no such deposit account shall hold an aggregate of cash and Cash Equivalents in excess of 110% of the aggregate value of the letters of credit it is securing and (b) with
respect to all such deposit accounts, the aggregate amount deposited there in at any time does not exceed $10,000,000. 
 “Latest
Balance Sheet” has the meaning set forth in Section 3.1(t). 
 “Lenders” has the meaning set forth in the preamble
to this Agreement. 
 “Liabilities” means all claims, actions, suits, judgments, damages, losses, liabilities, obligations,
responsibilities, fines, penalties, sanctions, costs, fees, Taxes, commissions, charges, disbursements and expenses (including those incurred upon any appeal or in connection with the preparation for and/or response to any subpoena or request for
document production relating thereto), in each case of any kind or nature (including interest accrued thereon or as a result thereto and fees, charges and disbursements of financial, legal and other advisors and consultants), whether joint or
several, and whether or not indirect, contingent, consequential, actual, punitive, treble or otherwise. 
 “Lien” means any
lien, pledge, preferential arrangement, mortgage, security interest, deed of trust, charge, assignment, hypothecation, title retention or other encumbrance on or with respect to property or interest in property having the practical effect of
constituting a security interest, in each case with respect to the payment of any obligation with, or from the proceeds of, any asset or revenue of any kind. For purposes of this Agreement and the other Loan Documents, any Loan Party or any
Subsidiary shall be deemed to own subject to a Lien any asset which it has acquired or holds subject to the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement relating to such asset.

 “Loan” means any loan made available from time to time by the Lenders to the Borrower pursuant to this Agreement or, as
the context may require, the principal amount thereof from time to time outstanding. “Loan” shall include any funded Disbursement. 

“Loan Disbursement Request” means that certain Loan Disbursement Request, dated as of the Agreement Date, executed and
delivered by the Borrower in favor of the Secured Parties. 
 “Loan Documents” means this Agreement, the Notes, the
Security Agreement, the Intercreditor Agreement, the Warrants, the Registration Rights Agreement, the Perfection Certificate, the Loan Disbursement Request, any patent security agreement, any trademark security agreement, any copyright security
agreement and other documents, agreements and instruments delivered in connection with any of the foregoing and dated the Agreement Date or subsequent thereto, whether or not specifically mentioned herein or therein, in each case, as amended,
restated, supplemented or otherwise modified from time to time. 

  
 17 

 “Loan Notes” means any Loan Note issued to any of the Lenders evidencing any
Loan or Disbursement funded by such Lenders in the form attached hereto as Exhibit A, in each case, as amended, restated, supplemented or otherwise modified from time to time. 

“Loan Parties” means the collective reference to the Borrower and all of the Guarantors. 

“Loss” has the meaning set forth in Section 6.11(a). 

“Margin Stock” means “margin stock” as such term is defined in Regulation T, U or X of the Federal Reserve Board.

 “Market Cap” means the number of outstanding shares of common stock of the Successor Entity listed on a National
Securities Exchange, multiplied by the per share Volume Weighted Average Price for such common stock as of the Trading Day immediately preceding the announcement of the Successor Entity Transaction. 

“Market Withdrawal” means a Person’s Removal or Correction of a distributed product which involves a minor violation
that would not be subject to legal action by the FDA or which involves no violation (e.g., normal stock rotation practices and routine equipment adjustments and repairs), etc. 

“Material Adverse Effect” means a material adverse effect on (a) the business, operations, results of operations,
financial condition or properties of the Loan Parties and their Subsidiaries, taken as a whole, (b) the legality, validity or enforceability of any provision of any Loan Document, (c) the ability of any Loan Party to timely perform the
Obligations, (d) the creation, perfection or priority of the Liens, taken as a whole for the Collateral, granted under the Loan Documents, or (e) the rights and remedies of the Secured Parties under any Loan Document. 

“Material Contracts” means (a) the Operative Documents, (b) the Convertible Note Documents, (c) the agreements
listed on Schedule 3.1(aa), and (d) each other agreement or contract to which such Loan Party or its Subsidiaries is a party the termination of which could reasonably be expected to result in a Material Adverse Effect; provided that
Capped Calls shall not be considered Material Contracts. 
 “Material Intangible Assets” means all of (i) each Loan
Party’s Intellectual Property and (ii) license or sublicense agreements or other agreements with respect to rights in Intellectual Property, in each case that are material to the financial condition, business or operations of the
applicable Loan Party. 
 “Maturity Date” means April 2, 2023. 

“Medicaid” means the medical assistance programs administered by state agencies and approved by CMS pursuant to the terms of
Title XIX of the Social Security Act, codified at 42 U.S.C. 1396 et seq. 
 “Medicare” means the program of health benefits
for the aged and disabled administered by CMS pursuant to the terms of Title XVIII of the Social Security Act, codified at 42 U.S.C. 1395 et seq. 

“Merrill Lynch Securities Account” means that certain securities account maintained in the name of the Borrower at Merrill
Lynch identified by account number XXXXX2509 that includes only assets that are cash or Cash Equivalents and which will have a balance of $0 (and will contain no cash, Cash Equivalents or other assets) on and after September 1, 2017. 

  
 18 

 “Multiemployer Plan” means any multiemployer plan, as defined in
Section 3(37) or 4001(a)(3) of ERISA, as to which any ERISA Affiliate incurs or otherwise has, or could reasonably be expected to have, any obligation or Liabilities (including under Section 4212 of ERISA). 

“National Securities Exchange” means the New York Stock Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market
(or, in each case, a successor thereto). 
 “Necessary Documents” has the meaning set forth in Section 3.1(l). 

“Net Income” means, for any period, the net income (or loss) of the Successor Entity set forth in the Successor Entity’s
most recent publicly reported income statement; provided that such amounts shall be limited to those of the Successor Entity only (and not any of its Subsidiaries) unless such Subsidiaries (other than any Excluded Subsidiaries) have completed
and consummated the Successor Entity Subsidiary Joinder Actions. 
 “Non-Callable Make Whole
Amount” means, on any date of prepayment or early redemption of all or any portion of the Loans, an amount in cash equal to all required interest payments due on the Loans that are prepaid from the date of repayment or early redemption
through and including the date that is the First Amortization Date, plus any accrued and unpaid interest and fees and unpaid costs and expenses incurred pursuant to the terms of the Loan Documents. 

“Notes” means the Loan Notes. 

“Obligations” means all Loans and Disbursements, any Non-Callable Make Whole Amount,
any CoC Fee, interest, fees, expenses, costs, liabilities, indebtedness and other obligations (monetary (including post-petition interest, costs, fees, expenses and other amounts, whether allowed or not) or otherwise) of (or owed by) the Borrower
and the other Loan Parties under or in connection with the Loan Documents, in each case howsoever created, arising or evidenced, whether direct or indirect (including those acquired by assignment), absolute or contingent, now or hereafter existing,
or due or to become due. 
 “OFAC” has the meaning set forth in Section 3.1(jj). 

“OID” means original issue discount. 

“Operative Documents” means the Loan Documents, the Financing Documents (as defined in the ABL Credit Facility as of the
Agreement Date) and the Subordinated Debt Documents (as defined in the ABL Credit Facility as of the Agreement Date). 

“Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities. 
 “Ordinary Course of Business” means, in respect of any transaction involving any Loan Party, the ordinary
course of business of such Loan Party, as conducted by such Loan Party in accordance with past practices, as applicable. 

“Organizational Documents” means, with respect to any Loan Party, the documents by which such Person was organized (such as a
certificate of incorporation, certificate of limited partnership or articles of organization, and including, without limitation, any certificates of designation for preferred stock or other forms of preferred equity) and which relate to the internal
governance of such Person (such as by-laws, a partnership agreement or an operating, limited liability company or members agreement), including any and all shareholder agreements or voting agreements relating
to the capital stock or other equity interests of such Person. 

  
 19 

 “Other Connection Taxes” means with respect to any Lender, Taxes imposed as a
result of a present or former connection between such Lender and the jurisdiction imposing such Tax (except a connection arising solely from such Lender having executed, delivered, become a party to, performed its obligations or received a payment
under, received or perfected a security interest under, engaged in any transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan Document). 

“Other Taxes” means any and all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes
arising from any payment made hereunder or from the execution, delivery, registration or enforcement of, or otherwise with respect to, any Loan Document. 

“Participant” has the meaning set forth in Section 6.5. 

“Parties” has the meaning set forth in the preamble to this Agreement. 

“PBGC” means the United States Pension Benefit Guaranty Corporation or any successor thereto. 

“Perfection Certificate” means each perfection certificate executed or delivered from time to time by any Loan Party or any
of its Subsidiaries to any Secured Party, in substantially the form of Exhibit B. 
 “Permitted 3.25% Convertible Note
Refinancing” has the meaning provided therefor in the definition of “Permitted Indebtedness.” 
 “Permitted ABL
Credit Facility Liens” has the meaning provided therefor in clause (u) of the definition of “Permitted Liens”. 

“Permitted Acquisition” means any Acquisition by a Loan Party, in each case, to the extent that each of the following
conditions shall have been satisfied: 
 (a) the Borrower shall have delivered to Agent (i) at least ten (10) Business Days prior
to the closing of the proposed Acquisition: (A) a description of the proposed Acquisition; (B) to the extent available, a due diligence package (including, to the extent available, a quality of earnings report); and (C) the most
recent drafts (or, if available, executed counterparts) of the respective agreements, documents or instruments pursuant to which such Acquisition is to be consummated, any available schedules and exhibits to such agreements, documents or instruments
and all other material ancillary agreements, instruments and documents to be executed or delivered in connection therewith, and to the extent required under the related acquisition agreement, all required regulatory and third party approvals and
copies of any environmental assessments and (ii) at the earlier of (A) the time of closing of the proposed Acquisition or (B) as early before the closing of the proposed Acquisition as available, in each case, final, fully executed
copies of the respective agreements, documents or instruments pursuant to which such Acquisition is to be consummated and all schedules and exhibits to such agreements, documents or instruments and all other material ancillary agreements,
instruments and documents executed or delivered in connection therewith; 
 (b) the Loan Parties (including any new Subsidiary to the extent
required by Section 5.1(l)) shall execute and deliver the agreements, instruments and other documents to the extent required by Section 5.1(l); 

  
 20 

 (c) no Event of Default or Default has occurred and is continuing, or would exist after giving
pro forma effect to, the proposed Acquisition; 
 (d) all transactions in connection with such Acquisition shall be consummated, in all
material respects, in accordance with applicable laws; 
 (e) the assets acquired in such Acquisition are for use in the same line of
business as the Loan Parties are currently engaged or a line of business reasonably related thereto; 
 (f) such Acquisition shall not be
hostile and, if applicable, shall have been approved by the board of directors (or other similar body) and/or the stockholders or other equity holders of any Person being acquired in such Acquisition; 

(g) no Indebtedness or Liens are assumed or created (other than Permitted Liens and Permitted Indebtedness) in connection with such
Acquisition; 
 (h) all conditions to Permitted Acquisitions (as defined in the ABL Credit Facility as of the Agreement Date) have been
satisfied and Agent shall have received any requested evidence showing satisfaction thereof; and 
 (i) the total consideration paid or
payable (including without limitation, costs and expenses, deferred purchase price, seller notes and other liabilities incurred, assumed or to be reflected on a consolidated balance sheet of the Loan Parties and their Subsidiaries after giving
effect to such Acquisition but excluding (A) any equity interests issued as consideration for such Acquisition and (B) the net proceeds of any issuance of equity interests made after the Agreement Date that are used for purposes of such
Acquisition) (such amounts, collectively, the “Acquisition Consideration”) shall be in an amount not to exceed $15,000,000 in the aggregate for all such Acquisitions during the term of this Agreement; provided,
however, that, in the case of each Acquisition, Agent has received prior to the consummation of such Acquisition evidence satisfactory to Agent that Borrower has, immediately before and immediately after giving effect to the consummation of
such Acquisition, unrestricted cash (it being understood and agreed that cash and Cash Equivalents shall not be considered “restricted” cash for purposes of this proviso solely due to compliance by the Loan Parties with the requirements
set forth in Section 5.1(k)) in one or more deposit accounts subject to a Control Agreement (and/or in the Merrill Lynch Securities Account in accordance with, and subject to the limitations set forth in, Section 5.1(k)) in an aggregate amount equal
to or greater than the positive value of the product of (x) eighteen (18) multiplied by (y) the Monthly Cash Burn Amount (as defined in the ABL Credit Facility as of the Agreement Date), as determined as of the last day of the month
immediately preceding such Acquisition. 
 “Permitted Contingent Obligations” means 

(a) Contingent Obligations arising in respect of the Indebtedness under the Loan Documents; 

(b) Contingent Obligations resulting from endorsements for collection or deposit in the Ordinary Course of Business; 

(c) Contingent Obligations outstanding on the date of this Agreement and set forth on Schedule 5.2(iv) (but not including any refinancings,
extensions, increases or amendments to the indebtedness underlying such Contingent Obligations other than extensions of the maturity thereof without any other material change in terms adverse to the Lenders); 

  
 21 

 (d) Contingent Obligations incurred in the Ordinary Course of Business with respect to surety and
appeal bonds, performance bonds and other similar obligations not to exceed $2,000,000 in the aggregate at any time outstanding; 
 (e)
Contingent Obligations arising under indemnity agreements with title insurers to cause such title insurers to issue to Agent mortgagee title insurance policies; 

(f) Contingent Obligations arising with respect to customary indemnification obligations in favor of purchasers in connection with dispositions
of personal property assets permitted under Section 5.2; 
 (g) so long as there exists no Event of Default both immediately before and
immediately after giving effect to any such transaction, Contingent Obligations existing or arising under any Swap Contract or Capped Call; provided, however, that such obligations are (or were) entered into by Borrower or an Affiliate
of Borrower for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and either (i) with respect to
a Swap Contract or a Capped Call, are (or were) entered into in the Ordinary Course of Business or (ii) with respect to a Capped Call, are (or were) entered into in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes, any
refinancings thereof permitted hereunder or in connection with this Agreement or any of the other Loan Documents; 
 (h) guarantees by
(A) one or more Loan Parties of the obligations of Foreign Subsidiaries up to $1,000,000 in the aggregate at any time outstanding, (B) any Loan Party of the obligations of any other Loan Party (but, for the avoidance of doubt, excluding
any Immaterial Subsidiary that may be a Loan Party where, before and immediately after giving effect to such guarantee (including any rights of contribution set forth in the Loan Documents or otherwise), the Loan Parties cannot represent and warrant
that such Immaterial Subsidiary is Solvent on an individual basis) and (C) any Foreign Subsidiary of the obligations of any other Foreign Subsidiary; 

(i) Contingent Obligations arising in connection with the issuance of letters of credit in an aggregate face amount not to exceed $10,000,000
at any one time outstanding secured solely by Liens permitted pursuant to clause (s) of the definition of Permitted Liens; 
 (j)
Contingent Obligations arising in respect of the Indebtedness under the Financing Documents (as defined in the ABL Credit Facility as of the Agreement Date); and 

(k) other Contingent Obligations not permitted by clauses (a) through (j) above, not to exceed $2,500,000 in the aggregate at any time
outstanding. 
 “Permitted Dispositions” means each of the following: 

(a) dispositions of inventory in the Ordinary Course of Business; 

(b) dispositions of furniture, fixtures and equipment in the Ordinary Course of Business that the applicable Loan Party or Subsidiary
determines in good faith is no longer used or useful in the business of such Loan Party and its Subsidiaries (or such Subsidiary and its subsidiaries); 

(c) to the extent constituting a Disposition, Permitted Investments and Permitted Licenses; 

(d) disposals of obsolete, worn out or surplus tangible personal property; 

  
 22 

 (e) without limiting transactions permitted under Section 5.2 hereof, dispositions by any
Loan Party to any other Loan Party so long as each Loan Party (other than, with respect to any transferring Person, an Immaterial Subsidiary) will remain Solvent after giving effect to the transfer; 

(f) abandonment of Intellectual Property that does not constitute a Material Intangible Asset; 

(g) the unwinding or terminating of Swap Contracts or any Capped Call permitted by clause (g) of the definition of “Permitted
Contingent Obligations” either (i) with respect to a Swap Contract or a Capped Call, in the Ordinary Course of Business or (ii) with respect to a Capped Call, that were entered into in connection with the 2.25% Convertible Notes, the
3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; 

(h) dispositions of equipment or real property to the extent that (i) such property is exchanged for credit against the purchase price of
replacement property or (ii) the proceeds of such disposition are promptly applied to the purchase price of such replacement property; 

(i) the entering into of any Permitted License; 

(j) Dispositions by any Foreign Subsidiary to any other Foreign Subsidiary or to any Loan Party; 

(k) Dispositions approved by Agent in writing; 

(l) to the extent constituting a Disposition, the payment of cash and Cash Equivalents in the Ordinary Course of Business; and 

(m) Other Dispositions (excluding dispositions of Intellectual Property) the proceeds of which, when aggregated with the proceeds of all other
Dispositions made pursuant to this clause (m) are less than $2,500,000 during the term of this Agreement; provided that (i) the consideration received for such assets shall be in an amount at least equal to the fair market value thereof
(determined in good faith by the board of directors (or similar governing body) of the Loan Party that owned such assets), (ii) no less than 75% thereof shall be paid in cash. 

“Permitted Indebtedness” means each of the following: 

(a) the Loan Parties’ and their Subsidiaries’ Indebtedness to Agent and each Lender under this Agreement and the other Loan
Documents; 
 (b) Indebtedness incurred as a result of endorsing negotiable instruments received in the Ordinary Course of Business; 

(c) Capital Leases and purchase money Indebtedness not to exceed $5,000,000 at any time (whether in the form of a loan or a lease) used solely
to acquire equipment used in the Ordinary Course of Business and secured only by such equipment; 
 (d) Indebtedness existing on the
Agreement Date and described on Schedule 3.1(f) (but not including any refinancings, extensions, increases or amendments to such Indebtedness other than Permitted Refinancings); 

  
 23 

 (e) so long as there exists no Event of Default both immediately before and immediately after
giving effect to any such transaction, Indebtedness existing or arising under any Swap Contract or Capped Call; provided, however, that such obligations are (or were) entered into by Borrower or an Affiliate of Borrower for the purpose
of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and either (i) with respect to a Swap Contract or a Capped
Call, are (or were) entered into in the Ordinary Course of Business or (ii) with respect to a Capped Call, are (or were) entered into in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes, any Permitted 3.25% Convertible
Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; 
 (f) Indebtedness in the form
of insurance premiums financed through the applicable insurance company; 
 (g) trade accounts payable arising and paid within 120 days of
the date when due and in the Ordinary Course of Business; 
 (h) [reserved]; 

(i) Subordinated Debt; 
 (j) the
ABL Debt under the ABL Credit Facility, in accordance with the terms of the Intercreditor Agreement; 
 (k) Indebtedness of the Loan Parties
incurred under the 3.25% Convertible Notes in an aggregate principal amount not to exceed the aggregate principal amount outstanding on the Agreement Date after giving effect to any repayments or prepayments thereon on the Agreement Date, and, so
long as no Event of Default has occurred and is continuing, any refinancing or extension thereof or new issuance in connection with the exchange thereof and/or a new issuance all or any portion of the proceeds of which will be used in connection
with the repurchase or other refinancing of all or any portion thereof therewith that (i) has an aggregate outstanding principal amount not greater than $200,000,000 (when taking into account all such existing, refinanced, extended and newly
issued Indebtedness), and does not provide for any amortization payments or other principal payments of any kind in advance of the first Business Day after the Maturity Date, (ii) has a maturity no shorter than the first Business Day after the
Maturity Date (in the case of clause (i) and clause (ii), it being understood that, in each case, any provision requiring an offer to purchase such Indebtedness as a result of a change in control, fundamental change, delisting, asset sale
or similar provision or any exercise or conversion of Stock (other than Disqualified Stock) shall not violate the foregoing restrictions in clause (i) or clause (ii)), (iii) is unsecured, (iv) does not have one or more obligors that
are not obligors under this Agreement and the other Loan Documents, (v) contains terms that are prevailing market terms at the time of issuing or initial borrowing for the type of financing and for the quality of issuer or borrower, as
determined by Borrower and its advisors in their reasonable business judgment, (vi) does not have an All-in Yield greater than the lesser of (A) 6% per annum and (B) an
All-in Yield that would result in more than $10,000,000 per annum being paid in interest thereunder, (vii) does not cause Borrower either on an individual basis or together with the other Loan Parties and
their Subsidiaries (on a consolidated basis), immediately before, at the time of and immediately after giving effect to such Indebtedness (and after giving effect to the use of the proceeds thereof), to no longer be Solvent (or such Persons are not
Solvent immediately prior to giving effect thereto), and (vii) if in existence at such time or on the same date, is permitted under the ABL Debt Documents (collectively, a “Permitted 3.25% Convertible Note Refinancing”); 

  
 24 

 (l) Indebtedness of the Loan Parties incurred under the 2.25% Convertible Notes in an aggregate
principal amount not to exceed the aggregate principal amount outstanding on the Agreement Date minus any prepayments, repayments, redemptions or payments thereon made on the Agreement Date or from time to time thereafter; 

(m) without limiting the provisions of Section 5.2 with respect to any Investment by a Loan Party, Indebtedness consisting of unsecured
intercompany loans and advances (i) incurred by any Loan Party owing to one or more other Loan Parties, (ii) incurred by any Foreign Subsidiaries owing to any Loan Party solely to the extent constituting a Permitted Investment made by such
Loan Party, or (iii) incurred by any Foreign Subsidiaries owing to any other Foreign Subsidiary; 
 (n) Indebtedness related to
commercial credit cards provided by Bank of America, N.A. (or such other commercial bank permitted under the definition of “Bank of America Cash Collateral Account) that, in the aggregate outstanding at any one time, does not exceed $2,500,000,
which Indebtedness may be secured by Liens permitted pursuant to clause (t) of the definition of Permitted Liens; 
 (o) to the extent
constituting Indebtedness, any Permitted Contingent Obligations; and 
 (p) Indebtedness incurred in respect of netting services, overdraft
protection and other like services, in each case, incurred in the Ordinary Course of Business; 
 (q) unsecured earn-out obligations and other similar contingent purchase price obligations incurred in connection with a Permitted Acquisition to the extent earned and payable and permitted pursuant to the definition of Permitted
Acquisition and the other terms of this Agreement; and 
 (r) other unsecured Indebtedness not to exceed $2,500,000 outstanding at any one
time. 
 “Permitted Investments” means each of the following: 

(a) Investments (i) shown on Schedule P-1 and existing on the Agreement Date and (ii) in
Subsidiaries made prior to the Agreement Date; 
 (b) cash and Cash Equivalents; 

(c) Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the Ordinary
Course of Business; 
 (d) Investments consisting of (i) travel advances and employee relocation loans and other employee loans and
advances in the Ordinary Course of Business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of Loan Parties or their Subsidiaries pursuant to employee stock purchase plans or agreements approved
by Loan Parties’ Board of Directors (or other governing body), but the aggregate of all such loans outstanding may not exceed $500,000 at any time; 

(e) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in
settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the Ordinary Course of Business; 

  
 25 

 (f) Investments consisting of notes receivable of, or prepaid royalties and other credit
extensions, to customers and suppliers who are not Affiliates, in the Ordinary Course of Business, provided, however, that this subpart (f) shall not apply to Investments of Loan Parties in any Subsidiary; 

(g) Investments consisting of (i) deposit accounts in which Agent has received a Control Agreement, (ii) deposit accounts that are
Excluded Accounts (subject to any caps and applicable restrictions set forth in such definition), and (iii) the Merrill Lynch Securities Account maintained in accordance with, and subject to the limitations set forth in, Section 5.1(k); 

(h) Investments by any Loan Party in any Subsidiary now owned or hereafter created by such Loan Party, which Subsidiary is a Loan Party or has
otherwise provided a Guarantee of the Obligations of the Loan Parties which Guarantee is secured by a Lien granted by such Subsidiary to Agent in all or substantially all of its property of the type described in the Guaranty and Security Agreement
and otherwise made in compliance with Section 5.1(l); 
 (i) Investments by (A) any Loan Party consisting solely of cash and Cash
Equivalents in a Foreign Subsidiary; provided that at the time of the making of such Investment and immediately after giving effect thereto (i) no Event of Default has occurred and is continuing and (ii) Loan Parties have unrestricted (it
being understood and agreed that cash and Cash Equivalents shall not be considered “restricted” cash for purposes of this proviso solely due to compliance by the Loan Parties with the requirements set forth in Section 5.1(k)) cash and Cash
Equivalents in an aggregate amount of not less than $10,000,000, which cash and Cash Equivalents (x) are subject to a first priority perfected lien in favor of Agent for the benefit of Lenders (subject to Permitted Liens) or in the Merrill
Lynch Securities Account in accordance with, and subject to the limitations set forth in, Section 5.1(k)), (y) are held in a deposit account that is subject to a Control Agreement or a securities account subject to a Control Agreement or in the
Merrill Lynch Securities Account in accordance with, and subject to the limitations set forth in, Section 5.1(k) and (z) unless the same could not be reasonably expected to reduce the amounts in such accounts below $10,000,000 at the time of
such Investment and immediately after giving effect thereto, do not include any drawn or committed but unpaid drafts, ACH or EFT transactions and (B) a Foreign Subsidiary in another Foreign Subsidiary; 

(j) Investments by any Loan Party consisting solely of inventory in Foreign Subsidiaries to the extent such Investments are made in the
Ordinary Course of Business consistent with its customary practices as in effect on and immediately prior to the Agreement Date; 
 (k) so
long as no Default or Event of Default shall have occurred and be continuing at the time thereof or would result therefrom, Investments consisting solely of cash and Cash Equivalents in joint ventures or similar arrangements in an amount not to
exceed $5,000,000 in the aggregate during the term of this Agreement; 
 (l) Permitted Acquisitions; 

(m) Investments deemed to exist under any Swap Contracts or Capped Calls; provided, however, that such obligations are (or were)
entered into by Borrower or an Affiliate of Borrower for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of
speculation and are (or were) entered into either (i) with respect to a Swap Contract or a Capped Call, in the Ordinary Course of Business or (ii) with respect to a Capped Call, in connection with the 2.25% Convertible Notes, the 3.25%
Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this Agreement or any of the other Loan Documents; and 

  
 26 

 (n) other Investments in an amount not exceeding $5,000,000 in the aggregate. 

“Permitted License” means (a) any non-exclusive license of patent rights of a
Loan Party or its Subsidiaries so long as all such Permitted Licenses are granted to third parties in the Ordinary Course of Business, do not result in a legal transfer of title to the licensed property, and have been granted in exchange for fair
consideration, and (b) any exclusive license of patent rights of a Loan Party or its Subsidiaries so long as such Permitted Licenses do not result in a legal transfer of title to the licensed property, are exclusive solely as to discrete
geographical areas outside of the United States, and have been granted in exchange for fair consideration. 
 “Permitted
Liens” means each of the following: 
 (a) Liens existing on the Agreement Date and set forth on Schedule 3.1(d); 

(b) Liens in favor of the Secured Parties under the Loan Documents; 

(c) carriers’, warehousemen’s, mechanics’, landlords’, materialmen’s, repairmen’s or other similar Liens arising
in the Ordinary Course of Business which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings, which proceedings have the effect of preventing the forfeiture or sale of the
assets or property subject thereto and for which adequate reserves in accordance with GAAP are being maintained; 
 (d) Liens for Taxes,
assessments or governmental charges or levies not past due or payable or that are being contested in good faith by appropriate proceedings and for which adequate reserves in accordance with GAAP are being maintained; 

(e) (A) Liens arising from judgments, decrees or attachments in circumstances not constituting an Event of Default or Default and
(B) pledges or cash deposits made in lieu of, or to secure the performance of, judgment or appeal bonds in respect to such judgments and proceedings; 

(f) Liens in favor of financial institutions arising in connection with the Borrower’s or its Subsidiaries’ deposit accounts
maintained in the Ordinary Course of Business held at such institutions to secure standard fees for services charged by, but not financing made available by, such institutions; 

(g) Liens (other than any Lien imposed by ERISA) consisting of pledges or deposits required in the Ordinary Course of Business in connection
with workers’ compensation, unemployment insurance and other social security legislation or to secure the performance of tenders, statutory obligations, surety, stay, customs and appeals bonds, bids, leases, governmental contract, trade
contracts, performance and return of money bonds and other similar obligations (exclusive of obligations for the payment of borrowed money or other funded Indebtedness) or to secure liability to insurance carriers; 

(h) easements, rights of way, restrictions and other similar encumbrances affecting real property which, in the aggregate, are not substantial
in amount, do not materially affect the value or marketability of such real property and which do not in any case materially interfere with the conduct of the business of any Loan Party or its Subsidiaries; 

(i) (i) any interest or title of a lessor, sublessor, licensor or sublicensor under any lease or license not prohibited by this Agreement
or (ii) non-exclusive licenses and sublicenses granted by a Loan Party or any Subsidiary of a Loan Party and leases and subleases (by a Loan Party or any Subsidiary of a Loan Party as lessor or sublessor)
to third parties in the Ordinary Course of Business not materially interfering with the business of the Loan Parties or any of their Subsidiaries; 

  
 27 

 (j) Liens of a collection bank arising under
Section 4-210 of the UCC (or equivalent in foreign jurisdictions) on items in the course of collection; 

(k) Liens on any assets or property acquired or held by any Loan Party or any Subsidiary of any Loan Party securing Indebtedness incurred or
assumed for the purpose of financing (or refinancing) all or any part of the cost of acquiring such assets or property and permitted under clause (c) of the definition of “Permitted Indebtedness”; provided that (i) such
Lien attaches solely to the assets or property so acquired in such transaction and the proceeds thereof and (ii) the principal amount of the Indebtedness secured thereby does not exceed 100% of the cost of such assets or property; 

(l) Liens securing Capital Leases permitted under clause (c) of the definition of “Permitted Indebtedness”; 

(m) Liens arising from the filing of precautionary uniform commercial code financing statements with respect to any lease not prohibited by
this Agreement; 
 (n) Liens arising out of consignment or similar arrangements for the sale of goods entered into by the Borrower or any
Subsidiary of the Borrower in the Ordinary Course of Business; 
 (o) Liens in favor of customs and revenue authorities arising as a matter
of law which secure payment of customs duties in connection with the importation of goods in the Ordinary Course of Business; 
 (p) Liens on
unearned insurance premiums securing the financing thereof to the extent permitted under clause (f) of the definition of “Permitted Indebtedness”; 

(q) [reserved]; 
 (r) Liens on
assets of the Loan Parties and their Subsidiaries arising in connection with seller notes, earn-outs and other similar payment obligations constituting Acquisition Consideration in connection with Permitted Acquisitions so long as such Liens are
subject at all times to a Subordination Agreement; 
 (s) Liens in favor of letter of credit issuers on the L/C Cash Collateral Account to
the extent securing obligations of the Loan Parties permitted pursuant to clause (i) of the definition of Permitted Contingent Obligations under the ABL Credit Facility as of the Agreement Date; 

(t) Liens in favor of Bank of America, N.A. (or such other commercial bank permitted under the definition of “Bank of America Cash
Collateral Account”) on the Bank of America Cash Collateral Account; provided that if Borrower is using credit card services from the agent or a lender under ABL Debt Documents that are required to be secured, Borrower shall promptly use
commercially reasonable efforts to terminate the Liens in respect of the Bank of America Cash Collateral Account; and 
 (u) Liens granted
under the ABL Credit Facility, in accordance with the terms of the Intercreditor Agreement (“Permitted ABL Credit Facility Liens”). 

“Permitted Priority Liens” means (a) solely with respect to the specific assets or property covered thereby, the Liens
granted pursuant to, and in accordance with, clause (u) of the definition of “Permitted Liens ,” (b) Permitted Liens granted over specific property pursuant to clauses (f) (solely with respect to such applicable deposit accounts), (i)
(solely with respect to the interest in such applicable lease, sublease, license or sublicense or the assets owned by such lessor, sublessor, licensor or sublicensor underlying 

  
 28 

 
same), (k) (solely with respect to the property permitted to be secured by such Indebtedness permitted pursuant to clause (c) of the definition of “Permitted Indebtedness”), (l)
(solely with respect to the property that is part of the Capital Lease), (m) (solely with respect to the specific assets covered by such lease that are owned by such lessor), (n) (with respect to the goods permitted to be consigned thereby), (p)
(solely with respect to such cash held by such insurance agency for such insurance premiums), (s) (solely with respect to the L/C Cash Collateral Account) and (t) (solely with respect to the Bank of America Cash Collateral Account) of the definition
of “Permitted Liens”, but, in each case, only to the extent only such Lien (i) attaches, as applicable, solely to the assets or property so acquired in such transaction and the proceeds thereof and (ii) has prior priority to the
Permitted ABL Credit Facility Liens, and (c) to the extent not otherwise covered by clause (b) above, non-consensual Permitted Liens that are solely provided by operation of (and in compliance with)
Applicable Law. 
 “Permitted Refinancing” means Indebtedness constituting a refinancing or extension of Indebtedness
evidenced by the permitted under clause (d) of the definition of “Permitted Indebtedness” and that (a) has an aggregate outstanding principal amount not greater than the aggregate principal amount of the Indebtedness being
refinanced or extended, (b) has a weighted average maturity (measured as of the date of such refinancing or extension) and maturity no shorter than that of the Indebtedness being refinanced or extended, (c) is not entered into as part of a
sale leaseback transaction, (d) is not secured by a Lien on any assets other than the collateral securing the Indebtedness being refinanced or extended, (e) the obligors of which are the same as the obligors of the Indebtedness being
refinanced or extended and (f) is otherwise on terms no less favorable to Loan Parties and their Subsidiaries, taken as a whole, than those of the Indebtedness being refinanced or extended. 

“Permitted Successor Transaction” means a transaction that satisfies all of the following conditions: (A) the Stock of
the Borrower is acquired by, or the Borrower is merged with, a corporation (each such transaction, a “Successor Entity Transaction”) that (i) is organized in a state of the United States that has both a Market Cap and an
Enterprise Value of at least $2,000,000,000 (as reasonably determined by the Agent), (ii) has common Stock registered under Section 12 of the Exchange Act and listed on a National Securities Exchange, (iii) is current in its reporting
requirements under the Exchange Act and (iv) is in compliance with all applicable listing standards of the National Securities Exchange on which its common stock is listed (such successor corporation, a “Successor Entity”), (B)
before, at the time of and after giving effect to such Successor Entity Transaction, no Event of Default has occurred and is continuing, (C) Agent (for the benefit of the Secured Parties) maintains a first priority security interest (subject
only to the Permitted Priority Liens) in all of the Collateral of the Loan Parties, and the Successor Entity and the Loan Parties shall take such actions and execute and deliver such documents, instruments and agreements required by Agent to
effectuate the foregoing in this clause (i)(C), (D) in connection with any such Successor Entity Transaction, the Successor Entity shall take such actions and execute such documents, instruments and agreements as may be reasonably required by Agent
to assume all of the Obligations on behalf of the Borrower and all Guarantors shall reaffirm and ratify its Guarantee of the Obligations (other than those Obligations under the Warrant, any Stock and the Registration Rights Agreement) and the Liens
securing the Obligations (other than those Obligations under the Warrant, any Stock and the Registration Rights Agreement) the Borrower and such Guarantors granted under the Loan Documents to secure such Guarantees and Obligations, in each case, in
a manner reasonably satisfactory to the Agent, (E) the Successor Entity and/or the Borrower shall take such actions requested by the Agent or any holder of the Warrants to effectuate the bargain, intention and agreements previously set forth in
the Warrants, the Registration Rights Agreement and the other Loan Documents, (F) before, at the time of and after giving effect to such Successor Entity Transaction, the Successor Entity (provided that the amounts related to the
Successor Entity shall be limited to those incurred by the Successor Entity only (and not any of its Subsidiaries) unless such Subsidiaries (other than any Excluded Subsidiaries) have completed and consummated the Successor Entity Subsidiary Joinder
Actions), the Loan Parties and their Subsidiaries shall have a Total Leverage Ratio on a pro forma basis (after giving effect to the Successor Entity 

  
 29 

 
Transaction and any Indebtedness that will remain or be assumed after such consummation thereof) of no greater than 2:1 and the Successor Entity and the Loan Parties shall deliver a certificate
certifying to the same and providing such evidence and calculations thereof that may be reasonably requested by Agent, (H) the Successor Entity both on an individual basis and together with the Loan Parties and their Subsidiaries (on a
consolidated basis), immediately before, at the time of and immediately after giving effect to such Successor Entity Transaction, is/are Solvent, (I) before, at the time of and after giving effect to such Successor Entity Transaction, the
representations and warranties set forth in the Loan Documents are true, correct and complete in all material respects (without giving effect to any double materiality) as of the date hereof (or, if such representation or warranty is made as of such
earlier specified date, as of such earlier specified date), (J) (1) each Subsidiary of the Successor Entity that was a Subsidiary of Endologix immediately prior to the consummation of the Successor Entity Transaction shall comply with Section
5.1(l) and shall take such actions and execute and deliver such agreements, instruments and other documents in connection therewith as reasonably requested by Agent and (2) if the Subsidiaries of the Successor Entity immediately prior to giving
effect to the Successor Entity Transaction and that will remain Subsidiaries of the Successor Entity after giving effect to the Successor Entity Transaction are to be included in the components of the definition of “Total Leverage Ratio”
(and all components of the various definitions of the capitalized financial terms used in such definitions and the definitions of each such other capitalized financial term related thereto) to determine whether clause (F) above is satisfied,
such Subsidiaries of the Successor Entity (other than any Excluded Subsidiaries) have completed and consummated the Successor Entity Subsidiary Joinder Actions in a manner reasonably satisfactory to Agent, and (K) the Successor Entity and the
Loan Parties shall deliver a certificate certifying that each of the foregoing conditions in this definition have been satisfied. 

“Person” means and includes any natural person, individual, partnership, joint venture, corporation, trust, limited liability
company, limited liability partnership, joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity. 

“Portfolio Interest Certificate” has the meaning set forth in Section 2.5(d). 

“Pre-Closing Attorney’s Fees Cap” has the meaning set forth in
Section 6.3. 
 “Principal Market” means the NASDAQ Global Select Market (or any successor to the foregoing). 

“Pro Rata Loan Share” means, with respect to any Lender, the applicable amount (as adjusted from time to time in accordance
with the terms hereof and the actual principal amount outstanding related thereto) specified opposite such Lender’s name on Annex A under the column “Disbursement Amounts.” 

“Pro Rata Share” means, with respect to any Lender, the applicable percentage (as adjusted from time to time in accordance
with the terms hereof) obtained by dividing (a) such Lender’s Pro Rata Loan Share of the outstanding Loans, by (b) the total outstanding amount of Loans held by all Lenders. 

“Products” means, from time to time, any products currently manufactured, sold, developed, tested or marketed by any Loan
Party or any of a Loan Party’s Subsidiaries. 
 “Put Notice” has the meaning set forth in Section 5.3. 

“Real Estate” means any real property owned, leased, subleased or otherwise operated or occupied by any Loan Party or any
Subsidiary of any Loan Party. 

  
 30 

 “Recall” means a Person’s Removal or Correction of a marketed product that
the FDA considers to be in violation of the laws it administers and against which the FDA would initiate legal action (e.g., seizure). 

“Refinancing ICA” has the meaning set forth in clause (ii)(A) of the definition of “ABL Credit Facility”. 

“Register” has the meaning set forth in Section 1.4(b). 

“Registration Rights Agreement” means that certain Registration Rights Agreement dated as of the Agreement Date entered into
by the Borrower and the Lenders and substantially in the form of Exhibit E. 
 “Regulation D” means Regulation D of the
Board of Governors of the Federal Reserve System as in effect from time to time and any successor to all or a portion thereof establishing reserve requirements. 

“Regulatory Required Permit” means any and all licenses, approvals and permits issued by the FDA, DEA or any other applicable
Governmental Authority, including without limitation Drug Applications, necessary for the testing, manufacture, marketing or sale of any Product by any applicable Loan Party (or Loan Parties) and its (or their) Subsidiaries as such activities are
being conducted by such Loan Party (or Loan Parties) and its (or their) Subsidiaries with respect to such Product at such time and any drug listings and drug establishment registrations under 21 U.S.C. Section 510, registrations issued by DEA
under 21 U.S.C. Section 823 (if applicable to any Product), and those issued by State governments for the conduct of the Loan Parties’ or any of their Subsidiaries’ business. 

“Related Parties” means, with respect to any Person, such Person’s Affiliates and the partners, directors, officers,
employees, agents, trustees, administrators, managers, attorneys, advisors and representatives of such Person and of such Person’s Affiliates. 

“Releases” means any release, threatened release, spill, emission, leaking, pumping, pouring, emitting, emptying, escape,
injection, deposit, disposal, discharge, dispersal, dumping, leaching or migration of Hazardous Material into or through the environment. 

“Removal” means the physical removal of a product from its point of use to some other location for repair, modification,
adjustment, relabeling, destruction or inspection. 
 “Reporting Period” has the meaning set forth in Section 5.1(h). 

“Required Lenders” means, at any time, Lenders having Pro Rata Shares the aggregate dollar equivalent amount of which exceeds
50% of the outstanding Loans. 
 “Restricted Payments” means, with respect to any Person, (i) the declaration or
making of any dividend payment or other distribution of assets, properties, cash, rights, obligations or securities on account of any of its Stock, (ii) the purchasing, redemption or other acquisition for value of any of its Stock now or
hereafter outstanding or (iii) the making of any payment or prepayment of principal of, premium, if any, interest, fees, redemption, exchange, purchase, retirement, defeasance, sinking fund or similar payment with respect to, any Indebtedness
subordinated to the Obligations as to right and time of payment or as to other rights and remedies thereunder. For the avoidance of doubt, the entry into, any payments or deliveries in respect of, and the performance, exercise and/or settlement of
the Borrower’s 2.25% Convertible Notes, 3.25% Convertible Notes (including, for the avoidance of doubt, any Permitted 3.25% Convertible Note Refinancing), Capped Calls, Warrants or under the ABL Credit Facility are not Restricted Payments. 

  
 31 

 “Rights Plan” has the meaning set forth in Section 3.1(rr). 

“Sanctioned Country” has the meaning set forth in Section 3.1(jj). 

“Sanctions” has the meaning set forth in Section 3.1(jj). 

“Sarbanes-Oxley” has the meaning set forth in Section 3.1(kk). 

“Scheduled First Amortization Payment” has the meaning set forth in Section 2.3(a). 

“SDN List” has the meaning set forth in Section 3.1(jj). 

“SEC” means the United States Securities and Exchange Commission. 

“SEC Documents” means all reports, schedules, forms, statements and other documents filed by the Borrower with the SEC
pursuant to the Securities Act or the Exchange Act since January 1, 2016 (including all financial statements and schedules included therein, all exhibits thereto and all documents incorporated by reference therein). 

“Secured Parties” means Agent, the Lenders and all Indemnified Persons. 

“Securities” means the Loans, the Notes, and the related guaranties set forth in the Security Agreement of the Guarantors,
the Warrants and the Warrant Shares. 
 “Securities Act” means the Securities Act of 1933, as amended, including the rules
and regulations promulgated thereunder. 
 “Security Agreement” means the Guaranty and Security Agreement executed and
delivered on the Agreement Date pursuant to which the Loan Parties party thereto grant to Agent for the benefit of the Secured Parties a security interest in all of their Collateral to secure the Obligations, as amended, restated, supplemented or
otherwise modified from time to time. 
 “Solvent” means, with respect to any Person as of any date of determination, that,
as of such date, (a) the value of the assets of such Person (both at fair value and present fair saleable value) is greater than the total amount of liabilities (including contingent and unliquidated liabilities) of such Person, (b) such
Person is able to pay all liabilities of such Person as such liabilities mature and (c) such Person does not have unreasonably small capital in relation to such Person’s business as contemplated as of the Agreement Date. In computing the
amount of contingent or unliquidated liabilities at any time, such liabilities shall be computed at the amount that, in light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become
an actual or matured liability. 
 “Stock” means (a) all shares of capital stock (whether denominated as common stock
or preferred stock), equity interests, beneficial, partnership or membership interests, joint venture interests, participations or other ownership or profit interests in or equivalents (regardless of how designated) of or in a Person (other than an
individual), whether voting or non-voting; and (b) all securities convertible into or exchangeable for any other Stock and all warrants, options or other rights (other than the 2.25% Convertible Notes,
the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder, any Capped Call transactions, and the Warrants) to purchase, subscribe for or otherwise acquire any other Stock, whether or not presently convertible,
exchangeable or exercisable. 

  
 32 

 “Subordinated Debt” means any Indebtedness of the Loan Parties incurred pursuant
to the terms of the Subordinated Debt Documents and with the prior written consent of Agent, all of which documents must be in form and substance acceptable to Agent in its sole discretion. As of the Agreement Date, there is no Subordinated Debt.

 “Subordinated Debt Documents” means any documents evidencing and/or securing Indebtedness governed by a Subordination
Agreement, all of which documents must be in form and substance acceptable to Agent in its sole discretion. As of the Agreement Date, there are no Subordinated Debt Documents. 

“Subordination Agreement” means any agreement between Agent and another creditor of one or more Loan Parties, as the same may
be amended, supplemented, restated or otherwise modified from time to time in accordance with the terms thereof, pursuant to which the Indebtedness owing from any Loan Party or Loan Parties and/or the Liens securing such Indebtedness granted by any
Loan Party or Loan Parties to such creditor are subordinated in any way to the Obligations and the Liens created under the Security Agreement, the terms and provisions of such Subordination Agreements to have been agreed to by, and be acceptable to,
Agent in the exercise of its sole discretion. 
 “Subsidiary” or “Subsidiaries” means, with respect to any
Person, (a) any corporation of which an aggregate of more than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the
time, capital stock of any other class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, owned legally or beneficially by such Person or one or
more Subsidiaries of such Person, or with respect to which any such Person has the right to vote or designate the vote of more than fifty percent (50%) of such capital stock whether by proxy, agreement, operation of law or otherwise, and
(b) any partnership or limited liability company in which such Person and/or one or more Subsidiaries of such Person shall have an interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty
percent (50%) or of which any such Person is a general partner or may exercise the powers of a general partner. Unless the context otherwise requires, each reference to a Subsidiary shall be a reference to a Subsidiary of a Loan Party. 

“Successor Entity” has the meaning set forth in the definition of “Permitted Successor Transaction.” 

“Successor Entity Subsidiary Joinder Actions” has the meaning set forth in the definition of “EBITDA”. 

“Successor Entity Transaction” has the meaning set forth in the definition of “Permitted Successor Transaction.”

 “Swap Contract” means any agreement, contract or transaction that constitutes a “swap” within the meaning of
Section 1a(47) of the Commodity Exchange Act, not including Capped Calls. 
 “Tax Affiliate” means (a) the Borrower
and its Subsidiaries and (b) any Affiliate of the Borrower with which the Borrower files or is required to file consolidated, combined or unitary tax returns. 

“Taxes” means all present or future taxes, levies, imposts, stamp or other duties, deductions, charges or withholdings
imposed by an Governmental Authority, together with any interest, additions to tax, penalties or other Liabilities with respect thereto. 

“Tax Returns” has the meaning set forth in Section 3.1(p). 

  
 33 

 “Third Party Obligation” has the meaning provided therefor in the definition of
“Contingent Obligation.” 
 “Third Party Payor” means Medicare, Medicaid, TRICARE, and other state or federal
health care program, Blue Cross and/or Blue Shield, private insurers, managed care plans and any other Person or entity which presently or in the future maintains Third Party Payor Programs. 

“Third Party Payor Programs” means all payment and reimbursement programs, sponsored by a Third Party Payor, in which a Loan
Party participates. 
 “Title IV Plan” means an Employee Benefit Plan subject to Title IV of ERISA, other than a
Multiemployer Plan, to which any ERISA Affiliate incurs or otherwise has or could reasonably be expected to have any obligation or Liabilities (including under Section 4069 of ERISA). 

“Total Leverage Ratio” means, with respect to any measurement period, the ratio of (a) Indebtedness reflected as
liabilities on the Successor Entity’s most recent publicly reported balance sheet as of the last day of such measurement period to (b) EBITDA as of the last day for such measurement period; provided that, in each case of
clause (a) and clause (b), such amounts shall be limited to those incurred by the Successor Entity only (and not any of its Subsidiaries) unless such Subsidiaries (other than any Excluded Subsidiaries) have completed and consummated the
Successor Entity Subsidiary Joinder Actions. 
 “Trading Day” means any day on which the common Stock of the applicable
Person is traded for at least six hours on a National Securities Exchange. 
 “Transactions” means (a) the repayment
of certain existing Indebtedness (including certain of the 2.25% Convertible Notes and, in connection with any loans funded on the Agreement Date under the Existing ABL Credit Facility or any other obligations outstanding on the Agreement Date under
the Existing ABL Credit Facility, all of the Indebtedness and other obligations evidenced by the Existing ABL Credit Facility and the Existing ABL Debt Documents), (b) the funding of the Disbursement, and (c) the payment of fees, commissions,
costs and expenses in connection with each of the foregoing. 
 “TRICARE” means the program administered pursuant to 10
U.S.C. Section 1071 et. seq), Sections 1320a-7 and 1320a-7a of Title 42 of the United States Code and the regulations promulgated pursuant to such statutes. 

“UCC” means the Uniform Commercial Code of any applicable jurisdiction and, if the applicable jurisdiction shall not have any
Uniform Commercial Code, the Uniform Commercial Code as in effect from time to time in the State of New York. 
 “United
States” and “U.S.” each means the United States of America. 
 “USA Patriot Act” means the
Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, P.L. 107-56, as amended from time to time. 

“Volume Weighted Average Price” for any security as of any Trading Day means the volume weighted average sale price of such
security on the National Securities Exchange on which such security is listed as reported by Bloomberg Financial Markets or an equivalent, reliable reporting service reasonably selected by the Agent (“Bloomberg”). Volume Weighted
Average Price will be determined without regard to after-hours trading or any other trading outside of the regular trading hours. 

  
 34 

 “Warrant Distributions” has the meaning set forth in Section 3.1(z). 

“Warrants” has the meaning set forth in Section 2.8(a). 

“Warrant Shares” has the meaning set forth in Section 3.1(z). 

Section 1.2 Interpretation. In this Agreement and the other Loan Documents, unless the context otherwise requires, all
words and personal pronouns relating thereto shall be read and construed as the number and gender of the party or parties requires and the verb shall be read and construed as agreeing with the required word and pronoun. The division of this
Agreement and the other Loan Documents into Articles and Sections and the use of headings and captions is for convenience of reference only and shall not modify or affect the interpretation or construction of this Agreement or any of its provisions.
The words “herein,” “hereof,” “hereunder,” “hereinafter” and “hereto” and words of similar import refer to this Agreement (or other applicable Loan Document) as a whole and not to any particular
Article or Section hereof (or thereof). The term “or” has, except where otherwise indicated, the inclusive meaning represented by the phrase “and/or.” The term “documents” and “agreements” include any and all
instruments, documents, agreements, certificates, indentures, notices and other writings, however evidenced. The use in any of the Loan Documents of the word “include” or “including,” when following any general statement, term or
matter, shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to similar items or matters, whether or not non-limiting
language (such as “without limitation” or “but not limited to” or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other items or matters that fall within the broadest possible
scope of such general statement, term or matter. References to a specified Article, Exhibit, Section or Schedule shall be construed as a reference to that specified Article, Exhibit, Section or Schedule of this Agreement (or other applicable Loan
Document). Unless specifically stated otherwise, any reference to any of the Loan Documents means such document as the same shall be amended, restated, supplemented or otherwise modified and from time to time in effect. The references to
“asset” (or “assets”) and “property” (or “properties”) in the Loan Documents are meant to be mean the same and are used throughout the Loan Documents interchangeably, and such words shall be deemed to refer to
any and all tangible and intangible assets and properties, including cash, securities, Stock, accounts and contract rights. Unless otherwise specified herein or therein, all terms defined in any Loan Document shall have the defined meanings when
used in any certificate or other document made or delivered pursuant hereto or thereto. The meanings of defined terms shall be equally applicable to the singular and plural forms of the defined terms. Terms (including uncapitalized terms) not
otherwise defined herein and that are defined in the UCC shall have the meanings therein described. In the computation of periods of time from a specified date to a later specified date, the word “from” means “from and
including”; the word “since” means “since and including”; the words “to” and “until” each mean “to but excluding,” and the word “through” means “to and including.” If any
provision of this Agreement or any other Loan Document refers to any action taken or to be taken by any Person, or which such Person is prohibited from taking, unless otherwise expressly stated, such provision shall be interpreted to encompass any
and all means, direct or indirect, of taking, or not taking, such action. References to any statute or regulation may be made by using either the common or public name thereof or a specific cite reference and, except as otherwise provided with
respect to FATCA, are to be construed as including all statutory and regulatory provisions related thereto or consolidating, amending, replacing, supplementing or interpreting the statute or regulation, and any reference to any law or regulation,
shall, unless otherwise specified, refer to such law or regulation as amended, modified or supplemented from time to time. Whenever any reference is made in any Loan Document to any Person such reference shall be construed to include such
Person’s permitted successors and permitted assigns. Any financial ratios required to be satisfied in order for a specific action to be permitted under any Loan Document shall be calculated by dividing the appropriate component by the other
component, carrying the result to one place more than the number of places by which such ratio is expressed herein or therein and rounding the result up or down to the nearest number (with a rounding-up if
there is no 

  
 35 

 
nearest number). Unless otherwise specified, all references in any Loan Document to times of day shall be references to New York City time. Notwithstanding anything to the contrary in any Loan
Document, any reference to “Organizational Document” or “Organizational Documents” of any Loan Party or any of its Subsidiaries in any Loan Document shall mean such written documents, agreements and arrangements that are in
effect on the Agreement Date after giving effect to the Transactions occurring on the Agreement Date that have been approved by Agent, without giving effect to any amendment, restatement, change, supplement, waiver or other modification thereto or
thereof that is not permitted by Section 5.2(x). 
 Section 1.3 Business Day Adjustment. Except as otherwise expressly
stated herein or in any other Loan Document, if the day by which any payment or other performance is due to be made is not a Business Day, that payment or performance shall be made by the next succeeding Business Day unless that next succeeding
Business Day falls in a different calendar month, in which case that payment or other performance shall be made by the Business Day immediately preceding the day by which such payment or other performance is due to be made; provided that
interest will continue to accrue each additional day in connection therewith. 
 Section 1.4 Loan Records. 

(a) The Borrower shall record on its books and records the amount of the Loan, the interest rate applicable thereto, all payments of principal
and interest thereon and the principal balance thereof from time to time outstanding. 
 (b) The Borrower shall establish and maintain at its
address referred to in Section 6.1, a record of ownership (the “Register”) in which the Borrower agrees to register by book entry the interests (including any rights to receive payment hereunder) of each Lender in the Loan and
any assignment of any such interest or interests, and (ii) accounts in the Register in accordance with its usual practice in which it shall record (1) the names and addresses of the Lenders (and any change thereto pursuant to this
Agreement), (2) the amount of the Loan and each funding of any participation therein, (3) the amount of any principal, interest, fee or other amount due and payable or paid, and (4) any other payment received by the Lenders from the
Borrower and its application to the Loan. 
 (c) The Loans made by each Lender are evidenced by this Agreement. Additionally, the Borrower
shall execute and deliver to each Lender (and/or, if applicable and if so requested by any assignee Lender pursuant to the assignment provisions of Section 6.5) on the Agreement Date (or, if such assignment is made after the Agreement Date,
promptly after such Lender’s request) a Loan Note (with respect to the Disbursement) payable to such Lender in an amount equal to the unpaid principal amount of the Loans held by such Lender (which, at the request of such Lender, may provide
separate Notes for separate or different parts of the Loans held by such Lender). Notwithstanding anything to the contrary contained in this Agreement, the Loans (including any Note(s) evidencing the Loans) are registered obligations, the right,
title and interest of the Lenders and their successors and assignees in and to the Loan shall be transferable only upon notation of such transfer in the Register and no assignment thereof shall be effective until recorded therein. This
Section 1.4 shall be construed so that the Loan is at all times maintained in “registered form” within the meaning of Sections 163(f), 871(h)(2) and 881(c)(2) of the Code. 

(d) The Borrower, Agent and the Lenders shall treat each Person whose name is recorded in the Register as a Lender for all purposes of this
Agreement. Information contained in the Register with respect to any Lender shall be available for access by the Borrower, Agent or such Lender at any reasonable time and from time to time upon reasonable prior notice, or when an Event of Default or
Default exists, with just notice (whether reasonable or not) by Agent or any such Lender. 

  
 36 

 Section 1.5 Accounting Terms and Principles. All accounting determinations required
to be made pursuant hereto shall, unless expressly otherwise provided herein, be made in accordance with GAAP. No change in the accounting principles used in the preparation of any financial statement hereafter adopted by the Borrower or its
Subsidiaries (including, with respect to GAAP, any change in GAAP that would require leases that would be classified as operating leases under GAAP on the Agreement Date to be reclassified as Capital Leases) shall be given effect for purposes of
measuring compliance with any provision of this Agreement or otherwise determining any relevant ratios and baskets which govern whether any action is permitted hereunder unless the Borrower and the Agent agree to modify such provisions to reflect
such changes in GAAP, and unless such provisions are modified, all financial statements and similar documents provided hereunder shall be provided together with a reconciliation between the calculations and amounts set forth therein before and after
giving effect to such changes in GAAP. Notwithstanding any other provision contained herein or in any other Loan Document, all terms of an accounting or financial nature used herein and in the other Loan Documents shall be construed, and all
computations of amounts and ratios referred to herein and in the other Loan Documents shall be made, without giving effect to any election under Statement of Financial Accounting Standards No. 159 (Codification of Accounting Standards 825-10) to value any Indebtedness or other liabilities of any Loan Party or any Subsidiary at “fair value,” as defined therein. 

Section 1.6 [Reserved]. 

Section 1.7 Officers. Any document, agreement or instrument delivered under the Loan Documents that is signed by an Authorized
Officer or another officer of a Loan Party shall be conclusively presumed to have been authorized by all necessary corporate, partnership and/or other action on the part of such Loan Party and such Authorized Officer or other officer shall be
conclusively presumed to have acted on behalf of such Loan Party in such person’s capacity as an officer of such Loan Party and not in any individual capacity. 

Section 1.8 Joint Drafting and Negotiation. The parties hereto have participated jointly in the negotiation and drafting of this
Agreement. In the event an ambiguity or question or intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any provisions of this Agreement. 
 ARTICLE 2 

AGREEMENT FOR THE LOAN 

Section 2.1 Use of Proceeds. The proceeds of the Disbursement will be used solely (i) to refinance certain of the
existing Indebtedness (including a certain amount of the existing 2.25% Convertible Notes and all outstanding obligations under the Existing ABL Credit Facility and the Existing ABL Debt Documents), (ii) to provide funds for the Borrower’s
working capital and general corporate purposes, and (iii) to pay a portion of the fees, costs and expenses related to this Agreement. 

Section 2.2 Disbursements. 

(a) The Disbursement. Subject to the satisfaction of the conditions set forth in Section 4.1 and this Section 2.2(a) on the Agreement Date and subject to the terms in this Agreement and in reliance on the representations and warranties in the Loan Documents, to the extent written
notice requesting such amounts is received by each Lender an Authorized Officer of the Borrower (and with such written notice certifying that all such aforementioned conditions set forth in this Section 2.2(a) are satisfied and with such written
notice being in form and substance reasonably satisfactory to each such Lender) on 

  
 37 

 
the Agreement Date with the proposed date of funding being required to be a Business Day, each Lender on the Agreement Date severally and not jointly agrees to lend to the Borrower on such date,
the principal amount set forth opposite such Lender’s name in Annex A under the heading “Disbursement Amount.” Amounts borrowed under this Section 2.2(a) are referred to as the “Disbursement.” 

(b) No Re-Borrowing of Disbursements or Loans. Amounts borrowed as an Disbursement which are
repaid or prepaid may not be re-borrowed under any circumstance. 
 Section 2.3 Payments;
Prepayments; No Call; Non-Callable Make Whole Amount. 
 (a) The Borrower shall pay in cash to
each of the Lenders its Pro Rata Share of the outstanding principal amount of the Loans and all other Obligations (other than those Obligations under the Warrant, any Stock and the Registration Rights Agreement) on the earliest of (i) the dates
(and in the amounts) set forth in the table below (as such installments may hereafter be adjusted as a result of prepayments made pursuant to this Section 2.3 with the application of any such prepayment being applied and adjusted as set forth
in Section 2.3(e)), (ii) the date the principal amount of the Obligations are declared to be or automatically becomes due and payable following an Event of Default and (iii) the date provided for in Section 5.3: 

 

			
	 Payment Dates
	  	 Principal Amortization

Payment

	 April 2, 2021 (the “First Amortization Date”)
	  	$40,000,000.00 (the “Scheduled First Amortization Payment”)
	 April 2, 2022
	  	$40,000,000.00
	 Maturity Date
	  	$40,000,000.00 or such lesser outstanding amount of the Loans

 (b) Any Lender which is also a holder of Warrants may, at such Lender’s sole option, in accordance with
Section 3(a)(iii) of the applicable Warrant, pay the Exercise Price (as defined in the applicable Warrant) by reducing the principal amount of such Lender’s Loans in an amount equal to such Exercise Price. In connection with any such reduction,
interest shall cease to accrue on such Loans for any day after the date such Exercise Price has been paid and Warrant Shares have been issued to such Lender for the portion of such Warrant that was exercised, and the accrued and unpaid interest on
such Loans shall be paid by the Borrower on the next succeeding Interest Payment Date. 
 (c) Notwithstanding anything to the contrary in any
of the Loan Documents, outstanding principal amounts on the Loans shall not be permitted to be prepaid, repaid, redeemed or paid prior to the First Amortization Date except solely as required or permitted by Section 5.3 or otherwise as set
forth in this Section 2.3(c). If any principal on Loans are prepaid, repaid, redeemed or paid (A) prior to the First Amortization Date for any reason (such as an acceleration of the Loans following the occurrence of an Event of Default, an
exercise of any Secured Party’s rights or remedies available under the Loan Documents, an exercise of any rights or remedies by ABL Agent, an ABL Lender or any other party to the ABL Debt Documents (subject to any applicable limitations thereon
set forth in clause (i) of the proviso in Section 5.4(s)), upon the consummation of a Change in Control, pursuant to Section 5.3, by any optional prepayment or otherwise), then the amount (in addition to the principal amount of the Loans
and any accrued and unpaid interest owed thereon) required to be prepaid, repaid, redeemed or paid shall be the Non-Callable Make Whole Amount applicable to the principal amount of Loans so prepaid, repaid,
redeemed or paid (plus, if In Connection with a Change in Control, the CoC Fee) or (B) on or after the First 

  
 38 

 
Amortization Date but prior to the Maturity Date, In Connection with a Change in Control, then the amount (in addition to the principal amount of the Loans and any accrued and unpaid interest
owed thereon) required to be prepaid, repaid, redeemed or paid shall be the CoC Fee. The Non-Callable Make Whole Amount (together with any applicable CoC Fee) shall be paid by the Borrower to the Secured
Parties based on their Pro Rata Share of the principal amount of the Loans on the date of such prepayment, repayment, redemption or payment. The Parties acknowledge and agree that, in light of the impracticality and extreme difficulty of
ascertaining actual damages, the Non-Callable Make Whole Amount and any CoC Fee are intended to be a reasonable calculation of the actual damages that would be suffered by the Secured Parties as a result of
any such prepayment, repayment, redemption or payment. The parties hereto further acknowledge and agree that the Non-Callable Make Whole Amount and the CoC Fee are not intended to act as a penalty or to punish
the Borrower for any such prepayment, repayment, redemption or payment. For the avoidance of doubt, other than as set forth above in clause (B) in the second sentence of this Section 2.3(c), prepayments of the Loans made on or after the
First Amortization Date, in whole or in part, are permitted and may be made without premium or penalty. 
 (d) Each prepayment, repayment,
redemption and payment by the Borrower shall be applied (i) first, to all fees, costs and expenses (including any attorneys’ fees) owed to Agent under the Loan Documents, (ii) second, ratably to all fees, costs and expenses (including
any attorneys’ fees) owed to any Lender under the Loan Documents, (iii) third, ratably to accrued and unpaid interest owed to the Lenders under the Loan Documents, (iv) fourth, ratably to the principal amount of the Loans (including
any Non-Callable Make Whole Amount and any CoC Fee, if applicable) owed to the Lenders, and, (v) fifth, to all other Obligations (other than any Obligations in respect of the Warrant, Stock underlying the
Warrant and the Registration Rights Agreement that are not at such time owing or unpaid) owing to Agent or any Lender, and, with respect to any such Obligations owed to the Lenders, shall be allocated among the Lenders in accordance with and in
proportion to their Pro Rata Shares. 
 (e) Any principal of any Loan that is prepaid, redeemed or paid pursuant to Section 2.3(b), Section
2.3(c) or Section 5.3 shall be applied to the scheduled payments of the Loans in the inverse order of maturity. 
 Section 2.4
Payment Details. All payments of the Obligations by the Borrower hereunder and under any of the other Loan Documents shall be made without setoff or counterclaim and shall be paid in cash in Dollars. Payments of any amounts and other
Obligations due to Agent or the Lenders under this Agreement or the other Loan Documents shall be made in Dollars in immediately available funds prior to 2:00 p.m. (New York City time) on such date that any such payment is due, using such wire
information or address for Agent or such applicable Lender that is set forth on Schedule 2.4 or at such other bank or place as Agent or such applicable Lenders shall from time to time designate in a writing delivered to the Borrower at least five
(5) Business Days prior to the date such payment is due. The Borrower shall pay all and any fees, costs and expenses (administrative or otherwise) imposed by banks, clearing houses or any other financial institutions in connection with making
any payments under any of the Loan Documents. 
 Section 2.5 Taxes. 

(a) Any and all payments on account of any Obligation of a Loan Party hereunder or under any other Loan Document (in each case in this
Section 2.5, for the avoidance of doubt, not including Obligations in respect of the Warrant or the Registration Rights Agreement) shall be made, in accordance with this Section 2.5, free and clear of and without deduction or withholding
for any and all present or future Taxes except as required by Applicable Law. If any Loan Party shall be required by Applicable Law to deduct or withhold any Taxes from or in respect of any sum payable hereunder or under any other Loan Document,
(i) such Loan Party shall make such deduction or withholding, (ii) such Loan Party shall pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with Applicable

  
 39 

 
Law, and (iii) to the extent that the deduction or withholding is made on account of Indemnified Taxes, the sum payable by the applicable Loan Party shall be increased by as much as shall be
necessary so that after making the required deduction or withholding (including deductions or withholdings applicable to additional sums payable under this Section 2.5), each Lender shall receive an amount equal to the sum it would have
received had no such deduction or withholding been made (any and all such additional amounts payable shall hereafter be referred to as the “Additional Amounts”). Within thirty (30) days after the date of any payment of such
Taxes, the Borrower shall furnish to the applicable Lender the original or a certified copy of a receipt evidencing payment thereof or other evidence of such payment reasonably satisfactory to such Lender. 

(b) In addition, the Loan Parties agree to pay and authorize each Lender to pay in their name, all Other Taxes. Within 30 days after the date
of any payment of Other Taxes by any Loan Party, the Borrower shall furnish to the applicable Lender the original or a certified copy of a receipt evidencing payment thereof or other evidence of such payment reasonably satisfactory to such Lender.

 (c) The Borrower shall reimburse and indemnify, within ten (10) days after receipt of demand therefor, each Lender for all
Indemnified Taxes (including all Indemnified Taxes imposed on amounts payable under this Section 2.5(c)) paid or payable by such Lender, whether or not such Indemnified Taxes were correctly or legally asserted. A certificate of the applicable
Lender(s) setting forth the amounts to be paid thereunder and delivered to the Borrower shall be conclusive, absent manifest error. 
 (d)
Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Loan Document shall deliver to the Borrower, at the time or times reasonably requested by the Borrower, such properly completed
and executed documentation reasonably requested by the Borrower as will permit such payments to be made without withholding or at a reduced rate of withholding. Any Lender that is entitled to an exemption from or reduction of withholding Tax with
respect to payments made under any Loan Document shall deliver to the Borrower and the Agent, at the time or times reasonably requested by the Borrower or the Agent, such properly completed and executed documentation reasonably requested by the
Borrower or the Agent as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Lender, if reasonably requested by the Borrower or the Agent, shall deliver such other documentation prescribed
by Applicable Law. Notwithstanding anything to the contrary in the preceding sentence, the completion, execution and submission of such documentation (other than such documentation set forth below in this Section 2.5(d) shall not be required if in
the Lender’s good faith judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender. Without limiting the
generality of the foregoing each Lender that is a United States person (as such term is defined in Section 7701(a)(30) of the Code) shall, on or before the date on which the Lender becomes a party to this Agreement, provide to Borrower a properly
completed and executed IRS Form W-9 certifying that such Lender is not subject to backup withholding tax. Each Lender that is not a United States person (as such term is defined in Section 7701(a)(30) of the
Code) (a “Foreign Lender”) and is entitled to an exemption from or reduction of U.S. federal withholding tax with respect to payments under this Agreement shall, on or before the date on which such Lender becomes a party to this
Agreement, provide Borrower with a properly completed and executed IRS Form W-8ECI, W-8BEN-E,
W-8IMY or other applicable forms or any other applicable certificate or document reasonably requested by the Borrower and prescribed by Applicable Law as a basis for claiming exemption from or a reduction in
U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by Applicable Law to permit the Borrower to determine the withholding or deduction required to be made and, if such Foreign Lender is
relying on the portfolio interest exception of Section 871(h) or Section 881(c) of the Code (or any successor provision thereto), shall also provide the Borrower with a certificate (the “Portfolio Interest Certificate”) representing
that such Foreign Lender is not a “bank” for purposes of Section 881(c) of the Code (or any successor provision thereto), is 

  
 40 

 
not a 10% holder of the Borrower described in Section 871(h)(3)(B) of the Code (or any successor provision thereto), and is not a controlled foreign corporation receiving interest from a related
person (within the meaning of Sections 881(c)(3)(C) and 864(d)(4) of the Code or any successor provisions thereto). If the Foreign Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio
interest exemption, such Foreign Lender may provide a Portfolio Interest Certificate on behalf of such partners. Each Lender shall provide new forms (or successor forms) as reasonably requested by the Borrower from time to time and shall notify the
Borrower in writing within a reasonable time after becoming aware of any event requiring a change in the most recent forms previously delivered by such Lender to the Borrower. 

(e) If a payment to a Lender under this Agreement would be subject to U.S. federal withholding tax imposed by FATCA if such Lender were to fail
to comply with the applicable reporting requirements of FATCA, such Lender shall deliver to the Borrower, at the times prescribed by law or as reasonably requested by Borrower, such documentation as is required in order for the Borrower to comply
with its obligations under FATCA, to determine that such Lender has or has not complied with its obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this Section 2.5(e),
“FATCA” shall include any amendments made to FATCA after the date of this Agreement. 
 (f) If a Lender determines, in its sole
discretion exercised in good faith, that it has received a refund of any Indemnified Taxes as to which it has been indemnified pursuant to this Section 2.5 (including all Indemnified Taxes imposed on amounts payable under Section 2.5(c)), such
Lender shall promptly pay such refund (but only to the extent of indemnity payments made under this Section 2.5 with respect to the Taxes refund) to the Borrower, net of all
out-of-pocket expense (including any Taxes imposed thereon) of such Lender incurred in obtaining such refund or making such payment, provided that the Borrower, upon the
request of such Lender, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to such Lender if such Lender is required to repay such refund to such
Governmental Authority. Notwithstanding anything to the contrary in this Section 2.5(f), in no event shall a Lender be required to pay any amount to the Borrower pursuant to this Section 2.5(f), the payment of which would place such Lender in a less
favorable net after-Tax position than such Lender would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted or otherwise imposed and the indemnification
payments with respect to such Tax had never been paid. Nothing in this Section 2.5(f) shall require any Lender to disclose any information it deems confidential (including its tax returns) to any Person, including the Borrower. 

Section 2.6 Interest. 

(a) From and after the Agreement Date, the outstanding principal amount of the Loans and any overdue interest shall bear interest at the
Interest Rate (calculated on the basis of a 360-day year for the actual number of days elapsed in each month). Interest shall be paid in cash to the Lenders quarterly in arrears for the preceding calendar
quarter on the first Business Day of each calendar quarter, whether by acceleration or otherwise, commencing on July 1, 2017 and on the first Business Day of each October, January, April and July thereafter, and on the maturity (and on any date
of prepayment, repayment, redemption or payment of the principal) of the Loans (each, an “Interest Payment Date”). 
 (b) As
the Warrants are being issued substantially concurrently with the making of the Loans hereunder, and as Lenders are entitled to the yield enhancement payment described in Section 2.7(a) below, OID shall be applicable and the parties hereto mutually
agree that the amount of OID with respect to the Notes for federal income tax purposes is $22,240,000. 

  
 41 

 (c) All interest and fees under each Loan Document shall be calculated on the basis of a 360-day year for the actual number of days elapsed. 
 (d) If the Obligations would otherwise constitute
“applicable high yield discount obligations” within the meaning of Section 163(i) of the Code (or any successor provision thereof), on each Interest Payment Date ending on or after the fifth anniversary of the Agreement Date, at
Borrower’s sole discretion, Borrower may pay in cash, on or prior to such Interest Payment Date, a minimum amount of interest (including OID) that has been previously accrued and unpaid, as shall be necessary to ensure the Obligations not be
considered “applicable high yield discount obligations”. 
 Section 2.7 Yield Enhancement Payment; Default
Interest; CoC Fee. 
 (a) On the Agreement Date, the Borrower shall pay in cash in Dollars to such Lender (as such Lender
funding such Disbursement shall direct) a yield enhancement payment in the amount of two and twenty-fifths of one hundred percent (2.25%) of the principal amount of such Disbursement funded by such Lender on the Agreement Date as consideration for
providing such Disbursement, and such payment, at the sole option of the applicable Lender, shall be deducted from such Disbursement. Such payment shall be fully earned when paid (or when deducted from such Disbursement) and shall not be refundable
for any reason whatsoever. 
 (b) At the election (which upon such election, to the extent permitted by Applicable Law, such additional
interest rate shall retroactively apply to the first day of existence of such Event of Default) of Agent or the Required Lenders while any Event of Default exists (or automatically while any Event of Default under Section 5.4(a) or 5.4(d) exists),
the Borrower shall pay interest (after as well as before entry of judgment thereon to the extent permitted by Applicable Law) on the Obligations (other than Obligations under the Warrant, the Registration Rights Agreement and any Stock) and past due
interest thereon, if any, from and after the date of occurrence of such Event of Default, at a rate per annum which is determined by adding (i) with respect to any Event of Default under Section 5.4(a), ten percent (10.0%) per annum to
the Interest Rate then in effect for the Loans and (ii) with respect to any other Event of Default, two percent (2%) per annum to the Interest Rate then in effect for the Loans. Such interest shall be payable in cash on demand. 

(c) Upon prepayment, repayment, redemption or payment of any principal of the Loans at any time (including, for the avoidance of doubt, before,
after and on the date of the First Amortization Date but excluding, for the avoidance of doubt, Loans paid in full on the Maturity Date) In Connection with a Change in Control, Borrower shall pay to the Secured Parties the CoC Fee (in addition to
any principal Obligations required to be paid pursuant to Section 5.3 and any applicable Non-Callable Make Whole Amount due pursuant to Section 2.3(c)) based on their Pro Rata Share of the principal of
the Loans on the date of such prepayment, repayment, redemption or payment of such Loans; provided however that if such prepayment, repayment, redemption or payment is In Connection with a Change in Control but prior to the consummation of the
Change in Control, the CoC Fee shall be due and payable contemporaneously with the consummation of a Change in Control. The CoC Fee shall be non-refundable upon receiving payment thereof. The Parties
acknowledge and agree that, in light of the impracticality and extreme difficulty of ascertaining actual damages occurring In Connection with a Change in Control, the CoC Fee is intended to be a reasonable calculation of the actual damages that
would be suffered by the Secured Parties as a result of any such prepayment, repayment, redemption or payment. The parties hereto further acknowledge and agree that the CoC Fee is not intended to act as a penalty or to punish the Borrower for any
such prepayment, repayment, redemption or payment. 

  
 42 

 Section 2.8 Delivery of Warrants. 

(a) On the Agreement Date, the Borrower shall issue to the Lenders, based on such Lenders’ Pro Rata Share, warrants to purchase 6,470,000
shares of Common Stock at an Exercise Price of 127.5% of $7.24 per share (each as subject to any adjustments provided for therein), each in substantially in the form of Exhibit C attached hereto (the “Warrants”) with an expiration
date of April 3, 2024. 
 (b) [Reserved]. 

(c) The Warrants issued pursuant to this Section 2.8 shall be allocated among the Lenders as set forth on Annex A.  
 ARTICLE 3 

REPRESENTATIONS AND WARRANTIES 

Section 3.1 Representations and Warranties of the Loan Parties. The Loan Parties, jointly and severally, represent and
warrant (A) with respect to Section 3.1(g)(i)(B), the first two sentences of Section 3.1(i), Section 3.1(y), Section 3.1(z)(A) and (C), Section 3.1(ee), the first sentence of Section 3.1(mm), Section 3.1(nn), Section 3.1(oo),
Section 3.1(rr), Section 3.1(ss) and Section 3.1(tt), at all times, and (B) with respect to all other provisions of Section 3.1, (I) as of the Agreement Date and (II) as of each date that this Agreement is amended or
modified (or any date any consent or waiver related to this Agreement is entered into or otherwise executed and delivered) in accordance with Section 6.6(b) (but with respect to any representation or warranty that speaks as of an earlier date, such
representation and warranty shall continue to speak only as of such earlier date): 
 (a) Each Loan Party is (i) conducting its business
in compliance with its Organizational Documents and (ii) not in violation of its Organizational Documents. Each Loan Party’s Organizational Documents are in full force and effect. 

(b) No Default or Event of Default has occurred or will result from the transactions contemplated by the Loan Documents. 

(c) Each Loan Party (i) is Solvent and (ii) has not taken action, and no such action has been taken by a third party, for its winding
up, dissolution or liquidation or similar executory or judicial proceeding or for the appointment of a liquidator, custodian, receiver, trustee, administrator or other similar officer for any Loan Party or any or all of its assets or revenues;
provided, however, that, for the avoidance of doubt, no such representation in this Section 3.1(c) is made in respect of any Immaterial Subsidiary. 

(d) No Lien exists on any Loan Party’s assets, except for Permitted Liens. 

(e) The obligation of the Loan Parties to make any payment under this Agreement or the other Loan Documents (together with all charges in
connection therewith) is absolute and unconditional. 
 (f) No Indebtedness of any Loan Party exists other than Permitted Indebtedness. 

(g) Each Loan Party is validly existing as a corporation, limited liability company or limited partnership, as applicable, and is in good
standing under the laws of the jurisdiction of its incorporation, organization or formation, as applicable. Each Loan Party (i) has full power and authority 

  
 43 

 
(and all governmental licenses, authorizations, Permits, consents and approvals) to (A) own its properties and conduct its business (solely with respect to governmental licenses,
authorizations, Permits, consents and approvals, except where the failure to have such governmental licenses, authorizations, Permits, consents and approvals could not reasonably be expected, individually or in the aggregate, to result in a Material
Adverse Effect) and (B) to (x) issue the Securities in accordance with the Loan Documents, (y) enter into, and perform its obligations under, the Loan Documents, including the issuance of the Securities and the reservation for issuance of
the Warrant Shares and (z) consummate the transactions contemplated under the Loan Documents, and (ii) is duly qualified as a foreign corporation, limited liability company or limited partnership, as applicable, and licensed and in good
standing, under the laws of each jurisdiction where its ownership, lease or operation of property or the conduct of its business requires such qualification or license, in each case of this clause (ii), where the failure to be so qualified,
licensed or in good standing could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 
 (h)
Other than as set forth on Schedule 3.1(h), there is not pending or, to the knowledge of the Loan Parties, threatened, any material action, suit or other proceeding before any Governmental Authority (i) to which any Loan Party is a party,
(ii) which purports to affect or pertain to the Loan Documents, the Transactions or the other transaction contemplated hereby or thereby or (iii) which has as the subject thereof any assets owned by any Loan Party or any of its
Subsidiaries, in each case which could reasonably be expected to result in monetary judgments or relief, individually or in the aggregate, in excess of $2,000,000. Other than as set forth on Schedule 3.1(h), there are no current or, to the knowledge
of the Loan Parties, pending, legal actions, suits or other proceedings, in each case which could reasonably be expected to result in monetary judgments or relief, individually or in the aggregate, in excess of $ 2,000,000, to which any Loan Party
or any of its Subsidiaries or any of their respective assets is subject. No injunction, writ, temporary restraining order or any order of any nature has been issued by any court or other Governmental Authority purporting to enjoin or restrain the
execution, delivery or performance of this Agreement or any other Loan Document or directing that the transactions provided for herein or therein not be consummated as herein or therein provided. Other than as set forth on Schedule 3.1(h), none of
the current directors (or equivalent persons) or current officers of the Borrower and its Subsidiaries has been involved as a defendant in securities-related litigation or other securities-related legal proceedings during the past five years. 

(i) The execution, delivery and performance of each of this Agreement and the other Loan Documents, including the issuance of the Securities
hereunder, has been, duly authorized by each Loan Party and no further consent or authorization is required by the Borrower, the Borrower’s board of directors (or other equivalent governing body) or the holders of the Borrower’s Stock.
Each of this Agreement and the other Loan Documents has been duly executed and delivered by each of the Loan Parties and constitutes a valid, legal and binding obligation of each Loan Party, enforceable in accordance with its respective terms,
except as such enforceability may be limited by applicable insolvency, bankruptcy, reorganization, moratorium or other similar laws affecting creditors’ rights generally. The execution, delivery and performance of this Agreement and the other
Loan Documents by each Loan Party party thereto and the consummation of the transactions (including the issuance of the Securities hereunder and thereunder) contemplated herein and therein will not (A) conflict with or result in a breach or
violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any Lien (other than pursuant to the Loan Documents) upon any assets of any such Loan Party pursuant to, any agreement,
document or instrument to which such Loan Party is a party or by which any Loan Party is bound or to which any of the assets or property of any Loan Party is subject, except, with respect to this clause (A), as could not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect, (B) result in any violation of or conflict with the provisions of the Organizational Documents, (C) result in the violation of any Applicable Law, (D) result in the
violation of any judgment, order, rule, regulation or decree of any Governmental Authority, or (E) violate, conflict with or cause a breach or a default under any agreement or instrument binding upon it, except, with respect to clauses (C)

  
 44 

 
and (E) only, as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No consent, approval, Authorization or order of, or registration or
filing with any Governmental Authority is required for (i) the execution, delivery and performance of this Agreement or any of the other Loan Documents, and the issuance of the Securities hereunder and thereunder, and (ii) the consummation
by any Loan Party of the Transactions or the other transactions contemplated hereby or thereby, except for (A) the filings necessary to perfect the Liens created by the applicable Loan Documents and (B) any necessary filings with the SEC.

 (j) Other than has been obtained, no Authorization is required for (i) the execution and delivery of this Agreement or the other Loan
Documents, or (ii) the consummation of the Transactions and the other transactions contemplated hereby and thereby, including the issuance and exercise of the Warrants. 

(k) Each Loan Party and its Subsidiaries are in compliance with Applicable Law except as could not reasonably be expected, individually or in
the aggregate, to have a Material Adverse Effect. 
 (l) Except as could not reasonably be expected, individually or in the aggregate, to
have a Material Adverse Effect, (i) (A) each Loan Party holds, and is operating in compliance in all material respects with, all franchises, grants, Authorizations, licenses, permits, easements, consents, certificates and orders of any
Governmental Authority (collectively, “Necessary Documents”) required for the conduct of its business and (B) all Necessary Documents are valid and in full force and effect and (ii) no Loan Party has (A) received
written notice of any revocation, non-renewal, amendment or other modification of any of the Necessary Documents and (B) reason to believe that any of the Necessary Documents will not be renewed in the
ordinary course of business. 
 (m) As of the Agreement Date, the Real Estate listed in Schedule 3.1(m) constitutes all of the Real Estate of
each Loan Party and each of its Subsidiaries. Each Loan Party has good and marketable title to all of its assets and property free and clear of all Liens, except Permitted Liens. Except as could not reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect, the property held under lease by each Loan Party is held under valid, subsisting and enforceable leases with only such exceptions with respect to any particular lease as do not interfere in any material
respect with the conduct of the business of such Loan Party. 
 (n) Each Loan Party owns, or has the right to use pursuant to a valid and
enforceable written license, free and clear of any Liens other than Permitted Licenses and Permitted Liens, all Intellectual Property that is necessary for the conduct of its business as currently conducted (the “IP”). All IP that
is registered with or issued by a Governmental Authority that is currently in the name of a Loan Party is valid and enforceable. Each patent constituting a Material Intangible Asset is valid and enforceable and no part of the Material Intangible
Assets has been judged invalid or unenforceable, in whole or in part; and there is no pending or, to the knowledge of the Loan Parties, threatened action, suit, other proceeding or claim by any Person challenging or contesting the validity,
ownership, or enforceability of any Material Intangible Asset, the use thereof by any Loan Party, or other rights of any Loan Party in or to any Material Intangible Asset, and no Loan Party has received any written notice regarding any such action,
suit, other proceeding or claim. Neither the conduct of the business of any Loan Party, nor any Loan Party, has infringed, misappropriated or otherwise violated, or is infringing, misappropriating or otherwise violating, any Intellectual Property of
any Person, except as could not reasonably be expected to result in a Material Adverse Effect. Other than as set forth on Schedule 3.1(h), there is no pending or, to the knowledge of the Loan Parties, threatened action, suit, other proceeding or
claim by any Person alleging that any Loan Party is infringing, misappropriating or violating, or otherwise using without authorization, any Intellectual Property of any Person, and no Loan Party has received any written notice regarding, any such
action, suit, 

  
 45 

 
other proceeding or claim. No Loan Party is a party to or bound by any options, licenses or other agreements, written or oral, granting any right, title or interest in or to any IP or otherwise
relating to any IP, other than licenses for computer software acquired in the ordinary course of business. 
 (o) No Loan Party is, except as
could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, in breach of or otherwise in default under, and no event has occurred which, with notice or lapse of time or both, would constitute such breach or
other default in the performance of any agreement or condition contained in any agreement under which it may be bound, or to which any of its assets is subject. 

(p) All U.S. federal, state and local income and franchise and other material Tax returns, reports and statements (collectively, the
“Tax Returns”) required to be filed by any Tax Affiliates have been filed with the appropriate Governmental Authorities, all such Tax Returns are true and correct in all material respects, and all Taxes, assessments and other
governmental charges and impositions reflected therein or otherwise due and payable have been paid prior to the date on which any material Liability may be added thereto for non-payment thereof except for
those contested in good faith by appropriate proceedings diligently conducted and for which adequate reserves are maintained on the books of the appropriate Tax Affiliate in accordance with GAAP. As of the Agreement Date, no material Tax Return is
under audit or examination by any Governmental Authority, and no Tax Affiliate has received written notice from any Governmental Authority of any audit or examination or any assertion of any claim for material Taxes. To the extent material, proper
and accurate amounts have been withheld by each Tax Affiliate from their respective employees for all periods in full and complete compliance with the Tax, social security and unemployment withholding provisions of Applicable Law and such
withholdings have been timely paid to the respective Governmental Authorities. No Tax Affiliate has participated in a “listed transaction” within the meaning of Treasury Regulation Section
1.6011-4(b)(2) or has been a member of an affiliated, combined or unitary group other than the group of which a Tax Affiliate is the common parent. 

(q) [Reserved]. 
 (r) Except as
could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect after the Agreement Date, each Loan Party: (A) at all times has complied with all Applicable Laws; (B) has not received any warning
letter or other correspondence or notice from the any Governmental Authority alleging or asserting noncompliance with any Applicable Laws or any Authorizations; (C) possesses and complies with the Authorizations, which are valid and in full
force and effect; (D) has not received written notice that any Governmental Authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorization and has no knowledge that any Governmental Authority is
considering such action; and (E) has filed, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations.

 (s) The Borrower has filed all of the SEC Documents, within the time frames prescribed by the SEC for the filing of such SEC Documents
such that each filing was timely filed with the SEC. The Borrower filed and made publicly available on the SEC’s Electronic Data Gathering, Analysis, and Retrieval system (including any successor thereto, “EDGAR”) on or prior
to the date this representation is made, true, correct and complete copies of the SEC Documents. As of their respective dates, each of the SEC Documents complied in all material respects with the requirements of the Securities Act and/or the
Exchange Act (as applicable) applicable to the SEC Documents. None of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Since the filing of the SEC Documents, no event has occurred that would require an amendment or supplement to any of the
SEC Documents and as to 

  
 46 

 
which such an amendment or a supplement has not been filed and made publicly available on EDGAR (and true, correct and complete copies of such amendment or supplement, if any, have been delivered
to the Secured Parties or their respective representatives) on or prior to the date this representation is made. The Borrower has not received any written comments from the SEC staff that have not been resolved, to the knowledge of the Borrower, to
the satisfaction of the SEC staff. 
 (t) As of their respective dates, the consolidated financial statements of the Borrower and its
Subsidiaries included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in
accordance with GAAP, consistently applied (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and lack of footnote disclosures), and fairly present in all
material respects the consolidated financial position of the Borrower and its Subsidiaries as of the dates thereof and the consolidated results of their operations, cash flows and changes in stockholders equity for the periods then ended (subject,
in the case of unaudited quarterly financial statements, to normal year-end audit adjustments and lack of footnote disclosures). The accounting firm that expressed its opinion with respect to the consolidated
financial statements included in the Borrower’s most recently filed annual report on 10-K, and reviewed the consolidated financial statements included in the Borrower’s most recently filed quarterly
report on 10-Q, was independent of the Borrower pursuant to the standards set forth in Rule 2-01 of Regulation S-X promulgated by
the SEC and as required by the applicable rules and guidance from the Public Company Accounting Oversight Board (United States), and such firm was otherwise qualified to render such opinion under Applicable Law and the rules and regulations of the
SEC. There is no transaction, arrangement or other relationship between the Borrower (or any of its Subsidiaries) and an unconsolidated or other off-balance-sheet Person that is required to be disclosed by the
Borrower in the SEC Documents that has not been so disclosed in the SEC Documents. Neither the Borrower nor any of its Subsidiaries is required to file or will be required to file any agreement, note, lease, mortgage, deed or other instrument
entered into prior to the date this representation is made and to which the Borrower or any of its Subsidiaries is a party or by which the Borrower or any of its Subsidiaries is bound that has not been previously filed as an exhibit (including by
way of incorporation by reference) to the Borrower’s reports filed or made with the SEC under the Exchange Act. Other than (i) the liabilities assumed or created pursuant to this Agreement and the other Loan Documents and any fees and
expenses in connection therewith, (ii) liabilities accrued for in the latest balance sheet included in the Borrower’s most recent periodic report (on 10-Q or
10-K) filed prior to the date this representation is made (the date of such balance sheet, the “Latest Balance Sheet Date”), (iii) liabilities incurred in the ordinary course of business
consistent with past practice since the later of the (A) Agreement Date and (B) the Latest Balance Sheet Date and (iv) liabilities set forth on the Schedules to this Agreement, the Borrower and its Subsidiaries do not have any other
material liabilities (whether fixed or unfixed, known or unknown, absolute or contingent, asserted or unasserted, choate or inchoate, liquidated or unliquidated, or secured or unsecured, and regardless of when any action, claim, suit or proceeding
with respect thereto is instituted). Since December 31, 2016, there has been no Material Adverse Effect or any event or circumstance which could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.
All financial performance projections delivered to any Secured Party, including the financial performance projections delivered on or prior to the Agreement Date, if any, represent the Borrower’s and its Subsidiaries’ good faith estimate
of future financial performance and are based on assumptions believed by the Borrower and its Subsidiaries to be fair and reasonable in light of current market conditions, it being acknowledged and agreed by Agent and the Lenders that projections as
to future events are not to be viewed as facts and that the actual results during the period or periods covered by such projections may differ from the projected results and such differences may be material. 

(u) The Borrower and its Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit 

  
 47 

 
preparation of financial statements in conformity with GAAP and to maintain asset and liability accountability, (iii) access to assets or incurrence of liability is permitted only in
accordance with management’s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken
with respect to any differences (such internal accounting controls (including clauses (i) – (iv) above), collectively, “Internal Controls”). The Borrower and its Subsidiaries have (A) timely filed and made publicly
available on EDGAR all certifications, statements and documents required by (1) Rule 13a-14 or Rule 15d-14 under the Exchange Act. The Borrower and its Subsidiaries
maintain disclosure controls and procedures required by Rule 13a-15 or Rule 15d-15 under the Exchange Act; such controls and procedures are effective to ensure that the
information required to be disclosed by the Borrower and its Subsidiaries in the reports that they file with or submit to the SEC (A) is recorded, processed, summarized and reported accurately within the time periods specified in the SEC’s
rules and forms and (B) is accumulated and communicated to the Borrower’s (and, to the extent applicable, its Subsidiaries’) management, including its or their principal executive officer and principal financial officer, as
appropriate to allow timely decisions regarding required disclosure. The Borrower and its Subsidiaries maintain internal control (including Internal Controls) over financial reporting required by Rule 13a-15
or Rule 15d-15 under the Exchange Act; such internal control (including Internal Controls) over financial reporting is effective and does not contain any material weaknesses. 

(v) [Reserved]. 
 (w) (i) No
Loan Party has engaged, and to the knowledge of the Loan Parties, no other Person has engaged in any “prohibited transaction” as defined under Section 406 of ERISA or Section 4975 of the Code that is not exempt under ERISA
Section 408 or Section 4975 of the Code, under any applicable regulations and published interpretations thereunder or under any applicable prohibited transaction, individual or class exemption issued by the Department of Labor, with
respect to any Employee Benefit Plan, except as for such transaction that could not be expected, individually or in the aggregate, to have a Material Adverse Effect, (ii) (A) at no time within the last seven years has the Borrower or any ERISA
Affiliate maintained, sponsored, participated in, contributed to or had any Liability with respect to, and (B) no Loan Party or any ERISA Affiliate has any Liability or obligation in respect of, any Title IV Plan, Multiemployer Plan or any
multiple employer plan for which the Borrower or any ERISA Affiliate has incurred or could incur Liability under Section 4063 or 4064 of ERISA, (iii) each Employee Benefit Plan is and has been operated in compliance with its terms and all
Applicable Laws, including ERISA and the Code, except for such failures to comply that could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (iv) (A) no ERISA Event has occurred and (B) no
event or condition exists or existed that could reasonably be expected to subject the Borrower or any ERISA Affiliate to any tax, fine, lien, penalty or Liability imposed by ERISA, the Code or other Applicable Law, except for any such ERISA Event or
tax, fine, lien, penalty or liability that could not be expected, individually or in the aggregate, to have a Material Adverse Effect, and (v) no Loan Party maintains or has any obligation or Liability with respect to any Foreign Benefit Plan
that, individually or in the aggregate, could be expected to have a Material Adverse Effect. 
 (x) As of the Agreement Date, the
Borrower’s Subsidiaries are set forth in Schedule 3.1(x) and the information set forth in Schedule 3.1(x) is true, correct and complete. 

(y) Subsequent to December 31, 2015, the Borrower has not declared or paid any dividends or made any distribution of any kind with respect
to its Stock, except as permitted hereunder. 
 (z) (A) All of the issued and outstanding shares of Stock of the Borrower are duly
authorized and validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal and state and foreign securities laws, were not issued in violation of or subject to any

  
 48 

 
preemptive rights or other rights to subscribe for or purchase securities that have not been waived in writing. The Borrower has reserved for issuance a number of shares of Common Stock
sufficient to cover all shares issuable upon the exercise of the Warrants (the “Warrant Shares”) (computed without regard to any limitations on the number of shares that may be issued on exercise thereof). The Warrants, the Warrant
Shares and any other distributions required to be made now or in the future pursuant to the Warrants (the “Warrant Distributions”) have been duly authorized. Upon the issuance in accordance with the terms of this Agreement, the
holders of the Warrants will be entitled to the rights set forth in the Warrants. Upon exercise in accordance with the Warrants, the Warrant Shares will be validly issued, fully paid and non-assessable and
free from all taxes and Liens with respect to the issue thereof, with the holders thereof being entitled to all rights accorded to a holder of Common Stock. The issuance by the Borrower of the Securities is exempt from registration under the
Securities Act (pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D thereunder) and applicable state securities laws. (B) As of the Agreement Date, all of the Borrower’s authorized, issued and outstanding shares of Stock of
the Borrower and each of its Subsidiaries are set forth in Schedule 3.1(z), and, except as set forth in Schedule 3.1(z), there are no (i) Stock options or other Stock incentive plans, employee Stock purchase plans or other plans, programs or
arrangements of the Borrower or any of its Subsidiaries under which Stock options, Stock or other Stock-based or Stock-linked awards are issued or issuable to officers, directors, employees, consultants or other Persons, (ii) outstanding
options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into or exchangeable or exercisable for, any Stock of the Borrower or any of its Subsidiaries, or
contracts, commitments, understandings or arrangements by which the Borrower or any of its Subsidiaries is or may become bound to issue additional Stock of the Borrower or any of its Subsidiaries, or options, warrants or scrip for rights to
subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into or exercisable or exchangeable for, any shares of Stock of the Borrower or any of its Subsidiaries, (iii) agreements or
arrangements under which the Borrower or any of its Subsidiaries is obligated to register the sale of any of their securities or Stock under the Securities Act (except the Registration Rights Agreement), (iv) outstanding Stock, securities or
instruments of the Borrower or any of its Subsidiaries that contain any redemption or similar provisions, or contracts, commitments, understandings or arrangements by which the Borrower or any of its Subsidiaries is or may become bound to redeem a
security of the Borrower other than under the Convertible Note Documents, (v) Stock or other securities or instruments containing anti-dilution or similar provisions that may be triggered by the issuance of securities of the Borrower or any of
its Subsidiaries other than under the Convertible Note Documents or (vii) stock appreciation rights or “phantom stock” plans or agreements or any similar plans or agreements to which Borrower or any of its Subsidiaries is a party or
by which the Borrower or any of its Subsidiaries is otherwise subject or bound. There are no (X) stockholders’ agreements, voting agreements or similar agreements to which Borrower or any of its Subsidiaries is a party or by which the
Borrower or any of its Subsidiaries is otherwise subject or bound, other than in connection with clauses (i), (k) and (n) of the definition of “Permitted Investments”, (Y) preemptive rights or any other similar rights to
which any Stock of the Borrower or any of its Subsidiaries is subject or (Z) any restrictions upon the voting or transfer of any Stock of the Borrower or any of its Subsidiaries (other than restrictions on transfer imposed by U.S. federal and
state securities laws and other than as set forth in the Loan Documents, the ABL Debt Documents and, if such instrument is permitted hereunder to be secured, the documents governing the Permitted 3.25% Convertible Note Refinancing). (C) The issuance
and delivery of the Warrants does not and, assuming full exercise of the Warrants, the exercise of the Warrants, will not: (i) require approval from any Governmental Authority; (ii) obligate the Borrower to issue shares of Common Stock or
other securities to any Person (other than the Secured Parties); and (iii) will not result in a right of any holder of the Borrower’s securities to adjust the exercise, conversion, exchange or reset price under and will not result in any
other adjustments (automatic or otherwise) under, any securities of the Borrower. (D) The Borrower has furnished to Agent and each Lender true, correct and complete copies of each Loan Parties’ Organizational Documents and any amendments,
restatements, supplements or modifications thereto, and all documents, agreements and instruments containing the terms of all securities and Stock convertible into, or exercisable or exchangeable for, Common Stock or other Stock of any Loan Party or
its Subsidiaries, and the material rights of the holders thereof in respect thereto. 

  
 49 

 (aa) Except for the Operative Documents, the Convertible Note Documents and the agreements set
forth on Schedule 3.1(aa), as of the Agreement Date there are no Material Contracts. The consummation of the transactions contemplated by the Loan Documents will not give rise to a right to termination in favor of any party to any Material Contract
(other than any Loan Party), except for such Material Contracts the noncompliance with which would not reasonably be expected to have a Material Adverse Effect. 

(bb) Neither the Borrower nor its Subsidiaries are in breach or default under any Material Contract, and, to the knowledge of the Loan Parties,
no other party to a Material Contract is in default or breach thereunder, except where any breach or default would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(cc) The proceeds of the Loans are intended to be and shall be used solely for the purposes set forth in and permitted by Section 2.1.

 (dd) Except as set forth in Schedule 3.1(dd) and except where any failures to comply could not reasonably be expected to result in, either
individually or in the aggregate, a Material Adverse Effect, each Loan Party and each Subsidiary of each Loan Party (a) are and have been in compliance with all applicable Environmental Laws, including obtaining and maintaining all Permits
required by any applicable Environmental Law, (b) is not party to, and no Real Estate currently (or to the knowledge of any Loan Party previously) owned, leased, subleased, operated or otherwise occupied by or for any such Person is subject to
or the subject of, any contractual obligation or any pending or, to the knowledge of any Loan Party, threatened, order, action, investigation, suit, proceeding, audit, Lien, claim, demand, dispute or notice of violation or of potential liability or
similar notice relating in any manner to any Environmental Law, (c) has not caused or suffered to occur a Release of Hazardous Materials at, to or from any Real Estate, (d) does not currently (or to the knowledge of any Loan Party,
previously) own, lease, sublease, operate or otherwise occupy no Real Estate that is contaminated by any Hazardous Materials and (e) is not, and has not been, engaged in, and has not permitted any current or former tenant to engage in,
operations in violation of any Environmental Law and knows of no facts, circumstances or conditions reasonably constituting notice of a violation of any Environmental Law, including receipt of any information request or notice of potential
responsibility under the Comprehensive Environmental Response, Compensation and Liability Act or similar Environmental Laws. 
 (ee) None of
any Loan Party, any Person controlling any Loan Party or any Subsidiary of any Loan Party is (a) an “investment company,” or a company “controlled” by an “investment company,” within the meaning of the Investment
Company Act, or otherwise registered or required to be registered, or subject to the restrictions imposed, by the Investment Company Act, or (b) subject to regulation under the Federal Power Act, the Interstate Commerce Act, any state public
utilities code, or any other federal or state statute, rule or regulation limiting its ability to incur Indebtedness, pledge its assets or perform its obligations under the Loan Documents. 

(ff) There are no strikes, boycotts, grievances, work stoppages, slowdowns, lockouts or other job actions existing, pending (or, to the
knowledge of any Loan Party, threatened) against or involving any Loan Party or any Subsidiary of any Loan Party, except for those that could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Except as
set forth on Schedule 3.1(ff), or except as could not reasonably be expected to have a Material Adverse Effect, as of the Agreement Date, (a) there is no memorandum of understanding, collective bargaining or similar agreement, and there is no
ongoing negotiation or duty to negotiate, with any union, labor organization, works council 

  
 50 

 
or similar representative covering any Employee or otherwise binding any Loan Party or any Subsidiary of any Loan Party, (b) to the Loan Parties’ knowledge, no petition for
certification or election of any such representative is existing or pending with respect to any Employee, (c) to the Loan Parties’ knowledge, no such representative has sought certification or recognition with respect to any Employee, and
(d) to the Loan Parties’ knowledge, no Employee or his or her representative is engaged in any organizing efforts. All current and former Employees are or were correctly classified as exempt or
non-exempt under, and are and have been paid in accordance with, all applicable federal, state, and local wage and hour laws. Further, all individuals who perform or have performed services for any Loan Party
or any Subsidiary of any Loan Party are or were correctly classified under each Employee Benefit Plan, ERISA, the Internal Revenue Code and other Applicable Law as common law employees, independent contractors or other
non-employee basis, or leased employees, except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Each Loan Party and Subsidiary of any Loan Party are in
material compliance with all Applicable Laws concerning employment, including without limitation hiring, background checks, compensation, benefits, wages (including payment of overtime), wage deductions and withholdings, classification, immigration,
work authorization, employment eligibility verification, reporting, taxation, occupational health and safety, equal rights, labor relations, accommodations, breaks, notices, employment policies, paid or unpaid time off work, accessibility, privacy,
and workers’ compensation, except for such noncompliance that could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(gg) Schedule 3.1(gg) lists each Loan Party’s jurisdiction of organization, legal name and organizational identification number, if any,
and the location of such Loan Party’s chief executive office or sole place of business, in each case as of the Agreement Date, and Schedule 3.1(gg) also lists all jurisdictions of organization and legal names of such Loan Party for the five
years preceding the Agreement Date. 
 (hh) [Reserved]. 

(ii) [Reserved]. 
 (jj) Each Loan
Party and each Subsidiary of each Loan Party is in compliance in all material respects with all U.S. economic sanctions laws, executive orders and implementing regulations (“Sanctions”) as administered by the U.S. Treasury
Department’s Office of Foreign Assets Control (“OFAC”) and the U.S. State Department. No Loan Party and no Subsidiary of a Loan Party (i) is a Person on the list of the Specially Designated Nationals and Blocked Persons
(the “SDN List”), (ii) is a Person who is otherwise the target of U.S. economic sanctions laws such that a U.S. Person cannot deal or otherwise engage in business transactions with such Person, (iii) is a Person organized or
resident in a country or territory subject to comprehensive Sanctions (a “Sanctioned Country”), or (iv) is owned or controlled by (including by virtue of such Person being a director or owning voting shares or interests), or
acts, directly or indirectly, for or on behalf of, any Person on the SDN List or a government of a Sanctioned Country such that the entry into, or performance under, this Agreement or any other Loan Document would be prohibited by U.S. law. Each
Loan Party and each Subsidiary of each Loan Party is in compliance with all laws related to terrorism or money laundering (“Anti-Money Laundering Laws”) including: (i) all applicable requirements of the Currency and Foreign
Transactions Reporting Act of 1970 (31 U.S.C. 5311 et. seq., (the Bank Secrecy Act)), as amended by Title III of the USA Patriot Act, (ii) the Trading with the Enemy Act, (iii) Executive Order No. 13224 on Terrorist Financing,
effective September 24, 2001 (66 Fed. Reg. 49079), and any other enabling legislation, executive order or regulations issued pursuant or relating thereto and (iv) other applicable federal or state laws relating to “know your
customer” or anti-money laundering rules and regulations. No action, suit or proceeding by or before any court or Governmental Authority with respect to compliance with such Anti-Money Laundering Laws is pending or threatened to the knowledge
of each Loan Party and each Subsidiary of each Loan Party. Each Loan Party and each Subsidiary of each 

  
 51 

 
Loan Party is in compliance in all material respects with all applicable anti-corruption laws, including the U.S. Foreign Corrupt Practices Act of 1977 (“FCPA”) and the U.K.
Bribery Act 2010 (“Anti-Corruption Laws”). None of any Loan Party or any Subsidiary of a Loan Party, nor to the knowledge of any Loan Party or any Subsidiary thereof, any director, officer, agent, employee or other Person acting on
behalf of the Loan Party or any Subsidiary of a Loan Party, has taken any action, directly or indirectly, that would result in a violation of applicable Anti-Corruption Laws. The Loan Party and each Subsidiary of a Loan Party maintains and
implements policies and procedures designed to ensure compliance by the Loan Parties, their Subsidiaries and their respective directors, officers, employees and agents with Sanctions, Anti-Money Laundering Laws and Anti-Corruption Laws. 

(kk) The Borrower and its Subsidiaries are in all material respects in compliance with applicable provisions of the Sarbanes-Oxley Act of 2002,
as amended, and the rules and regulations thereunder (collectively, “Sarbanes-Oxley”). 
 (ll) Neither the Borrower nor any
of its Subsidiaries nor, to the Borrower’s knowledge, any director, officer or employee, of the Borrower or any of its Subsidiaries, has received or otherwise obtained any material complaint, allegation, assertion or claim, whether written or
oral, regarding the accounting or auditing practices, procedures, methodologies or methods of the Borrower or any of its Subsidiaries or its internal accounting controls, including any complaint, allegation, assertion or claim that the Borrower or
any of its Subsidiaries has engaged in questionable accounting or auditing practices. No attorney representing the Borrower or any of its Subsidiaries, whether or not employed by the Borrower or any of its Subsidiaries, has reported evidence of a
material violation of securities laws or breach of fiduciary duty or similar violation by the Borrower or any of its Subsidiaries or any of their respective officers, directors, employees or agents to the Borrower’s or any of its
Subsidiaries’ board of directors (or equivalent governing body) or any committee thereof or to any director (or equivalent person) or officer of the Borrower or any of its Subsidiaries pursuant to Section 307 of Sarbanes-Oxley, and the
SEC’s rules and regulations promulgated thereunder. There have been no internal or SEC investigations regarding accounting or revenue recognition discussed with, reviewed by or initiated at the direction of the chief executive officer, the
principal financial officer or the principal accounting officer (in each case, or officer holding such equivalent position) of the Borrower or any of its Subsidiaries, the Borrower’s or any of its Subsidiaries’ board of directors (or
equivalent governing body) or any committee thereof. 
 (mm) The Borrower is not, and never has been, a “shell company” (as defined
in Rule 12b-2 under the Exchange Act). The Borrower is eligible to register the Warrant Shares for resale by the holders thereof on a registration statement on Form S-3
under the Securities Act. 
 (nn) Neither the Borrower, nor any of its Affiliates, nor any Person acting on its or their behalf, has engaged
or will engage in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer, sale or issuance of the Securities. 

(oo) Neither the Borrower, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made, or will
make, any offers or sales of any security or Stock or solicited any offers to buy any security or Stock, under circumstances that would require registration of any of the Securities under the Securities Act or cause this offering of the Securities
to be integrated with prior offerings by the Borrower for purposes of the Securities Act or any applicable holder of Stock approval provisions of the Principal Market or any other authority. 

(pp) The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and neither the Borrower nor any of its Subsidiaries has
taken, or will take, any action designed to terminate, or which to the knowledge of the Borrower and its Subsidiaries is likely to have the effect of 

  
 52 

 
terminating, the registration of the Common Stock under the Exchange Act, nor has the Borrower or any of its Subsidiaries received any notification that the SEC is contemplating terminating such
registration. Neither the Borrower nor any of its Subsidiaries is in violation of any of the rules, regulations or requirements of the Principal Market, and, to the knowledge of the Borrower and its Subsidiaries, there are no facts or circumstances
that could reasonably lead to suspension or termination of trading of the Common Stock on the Principal Market. For not less than the five years preceding the Agreement Date, (i) the Common Stock has been listed or designated for quotation, as
applicable, on the Principal Market, (ii) trading in the Common Stock has not been suspended or deregistered by the SEC or the Principal Market, and (iii) neither the Borrower nor any of its Subsidiaries has received any communication,
written or oral, from the SEC or the Principal Market regarding the suspension or termination of trading of the Common Stock on the Principal Market. 

(qq) The Common Stock is eligible for clearing through The Depository Trust Company (“DTC”), through its Deposit/Withdrawal At
Custodian (DWAC) system, and the Borrower is eligible for and participating in the Direct Registration System (DRS) of DTC with respect to the Common Stock. The transfer agent for the Common Stock is a participant in, and the Common Stock is
eligible for transfer pursuant to, DTC’s Fast Automated Securities Transfer Program. The Common Stock is not, and has not at any time been, subject to any DTC “chill,” “freeze” or similar restriction with respect to any DTC
services, including the clearing of transactions in shares of Common Stock through DTC. 
 (rr) The Borrower and the Borrower’s board of
directors (or equivalent governing body) have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination or other similar anti-takeover provision under the Borrower’s Organizational
Documents or the laws of the State of Delaware that is or could become applicable to any of the Secured Parties as a result of the transactions contemplated by the Loan Documents and the Borrower’s fulfilling its obligations with respect
thereto, including the Borrower’s issuance of the Securities and any Secured Party’s ownership of the Securities. As of the Agreement Date, the Borrower has not adopted a stockholders rights plan (or “poison pill”) or similar
arrangement relating to accumulations of beneficial ownership of Common Stock or a change in control of the Borrower (any such plan or arrangement, a “Rights Plan”), and after the Agreement Date, the Borrower will not have adopted
any Rights Plan that in any way interferes with, or otherwise adversely affects, any Lender’s (or other holder’s) exercise in full of its rights under the Warrants or ownership of all of the Warrant Shares or that otherwise affects or
applies to any Lender (or such other holder of Warrants or Warrant Shares) in any respect that is less favorable than its effect on the most favorably treated holder of Stock of the Borrower under such Rights Plan. 

(ss) It is understood and acknowledged by the Borrower that none of the Secured Parties nor holders of the Securities has been asked to agree,
nor has any Secured Party agreed, to desist from purchasing or selling, long and/or short, Stock or other securities of the Borrower, or “derivative” securities or Stock based on Stock or other securities issued by the Borrower or to hold
the Securities for any specified term; and no Secured Party nor holder of Securities shall be deemed to have any affiliation with or control over any arm’s length counterparty in any “derivative” transaction. The Borrower further
understands and acknowledges that (i) one or more Secured Parties or holders of Securities may engage in hedging and/or trading activities at various times during the period that the Securities are outstanding, and (ii) such hedging and/or
trading activities, if any, can reduce the value of the Stock held by the existing holders of Stock of the Borrower, both at and after the time the hedging and/or trading activities are being conducted. The Borrower acknowledges that any such
hedging and/or trading activities do not constitute a breach of any Loan Document or affect the rights of any Secured Party or holder of Securities under any Loan Document. The Borrower further acknowledges that its obligations under the Loan
Documents, including its obligation to issue the Warrant Shares upon exercise of the Warrants, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of any claim any Loan Party may have
against any of the Secured Parties and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Borrower. 

  
 53 

 (tt) The Borrower and the other Loan Parties are solely responsible for the payment of any fees,
costs, expenses and commissions of any placement agent, broker or financial adviser relating to or arising out of the transactions contemplated by the Loan Documents. The Borrower and the other Loan Parties will pay, and hold each of the Secured
Parties harmless against, any liability, loss or expense (including attorneys’ fees, costs and expenses) arising in connection with any claim for any such payment, other than those arising from the gross negligence or willful misconduct of
Agent or any Lender as determined by a final, non-appealable judgment of a court of competent jurisdiction. 

(uu) [Reserved]. 
 (vv) With
respect to any Product, (i) the Loan Parties and their Subsidiaries have received, and such Product is the subject of, all Regulatory Required Permits needed in connection with the testing, manufacture, marketing or sale of such Product as
currently being conducted by or on behalf of such Loan Parties or Subsidiaries, except where the failure to have such Regulatory Required Permits would not have a Material Adverse Effect, and (ii) such Product is being tested, manufactured,
marketed or sold, as the case may be, in compliance in all material respects with all Applicable Laws and Authorizations. 
 (ww) None of the
Loan Parties are in violation of any Healthcare Laws, except where any such violation would not have a Material Adverse Effect. 
 (xx)
[Reserved]. 
 (yy) No Loan Party is participating in any Third Party Payor Program. 

(zz) To the knowledge of any of the Loan Parties’ Authorized Officers, none of the Loan Parties’ officers, directors, employees,
equityholders, agents or Affiliates has made an untrue statement of material fact or fraudulent statement to the FDA or failed to disclose a material fact required to be disclosed to the FDA, committed an act, made a statement, or failed to make a
statement that could reasonably be expected to provide a basis for the FDA to invoke its policy respecting “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,” set forth in 56 Fed. Regulation 46191 (September 10,
1991). 
 (aaa) No Loan Party has received any written notice that any Governmental Authority, including the FDA, the Office of the Inspector
General of the United States Department of Health and Human Services or the United States Department of Justice has commenced or threatened to initiate any action against a Loan Party, any action to enjoin a Loan Party, or any of its officers,
directors, employees, equityholders, agents or Affiliates, from conducting their businesses at any facility owned or used by them or for any civil penalty, injunction, seizure or criminal action, in each case, which could reasonably be expected to
result in a Material Adverse Effect. 
 (bbb) Borrower has not received from the FDA a Warning Letter, Form
FDA-483, “Untitled Letter,” other correspondence or notice setting forth allegedly objectionable observations or alleged violations of laws or regulations enforced by the FDA, or any comparable
correspondence from any state or local authority responsible for regulating drug products and establishments, or any comparable correspondence from any foreign counterpart of the FDA, or any comparable correspondence from any foreign counterpart of
any state or local authority with regard to any Product or the manufacture, processing, packing, or holding thereof, in each case, which could reasonably be expected to result in a Material Adverse Effect. 

  
 54 

 (ccc) Borrower has not engaged in any Recalls, Market Withdrawals, or other forms of product
retrieval from the marketplace of any Products which could reasonably be expected to result in a Material Adverse Effect. 
 (ddd) Each
Product (a) is not adulterated or misbranded within the meaning of the FDCA; (b) is not an article prohibited from introduction into interstate commerce under the provisions of Sections 404, 505 or 512 of the FDCA; (c) has been and/or
shall be manufactured, imported, possessed, owned, warehoused, marketed, promoted, sold, labeled, furnished, distributed and marketed, and each service has been conducted, in accordance in all material respects with all applicable Authorizations and
Applicable Laws; and (d) has been and/or shall be manufactured in accordance with Good Manufacturing Practices, in each case, except where the failure to do so would not have a Material Adverse Effect. 

(eee) No Loan Party is subject to any proceeding, suit or, to any Loan Party’s knowledge, investigation by any federal, state or local
government or quasi-governmental body, agency, board or authority or any other administrative or investigative body (including the Office of the Inspector General of the United States Department of Health and Human Services) which would have a
Material Adverse Effect on any Loan Party; 
 (fff) The Loan Parties have not received any notice, and are not aware, of any violation of
applicable antitrust laws, employment or landlord-tenant laws of any federal, state or local government or quasi-governmental body, agency, board or other authority with respect to the Loan Parties that could reasonably be expected to result in a
Material Adverse Effect. 
 (ggg) None of the proceeds from the Loans have been or will be used, directly or indirectly, for the purpose of
purchasing or carrying any Margin Stock, for the purpose of reducing or retiring any Indebtedness which was originally incurred to purchase or carry any Margin Stock or for any other purpose which might cause any of the Loans to be considered a
“purpose credit” within the meaning of Regulation T, U or X of the Federal Reserve Board. 
 (hhh) None of the written information
(financial or otherwise) (other than projections, other forward-looking information and industry information) furnished by or on behalf of any Loan Party to Agent or any Lender in connection with the consummation of the transactions contemplated by
the Loan Documents, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained herein or therein not materially misleading in light of the circumstances under which such statements
were made. 
 (iii) The rate of interest paid under the Notes and the method and manner of the calculation thereof do not violate any usury
or other Applicable Laws, any of the Organizational Documents, or any of the Loan Documents. 
 (jjj) The Loan Parties do not own any stock,
partnership interests, limited liability company interest or other equity securities or Subsidiaries except for Permitted Investments. 

(kkk) All information set forth in the Schedules to this Agreement is true, accurate and complete in all material respects as of the Agreement
Date and any other subsequent date in which the Loan Parties are requested to update such Schedules. All information set forth in the Perfection Certificate is true, accurate and complete in all material respects as of the Agreement Date and any
other subsequent date in which the Loan Parties are requested to update such certificate. 

  
 55 

 Section 3.2 Borrower Acknowledgment. The Loan Parties (on their behalf and on
their Subsidiaries’ behalf) acknowledge that they have made the representations and warranties referred to in Section 3.1 with the intention of persuading Agent and the Lenders to enter into the Loan Documents and that Agent and the
Lenders have entered into the Loan Documents on the basis of, and in full reliance on, each of such representations and warranties, each of which shall survive the execution and delivery of this Agreement, the other Loan Documents, the making of any
Disbursement and the issuance of the Securities until the later of (a)(i) all of the Obligations are repaid in full and (ii) all of the Warrants have expired or been terminated and (b) the end of the Reporting Period. 

Section 3.3 Representations and Warranties of the Lenders. Each Lender, severally and not jointly, represents and warrants
to the Borrower as of the Agreement Date that: 
 (a) Such Lender (i) is acquiring the Loans and the Notes (together with the related
guaranties set forth in the Security Agreement of the Guarantors) provided by such Lender and the Warrants related to the Loans made by such Lender hereunder and (ii) upon any exercise of such Warrants, will acquire the Warrant Shares
then-issuable upon exercise thereof for its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under, or exempted from, the registration
requirements of the Securities Act; provided, however, that by making the representations herein, such Lender does not agree to hold any of the Securities for any minimum or other specific term and reserves the right to assign,
transfer or otherwise dispose of any of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under the Securities Act. 

(b) Such Lender is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D. 

(c) Such Lender understands that the Securities are being offered and sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Borrower is relying in part upon the truth and accuracy of, and such Lender’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of such Lender set forth herein in order to determine the availability of such exemptions. 
 (d) Such Lender and its
advisors, if any, have been furnished with all materials relating to the business, finances and operations of the Loan Parties and their Subsidiaries and materials relating to the offer and sale of the Securities that have been requested by such
Lender. Such Lender and its advisors, if any, have been afforded the opportunity to ask questions of the Loan Parties. Neither such inquiries nor any other due diligence investigations conducted by such Lender or its advisors, if any, or its
representatives shall modify, amend or otherwise affect such Lender’s right to rely on the representations and warranties of the Loan Parties and their Subsidiaries contained in Article 3 and elsewhere in the Loan Documents. Such Lender can
bear the economic risk of a total loss of its investment in the Securities being offered and has such knowledge and experience in business and financial matters so as to enable it to understand the risks of and investment decision with respect to
its investment in the Securities. 
 (e) Such Lender understands that no United States federal or state agency or any other government or
Governmental Authority has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the
Securities. 
 (f) Such Lender is duly organized and validly existing under the laws of the jurisdiction of its formation. 

  
 56 

 (g) Each Loan Document to which such Lender is a party has been duly authorized, executed and
delivered by such Lender and constitutes the valid and legally binding obligation of such Lender, enforceable against such Lender in accordance with its terms, except as such enforceability may be limited by (i) applicable insolvency,
bankruptcy, reorganization, moratorium or other similar laws affecting creditors’ rights generally, and (ii) applicable equitable principles (whether considered in a proceeding at law or in equity). 

(h) Such Lender has the requisite power and authority to enter into and perform its obligations under each of the Loan Documents to which such
Lender is a party. 
 (i) Such Lender understands that the Securities are characterized as “restricted securities” under the U.S.
federal securities laws inasmuch as they are being acquired from the Borrower (or the Guarantors, as applicable) in a transaction not involving a public offering and that none of the Securities may be resold and/or hedged except pursuant to an
effective registration statement under the Securities Act or an exemption from the registration requirements of the Securities Act, including Rule 144 under the Securities Act, Section 4(a)(7) of the Securities Act or a so-called “4[(a)] and a half” transaction. 
 ARTICLE 4 

CONDITIONS OF DISBURSEMENT 

Section 4.1 Conditions to the Disbursement. The obligation of the Lenders to make the Disbursement shall be subject to the
fulfillment and satisfaction of all of the following conditions: 
 (a) Agent and the Lenders shall have received executed counterparts of
this Agreement and each other Loan Document (including the Intercreditor Agreement) set forth on the closing checklist attached hereto as Exhibit D; 

(b) all actions required to be taken by the Borrower pursuant to Section 2.8 shall have been taken; 

(c) each representation and warranty by any Loan Party or any of its Subsidiaries contained herein or in any other Loan Document is true,
correct and complete in all material respects (without duplication of any materiality qualified contained therein) as of such date, except to the extent that such representation or warranty expressly relates to an earlier date (in which event such
representations and warranties were true, correct and complete in all material respects (without duplication of any materiality qualifier contained therein) as of such earlier date); 

(d) neither the Borrower nor any of its Subsidiaries shall have any Indebtedness, other than Permitted Indebtedness and all other Indebtedness
shall be paid off pursuant to payoff letters reasonably satisfactory to Agent and any Liens relating thereto shall be terminated in a manner reasonably satisfactory to Agent; 

(e) all actions necessary to establish that Agent (for the benefit of itself and the Lenders) will have perfected first priority security
interests (subject only to the prior priority of the Permitted Priority Liens and Liens in the Collateral under the Loan Documents shall have been taken; 

(f) all fees required to be paid on the Agreement Date pursuant to this Agreement and the other Loan Documents and all costs and expenses
required to be paid on the Agreement Date (including pursuant to Sections 2.7(a) and 6.3) pursuant to this Agreement and the other Loan Documents (which amounts, at the sole option of the Lenders, may be offset against the proceeds of the
Disbursement); 

  
 57 

 (g) Agent and the Lenders shall have received at least three (3) Business Days prior to the
Agreement Date all documentation and other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the USA Patriot Act, that has been reasonably
requested by Agent or any Lender; 
 (h) the conditions set forth in Section 2.2(a) have been satisfied and the terms set forth in Section
2.2(a) have been completely complied with; 
 (i) no Default or Event of Default shall have occurred or would result from such Disbursement
or the use of the proceeds therefrom; 
 (j) the Lenders shall have received Notes aggregating the amount of the funded Disbursement; 

(k) the Borrower shall have delivered to the Secured Parties a letter from the transfer agent for the Common Stock certifying the number of
shares of Common Stock outstanding as of a date within two (2) Business Days prior to the Agreement Date; 
 (l) (i) Agent shall
have received copies of the (A) executed payoff letter evidencing the payoff of all Indebtedness under the Existing ABL Credit Facility and all other Existing ABL Debt Documents and all other Indebtedness owed to MidCap Financial Trust or its
Affiliates by any Loan Party or any of its Subsidiaries, the termination of all revolving commitments and lines of credit and other products and services provided thereunder and the termination and release of all Liens granted thereunder or thereto,
and (B) release and termination documents evidencing such termination of all such Liens (including UCC-3 termination statements) and (ii) Existing ABL Agent and Existing ABL Lenders shall have taken
all actions and made all recordings and filings to effectuate the foregoing, or shall have given Borrower and/or Agent the authority to do so as requested by the Secured Parties; and 

(m) Agent shall have received the ABL Debt Documents, which shall be in form and substance reasonably satisfactory to the Agent and the Lenders
and the Agent and the Lenders shall have received evidence reasonably satisfactory to them that all conditions set forth in the ABL Debt Documents to make such documents effective and closed and to fund loans thereunder have been satisfied in all
respects. 
 ARTICLE 5 

PARTICULAR COVENANTS AND EVENTS OF DEFAULT 

Section 5.1 Affirmative Covenants. 

For so long as the Obligations (other than unasserted contingent indemnification obligations and other than those Obligations under the Warrant, any Stock and
the Registration Rights Agreement; provided that Sections 5.1(h), (p) and (s) shall survive until the end of the Reporting Period) remain outstanding: 

(a) The Loan Parties shall and shall cause their Subsidiaries to (i) preserve and maintain in full force and effect its organizational
existence and good standing under the Applicable Laws of its jurisdiction of incorporation, organization or formation, as applicable, other than as permitted under Section 5.2(i), and (ii) preserve and maintain all qualifications to do business
in each other jurisdiction not covered by clause (i) above that the failure to be so qualified could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

  
 58 

 (b) The Loan Parties shall, and shall cause their Subsidiaries to, (i) comply in all
material respects with all Applicable Laws, except where the necessity of compliance therewith is contested in good faith by appropriate proceedings or where failure to do so could not reasonably be expected, individually or in the aggregate, to
have a Material Adverse Effect, and (ii) maintain in effect and enforce policies and procedures designed to ensure compliance by the Loan Parties, their Subsidiaries and their respective directors, officers and employees with Anti-Corruption
Laws, Anti-Money Laundering Laws and applicable Sanctions. 
 (c) The Loan Parties shall, and shall cause their Subsidiaries to, obtain, make
and keep in full force and effect all licenses, certificates, approvals, registrations, clearances, Authorizations and permits required to conduct their businesses, except where the failure to make and keep such licenses, certificates, approvals,
registrations, clearances, authorizations and permits in full force and effect could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. 

(d) Each Loan Party shall, except as otherwise permitted by this Agreement, maintain, and shall cause each of its Subsidiaries to maintain, and
preserve all its assets and property which is used or useful in its business in good working order and condition, ordinary wear and tear excepted and shall make all necessary repairs thereto and renewals and replacements thereof, except, in each
case, where the failure to do so could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(e) The Loan Parties shall, and shall cause each of their Subsidiaries to, maintain with financially sound and reputable insurance companies
insurance with respect to their assets, properties and business, against such hazards and liabilities, of such types and in such amounts, as is customarily maintained by companies in the same or similar businesses similarly situated. Each such
policy of insurance shall (i) in the case of each liability policy, name Agent on behalf of the Secured Parties as an additional insured thereunder as its interests may appear and (ii) in the case of each casualty insurance policy contain
a lender’s loss payable clause or endorsement that names Agent, on behalf of the Secured Parties, as the lender’s loss payee thereunder and, to the extent available, provide for at least thirty (30) days’ prior written notice to
Agent of any modification or cancellation of such policy (or ten (10) days’ prior written notice in the case of the failure to pay any premiums thereunder); provided, however, that, for the avoidance of doubt, Agent need not be named on
any workers compensation or D&O policies. A true and complete listing of such insurance, including issuers, coverages and deductibles, shall be provided to Agent promptly following Agent’s request. 

(f) Each Loan Party shall, and shall cause each of its Subsidiaries to, pay, discharge and perform as the same shall become due and payable or
required to be performed all Tax liabilities, assessments and governmental charges or levies upon it or its property, unless the same are being contested in good faith by appropriate proceedings diligently prosecuted which stay the enforcement of
any Lien and for which adequate reserves in accordance with GAAP are being maintained by such Person. 
 (g) The Loan Parties shall promptly
after knowledge (and, in any event, within two Business Days after knowledge) notify the Agent of the occurrence of (A) any Default or Event of Default and (B) so long as such type of notification would not be material nonpublic
information of the Borrower, any claims (other than in connection with the denial of plan claims in the ordinary course of business), litigation, arbitration, mediation or administrative or regulatory proceedings that are instituted or threatened
against any Loan Party, in each case of this clause (B), to the extent such claim, litigation, arbitration, mediation or administrative or regulatory proceeding could reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect. 

  
 59 

 (h) From the Agreement Date until the later of (y) the first date on which no Warrants
remain outstanding, and (z) the first date on which the Secured Parties no longer own any Securities (the period ending on such latest date, the “Reporting Period”), the Borrower and its Subsidiaries shall (i) timely
(without giving effect to any extensions pursuant to Rule 12b-25 of the Exchange Act) file all reports required to be filed with the SEC pursuant to the Exchange Act, and the Borrower and its Subsidiaries
shall not terminate the registration of the Common Stock under the Exchange Act or otherwise terminate its status as an issuer required to file reports under the Exchange Act, even if the securities laws would otherwise permit any such termination
and (ii) deliver to Agent a Compliance Certificate with each of its 10-Q and 10-K filings on the date such filings are made with the SEC. Each of such reports in
Section 5.1(h)(i) above will comply in all material respects with the applicable requirements of the Exchange Act and each of such reports in Section 5.1(h)(i) above and such Compliance Certificate will not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The consolidated financial statements included in
such reports will comply as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, will be prepared in accordance with GAAP, consistently applied (subject, in
the case of unaudited quarterly financial statements, to normal year-end adjustments and lack of footnote disclosures), and will fairly present in all material respects the consolidated financial position of
the Borrower and its Subsidiaries as of the dates thereof and the consolidated results of their operations, cash flows and changes in stockholders equity for the periods presented (subject, in the case of unaudited quarterly financial statements, to
normal year-end audit adjustments and lack of footnote disclosures). The Borrower hereby agrees that, during the Reporting Period, the Borrower shall send to each Secured Party copies of (A) any notices
and other information made available or given to the holders of the Stock of the Borrower generally, contemporaneously with the Borrower’s making available or giving such notices and other information to such holders of Stock (it being
understood and agreed that delivery shall be deemed to have occurred if such notices or other information is posted to EDGAR) and (B) all other documents, reports, financial data and other information not available on EDGAR that does not
contain any material nonpublic information of the Borrower, that any Secured Party may reasonably request. 
 (i) On and after the date that
an Event of Default has occurred and is continuing, each Loan Party shall, and shall cause each of its Subsidiaries to, with respect to each owned, leased or controlled property, at all times and without notice, at the sole option of Agent or any
Lender: (a) provide access to such property to Agent, the Lenders and their respective representatives, as frequently as Agent or any Lender determines to be appropriate; and (b) permit Agent or any Lender to conduct field examinations,
appraise, inspect, and make extracts and copies (or take originals if reasonably necessary) from all of such Loan Party’s and its Subsidiaries’ books and records, and evaluate and conduct appraisals and evaluations in any manner and
through any medium that Agent or any Lender considers advisable, in each instance, at the Loan Parties’ sole expense. Any Lender may accompany Agent or its representatives in connection with such inspection. 

(j) Each Loan Party shall ensure that all written information, exhibits and reports furnished to any Secured Party, when taken as a whole, do
not and will not contain any untrue statement of a material fact and do not and will not omit to state any material fact or any fact necessary to make the statements contained therein not materially misleading in light of the circumstances in which
made, and will promptly disclose, after knowledge of any defect of a material fact, untrue statement of material fact, material misstatement or error of a material fact, to Agent and the Lenders and correct any such defect, untrue statement of
material fact, material misstatement or error of a material fact that has been discovered therein or in any Loan Document or in the execution, acknowledgement or recordation thereof; it being acknowledged and agreed that any projections provided to
the Secured Parties are not to be viewed as facts, are not a guarantee of financial performance, and are subject to uncertainties and contingencies. 

  
 60 

 (k) Each Loan Party shall enter into, and cause each depository, securities intermediary or
commodities intermediary to enter into, Control Agreements with respect to each deposit, securities, commodity or similar account maintained by such Person (other than (i) deposit accounts exclusively used for payroll, payroll taxes and other
employee wage and benefit payments to or for the benefit of the Borrower’s employees and identified to Agent by the Borrower as such, (ii) zero balance accounts; provided that such accounts have been identified to Agent by the Borrower as
such, (iii) such other petty cash deposit accounts, amounts on deposit in which do not exceed $100,000 in the aggregate at any one time, (iv) escrow, trust and fiduciary accounts, (v) each account of Excluded Foreign Subsidiaries,
(vi) deposit account #XXXXX7912 of TriVascular Canada LLC at Bank of Montreal; provided the aggregate amount on deposit in such deposit account(s) does not exceed 1,000,000 Canadian dollars at any time, (vii) the Bank of America
Cash Collateral Account, and (viii) the L/C Cash Collateral Accounts (such accounts in clauses (i) through (viii), the “Excluded Accounts”)) as of and after the Agreement Date; provided that (x) the Loan
Parties shall have until the date that is forty-five (45) days following the Agreement Date or the closing date of any Permitted Acquisition, as applicable (or such later date as may be agreed to by Agent in its sole reasonable discretion) to
comply with the provisions of this Section 5.1(k) with regard to such accounts (other than Excluded Accounts) of the Loan Parties existing on the Agreement Date or acquired in connection with such Permitted Acquisition, as applicable, and
(y) until the earlier of the date of (A) the date that any Person (other than the Merrill Lynch branch where the Merrill Lynch Securities Account is maintained) has a Lien on or “control” (as defined in the UCC) (including by way
of a Control Agreement) of the Merrill Lynch Securities Account and (B) on or after September 1, 2017, the date that the Merrill Lynch Securities Account has any cash, Cash Equivalents or other assets with a value in excess of $0, the Loan
Parties shall not be required to enter into a Control Agreement in respect of the Merrill Lynch Securities Account as long as Borrower does not deposit any additional funds, amounts or other assets of any kind into such Merrill Lynch Securities
Account after the Agreement Date and as long as promptly upon the maturity of each tranche of the securities and Cash Equivalents in such Merrill Lynch Securities Account, Borrower shall transfer the applicable amount of cash invested in such
matured tranche of securities or Cash Equivalents to a deposit account or securities account over which the Agent has “control” for UCC purposes under a Control Agreement in favor of the Agent covering such deposit account or securities
account and (z) for deposit accounts, securities accounts and commodities accounts opened after the Agreement Date, the Loan Parties shall have until the date that is thirty (30) days following the opening of any such new account (or such
later date as may be agreed to by Agent in its sole reasonable discretion) to comply with this clause (k). As of the end of the last Business Day of each calendar month, the Loan Parties shall have at least $10,000,000 of cash and Cash Equivalents
maintained in the deposit accounts or securities accounts of the Loan Parties, in each case, subject to Control Agreements (or, to the extent in compliance, and in accordance, with the provisions in this Section 5.1(k), in the Merrill Lynch
Securities Account) in compliance with the foregoing provisions of this Section 5.1(k), and, upon written request by the Agent, the Borrower shall provide Agent with written evidence reasonably satisfactory to the Agent as of such Business Day or
the next Business Day showing compliance therewith. 
 (l) Promptly upon request by Agent, the Loan Parties shall (and, subject to the
limitations set forth herein and in the other Loan Documents, shall cause each of their Subsidiaries to) take such additional actions and execute such documents as Agent may reasonably require from time to time in order (i) to carry out more
effectively the purposes of this Agreement or any other Loan Document, (ii) to subject to the Liens created by any of the Loan Documents any of the assets or properties, rights or interests covered by any of the Loan Documents (other than under
the Warrant, any Stock and the Registration Rights Agreement), (iii) to perfect and maintain the validity, effectiveness and priority of any of the Loan Documents and the Liens intended to be created thereby (other than, with respect to any Liens
created thereby, the Warrant, any Stock and the Registration Rights Agreement), and (iv) to better assure, grant, preserve, protect and confirm to the Secured Parties the rights granted or now or hereafter intended to be granted to the Secured
Parties under any Loan Document (other than, with respect to any Liens or Guarantees provided under the Loan Documents, those Obligations under the Warrant, any Stock and the 

  
 61 

 
Registration Rights Agreement). Without limiting the generality of the foregoing, the Loan Parties shall cause each of their Subsidiaries (other than Excluded Subsidiaries) promptly after (but,
in any event, (A) within fifteen (15) days thereof for any Subsidiary that is not an Immaterial Subsidiary and (B) within thirty (30) days thereof for any Immaterial Subsidiary) the date of the formation or acquisition thereof,
to guaranty the Obligations (other than those Obligations under the Warrant, any Stock and the Registration Rights Agreement) and to cause each such Subsidiary to grant to Agent, for the benefit of the Secured Parties, a security interest in,
subject to the limitations set forth herein and in the Loan Documents, all of such Subsidiary’s assets and property to secure such guaranty. Furthermore, the Borrower shall notify Agent and the Lenders in writing promptly after (but, in any
event, (A) within fifteen (15) days thereof for any Loan Party or any Subsidiary that is not an Immaterial Subsidiary and (B) within thirty (30) days thereof for any Immaterial Subsidiary) the date of the issuance by or to any
Loan Party (other than by the Borrower) of any Stock of any corporation or any other Person that has “opted into” Article 8 of the UCC (in each case, other than Excluded Property) to have its Stock constitute “securities” under
Article 8 of the UCC and each Loan Party shall pledge, and shall cause each of its Subsidiaries (other than Excluded Subsidiaries) to pledge, all of the Stock of each of its Subsidiaries (other than Excluded Subsidiaries), and sixty-five percent
(65%) of the outstanding voting Stock and one hundred percent (100%) of the outstanding non-voting Stock of each Excluded Foreign Subsidiary and each Excluded Domestic Holdco, directly owned by a Loan Party,
in each instance, to Agent, for the benefit of the Secured Parties, to secure the Obligations (other than those Obligations under the Warrant, any Stock and the Registration Rights Agreement), promptly after formation or acquisition of such
Subsidiary. The Loan Parties shall deliver, or cause to be delivered, to Agent, appropriate resolutions, secretary certificates, certified Organizational Documents and, if reasonably requested by Agent, legal opinions relating to the matters
described in this Section 5.1(l) (which opinions shall be in form and substance reasonably acceptable to Agent and, to the extent applicable, substantially similar to the opinions delivered on the Agreement Date), in each instance with respect to
each Loan Party formed or acquired, and each Loan Party or Person (other than a Loan Party) whose Stock is being pledged, after the Agreement Date. In connection with each pledge of Stock, the Loan Parties shall deliver, or cause to be delivered, to
Agent, irrevocable proxies and Stock powers and/or assignments, as applicable, duly executed in blank. 
 (m) Each Loan Party shall, and
shall cause each of its Subsidiaries to, comply with, and maintain its Real Estate, whether owned, leased, subleased or otherwise operated or occupied, in compliance with all applicable Environmental Laws and Healthcare Laws or that is required by
orders and directives of any Governmental Authority, except where the failure to comply could not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect. 

(n) Promptly upon becoming aware that any of the following events has occurred, the Borrower will provide written notice to the Agent
specifying the nature of such event, what action the Loan Party or any ERISA Affiliates has taken, is taking or proposes to take with respect thereto and, when known, if applicable, any action taken or threatened by the Internal Revenue Service, the
Department of Labor or the PBGC with respect thereto: (i) any ERISA Event which could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (ii) a “prohibited transaction” as defined under
Section 406 of ERISA or Section 4975 of the Code that is not exempt under ERISA Section 408 or Section 4975 of the Code, under any applicable regulations and published interpretations thereunder or under any applicable prohibited
transaction, individual or class exemption issued by the Department of Labor, with respect to any Employee Benefit Plan, which could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, or (iii) the
imposition of any Lien on any asset of a Loan Party or a Subsidiary of a Loan Party with respect to any Title IV Plan or Multiemployer Plan. 

(o) The Borrower agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof to
each Secured Party promptly after such filing. The Borrower shall make all filings and reports relating to the offer and sale of the Securities required under applicable securities or “Blue Sky” laws of the states of the United States
following the Agreement Date. 

  
 62 

 (p) The Borrower shall take all actions necessary to cause the Common Stock to remain listed on
the Principal Market during the Reporting Period. The Borrower shall not, and shall cause each of the Subsidiaries not to, take any action that would be reasonably expected to result in the delisting or suspension or termination of trading of the
Common Stock on the Principal Market. The Loan Parties shall pay all fees, costs and expenses in connection with satisfying its obligations under this Section 5.1(p). 

(q) At or prior to 5:30 a.m. (New York City time) on the fourth (4th) Business Day
following the Agreement Date, the Borrower shall file a Form 8-K with the SEC describing the terms of the transactions contemplated by the Loan Documents and including as exhibits to such Form 8-K this Agreement (including the schedules and exhibits hereto), the form of Note, the form of Warrant and the Registration Rights Agreement (such Form 8-K, the
“Announcing Form 8-K”). Subject to the foregoing, no Loan Party shall issue any press releases or any other public statements with respect to the transactions contemplated by any Loan Document
or disclosing the name of any Secured Party; provided, however, that the Borrower shall be entitled, without the prior approval of any Secured Party, to make any press release or other public disclosure with respect to such
transactions (i) in substantial conformity with the Announcing Form 8-K and contemporaneously therewith and (ii) as is required by Applicable Law and regulations (provided that each Secured
Party shall be consulted by the Borrower in connection with any such press release or other public disclosure prior to its release and shall be provided with a copy thereof other than filings required by the Exchange Act to be made with the SEC,
which Borrower may make without such consultation or notice). From and after the Borrower’s filing of the Announcing Form 8-K, no Secured Party shall be in possession of any material nonpublic information
received from the Borrower or any of its Subsidiaries or Affiliates or any of its or their respective officers, directors, employees, attorneys, representatives or agents. Notwithstanding any other requirement of this Agreement or any other Loan
Document, each Loan Party shall not, and shall cause each of its Subsidiaries and Affiliates and its and each of their respective officers, directors, employees. Attorneys, representatives and agents to not, provide any Secured Party with any
material nonpublic information regarding the Borrower or any of its Subsidiaries or Affiliates from and after the filing of the Announcing Form 8-K with the SEC without the express prior written consent of
such Secured Party. Each Loan Party hereby acknowledges and agrees that no Secured Party (nor any of such Secured Party’s Affiliates) shall have any duty of trust or confidence with respect to any material nonpublic information regarding the
Borrower or any of its Subsidiaries or Affiliates provided by, or on behalf of, the Borrower or any of its Subsidiaries or Affiliates, or any of its or their respective officers, directors, employees, attorneys, representatives or agents, in
violation of the foregoing covenant. Notwithstanding anything to the contrary herein, in the event that any Loan Party believes that a notice or communication to any Secured Party contains material, nonpublic information relating to any Loan Party,
any of its Subsidiaries or Affiliates or any of their respective property or Stock, the Borrower shall so indicate to the Secured Parties contemporaneously with delivery of such notice or communication, and such indication shall provide the Secured
Parties the means to refuse to receive such notice or communication; and in the absence of any such indication, the holders of the Securities shall be allowed to presume that all matters relating to such notice or communication do not constitute
material, nonpublic information relating to any Loan Party, any of its Subsidiaries or Affiliates or any of their respective property or Stock. Upon receipt or delivery by any Loan Party or any of its Subsidiaries of any notice in accordance with
the terms of the Loan Documents, unless the Borrower has in good faith determined that the matters relating to such notice do not constitute material, nonpublic information relating to any Loan Party or any of its Subsidiaries or Affiliates or their
respective property or Stock, the Loan Parties shall, within one Business Day after any such receipt or delivery publicly disclose such material, nonpublic information. In the event of a breach of any of the foregoing covenants by any Loan Party or
any of its Subsidiaries or Affiliates, or any of its or their respective officers, directors (or equivalent persons), employees, attorneys, representatives or agents, in addition to any other remedies provided in the Loan Documents or otherwise
available at law or in 

  
 63 

 
equity, the Secured Parties shall have the right to make a public disclosure in the form of a press release, public advertisement or otherwise, of the applicable material nonpublic information
regarding the Borrower or its Subsidiaries or Affiliates without the prior approval by any Loan Party or its Subsidiaries or Affiliates, or any of its or their respective officers, directors (or equivalent persons), employees, attorneys,
representatives or agents, and no Secured Party shall have any liability to any Loan Party, any of its Subsidiaries or Affiliates or any of its or their respective officers, directors (or equivalent persons), employees, equityholders, attorneys,
representatives or agents for any such disclosure. 
 (r) The Borrower acknowledges and agrees that the Securities may be pledged by a holder
thereof in connection with a bona fide margin agreement or other loan, financing or Indebtedness secured by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities under the Loan Documents,
and no such holder effecting any such pledge of Securities shall be required to provide any Loan Party or any of its Subsidiaries with any notice thereof or otherwise make any delivery to any Loan Party pursuant to any Loan Document. The Borrower
hereby agrees to execute and deliver such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of the Securities to such pledgee by a holder of Securities. 

(s) During the Reporting Period, except as otherwise provided in the Loan Documents, the Borrower shall not in any manner issue or sell any
Options or Convertible Securities that are convertible into or exchangeable or exercisable for shares of Common Stock at a price that varies or may vary with the market price of the Common Stock, including by way of one or more resets to a fixed
price or increases in the number of shares of Common Stock issued or issuable, or at a price that upon the passage of time or the occurrence of certain events automatically is reduced or is adjusted or at the option of any Person may be reduced or
adjusted, whether or not based on a formulation of the then current market price of the Common Stock (other than proportional adjustments as a result of subdivisions or combinations of the Common Stock in the form of stock splits, stock dividends,
reverse stock splits, combinations or recapitalizations). For the avoidance of doubt, this clause (s) does not prohibit any convertible notes contemplated under clause (k) of the definition of “Permitted Indebtedness” with a
fixed conversion rate subject to anti-dilution adjustments or other provisions related to the conversion price and/or conversion rate that are broadly similar to the analogous provisions in the 2.25% Convertible Note Documents or the 3.25%
Convertible Note Documents or any Permitted 3.25% Convertible Note Refinancing permitted hereunder. 
 (t) Within five Business Days after
the filing of its 10-K or 10-Q, as the case may be, the Loan Parties and their Subsidiaries shall deliver to Agent an updated Perfection Certificate. Upon the reasonable
request of any Secured Party, the Loan Parties and their Subsidiaries shall promptly deliver to such Secured Party such additional business, financial, corporate affairs, perfection certificates, items or documents related to creation, perfection or
priority of Agent’s Liens in the Collateral and other information as any Secured Party may from time to time reasonably request. 
 (u)
The Borrower shall, and shall cause each Loan Party to, obtain all Regulatory Required Permits necessary for compliance in all material respects with Applicable Laws with respect to testing, manufacturing, developing, selling or marketing of
Products and shall, and shall cause each Loan Party to, maintain and comply fully and completely in all respects with all such Regulatory Required Permits, the noncompliance with which could have a Material Adverse Effect. 

(v) Each Loan Party will comply, and cause each Subsidiary to comply, with the requirements of all Applicable Laws and Material Contracts,
except to the extent that failure to so comply could not reasonably be expected to (a) have a Material Adverse Effect, or (b) result in any Lien upon either (i) a material portion of the assets of any such Person in favor of any
Governmental Authority, or (ii) any Collateral (other than Permitted Liens). 

  
 64 

 (w) With respect to the ABL Debt Documents, to the extent any of the ABL Lenders (or their
Affiliates) are not the Agent under this Agreement (but regardless for purpose of the Convertible Note Documents), the Borrower shall, within two Business Days after delivery by a Loan Party or receipt or knowledge thereof, provide written notice to
Agent of any default or event of default under any of the ABL Debt Documents or any of the Convertible Note Documents, and of any amendments, restatements, supplements, waivers or other modifications to (or any consents to any events or actions
under) any of the ABL Debt Documents or any of the Convertible Note Documents or any prepayment of any of the Indebtedness thereunder. 
 (x)
Until the requirements in clause 4 (with respect to TriVascular Sales LLC) and clause 6 (with respect to RMS/Endologix Sideways Merger Corp.) of Schedule 5.1(y) (and Section 5.1(y)) are satisfied, such applicable Subsidiary shall at
all times remain an Immaterial Subsidiary. 
 (y) Each Loan Party shall execute and deliver the documents and complete the tasks and other
actions set forth on Schedule 5.1(y), in each case, within the time limits specified therein (or such longer period agreed to by Agent in its sole discretion). 

(z) Endologix agrees that, solely in connection with a refinancing of the ABL Credit Facility referenced in clause (i) of the definition
of “ABL Credit Facility” whereby (1) Endologix is not entering into a new credit facility that refinances or replaces the ABL Credit Facility referenced in clause (i) of the definition of “ABL Credit Facility” but
rather is seeking a financial institution (or other Person) and its Affiliates that are not Deerfield ELGX Revolver, LLC or its Affiliates to replace Deerfield ELGX Revolver, LLC and its Affiliates as ABL Agent and as the ABL Lenders under such ABL
Credit Facility pursuant to an assignment of the agency and the loans and commitments thereunder, and (2) the assignment documentation for the agency and the loans and commitments thereunder requires the written consent of Endologix (even if
the terms of the ABL Credit Facility do not otherwise require such consent), then Endologix shall advise the Agent in writing on or prior to Endologix providing its written consent to such applicable assignment that under Section 5.4(s)(i) of this
Agreement, a breach, event of default or acceleration (or an exercise of remedies in connection with such breach or event of default) of the ABL Financial Covenant shall not cause an Event of Default hereunder. 

Section 5.2 Negative Covenants. 
 For
so long as the Obligations (other than unasserted contingent indemnification obligations and other than those Obligations under the Warrant, any Stock and the Registration Rights Agreement; provided that Section 5.2(xvii) shall survive until
the end of the Reporting Period) remain outstanding: 
 (i) No Loan Party shall, nor shall it permit any of its Subsidiaries
to, directly or indirectly, merge with, consolidate with or into, dissolve or liquidate into or convey, transfer, lease or otherwise dispose of (whether in one transaction or in a series of transactions) all or substantially all of its assets
(whether now owned or hereafter acquired) to or in favor of any Person, except (1) a Subsidiary that is not a Loan Party may merge into any Loan Party or any Subsidiary of a Loan Party (provided that, to the extent such Subsidiary that
is not a Loan Party has its equity pledged to Agent, then any Person it merges with must also have its equity pledged to Agent by at least the same percentage), (2) a Subsidiary that is a Loan Party may merge into any other Loan Party
(provided that, (y) to the extent such Subsidiary being merged has its equity pledged to Agent, then any Person it merges with must also have its equity pledged to Agent by at least the same percentage and (z) to the extent the
Borrower is part of such transaction, the Borrower must be the surviving Person), (3) any Subsidiary of the Borrower (other than, for the avoidance of doubt, the Borrower) may liquidate or dissolve if (i) the Borrower determines in good

  
 65 

 
faith that such liquidation or dissolution is in the best interests of the Borrower and it is not materially disadvantageous to the Secured Parties and (ii) to the extent such Subsidiary is
a Guarantor, any such assets or business held by such subject Subsidiary shall be transferred to, or otherwise owned or conducted by, a Loan Party after giving effect to such liquidation or dissolution, and (4) Permitted Acquisitions. The
Borrower shall not permit the Borrower to establish or form any Subsidiary, unless such Subsidiary complies with Section 5.1(l), if applicable, and such Subsidiary (if not an Excluded Subsidiary) executes and/or delivers all other documents,
agreements and instruments reasonably requested by Agent or the Required Lenders to perfect a Lien in favor of Agent (for the benefit of the Secured Parties) on such Subsidiary’s (if not an Excluded Subsidiary) assets and to make such
Subsidiary (if not an Excluded Subsidiary) a Guarantor under the Loan Documents. 
 (ii) No Loan Party shall, nor shall it
permit any of its Subsidiaries to, (a) enter into any joint venture or any similar arrangement, other than as may be permitted under Permitted Investments or (b) make any Restricted Payments, other than (1) dividends by any direct or
indirect Subsidiary of any Loan Party (A) that are not Loan Parties to its parent or parent entities or (B) that are Loan Parties to its parent or parent entities that are Loan Parties; (2) dividends payable solely in common Stock;
(3) repurchases of Stock of former employees, directors or consultants so long as an Event of Default does not exist at the time of such repurchase and would not exist after giving effect to such repurchase, provided, however,
that such repurchase does not exceed $2,500,000 in the aggregate per fiscal year; (4) any Restricted Payments made under Subordinated Debt Documents to the extent permitted under the terms of the applicable Subordination Agreement; and
(5) any Restricted Payments made pursuant to the Loan Documents. 
 (iii) No Loan Party shall, nor shall it permit any
of its Subsidiaries to, (a) directly or indirectly make, create, incur, assume or suffer to exist any Lien upon or with respect to any of its assets or property, except Permitted Liens, or (b) directly or indirectly Dispose of (whether in
one or a series of transactions) any assets or property (including the Stock of any Subsidiary of any Loan Party, whether in a public or private offering or otherwise, and accounts and notes receivable, with or without recourse), except Permitted
Dispositions or as otherwise permitted by Section 5.2(i). 
 (iv) No Loan Party shall, nor shall it permit any of its
Subsidiaries to, directly or indirectly, create, incur, assume, guarantee, permit to exist or be liable with respect to any Indebtedness, other than Permitted Indebtedness. No Loan Party will, or will permit any Subsidiary to, directly or
indirectly, create, assume, incur or suffer to exist any Contingent Obligations, except for Permitted Contingent Obligations. 

(v) No Loan Party shall, nor shall it permit any of its Subsidiaries to, directly or indirectly, (i) purchase or acquire
any Stock, or any obligations or other securities of, or any interest in, any Person, including the establishment or creation of a Subsidiary, or (ii) make or commit to make any Acquisitions, or any other acquisition of any of the assets of
another Person other than (A) Permitted Investments or (B) in the Ordinary Course of Business, or of any business or division of any Person, including by way of merger, consolidation, other combination or otherwise other than Permitted
Investments, or (iii) make, purchase or acquire any advance, loan, extension of credit (other than trade payables in the ordinary course of business) or capital contribution to or any other investment in, any Person including the Borrower, any
Affiliate of the Borrower or any Subsidiary of the Borrower (the items described in clauses (i), (ii) and (iii) are referred to as “Investments”), except for Permitted Investments. 

  
 66 

 (vi) [Reserved]. 

(vii) Except as otherwise disclosed on Schedule 5.2(vii), and except for transactions that contain terms that are no less
favorable to the applicable Loan Party or any Subsidiary, as the case may be, than those which might be obtained from a third party not an Affiliate of any Loan Party, no Loan Party will, or permit any Subsidiary to, directly or indirectly, enter
into or permit to exist any transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of any Loan Party that is not itself a Loan Party. 

(viii) No ERISA Affiliate shall cause or suffer to exist (a) any event that could result in the imposition of a Lien on
any asset of a Loan Party or a Subsidiary of a Loan Party with respect to any Title IV Plan or Multiemployer Plan, or (b) any other ERISA Event, which other ERISA Event could reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect. 
 (ix) No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to, engage in
any line of business different from those lines of business carried on by it on the Agreement Date and businesses reasonably related thereto. 

(x) Except as permitted under Section 5.2(i), no Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to,
directly or indirectly amend or otherwise modify any of its Organizational Documents or, after the execution thereof, any agreements or documents evidencing or contemplating any Permitted Acquisition in any respect materially adverse to any Secured
Party. No Loan Party will, or will permit any Subsidiary to, directly or indirectly, amend or otherwise modify any Material Contract, which amendment or modification in any case: (a) is contrary to the terms of this Agreement or any other Loan
Document; or (b) could reasonably be expected to be materially adverse to the rights, interests or privileges of Agent or the Lenders or their ability to enforce the same; provided, however, that the foregoing shall not restrict
(x) any changes expressly required under the terms of the 2.25% Convertible Notes as of the Agreement Date, the 3.25% Convertible Notes as of the Agreement Date or any indenture governing any Permitted 3.25% Convertible Note Refinancing meeting
the requirements set forth in the definition of “Permitted 3.25% Convertible Note Refinancing” or (y) any refinancing of the ABL Credit Facility (and related documents), in each case of this clause (y) meeting the requirements
set forth in the definition of “ABL Credit Facility”. 
 (xi) No Loan Party shall, and no Loan Party shall suffer
or permit any of its Subsidiaries to, (a) make any significant change in accounting treatment or reporting practices, except as required by GAAP, (b) change the fiscal year or method for determining the fiscal quarters of any Loan Party or
of any Subsidiary of any Loan Party, (c) change its name as it appears in official filings in its jurisdiction of organization or formation, or (d) change its jurisdiction of organization or formation, in the case of clauses (c) and
(d), without at least ten (10) days’ prior written notice to Agent (or such shorter period as may be agreed by Agent in its sole reasonable discretion). 

(xii) No Loan Party shall, nor shall it permit any of its Affiliates to, (A) declare, pay, make or set aside any amount
for payment in respect of Subordinated Debt, except for payments made in full compliance with and permitted under the Subordination Agreement, (B) amend or otherwise modify the terms of any Subordinated Debt, except for amendments and
modifications made in full compliance with the Subordination 

  
 67 

 
Agreement; or (C) declare, pay, make or set aside any amount for payment in respect of any Indebtedness hereinafter incurred that, by its terms, or by separate agreement, is subordinated to
the Obligations, except for payments made in full compliance with and permitted under the subordination provisions applicable thereto. 

(xiii) No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to, directly or indirectly, create or
otherwise cause or suffer to exist or become effective any consensual restriction or encumbrance of any kind on the ability of any Loan Party or Subsidiary to pay dividends or make any other distribution on any of such Loan Party’s or
Subsidiary’s Stock or to pay fees, including management fees, or make other payments and distributions to the Borrower or any other Loan Party, except for those in the Loan Documents and the ABL Debt Documents. No Loan Party shall, and no Loan
Party shall permit any of its Subsidiaries to, directly or indirectly (y) enter into, assume or become subject to any contractual obligation prohibiting or otherwise restricting the existence of any Lien upon any of its assets in favor of
Agent, whether now owned or hereafter acquired or (z) create or otherwise suffer to exist or become effective any consensual encumbrance or restriction of any kind on the ability of any Subsidiary to (1) pay any Indebtedness owed to
Borrower or any of its Subsidiaries, (2) make loans or advances to Borrower or any of its Subsidiaries or (3) transfer any of its property or assets to Borrower or any of its Subsidiaries, except (A) those in the Loan Documents and
the ABL Debt Documents, (B) an encumbrance or restriction consisting of customary non-assignment provisions in leases or licenses entered into in the Ordinary Course of Business, (C) customary provisions in joint venture agreement and
other similar agreements that restrict the transfer of ownership interests in such joint ventures or provisions limiting the disposition or distribution of assets or property (other than dividends on a pro rata basis based on ownership percentage)
of the applicable joint venture, which limitation is applicable only to the assets that are the subject of such agreements; provided that such agreement was not entered into in contravention of the terms of this Agreement, and
(D) limitations set forth in Subordinated Debt (if acceptable to the Agent in its sole discretion). 
 (xiv) No Loan
Party shall, and no Loan Party shall permit any of its Subsidiaries to fail to comply with the laws, regulations and executive orders referred to in Section 3.1(jj). No Loan Party or Subsidiary of a Loan Party, nor to the knowledge of any Loan Party
or any of its Subsidiaries, any director, officer, agent, employee or other Person acting on behalf of any Loan Party or any such Subsidiary, will request or use the proceeds of any Loan, directly or indirectly, (A) for any payments to any
Person, including any government official or employee, political party, official of a political party, candidate for political office or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper
advantage, or otherwise take any action, directly or indirectly, that would result in a violation of any Anti-Corruption Laws, (B) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any
Person on the SDN List or a government of a Sanctioned Country, to the extent such activities, business or transaction would be prohibited by Sanctions if conducted by a corporation incorporated in the United States or in a European Union member
state, or (C) in any manner that would result in the violation of any Sanctions applicable to any party hereto. Furthermore, the Loan Parties will not, directly or indirectly, use the proceeds of the Transaction, or lend, contribute or
otherwise make available such proceeds to any Subsidiary, Affiliate, joint venture partner or other Person, to fund any activities of or business with any Person, or in any country or territory, that, at the time of such funding, is the subject of
Sanctions, or in any other manner that will result in a violation by any Person participating in the Transaction of any Sanctions. No Loan Party will, or will permit any Subsidiary to, directly or indirectly, knowingly enter into any Material
Contracts with any Person on the SDN List. 

  
 68 

 (xv) No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries
to, engage in a sale leaseback, synthetic lease or similar transaction involving any of its assets, including pursuant to a substantially contemporaneous transaction, whereby a Loan Party or one of its Subsidiaries sells or transfers all or
substantially all of its right, title and interest in an asset and, in connection therewith, acquires or leases back the right to use such asset. 

(xvi) No Loan Party shall, and no Loan Party shall permit any of its Subsidiaries to, cause or suffer to exist any Release of
any Hazardous Material at, to or from any Real Estate that would violate or form the basis of Liability under any Environmental Law or Healthcare Law, other than such violations or liabilities that could not reasonably be expected, individually or
in the aggregate, to result in a Material Adverse Effect. 
 (xvii) No Loan Party shall, and no Loan Party shall permit any
of its Subsidiaries to, be an “investment company” or a company “controlled” by an “investment company,” as such terms are defined in the Investment Company Act, or to otherwise be registered or required to be
registered, or be subject to the restrictions imposed by, the Investment Company Act. 
 (xviii) No Loan Party shall, and no
Loan Party shall permit any of its Subsidiaries to, (A) make any payment, or take any action, with respect to the ABL Debt that is in violation or breach of the Intercreditor Agreement; (B) make any amendment, restatement, supplement or
modification of any ABL Debt Document in violation or breach of the Intercreditor Agreement; provided however that, for the avoidance of doubt, in connection with the ABL Credit Facility referenced in clause (i) of the definition thereof,
clauses (A) and (B) of this Section 5.2(xviii) shall not prohibit Borrower from (y) refinancing such facility in accordance with (and subject to the terms of) the definition of “ABL Credit Facility” or (z) terminating such
ABL Credit Facility (or such refinanced facility mentioned in clause (y) above) or making any payments on such ABL Credit Facility (or such refinanced facility mentioned in clause (y) above) at any time so long as, in each case of the
foregoing, in accordance with the terms of such facility and in accordance with the definition of “ABL Credit Facility” and the other applicable provisions of this Agreement and the applicable Intercreditor Agreement; or (C) join any
Subsidiary or any Affiliate of any Loan Party as a borrower, guarantor or obligor, or have such Person pledge or grant a Lien on any of its property or assets, under the ABL Debt Documents, unless, in each case, the same Person becomes a Loan Party
in the same capacity (and/or pledges and grants Liens on the same property or assets (and with no Person having priority in between the Liens granted under the ABL Debt Documents and the Liens granted under the Loan Documents in connection with this
Section 5.2(xviii))) under the Loan Documents and such Person executes and delivers such agreements, instruments and documents reasonably requested by Agent to effectuate any of the foregoing. 

(xix) Notwithstanding anything to the contrary in this Agreement or in any other Loan Documents, no Loan Party shall, and no
Loan Party shall permit any of its Subsidiaries to, create, incur or suffer to exist any Indebtedness which is subordinated or junior (either in respect of Lien priority or in right of payment or any combination thereof) to any of the ABL Debt
unless such Indebtedness is expressly subordinated or junior to the Obligations (both in terms of Lien priority and in right of payment) on terms and 

  
 69 

 
conditions acceptable to Agent and the Lenders; it being understood and agreed that the foregoing shall in no way limit the incurrence of unsecured Indebtedness otherwise permitted hereunder that
is not payment subordinated to the ABL Debt when not also payment subordinated to the same extent to the Obligations. 
 (xx)
No Loan Party will, or will permit any Subsidiary to, declare, pay, make any payment in respect of the 3.25% Convertible Notes or the 2.25% Convertible Notes, except for: (a) regularly scheduled payments of interest and principal as set forth
in the applicable Convertible Note Documents (in addition to allowing any cash principal payments at maturity of the applicable 3.25% Convertible Notes and the 2.25% Convertible Notes, such amounts may also be paid in the applicable Stock of the
Borrower or through any other conversion feature that does not effectively cause more payments to be made at maturity thereof than the cash principal payments currently provided for in the applicable Convertible Note Documents as of the Agreement
Date), (b) in connection with any Permitted 3.25% Convertible Note Refinancing, (c) the issuance of shares of common stock of the Borrower in connection with any conversion of the 3.25% Convertible Notes, the 2.25% Convertible Notes or any
convertible notes that are not Disqualified Stock issued in a Permitted 3.25% Convertible Note Refinancing, and any cash solely in lieu of fractional shares (but no other cash settlement other than as otherwise permitted by this clause (xx)), (d)
payments and conversions (other than for any Disqualified Stock) made in connection with the repurchase (whether for cash, upon exchange and/or for other consideration), redemption and retirement in respect of the 2.25% Convertible Notes or 3.25%
Convertible Notes in a single or series of related transactions; provided that (1) no Event of Default exists at the time such payments are made or would exist immediately after giving effect thereto and (2) such cash payments are
made solely (A) with proceeds received by the Borrower from the issuance of its common Stock after the Agreement Date for the purpose of making such payment, (B) regarding the 2.25% Convertible Notes, with the proceeds of the Loans made
hereunder or the proceeds of advances made under the ABL Credit Facility and (C) regarding the 3.25% Convertible Notes, with the proceeds of Indebtedness raised in a Permitted 3.25% Convertible Note Refinancing, with the proceeds of the Loans
made hereunder or with the proceeds of advances made under the ABL Credit Facility, and (e) if the foregoing conditions do not otherwise permit such payment, then, with the express prior written consent of the Agent (which may be withheld in
its sole discretion), payments in connection with the retirement, redemption and repurchase of the 2.25% Convertible Notes or the 3.25% Convertible Notes. 

(xxi) (a) No Loan Party will, or permit any Subsidiary (other than a Foreign Subsidiary) to commingle any of its assets
(including any bank accounts, cash or Cash Equivalents) with the assets of any Person other than a Loan Party; and (b) no Loan Party will, or permit any Subsidiary to enter into or own any interest in a joint venture that is not itself a
corporation or limited liability company or other legal entity in respect of which the equity holders are not liable for the obligations of such entity as a matter of law. 

(xxii) No Loan Party will, or will permit any Subsidiary to, amend or otherwise modify the terms of any Indebtedness referred
to in Section 5.2(xx) above (other than with respect to 3.25% Convertible Notes, in connection with a Permitted 3.25% Convertible Note Refinancing) if the effect of such amendment or modification is to (a) increase the interest rate or fees on,
or change the manner or timing of payment of, such Indebtedness if in any way adverse to the Agent or the Lenders, (b) accelerate or shorten the dates upon which payments of principal or interest are due on, or the principal amount of, such
Indebtedness, (iii) change in a manner adverse to any Loan Party or Agent any event of 

  
 70 

 
default or add or make more restrictive any covenant with respect to such Indebtedness, (iv) change the prepayment provisions of such Indebtedness or any of the defined terms related thereto
in a manner adverse to Agent or the Lenders, or (vi) change or amend any other term if such change or amendment would materially increase the obligations of the obligor or confer additional material rights on the holder of such Indebtedness in
a manner adverse to any Loan Party, any Subsidiaries, Agent or Lenders; provided, however, that the foregoing shall not restrict any changes expressly required under the terms of the 3.25% Convertible Notes as in effect as of the
Agreement Date, the 2.25% Convertible Notes as in effect as of the Agreement Date or any changes that are permitted to be made hereunder in connection with a Permitted 3.25% Convertible Note Refinancing or any changes expressly required under any
indenture governing any Permitted 3.25% Convertible Note Refinancing that satisfies the conditions and requirements set forth in the definition of “Permitted 3.25% Convertible Note Refinancing”. The Loan Parties shall, prior to entering
into any such amendment or modification, deliver to Agent reasonably in advance of the execution thereof, any final or execution form copy thereof. 

(xxiii) Borrower shall not issue any Stock (a) senior to its shares of Common Stock or (b) convertible into or
exercisable or exchangeable for Stock senior to its Common Stock. 
 Section 5.3 Change in Control. 

(a) Lender’s Put Option. The Borrower, on behalf of the Loan Parties and their Subsidiaries, shall give Agent written
notice of a Change in Control at least fifteen (15) days prior to the consummation thereof but in any event not later than two (2) Business Days following the first public announcement thereof. Other than with respect to a Permitted
Successor Transaction (in, which case, no such Put Notice may be delivered by the Lenders), the Lenders, within five (5) days after the receipt of such notice, in the exercise of their sole discretion, may deliver a notice to the Borrower (the
“Put Notice”) that the Final Payment (including, for the avoidance of doubt, any applicable Non-Callable Make Whole Amount and the CoC Fee) shall be due and payable upon the consummation of
such Change in Control, with no further action taken by any Person as of or after the date of such Put Notice. If the Lenders deliver a Put Notice, then simultaneously with consummation of such Change in Control (other than a Permitted Successor
Transaction), the Borrower shall make (or cause to be made) the Final Payment (including, for the avoidance of doubt, any applicable Non-Callable Make Whole Amount and the CoC Fee) to the Lenders as of the
date of such Put Notice. In such case of a Put Notice delivered with respect to any Change in Control (other than a Permitted Successor Transaction), the Loan Parties shall make arrangements satisfactory to the Agent, as determined by the Agent in
its sole discretion, that the Final Payment will be paid in full to the Lenders, in each case, concurrently with the consummation of such Change in Control (other than a Permitted Successor Transaction) (which arrangements may include obtaining a
written agreement from the acquiring Person, as applicable, that payment of the Final Payment shall be made to the Lenders upon the consummation of such Change in Control (other than a Permitted Successor Transaction)). The Loan Parties hereby
acknowledge and agree that, if the Loan Parties or any of their Subsidiaries of Affiliates violate or breach any portion of this Section 5.3(a), the Secured Parties shall have the right to apply for an injunction in any state or federal courts
sitting in the City of New York to prevent the consummation of such Change in Control, unless, if the Lenders have exercised their Put Right, arrangements reasonably satisfactory to the Agent for the Final Payment (including, for the avoidance of
doubt, any applicable Non-Callable Make Whole Amount and the CoC Fee) have been made (or, as applicable, paid) and, if the Lenders have not exercised their Put Right, arrangements reasonably satisfactory to
the Agent in respect of the Loans have been made. The Loan Parties shall not, and shall not permit any of their Subsidiaries to consummate any Change in Control (other than a Permitted Successor Transaction) without complying in all respects with
the applicable provisions of this Section 5.3(a). Notwithstanding anything to the contrary in this Agreement, for the avoidance of doubt, the Black-Scholes payments or exercises related to a “Major Transaction” (as defined in any Warrant)
that are set forth in the Warrants are in addition to any Final Payment. 

  
 71 

 (b) Borrower’s Prepayment Right. Notwithstanding anything to the
contrary in this Agreement and for the avoidance of doubt, Borrower shall be permitted to prepay the Loans and other Obligations (other than Obligations under the Warrant and the Registration Rights Agreement, the treatment of which are addressed
separately in such agreements) so long as (i) to the extent any such prepayment is made prior to the First Amortization Date, the applicable Non-Callable Make Whole Amount on the Loans so prepaid is paid
at the same time in accordance with Section 2.3(c) and (ii) if In Connection with a Change in Control, the CoC Fee is paid at the time set forth in Section 2.7(c). 

Section 5.4 General Acceleration Provision upon Events of Default. For so long as the Obligations (other than unasserted
contingent indemnification obligations and other than those Obligations under the Warrant, any Stock and the Registration Rights Agreement) remain outstanding, if one or more of the events specified in this Section 5.4 shall have happened or
occurred and have continued beyond any applicable cure period expressly provided in this Section 5.4 (each, an “Event of Default”), the Required Lenders or Agent may, or Agent (upon written election by the Required
Lenders but subject to the protections for Agent set forth in Section 6.15) shall, by (subject to Section 5.5(a), which, for the avoidance of doubt, shall not require any such notice and shall occur automatically) written notice to the
Borrower, declare the principal of, and accrued and unpaid interest on, all of the Loans and other Obligations or any part of any of them (together with any other amounts accrued or payable under the Loan Documents) to be, and the same shall
thereupon become, immediately due and payable, without any further notice and without any presentment, demand or protest of any kind, all of which are hereby expressly waived by the Borrower and the other Loan Parties, appoint a receiver for the
Loan Parties and their Subsidiaries, and take any further action available at law or in equity or that are provided in the Loan Documents, including the sale or transfer of the Loan and other Obligations and all other rights acquired in connection
with the Loan or the other Obligations or under the Loan Documents: 
 (a) The Borrower or any other Loan Party shall have failed (i) to
pay when and as required to be paid herein or in any other Loan Document, any amount of principal of any Loan, including after maturity of the Loans, or (ii) to pay within three (3) Business Days after the same shall become due, interest
on any Loan, any fee or any other amount or Obligation payable hereunder or pursuant to any other Loan Document. 
 (b) Any Loan Party shall
have failed to comply with or observe (i) Section 2.1, Section 5.1(a), 5.1(b)(ii), 5.1(c), 5.1(e), 5.1(f), 5.1(g), 5.1(h), 5.1(k), 5.1(l), 5.1(o), 5.1(p), 5.1(q), 5.1(r), 5.1(s), 5.1(t), 5.1(u), 5.1(v), 5.1(w), 5.1(x), 5.1(y) or 5.1(z),
Section 5.2 or Section 5.3 of this Agreement or Sections 5.2(a), 5.2(c), 5.2(d), 5.3, 5.4, 5.5, 5.7, and 5.10 of the Security Agreement, (ii) Section 5.1 of the Security Agreement and such failure, with respect to this Section
5.2(b)(ii) only, shall not have been cured within ten (10) days after the earlier to occur of (y) the date upon which any officer of any Loan Party or any of its Subsidiaries becomes aware of such failure and (z) the date upon which
written notice thereof is given to any Loan Party or any of its Subsidiaries by any Secured Party or (iii) any covenant contained in any Loan Document (other than the covenants described in Section 5.4(a), Section 5.4(b)(i) or Section
5.4(b)(ii) above and other than in respect of the Warrants or the Registration Rights Agreement), and such failure, with respect to this Section 5.2(b)(iii) only, shall not have been cured within thirty (30) days after the earlier to occur of
(y) the date upon which any officer of any Loan Party or any of its Subsidiaries becomes aware of such failure and (z) the date upon which written notice thereof is given to any Loan Party or any of its Subsidiaries by any Secured Party.

  
 72 

 (c) Any representation or warranty made by any Loan Party in any Loan Document shall have been
incorrect, false or misleading in any material respect (except to the extent that such representation or warranty is qualified by reference to materiality or Material Adverse Effect, to which extent it shall have been incorrect, false or misleading
in any respect) as of the date it was made; it being acknowledged and agreed that any projections provided to the Secured Parties are not to be viewed as facts, are not a guarantee of financial performance, and are subject to uncertainties and
contingencies. 
 (d) (i) Any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) shall generally be unable to
pay its debts as such debts become due, or shall admit in writing its inability to pay its debts as they come due or shall make a general assignment for the benefit of creditors; (ii) any Loan Party or any of its Subsidiaries (other than
Immaterial Subsidiaries) shall declare a moratorium on the payment of its debts; (iii) the commencement by any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) of proceedings to be adjudicated bankrupt or insolvent, or
the consent by it to the commencement of bankruptcy or insolvency proceedings against it, or the filing by it of a petition or answer or consent seeking reorganization, intervention or other similar relief under any Applicable Law, or the consent by
it to the filing of any such petition or to the appointment of an intervenor, receiver, liquidator, assignee, trustee, sequestrator or other similar official of all or substantially all of its assets; (iv) the commencement against any Loan
Party or any of its Subsidiaries (other than Immaterial Subsidiaries) of a proceeding in any court of competent jurisdiction under any bankruptcy or other Applicable Law (as now or hereafter in effect) seeking its liquidation, winding up,
dissolution, reorganization, arrangement or adjustment, or the appointment of an intervenor, receiver, liquidator, assignee, trustee, sequestrator or other similar official, and any such proceeding shall continue undismissed, or any order, judgment
or decree approving or ordering any of the foregoing shall continue unstayed or otherwise in effect, for a period of sixty (60) days; (v) the making by any Loan Party or any of its Subsidiaries (other than Immaterial Subsidiaries) of an
assignment for the benefit of creditors, or the admission by it in writing of its inability to pay its debt generally as they become due; or (vi) any other event shall have occurred which under any Applicable Law would have an effect analogous
to any of those events listed above in this subsection. 
 (e) One or more judgments, orders or decrees or settlements shall be rendered
against any Loan Party or any Subsidiary of a Loan Party that exceeds by more than $1,000,000 any insurance coverage applicable thereto (to the extent the relevant insurer has been notified of such claim and has not denied coverage therefor) or one
or more non-monetary judgments, orders or decrees or settlements shall be rendered against any Loan Party or any Subsidiary of a Loan Party that could reasonably be expected, individually or in the aggregate,
to result in a Material Adverse Effect, and in either case (i) enforcement proceedings shall have been commenced by any creditor upon any such judgment, order or decree or (ii) there shall be any period of twenty (20) consecutive days
during which such judgment, order or decree shall not have been vacated or discharged or there shall not be in effect (by reason of a pending appeal or otherwise) any stay of enforcement thereof. 

(f) Any authorization of a Governmental Authority necessary for the execution, delivery or performance of any Loan Document or for the validity
or enforceability of any of the Obligations under any Loan Document is not given or is withdrawn or ceases to remain in full force or effect. 

(g) Any Applicable Law shall purport to render any material provision of any Loan Document invalid or unenforceable or shall purport to prevent
or materially delay the performance or observance by any Loan Party or any of its Subsidiaries of the Obligations (which, for the avoidance of doubt, shall not apply to the process of SEC comments in respect of share registration). 

  
 73 

 (h) Any Loan Party or any Subsidiary of any Loan Party (i) shall fail to make any payment in
respect of any Indebtedness (other than the Obligations or the ABL Debt (which is covered below in Section 5.4(s)) having an individual principal amount (including undrawn committed or available amounts and including amounts owing to all creditors
under any combined or syndicated credit arrangement) in excess of $3,000,000 or having an aggregate principal amount (including undrawn committed or available amounts and including amounts owing to all creditors under any combined or syndicated
credit arrangement) of more than $8,000,000 when due (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise) and such failure continues after the applicable grace or notice period, if any, specified in the documents
relating thereto on the date of such failure; or (ii) shall fail to perform or observe any other condition or covenant, or any other event shall occur or condition exist, under any agreement or instrument relating to any such Indebtedness of
the type covered in Section 5.4(h)(i) above, if the effect of such failure, event or condition is to cause, or to permit the holder or holders of such Indebtedness or beneficiary or beneficiaries of such Indebtedness (or a trustee or agent on
behalf of such holder or holders or beneficiary or beneficiaries) to cause, such Indebtedness to be declared to be due and payable (or otherwise required immediately to be prepaid, redeemed, purchased or defeased) prior to its stated maturity
(without regard to any subordination terms with respect thereto) or cash collateral in respect thereof to be demanded; provided however that, notwithstanding the foregoing, any event or condition that occurs that permits holders of
convertible Indebtedness permitted hereunder to convert such Indebtedness into Stock (other than Disqualified Stock) or such other consideration permitted pursuant to Section 5.2(xx) pursuant to the terms of the applicable indenture shall not
constitute a Default or Event of Default hereunder on such basis alone. 
 (i) Any material provision of any Loan Document shall for any
reason cease to be valid and binding on or enforceable against any Loan Party or any Subsidiary of any Loan Party party thereto or any Loan Party or any Subsidiary of any Loan Party shall so state in writing or bring an action to limit its
obligations or liabilities thereunder or otherwise contest the validity, binding effect or enforceability of the Loan Documents; or any Loan Document shall for any reason (other than pursuant to the terms thereof) cease to create a valid security
interest in any of the Collateral in excess of such Collateral that has a fair market value of $50,000 as determined by the Agent in its sole reasonable discretion (to the extent that such perfection or priority is required hereby) purported to be
covered thereby or such security interest shall for any reason cease to be a perfected and first priority security interest (subject only to the prior priority of the Permitted Priority Liens). 

(j) (i) The occurrence of any ERISA Event that could reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect or (ii) the imposition of a Lien on any asset of a Loan Party or a Subsidiary of a Loan Party with respect to any Title IV Plan or Multiemployer Plan. 

(k) The occurrence of any Event of Default (as such term is defined in the Warrants). 

(l) The Common Stock shall cease to be registered under the Exchange Act or to be listed on the Principal Market. 

(m) The voluntary withdrawal or institution of any action or proceeding by the FDA or similar Governmental Authority to order the withdrawal of
any Product or Product category from the market or to enjoin a Loan Party, such Loan Party’s Subsidiaries or any representative of a Loan Party or its Subsidiaries from manufacturing, marketing, selling or distributing any Product or Product
category that has or could reasonably be expected to have a Material Adverse Effect, (ii) the institution of any action or proceeding by the DEA, the FDA, or any other Governmental Authority to revoke, suspend, reject, withdraw, limit, or
restrict any Regulatory Required Permit held by a Loan Party, its Subsidiaries or any representative of a Loan Party or its Subsidiaries, which, in each case, has or could reasonably be expected to result in Material Adverse Effect, (iii) the
commencement of any enforcement action against a Loan Party, a Loan Party’s Subsidiaries or any representative of a Loan Party or its Subsidiaries (with respect to 

  
 74 

 
the business of a Loan Party or its Subsidiaries) by the DEA, the FDA, or any other Governmental Authority which has or could reasonably be expected to result in a Material Adverse Effect, or
(iv) the occurrence of adverse test results in connection with a Product which could result in Material Adverse Effect. 
 (n) The
introduction of, or any change in, any law or regulation governing or affecting the healthcare industry, including any Healthcare Laws, that has or could reasonably be expected to have a Material Adverse Effect. 

(o) Any Loan Party defaults under or breaches any Material Contract (after any applicable grace period contained therein), or a Material
Contract shall be terminated by a third party or parties party thereto prior to the expiration thereof (other than in accordance with its terms) (other than the Warrant, the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing
or the 2.25% Convertible Notes, any ABL Debt or any Financing Documents (as defined in any permitted ABL Credit Facility), or there is a loss of a material right of a Loan Party under any Material Contract to which it is a party, in each case which
could reasonably be expected to result in a Material Adverse Effect. 
 (p) The occurrence of any breach or default under any terms or
provisions of any Convertible Note Document or any Subordinated Debt Document or the occurrence of any event requiring the prepayment or mandatory redemption of any 3.25% Convertible Note (or any Permitted 3.25% Convertible Note Refinancing thereof
or any indenture or related document governing any Permitted 3.25% Convertible Note Refinancing), any 2.25% Convertible Note or of any Subordinated Debt; provided, however, that, notwithstanding the foregoing, any event or condition
that occurs that permits holders of convertible Indebtedness permitted hereunder to convert such Indebtedness into Stock (other than Disqualified Stock) or such other consideration permitted pursuant to Section 5.2(xx) pursuant to the terms of the
applicable agreement shall not constitute a Default or Event of Default hereunder on such basis alone. 
 (q) The institution by any
Governmental Authority of criminal proceedings against any Loan Party. 
 (r) Any Loan Party makes any payment on account of any Indebtedness
that has been subordinated to any of the Obligations, other than payments specifically permitted by the terms of such subordination. 
 (s)
Any Loan Party or any Subsidiary (A) fails to make any payment when due (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of the ABL Debt, or (B) fails to observe or perform any other
agreement or condition relating to the ABL Debt or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event occurs, the effect of which default or other event is to cause, or to permit the holder or
holders of such ABL Debt or the beneficiary or beneficiaries of any Guarantee related thereto (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, such ABL Debt to be demanded or to become due or to
be repurchased, prepaid, defeased or redeemed (automatically or otherwise), or an offer to repurchase, prepay, defease or redeem such ABL Debt to be made, prior to its stated maturity, or such Guarantee to become payable or cash collateral in
respect thereof to be demanded; provided that, notwithstanding the foregoing in this Section 5.4(s), solely from a breach by any Loan Party of the minimum net revenue test set forth in Section 6.2 of the ABL Credit Facility (or any
replacement financial covenant, if there is a financial covenant, in any refinanced ABL Credit Facility permitted pursuant to the definition of “ABL Credit Facility”) (such financial covenant, the “ABL Financial
Covenant”), (i) if such ABL Financial Covenant breach is under the ABL Credit Facility referenced in clause (i) of the definition of ABL Credit Facility, such breach of the ABL Financial Covenant in such ABL Credit Facility shall
not cause an Event of Default hereunder, even if (subject to the following proviso) the ABL Agent has 

  
 75 

 
accelerated the ABL Debt solely with respect to a breach of an ABL Financial Covenant when no other event of default under the ABL Credit Facility is existing and is exercising its remedies
solely due to such breach of the ABL Financial Covenant when no other event of default under the ABL Credit Facility is existing; provided further that, notwithstanding anything to the contrary in the Loan Documents, the foregoing proviso
shall not limit in any way the applicability of Section 5.4(s)(A) (including an Event of Default resulting from the separate event of default under the ABL Credit Facility that would result from the
non-payment of any of the ABL Debt upon being accelerated due to a breach of the ABL Financial Covenant); (ii) if such ABL Financial Covenant breach is under the ABL Credit Facility referenced in clause
(ii) of the definition of ABL Credit Facility, and the priority of the Lien in favor of the ABL Agent is prior to the priority of the Lien in favor of the Agent hereunder solely with respect to certain specified asset groups (such as accounts
receivable, inventory, equipment, cash and/or related assets), such breach of the ABL Financial Covenant in such ABL Credit Facility shall result in an Event of Default hereunder if the effect of such breach is to cause, or to permit the holder or
holders of such ABL Debt or the beneficiary or beneficiaries of any Guarantee related thereto (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, such ABL Debt to be demanded or to become due or to
be repurchased, prepaid, defeased or redeemed (automatically or otherwise), or an offer to repurchase, prepay, defease or redeem such ABL Debt to be made, prior to its stated maturity, or such Guarantee to become payable or cash collateral in
respect thereof to be demanded; and (iii) if such ABL Financial Covenant breach is under the ABL Credit Facility referenced in clause (ii) of the definition of ABL Credit Facility, and the priority of the Lien in favor of the ABL Agent is
prior to the priority of the Lien in favor of the Agent hereunder with respect to all Collateral, such breach of the ABL Financial Covenant in such ABL Credit Facility shall only result in an Event of Default hereunder if the ABL Lenders the other
holders of such ABL Debt or the beneficiary or beneficiaries of any Guarantee related thereto (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) have caused such ABL Debt to be demanded or to become due or to
be repurchased, prepaid, defeased or redeemed (automatically or otherwise), or an offer to repurchase, prepay, defease or redeem such ABL Debt to be made, prior to its stated maturity, or such Guarantee thereof to become payable or cash collateral
in respect thereof to be demanded or has actually commenced the exercise of remedies as a secured creditor. 
 (t) Any provisions of the
Intercreditor Agreement shall for any reason be revoked or invalidated, or otherwise cease to be in full force and effect, other than in accordance with the terms thereof, or any Person shall contest in any manner the validity or enforceability
thereof or deny that it has any further liability or obligation thereunder. 
 Section 5.5 Additional Remedies. 

(a) Automatic Acceleration on Dissolution or Bankruptcy. Notwithstanding any other provisions of this Agreement, if an Event of Default
under Section 5.4(d) shall occur, the principal of the Loans (together with any interest, other amounts and Obligations accrued or payable under this Agreement or the other Loan Documents (including the
Non-Callable Make Whole Amount, if applicable)) shall thereupon become immediately and automatically due and payable, in each case, without any presentment, demand, protest or notice of any kind, all of which
are hereby expressly waived by the Borrower and the other Loan Parties. 
 (b) Power of Attorney. Notwithstanding anything to the
contrary in this Agreement, the Warrants, and the other Loan Documents, each Loan Party hereby irrevocably and unconditionally constitutes and appoints Agent and any of Agent’s Affiliates, attorneys, representatives or agents, with full power
of substitution, as such Loan Party’s true and lawful attorney-in-fact with full irrevocable and unconditional power and authority in the place and stead of such
Loan Party and in the name of such Loan Party or in its own name, for the purpose of carrying out the terms of this Agreement, the Warrants, and the other Loan Documents, to take any appropriate steps or actions and to execute and deliver (and
perform 

  
 76 

 
under on such Loan Party’s behalf) any agreement, document or instrument that may be necessary or desirable to accomplish the purposes and/or effectuate the items and actions set forth in
this Agreement, the Warrants, and the other Loan Documents, in each case, (i) that any such Loan Party fails to take that are required under such documents, agreements or instruments, (ii) during the existence of any Event of Default, or
(iii) in delivering the original shares of Common Stock to be issued under any Warrants to the applicable holder thereof upon such holder exercising its rights pursuant to the terms of such Warrants. 

Section 5.6 Recovery of Amounts Due. If any Obligation or other amount payable hereunder or under any of the other Loan Documents
is not paid as and when due, the Borrower and the other Loan Parties hereby authorize Agent and the Lenders to proceed, to the fullest extent permitted by Applicable Law, without prior notice, by right of
set-off, banker’s lien or counterclaim, against any moneys or other assets of the Borrower or any other Loan Party to the full extent of all Obligations or other amounts payable to Agent and/or the
Secured Parties. 
 Section 5.7 Credit Bidding. The Loan Parties and the Lenders hereby irrevocably authorize Agent based upon
the written instruction of the Lenders, to (a) credit bid and in such manner purchase (either directly or through one or more acquisition vehicles) all or any portion of the Collateral at any sale thereof conducted under the provisions of the
Bankruptcy Code, including under Section 363 of the Bankruptcy Code or any similar laws in any other jurisdictions to which a Loan Party is subject, or (b) credit bid and in such manner purchase (either directly or through one or more
acquisition vehicles) all or any portion of the Collateral at any other sale or foreclosure conducted by (or with the consent or at the direction of) Agent (whether by judicial action or otherwise) in accordance with Applicable Law. In connection
with any such credit bid and purchase, the Obligations owed to any Lender shall be entitled to be, and shall be, credit bid on a ratable basis (with Obligations with respect to contingent or unliquidated claims being estimated for such purpose if
the fixing or liquidation thereof would not unduly delay the ability of Agent to credit bid and purchase at such sale or other disposition of the Collateral and, if such claims cannot be estimated without unduly delaying the ability of Agent to
credit bid, then such claims shall be disregarded, not credit bid, and not entitled to any interest in the asset or assets purchased by means of such credit bid) and the Lenders whose Obligations are credit bid shall be entitled to receive interests
(ratably based upon the proportion of their Obligations credit bid in relation to the aggregate amount of Obligations so credit bid) in the asset or assets so purchased (or in the Stock of the acquisition vehicle or vehicles that are used to
consummate such purchase). Except as provided above and otherwise expressly provided for herein or in the other Loan Documents, Agent will not execute nor deliver a release of any Lien on any Collateral. Upon request by Agent or the Borrower at any
time, the Lenders will confirm in writing Agent’s authority to release any such Liens on particular types or items of Collateral pursuant to this Section 5.7. 

ARTICLE 6 

MISCELLANEOUS 

Section 6.1 Notices. Any notices or other information (including an financial information) required or permitted to be given under
the terms hereof shall be sent by certified or registered mail (return receipt requested) or delivered personally or by courier (including a recognized overnight delivery service) or by facsimile or by electronic mail and shall be effective five
(5) days after being placed in the mail, if mailed by regular United States mail, or upon receipt, if delivered personally or by courier (including a recognized overnight delivery service) or by facsimile, or when received by electronic mail in
each case addressed to a party as follows (or such other address, facsimile or electronic mail address provided by such party to such other parties pursuant to the below (or such later address, facsimile or electronic mail address provided in
accordance herewith): 

  
 77 

 If to the Borrower or any other Loan Party: 

Endologix, Inc. 
 2 Musick 

Irvine, CA 92618 
 E-mail: vmahboob@endologix.com 
 E-mail: jtejedor@endologix.com

 Attn: Vaseem Mahboob, CFO 

Attn: James Tejedor, Treasury Manager 
 With a
copy to (which shall not be deemed to constitute notice): 
 Stradling Yocca Carlson & Rauth, P.C. 

660 Newport Center Dr # 1600 

Newport Beach, CA 92660 
 E-mail: mlawhead@sycr.com 
 Attn: Mike Lawhead 

Stradling Yocca Carlson & Rauth, P.C. 

100 Wilshire Blvd., Fourth Floor 

Santa Monica, CA 90401 
 E-mail: drosen@sycr.com 
 Attn: Dayan Rosen 

If to Agent: 
 c/o Deerfield Management Company,
L.P. 
 780 Third Avenue, 37th Floor 

New York, NY 10017 
 Facsimile: 212-599-3075 
 E-mail:
dclark@deerfield.com 
 Attn: David J. Clark, Esq. 

With a copy to (which shall not be deemed to constitute notice): 

Katten Muchin Rosenman LLP 
 575
Madison Avenue 
 New York NY 10022-2585 

Facsimile: (212) 894-5877 

E-mail: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com 

Attn: Mark I. Fisher, Esq. 
 Attn:
Mark D. Wood, Esq. 
 If to any Lender, the information for notices included on Schedule 2.4 or pursuant to any assignment agreement assigning any
Obligations to any new Lender. 
 Section 6.2 Waiver of Notice. Whenever any notice is required to be given to the
Lenders or the Borrower under the any of the Loan Documents, a waiver thereof in writing signed by the Person or Persons entitled to such notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such
notice. 

  
 78 

 Section 6.3 Fees, Charges, Costs and Expenses Reimbursement. The Loan Parties
agree to pay on or prior to the Agreement Date and, within ten (10) Business Days (or such later date as the Agent may agree in its sole discretion) after delivery of an invoice therefor after the Agreement Date, (a) all reasonable fees,
reasonable costs and reasonable, out-of-pocket expenses of Agent and the Lenders and of legal counsel to Agent and the Lenders of negotiation, documentation,
preparation, execution, delivery and closing, of the Loan Documents and in connection with the consummation of the Transactions and the other transactions contemplated hereby and thereby, (b) any consents, amendments, waivers or other
modifications to the Loan Documents or otherwise in connection with the consummation of the Transactions and the other transactions contemplated hereby and thereby, (c) all fees, costs and expenses of creating and perfecting Liens in favor of
Agent on behalf of the Secured Parties pursuant to any Loan Document, including filing and recording fees, expenses and Taxes, search fees, title insurance premiums, and fees, costs, expenses and disbursements of counsel to Agent and the Lenders and
of counsel providing any opinions that Agent or the Lenders may request in respect of any Loan Documents or the Liens created pursuant to the Loan Documents, (d) all costs and expenses incurred by Agent or any Lender in connection with the
custody or preservation of any of the Collateral, (e) all costs and expenses, including the reasonable out-of-pocket documented fees, costs and expenses of legal
counsel to Agent and the Lenders and reasonable out-of-pocket documented fees, costs and expenses of accountants, advisors and consultants, incurred by Agent, any Lender
and its counsel relating to efforts to protect, evaluate, assess or dispose of any of the Collateral, (f) all costs and expenses, including fees, costs and expenses of legal counsel to Agent and the Lenders and all fees, costs and expenses of
accountants, advisors and consultants and costs of settlement, incurred by the Agent and the Lenders in enforcing any of the Loan Documents or any Obligations of, or in collecting any payments due from, any Loan Party hereunder or under the other
Loan Documents (including in connection with the sale of, collection from, or other realization upon any of the Collateral or the enforcement of the Loan Documents) or in connection with any refinancing or restructuring of the credit arrangements
provided under this Agreement in the nature of a “work-out” or pursuant to any proceeding or event of the type set forth in Section 5.4(d), (g) the cost of purchasing insurance that the Loan Parties
fail to obtain as required by the Loan Documents, (h) providing any notices under the Loan Documents that are required or recommended by Applicable Law (i) providing any new Notes or amended and restated Notes and (j) any other
actions taken after the Agreement Date related to the Obligations or the Loan Documents. Without limiting any of the foregoing provisions of this Section 6.3, any action taken by any Loan Party under or with respect to any Loan Document,
even if required under any Loan Document or at the request of the Agent or any other Secured Party, shall be at the sole expense of such Loan Party, and neither Agent nor any other Secured Party shall be required under any Loan Document to reimburse
any Loan Party or any Subsidiary of any Loan Party therefor. Notwithstanding anything to the contrary contained in this Section 6.3, the Loan Parties shall only be obligated to pay the attorney’s fees provided for under clause (a) of
this Section 6.3 that are incurred solely prior to the Agreement Date (but not thereafter) up to a maximum of $250,000 (for the avoidance of doubt, which cap is inclusive of any attorney’s fees incurred pursuant to Section 12.14(a) of the
ABL Credit Facility prior to the date hereof by the applicable Affiliate of Deerfield Facility Entity as the ABL Agent under the ABL Credit Facility in connection with negotiating and closing the ABL Credit Facility) (the “Pre-Closing Attorney’s Fees Cap”). 
 Section 6.4 Governing
Law; Venue; Jurisdiction; Service of Process; Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this Agreement and, unless otherwise expressly stated therein, the other Loan
Documents shall be governed by and construed and enforced in accordance with the laws of the State of New York applicable to contracts made and to be performed in such State. Each Party agrees that all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by this Agreement and, unless otherwise expressly stated therein, the other Loan Documents (whether brought against a party hereto or its respective Affiliates, directors,
officers, shareholders, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, Borough of Manhattan. Each 

  
 79 

 
Party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute hereunder
or under the other Loan Documents or in connection herewith or with the other Loan Documents or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, or that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each Party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such Party at the address in effect for notices to it under
this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. THE
PARTIES HERETO, TO THE EXTENT PERMITTED BY LAW, WAIVE ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT, OR PROCEEDING ARISING OUT OF, IN CONNECTION WITH OR RELATING TO, THIS AGREEMENT, THE OTHER LOAN DOCUMENTS AND ANY TRANSACTION CONTEMPLATED HEREBY
AND THEREBY. THIS WAIVER APPLIES TO ANY ACTION, SUIT OR PROCEEDING WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE. EACH PARTY HERETO (A) CERTIFIES THAT NO OTHER PARTY AND NO AGENT, REPRESENTATIVE OR OTHER PERSON AFFILIATED WITH OR RELATED TO
ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER
INTO THE LOAN DOCUMENTS, AS APPLICABLE, BY THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6.4. 
 Section 6.5 Successors and
Assigns. This Agreement shall bind and inure to the respective successors and assigns of the Parties, except that no Loan Party may assign or otherwise transfer all or any part of their rights or obligations (including the Obligations)
under the Loan Documents without the prior written consent of all of the Lenders (other than in any Permitted Successor Transaction), and any prohibited assignment by the Loan Parties shall be absolutely void ab initio. Any Lender may assign
or transfer its rights or Obligations under the Loan Documents to an Eligible Assignee, so long as (a) with respect to any assignment to a Person mentioned in clause (d) of the definition of “Eligible Assignee”, the amount of
such assignment is for Loans in an aggregate principal amount not less than $5,000,000 (or, if less, the entire remaining principal amount of Loans held by such Lender); provided that such threshold amount shall be aggregated between such
Persons that are assignees mentioned in such clause (d) of the definition of “Eligible Assignee” that are Affiliates of each other. Upon a Lender’s assignment of any of the Loans held by it in accordance with this
Section 6.5, such Lender shall provide notice of the transfer to Borrower (with a copy to Agent) for recordation in the Register pursuant to Section 1.4. Upon receipt of a notice of a permitted transfer of an interest in a Loan, the
Borrower shall record the identity of the transferee and other relevant information in the Register and the transferee shall (to the extent of the interests transferred to such transferee) have all the rights and obligations of, and shall be deemed,
a Lender with respect to such Loan hereunder or under the other Loan Documents. Notwithstanding anything to the contrary in any Loan Document, no Lender shall assign or transfer, or provide any participation in, any of the Loans or other Obligations
to any Loan Party or any of their Affiliates without the written consent of Agent. If a Lender sells participating interests in its Loans or other interests hereunder (any such Person, a “Participant”), (i) such Lender’s
obligations hereunder with respect to those sold to the Participant shall remain unchanged for all purposes, (ii) the Borrower and Agent shall continue to deal solely and directly with such Lender in connection with such Lender’s rights
and obligations hereunder with respect to those sold to the Participant, and (iii) all amounts payable by the Borrower shall be determined as if such Lender had not sold such participation and shall be paid directly to such Lender. 

  
 80 

 In addition to the other rights provided in this Section 6.5, each Secured Party may grant a
security interest in, or otherwise assign as collateral, any of its rights under the Loan Documents, whether now owned or hereafter acquired (including rights to payments of principal or interest on the Loans), to any holder of, or trustee for the
benefit of the holders of, such Secured Party’s Indebtedness or equity securities; provided however that no such security interest or assignment shall release such Secured Party from any of its obligations hereunder or substitute any such
holder of a security interest or assignee for such Secured Party as a party hereto. 
 Section 6.6 Entire Agreement; Amendments.

 (a) The Loan Documents contain the entire understanding of the Parties with respect to the matters covered thereby and supersede any and
all other written and oral communications, negotiations, commitments and writings with respect thereto. 
 (b) No amendment, restatement,
modification, supplement, change, termination or waiver of any provision of this Agreement or the other Loan Documents (other than the Warrants, the Registration Rights Agreement, any Control Agreement or any similar agreement or any landlord
agreement or bailee or mortgagee waiver, each of which may be amended, changed or waived in accordance with the terms thereof), and no consent to any departure by any Loan Party therefrom, shall in any event be effective without the written
concurrence of the Borrower, the Agent and the Required Lenders; provided that no such amendment, restatement, modification, change, termination, waiver or consent to this Agreement shall, without the consent of each Lender with Obligations
directly and adversely affected thereby, do any of the following: (i) reduce any Loan of such Lender; (ii) postpone the Maturity Date or other scheduled final maturity date of any Loan of such Lender, or postpone the date or reduce the
amount of any scheduled payment (but not mandatory prepayment) of principal of any Loan of such Lender; (iii) decrease the interest rate borne by any Loan of such Lender (other than any waiver of any increase in the interest rate applicable to
any of the Loans pursuant to Section 2.7(b)) or the amount of any premium or fees payable hereunder; or (iv) amend this proviso of this Section 6.6 to the extent providing for consent by all directly and adversely affected Lenders in a
manner to remove such consent. 
 (c) No consideration shall be offered or paid (in any form, whether cash, Stock, other property or
otherwise) to any Secured Party to amend, restate, supplement, modify or change or consent to a waiver of (or a diversion from) any provision of any of the Loan Documents unless the same consideration also is offered to all of the Lenders under the
Loan Documents. For clarification purposes, this provision constitutes a separate right granted to each Lender and is not intended for the Borrower or any other Loan Party to treat the Lenders as a class and shall not be construed in any way as the
Lenders acting in concert or otherwise as a group with respect to the purchase, disposition or voting of securities or Stock or otherwise. 

Section 6.7 Severability. If any provision of this Agreement or any of the other Loan Documents shall be invalid, illegal
or unenforceable in any respect under any law, the validity, legality and enforceability of the remaining provisions hereof or thereof shall not in any way be affected or impaired thereby. The Parties shall endeavor in good faith negotiations to
replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provision. 

Section 6.8 Counterparts. This Agreement may be executed in several counterparts, and by each Party on separate
counterparts, each of which and any photocopies, facsimile copies and other electronic methods of transmission thereof shall be deemed an original, but all of which together shall constitute one and the same agreement. 

  
 81 

 Section 6.9 Survival; Releases of Guarantees and Liens. 

(a) In addition to Section 3.2, this Agreement and all agreements, representations and warranties and covenants made in the Loan
Documents, and in any document, certificate or statement delivered pursuant thereto or in connection therewith shall be considered to have been relied upon by the other Parties and shall survive the execution and delivery of this Agreement and the
other Loan Documents and the making of the Loan hereunder or thereunder, in each case until termination of such provision in accordance with this Section 6.9, regardless of any investigation made by any such other Party or on its behalf. Agent
and the Lenders shall not be deemed to have waived, by reason of making the Loan, any Event of Default that may arise by reason of such representation or warranty proving to have been false or misleading, notwithstanding that the Lenders may have
had notice or knowledge of any such Event of Default or may have had notice or knowledge that such representation or warranty was false or misleading at the time the Disbursement was made. 

(b) All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or
in connection herewith or therewith shall survive the execution and delivery hereof and thereof (and, with respect to Section 3.1(g)(i)(B), the first two sentences of Section 3.1(i), Section 3.1 (y), Section 3.1 (z)(A) and (C), Section
3.1(ee), the first sentence of Section 3.1(mm), Section 3.1(nn), Section 3.1(oo), Section 3.1(rr), Section 3.1(ss) and Section 3.1 (tt), shall continue to be made in accordance with the terms hereof and thereof, including at
all times after the execution and delivery hereof and thereof). Such representations and warranties have been or will be relied upon by the Secured Parties, regardless of any investigation made by the Secured Parties or on their behalf and
notwithstanding that any Secured Party may have had notice or knowledge of any Default at the time of any Loan, and shall continue in full force and effect as long as either (i) any Loan or any other Obligation hereunder shall remain
outstanding, unpaid or unsatisfied or (ii) the Maturity Date has not occurred. Notwithstanding anything to the contrary in the Loan Documents, the obligations of the Loan Parties under Section 2.5 and the obligations of the Loan Parties
and the Lenders under this Article 6 shall survive and remain in full force and effect regardless of the consummation of the transactions contemplated hereby, the repayment of the Loans and the other Obligations, the expiration or termination of the
Warrants or the termination of this Agreement or any of the other Loan Documents or any provision hereof or thereof. For the avoidance of doubt and notwithstanding anything to the contrary in any Loan Documents, (a) the making of the
representations and warranties herein or in any other Loan Document that relate to the Warrants or any securities laws shall survive the payment in full of the Loans and any other Obligations until such time that Warrants are fully and completely
paid, performed, extinguished and terminated in accordance with their terms, (b) all rights set forth in the Warrants and the Registration Rights Agreement and all transactions contemplated thereby (other than this Agreement and the other Loan
Documents with respect to provisions that are not mentioned herein or therein to survive the payment in full of the Loans) shall continue to, and at all times, exist until (i) with respect to the Warrants, such Warrants are fully and completely
paid, performed, extinguished and terminated in accordance with their terms and (ii) with respect to the Registration Rights Agreement, such Registration Rights Agreement is fully and completely terminated in accordance with its terms,
(c) Sections 5.1(h), (p) and (s) and Section 5.2(xvii) will survive until the end of the Reporting Period, but all other affirmative and negative covenants, events of default, fees, penalties and other provisions not expressly surviving
pursuant to this Section 6.9 shall terminate upon the payment in full of the Obligations (not including unasserted contingent indemnification obligations or any Obligations in respect of the Warrants, the Registration Rights Agreement or any
Stock) and (d) all Liens granted on the Collateral under any Loan Document shall remain in effect and shall continue to secure the Obligations (but not including any Obligations in respect of the Warrants, the Registration Rights Agreement or
any Stock) under the Loan Documents (x) until all of the Obligations (other than unasserted contingent indemnification obligations and other than any Obligations under the Warrants, the Registration Rights Agreement and any Stock in connection
therewith) have been paid in full in cash in accordance with such Loan Documents and (y) other than Liens on any Collateral disposed of in a Permitted Disposition or 

  
 82 

 
as otherwise agreed in writing by the Required Lenders (or such greater percentage of Lenders required pursuant to Section 6.6) (but such release shall only be for the Liens on such
Collateral so disposed in a Permitted Disposition or as may be agreed in writing by the Required Lenders (or such greater percentage of Lenders required pursuant to Section 6.6)). 

(c) Upon payment in full of all Obligations (other than unasserted contingent indemnification obligations and other than any Obligations in
connection with the Warrants, the Stock underlying such Warrants and the Registration Rights Agreement) in cash in accordance with the Loan Documents, subject to the second sentence of Section 6.22, all Collateral shall be automatically
released from the Liens created by the Security Agreement, any other Loan Document or otherwise and all rights of the Secured Parties in the Collateral shall automatically terminate, all without delivery of any instrument or any additional
performance by any Person. 
 (d) Notwithstanding anything to the contrary contained herein or in any other Loan Document, the Agent is
hereby unconditionally authorized and instructed by each Secured Party (without requirement of notice to or consent of any Secured Party) to take any action to release or terminate any Lien granted under the Loan Documents to secure the Obligations
in the Collateral (it being understood and agreed that no security interest is granted under any Loan Document or otherwise in any Obligations, in each case, in respect of (and only in respect of) the Warrants, the Registration Rights Agreement or
any underlying Stock in connection therewith) upon (i) payment in full of all Obligations (other than unasserted contingent indemnification obligations and other than the Obligations under the Warrants and the Registration Rights Agreement and
any Stock) in cash in accordance with the Loan Documents, (ii) a written agreement by the requisite number of Lenders required by Section 6.6 and (iii) a Permitted Disposition (but solely in the Collateral so disposed of in a
Permitted Disposition and not in any other property or assets). 
 (e) In each case in accordance with this Section 6.9 whereby a Lien on all
or a portion of the Collateral is released, the Agent will (and each Lender irrevocably authorizes and instructs the Agent to), at the Borrower’s expense, execute and deliver to the applicable Loan Party such documents as such Loan Party may
reasonably request to evidence the release of (i) all Collateral from the Liens granted under the Loan Documents upon payment in full of all Obligations (other than unasserted contingent indemnification obligations and other than the
Obligations under the Warrants and the Registration Rights Agreement and any Stock) in cash in accordance with the Loan Documents, in each case, in accordance with the terms of the Loan Documents and this Section 6.9, (ii) Collateral permitted
to be sold pursuant to clause (d)(ii) of this Section 6.9 (but solely in such Collateral) and (iii) the Liens on that Collateral sold pursuant to a Permitted Disposition (but solely in such Collateral sold pursuant to such Permitted
Disposition). 
 (f) Notwithstanding anything to the contrary in the Loan Documents and for the avoidance of doubt, the holders of the
Warrants and parties to the Registration Rights Agreement shall be entitled to exercise all rights and remedies available to them under law and at equity and under the Warrants and the Registration Rights Agreement for any breaches of provisions
that survive the payment in full of the Obligations (other than the payment in full of unasserted contingent indemnification obligations and other than Obligations under the Warrants, the Registration Rights Agreement and any Stock). 

Section 6.10 No Waiver. Neither the failure of, nor any delay on the part of, any Party in exercising any right, power or
privilege hereunder, or under any agreement, document or instrument mentioned herein or under any other Loan Document, shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege hereunder, under any
other Loan Document or under any other agreement, document or instrument mentioned herein, preclude other or further exercise thereof or the exercise of any other right, power or privilege; nor shall any waiver of any right, power, privilege or
default 

  
 83 

 
hereunder, under any other Loan Document or under any agreement, document or instrument mentioned herein, constitute a waiver of any other right, power, privilege or default or constitute a
waiver of any default of the same or of any other term or provision. No course of dealing and no delay in exercising, or omission to exercise, any right, power or remedy accruing to Agent or the Lenders upon any breach, Default or Event of Default
under this Agreement, any other Loan Document or any other agreement shall impair any such right, power or remedy or be construed to be a waiver thereof or an acquiescence therein; nor shall the action of Agent or the Lenders in respect of any such
breach, Default or Event of Default or any acquiescence by it therein, affect or impair any right, power or remedy of Agent or the Lenders in respect of any other breach, Default or any Event of Default. All rights and remedies herein or in the
other Loan Documents provided are cumulative and not exclusive of any rights or remedies otherwise provided by (or available at) law or in equity. 

Section 6.11 Indemnity. 

(a) The Loan Parties shall, at all times, indemnify and hold harmless (the “Indemnity”) the Secured Parties and each of their
respective directors, partners, officers, employees, agents, counsel and advisors (each, an “Indemnified Person”) in connection with any losses, claims (including the reasonable attorneys’ fees incurred in defending against
such claims), damages, liabilities, penalties or other expenses arising out of, or relating to, the Loan Documents, the extension of credit hereunder or the Loan or the other Obligations or the use or intended use of the Loan or the other
Obligations, which an Indemnified Person may incur or to which an Indemnified Person may become subject (each, a “Loss”). The Indemnity shall not apply to the extent that a court or arbitral tribunal of competent jurisdiction issues
a final non-appealable judgment that such Loss of an Indemnified Person resulted from the gross negligence, bad faith or willful misconduct of such Indemnified Person. The Indemnity is independent of and in
addition to any other agreement of any Party under any Loan Document to pay any amount to the Secured Parties, and any exclusion of any obligation to pay any amount under this Section 6.11(a) shall not affect the requirement to pay such amount under
any other section hereof or under any other agreement. For the avoidance of doubt, this Section 6.11 shall not apply to Taxes other than Taxes that represent losses, claims, damages, etc. arising from any
non-Tax claim. 
 (b) An Indemnified Person shall have the right to retain its own legal counsel with
the fees, costs and expenses of such legal counsel and of such Indemnified Person to be paid by the indemnifying Person. The indemnification required by this Section 6.11 shall be made and paid by such indemnifying Person within ten
(10) Business Days of written demand by such Indemnified Person. 
 (c) No settlement of any Loss shall be entered into by such
indemnifying Person without the written consent of the applicable Indemnified Person. 
 (d) No Loan Party shall, nor shall it permit any of
its Subsidiaries, assert, and each Loan Party on behalf of itself and its Subsidiaries, hereby waives, any claim, loss or amount against any Indemnified Person with respect to any special, indirect, consequential or punitive damages (as opposed to
direct or actual damages) arising out of, in connection with, or as a result of, this Agreement or the other Loan Documents or any undertaking or transaction contemplated hereby or thereby. No Indemnified Person shall be liable for any damages
arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with the Loan Documents or the transactions
contemplated hereby or thereby. 
 Section 6.12 No Usury. The Loan Documents are hereby expressly limited so that in no
contingency or event whatsoever, whether by reason of acceleration or otherwise, shall the amount paid or agreed to be paid to Agent or the Lenders for the Loan or the other Obligations exceed the maximum amount permissible under Applicable Law. If
from any circumstance whatsoever fulfillment of any 

  
 84 

 
provision hereof or any other Loan Document, at the time performance of such provision shall be due, shall involve transcending the limit of validity prescribed by law, then, ipso facto,
the obligation to be fulfilled shall be reduced to the limit of such validity, and if from any such circumstance Agent or the Lenders shall ever receive anything which might be deemed interest under Applicable Law, that would exceed the highest
lawful rate, such amount that would be deemed excessive interest shall be applied to the reduction of the principal amount owing on account of the Loan or the other Obligations, or if such deemed excessive interest exceeds the unpaid balance of
principal of the Loan or the other Obligations, such deemed excess shall be refunded to the Borrower. All sums paid or agreed to be paid to the Lenders for the Loan or the other Obligations shall, to the extent permitted by Applicable Law, be deemed
to be amortized, prorated, allocated and spread throughout the full term of the Loan and the other Obligations until payment in full so that the deemed rate of interest on account of the Loan and the other Obligations is uniform throughout the term
thereof. The terms and provisions of this Section shall control and supersede every other provision of this Agreement, the Notes and the other Loan Documents. 

Section 6.13 Specific Performance. The Loan Parties agree that irreparable damage, for which monetary relief, even if available,
would not be an adequate remedy, would occur in the event that any provision of the Loan Documents is not performed in accordance with its specific terms or is otherwise breached, including if the Loan Parties hereto fail to take any action required
of them hereunder or thereunder to consummate the transactions contemplated by the Loan Documents. In light of the foregoing, the Loan Parties hereby agree that, until all Obligations have been paid in full in accordance with the Loan Documents,
(a) the Secured Parties shall be entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of the Loan Documents and to enforce specifically the terms and provisions hereof and thereof in the
courts described in Section 6.4 without proof of damages or otherwise and (b) the right of specific performance and other equitable relief is an integral part of the transactions contemplated by the Loan Documents and without that right,
the Secured Parties would not have entered into the Loan Documents or have provided Loans or Disbursements hereunder or under the other Loan Documents. The Loan Parties hereby agree not to assert (or have any of their Subsidiaries or their
attorneys, agents or representatives assert or any other Person on their behalf to assert) that a remedy of specific performance or other equitable relief is unenforceable, invalid, contrary to Applicable Law or inequitable for any reason, and not
to assert that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at law. The Loan Parties hereby acknowledge and agree that any Secured Party seeking an injunction or injunctions to
prevent breaches of, or defaults under, the Loan Documents, to prevent any Default or Event of Default and to enforce specifically the terms and provisions of the Loan Documents in accordance with this Section 6.13 shall not be required to
provide any bond or other security in connection with any such injunction or other order or proceeding. The remedies available to the Secured Parties pursuant to this Section 6.13 shall be in addition to any other remedy which may be available
under the Loan Documents, at law, in equity or otherwise. 
 Section 6.14 Further Assurances. From time to time, the Loan
Parties shall perform any and all acts and execute and deliver to Agent and the Lenders such additional documents, agreements and instruments as may be reasonably requested by Agent or any of the Lenders to carry out the purposes of any Loan
Document or to preserve and protect Agent’s or the Lenders’ rights as contemplated therein. 
 Section 6.15 Agent.

 (a) Each Lender hereby irrevocably appoints Deerfield Private Design Fund IV, L.P. (together with any successor Agent appointed by
Deerfield Private Design Fund IV, L.P. or any successor Agent that was appointed by the Lenders or any prior Agent) as Agent hereunder and under the other Loan Documents and authorizes Agent to (i) execute and deliver the Loan Documents and
accept delivery thereof on its behalf from any Loan Party, (ii) take such other actions on its behalf and to exercise all rights, powers and remedies and perform the duties as are expressly delegated to Agent under the Loan Documents and

  
 85 

 
(iii) exercise such powers as are reasonably incidental thereto. Notwithstanding any provision to the contrary contained elsewhere in this Agreement or in any other Loan Document, Agent shall not
have any duty or responsibility except those expressly set forth herein, nor shall Agent have or be deemed to have any fiduciary relationship with any Lender or participant, and no implied covenants, functions, responsibilities, duties, obligations
or liabilities shall be read into this Agreement or any other Loan Document or otherwise exist against Agent. Without limiting the generality of the foregoing sentence, the use of the term “agent” herein and in other Loan Documents with
reference to Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any Applicable Law. Instead, such term is used merely as a matter of market custom, and is intended to create or
reflect only an administrative relationship between independent contracting parties. 
 (b) Agent may execute any of its duties under this
Agreement or any other Loan Document by or through agents, employees or attorneys in fact and shall be entitled to advice of counsel and other consultants or experts concerning all matters pertaining to such duties. Agent shall not be responsible
for the negligence or misconduct of any agent or attorney in fact that it selects in the absence of gross negligence or willful misconduct as determined by a final, non-appealable judgment of a court of
competent jurisdiction. 
 (c) None of Agent nor any of its directors, officers, employees, attorneys, advisors, representatives or agents
shall (i) be liable for any action taken or omitted to be taken by any of them under or in connection with this Agreement or any other Loan Document or the Transactions or the transactions contemplated hereby or thereby (except to the extent
resulting from its own gross negligence or willful misconduct in connection with its duties expressly set forth herein as determined by a final, non-appealable judgment of a court of competent jurisdiction),
or (ii) be responsible in any manner to any Lender or participant for any recital, statement, representation or warranty made by any Loan Party or Affiliate of any Loan Party, or any officer thereof, contained in this Agreement or in any other
Loan Document, or in any certificate, report, statement or other document referred to or provided for in, or received by the Agent under or in connection with, this Agreement or any other Loan Document, or the validity, effectiveness, genuineness,
enforceability or sufficiency of this Agreement or any other Loan Document (or the creation, perfection or priority of any Lien or security interest therein), or for any failure of any Loan Party or any other party to any Loan Document to perform
its obligations (including the Obligations) hereunder or thereunder. Agent shall not be under any obligation to any Lender to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this
Agreement or any other Loan Document, or to inspect the properties, books or records of any Loan Party or any Loan Party’s Subsidiaries or Affiliates. 

(d) Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing, communication, signature, resolution,
representation, notice, consent, certificate, electronic mail message, affidavit, letter, telegram, facsimile, telex or telephone message, statement or other document or conversation believed by it to be genuine and correct and to have been signed,
sent or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to any Loan Party), independent accountants and other experts selected by Agent. Agent shall be fully justified in failing or refusing
to take any action under this Agreement or any other Loan Document unless it shall first receive such advice or concurrence of the Lenders as it deems appropriate and, if it so requests, shall receive confirmation from the Lenders of their
obligation to indemnify Agent against any and all liabilities and expenses (including any fees and expenses of counsel to Agent) which may be incurred by it by reason of taking or continuing to take any such action. Agent shall in all cases be fully
protected in acting, or in refraining from acting, under this Agreement or any other Loan Document in accordance with a request or consent of the Lenders and such request and any action taken or failure to act pursuant thereto shall be binding upon
each Lender. 

  
 86 

 (e) Agent shall not be deemed to have knowledge or notice of the occurrence of any Event of
Default or Default, unless Agent shall have received written notice from a Lender or any Loan Party referring to this Agreement and the other Loan Documents, describing such Event of Default or Default and stating that such notice is a “notice
of default.” Agent shall take such action with respect to such Event of Default or Default as may be requested by the Lenders; provided that unless and until the Agent has received any such request, the Agent may (but shall not be obligated to)
take such action, or refrain from taking such action, with respect to such Event of Default or Default as it shall deem advisable or in the best interest of itself and the Lenders. 

(f) Each Lender acknowledges that Agent has not made any representation or warranty to it, and that no act by Agent hereafter taken, including
any consent and acceptance of any assignment or review of the affairs of the Loan Parties or any of their Subsidiaries, shall be deemed to constitute any representation or warranty by Agent to any Lender as to any matter, including whether Agent has
disclosed material information in its possession. Each Lender represents to Agent that it has, independently and without reliance upon Agent and based on such documents and information as it has deemed appropriate, made its own appraisal of and
investigation into the business, prospects, operations, property, financial and other condition and creditworthiness of Borrower and the other Loan Parties, and made its own decision to enter into this Agreement and the other Loan Documents and to
extend credit to Borrower hereunder and under the other Loan Documents. Each Lender also represents that it will, independently and without reliance upon Agent and based on such documents and information as it shall deem appropriate at the time,
continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Loan Documents, and to make such investigations as it deems necessary or appropriate to inform itself as to the
business, prospects, operations, property, financial and other condition and creditworthiness of Borrower and the other Loan Parties. Except for notices, reports and other documents expressly herein required to be furnished to the Lenders by Agent,
Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the business, prospects, operations, property, financial or other condition or creditworthiness of Borrower or any other Loan Party
which may come into the possession of Agent. 
 (g) Whether or not the transactions contemplated hereby are consummated, each Lender shall
indemnify upon demand Agent and its directors, officers, partners, employees, attorneys, advisors, representatives and agents (to the extent not reimbursed by or on behalf of any Loan Party and without limiting the obligation of Borrower to do so),
according to its applicable Pro Rata Share, from and against any and all losses, claims (including the reasonable attorneys’ fees incurred in defending against such claims), damages, liabilities, penalties or other expenses arising out of, or
relating to, any of Agent’s duties, responsibilities or actions set forth in or that taken pursuant to the Loan Documents; provided that no Lender shall be liable for any payment to any such Person of any portion of the foregoing to the extent
determined by a final, non-appealable judgment by a court of competent jurisdiction to have resulted from the applicable Person’s own gross negligence or willful misconduct. No action taken in accordance
with the directions of the Lenders shall be deemed to constitute gross negligence or willful misconduct for purposes of this Section 6.15(g). Without limitation of the foregoing, each Lender shall reimburse Agent upon demand for its ratable share of
any costs or out of pocket expenses incurred by Agent in connection with the preparation, execution, delivery, administration, modification, amendment or enforcement (whether through negotiations, legal proceedings or otherwise) of, or legal advice
in respect of rights or responsibilities under, this Agreement, any other Loan Document or any document contemplated by or referred to herein or therein, to the extent that Agent is not reimbursed for such fees, costs and expenses by or on behalf of
the Loan Parties. The undertaking in this Section 6.15(g) shall survive repayment of the Loans and the other Obligations, any foreclosure under, or modification, release or discharge of, any or all of the Loan Documents, termination of this
Agreement or the other Loan Documents and the resignation or replacement of Agent. 

  
 87 

 (h) Agent may resign as Agent upon thirty (30) days’ notice to the Lenders. If Agent
resigns under this Agreement, the Lenders shall appoint from among the Lenders a successor Agent for such successor Agent and the Lenders. If no successor Agent is appointed prior to the effective date of the resignation of Agent, Agent may appoint,
after consulting with the Lenders, a successor Agent from among the Lenders. Upon the acceptance of its appointment as successor Agent hereunder, such successor Agent shall succeed to all the rights, powers and duties of the retiring Agent and the
term “Agent” shall mean such successor Agent, and the retiring Agent’s appointment, powers and duties as Agent shall be terminated. After any retiring Agent’s resignation hereunder as Agent, the provisions of this
Section 16.15 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Agent under this Agreement and the other Loan Documents. If no successor Agent has accepted appointment as Agent by the date which is 30
days following a retiring Agent’s notice of resignation, the retiring Agent’s resignation shall nevertheless thereupon become effective and the Lenders shall perform all of the duties of Agent hereunder until such time, if any, as the
Lenders appoint a successor Agent as provided for above. 
 Section 6.16 USA Patriot Act. Each Lender that is subject to the USA
Patriot Act (and Agent (for itself and not on behalf of any Lender)) hereby notifies the Loan Parties that, pursuant to the requirements of the USA Patriot Act, it is required to obtain, verify and record information that identifies each Loan Party,
which information includes the name and address of each Loan Party and other information that will allow such Lender or Agent to identify each Loan Party in accordance with the USA Patriot Act. 

Section 6.17 Placement Agent. The Borrower and the other Loan Parties shall be solely responsible for the payment of any fees,
costs, expenses and commissions of any placement agent, broker or financial adviser relating to or arising out of the transactions contemplated by the Loan Documents. The Borrower and the other Loan Parties shall pay, and hold each of the Secured
Parties harmless against, any liability, loss or expense (including attorneys’ fees, costs and expenses) arising in connection with any claim for any such payment. 

Section 6.18 No Fiduciary Relationship. No Secured Party has any fiduciary relationship or duty to any Loan Party arising out of
or in connection with, and there is no agency, tenancy or joint venture relationship between the Secured Parties and the Loan Parties by virtue of, any Loan Document or any transaction contemplated therein. 

Section 6.19 Joint and Several. The obligations of the Loan Parties hereunder and under the other Loan Documents are joint and
several. Without limiting the generality of the foregoing, reference is hereby made to Sections 2, 4 and 8.3 of the Security Agreement, to which the obligations of the Loan Parties are subject. 

Section 6.20 No Third Parties Benefited. This Agreement is made and entered into for the sole protection and legal benefit of the
Loan Parties and the Secured Parties party hereto (and the indemnitees mentioned herein), and their successors and permitted assigns, and no other Person shall be a direct or indirect legal beneficiary of, or have any direct or indirect cause of
action or claim in connection with, this Agreement or any of the other Loan Documents. No Secured Party shall have any obligation to any Person not a party to this Agreement or the other Loan Documents. 

Section 6.21 Binding Effect. This Agreement shall become effective when it shall have been executed by each of the Loan Parties
party hereto, each Lender party hereto and Agent and such executed counterparts have been delivered to Agent pursuant to the terms of this Agreement. Thereafter, it shall be binding upon and inure to the benefit of, each Loan Party party hereto and
each Secured Party party thereto and the indemnitees mentioned herein and, in each case, their respective successors and permitted assigns. 

  
 88 

 Section 6.22 Marshaling; Payments Set Aside. No Secured Party shall be under any
obligation to marshal any property in favor of any Loan Party or any other Person or against or in payment of any Obligation. To the extent that any Secured Party receives a payment from the Borrower, from any other Loan Party, from the proceeds of
the Collateral, from the exercise of its rights of setoff, any enforcement action or otherwise, and such payment is subsequently, in whole or in part, invalidated, declared to be fraudulent or preferential, set aside or required to be repaid to a
trustee, receiver or any other party, then to the extent of such recovery, the Obligation or part thereof originally intended to be satisfied, and all Liens, rights and remedies therefor, shall be revived and continued in full force and effect as if
such payment had not occurred. 
 Section 6.23 No Waiver; Cumulative Remedies. No failure to exercise and no delay in
exercising, on the part of any Secured Party, any right, remedy, power or privilege under any Loan Document, shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any
other or further exercise thereof or the exercise of any other right, remedy, power or privilege. No course of dealing between any Loan Party, any Affiliate of any Loan Party or any Secured Party shall be effective to amend, modify or discharge any
provision of any of the Loan Documents. 
 Section 6.24 Right of Setoff. Each Secured Party and each of its Affiliates is hereby
authorized, without notice or demand (each of which is hereby waived by each Loan Party), at any time and from time to time during the continuance of any Event of Default and to the fullest extent permitted by Applicable Law, to set off and apply
any and all deposits (whether general or special, time or demand, provisional or final) at any time held and other Indebtedness, claims or other obligations at any time owing by any Secured Party or any of its Affiliates to or for the credit or the
account of the Borrower or any other Loan Party against any Obligation of any Loan Party now or hereafter existing, whether or not any demand was made under any Loan Document with respect to such Obligation and even though such Obligation may be
unmatured. No Lender shall exercise any such right of setoff without the prior consent of Agent. Each Secured Party agrees promptly to notify Agent after any such setoff and application made by such Secured Party or its Affiliates. The rights under
this Section 6.24 are in addition to any other rights and remedies (including other rights of setoff) that any Secured Party or any of its Affiliates may have. 

Section 6.25 Independent Nature of Secured Parties. The obligations of each Secured Party under the Loan Documents are several and
not joint with the obligations of any other Secured Party, and no Secured Party shall be responsible in any way for the performance of the obligations of any other Secured Party under the Loan Documents. Each Secured Party shall be responsible only
for its own representations, warranties, agreements and covenants under the Loan Documents. The decision of each Lender to acquire the Securities pursuant to the Loan Documents has been made by such Lender independently of any other Lender and
independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition (financial or otherwise) or prospects of the Borrower or any of its
Subsidiaries which may have been made or given by any other Secured Party or by any agent, attorney, advisor, representative or employee of any other Secured Party, and no Secured Party or any of its agents, attorneys, advisors, representatives or
employees shall have any liability to any other Secured Party (or any other Person) relating to or arising from any such information, materials, statements or opinions. Nothing contained in the Loan Documents, and no action taken by any Secured
Party pursuant hereto or thereto (including a Lender’s acquisition of Obligations, Notes or Warrants at the same time as any other Secured Party), shall be deemed to constitute the Secured Parties as a partnership, an association, a joint
venture or any other kind of entity, or create a presumption that the Secured Parties are in any way acting in concert or as a group with respect to such Obligations or the transactions contemplated by any of the Loan Documents. Each Secured Party
shall be entitled to independently protect and enforce its rights, including the rights arising out of the Loan Documents, and it shall not be necessary for any other Secured Party to be joined as an additional party in any proceeding for such
purpose. 

  
 89 

 Section 6.26 Sharing of Payments, Etc.If any Lender, directly or through any of its
Affiliates, obtains any payment of any Obligation of any Loan Party (whether voluntary, involuntary or through the exercise of any right of setoff or the receipt of any Collateral or “proceeds” (as defined under the applicable UCC) of
Collateral) (and other than pursuant to Section 6.5) and such payment exceeds the amount such Lender would have been entitled to receive if all payments had gone to, and been distributed in accordance with the provisions of the Loan Documents,
such Lender shall purchase for cash from other Lenders such participations in their Obligations as necessary for such Lender to share such excess payment with such Lenders to ensure such payment is applied as though it had been applied in accordance
with this Agreement; provided, however, that (i) if such payment is rescinded or otherwise recovered from such Lender in whole or in part, such purchase shall be rescinded and the purchase price therefor shall be returned to such
Lender without interest and (ii) such Lender shall, to the fullest extent permitted by Applicable Law, be able to exercise all its rights of payment (including the right of setoff) with respect to such participation as fully as if such Lender
were the direct creditor of the applicable Loan Party in the amount of such participation. 
 Section 6.27
Confidentiality. 
 (a) Each of the Agent and the Lenders agrees to maintain the confidentiality of the Information (as defined below),
except that Information may be disclosed (a) to its Affiliates and to its Related Parties (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to
keep such Information confidential), (b) to the extent required or requested by any regulatory authority purporting to have jurisdiction over such Person or its Related Parties (including any self-regulatory authority), (c) to the extent required by
Applicable Laws or regulations or by any subpoena or similar legal process, (d) to any Secured Party or any other party hereto, (e) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or
proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement containing provisions substantially the same as those of this Section, to (i) any assignee
of or Participant in, or any prospective assignee of or Participant in, any of its rights and obligations under this Agreement or the other Loan Documents or (ii) any actual or prospective party (or its Related Parties) to any transaction under
which payments are to be made by reference to the Loan Parties and their obligations, this Agreement, the other Loan Documents or payments hereunder or thereunder, (g) on a confidential basis to (i) any rating agency in connection with
rating any Loan Party or its Subsidiaries or the credit facilities provided hereunder or (ii) the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers or other market identifiers with
respect to the credit facilities provided hereunder, (h) with the consent of any Loan Party or any of its Affiliates, (i) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section
6.27(a) or (y) becomes available to any Secured Party or any of its Affiliates on a nonconfidential basis from a source other than the Borrower, or (j) as provided in Section 5.1(q). In addition, the Secured Parties may disclose the
existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry and service providers to the Secured Parties in connection with the administration of the Loans and this
Agreement and the other Loan Documents. 
 (b) For purposes of this Section, “Information” means all information received from a
Loan Party relating to the Loan Parties or any Subsidiary or any of their respective businesses, other than any such information that is available to Agent or any Lender on a nonconfidential basis prior to disclosure by such Loan Party or any
Subsidiary; provided that, notwithstanding anything to the contrary in the Loan Documents, in the case of information received from the Borrower or any of its Subsidiaries after the date 

  
 90 

 
hereof, such Information is both (y) clearly identified at the time of delivery as confidential and (z) provided to the Secured Parties at a time when the Secured Parties have requested
in writing to receive material nonpublic information. Any Person required to maintain the confidentiality of Information as provided in this Section 6.27 shall be considered to have complied with its obligation to do so if such Person has
exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information. 

(c) The Loan Parties and their Affiliates agree that they will not issue any press release announcing the transactions contemplated hereby
without the prior written consent of the Agent, unless (and only to the extent that) the Loan Parties or such Affiliate is required to do so under Applicable Law and, in any event the Loan Parties and their Affiliates will provide the Agent with a
copy of, and consult with the Agent before issuing, any such press release or other public disclosure with respect to this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby and will consider in good faith any
comments of the Agent. 
 Section 6.28 Intercreditor Agreement. 

(a) Notwithstanding anything to the contrary in this Agreement or in any other Loan Document: (a) the Liens granted to the Agent in favor
of the Secured Parties pursuant to the Loan Documents and the exercise of any right related to any Collateral shall be subject, in each case, to the terms of the Intercreditor Agreement, (b) in the event of any conflict between the express
terms and provisions of this Agreement or any other Loan Document, on the one hand, and of the Intercreditor Agreement, on the other hand, the terms and provisions of the Intercreditor Agreement, shall control, (c) any Collateral held by (or in
the possession or control of) the ABL Agent (or its agents or bailees) shall be held as agent and bailee for security, Lien perfection and control purposes in favor of Agent (for the benefit of the Secured Parties) in accordance with the terms of
the Intercreditor Agreement and the Loan Documents, and (d) each Lender (and, by its acceptance of the benefits of any Loan Document, each other Secured Party) hereunder authorizes and instructs Agent to execute the Intercreditor Agreement on
behalf of such Lender, and such Lender agrees to be bound by the terms thereof. 
 (b) Each Lender (and, by its acceptance of the benefits of
any Loan Document, each other Secured Party) hereunder authorizes and instructs the Agent, as Agent and on behalf of such Lender or other Secured Party, to enter into one or more intercreditor agreements (including any Intercreditor Agreement) from
time to time pursuant to, or as contemplated by, the terms of this Agreement and agrees that it will be bound by the terms and provisions thereof and will take no actions contrary to the terms and provisions thereof. 

[SIGNATURE PAGE FOLLOWS] 

  
 91 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the first
day written above. 
  

			
	BORROWER:
	
	 ENDOLOGIX, INC.,
 a Delaware
corporation

		
	By:	 	/s/ Vaseem Mahboob
	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer
	
	OTHER LOAN PARTIES:
	
	 CVD/RMS ACQUISITION CORP.,
 a
Delaware corporation

		
	By:	 	/s/ Vaseem Mahboob
	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer
	
	 NELLIX, INC.,
 a Delaware
corporation

		
	By:	 	/s/ Vaseem Mahboob
	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer
	
	 TRIVASCULAR TECHNOLOGIES, INC.,

a Delaware corporation

		
	By:	 	/s/ Vaseem Mahboob
	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer
	
	 TRIVASCULAR, INC.,
 a
California corporation

		
	By:	 	/s/ Vaseem Mahboob
	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer

 [Signature Page to Facility Agreement] 

			
	 TRIVASCULAR CANADA, LLC,
 a
Delaware limited liability company

		
	By:	 	/s/ Vaseem Mahboob
	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer

 [Signature Page to Facility Agreement] 

			
	LENDERS:
	
	DEERFIELD PRIVATE DESIGN FUND III, L.P.
	
	By: Deerfield Mgmt III, L.P., General Partner
	
	By: J.E. Flynn Capital III, LLC, General Partner
		
	By:	 	/s/ David J. Clark
	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	DEERFIELD INTERNATIONAL MASTER FUND, L.P.
	
	By: Deerfield Mgmt, L.P., General Partner
	
	By: J.E. Flynn Capital, LLC, General Partner
		
	By:	 	/s/ David J. Clark
	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	DEERFIELD PARTNERS, L.P.
	
	By: Deerfield Mgmt, L.P., General Partner
	
	By: J.E. Flynn Capital, LLC, General Partner
		
	By:	 	/s/ David J. Clark
	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	DEERFIELD PRIVATE DESIGN FUND IV, L.P.
	
	By: Deerfield Mgmt IV, L.P., General Partner
	
	By: J.E. Flynn Capital IV, LLC, General Partner
		
	By:	 	/s/ David J. Clark
	Name:	 	David J. Clark
	Title:	 	Authorized Signatory

 [Signature Page to Facility Agreement] 

			
	AGENT:
	
	DEERFIELD PRIVATE DESIGN FUND IV, L.P.
	
	By: Deerfield Mgmt IV, L.P., General Partner
	
	By: J.E. Flynn Capital IV, LLC, General Partner
		
	By:	 	/s/ David J. Clark
	Name:	 	David J. Clark
	Title:	 	Authorized Signatory

 [Signature Page to Facility Agreement] 

 ANNEX A 

DISBURSEMENT AMOUNT AND WARRANTS 
  

													
	 Lender
	  	Disbursement Amount	 	  	% of Total
Disbursement Amount	 	 	% of Total
Warrants	 
	 Deerfield Private Design Fund III, L.P.
	  	$	40,000,000	 	  	 	33.33	% 	 	 	33.33	% 
	 Deerfield Private Design Fund IV, L.P.
	  	$	40,000,000	 	  	 	33.33	% 	 	 	33.33	% 
	 Deerfield Partners, L.P.
	  	$	17,680,000	 	  	 	14.73	% 	 	 	14.73	% 
	 Deerfield International Master Fund, L.P.
	  	$	22,320,000	 	  	 	18.60	% 	 	 	18.60	% 
		  	  
	  
	 	  	  
	  
	 	 	  
	  
	 
	 Total
	  	$	120,000,000.00	 	  	 	100	% 	 	 	100	% 
		  	  
	  
	 	  	  
	  
	 	 	  
	  
	 

 EXHIBIT A 

FORM OF LOAN NOTE 
 THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF
(A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN, FINANCING OR
INDEBTEDNESS ARRANGEMENT SECURED BY THE SECURITIES. 
 THE FOLLOWING INFORMATION IS PROVIDED PURSUANT TO TREAS. REG.
SECTION 1.1275-3: THE BORROWER (AS DEFINED BELOW) WILL MAKE AVAILABLE ON REQUEST TO HOLDER(S) OF THIS DEBT INSTRUMENT THE FOLLOWING INFORMATION: ISSUE PRICE, AMOUNT OF ORIGINAL ISSUE DISCOUNT, ISSUE DATE
AND YIELD TO MATURITY. 
 THIS LOAN NOTE IS BEING ISSUED WITH ORIGINAL ISSUE DISCOUNT IN THE AMOUNT OF
$                    .1 

LOAN NOTE 
  

			
	
Lender:                 
   
	  	
	 Principal Amount:
$                    
	  	                    , 20        

 FOR VALUE RECEIVED, the undersigned, Endologix, Inc., a Delaware corporation (the
“Borrower”), hereby unconditionally promises to pay to the Lender set forth above (the “Lender”) the Principal Amount set forth above, or, if less, the aggregate unpaid principal amount of the Loan (as defined in
the Facility Agreement referred to below) of the Lender to the Borrower, payable at such times and in such amounts as are specified in the Facility Agreement. 

The Borrower promises to pay interest on the outstanding principal amount of the Loan and any overdue interest from and after the Agreement
Date until such outstanding principal amount of the Loan and any overdue interest are paid in full, payable at such times and at such interest rates as are specified in the Facility Agreement. The Borrower promises to pay any Non-Callable Make Whole Amount that is due on the Loan in accordance with the Facility Agreement. Demand, diligence, presentment, protest and notice of non-payment and protest
are hereby waived by the Borrower. 
 Principal and interest (and any Non-Callable Make Whole
Amount) are payable in Dollars to the Lender in the manner set forth in the Facility Agreement. 
 This Loan Note (this “Loan
Note”) is one of the “Loan Notes” and “Notes” referred to in, and is entitled to the benefits of, the Facility Agreement, dated as of April 3, 2017 (as the same may be amended, restated, supplemented or otherwise
modified from time to time, the “Facility Agreement”), by and among 
  

	1 	 NTD: number to be calculated and agreed pursuant to Section 2.7 of the Facility Agreement.

  
 EX. A - 1 

 
the Borrower, the other Loan Parties party thereto, the Lenders party thereto and Deerfield Private Design Fund IV, L.P., as agent for the Secured Parties, and the other Loan Documents.
Capitalized terms used herein without definition are used as defined in the Facility Agreement. 
 The Facility Agreement, among other
things, (a) provides for the making of a Loan by the Lender to the Borrower in an aggregate amount not to exceed at any time outstanding the Principal Amount set forth above, the indebtedness of the Borrower resulting from such Loan being
evidenced by this Loan Note and (b) contains provisions for acceleration of the maturity of the unpaid principal amount of this Loan Note upon the happening of certain stated events and also for prepayments pursuant to Section 5.3 of the
Facility Agreement on account of the principal hereof prior to the maturity hereof upon the terms and conditions specified therein. 
 This
Loan Note is a Loan Document, is entitled to the benefits of the Loan Documents and is subject to certain provisions of the Facility Agreement, including Sections 1.2 (Interpretation) and 6.4 (Governing Law; Venue; Jurisdiction; Service of
Process; Waiver of Jury Trial) thereof. 
 This Loan Note is assignable or transferable only to the extent such assignment or transfer
is permitted pursuant to the terms of the Facility Agreement. 
 Subject to the terms of the Facility Agreement, all payments will be free
and clear of, and without deduction or withholding for, any present or future taxes. The Borrower shall pay all and any costs (administrative or otherwise) imposed by the Borrower’s banks, clearing houses, or any other financial institution, in
connection with making any payments hereunder. 
 The Borrower shall pay all costs and expenses (including attorney’s fees) of the
Lender incurred in connection with this Note in accordance with Section 6.3 of the Facility Agreement. 
 Other than those notices
required to be provided by the Lender to the Borrower under the terms of the Facility Agreement, the Borrower and every endorser of this Note, or the obligations represented hereby, expressly waives presentment, protest, demand, notice of dishonor
or default, and notice of any kind with respect to this Note and the Facility Agreement or the performance of the obligations under this Note and/or the Facility Agreement. No renewal or extension of this Note or the Facility Agreement, no delay in
the enforcement of payment of this Note or the Facility Agreement, and no delay or omission in exercising any right or power under this Note or the Facility Agreement shall affect the liability of the Borrower or any endorser of this Note. 

No delay or omission by the Lender in exercising any power or right hereunder shall impair such right or power or be construed to be a waiver
of any default, nor shall any single or partial exercise of any power or right hereunder preclude the full exercise thereof or the exercise of any other power or right. The provisions of this Note may be waived or amended, restated, supplemented or
otherwise modified only in a writing signed by the Borrower and the Lender. 
 This Loan Note shall be governed by, and be construed and
enforced in accordance with, the laws of the State of New York applicable to contracts made and to be performed in such State. 
 [Signature
Page Follows] 
  

  
 EX. A - 2 

 IN WITNESS WHEREOF, the Borrower has caused this Loan Note to be executed and delivered by its
duly authorized officer as of the day and year set forth above. 
  

			
	 ENDOLOGIX, INC., 

a Delaware corporation

		
	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

  
 3 

 EXHIBIT B 

FORM OF PERFECTION CERTIFICATE 

                    ,
20     
 Each of the parties signatory hereto hereby represents and warrants to (i) the Agent (as defined
in the Facility Agreement defined below) and the Lenders (as defined in the Facility Agreement defined below) with reference to that certain Facility Agreement dated as of the date hereof, by and among the Loan Parties (as defined in the Facility
Agreement defined below), the Lenders (as defined in the Facility Agreement defined below) party thereto, and Deerfield Private Design Fund IV, L.P., as the Agent (as amended, restated, supplemented or otherwise modified, the “Facility
Agreement”), and (ii) the Agent (as defined in the Credit Agreement defined below) and the Lenders (as defined in the Credit Agreement defined below) with reference to that certain Credit and Security Agreement dated as of the date
hereof, by and among the Borrowers (as defined in the Credit Agreement defined below; such Borrowers, collectively with the “Loan Parties” under the Facility Agreement, are referred to as the “Loan Parties” herein except
in clause (i) above), the Lenders (as defined in the Credit Agreement defined below) party thereto, and Deerfield ELGX Revolver, LLC, as the Agent (as amended, restated, supplemented or otherwise modified, the “Credit
Agreement”) (terms that are not defined herein but are defined in such Facility Agreement and/or such Credit Agreement have the same meanings herein as specified therein, as applicable), as follows: 

1. NAMES AND OTHER ORGANIZATIONAL RELATED INFORMATION OF LOAN PARTIES AND THEIR SUBSIDIARIES 

a. The name of each Loan Party and each of its Subsidiaries, as it appears in such Loan Party’s or Subsidiary’s current Articles of
Incorporation, Certificate of Formation or similar organizational document as in effect on this date, is: 
  

			
	 Entity Name
	  	 Parent/Subsidiary

		  	Sub ☐ Parent ☐ of                    
		  	Sub ☐ Parent ☐ of                     
		  	Sub ☐ Parent ☐ of                     

 b. The federal employer identification number of each Loan Party and each of its Subsidiaries is: 

 

			
	 Loan Party/Subsidiary
	  	 Federal Employer Identification Number

		  	
		  	
		  	

  
 4 

 c. The Loan Parties and their Subsidiaries, respectively, are formed under the laws of the
following jurisdictions: 
  

			
	 Loan Party/Subsidiary
	  	 State/Country

		  	
		  	

 d. The organizational identification number of each Loan Party issued by its respective jurisdiction of
formation is: 
  

			
	 Loan Party
	  	 Organizational Identification Number

		  	
		  	

 e. Each Loan Party, respectively, transacts business in the following jurisdictions (list jurisdictions other
than jurisdictions of formation): 
  

			
	 Loan Party
	  	 Jurisdiction(s)

		  	
		  	

 f. Each Loan Party, respectively, is duly qualified to transact business as a foreign entity in the following
jurisdictions (list jurisdictions other than jurisdictions of formation): 
  

			
	 Loan Party
	  	 Jurisdiction(s)

		  	
		  	
		  	

 g. The following is a list of all other names (including fictitious names, d/b/a’s, trade names or
similar names and including former legal names (as defined in Section 9-503(a) of the UCC)) currently used by a Loan Party or any of its Subsidiaries or used by a Loan Party or any of its Subsidiaries within
the past five years: 
  

					
	 Loan Party/Subsidiary
	  	 Name
	  	 Period of Use

		  		  	

  
 5 

					
		  		  	

 h. The following are the names of all entities which have been merged into any Loan Party or any of its
Subsidiaries during the past five years: 
  

					
	 Loan Party/Subsidiary
	  	 Name of Merged Entity
	  	 Year of Merger

		  		  	

 i. The following are the names and addresses of all entities from whom any Loan Party or any of its
Subsidiaries has acquired any personal property in a transaction not in the ordinary course of business during the past five years, together with the date of such acquisition and the type of personal property acquired (e.g., equipment, inventory,
etc.): 
  

							
	 Name
	  	 Address
	  	 Date of Acquisition
	  	 Type of Property

		  		  		  	

 2. LOCATIONS OF LOAN PARTIES AND THEIR SUBSIDIARIES 

a. The chief executive offices of each Loan Party and each of the Loan Parties’ Subsidiaries, respectively, are presently located at the
following addresses: 
  

			
	 Complete Street and Mailing Address, including County and Zip Code
	  	 Loan Party/Subsidiary

		  	
		  	

 b. The books and records of each Loan Party and those of their Subsidiaries, respectively, are located at the
following additional addresses (complete this clause b only if different from clause a above): 
  

			
	 Complete Street and Mailing Address, including Zip Code
	  	 Loan Party/Subsidiary

		  	

 c. The following are all the locations where a Loan Party or any of the Loan Parties’ Subsidiaries,
respectively, owns or leases, or occupies any real property: 
  

					
	 Complete Mailing Address, including Zip Code
	  	 Leased/ Owned/ Occupied
	  	 Loan Party/Subsidiary

  
 6 

					
		  		  	
		  		  	

 d. The following are all of the locations where a Loan Party or any of the Loan Parties’ Subsidiaries,
respectively, maintains any inventory, equipment or other property: 
  

			
	 Complete Address
	  	 Loan Party/Subsidiary

		  	
		  	

 e. The following are the names and addresses of all warehousemen, bailees, or other third-parties who have
possession of any of the Loan Parties’ inventory or equipment or the inventory or equipment of any of the Loan Parties’ Subsidiaries: 
  

					
	 Name
	  	 Complete Street and Mailing Address, including
Zip
Code
	  	 Loan Party/Subsidiary

		  		  	

 f. The following is a complete list of all other offices or other facilities (other than those described
above) where a Loan Party or any of the Loan Parties’ Subsidiaries has done business in the past 5 years. 
  

			
	 Complete Address
	  	 Loan Party/Subsidiary

		  	

 3. INTELLECTUAL PROPERTY 

a. Set forth below is a list of all patents, copyrights, trademarks, trade names and service marks registered or for which applications are
pending in the name of a Loan Party or any of the Loan Parties’ Subsidiaries. Please include the name of such intellectual property, the grant date or application date, as applicable, the registration or application number, as applicable, and
the country of such registration or application. 
  

											
	 Loan Party/

Subsidiary
	  	 Name of Intellectual
Property
	  	 Registered/

Application Pending
	  	 Grant/

Application Date
	  	 Registration/

Application Number
	  	 Country of
Registration/

Application

		  		  		  		  		  	

  
 7 

 b. Set forth below is a list of all licenses, franchise or other agreements relating to
trademarks, patents, copyrights and other know-how to which a Loan Party or any of the Loan Parties’ Subsidiaries is a party and that require annual payments in excess of $25,000 individually. 

4. INVESTMENT PROPERTY; INSTRUMENTS; ACCOUNTS 

a. The following is a complete list of all stocks, bonds, debentures, notes, commodity contracts and other securities (as defined in Article 8
of the Uniform Commercial Code), owned by a Loan Party or any of the Loan Parties’ Subsidiaries: 
  

					
	 Name of Issuer
	  	 Description and Value of Security
	  	 Loan Party/Subsidiary

		  		  	
		  		  	
		  		  	

 b. The following are all banks and other financial institutions, securities intermediary or commodity
intermediary at which any Loan Party or any of the Loan Parties’ Subsidiaries maintains deposit, securities, commodities or similar accounts, which correctly identifies the name, address and any other relevant contact information with respect
to each depository or intermediary, the name in which the account is held, a description of the purpose of the account, and the complete account number therefor: 
  

									
	 Bank Name
	  	 Address and Other

Contact Information
	  	 Name in Which

Account is Held
	  	 Purpose of Account
	  	 Complete Account
Number

		  		  		  		  	
		  		  		  		  	

 c. The following are all securities or commodity intermediaries at which a Loan Party or any of the Loan
Parties’ Subsidiaries maintains securities accounts or commodities accounts: 
  

									
	 Securities or Commodities
Intermediary Name
	  	 Address and Other

Contact Information
	  	 Name in Which

Account is Held
	  	 Purpose of Account
	  	 Complete Account
Number

		  		  		  		  	

  
 8 

 d. Does any Loan Party or any of the Loan Parties’ Subsidiaries or is it contemplated that
any Loan Party or any of the Loan Parties’ Subsidiaries will regularly receive letters of credit from customers or other third parties to secure payments of sums owed to such company? 

e. The following is a list of letters of credit naming a Loan Party or any of the Loan Parties’ Subsidiaries as “beneficiary”
thereunder: 
  

							
	 LC Number
	  	 Name of LC Issuer
	  	 LC Applicant
	  	 Loan Party/Subsidiary

		  		  		  	

 f. The approximate aggregate total amount of funds, amounts, and other assets of any kind in the
                     Account is
$                    . 
 5.
INDEBTEDNESS 
 Set forth below is a list and attached hereto are copies of, all agreements, promissory notes, indentures and
other documents relating to any indebtedness for borrowed money of a Loan Party or any of the Loan Parties’ Subsidiaries, including without limitation loan agreements, note indentures, letters of credit, reimbursement agreements, mortgages and
guaranties of the indebtedness for borrowed money of others. 
  

							
	 Debtor
	  	 Creditor
	  	 Amount of Indebtedness
Outstanding
	  	 Maturity Date

6. ENCUMBRANCES 
 Other than the
Liens already described in Section 1.j. above, the property of the Loan Parties and/or any of the Loan Parties’ Subsidiaries is subject to the following Liens or encumbrances: 

 

					
	 Loan Party/Subsidiary
	  	 Name of Holder of Lien
	  	 Description of Property Encumbered

7. LITIGATION; COMMERCIAL TORT CLAIMS 

a. The following is a complete list of pending and threatened litigation or claims involving amounts claimed against a Loan Party or any of the
Loan Parties’ Subsidiaries in an indefinite amount or in excess of $25,000 in each case: 

  
 9 

 b. The following are the only claims (including, without limitation, commercial tort claims)
which a Loan Party or any of the Loan Parties’ Subsidiaries has against others (other than claims on accounts receivable), which such Loan Party or Subsidiary is asserting or intends to assert, and in which the potential recovery exceeds
$25,000: 
 8. TAXES 
 The
following tax assessments against any of the Loan Parties or any of the Loan Parties’ Subsidiaries are currently outstanding and unpaid: 
  

			
	 Assessing Authority
	  	 Amount and Description

		  	

 9. INSURANCE BROKER 

The following brokers handle the Loan Parties’ and the Loan Parties’ Subsidiaries’ property and liability insurance: 

 

									
	 Broker
	  	 Contact
	  	 Telephone
	  	 Fax
	  	 Email

		  		  		  		  	

 [remainder of page intentionally left blank] 

  
 10 

 The Loan Parties agree to advise you of any change or modification to any of the foregoing
information or any supplemental information provided on any continuation pages attached hereto, and, until such notice is received by you, you shall be entitled to rely upon such information and presume it is correct. The Loan Parties acknowledge
that your acceptance of this Perfection Certificate and any continuation pages does not imply any commitment on your part to enter into a loan transaction with the Loan Parties, and that any such commitment may only be made by an express written
loan commitment, signed by one of your authorized officers. The Loan Parties agree that this Perfection Certificate shall constitute a “Loan Document” under the Facility Agreement and a “Financing Document” under the Credit
Agreement. 
 Dated as of the date first written above 
  

							
	LOAN PARTIES:	 		 	ENDOLOGIX, INC., a Delaware corporation
				
		 		 	By:	 	                                      
                                         
                                     
		 		 	Name:	 	
		 		 	Title:	 	
			
		 		 	CVD/RMS ACQUISITION CORP., a Delaware corporation
				
		 		 	By:	 	                                      
                                         
                                     
		 		 	Name:	 	
		 		 	Title:	 	
			
		 		 	NELLIX, INC., a Delaware corporation
				
		 		 	By:	 	                                      
                                         
                                     
		 		 	Name:	 	
		 		 	Title:	 	
			
		 		 	TRIVASCULAR TECHNOLOGIES, INC., a Delaware corporation
				
		 		 	By:	 	                                      
                                         
                                     
		 		 	Name:	 	
		 		 	Title:	 	

 [Signature Page to Perfection Certificate] 

							
	LOAN PARTIES CONTINUED:	 		 	TRIVASCULAR, INC., a California corporation
				
		 		 	By:	 	                                      
                                         
                                     
		 		 	Name:	 	
		 		 	Title:	 	
			
		 		 	TRIVASCULAR CANADA, LLC,
		 		 	a Delaware limited liability company
				
		 		 	By:	 	                                      
                                         
                                     
		 		 	Name:	 	
		 		 	Title:	 	

 EXHIBIT C 

FORM OF WARRANT 
 THIS WARRANT AND THE
SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT, INCLUDING PURSUANT TO SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER THE SECURITIES ACT OR PURSUANT TO A
PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1) AND A HALF SALE.” NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 
 AN INVESTMENT IN THESE SECURITIES
INVOLVES A HIGH DEGREE OF RISK. HOLDERS MUST RELY ON THEIR OWN ANALYSIS OF THE INVESTMENT AND ASSESSMENT OF THE RISKS INVOLVED. 
  

			
	 Warrant to Purchase shares
	  	Warrant Number:                

 Warrant to Purchase Common Stock 

of 
 Endologix, Inc.

 THIS CERTIFIES that                      or any
subsequent holder hereof (“Holder”) has the right to purchase from Endologix, Inc., a Delaware corporation (the “Company”),
                     (                ) fully paid and nonassessable
shares of the Company’s common stock, $0.001 par value per share (“Common Stock”), subject to adjustment as provided herein, at a price equal to the Exercise Price (as defined in Section 3 below), at any time during the Term (as
defined in Section 1 below). 
 Holder agrees with the Company that this Warrant to Purchase Common Stock of the Company (this “Warrant” or
this “Agreement”) is issued and all rights hereunder shall be held subject to all of the conditions, limitations and provisions set forth herein. 

1. Date of Issuance and Term. 
 This Warrant shall be
deemed to be issued on                      (“Date of Issuance”). The term of this Warrant begins on the Date of Issuance and ends at 5:00
p.m., New York City time, on the date that is seven (7) years after the Date of Issuance (the “Term”). This Warrant was issued pursuant to that certain Facility Agreement (as may be amended, restated, supplemented or otherwise 

 

 
modified from time to time in accordance with the terms thereof, the “Facility Agreement”) by and among the Company and Deerfield Private Design Fund III, L.P., Deerfield Private Design
Fund IV, L.P., Deerfield Partners, L.P. and Deerfield International Master Fund, L.P., dated as of April 3, 2017, and in conjunction with that certain Registration Rights Agreement (as may be amended, restated, supplemented or otherwise
modified from time to time in accordance with the terms thereof, the “Registration Rights Agreement”) by and among the Company and Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P.
and Deerfield International Master Fund, L.P., dated as of April 3, 2017. 
 Notwithstanding anything herein to the contrary, the Company shall not
issue to Holder, and Holder may not acquire, a number of shares of Common Stock upon exercise of this Warrant to the extent that, upon such exercise, the number of shares of Common Stock then beneficially owned by Holder and its Affiliates and any
other persons or entities whose beneficial ownership of Common Stock would be aggregated with Holder’s for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (including shares held
by any “group” of which Holder is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that have limitations on the right to convert, exercise or purchase similar to the
limitation set forth herein), would exceed 4.985% of the total number of shares of Common Stock then issued and outstanding (the “4.985% Cap”); provided, however, that the 4.985% Cap shall only apply to the extent that the Common Stock is
deemed to constitute an “equity security” pursuant to Rule 13d-1(i) promulgated under the Exchange Act. For purposes hereof, “group” has the meaning set forth in Section 13(d) of the
Exchange Act and applicable regulations of the Securities and Exchange Commission (the “SEC”), and the percentage held by Holder shall be determined in a manner consistent with the provisions of Section 13(d) of the Exchange Act. Upon
the written request of Holder, the Company shall, within two (2) Trading Days, confirm orally and in writing to Holder the number of shares of Common Stock then outstanding. 

For purposes hereof: 
 “Affiliate” means any person or
entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a person or entity, as such terms are used in and construed under Rule 144 (“Rule 144”) under the
Securities Act of 1933, as amended (the “Securities Act”). With respect to a Holder, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as such Holder shall, for purposes hereof,
be deemed to be an Affiliate of such Holder. 
 “Asset Sale” means a transaction covered by the provisions of clause (B) of the definition of
“Major Transaction” involving the sale or transfer of all or substantially all of the assets of the Company (including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries (as defined in
the Facility Agreement), taken as a whole) in connection with which the Company has announced its intention to liquidate and distribute its assets to stockholders. 

“Black-Scholes Value” shall mean the Black-Scholes value of this Warrant, or applicable portion thereof, as determined by use of the Black-Scholes
Option Pricing Model using the criteria set forth on Schedule 1 hereto. 

  
 3 

 “Business Day” means a day other than a Saturday or Sunday or any other day on which commercial banks
are authorized or required by law to close in New York City. 
 “Cashless Default Exercise” shall mean an exercise of this Warrant as a
“Cashless Default Exercise” in accordance with Sections 3(c) and 11(b) hereof. 
 “Cashless Major Exercise” shall mean an exercise of
this Warrant or portion thereof as a “Cashless Major Exercise” in accordance with Sections 3(b) and 5(b)(i) hereof. 
 “Cash Out Major
Transaction” means a Major Transaction in which the consideration payable to holders of Common Stock in connection with the Major Transaction consists solely of cash. 

“Eligible Market” means the New York Stock Exchange, the NASDAQ Capital Market, the NASDAQ Global Market, the NASDAQ Global Select Market, the NYSE
MKT or, in each case, any successor thereto. 
 “Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable
Person and whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the
date of consummation of a Major Transaction. 
 “Person” means an individual, a limited liability company, a partnership, a joint venture, a
corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof. 
 “Standard Settlement
Period” means the standard settlement period for equity trades effected on securities exchanges in the United States, expressed in a number of Trading Days, as in effect on the applicable Date of Exercise (as defined in Section 2(b)). 

“Successor Entity” means any Person purchasing the Company’s assets or Common Stock, or any successor entity resulting from such Major
Transaction, or if the Warrant is to be exercisable for shares of capital stock of a Parent Entity (as defined above), such Person’s Parent Entity. 

“Successor Major Transaction” means either a Takeout Major Transaction or an Asset Sale. 

“Successor Major Transaction Consideration” means (i) in the case of a Takeout Major Transaction (other than a Cash Out Major Transaction), the
amount of cash and other assets and the number of securities or other property of the Successor Entity or other entity that would be issuable in such Major Transaction, in respect of a number of shares equal to the Successor Major Transaction
Conversion Share Amount and (ii) in the case of an Asset Sale or a Cash Out Major Transaction, an amount of cash equal to the Black-Scholes Value of the Warrant. 

“Successor Major Transaction Conversion Share Amount” means an amount equal to the Black-Scholes Value of the Warrant (or such applicable portion
subject to a Successor Major Transaction Conversion), divided by the closing price of the Common Stock on the principal securities exchange or other securities market on which the Common Stock is then traded on the Trading Day immediately preceding
the date on which the applicable Major Transaction is consummated. 

  
 4 

 “Takeout Major Transaction” means a transaction covered by the provisions of clause (A) of the
definition of “Major Transaction” in which the shares of Common Stock of the Company are converted into the right to receive cash, securities of another entity and/or other assets. 

“Trading Day” shall mean any day on which the Common Stock is traded for any period on the NASDAQ Global Select Market (“NasdaqGS”) or, if
the NasdaqGS is not the principal trading market for the Common Stock, on the principal securities exchange or other securities market on which the Common Stock is then being traded; provided, however, that during any period in which the Common
Stock is not listed or quoted on the NasdaqGS or any other securities exchange or market, the term “Trading Day” shall mean a Business Day. 
 2.
Exercise. 
 (a) Manner of Exercise. During the Term (or, in respect of a Cashless Major Exercise, the Cashless Major Exercise Period (as
defined below)), this Warrant may be Exercised as to all or any lesser number of whole shares of Common Stock covered hereby (the “Warrant Shares” or the “Shares”) by sending to the Company the Exercise Form attached hereto as
Exhibit A-1 (the “Exercise Form”) duly completed and executed, and, if applicable, the full Exercise Price (as defined below, which may be satisfied by a Cash Exercise, a
Cashless Exercise or a Note Exchange Exercise, as each is defined below) for each share of Common Stock as to which this Warrant is Exercised, at the office of the Company, 2 Musick, Irvine, CA 92618, Attention: Chief Financial Officer;
Phone: (949) 595-7200, Email: vmahboob@endologix.com, or at such other office or agency as the Company may designate in writing, by overnight mail or electronic mail (any such exercise of the Warrant
being hereinafter called an “Exercise” of this Warrant). 
 (b) Date of Exercise. The “Date of Exercise” of the
Warrant shall, in each case, be the date that the Exercise Form attached hereto as Exhibit A-1, completed and executed, is sent by electronic mail to the Company, provided that the
Exercise Price is satisfied as soon as practicable thereafter but in no event later than two (2) Business Days following the date of such electronic mail. Alternatively, the Date of Exercise shall be defined as the date the original Exercise
Form is received by the Company, if Holder has not previously sent the Exercise Form by electronic mail. Upon delivery of the Exercise Form to the Company by electronic mail or otherwise, Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been Exercised, irrespective of the date such Warrant Shares are credited to Holder’s or its designee’s Depository Trust Company (“DTC”)
account or the date of delivery of the certificates evidencing such Warrant Shares, as the case may be; provided, however, that in the event an Exercise Form in respect of a Cashless Major Exercise is delivered prior to the occurrence of the
applicable Major Transaction, Holder shall be deemed to have become the holder of record of the shares issuable upon such exercise immediately prior to the consummation of such Major Transaction and the Date of Exercise shall in such event be deemed
to have occurred on the date of the occurrence of the Major Transaction. Holder shall not be required to physically surrender this Warrant to the Company until Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days following the date the final Exercise Form is delivered to the Company. Execution and delivery of an
Exercise Form with respect to a partial Exercise shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant Shares. 

  
 5 

 (c) Delivery of Common Stock Upon Exercise. Within the earlier of (x) three (3) Trading Days and
(y) the number of Trading Days comprising the Standard Settlement Period after any Date of Exercise (but, in the case of a Cash Exercise, within two (2) Business Days following the Company’s receipt of the full Exercise Price, if
later) or in the case of a Cashless Default Exercise (as defined in Section 5(b) below), within the period provided in Section 3(c), as applicable (the “Delivery Period”), the Company shall issue and deliver (or cause its transfer agent
(the “Transfer Agent”) to issue and deliver) in accordance with the terms hereof to or upon the order of Holder that number of shares of Common Stock (“Exercise Shares”) for the portion of this Warrant exercised as shall be
determined in accordance herewith. Upon the Exercise of this Warrant or any part hereof, the Company shall, at its own cost and expense, take all necessary action, including obtaining and delivering an opinion of counsel, to assure that the Transfer
Agent shall issue stock certificates in the name of Holder (or its nominee) or such other persons as designated by Holder and in such denominations as Holder shall specify at Exercise, representing the number of shares of Common Stock issuable upon
such Exercise. The Company warrants that no instructions other than these instructions have been or will be given to the Transfer Agent and that, unless waived by Holder, this Warrant and the Exercise Shares will be free-trading, and freely
transferable, and will not contain or be subject to a legend (or be subject to any stop transfer instruction) restricting the resale or transferability of the Exercise Shares if the Unrestricted Conditions (as defined below) are met. 

The Company shall be responsible for paying all present or future stamp, court or documentary, intangible, recording, filing or similar taxes that arise from
any payment or issuance made under, from the execution, delivery, performance or enforcement of, or otherwise with respect to, this Warrant.
 (d)
Delivery Failure. In addition to any other remedies which may be available to Holder, in the event that the Company fails for any reason to effect delivery of the Exercise Shares by the end of the Delivery Period (a “Delivery
Failure”), Holder will be entitled to revoke all or part of the relevant Exercise by delivery of a notice to such effect to the Company whereupon the Company and Holder shall each be restored to their respective positions immediately prior to
the delivery of such notice of revocation, except that the Failure Payments under Section 10(b) shall be payable through the date such notice of revocation is given to the Company. 

(e) Legends. 
 (i) Restrictive Legend. Holder
understands that until such time as this Warrant, the Exercise Shares and the Failure Payment Shares (as defined below) have been registered under the Securities Act or otherwise may be sold pursuant to Rule 144 or an exemption from
registration under the Securities Act without any restriction as to the number of securities as of a particular date that can then be immediately sold, this Warrant, the Exercise Shares and the Failure Payment Shares, as applicable, may bear a
restrictive legend in substantially the following form (and a stop-transfer order consistent therewith may be placed against transfer of the certificates for such securities): 

  
 6 

 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION
FROM REGISTRATION UNDER SAID ACT INCLUDING PURSUANT TO SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER SAID ACT OR PURSUANT TO A PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1) AND A HALF” SALE.” NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
SECURITIES. 
 “THE SALE, TRANSFER OR ASSIGNMENT OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND
CONDITIONS OF A CERTAIN REGISTRATION RIGHTS AGREEMENT DATED AS OF APRIL 3, 2017, AS AMENDED FROM TIME TO TIME, AMONG THE COMPANY AND CERTAIN HOLDERS OF ITS OUTSTANDING SECURITIES. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN
REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY.” 
 (ii) Removal of Restrictive Legends. This Warrant
and the certificates (or electronic book entries, if applicable) evidencing the Exercise Shares and the Failure Payment Shares, as applicable, shall not contain or be subject to any legend restricting the transfer thereof (including the legend set
forth above in subsection 2(e)(i)) or be subject to any stop-transfer instructions: (A) while a registration statement (including a Registration Statement, as defined in the Registration Rights Agreement) covering the sale or resale of such
security is effective under the Securities Act, or (B) following any sale of such Warrant, Exercise Shares and/or Failure Payment Shares pursuant to Rule 144, or (C) if such Warrant, Exercise Shares and/or Failure Payment Shares are
eligible for sale under Rule 144(b)(1), or (D) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the SEC) (collectively, the
“Unrestricted Conditions”). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date, or at such other time as any of the Unrestricted Conditions have been met, if required by the
Transfer Agent to effect the issuance of this Warrant, the Exercise Shares or the Failure Payment Shares, as applicable, without a restrictive legend or removal of the legend hereunder. If any of the Unrestricted Conditions are met at the time of
issuance of this Warrant, the Exercise Shares or the Failure Payment Shares, then such Warrant, Exercise Shares or Failure Payment Shares, as applicable, shall be issued free of all legends and stop-transfer instructions. The Company agrees that
following the Effective Date, or at such time as the Unrestricted Conditions are met or such legend is otherwise no longer required under this Section 2(e), it will, no later than the earlier of (x) three (3) Trading Days and

  
 7 

 
(y) the number of Trading Days comprising the Standard Settlement Period following the delivery (the “Unlegended Shares Delivery Deadline”) by Holder to the Company or the Transfer
Agent of this Warrant and a certificate representing Exercise Shares and/or Failure Payment Shares, as applicable, issued with a restrictive legend (such third Trading Day, the “Legend Removal Date”), deliver or cause to be delivered to
Holder this Warrant and/or a certificate (or electronic transfer) representing such shares that is free from all restrictive and other legends (and stop transfer instructions). For purposes hereof, “Effective Date” shall mean the date that
the first Registration Statement that the Company is required to file pursuant to the Registration Rights Agreement has been declared effective by the SEC. 

(iii) Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities
as set forth in Section 2(e) above is predicated upon the Company’s reliance that Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of
the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set
forth therein. 
 (f) Cancellation of Warrant. This Warrant shall be canceled upon the full Exercise of this Warrant, and, as soon as practical after
the Date of Exercise, Holder shall be entitled to receive Common Stock for the number of shares purchased upon such Exercise of this Warrant, and if this Warrant is not Exercised in full, Holder shall be entitled to receive a new Warrant (containing
terms identical to this Warrant) representing any unexercised portion of this Warrant in addition to such Common Stock; provided, however, as set forth in Section 2(b), Holder shall not be required to physically surrender this warrant if the Warrant
is not Exercised in full. 
 (g) Holder of Record. Each person in whose name any Warrant for shares of Common Stock is issued shall, for all
purposes, be deemed to be Holder of record of such shares on the Date of Exercise, irrespective of the date of delivery of the Common Stock purchased upon the Exercise of this Warrant. Prior to the exercise of this Warrant, nothing in this Warrant
shall be construed as conferring upon Holder any rights as a stockholder of the Company. 
 (h) Delivery of Electronic Shares. In lieu of delivering
physical certificates representing the Common Stock issuable upon Exercise or legend removal, or representing Failure Payment Shares, upon written request of Holder, the Company shall use its best efforts to cause the Transfer Agent to
electronically transmit the Common Stock issuable upon Exercise to Holder by crediting the account of Holder’s prime broker with DTC through its Deposit/Withdrawal at Custodian (DWAC) system. The time periods for delivery and penalties
described herein shall apply to the electronic transmittals described herein. Any delivery not effected by electronic transmission shall be effected by delivery of physical certificates. 

(i) Buy-In. In addition to any other rights or remedies available to Holder hereunder or otherwise at law or in
equity, if the Company fails to cause its Transfer Agent to deliver to Holder a certificate or certificates, or electronic shares through DWAC, representing the Exercise Shares pursuant to an Exercise on or before the last day of the Delivery Period
(other than a failure caused by any incorrect or incomplete information provided by Holder to the Company hereunder), and if after such date Holder is required by its broker to purchase (in an open market transaction or

  
 8 

 
otherwise) or Holder or Holder’s brokerage firm otherwise purchases shares of Common Stock to deliver in satisfaction of a sale by Holder of the Exercise Shares which Holder was entitled to
receive upon such Exercise (a “Buy-In”), then the Company shall (1) pay in cash to Holder the amount by which (x) Holder’s total purchase price (including brokerage commissions, if
any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the number of Exercise Shares that the Company was required to deliver to Holder in connection with the Exercise at issue by (B) the
price at which the sell order giving rise to such purchase obligation was executed, and (2) at the option of Holder, either reinstate the portion of the Warrant and equivalent number of Exercise Shares for which such Exercise was not honored
(and refund the Exercise Price therefor, to the extent paid by Holder, and/or reinstate the principal amount of any indebtedness used to satisfy the applicable Exercise Price) or deliver to Holder the number of shares of Common Stock that would have
been issued had the Company timely complied with its Exercise and delivery obligations hereunder. For example, if Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with
respect to an attempted Exercise to cover the sale of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (1) of the immediately preceding sentence the Company shall be required to pay
Holder $1,000. Holder shall provide the Company written notice indicating the amounts payable to Holder in respect of the Buy-In, together with applicable confirmations and other evidence reasonably requested
by the Company. Nothing herein shall limit Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including a decree of specific performance and/or injunctive relief with respect to the Company’s failure
to timely deliver certificates representing shares of Common Stock upon Exercise of the Warrant as required pursuant to the terms hereof. 
 (j) HSR
Submissions. If Holder determines that, in connection with the exercise of this Warrant, it and the Company are required to file Premerger Notification Reports with the Federal Trade Commission (the “FTC”) and the United States
Department of Justice (“DOJ”) and observe the Waiting Period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, and the related rules and regulations promulgated thereunder (collectively, the “HSR Act”),
the Company agrees to (i) cooperate with Holder in Holder’s preparing and making such submission and any responses to inquiries of the FTC and DOJ; (ii) prepare and make any submission required to be filed by the Company under the HSR
Act and respond to inquiries of the FTC and DOJ in connection therewith; and (iii) reimburse Holder for the cost of the required filing fee for Holder’s submission under the HSR Act. For the avoidance of doubt, Holder shall bear all of its
other costs and expenses in connection with such submission, including any attorneys’ fees associated therewith. 
 3. Payment of Warrant Exercise
Price for Cash Exercise or Cashless Exercise; Cashless Major Exercise and Cashless Default Exercise. 
 (a) Exercise Price. The exercise price
shall initially equal $                     per share, subject to adjustment pursuant to the terms hereof (as so adjusted, the “Exercise
Price”), including but not limited to Section 5 below. 
 Payment of the Exercise Price may be made by either of the following, or a combination
thereof, at the election of Holder: 

  
 9 

 (i) Cash Exercise: Holder may exercise this Warrant in cash, bank or cashier’s check or wire transfer
(a “Cash Exercise”); 
 (ii) Cashless Exercise: In lieu of paying all or any portion of the Exercise Price in cash, Holder, at its option,
may exercise this Warrant (in whole or in part) on a cashless basis by making appropriate notation on the applicable Exercise Form, in which event the Company shall issue Holder a number of shares of Common Stock computed using the following formula
(a “Cashless Exercise”): 
 X = Y (A-B)/A 

where: X = the number of shares of Common Stock to be issued to Holder. 

Y = the number of shares of Common Stock for which this Warrant is being Exercised. 

A = the Market Price of one (1) share of Common Stock (for purposes of this Section 3(a)(ii), where “Market Price,” as of
any date, means the Volume Weighted Average Price (as defined herein) of the Company’s Common Stock over the ten (10) consecutive Trading Day period immediately preceding the Date of Exercise or other date in question, as applicable. 

B = the Exercise Price. 
 As used
herein, the “Volume Weighted Average Price” for any security as of any date means the volume weighted average sale price on the NasdaqGS as reported by, or based upon data reported by, Bloomberg Financial Markets or an equivalent, reliable
reporting service mutually acceptable to and hereafter designated by holders of a majority in interest of the Warrants and the Company (“Bloomberg”) or, if the NasdaqGS is not the principal trading market for such security, the volume
weighted average sale price of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or, if no volume weighted average sale price is reported for such security, then
the last closing trade price of such security as reported by Bloomberg, or, if no last closing trade price is reported for such security by Bloomberg, the average of the bid prices of any market makers for such security that are listed or quoted on
the OTC Bulletin Board, the OTCQX Market, the OTCQB Market or on the “pink” market of OTC Markets Group Inc. If the Volume Weighted Average Price cannot be calculated for such security on such date in the manner provided above, the volume
weighted average price shall be the fair market value as mutually determined by the Company and Holders of a majority in interest of the Warrants being Exercised for which the calculation of the volume weighted average price is required in order to
determine the Exercise Price of such Warrants. 
 (iii) Note Exchange Exercise: In lieu of paying all or any portion of the Exercise Price in cash,
Holder, at its option, may exercise this Warrant (in whole or in part) through a reduction of an amount of principal outstanding under any Notes in accordance with Section 2.3(b) of the Facility Agreement, then held by Holder (a “Note Exchange
Exercise”) 

  
 10 

 For purposes of Rule 144 and subsection (d)(3)(ii) thereof, it is intended, understood and acknowledged that the
Common Stock issuable upon Exercise of this Warrant in a Cashless Exercise transaction or a Note Exchange Exercise transaction shall be deemed to have been acquired at the time this Warrant was issued (in the case of a Cashless Exercise) or at the
time the applicable Note was issued (in the case of a Note Exchange Exercise). Moreover, it is intended, understood and acknowledged that the holding period for the Common Stock issuable upon Exercise of this Warrant in a Cashless Exercise
transaction or a Note Exchange Exercise transaction shall be deemed to have commenced on the date this Warrant was issued (in the case of a Cashless Exercise) or on the date the applicable Note was issued (in the case of a Note Exchange Exercise).
As provided in Section 2(b), Holder shall only be required to physically surrender this Warrant in the event that Holder is exercising this Warrant in full. 

(b) Cashless Major Exercise. To the extent Holder shall exercise this Warrant as a Cashless Major Exercise pursuant to Section 5(b)(i) and 5(b)(iii)
below, Holder shall send to the Company (in any manner permitted under Section 2(a)) the Exercise Form indicating that Holder is exercising this Warrant (or any portion thereof) pursuant to a Cashless Major Exercise, in which event the Company shall
issue a number of shares of Common Stock equal to the Black-Scholes Value of the Warrant (or such applicable portion being exercised) divided by the closing price of the Common Stock on the principal securities exchange or other securities market on
which the Common Stock is then traded on the Trading Day immediately preceding the date on which the applicable Major Transaction is consummated, or, if in respect of a Cashless Major Exercise made after the date of consummation of the applicable
Major Transaction, on the Trading Day immediately preceding the date on which the exercise form in respect of such Cashless Major Exercise is delivered. As provided in Section 2(b), Holder shall only be required to physically surrender this Warrant
in the event that Holder is exercising this Warrant in full. Holder shall be permitted to make successive Cashless Major Exercises and send successive Exercise Forms in respect of a Cashless Major Exercise from time to time at any time during the
Cashless Major Exercise Period. 
 (c) Cashless Default Exercise. To the extent Holder exercises this Warrant as a Cashless Default Exercise pursuant
to Section 11(b)(i) below, Holder shall send to the Company (in any manner permitted under Section 2(a)) the Exercise Form indicating that Holder is exercising this Warrant pursuant to a Cashless Default Exercise, in which event the Company shall
issue to Holder, within five (5) Trading Days of the applicable Default Notice, a number of shares of Common Stock (which shares shall be valued at the closing price of the Common Stock on the principal securities exchange or other securities
market on which the Common Stock is then traded on the Trading Day immediately preceding the date on which the Exercise Form in respect of such Cashless Default Exercise is delivered) equal to the Black-Scholes Value of the remaining unexercised
portion of this Warrant (or such portion thereof subject to such exercise) as of the date of such Default Notice (or in the case of an Event of Default referred to in Section 11(a)(vi), on the Trading Day immediately preceding the date the dividend
or distribution is declared or, if not first declared, is paid). As provided in Section 2(b), the Holder shall be permitted to make successive Cashless Default Exercises and send successive Exercise Forms in respect of a Cashless Default Exercise,
from time to time at any time from and after the date of the applicable Default Notice through the Term of this Warrant. 

  
 11 

 (d) Dispute Resolution. In the case of a dispute as to the determination of the closing price or the
Volume Weighted Average Price of the Company’s Common Stock or the arithmetic calculation of the Exercise Price, Market Price or the Successor Major Transaction Consideration, or the number of shares issuable upon a Cashless Major Exercise, the
Company shall submit the disputed determinations or arithmetic calculations via electronic mail within two (2) Business Days of receipt, or deemed receipt, of the Exercise Form or Major Transaction Early Termination Notice, or other event
giving rise to such dispute, as the case may be, to Holder. If Holder and the Company are unable to agree upon such determination or calculation within two (2) Business Days of such disputed determination or arithmetic calculation being
submitted to Holder, then the Company shall, within two (2) Business Days submit via electronic mail (i) the disputed determination of the closing price or the Volume Weighted Average Price of the Company’s Common Stock to an
independent, reputable investment bank selected by the Company and approved by Holder, which approval shall not be unreasonably withheld, or (ii) the disputed arithmetic calculation of the Exercise Price, Market Price, any Successor Major
Transaction Consideration or number of shares issuable upon a Cashless Major Exercise to the Company’s independent, outside registered public accountants. The Company shall use its reasonable best efforts to cause the investment bank or the
accountants, as the case may be, to perform the determinations or calculations and notify the Company and Holder of the results no later than five (5) Trading Days from the time it receives the disputed determinations or calculations. Such
investment bank’s or accountants’ determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error, and the Company and Holder shall each pay one half of the fees and costs of such investment
banker or accountant. Notwithstanding the existence of a dispute contemplated by this paragraph, if requested by Holder, the Company shall issue to Holder the Exercise Shares not in dispute in accordance with the terms hereof. 

4. Transfer and Registration. 
 (a) Transfer
Rights. Subject to the provisions of Section 8 of this Warrant, this Warrant may be transferred on the books of the Company, in whole or in part, in person or by attorney, upon surrender of this Warrant properly completed and endorsed. This
Warrant shall be canceled upon such surrender and, as soon as practicable thereafter, the person to whom such transfer is made shall be entitled to receive a new Warrant or Warrants as to the portion of this Warrant transferred, and Holder shall be
entitled to receive a new Warrant as to the portion hereof retained. 
 (b) Registrable Securities. The Common Stock issuable upon the Exercise of
this Warrant entitles Holder (and applicable assignees or transferees of such Common Stock) to registration and other rights pursuant to the Registration Rights Agreement. 

5. Adjustments Upon Certain Events. 
 (a)
Recapitalization or Reclassification. If the Company shall at any time effect a stock split, payment of stock dividend, recapitalization, reclassification or other similar transaction of such character that the shares of Common Stock shall be
changed into or become exchangeable for a larger or smaller number of shares, then upon the effective date thereof, the number of shares of Common Stock which Holder shall be entitled to purchase upon Exercise of this Warrant, shall be increased or
decreased, as the case may be, in direct proportion to the increase or decrease in the number of shares of Common Stock by reason of such stock split, payment of stock dividend, 

  
 12 

 
recapitalization, reclassification or similar transaction, and the Exercise Price shall be, in the case of an increase in the number of shares, proportionally decreased and, in the case of
decrease in the number of shares, proportionally increased. The Company shall give Holder the same notice it provides to holders of Common Stock of any transaction described in this Section 5(a). 

(b) Rights Upon Major Transaction. 
 (i) Major
Transaction. In the event that a Major Transaction occurs, then (1) in the case of a Successor Major Transaction, Holder, at its option, may elect to cause the conversion of this Warrant (a “Successor Major Transaction
Conversion”), in whole or in part, into the right to receive the Successor Major Transaction Consideration, upon consummation of the Major Transaction, and (2) in the case of all other Major Transactions, Holder shall have the right to
exercise this Warrant (or any portion thereof), at any time and from time to time following the occurrence of such event, as a Cashless Major Exercise. In the event Holder shall not have exercised any of its rights under clauses (1) or (2)
above within the applicable time periods set forth herein, then the Major Transaction shall be treated as an Assumption (as defined below) in accordance with Section 5(b)(ii) below unless Holder waives its rights under this Section 5(b) with respect
to such Major Transaction. Each of the following events shall constitute a “Major Transaction”: 
 (A) a consolidation, merger,
exchange of shares, recapitalization, reorganization, business combination or other similar event, (1) following which the holders of Common Stock immediately preceding such consolidation, merger, exchange, recapitalization, reorganization,
combination or event either (a) no longer hold a majority of the shares of Common Stock or (b) no longer have the ability to elect a majority of the board of directors of the Company or (2) as a result of which shares of Common Stock
shall be changed into (or the shares of Common Stock become entitled to receive) the same or a different number of shares of the same or another class or classes of stock or securities of the Company or another entity (collectively, a “Change
of Control Transaction”); 
 (B) the sale or transfer, in one transaction or a series of related transactions, of (I) all or
substantially all of the assets of the Company (including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole) to any Person other than a wholly-owned subsidiary of the Company or
(II) assets of the Company (including, for the avoidance of doubt, all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole) for a purchase price equal to more than 50% of the Equity Value (as defined below)
of the Company. For purposes of this clause (B), “Equity Value” shall mean (I) the product of (x) the number of issued and outstanding shares of Common Stock on the date the Company delivers the Major Transaction Notice (defined
below) multiplied by (y) the per share closing price of the Common Stock on such date on the NasdaqGS as reported by, or based upon data reported by, Bloomberg or, if the NasdaqGS is not the principal trading market for such security, the
closing sale price of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg; 

  
 13 

 (C) a purchase, tender or exchange offer made to the holders of outstanding shares of Common
Stock, such that following such purchase, tender or exchange offer a Change of Control Transaction shall have occurred; 
 (D) the
liquidation, bankruptcy, insolvency, dissolution or winding-up (or the occurrence of any analogous proceeding) affecting the Company; 

(E) the shares of Common Stock cease to be listed, traded or publicly quoted on the NasdaqGS and are not promptly re-listed or requoted on the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Market or the NASDAQ Capital Market; or 

(F) the Common Stock ceases to be registered under Section 12 of the Exchange Act. 

(ii) Assumption. Any assumption of Company obligations under this paragraph shall be referred to herein as an “Assumption.” Unless
otherwise provided in writing by Holder, the Company shall not consummate a Major Transaction in which the Company is not the surviving entity or as a result of which the Company has a new Parent Entity, unless (A) each Person acquiring the
Company’s assets or Common Stock (or Parent Entity thereof, as applicable), or any other successor entity resulting from such Major Transaction (in each case, a “Successor Entity”), assumes in writing all of the obligations of the
Company under this Warrant, the Facility Agreement (but, other than with respect to the Company’s obligations pursuant to Section 5.1(e) and 5.1(p) of the Facility Agreement and the other provisions of the Facility Agreement that expressly
survive the repayment of the Loans (which shall be assumed in any Assumption), only if there are outstanding Loans under the Facility Agreement immediately following the consummation of the Major Transaction) and the Registration Rights Agreement in
accordance with the provisions of this Section 5(b)(ii) pursuant to written agreements in form and substance reasonably satisfactory to Holder and approved by Holder prior to the consummation of such Major Transaction (such approval not to be
unreasonably withheld or delayed), including agreements to deliver to Holder in exchange for its Warrants a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Warrants, that, among
other things, (1) is exercisable for the appropriate number of shares of the Successor Entity’s capital stock (without regard to the 4.985% Cap or any other restriction or limitation on exercise, provided that such instrument shall contain
a limitation on exercise comparable to that contained in the second paragraph of Section 1 of this Warrant), (2) has an exercise price similar to the then-effective Exercise Price (taking into account any conversion or exchange ratio applicable
to the Common Stock in the Major Transaction) and exercise price adjustment provisions similar to those in the Warrants; or (3) entitles Holder to such additional securities or other consideration as Holder would be entitled pursuant to Section
5(b)(i) in connection with the Major Transaction; and (4) provides for registration rights similar to those provided by the Registration Rights Agreement, in each case reasonably satisfactory to Holder, and (B) the Successor Entity
(including 

  
 14 

 
its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. For the avoidance of doubt, Holders’ reasonable satisfaction
referred to in the immediately preceding sentence shall be construed only to apply to confirmation that the warrant or other comparable security and registration rights agreement delivered to Holder upon an assumption hereunder shall conform to the
requirements of this Section 5(b)(ii), and this Section 5(b)(ii) shall not be construed as granting consent or approval rights to Holder with respect to the terms of such Major Transaction or to permit Holder to demand any additional
consideration in respect of this Warrant other than as provided herein. Upon the occurrence of any Major Transaction, any Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Major Transaction, the
provisions of this Warrant and the Registration Rights Agreement referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the
Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of the Major Transaction, the Successor Entity shall deliver to Holder confirmation that there shall be issued upon
exercise of this Warrant at any time after the consummation of the Major Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property) issuable upon the exercise of the Warrants prior to such Major
Transaction, such shares of publicly traded common stock (or their equivalent) of the Successor Entity, as adjusted in accordance with the provisions of this Warrant. The provisions of this Section shall apply similarly and equally to successive
Major Transactions and shall be applied without regard to any limitations on the exercise of this Warrant other than any applicable beneficial ownership limitations. 

(iii) Major Transaction Notice; Major Transaction Early Termination Right; Notice of Cashless Major Exercise. At least thirty (30) days prior to
the consummation of any Major Transaction, but, in any event, within five (5) Trading Days following the first to occur of (x) the date of the public announcement of such Major Transaction if such announcement is made before 4:00 p.m., New
York City time, or (y) the day following the public announcement of such Major Transaction if such announcement is made on and after 4:00 p.m., New York City time, the Company shall deliver written notice thereof via electronic mail and
overnight courier to Holder (a “Major Transaction Notice”). At any time during the period beginning after Holder’s receipt of a Major Transaction Notice in respect of a Successor Major Transaction and ending five (5) Trading Days
prior to the consummation of such Major Transaction (the “Early Termination Period”), Holder may elect a Successor Major Transaction Conversion by delivering written notice thereof (“Major Transaction Early Termination Notice”)
to the Company, which Major Transaction Early Termination Notice shall indicate the portion of the Warrant (with reference to the number of shares of Common Stock issuable upon a Cash Exercise of such portion, without regard to the 4.985% Cap) that
Holder is electing to be treated as a Successor Major Transaction Conversion. The portion of this Warrant subject to early termination pursuant to this Section 5(b)(iii), shall be converted into the right to receive the Successor Major
Transaction Consideration 
 To the extent Holder shall elect to effect a Cashless Major Exercise in respect of a Major Transaction, Holder shall deliver its
Exercise Form in accordance with Section 3(b), at any time and from time to time following receipt by Holder of the Major Transaction Notice until the later of (x) the Term of this Warrant and (y) the
one-year anniversary of the applicable Major Transaction (the “Cashless Major Exercise Period”). For the avoidance of doubt, Holder shall be permitted to make successive Cashless Major Exercises and
send successive Exercise Forms in respect of a Cashless Major Exercise from time to time at any time during the Cashless Major Exercise Period. 

  
 15 

 (iv) Escrow; Payment of Successor Major Transaction Consideration. Following the receipt of a Major
Transaction Early Termination Notice in respect of a Successor Major Transaction from Holder, the Company shall not effect a Successor Major Transaction with respect to which Holder has elected a Successor Major Transaction Conversion unless either
(A) it obtains, as a condition precedent to such Major Transaction, the written agreement of the Successor Entity that payment of the Successor Major Transaction Consideration shall be made to Holder concurrently with consummation of such
Successor Major Transaction, or (B) it shall place the Successor Major Transaction Consideration into an escrow account with an independent escrow agent, and shall instruct the escrow agent to deliver the Successor Major Transaction
Consideration to Holder, concurrently with the consummation of the Major Transaction. Notwithstanding clauses (A) and (B) above, Holder shall be treated on a pari passu basis with, and shall not have priority to payments to, the
holders of Common Stock in connection with a Major Transaction. For purposes of determining the amount required to be placed in escrow pursuant to the provisions of this subsection (iv) and without affecting the amount of the actual Successor
Major Transaction Consideration, the calculation of the price referred to in clause (1) of the first column of Schedule 1 hereto with respect to Stock Price shall be determined based on the Closing Market Price (as defined on Schedule I)
of the Common Stock on the Trading Day immediately preceding the date that the Successor Major Transaction Consideration is deposited with the escrow agent. 

(v) Injunction. Following the receipt of a Major Transaction Early Termination Notice from Holder, in the event that the Company attempts to consummate
a Successor Major Transaction without either (1) placing the Successor Major Transaction Consideration in escrow in accordance with subsection (iv) above, or (2) obtaining the written agreement of the Successor Entity as described in
subsection (iv) above, Holder shall have the right to apply for an injunction in any state or federal court sitting in the City of New York, Borough of Manhattan to prevent the closing of such Major Transaction until the Successor Major
Transaction Consideration is delivered to Holder. 
 An early termination required by this Section 5(b) shall be made in accordance with the provisions
of Section 12. To the extent an early termination required by this Section 5(b) is deemed or determined by a court of competent jurisdiction to be prepayments of the Warrant by the Company, such early termination shall be deemed to be
voluntary prepayments. Notwithstanding anything to the contrary in this Section 5, until the Successor Major Transaction Consideration is paid in full, this Warrant may be exercised, in whole or in part, by Holder into shares of Common Stock,
or in the event the Exercise Date is after the consummation of the Major Transaction, shares of publicly traded common stock (or their equivalent) of the Successor Entity pursuant to Section 5(b). The parties hereto agree that in the event of the
Company’s early termination of any portion of the Warrant under this Section 5(b), Holder’s damages would be uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the
uncertainty of the availability of a suitable substitute investment opportunity for Holder. Accordingly, any premium due under this Section 5(b) is intended by the parties to be, and shall be deemed, a commercially reasonable estimate of
Holder’s actual loss of its investment opportunity and not as a penalty. 

  
 16 

 (c) Exercise Price Adjusted. As used in this Warrant, the term “Exercise Price” shall
mean the purchase price per share specified in Section 3(a) of this Warrant, until the occurrence of an event stated in this Section 5 or otherwise set forth in this Warrant, and thereafter shall mean said price as adjusted from time to
time in accordance with the provisions of said subsection. No adjustment made pursuant to any provision of this Section 5 shall have the net effect of increasing the aggregate Exercise Price payable hereunder or, except as expressly provided in
Section 5(a), otherwise increasing the Exercise Price. 
 (d) Adjustments: Additional Shares, Securities or Assets. In the event that
at any time, as a result of an adjustment made pursuant to this Section 5 or otherwise, Holder shall, upon Exercise of this Warrant, become entitled to receive shares and/or other securities or assets (other than Common Stock) then, wherever
appropriate, all references herein to shares of Common Stock shall be deemed to refer to and include such shares and/or other securities or assets; and thereafter the number of such shares and/or other securities or assets shall be subject to
adjustment from time to time in a manner and upon terms as nearly equivalent as practicable to the provisions of this Section 5. 
 (e)
Notice of Adjustments. Whenever the Exercise Price and/or number or type of securities issuable upon Exercise is adjusted pursuant to the terms of this Warrant, the Company shall promptly mail to Holder a notice (an “Exercise Price
Adjustment Notice”) setting forth the Exercise Price and/or number or type of securities issuable upon Exercise after such adjustment and setting forth a statement of the facts requiring such adjustment. The Company shall, upon the written
request at any time of Holder, furnish to Holder a like Warrant setting forth (i) such adjustment or readjustment, (ii) the Exercise Price at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of
other securities or property which at the time would be received upon Exercise of the Warrant. For purposes of clarification, whether or not the Company provides an Exercise Price Adjustment Notice pursuant to this Section 5(e), upon the
occurrence of any event that leads to an adjustment of the Exercise Price, Holder would be entitled to receive a number of Exercise Shares based upon the new Exercise Price, as adjusted, for exercises occurring on or after the date of such
adjustment, regardless of whether Holder accurately refers to the adjusted Exercise Price in the Exercise Form. 
 6. Fractional Interests. 

No fractional shares or scrip representing fractional shares shall be issuable upon the Exercise of this Warrant, but on Exercise of this Warrant, Holder may
purchase only a whole number of shares of Common Stock. If, on Exercise of this Warrant, Holder would be entitled to a fractional share of Common Stock or a right to acquire a fractional share of Common Stock, such fractional share shall be
disregarded and the number of shares of Common Stock issuable upon Exercise shall be the next higher whole number of shares. 
 7. Reservation of
Shares. 
 From and after the date hereof, the Company shall at all times reserve for issuance such number of authorized and unissued shares of Common
Stock (or other securities substituted therefor as herein above provided) as shall be sufficient for the Exercise of this Warrant and payment of the Exercise Price. If at any time the number of shares of Common Stock authorized and reserved for
issuance 

  
 17 

 
is below the number of shares sufficient for the Exercise of this Warrant (a “Share Authorization Failure”) (based on the Exercise Price in effect from time to time), the Company will
promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including calling a special meeting of stockholders to authorize additional shares to meet the Company’s obligations under this Section 7,
in the case of an insufficient number of authorized shares, and using its best efforts to obtain stockholder approval of an increase in such authorized number of shares. The Company covenants and agrees that upon the Exercise of this Warrant, all
shares of Common Stock issuable upon such Exercise shall be duly and validly issued, fully paid and nonassessable and not subject to preemptive rights, rights of first refusal or similar rights of any Person. The Company covenants and agrees that
all shares of Common Stock issuable upon Exercise of this Warrant shall be approved for listing on the NasdaqGS, or, if the NasdaqGS is not the principal trading market for the Common Stock, such principal market on which the Common Stock is traded
or listed. 
 B. Restrictions on Transfer. 
 (a)
Registration or Exemption Required. This Warrant has been issued in a transaction exempt from the registration requirements of the Securities Act by virtue of Section 4(a)(2) of the Securities Act and Rule 506 thereunder and exempt from
registration or qualification under applicable state securities (or “blue sky”) laws. None of the Warrant, the Exercise Shares or Failure Payment Shares may be pledged, transferred, sold or assigned except pursuant to an effective
registration statement or an exemption to the registration requirements of the Securities Act and applicable state laws, including Section 4(a)(7) of the Securities Act or a so-called “4[(a)](1) and a
half” transaction. 
 (b) Assignment. Subject to Section 8(a), Holder may sell, transfer, assign, pledge, or otherwise dispose of
this Warrant, in whole or in part. Holder shall deliver a written notice to the Company, substantially in the form of the Assignment attached hereto as Exhibit B, indicating the Person or Persons to whom the Warrant shall
be assigned and the respective number of warrants to be assigned to each assignee. The Company shall effect the assignment within three (3) Business Days of its receipt of a completed and executed form of Assignment (the “Transfer Delivery
Period”), and shall deliver to the assignee(s) designated by Holder a Warrant or Warrants of like tenor and terms entitling Holder to purchase the appropriate number of shares. This Warrant and the rights evidenced hereby shall inure to the
benefit of and be binding upon the successors and assigns of Holder. The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant, and shall be enforceable by any such Holder. For avoidance of
doubt, in the event Holder notifies the Company that such sale or transfer is a so called “4[(a)](1) and half” transaction, the parties hereto agree that a legal opinion from outside counsel for Holder delivered to counsel for the Company
substantially in the form attached hereto as Exhibit C shall be the only requirement to satisfy an exemption from registration under the Securities Act to effectuate such “4[(a)](1) and half” transaction. 

9. Noncircumvention. 
 The Company hereby covenants and
agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other

  
 18 

 
voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and
take all action as may be required to protect the rights of Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant
above the Exercise Price then in effect, and (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of
this Warrant. 
 10. Events of Failure; Definition of Black Scholes Value. 

(a) Definition. 
 The occurrence of each of the following
shall be considered to be an “Event of Failure.” 
 (i) A Delivery Failure occurs, where a “Delivery Failure” shall be
deemed to have occurred if the Company fails to use its best efforts to deliver Exercise Shares to Holder within any applicable Delivery Period (other than due to the limitation contained in the second paragraph of Section 1); 

(ii) A Legend Removal Failure occurs, where a “Legend Removal Failure” shall be deemed to have occurred if the Company fails to use
its best efforts to issue this Warrant and/or Exercise Shares without a restrictive legend, or fails to use it best efforts to remove a restrictive legend, when and as required under Section 2(e) hereof; 

(iii) a Transfer Delivery Failure occurs, where a “Transfer Delivery Failure” shall be deemed to have occurred if the Company fails
to use its best efforts to deliver a Warrant within any applicable Transfer Delivery Period; and 
 (iv) a Registration Failure (as defined
below). 
 For purpose hereof, “Registration Failure” means that (A) the Company fails to file with the SEC on or before the Filing Deadline
(as defined in the Registration Rights Agreement) any Registration Statement required to be filed pursuant to Section 2(a) of the Registration Rights Agreement, (B) the Company fails to use its reasonable best efforts to obtain
effectiveness with the SEC, prior to the Registration Deadline (as defined in the Registration Rights Agreement), and if such Registration Statement does not become effective prior to the Registration Deadline, as soon as possible thereafter, of any
Registration Statement (as defined in the Registration Rights Agreement) that is required to be filed pursuant to Section 2(a) of the Registration Rights Agreement, or fails to use its reasonable best efforts to keep such Registration Statement
current and effective as required in Section 3 of the Registration Rights Agreement, (C) the Company fails to file any additional Registration Statement required to be filed pursuant to Section 2(a)(ii) of the Registration Rights Agreement
on or before the Additional Filing Deadline or fails to use its reasonable best efforts to cause such new Registration Statement to become effective on or before the Additional Registration Deadline, and if such effectiveness does not occur within
such period, as soon as possible thereafter, (D) the Company fails to file any amendment to any Registration Statement, or any additional Registration Statement required to be filed pursuant to Section 3(b) of the Registration Rights
Agreement within thirty (30) days of the applicable Registration Trigger Date (as defined in the Registration Rights Agreement), or fails to use its reasonable best efforts to cause such amendment and/or new Registration Statement to become
effective within ninety 

  
 19 

 
(90) days of the applicable Registration Trigger Date, and, if such effectiveness does not occur within such period, as soon as possible thereafter, (E) any Registration Statement
required to be filed under the Registration Rights Agreement, after its initial effectiveness and during the Registration Period (as defined in the Registration Rights Agreement), lapses in effect or, other than on a day during an Allowable Grace
Period (as defined in the Registration Rights Agreement), sales of all of the Registrable Securities (as defined in the Registration Rights Agreement) cannot otherwise be made thereunder (whether by reason of the Company’s failure to amend or
supplement the prospectus included therein in accordance with the Registration Rights Agreement, the Company’s failure to file and use its reasonable best efforts to obtain effectiveness with the SEC of an additional Registration Statement or
amended Registration Statement required pursuant to Sections 2(a)(ii) or 3(b) of the Registration Rights Agreement, as applicable, or otherwise), or (F) the Company fails to provide a commercially reasonable written response to any
comments to any Registration Statement submitted by the SEC within twenty-five (25) days of the date that such SEC comments are received by the Company. 

(b) Failure Payments; Black-Scholes Determination. The Company understands that any Event of Failure (as defined above) could result in economic loss to
Holder. In the event that any Event of Failure occurs, as compensation to Holder for such economic loss, the Company agrees to pay to Holder an amount payable, at the Company’s option, either (i) in cash or (ii) in shares of Common
Stock that are valued for these purposes at the Volume Weighted Average Price on the date of such calculation (“Failure Payments” and such shares, “Failure Payment Shares”), in each case equal to the total economic loss of Holder
determined on a commercially reasonable basis in connection with such Event of Failure for the relevant period (as recalculated on the first Business Day of each month thereafter for as long as Failure Payments shall continue to accrue) from the
date of such Event of Failure until the Event of Failure is cured; provided, however, that in the event the Company elects to make Failure Payments in Failure Payment Shares, the Company shall issue, and Holder shall only receive, up to such number
of shares of Common Stock in respect of Failure Payments such that Holder and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with Holder’s for purposes of Section 13(d) of the Exchange Act
(including shares held by any “group” of which Holder is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that have limitations on the right to convert, exercise or
purchase similar to the limitation set forth herein) shall not collectively beneficially own greater than 4.985% of the total number of shares of Common Stock of the Company then issued and outstanding, and the balance of such Failure Payments shall
be paid in cash. For purposes of clarification, it is agreed and understood that Failure Payments shall continue to accrue following any Event of Default until the applicable Default Amount is paid in full. The Company shall satisfy any Failure
Payments under this Section pursuant to Section 10(c) below. Failure Payments are in addition to any Shares that Holder is entitled to receive upon Exercise of this Warrant. 

(c) Payment of Accrued Failure Payments. The Failure Payments and Failure Payment Shares representing accrued Failure Payments for each Event of Failure
shall be paid or issued and delivered, as the case may be, on or before the fifth (5th) Business Day of each month following a month in which Failure Payments accrued. Nothing herein shall limit Holder’s right to pursue actual damages (to
the extent in excess of the Failure Payments) for the Company’s Event of Failure, and Holder shall have the right to pursue all remedies available at law or in equity (including a decree of specific performance and/or injunctive relief).
Notwithstanding the above, if 

  
 20 

 
a particular Event of Failure results in an Event of Default pursuant to Section 11 hereof, then the Failure Payment, for that Event of Failure only, shall be considered to have been
satisfied upon payment to Holder of an amount equal to the greater of (i) the Failure Payment, or (ii) the Default Amount, payable in accordance with Section 11. 

(d) Maximum Interest Rate. Nothing contained herein or in any document referred to herein or delivered in connection herewith shall be deemed to
establish or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest or dividends required to be paid or other charges hereunder exceed the maximum
permitted by such law, any payments in excess of such maximum shall be credited against amounts owed by the Company to Holder and thereby refunded to the Company. 

11. Default. 
 (a) Events Of Default. Each of
the following events shall be considered to be an “Event of Default,” unless waived by Holder: 
 (i) Failure To Effect Registration. With
respect to all Registration Failures, a Registration Failure occurs and remains uncured for a period of more than forty-five (45) days (or sixty (60) days in the case where the Company (i) has, by the Filing Deadline (as defined the
Registration Rights Agreement) filed a Registration Statement (as defined in the Registration Rights Agreement) covering this Warrant and the number of shares required by the Registration Rights Agreement, and (ii) has responded in writing to
any comments to the Registration Statement that the Company has received from the SEC, within ten (10) Business Days of such receipt, and nevertheless the SEC has not declared effective a Registration Statement covering the this Warrant and the
Shares by the Registration Deadline (as defined in the Registration Rights Agreement)), and such Registration Failure relates solely to the Company’s failure to have the Registration Statement declared effective by the Registration
Deadline (as defined in the Registration Rights Agreement) and with respect to a Registration Failure provided in clause (E) of the definition of “Registration Failure,” such Registration Failure occurs and remains uncured for a
period of more than forty-five (45) days. 
 (ii) Failure To Deliver Common Stock. A Delivery Failure (as defined above) occurs and remains
uncured for a period of more than twenty (20) days; or at any time, the Company announces or states in writing that it will not honor its obligations to issue shares of Common Stock to Holder upon Exercise by Holder of the Exercise rights of
Holder in accordance with the terms of this Warrant. 
 (iii) Legend Removal Failure. A Legend Removal Failure (as defined above) occurs and remains
uncured for a period of twenty (20) days; 
 (iv) Transfer Delivery Failure. A Transfer Delivery Failure (as defined above) occurs and remains
uncured for a period of twenty (20) days; 
 (v) Corporate Existence; Major Transaction. (A) The Company has failed to (1) place the
Successor Major Transaction Consideration into escrow and instruct the escrow agent to release the Successor Major Transaction Consideration to the Holder pursuant to Section 5(b)(iii), or (2) obtain the written agreement of the Successor
Entity and cause the Successor Entity to make 

  
 21 

 
payment as described in Section 5(b)(iii), (B) the Successor Major Transaction Consideration is not paid contemporaneously with the consummation of the Successor Major Transaction, or
(C) with respect to a Major Transaction that is to be treated as an Assumption under the terms hereof, the Company has failed to meet the Assumption requirements of Section 5(b)(i); or 

(vi) Section 13 Breach. During the Dividend Restriction Period, the Company declares or pays any dividend or distribution of any kind
to the holders of Common Stock of the Company. 
 (b) Mandatory Early Termination. 

(i) Mandatory Early Termination Amount; Cashless Default Exercise. The Company shall notify Holder in writing within two (2) Business Days of the
occurrence of an Event of Default. If any Events of Default shall occur then, at the option of Holder, such option exercisable through the delivery of written notice to the Company by such Holder (the “Default Notice”), the Company shall
have the right to terminate the outstanding amount of this Warrant and pay to Holder (a “Mandatory Early Termination”), in full satisfaction of its obligations hereunder by delivery of a notice to such effect to Holder within two
(2) Business Days following receipt of the Default Notice, an amount payable in cash (the “Mandatory Early Termination Amount” or the “Default Amount”) equal to the Black-Scholes Value of the remaining unexercised portion of
this Warrant on the date of such Default Notice (or in the case of an Event of Default referred to in Section 11(a)(vi), on the Trading Day immediately preceding the date the dividend or distribution is declared or, if not first declared, is paid).
In the event the Company does not exercise its right to consummate a Mandatory Early Termination, then Holder shall have the right to exercise this Warrant, at any time and from time to time, pursuant to a Cashless Default Exercise in accordance
with Section 3(c) above. 
 The Mandatory Early Termination Amount shall be payable within five (5) Business Days following the date of the applicable
Default Notice. 
 (ii) Liquidated Damages. The parties hereto acknowledge and agree that the sums payable as Failure Payments or pursuant to a
Mandatory Early Termination shall constitute partial liquidated damages and not penalties. The parties further acknowledge that (i) the amount of loss or damages likely to be incurred by Holder is incapable or is difficult to precisely
estimate, (ii) the amounts specified bear a reasonable proportion and are not plainly or grossly disproportionate to the probable loss likely to be incurred by Holder, and (iii) the parties are sophisticated business parties and have been
represented by sophisticated and able legal and financial counsel and negotiated this Agreement at arm’s length. 
 Upon the occurrence of an Event of
Default, the Default Amount, together with all other amounts payable hereunder, shall immediately become due and payable, all without demand, presentment or notice, all of which hereby are expressly waived, together with all costs, including legal
fees and expenses, of collection, and Holder shall be entitled to exercise all other rights and remedies available at law or in equity. 
 (c) Posting Of
Bond. In the event that any Event of Default occurs hereunder, the Company may not raise as a legal defense (in any Lawsuit, as defined below, or otherwise) or justification to such Event of Default any claim that such Holder or any one
associated or affiliated 

  
 22 

 
with such Holder has been engaged in any violation of law, unless the Company has posted a surety bond (a “Surety Bond”) for the benefit of such Holder in the amount of 130% of the
aggregate Surety Bond Value (as defined below) of all of Holder’s Warrants (the “Bond Amount”), which Surety Bond shall remain in effect until the completion of litigation of the dispute and the proceeds of which shall be payable to
such Holder to the extent Holder obtains judgment. 
 For purposes hereof, a “Lawsuit” shall mean any lawsuit, arbitration or other dispute
resolution filed by either party herein pertaining to any of this Warrant, the Facility Agreement, the Registration Rights Agreement or any other Loan Document (as defined in the Facility Agreement). 

“Surety Bond Value,” for the Warrants shall mean 130% of the of the Black-Scholes Value of the remaining unexercised portion of this Warrant on the
Trading Day immediately preceding the date that such bond goes into effect. 
 (d) Injunction And Posting Of Bond. In the event that the Event of
Default referred to in subsection (a) of this Section 11 pertains to the Company’s failure to deliver unlegended shares of Common Stock to Holder pursuant to a Warrant Exercise, legend removal request, or otherwise, the Company may
not refuse such unlegended share delivery based on any claim that such Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, unless an injunction from a court, on prior notice to Holder, restraining
and or enjoining Exercise of all or part of said Warrant shall have been sought and obtained by the Company and the Company has posted a Surety Bond for the benefit of such Holder in the amount of the Bond Amount, which Surety Bond shall remain in
effect until the completion of litigation of the dispute and the proceeds of which shall be payable to such Holder to the extent Holder obtains judgment. 

(e) Remedies, Other Obligations, Breaches And Injunctive Relief. The remedies provided in this Warrant shall be cumulative and in addition to all other
remedies available under this Warrant, the Facility Agreement, the Registration Rights Agreement and any other Loan Document, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall
limit the right of Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to Holder and that the
remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach (including a breach or threatened breach of Section 13), the holder of this Warrant shall be entitled,
in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required. 

12. Holder’s Early Terminations. 
 (a)
Mechanics of Holder’s Early Terminations. In the event that the Company does not deliver the applicable Successor Major Transaction Consideration or Default Amount or the Exercise Shares in respect of an election of a Successor Major
Transaction Conversion, Cashless Major Exercise, Cashless Default or Exercise, as the case may be, to Holder within the time period or as otherwise required pursuant to the terms hereof, at any time thereafter Holder shall have the

  
 23 

 
option, upon notice to the Company, in lieu of an election of a Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, to
require the Company to promptly return to Holder all or any portion of this Warrant that was submitted for election of a Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be. Upon
the Company’s receipt of such notice, (x) the applicable election of Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, shall be null and void with respect to such
applicable portion of this Warrant, (y) the Company shall immediately return this Warrant, or issue a new Warrant to Holder representing the portion of this Warrant that was submitted for election of Successor Major Transaction Conversion,
Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, and (z) the Exercise Price of this Warrant or such new Warrant shall be adjusted to the Exercise Price as in effect on the date on which the applicable election
of Successor Major Transaction Conversion, Cashless Major Exercise, Cashless Default Exercise or Exercise, as the case may be, is voided. Holder’s delivery of a notice voiding an election of a Successor Major Transaction Conversion, Cashless
Major Exercise, Cashless Default Exercise or Exercise, as the case may be, and exercise of its rights following such notice shall not affect the Company’s obligations to make any Failure Payments which have accrued prior to the date of such
notice with respect to the Warrant subject to such notice. 
 13. Dividend Restrictions. 

Until the earlier of the expiration of the Term and the date Holder Exercises this Warrant in full (the “Dividend Restriction Period”), the Company
shall not declare or pay any dividend or distribution of any kind to the holders of Common Stock of the Company. 
 14. Benefits of this Warrant.

 Nothing in this Warrant shall be construed to confer upon any person other than the Company and Holder any legal or equitable right, remedy or claim
under this Warrant and this Warrant shall be for the sole and exclusive benefit of the Company and Holder. 
 15. Governing Law. 

All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in
accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, stockholders, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New
York, Borough of Manhattan. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby 

  
 24 

 
irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. The parties hereby waive all rights to a trial by jury. If either party shall commence an action or proceeding to enforce any provisions of this
Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action
or proceeding. 
 16. Loss of Warrant. 
 Upon receipt
by the Company of evidence of the loss, theft, destruction or mutilation of this Warrant, and (in the case of loss, theft or destruction) of indemnity or security reasonably satisfactory to the Company, and upon surrender and cancellation of this
Warrant, if mutilated, the Company shall execute and deliver a new Warrant of like tenor and date. 
 17. Notice or Demands. 

Except as otherwise provided herein, notices or demands pursuant to this Warrant to be given or made by Holder to or on the Company shall be sufficiently
given or made if sent by overnight delivery with a nationally recognized overnight courier service, certified or registered mail, return receipt requested, postage prepaid, and addressed, until another address is designated in writing by the
Company, to the address set forth in Section 2(a) above. To the extent any notice or demand pursuant to this Warrant can be made by electronic mail, such notice or demand given or made by Holder to or on the Company shall be sufficiently given
or made if it is sent by electronic mail to the addresses that the Company shall designate in writing from time to time. Notices or demands pursuant to this Warrant to be given or made by the Company to or on Holder shall be sufficiently given or
made if sent by overnight delivery with a nationally recognized overnight courier service or certified or registered mail, return receipt requested, postage prepaid, and addressed, to the address of Holder set forth in the Company’s records,
until another address is designated in writing by Holder. 
 18. Construction. 

Unless the context otherwise requires, (a) all references to Articles, Sections, Schedules or Exhibits are to Articles, Sections, Schedules or Exhibits
contained in or attached to this Warrant, (b) words in the singular or plural include the singular and plural and pronouns stated in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter and
(c) the use of the word “including” in this Warrant shall be by way of example rather than limitation. 
 19. Signatures. 

In the event that any signature to this Warrant or any amendment hereto is delivered by electronic mail delivery of a “.pdf” format data file, such
signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such “.pdf” signature page were an original thereof. Notwithstanding the
foregoing, the 

  
 25 

 
Company shall be obligated to deliver to Holder an original signature to this Warrant. At the request of any party, each other party shall promptly
re-execute an original form of this Warrant or any amendment hereto and deliver the same to the other party. No party hereto shall raise the use of electronic mail delivery of a “.pdf” format data
file to deliver a signature to this Warrant or any amendment hereto or the fact that such signature was transmitted or communicated through the use of electronic mail delivery of a “.pdf” format data file as a defense to the formation or
enforceability of a contract, and each party hereto forever waives any such defense. 

  
 26 

 IN WITNESS WHEREOF, the undersigned has executed this Warrant as of the date first written above. 

 

			
	ENDOLOGIX, INC.
		
	By:	 	  

		 	Print Name:
		 	Title:

  
 27 

 EXHIBIT A-1 

EXERCISE FORM FOR WARRANT 
 TO:
[                    ] 
 CHECK THE APPLICABLE BOX:

  

			
	☐	  	Cash Exercise, Cashless Exercise or Note Exchange Exercise
		  	 The undersigned hereby irrevocably exercises Warrant Number          (the “Warrant”) with
respect to [            ] shares of Common Stock (the “Common Stock”) of Endologix, Inc., a Delaware corporation (the “Company”). [IF APPLICABLE: The undersigned hereby
encloses $         as payment of the Exercise Price.]
  

☐ The undersigned is exercising the Warrant with respect to [            ] shares of Common
Stock pursuant to a Cashless Exercise, and hereby makes payment of the Exercise Price with respect to such shares in full, all in accordance with the conditions and provisions of the Warrant applicable to such Cashless Exercise.

 
 ☐ The undersigned is exercising the Warrant with respect to
[            ] shares of Common Stock pursuant to a Note Exchange Exercise. The undersigned hereby agrees to cancel $         of principal
outstanding under Notes of the Company held by Holder in satisfaction of the Exercise Price in accordance with the conditions and provisions of the Warrant applicable to such Note Exchange Exercise.

 

	☐	  	 Cashless Major Exercise
  

The undersigned hereby irrevocably exercises the Warrant with respect to         % of the Warrant currently outstanding
pursuant to a Cashless Major Exercise in accordance with the terms of the Warrant.
  

	☐	  	 Cashless Default Exercise
  

The undersigned hereby irrevocably exercises the Warrant pursuant to a Cashless Default Exercise, in accordance with the terms of the Warrant.

 1. The undersigned requests that any stock certificates for such shares be issued free of any restrictive legend, if
appropriate, and, if requested by the undersigned, a warrant representing any unexercised portion hereof be issued, pursuant to the Warrant in the name of the undersigned and delivered to the undersigned at the address set forth below. 

2. Capitalized terms used but not otherwise defined in this Exercise Form shall have the meaning ascribed thereto in the Warrant. 

Dated:                      

 
  

Signature 
  

 
 Print Name 

 
  

Address 

  
 28 

 NOTICE 
 The
signature to the foregoing Exercise Form must correspond to the name as written upon the face of the attached Warrant in every particular, without alteration or enlargement or any change whatsoever. 

  
 29 

 EXHIBIT B 

ASSIGNMENT 
 (To be executed by
the registered holder 
 desiring to transfer the Warrant) 

FOR VALUE RECEIVED, the undersigned holder of the attached warrant (the “Warrant”) hereby sells, assigns and transfers unto the person or persons
below named the right to purchase                      shares of the Common Stock of
[                    ], a Delaware corporation, evidenced by the attached Warrant and does hereby irrevocably constitute and appoint
                     attorney to transfer the said Warrant on the books of the Company, with full power of substitution in the premises. 

 

					
	 Dated:
                    
	 		 	  

		 		 	Signature

  

	
	 Fill in for new registration of Warrant:

	
	  
 Name

	
	  

Address

	
	  

Please print name and address of assignee

(including zip code number)

 NOTICE 
 The signature to the
foregoing Assignment must correspond to the name as written upon the face of the attached Warrant in every particular, without alteration or enlargement or any change whatsoever. 

  
 30 

 EXHIBIT C 

FORM OF OPINION 

            , 20         

[                    ] 

Re: [                ] (the
“Company”) 
 Dear Sir: 

[                    ]
(“[                    ]”) intends to transfer
                     Warrants (the “Warrants”) of the Company
to                    
(“                    ”) without registration under the Securities Act of 1933, as amended (the “Securities Act”). In connection
therewith, we have examined and relied upon the truth of representations contained in an Investor Representation Letter attached hereto and have examined such other documents and issues of law as we have deemed relevant. 

Based on and subject to the foregoing, we are of the opinion that the transfer of the Warrants by
                     to                      may
be effected without registration under the Securities Act, provided, however, that the Warrants to be transferred to                      contain a
legend restricting its transferability pursuant to the Securities Act and that transfer of the Warrants is subject to a stop order. 
 The foregoing opinion
is furnished only to                      and may not be used, circulated, quoted or otherwise referred to or relied upon by you for any purposes
other than the purpose for which furnished or by any other person for any purpose, without our prior written consent. 
 Very truly yours, 

  
 31 

 [FORM OF INVESTOR REPRESENTATION LETTER] 

            , 20         

[                    ] 

Gentlemen: 

                    
(“        ”) has agreed to purchase                      Warrants (the “Warrants”) of
[                ] (the “Company”) from
[                     ]
(“[                     ]”). We understand that the Warrants are “restricted securities.” We represent and warrant that
                     is a sophisticated institutional investor that would qualify as an “Accredited Investor” as defined in Rule 501 of
Regulation D under the Securities Act of 1933, as amended (the “Securities Act”). 

             represents and warrants as of the date hereof as follows: 

1. That it is acquiring the Warrants and the shares of common stock, $0.001 par value per share underlying such Warrants (the “Exercise
Shares”) solely for its account for investment and not with a view to or for sale or distribution of said Warrants or Exercise Shares or any part thereof in violation of the Securities Act.
                     also represents that the entire legal and beneficial interests of the Warrants and Exercise Shares
                     is acquiring is being acquired for, and will be held for, its account only; 

2. That the Warrants and the Exercise Shares must be held indefinitely unless they are registered under the Securities Act or an exemption from
such registration is available.                      recognizes that the Company has no obligation to register the Warrants, or to comply with any
exemption from such registration; 
 3. That neither the Warrants nor the Exercise Shares may be sold pursuant to Rule 144 adopted under the
Securities Act unless certain conditions are met; 
 We acknowledge that the Company will place stop orders with respect to the Warrants and the Exercise
Shares, and if a registration statement is not effective, the Exercise Shares shall bear the following restrictive legend: 
 “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING PURSUANT TO SECTION 4(A)(7) OF THE SECURITIES ACT OR RULE 144 UNDER SAID ACT OR PURSUANT TO A PRIVATE SALE EFFECTED
UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4[(a)](1) AND A HALF” SALE. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.” 
 “THE SALE, TRANSFER OR ASSIGNMENT OF
THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN REGISTRATION RIGHTS AGREEMENT DATED AS OF APRIL 3, 2017, AS AMENDED FROM TIME TO TIME, AMONG THE COMPANY AND CERTAIN HOLDERS OF ITS OUTSTANDING
SECURITIES. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY.” 

  
 32 

 At any time and from time to time after the date hereof,
                     shall, without further consideration, execute and deliver to
[                     ] or the Company such other instruments or documents and shall take such other actions as they may reasonably request to carry
out the transactions contemplated hereby. 
 Very truly yours, 

  
 33 

 Schedule 1 

Black-Scholes Value 
  

					
		  	Calculation Under Sections 3(b) and 5(b)(iii) 	  	Calculation Under Section 10(b) or 11(b) 
			
	Remaining Term	  	Number of calendar days from date of public announcement of the Major Transaction until the last date on which the Warrant may be exercised.	  	Number of calendar days from the date of the Event of Failure, or in the case of an Event of Default, the date of the Default Notice, until the last date on which the Warrant may be exercised.
			
	Interest Rate	  	A risk-free interest rate corresponding to the US$ LIBOR/Swap rate for a period equal to the Remaining Term.	  	A risk-free interest rate corresponding to the US$ LIBOR/Swap rate for a period equal to the Remaining Term.
			
	Cost to Borrow	  	Zero	  	Zero
			
	Volatility	  	 If the first public announcement of the Major Transaction is made at or prior to 4:00 p.m., New York City time, the arithmetic mean of the
historical volatility for the 10, 30 and 50 Trading Day periods ending on the date of such first public announcement, obtained from the HVT or similar function on Bloomberg.
  

If the first public announcement of the Major Transaction is made after 4:00 p.m., New York City time, the arithmetic mean of the historical volatility for the
10, 30 and 50 Trading Day periods ending on the next succeeding Trading Day following the date of such first public announcement, obtained from the HVT or similar function on Bloomberg.
	  	The arithmetic mean of the historical volatility for the 10, 30 and 50 Trading Day periods ending on the date of such determination, obtained from the HVT or similar function on Bloomberg.
			
	Stock Price	  	As selected by Holder in its commercially reasonable discretion in order to produce a commercially reasonable result, any of: (1) the closing price of the Common Stock on NYSE, or, if that is not the principal trading market
for the Common Stock, such principal market on which the Common Stock is traded or listed (the “Closing Market Price”) on the Trading Day immediately preceding the date on which a Major Transaction is consummated, (2) the first
Closing Market Price following the first public announcement of a Major Transaction, (3) the Closing Market Price as of the date immediately preceding the first public announcement of the Major Transaction or (4) the cash amount payable
per share of Common Stock. The Company and Holder acknowledge and agree that any of the above will produce a commercially reasonable result.	  	The volume Weighted Average Price on the date of such determination.
			
	Dividends	  	Zero.	  	Zero.
			
	Strike Price	  	Exercise Price as defined in section 3(a).	  	Exercise Price as defined in section 3(a).

  

 EXHIBIT D 

DEERFIELD / ENDOLOGIX 

CLOSING CHECKLIST 

Facility Agreement Parties: 
  

			
	Term Borrower	  	Endologix, Inc., a Delaware corporation
		
	Term Guarantors (collectively with the Term Borrower, the “Loan Parties”)	  	See attached Schedule A 
		
	Term Lenders	  	Deerfield Private Design Fund IV, L.P.; Deerfield International Master Fund, L.P.; Deerfield Partners, L.P.; and Deerfield Private Design Fund III, L.P.
		
	Term Agent	  	Deerfield Private Design Fund IV, L.P.
		
	Katten	  	Katten Muchin Rosenman LLP, Counsel to Term Agent
		
	SYCR	  	Stradling Yocca Carlson & Rauth, P.C., Counsel to the Loan Parties

 ABL Agreement Parties: 
  

			
	ABL Borrowers (also referred to as the “Credit Parties”)	  	Endologix, Inc., a Delaware corporation, and as listed on attached Schedule A 
		
	ABL Lender	  	Deerfield ELGX Revolver, LLC
		
	ABL Agent	  	Deerfield ELGX Revolver, LLC
		
	Katten	  	Katten Muchin Rosenman LLP, Counsel to ABL Agent
		
	SYCR	  	Stradling Yocca Carlson & Rauth, P.C., Counsel to the Credit Parties

 FACILITY AGREEMENT DOCUMENTS AND DELIVERABLES: 

 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	A.	  	DEBT DOCUMENTS – AGREEMENTS
	1.	  	Facility Agreement	  	Katten	  	 ☐ Term Borrower
 ☐ Term
Guarantors
 ☐ Term Agent
 ☐ Term Lenders
	  	Final and Executed
					
	2.	  	Annexes to Facility Agreement	  		  		  	
					
	3.	  	Disbursement Amount and Warrants	  	Katten	  	N/A	  	In final form
					
	4.	  	Schedules to Facility Agreement	  		  		  	
					
	5.	  	Schedule P-1—Existing Investments	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	6.	  	Schedule 2.4—List of Agreement Date Lenders and Such Lenders’ Wire Instructions and Information for Notices	  	Katten/Agent	  	N/A	  	In final form

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	7.	  	Schedule 3.1(d)—Existing Liens	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	8.	  	Schedule 3.1(f)—Existing Indebtedness	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	9.	  	Schedule 3.1(h)—Litigation	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	10.	  	Schedule 3.1(m)—Real Estate	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	11.	  	Schedule 3.1(x)—Borrower’s Subsidiaries	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	12.	  	Schedule 3.1(z)—Borrower’s Outstanding Shares of Stock, Options and Warrants	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	13.	  	Schedule 3.1(aa)—Material Contracts	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	14.	  	Schedule 3.1(dd)—Environmental	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	15.	  	Schedule 3.1(ff)—Labor Relations	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	16.	  	Schedule 3.1(gg)—Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	17.	  	Schedule 5.1(y)—Post-Closing Requirements	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	18.	  	Schedule 5.2(iv)—Contingent Obligations	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	19.	  	Schedule 5.2(vii)—Transactions with Affiliates	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	20.	  	Exhibits to Facility Agreement	  		  		  	
					
	21.	  	Exhibit A—Form of Loan Note	  	Katten	  	N/A	  	In final form
					
	22.	  	Exhibit B—Form of Perfection Certificate	  	Katten	  	N/A	  	In final form
					
	23.	  	Exhibit C—Form of Warrant	  	Katten	  	N/A	  	In final form
					
	24.	  	Exhibit D—Closing Checklist	  	Katten	  	N/A	  	
					
	25.	  	Exhibit E—Form of Registration Rights Agreement	  	Katten	  	N/A	  	In final form
					
	26.	  	Exhibit F—Form of Compliance Certificate	  	Katten	  	N/A	  	In final form
					
	27.	  	Original Notes in favor of each Term Lender	  	Katten	  	☐ Term Borrower	  	Final and Executed
					
	28.	  	Guaranty and Security Agreement	  	Katten	  	 ☐ Term Borrower
 ☐ Term
Guarantors
 ☐ Term Agent
	  	Final and Executed
					
	29.	  	Schedules to Guaranty and Security Agreement	  	SYCR	  		  	

  
 4 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	30.	  	Schedule 1–Pledged Equity and Pledged Debt Instruments	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	31.	  	Schedule 1A—Pledged Investmetn Property	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	32.	  	Schedule 2—Filings and Perfection	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	33.	  	Schedule 3—Grantor Information	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	34.	  	Schedule 4—Places of Business/Location of Collateral	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	35.	  	Schedule 5—Commercial Tort Claims	  	Loan
Parties/SYCR	  	N/A	  	In final form
					
	36.	  	Perfection Certificate	  	Katten (form)/Loan Parties/SYCR (substance)	  	 ☐ Term Borrower
 ☐ Term
Guarantors
	  	Final and Executed
					
	37.	  	Original Warrants in favor of each Term Lender	  	Katten	  	☐ Term Borrower	  	Final and Executed
					
	38.	  	Registration Rights Agreement	  	Katten	  	 ☐ Term Borrower
 ☐ Term
Lenders
	  	Final and Executed
					
	39.	  	UCC-1 Financing Statements for each Loan Party	  	Katten	  	N/A	  	In final form
					
	40.	  	Patent Security Agreement(s)	  	Katten	  	 ☐ Applicable Term Borrower(s)
 ☐
Term Agent
	  	Final and Executed
					
	41.	  	Schedule to Patent Security Agreement(s)	  	SYCR	  		  	In final form
					
	42.	  	Trademark Security Agreement(s)	  	Katten	  	 ☐ Applicable Term Borrower(s)
 ☐
Term Agent
	  	Final and Executed
					
	43.	  	Schedule to Trademark Security Agreement(s)	  	SYCR	  		  	In final form
					
	44.	  	Receipt by ABL Agent of original Certificates for certificated Equity Interests and Equity Interests Powers and Language in Intercreditor Agreement that ABL Agent is holding such Collateral also on behalf of Term Agent for the
benefit of Term Agent and Term Lenders	  	Katten/SYCR	  		  	Process confirmed
					
	45.	  	Executed Insurance Certificates of the Loan Parties and their Subsidiaries evidencing liability and casualty insurance, naming Term Agent on behalf of the Secured Parties as additional insured (liability insurance) or lender’s
loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	SYCR	  	☐ Insurance Broker (for insurance certificates)	  	In final form

  
 5 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	46.	  	Intercreditor Agreement	  	Katten	  	 ☐ Term Borrower
 ☐ ABL Borrowers

☐ Term Agent
 ☐ Term Lenders

☐ ABL Agent
 ☐ ABL Lender
	  	Final and Executed
					
	47.	  	Written notice requesting the Disbursement of the proposed date of funding and satisfying the conditions in Section 2.2(a) of the Facility Agreement	  	Loan
Parties/SYCR	  	☐ Term Borrower	  	Final and Executed
					
	48.	  	 A.     Funds Flow
	  	Loan
Parties/SYCR	  		  	
					
	49.	  	Irrevocable Proxies	  	Katten	  		  	Final and Executed
					
	B.	  	CERTIFICATES AND MISCELLANEOUS	  		  		  	
					
	50.	  	Lien Searches and IP Searches for Loan Parties	  	SYCR	  	N/A	  	Complete
					
	51.	  	Secretary’s Certificate of each Loan Party, attaching Organization Documents, resolutions, incumbency and good standings	  	SYCR	  	See attached Schedule A 	  	In final form
					
		  	 A.     Certificate of Incorporation or Formation
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 B.     Bylaws or Operating Agreement
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 C.     Resolutions
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 D.     Incumbency
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 E.     Good Standings
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
	52.	  	 Agreement Date Officer’s Certificate from an Authorized Officer of Endologix, Inc. certifying to each of the following:

 
 a)     The conditions set
forth in Section 2.2(a) have been satisfied and the terms set forth in Section 2.2(a) have been completely complied with
  

b)     No Default or Event of Default shall have occurred or would result from the Disbursement or
the use of the proceeds therefrom
  

c)     All of the representations and warranties in the Loan Documents are true and correct

 
 d)     All conditions set
forth in Section 4.1 of the Facility Agreement have been satisfied
	  	SYCR	  	☐ Endologix, Inc.	  	Final and Executed

  
 6 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	53.	  	Solvency Certificate	  	SYCR	  	☐ Term Borrower	  	Final and Executed
					
	54.	  	Legal Opinion of the Loan Parties	  	SYCR	  	☐ SYCR	  	Final and Executed
					
	55.	  	Receipt by the Term Agent and the Term Lenders of any fees required to be paid on or before the Agreement Date	  	Loan Parties	  	N/A	  	
					
	56.	  	Payment by Loan Parties of all costs and expenses required to be paid on the Agreement Date (including pursuant to Sections 2.7(a) and 6.3 of the Facility Agreement) to the Term Agent	  	Loan Parties	  	N/A	  	
					
	57.	  	Receipt by Term Agent and Term Lenders at least 3 Business Days prior to the Agreement Date all KYC and anti-money laundering rules and regulations	  	Loan Parties	  	☐ Loan Parties	  	
					
	58.	  	Transfer Agent Letter as to shares outstanding	  	Loan Parties	  	☐ Transfer Agent	  	Final and Executed
					
	59.	  	Payoff of MidCap	  		  		  	
					
		  	 A. Payoff Letter
	  	Loan Parties	  	 ☐ MidCap
 ☐ Loan Parties
	  	Final and Executed
					
		  	 B. UCC-3s
	  	Loan Parties/MidCap	  	N/A	  	In final form
					
		  	 C. DACA Terminations
	  	Loan Parties	  		  	
					
		  	 a. SVB
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 b. BoA
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 c. Wells Fargo
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 D. Landlord Waiver Terminations
	  	Loan Parties	  		  	
					
		  	 a. Sonoma
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 b. Northwestern
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 c. FedEx (bailee)
	  	Loan Parties	  	☐ MidCap	  	Final and Executed

  
 7 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	C.	  	POST-CLOSING ITEMS	  		  		  	
	60.	  	 Landlord/Bailee Waivers
  

•    2 Musick, Irvine, County of Orange, CA 92618 U.S.A.

 
 •    3910 Brickway
Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.
  

•    5025 Tuggle Road, Memphis, TN 38118

 
 •    [Foreign
Locations]
	  	Loan Parties/SYCR	  	 ☐ Applicable Loan Parties
 ☐
Applicable Landlord
 ☐ Term Agent
 ☐ ABL
Agent
	  	
					
	61.	  	 Account Control Agreements
  

•    Wells Fargo
  

•    Bank of America
  

•    Silicon Valley Bank

 
 •    [Foreign
Accounts]
	  	Loan Parties/SYCR	  	 ☐ Applicable Loan Parties
 ☐
Applicable Bank
 ☐ Term Agent
 ☐ ABL Agent
	  	
					
	62.	  	Executed Insurance Endorsements of the Loan Parties and their Subsidiaries evidencing liability and casualty insurance, naming Term Agent on behalf of the Secured Parties as additional insured (liability insurance) or lender’s
loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	SYCR	  	☐ Insurance Carriers (for insurance endorsements)	  	Final and Executed

 ABL AGREEMENT DOCUMENTS AND DELIVERABLES 

 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	A.	  	DEBT DOCUMENTS – AGREEMENTS
					
	1.	  	Credit and Security Agreement	  	Katten	  	 ☐ ABL Borrowers
 ☐ ABL Agent

☐ ABL Lender
	  	Final and Executed
					
	2.	  	Annexes to Facility Agreement	  		  		  	
					
	3.	  	 Annex A –Commitment Annex
	  	Katten	  	N/A	  	In final form
					
	4.	  	Schedules to Facility Agreement	  		  		  	
					
	5.	  	 Schedule 3.1—Existence, Organizational ID Numbers, Foreign Qualification, Prior Names
	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	6.	  	Schedule 3.4—Capitalization	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	7.	  	Schedule 3.6—Litigation	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	8.	  	Schedule 3.15—Broker’s Fees	  	Credit Parties/SYCR	  	N/A	  	In final form

  
 8 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	9.	  	Schedule 3.17—Material Contracts	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	10.	  	Schedule 3.18—Environmental Compliance	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	11.	  	Schedule 4.9—Notice of Litigation and Defaults	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	12.	  	Schedule 4.22—Post-Closing Items	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	13.	  	Schedule 5.1—Debt; Contingent Obligations	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	14.	  	Schedule 5.2—Liens	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	15.	  	Schedule 5.7—Permitted Investments	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	16.	  	Schedule 5.8—Affiliate Transactions	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	17.	  	Schedule 5.11—Business Description	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	18.	  	Schedule 5.14—Deposit Accounts and Securities Accounts	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	19.	  	Schedule 6.2—Minimum Net Revenue	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	20.	  	Schedule 8.2(b)—Exceptions to Healthcare Representations and Warranties	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	21.	  	Schedule 9.1—Collateral	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	22.	  	Schedule 9.2—Location of Collateral	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	23.	  	Schedule 9.2(vii)—Governmental Authority Account Debtors	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	24.	  	Exhibits to Credit Agreement	  		  		  	
					
	25.	  	Exhibit A—Closing Checklist	  	Katten	  	N/A	  	
					
	26.	  	Exhibit B—Form of Compliance Certificate	  	Katten	  	N/A	  	In final form
					
	27.	  	Exhibit C—Borrowing Base Certificate	  	Katten	  	N/A	  	In final form
					
	28.	  	Exhibit D—Form of Notice of Borrowing	  	Katten	  	N/A	  	In final form
					
	29.	  	Original Notes in favor of each ABL Lender	  	Katten	  	☐ ABL Borrower	  	Final and Executed
					
	30.	  	Pledge Agreement	  	Katten	  	 ☐ ABL Borrowers
 ☐ Pledgees

☐ ABL Agent
	  	Final and Executed
					
	31.	  	Schedules to Pledge Agreement	  	SYCR	  		  	In final form

  
 9 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	32.	  	Perfection Certificate	  	Katten (form)/Credit Parties/SYCR (substance)	  	See above	  	See above
					
	33.	  	UCC-1 Financing Statements for each Credit Party	  	Katten	  	N/A	  	
					
	34.	  	Delivery of original Certificates for certificated Equity Interests and Equity Interests Powers	  	Katten	  		  	See above
					
	35.	  	Executed Insurance Certificates of the Credit Parties and their Subsidiaries evidencing liability and casualty insurance, naming the ABL Agent on behalf of the Secured Parties as additional insured (liability insurance) or
lender’s loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	SYCR	  	☐ Insurance Broker	  	In final form
					
	36.	  	Intercreditor Agreement	  	Katten	  	See above	  	See above
					
	37.	  	Patent Security Agreement(s)	  	Katten	  	 ☐ Applicable ABL Borrower(s)
 ☐ ABL
Agent
	  	Final and Executed
					
	38.	  	Schedule to Patent Security Agreement(s)	  	SYCR	  		  	In final form
					
	39.	  	Trademark Security Agreement(s)	  	Katten	  	 ☐ Applicable ABL Borrower(s)
 ☐ ABL
Agent
	  	Final and Executed
					
	40.	  	Schedule to Trademark Security Agreement(s)	  	SYCR	  		  	In final form
		
	B.	  	CERTIFICATES AND MISCELLANEOUS
					
	41.	  	Lien Searches and IP Searches for Credit Parties	  	SYCR	  	N/A	  	See above
					
	42.	  	Secretary’s Certificate of each Credit Party, attaching Organization Documents, resolutions, incumbency and good standings	  	SYCR	  	See attached Schedule A 	  	In final form
					
		  	 A.     Certificate of Incorporation or Formation
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 B.     Bylaws or Operating Agreement
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 C.     Resolutions
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 D.     Incumbency
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 

  
 10 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

		  	E. Good Standings	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
	43.	  	 Agreement Date Officer’s Certificate from an Authorized Officer of Endologix, Inc. certifying to each of the following:

 
 a)    Since December 31,
2016, the absence of any MAE
  

b)    The representations and warranties of each Credit Party contained in the Financing Documents
are true, correct and complete on and as of the Closing Date, except to the extent that any such representation or warranty relates to a specific date in which case such representation or warranty is true and correct as of such earlier date

 
 c)    All conditions set
forth in Section 7.1 of the Facility Agreement have been satisfied
  

d)    Immediately after such borrowing and after application of the proceeds thereof or after such
issuance, the Revolving Loan Outstandings will not exceed the Revolving Loan Limit
  

e)    Immediately before and after such advance or issuance, no Default or Event of Default shall
have occurred and be continuing
	  	SYCR	  	☐ Endologix, Inc.	  	See above
					
	44.	  	Solvency Certificate	  	SYCR	  	☐ ABL Borrower	  	Final and Executed
					
	45.	  	Borrowing Base Certificate	  	SYCR	  	☐ [ABL Borrower]	  	
					
	46.	  	Legal Opinion of the Credit Parties	  	SYCR	  	☐ SYCR	  	Final and Executed
					
	47.	  	Receipt by the ABL Agent and the ABL Lender of any fees, costs and expenses required to be paid on or before the Closing Date	  	Credit Parties	  	N/A	  	
					
	48.	  	Receipt by ABL Agent and ABL Lender at least 3 Business Days prior to the Agreement Date all KYC and anti-money laundering rules and regulations	  	Credit Parties	  	☐ Credit Parties	  	

  
 11 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	49.	  	Payoff of MidCap	  	See above	  	See above	  	See above
		
	C.	  	POST-CLOSING ITEMS
					
	50.	  	Landlord/Bailee Waivers	  	Credit Parties/SYCR	  	See above	  	See above
					
	51.	  	Account Control Agreements	  	Credit Parties/SYCR	  	See above	  	See above
					
	52.	  	Cortland Documentation (including KYC items)	  	Cortland	  	TBD	  	
					
	53.	  	Setting up of Cash Dominion Mechanics	  	ABL Agent	  	N/A	  	
					
	54.	  	Executed Insurance Endorsements of the Credit Parties and their Subsidiaries evidencing liability and casualty insurance, naming the ABL Agent on behalf of the Secured Parties as additional insured (liability insurance) or
lender’s loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	SYCR	  	☐ Insurance Carriers	  	In final form

  
 12 

 Schedule A 

Secretary’s Certificates 
  

															
	 Borrower/Guarantor
	  	 Loan Party/Credit Party
	  	 Certificate of
Formation /
Articles
of
Organization
	  	 Operating
Agreement
/ Bylaws
	  	 Resolutions
	  	 Incumbency
	  	 Good
Standings

	 Facility

Agreement
	  	 ABL

Agreement
	  	  	  	  	  	  
	Borrower	  	Borrower	  	Endologix, Inc., a Delaware corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	CVD/RMS Acquisition Corp., a Delaware corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	Nellix, Inc., a Delaware corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	TriVascular Technologies, Inc., a Delaware corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	TriVascular, Inc., a California corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	Trivascular Canada, LLC, a Delaware limited liability company	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received

  

 EXHIBIT E 

FORM OF REGISTRATION RIGHTS AGREEMENT 

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of             ,
20    , by and among Endologix, Inc., a Delaware corporation (the “Company”), and Deerfield Private Design Fund IV, L.P., Deerfield International Master Fund, L.P., Deerfield Partners, L.P. and Deerfield Private Design
Fund III, L.P. (each individually, a “Lender” and together, the “Lenders”). 
 WHEREAS: 

A. In connection with the Facility Agreement, of even date herewith, by and among the parties hereto, the other Loan Parties (as defined therein) and Deerfield
Private Design Fund IV, L.P., as agent for itself and the Lender (the “Facility Agreement”) (i) the Company has agreed, upon the terms and subject to the conditions contained therein, to issue and sell the Warrants (as defined below) to
the Lenders in the amounts described in the Facility Agreement, each of which Warrants is exercisable into shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), and (ii) the Company may issue
shares of Common Stock to satisfy obligations to pay interest due and payable under the Facility Agreement, upon the terms and conditions and subject to the limitations and conditions set forth therein; and 

B. To induce the Lenders to execute and deliver the Facility Agreement, the Company has agreed to provide certain registration rights under the Securities Act
of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “Securities Act”), and applicable state securities laws; 

NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and each of the Lenders hereby agree as follows: 
 1. DEFINITIONS. 

a. As used in this Agreement, the following terms shall have the following meanings: 

(i) “Additional Filing Deadline” means, with respect to any Registration Statements that may be required pursuant to Section 2(a)(ii), (A) the first
date or time that such Registrable Securities may then be included in a Registration Statement if such Registration Statement 

 
is required because the SEC shall have notified the Company in writing that certain Registrable Securities were not eligible for inclusion on a previously filed Registration Statement, or
(B) if such additional Registration Statement is required for a reason other than as described in (A) above, the twentieth (20th) day following the date on which the Company first knows,
or reasonably should have known, that such additional Registration Statement is required. 
 (ii) “Additional Registration Deadline” means, with
respect to any additional Registration Statement(s) required pursuant to Section 2(a)(ii), the thirtieth (30th) day following (A) the first date or time that such Registrable Securities may
then be included in a Registration Statement if such Registration Statement is required because the SEC shall have notified the Company in writing that certain Registrable Securities were not eligible for inclusion on a previously filed Registration
Statement, or (B) if such additional Registration Statement is required for a reason other than as described in (A) above, the fortieth (40th) day following the date on which the Company
first knows, or reasonably should have known, that such additional Registration Statement(s) is required. 
 (iii) “Investor” means any Lender and
any transferee or assignee who agrees to become bound by the provisions of this Agreement in accordance with Section 10 hereof. 
 (iv) “Exchange
Act” means the Securities Exchange Act of 1934, as amended, together with the rules and regulations promulgated thereunder, and any successor statute. 

(v) “FINRA” means the Financial Industry Regulatory Authority (or successor thereto). 

(vi) “Filing Deadline,” for the Registration Statement required pursuant to Section 2(a)(i), shall mean the date that is thirty (30) calendar
days following the Agreement Date (as defined in the Facility Agreement), and, for each Registration Statement required pursuant to Section 2(a)(ii) shall mean the Additional Filing Deadline. 

(vii) “Person” means and includes any natural person, partnership, joint venture, corporation, trust, limited liability company, limited company,
joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity. 
 (viii)
“Prospectus” means (i) any prospectus (preliminary or final) included in any Registration Statement, as may be amended or supplemented by any prospectus supplement with respect to the terms of the offering of any portion of the
Registrable Securities covered by such Registration Statement and by all other amendments and supplements to such prospectus, including post-effective amendments, and all material incorporated by reference in such prospectus, and (ii) any
“free writing prospectus” as defined in Rule 405 under the Securities Act relating to any offering of Registrable Securities pursuant to a Registration Statement. 

 (ix) “Register,” “Registered,” and “Registration” refer to a registration effected
by preparing and filing a Registration Statement or Statements in compliance with the Securities Act and pursuant to Rule 415, and the declaration or ordering of effectiveness of such Registration Statement by the United States Securities and
Exchange Commission (the “SEC”). 
 (x) “Registrable Securities,” for a given Registration, means (a) any shares of Common Stock
(the “Warrant Shares”) issued or issuable upon exercise of, or otherwise pursuant to, the Warrants (without giving effect to any limitations on exercise set forth in the Warrants), (b) any shares of Common Stock issued or issuable pursuant
to Section 2.6 of the Facility Agreement and Exhibit 2.6 thereto, (c) any shares of capital stock issued or issuable as a dividend on or in exchange for or otherwise with respect to any of the foregoing, (d) any additional shares of
Common Stock issuable in connection with any anti-dilution provisions in the Warrants, (e) any other shares of Common Stock issuable pursuant to the terms of the Warrants, the Facility Agreement or this Registration Rights Agreement, and
(f) any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to any of the foregoing. 

(xi) “Registration Deadline” shall mean, for purposes of the Registration Statement required pursuant to Section 2(a)(i), the earlier of (i) the
date that is seventy-five (75) days after the date that the applicable Registration Statement is actually filed or (ii) the date that is seventy-five (75) days after the applicable Filing Deadline and, with respect to any Registration
Statement required pursuant to Section 2(a)(ii), the Additional Registration Deadline. 
 (xii) “Registration Statement(s)” means any registration
statement(s) of the Company filed under the Securities Act that covers the resale of any of the Registrable Securities pursuant to the provisions of this Agreement, all amendments and supplements to such Registration Statement, including
post-effective amendments, and all exhibits to, and all material incorporated by reference in, such Registration Statement. 
 (xiii) “Rule 415”
means Rule 415 under the Securities Act or any successor rule providing for the offering of securities on a continuous basis 
 (xiv) “Warrants”
means the warrants issued by the Company pursuant to the Facility Agreement. 

 2. REGISTRATION. 

a. MANDATORY REGISTRATION. (i) Following the Agreement Date, the Company shall prepare, and, on or prior to the applicable Filing Deadline, file
with the SEC a Registration Statement (the “Mandatory Registration Statement”) on Form S-3 (or, if Form S-3 is not then available, on such form of Registration
Statement as is then available to effect a registration of the Registrable Securities, subject to the consent of the Investors, which consent shall not be unreasonably withheld) covering the resale of the Registrable Securities, which Registration
Statement, to the extent allowable under the Securities Act and the rules and regulations promulgated thereunder (including Rule 416), shall state that such Registration Statement also covers such indeterminate number of additional shares of Common
Stock as may become issuable upon exercise of or otherwise pursuant to the Warrants or the Warrant Shares to prevent dilution resulting from stock splits, stock dividends, stock issuances or similar transactions. The number of shares of Common Stock
initially included in such Registration Statement shall be no less than the aggregate number of Warrant Shares that are then issuable upon exercise of or otherwise pursuant to the Warrants, without regard to any limitations on the Investors’
ability to exercise the Warrants. Each Registration Statement (and each amendment or supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided to (and shall be subject to the approval, which shall not be
unreasonably withheld or delayed, of) the Investors and their counsel prior to its filing or other submission. 
 (ii) If for any reason, despite the
Company’s use of its best efforts to include all of the Registrable Securities in the Registration Statement filed pursuant to Section 2 (a)(i) above (and subject to Section 3(q) below), the SEC does not permit all of the Registrable
Securities to be included in, or for any other reason any Registrable Securities are not then included in, such Registration Statement, then the Company shall prepare, and, as soon as practicable but in no event later than the Additional Filing
Deadline, file with the SEC an additional Registration Statement covering the resale of all Registrable Securities not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to
Rule 415. 
 b. PIGGY-BACK REGISTRATIONS. If at any time prior to the expiration of the Registration Period (as hereinafter defined) the Company shall
determine (i) to file with the SEC a registration statement under the Securities Act relating to an offering for its own account or for the account of any other holder of its equity securities (other than securities being registered on Form S-4 or Form S-8 or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities
issuable in connection with stock option or other employee benefit plans), and/or (ii) otherwise to effect an underwritten offering of any securities of the Company of a type included in a then effective Registration Statement, the Company
shall send to each Investor written notice of such determination and, if within fifteen (15) days after the effective date of such notice, the Investor shall so request in writing, the Company shall include in such Registration Statement and/or
include in such underwritten offering, as applicable, all or any part of such Investor’s Registrable Securities that the Investor requests to be registered and/or included in the underwritten offering, as applicable, except that if, in
connection with any underwritten offering for the account of the Company, the managing underwriter(s) thereof shall impose a limitation on the number of Registrable Securities which may be included in such offering because, in such
underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated to include in such underwritten offering only such limited portion of the
Registrable Securities with respect to which the Investor has requested inclusion hereunder as the underwriter(s) shall permit; 

 provided, however, that the Company shall not exclude any Registrable Securities unless the Company
has first excluded all outstanding securities to be sold for the accounts of any holders of the Company’s equity securities which are not entitled by contract to inclusion of such securities in an underwritten offering or are not entitled to
pro rata inclusion with the Registrable Securities; and 
 provided, further, however, that, after giving effect to the immediately preceding
proviso, any exclusion of Registrable Securities shall be made pro rata with holders of other securities having the contractual right to include such securities in such underwritten offering other than holders of securities entitled to inclusion of
their securities in such underwritten offering by reason of demand registration rights. No right to registration of Registrable Securities under this Section 2(b) shall be construed to limit any registration required under Section 2(a) hereof. If an
Investor’s Registrable Securities are included in an underwritten offering pursuant to this Section 2(b), then such Investor shall, unless otherwise agreed by the Company, offer and sell such Registrable Securities in such underwritten offering
using the same underwriter or underwriters and, subject to the provisions of this Agreement, on the same terms and conditions as other shares of Common Stock included in such underwritten offering. Notwithstanding anything to the contrary set forth
herein, the rights of the Investors pursuant to this Section 2(b) shall only be available in the case of an underwritten offering or in the event the Company fails to timely file, obtain effectiveness or maintain effectiveness of any Registration
Statement to be filed pursuant to Section 2(a) in accordance with the terms of this Agreement. 
 3. OBLIGATIONS OF THE COMPANY. In connection with
any registration of the Registrable Securities hereunder, the Company shall have the following obligations: 
 a. The Company shall prepare promptly, and
file with the SEC as soon as practicable after such registration obligation arises hereunder (but in no event later than the applicable Filing Deadline), a Registration Statement with respect to the number of Registrable Securities provided in
Section 2(a), as applicable, and thereafter use its reasonable best efforts to cause each such Registration Statement relating to Registrable Securities to become effective as soon as possible after such filing, but in any event shall use its
reasonable best efforts to cause each such Registration Statement relating to Registrable Securities to become effective no later than the Registration Deadline, and shall thereafter use its reasonable best efforts to keep the Registration Statement
current and effective pursuant to Rule 415 at all times until such date as is the earlier of (i) the date on which all of the Registrable Securities included in such Registration Statement have been sold and (ii) assuming all of the
Warrants will be exercised pursuant to Cash Exercises (as defined in the Warrants), the date on which all of the Registrable Securities included in such Registration Statement (in the opinion of counsel to the Investors) may be immediately sold to
the public without registration or restriction (including without limitation as to volume by each holder thereof), and without compliance with any “current public information” requirement, pursuant to Rule 144 under the Securities Act (the
“Registration Period”), which Registration Statement (including any amendments or supplements thereto and prospectuses contained therein), except 

 
for information provided in writing by an Investor pursuant to Section 4(a), shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein, or necessary to make the statements therein not misleading. In the event that Form S-3 is not available for the registration of the resale of any Registrable Securities hereunder (but, for the
avoidance of doubt, without in any way affecting the Company’s obligation to register the resale of the Registrable Securities on such other form as is available, as provided in Section 2(a)), (i) the Company shall undertake to file, within
twenty (20) days of such time as such form is available for such registration, a post-effective amendment to the Registration Statement then in effect, or otherwise file a Registration Statement on Form
S-3, registering such Registrable Securities on Form S-3; provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until
such time as a Registration Statement (or post-effective amendment) on Form S-3 covering such Registrable Securities has been declared effective by the SEC, and (ii) the Company shall provide that any
Registration Statement on Form S-1 filed hereunder shall incorporate documents by reference (including by way of forward incorporation by reference) to the maximum extent possible. 

b. The Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to each Registration Statement and the
prospectus used in connection with each Registration Statement as may be necessary to keep each Registration Statement current and effective at all times during the Registration Period, and, during the Registration Period, shall comply with the
provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company covered by each Registration Statement until such time as all of such Registrable Securities have been disposed of in accordance with the
intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement. In the event that on any Trading Day (as defined below) (the “Registration Trigger Date”) the number of shares available under
the Registration Statements filed pursuant to this Agreement is insufficient to cover all of the Registrable Securities issued or issuable upon exercise of or otherwise pursuant to the Warrants, including any additional shares of Common Stock issued
in connection with any anti-dilution provisions contained in the Warrants, without giving effect to any limitations on the Investors’ ability to exercise the Warrants, the Company shall amend the Registration Statements, or file a new
Registration Statement (on the short form available therefor, if applicable), or both, so as to cover the total number of Registrable Securities so issued or issuable (without giving effect to any limitations on exercise contained in the Warrants)
as of the Registration Trigger Date as soon as practicable, but in any event within twenty (20) days after the Registration Trigger Date. The Company shall use its best efforts to cause such amendment and/or new Registration Statement to become
effective as soon as practicable following the filing thereof, but in any event the Company shall cause such amendment and/or new Registration Statement to become effective within sixty (60) days of the Registration Trigger Date or as promptly
as practicable in the event the Company is required to increase its authorized shares. “Trading Day” shall mean any day on which the Common Stock is traded for any period on the NASDAQ Global Select Market (the “NasdaqGS”), or if
not the NasdaqGS, the principal securities exchange or other securities market on which the Common Stock is then being traded. 

 c. The Company shall furnish to each Investor and its legal counsel (i) promptly after the same is prepared
and publicly distributed, filed with the SEC or received by the Company, one copy of each Registration Statement and any amendment thereto, each preliminary prospectus and prospectus and each amendment or supplement thereto, and, in the case of a
Registration Statement referred to in Section 2(a), each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such
Registration Statement (other than any portion of any thereof which contains information for which the Company has sought or intends to seek confidential treatment or which relates to Company matters that are in the reasonable judgment of the
Company not relevant to the Investor’s interests with respect to the Registrable Securities), and (ii) such number of copies of a prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such other
documents as an Investor may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Investor; provided that the Company may determine in its reasonable judgment to provide any such copies in electronic
form only. The Company will promptly notify each of the Investors by electronic mail of the effectiveness of each Registration Statement or any post-effective amendment. The Company will promptly respond to any and all comments received from the
SEC, with a view towards causing each Registration Statement or any amendment thereto to be declared effective by the SEC as soon as practicable and, as soon as practicable, but in no event later than three (3) business days, following the
resolution or clearance of all SEC comments or, if applicable, following notification by the SEC that any such Registration Statement or any amendment thereto will not be subject to review, shall file a request for acceleration of effectiveness of
such Registration Statement to a time and date not later than two (2) business days after the submission of such request. No later than the first business day after such Registration Statement becomes effective, the Company will file with the
SEC the final prospectus included therein pursuant to Rule 424 (or successor thereto) under the Securities Act. 
 d. The Company shall use its reasonable
best efforts to (i) register and qualify, in any jurisdiction where registration and/or qualification is required, the Registrable Securities covered by the Registration Statements under such other securities or “blue sky” laws of
such jurisdictions in the United States as the Investors shall reasonably request, (ii) prepare and file in those jurisdictions such amendments (including post-effective amendments) and supplements to such registrations and qualifications as
may be reasonably necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be reasonably necessary to maintain such registrations and qualifications in effect at all times during the
Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith or as
a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(d), (y) subject itself to general taxation in any such jurisdiction, or (z) file a
general consent to service of process in any such jurisdiction. 
 e. As promptly as practicable after becoming aware of such event, the Company shall notify
each Investor that holds Registrable Securities of the happening of any event, of which the Company has knowledge, as a result of which the prospectus included in any Registration Statement, as then in effect, includes an untrue statement of a
material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and promptly prepare a supplement or amendment to any Registration Statement to correct such untrue statement
or omission, and deliver such number of copies of such supplement or amendment to each Investor as such Investor may reasonably request. 

 f. The Company shall use its reasonable best efforts to prevent the issuance of any stop order or other
suspension of effectiveness of any Registration Statement, and, if such an order is issued, to obtain the withdrawal of such order at the earliest possible moment and to notify each Investor that holds Registrable Securities (and, in the event of an
underwritten offering, the managing underwriters) of the issuance of such order and the resolution thereof. 
 g. The Company shall permit a single firm of
counsel designated by the Investors (“Legal Counsel”) to review such Registration Statement and all amendments and supplements thereto (as well as all requests for acceleration or effectiveness thereof), a reasonable period of time prior
to their filing with the SEC (not less than five (5) business days but not more than eight (8) business days) and not file any documents in a form to which Legal Counsel reasonably objects and will not request acceleration of such
Registration Statement without prior notice to Legal Counsel. 
 h. The Company shall hold in confidence and not make any disclosure of information
concerning an Investor provided to the Company unless (i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary to avoid or correct a misstatement
or omission in any Registration Statement, (iii) the release of such information is ordered pursuant to a subpoena or other order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally
available to the public other than by disclosure in violation of this or any other agreement. The Company agrees that it shall, upon learning that disclosure of such information concerning any Investor is sought in or by a court or governmental body
of competent jurisdiction or through other means, give prompt notice to such Investor prior to making such disclosure, and allow such Investor, at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order
for, such information. 
 i. The Company shall use its reasonable best efforts to cause all the Registrable Securities covered by each Registration Statement
to be listed on each securities exchange on which securities of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange, and, to arrange
for at least two market makers to register with the Financial Industry Regulatory Authority, Inc. (“FINRA”) as such with respect to such Registrable Securities. 

j. The Company shall provide a transfer agent and registrar, which may be a single entity, for the Registrable Securities not later than the effective date of
the initial Registration Statement. 

 k. The Company shall cooperate with each Investor that holds Registrable Securities being offered and the
managing underwriter or underwriters with respect to an applicable Registration Statement, if any, to facilitate the timely (i) preparation and delivery of certificates (not bearing any restrictive legends) representing Registrable Securities
to be offered pursuant to such Registration Statement, and enable such certificates to be registered in such names and in such denominations or amounts, as the case may be, or (ii) crediting of the Registrable Securities to be offered pursuant
to a Registration Statement to the applicable account (or accounts) with The Depository Trust Company through its Deposit/Withdrawal At Custodian (DWAC) system, in any such case as such Investor or the managing underwriter or underwriters, if any,
may reasonably request. Within three (3) business days after a Registration Statement which includes Registrable Securities becomes effective, the Company shall deliver, and shall cause legal counsel selected by the Company to deliver, to the
transfer agent for the Registrable Securities (with copies to each Investor) an appropriate instruction and an opinion of such counsel in the form required by the transfer agent in order to issue the Registrable Securities free of restrictive
legends. 
 l. At the reasonable request of an Investor, the Company shall prepare and file with the SEC such amendments (including post-effective
amendments) and supplements to a Registration Statement and any prospectus used in connection with the Registration Statement as may be necessary in order to change the plan of distribution set forth in such Registration Statement. 

m. The Company shall not, and shall not agree to, allow the holders of any securities of the Company to include any of their securities (other than Registrable
Securities) in any Registration Statement filed pursuant to Section 2(a) hereof or any amendment or supplement thereto under Section 3(b) hereof without the consent of Investors holding a majority-in-interest of the then outstanding Registrable Securities. In addition, the Company shall not include any securities for its own account or the account of others in any Registration Statement filed
pursuant to Section 2(a) hereof or any amendment or supplement thereto filed pursuant to Section 3(b) hereof without the consent of Investors holding a
majority-in-interest of the then outstanding Registrable Securities. 
 n.
Reserved. 
 o. The Company shall comply with all applicable laws related to a Registration Statement and offering and sale of securities and all applicable
rules and regulations of governmental authorities in connection therewith (including the Securities Act and the Exchange Act and the rules and regulations promulgated by the SEC). 

p. If required by the FINRA Corporate Financing Department, the Company shall promptly effect a filing with FINRA pursuant to FINRA Rule 5110 (or successor
thereto) with respect to the public offering contemplated by resales of securities under the Registration Statement (an “Issuer Filing”), and pay the filing fee required by such Issuer Filing. The Company shall use its reasonable best
efforts to pursue the Issuer Filing until FINRA issues a letter confirming that it does not object to the terms of the offering contemplated by the Registration Statement. 

 q. If at any time the SEC advises the Company in writing that the offering of some or all of the Registrable
Securities in a Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the Securities Act, the Company shall use its reasonable best efforts to persuade the SEC that the offering
contemplated by a Registration Statement is a bona fide secondary offering and not an offering “by or on behalf of the issuer” as defined in Rule 415 and that none of the Investors is an “underwriter.” The Investors shall have
the right to participate or have their respective counsel participate in any meetings or discussions with the SEC regarding the SEC’s position and to comment or have their respective counsel comment on any written submission made to the SEC
with respect thereto. No such written submission shall be made to the SEC to which any Investor’s counsel reasonably objects. In the event that, despite the Company’s reasonable best efforts and compliance with the terms of this Section
3(q), the SEC refuses to alter its position, the Company shall remove from the Registration Statement such portion of the Registrable Securities as the SEC requires in writing be removed therefrom. Any such
cut-back imposed by the SEC as contemplated by this Section 3(q) shall be imposed on a pro rata basis (based upon the Registrable Securities held by each of the Investors), first, to the Registrable Securities
that are not Warrant Shares until all of such Registrable Securities are removed from the Registration Statement, and only then to the Warrant Shares, unless otherwise required by the SEC. 

r. Notwithstanding anything to the contrary in Section 3(e), at any time after the effective date of the applicable Registration Statement, the Company
may delay the disclosure of material non-public information concerning the Company the disclosure of which at the time is not, in the good faith opinion of the Board of Directors of the Company and its
counsel, in the best interest of the Company and not, in the opinion of counsel to the Company, otherwise required (a “Grace Period”); provided, that the Company shall (i) promptly notify the Investors in writing of the
existence of material non-public information giving rise to a Grace Period (provided that in each notice the Company shall not disclose the content of such material
non-public information to any Investor unless otherwise requested in writing by such Investor) and the date on which the Grace Period will begin, and (ii) as soon as such date may be determined, promptly
notify the Investors in writing of the date on which the Grace Period ends; and, provided, further, that (A) no Grace Period shall exceed forty-five (45) consecutive days, (B) during any three hundred sixty five
(365) day period, such Grace Periods shall not exceed an aggregate of seventy-five (75) days, (C) the first day of any Grace Period must be at least ten (10) business days after the last day of any prior Grace Period and (D) no
Grace Period shall be in effect on any day during any period beginning on (and including) the date that is ten (10) business days prior to any issuance by the Company of Common Stock pursuant to Section 2.7 of the Facility Agreement and
Exhibit 2.7 thereto and ending on (and including) the date that is fifteen (15) business days after such issuance (each Grace Period that satisfies all of the requirements of this Section 3(r) being referred to as an “Allowable
Grace Period”). For purposes of determining the length of a Grace Period above, the Grace Period shall begin on and include the date the Investors receive the notice referred to in clause (i) and shall end on and include the later of
the date the Investors receive the notice referred to in clause (ii) and the date referred to in such notice. The provisions of Section 3(e) hereof shall not be applicable during the period of any Allowable Grace Period, Failure Payments
(as defined in the Warrants) shall not accrue on any day during an Allowable Grace Period, and the unavailability of a Registration Statement for resales of the Registrable Securities on any day during an Allowable Grace Period shall not constitute
a “Registration Failure” (as defined in the Warrants). Upon expiration of the Grace Period, the Company shall again be bound by the first sentence of Section 3(e) with respect to the information giving rise thereto unless such
material non-public information is no longer applicable. 

 4. OBLIGATIONS OF THE INVESTOR. In connection with the registration of the Registrable Securities, each
Investor shall have the following obligations: 
 a. It shall be a condition precedent to the obligations of the Company to complete the registration
pursuant to this Agreement with respect to the Registrable Securities of an Investor that such Investor shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of
the Registrable Securities held by it as shall be reasonably required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request. At least
five (5) business days prior to the first anticipated filing date of a Registration Statement, the Company shall notify each Investor of the information the Company requires from such Investor. Any such information shall not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein not misleading. An Investor must provide such information to the Company at least two (2) business days
prior to the first anticipated filing date of such Registration Statement if such Investor elects to have any Registrable Securities included in the Registration Statement. 

b. Each Investor, by such Investor’s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of a Registration Statement hereunder, unless such Investor has notified the Company in writing of such Investor’s election to exclude all of the Investor’s Registrable Securities from such
Registration Statement. 
 c. In the event of an underwritten offering pursuant to Section 2(b) in which any Registrable Securities of any Investor are to be
included, such Investor agrees to enter into and perform the Investor’s obligations under an underwriting agreement, in usual and customary form, including customary indemnification and contribution obligations (as applicable to selling
security holders generally), with the managing underwriter of such offering and take such other actions as are reasonably required in order to expedite or facilitate the disposition of such Investor Registrable Securities. 

d. Each Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(e) or 3(f), such
Investor will immediately discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until such Investor’s receipt of the copies of the supplemented or amended prospectus
contemplated by Section 3(e) or 3(f). 

 e. Each Investor agrees that it will promptly notify the Company of any material changes in the information set
forth in a Registration Statement furnished by or regarding such Investor, other than changes in the number of shares beneficially owned. 
 5.
REGISTRATION FAILURE. In the event of a Registration Failure (as defined in the Warrants), the Investors shall be entitled to Failure Payments (as defined in the Warrants) and such other rights as set forth in the Warrants. 

6. EXPENSES OF REGISTRATION. All reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations,
filings or qualifications pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualification fees, printers and accounting fees, and the fees and disbursements of counsel for the Company shall be borne by the
Company. The Company shall also reimburse the Investors for the reasonable fees and disbursements of Legal Counsel in the aggregate amount up to $25,000 per registration in connection with registrations pursuant to Section 2 or 3 of this
Agreement. 
 7. INDEMNIFICATION. In the event any Registrable Securities are included in a Registration Statement under this Agreement: 

a. The Company will indemnify, hold harmless and defend (i) each Investor, (ii) the directors, officers, partners, managers, members, employees,
agents of each Investor, and each Person who controls any Investor within the meaning of the Securities Act or the Exchange Act, if any, (iii) any underwriter (as defined in the Securities Act) for each Investor in connection with an
underwritten offering pursuant to Section 2(b) hereof, and (iv) the directors, officers, partners, employees and each Person who controls any such underwriter within the meaning of the Securities Act or the Exchange Act, if any (each, an
“Indemnified Person”), against any joint or several losses, claims, damages, liabilities or expenses (collectively, together with actions, proceedings or inquiries by any regulatory or self-regulatory organization, whether commenced or
threatened, in respect thereof, “Claims”) to which any of them may become subject insofar as such Claims arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in any Registration
Statement, or any amendment as supplement thereto, or any filing made under state securities laws as required hereby, or the omission or alleged omission to state therein a material fact required to be stated or necessary to make the statements
therein not misleading; (ii) any untrue statement or alleged untrue statement of a material fact contained in any Prospectus, or any amendment or supplement thereto, or the omission or alleged omission to state therein any material fact
necessary to make the statements made therein, in the light of the circumstances under which the statements therein were made, not misleading; or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act,
any other law, including any state securities law, or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities (the matters in the foregoing clauses (i) through (iii) being, collectively,
“Violations”). The Company shall reimburse the Indemnified Person, promptly as such expenses are incurred and are due and payable, for any reasonable legal fees and other reasonable expenses incurred by them in connection with
investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 7(a) shall not apply to a Claim arising out of or based upon a Violation to the extent that
such Violation occurs in reliance upon and in conformity with 

 
information furnished in writing to the Company by or on behalf of any Indemnified Person expressly for use in connection with the preparation of such Registration Statement or any such amendment
thereof or supplement thereto, or (B) to any amounts paid in settlement of any Claim effected without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by any of the Investors pursuant to Section 10. 

b. Promptly after receipt by an Indemnified Person under this Section 7 of notice of the commencement of any action (including any governmental action),
such Indemnified Person shall, if a Claim in respect thereof is to be made against the Company under this Section 7, deliver to the Company a written notice of the commencement thereof, and the Company shall have the right to participate in,
and, to the extent the Company so desires, to assume control of the defense thereof with counsel mutually satisfactory to the Company and the Indemnified Person, as the case may be; 

provided, however, that an Indemnified Person shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by
the Company, if, in the reasonable opinion of counsel for such Indemnified Person, the representation by such counsel of the Indemnified Person and the Company would be inappropriate due to actual or potential differing interests between such
Indemnified Person and any other party represented by such counsel in such proceeding. The Company shall pay for only one separate legal counsel for the Indemnified Persons, and such legal counsel shall be selected by the Investors. The failure to
deliver written notice to the Company within a reasonable time of the commencement of any such action shall not relieve the Company of any liability to the Indemnified Person under this Section 7, except to the extent that the Company is
actually prejudiced in its ability to defend such action, and shall not relieve the Company of any liability to the Indemnified Person otherwise than pursuant to this Section 7. The Company shall not, without the prior written consent of the
Indemnified Persons, consent to entry of any judgment or enter into any settlement or other compromise with respect to any Claim in respect of which indemnification or contribution may be or has been sought hereunder (whether or not any such
Indemnified Party is an actual or potential party to such action or claim) which does not include as an unconditional term thereof the giving by the claimant or plaintiff to the Indemnified Persons of a full release from all liability with respect
to such Claim or which includes any admission as to fault or culpability on the part of any Indemnified Person. The indemnification required by this Section 7 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as any expense, loss, damage or liability is incurred. 
 c. Each Investor will indemnify, hold harmless and defend (i) the
Company, and (ii) the directors, officers, partners, managers, members, employees, or agents of the Company, if any (each, a “Company Indemnified Person”), against any Claims to which any of them may become subject insofar as such
Claims arise out of or are based upon any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any other law, including any state securities law, or any rule or regulation thereunder relating to the offer or sale of
the Registrable Securities, which occurs due to the inclusion by the Company in a Registration Statement of false or 

 
misleading information about an Investor, where such information was furnished in writing to the Company by or on behalf of such Investor expressly for the purpose of inclusion in such
Registration Statement. Notwithstanding anything herein to the contrary, the indemnity agreement contained in this Section 7(c) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written
consent of the Investors, which consent shall not be unreasonably withheld or delayed; and provided, further, however, that an Investor shall be liable under this Section 7(c) for only that amount of a Claim as does not exceed the net
amount of proceeds received by such Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement. 
 d. Promptly after
receipt by a Company Indemnified Person under this Section 7 of notice of the commencement of any action (including any governmental action), such Company Indemnified Person shall, if a Claim in respect thereof is to be made against any
Investor under this Section 7, deliver to such Investor a written notice of the commencement thereof, and such Investor shall have the right to participate in, and, to the extent such Investor so desires, to assume control of the defense
thereof with counsel mutually satisfactory to such Investor and such Company Indemnified Person. 
 8. CONTRIBUTION. If for any reason the
indemnification provided for in Section 7(a) or 7(c) (as applicable) is unavailable to an Indemnified Person or Company Indemnified Person (as applicable) or insufficient to hold it harmless, other than as expressly specified therein, then the
indemnifying party shall contribute to the amount paid or payable by the Indemnified Person or Company Indemnified Person (as applicable) as a result of the Claim in such proportion as is appropriate to reflect the relative fault of the Indemnified
Person or Company Indemnified Person (as applicable) and the indemnifying party (provided that the relative fault of any Company Indemnified Person shall be deemed to include the fault of all other Company Indemnified Persons), as well as any other
relevant equitable considerations. No Person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any Person not guilty of such fraudulent misrepresentation. In
no event shall the contribution obligation of an Investor be greater in amount than the net amount of proceeds received by such Investor as a result of the sale of Registrable Securities giving rise to such contribution obligation pursuant to the
applicable Registration Statement (net of the aggregate amount of any damages or other amounts such Investor has otherwise been required to pay (pursuant to Section 7(c) or otherwise) by reason of such Investor’s untrue or alleged untrue
statement or omission or alleged omission). 
 9. REPORTS UNDER THE 1934 ACT. With a view to making available to the Investors the benefits of
Rule 144 promulgated under the Securities Act or any other similar rule or regulation of the SEC that may at any time permit the Investors to sell securities of the Company to the public without registration, the Company agrees to: 

a. make and keep public information available, as those terms are understood and defined in Rule 144; 

 b. file with the SEC in a timely manner all reports and other documents required of the Company under the
Exchange Act so long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and 

c. so long as any of the Investors owns Registrable Securities, promptly upon request, furnish to such Investor (i) a written statement by the Company
that it has complied with the reporting requirements of the Exchange Act as required for applicable provisions of Rule 144, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed
by the Company and (iii) such other information as may be reasonably requested to permit such Investor to sell such Registrable Securities pursuant to Rule 144 without registration. 

10. ASSIGNMENT OF REGISTRATION RIGHTS. The rights under this Agreement shall be automatically assignable by each Investor to any transferee of all or
any portion of the Registrable Securities if: (i) such Investor agrees in writing with the transferee or assignee to assign such rights, and a copy of such agreement is furnished to the Company within a reasonable time after such assignment,
(ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or assignee, and (b) the securities with respect to which such registration
rights are being transferred or assigned, and (iii) at or before the time the Company receives the written notice contemplated in clause (ii) of this sentence, the transferee or assignee agrees in writing with the Company to be bound
by all of the provisions contained herein as applicable to the Investors. In the event that the Company receives written notice from an Investor that it has transferred all or any portion of its Registrable Securities pursuant to this Section, the
Company shall have up to ten (10) days to file any amendments or supplements necessary to keep a Registration Statement current and effective pursuant to Rule 415, and the commencement date of any Event of Failure (as defined in the
Warrants) or Event of Default (as defined in the Warrants) under the Warrants caused thereby will be extended by ten (10) days. Each Investor shall at all times comply with the restrictions on transfer set forth in Section 8 of the Warrant
(to the extent applicable to such Investor), which provisions are hereby incorporated by reference and made a part hereof. 
 11. AMENDMENT OF
REGISTRATION RIGHTS. Provisions of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only with written consent of the Company and the
holders of a majority in interest of then-outstanding Registrable Securities. Any amendment or waiver effected in accordance with this Section 11 shall be binding upon each of the Investors and the Company. 

12. MISCELLANEOUS. 
 a. A Person is deemed to hold, and be
a holder of, shares of Common Stock or other Registrable Securities whenever such Person owns of record or beneficially through a “street name” holder such shares of Common Stock or other Registrable Securities (or the Warrants or other
securities upon exercise, conversion or exchange of which such Registrable Securities are directly or indirectly issuable, without 

 
giving effect to any limitations on exercise, conversion or exchange of the Warrants or other securities), and solely for purposes hereof, Registrable Securities shall be deemed outstanding to
the extent they are directly or indirectly issuable upon exercise, conversion or exchange of the Warrants or other outstanding securities, Registrable Securities, without giving effect to any limits on exercise, conversion or exchange of the
Warrants or other securities. If the Company receives conflicting instructions, notices or elections from two or more Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election
received from the registered owner of such Registrable Securities (or the Warrants or other securities upon exercise, conversion or exchange of which such Registrable Securities are directly or indirectly issuable). 

b. Any notices required or permitted to be given under the terms hereof shall be sent by certified or registered mail (return receipt requested) or delivered
personally or by courier (including a recognized overnight delivery service) or by electronic mail and shall be effective five days after being placed in the mail, if mailed by regular United States mail, or upon receipt, if delivered personally or
by courier (including a recognized overnight delivery service) or by electronic mail, in each case addressed to a party. The addresses for such communications shall be: 

If to the Company: 
 Endologix, Inc. 

2 Musick 
 Irvine, CA 92618 

Email: vmahboob@endologix.com 
 Attn: Vaseem Mahboob, Chief
Financial Officer 
 With copy to: 
 Stradling Yocca
Carlson & Rauth, P.C. 
 660 Newport Center Drive, Suite 1600 

Newport Beach, CA 92660 
 Email: lcohn@sycr.com;
mlawhead@sycr.com 
 Attn:    Lawrence B. Cohn 

            Michael L. Lawhead 

 If to an Investor: 

c/o Deerfield Mgmt, L.P. 
 780 Third Avenue, 37th Floor 
 New York, NY 10017 

Fax: (212) 599-1248 

Email: 
 Attn: David J. Clark, Esq. 

With a copy to: 
 Katten Muchin Rosenman LLP 

575 Madison Avenue 
 New York, NY 10022 

Fax: (212) 940-8776 

Email: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com 

Attn: Mark I. Fisher, Esq. 
 Mark D. Wood, Esq.

 Each party shall provide notice to the other party of any change in address. 

c. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not
operate as a waiver thereof. 
 d. Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the City of New York, borough of Manhattan. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of
any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any 

 
right to serve process in any other manner permitted by law. The parties hereby waive all rights to a trial by jury. If either party shall commence an action or proceeding to enforce any
provision of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and
prosecution of such action or proceeding. 
 e. This Agreement, the Warrants and the Facility Agreement (including all schedules and exhibits thereto)
constitute the entire agreement among the parties hereto with respect to the subject matter hereof. This Agreement, the Warrants and the Facility Agreement (including all schedules and exhibits thereto) supersede all prior agreements and
understandings among the parties hereto with respect to the subject matter hereof. 
 f. Subject to the requirements of Section 10 hereof, this
Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of the parties hereto, and the provisions of Sections 7 and 8 hereof shall inure to the benefit of, and be enforceable by, each Indemnified Person and
Company Indemnified Person (as applicable). 
 g. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise
affect the meaning hereof. 
 h. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall
constitute one and the same agreement. This Agreement, once executed by a party, may be delivered to the other party hereto by electronic transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement. 

i. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other
agreements, certificates, instruments and documents, as the other parties may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby. 

j. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Investors by vitiating the intent and purpose
of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for breach of its obligations hereunder will be inadequate and agrees, in the event of a breach or threatened breach by the Company of any of the
provisions hereunder, that the Investors shall be entitled, in addition to all other available remedies in law or in equity, to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement and to enforce specifically
the terms and provisions hereof, without the necessity of showing economic loss and without any bond or other security being required. 
 k. The language
used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 

 l. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or
rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under
any law shall not affect the validity or enforceability of any other provision hereof. 
 m. In the event an Investor shall sell or otherwise transfer any of
such holder’s Registrable Securities, each transferee shall be allocated a pro rata portion of the number of Registrable Securities included in a Registration Statement for such transferor. 

n. There shall be no oral modifications or amendments to this Agreement. This Agreement may be modified or amended only in writing. 

o. The Company shall not grant any Person any registration rights with respect to shares of Common Stock or any other securities of the Company other than
registration rights that will not adversely affect the rights of the Investors hereunder (including by limiting in any way the number of Registrable Securities that could be included in any Registration Statement pursuant to Rule 415) and shall not
otherwise enter into any agreement that is inconsistent with the rights granted to the Investors hereunder. 
 p. The obligations of each Investor hereunder
are several and not joint with the obligations of any other Investor, and no provision of this Agreement is intended to confer any obligations on any Investor
vis-à-vis any other Investor. Nothing contained herein, and no action taken by any Investor pursuant hereto, shall be deemed to constitute the Investors as a
partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated herein. 

q. Unless the context otherwise requires, (i) all references to Sections, Schedules or Exhibits are to Sections, Schedules or Exhibits contained in or
attached to this Agreement, (ii) words in the singular or plural include the singular and plural, and pronouns stated in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter, and (ii) the use
of the word “including” in this Agreement shall be by way of example rather than limitation. 
 [Remainder of page left
intentionally blank] 
 [Signature page follows] 

 IN WITNESS WHEREOF, the undersigned Investors and the Company have caused this Registration
Rights Agreement to be duly executed as of the date first written above. 
  

			
	COMPANY:
	
	ENDOLOGIX, INC., a Delaware corporation
		
	By:	 	                                      
                                         
          
	Name:	 	
	Title:	 	

 IN WITNESS WHEREOF, the undersigned Investors and the Company have caused this Registration
Rights Agreement to be duly executed as of the date first written above. 
  

			
	INVESTORS:
	
	DEERFIELD PRIVATE DESIGN FUND IV, L.P.
	
	By: Deerfield Mgmt IV, L.P., General Partner
	
	By: J.E. Flynn Capital IV, LLC, General Partner
		
	By:	 	  

	Name:	 	James E. Flynn
	Title:	 	President
	
	DEERFIELD PRIVATE DESIGN FUND III, L.P.
	
	By: Deerfield Mgmt III, L.P., General Partner
	
	By: J.E. Flynn Capital III, LLC, General Partner
		
	By:	 	  

	Name:	 	James E. Flynn
	Title:	 	President
	
	DEERFIELD INTERNATIONAL MASTER FUND, L.P.
	
	By: Deerfield Mgmt, L.P., General Partner
	
	By: J.E. Flynn Capital, LLC, General Partner
		
	By:	 	  

	Name:	 	James E. Flynn
	Title:	 	President
	
	DEERFIELD PARTNERS, L.P.
	
	By: Deerfield Mgmt, L.P., General Partner
	
	By: J.E. Flynn Capital, LLC, General Partner
		
	By:	 	  

	Name:	 	James E. Flynn
	Title:	 	President

 EXHIBIT F 

FORM OF COMPLIANCE CERTIFICATE 

_______________, 2017 
 Deerfield Private Design
Fund IV, L.P. 
 c/o Deerfield Management Company, L.P. 
 780
Third Avenue, 37th Floor 
 New York, New York 10017 

Ladies and Gentlemen: 
 The undersigned,
ENDOLOGIX, INC., a Delaware corporation (“Borrower”) pursuant to Section 5.1(h) of the Facility Agreement dated as of April 3, 2017 (as amended, restated, supplemented or otherwise modified from time to time, the
“Facility Agreement”) between Borrower, the other Loan Parties, Deerfield Private Design Fund IV, L.P. (in its capacity as agent for the Secured Parties, the “Agent”) and the “Lenders” from time to time
party thereto, hereby delivers this Compliance Certificate. Capitalized terms used but not otherwise defined herein are used herein as defined in the Facility Agreement. 

Borrower hereby certifies and warrants to Agent and the Lenders that attached hereto as Annex I is a true, correct and complete copy of its [10-Q][10-K] filing (the “Report”) made with the United States Securities and Exchange Commission (the “SEC”). The Report complies in all
material respects with the applicable requirements of the Exchange Act and does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The consolidated financial statements included in the Report comply as to form in all material respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto, were prepared in accordance with GAAP, consistently applied [(subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and
lack of footnote disclosures)]2, and fairly present in all material respects the consolidated financial position of the Borrower and its Subsidiaries as of the dates hereof and the consolidated
results of their operations, cash flows and changes in stockholders equity for the periods presented [(subject, in the case of unaudited quarterly financial statements, to normal year-end audit adjustments and
lack of footnote disclosures)]3. 
  
  

 

	2 	The bracketed information shall only be included with a 10-Q filing, but not with a 10-K filing. 

	3 	The bracketed information shall only be included with a 10-Q filing, but not with a 10-K filing. 

 Borrower further certifies to Agent and the Lenders that as of the date hereof (a) no
Default or Event of Default or (b) event of default under the ABL Debt Documents or the Convertible Note Documents, in each case, has occurred and is continuing or, if such a Default, Event of Default or event of default has occurred and is
continuing, set forth below is a description of the nature and period of existence of such Default, Event of Default or event of default and what action Borrower has taken, is undertaking and proposes to take with respect thereto. 

As of the last Business Day of each calendar month in the period covered by the Report, the Borrower has had at least $10,000,000 of cash and
Cash Equivalents maintained in deposit accounts and securities accounts of the Borrower subject to Control Agreements reasonably satisfactory to the Agent (or, to the extent in compliance, and in accordance, with the provisions in
Section 5.1(k) of the Facility Agreement in the Merrill Lynch Securities Account) in compliance with the provisions and terms of Section 5.1(k) of the Facility Agreement. 

[Signature follows on next page.] 

 IN WITNESS WHEREOF, Borrower has caused this Compliance Certificate to be executed and delivered
by its Responsible Officer on the date first set forth above. 
  

			
	 ENDOLOGIX, INC., a Delaware corporation

		
	 By:
	 	
                   
                                         
                             

	 Name:
	 	
                   
                                         
                             

	 Title:
	 	
                   
                                         
                             

 ANNEX I 

TO 
 COMPLIANCE
CERTIFICATE 
 [See Attached] 

 Schedule P-1 

Existing Investments 
  

					
	 Name of Issuer
	  	 Description and Value of Security
	  	 Loan Party/Subsidiary

	Cianna Medical, Inc.	  	8,677 Shares of Series A Preferred Stock	  	Endologix, Inc.
			
	RMS/Endologix Sideways Merger Corp.	  	100 Shares of Common Stock	  	Endologix, Inc.
			
	ELGX International Holdings GP	  	Unspecified Number of Partnership Interests	  	Endologix, Inc.
			
	Endologix Bermuda, L.P.	  	Unspecified Number of Partnership Interests	  	Endologix, Inc.
			
	Endologix Singapore Private Limited	  	Unspecified Number of Company Interests	  	Endologix, Inc.
			
	Endologix New Zealand Co.	  	Unspecified Number of Company Interests	  	Endologix, Inc.
			
	Endologix International Holdings B.V.	  	Unspecified Number of Company Interests	  	Endologix Bermuda, L.P.
			
	Endologix Poland spolkda z ograniczona odpowiedzialnoscia	  	Unspecified Number of Company Interests	  	Endologix International Holdings B.V.
			
	Endologix International B.V.	  	Unspecified Number of Company Interests	  	Endologix International Holdings B.V.
			
	Endologix Italia S.r.l	  	Unspecified Number of Company Interests	  	Endologix International Holdings B.V.
			
	TriVascular Sales LLC	  	1,000 Units of Membership Interests	  	TriVascular, Inc.
			
	TriVascular Italia Sarl	  	Unspecified Number of Company Interests	  	TriVascular, Inc.
			
	TriVascular Germany GmbH	  	Unspecified number of Company Interests	  	TriVascular, Inc.
			
	 TriVascular Switzerland Sárl
	  	Unspecified number of Company Interests	  	TriVascular, Inc.

  

 Schedule 2.4 

List of Agreement Date Lenders and Such Lenders’ Wire Instructions and Information for Notices 

 

					
	 Name of Lender
	  	 Wire Instructions/ Address for

Payments to Lender
	  	 Information for Notices

	Deerfield Partners, L.P.	  	 Citibank, N.A. New York
 ABA # 021-000-089
 A/C Morgan Stanley & Co. NY

A/C # 38890774
 Sub A/C Deerfield Partners, L.P.

Sub A/C # 038-036208
	  	 Deerfield Partners, L.P.
 c/o Deerfield
Management Company, L.P.
 780 Third Avenue, 37th Floor
 New
York, NY 10017
 Facsimile: 212-599-3075

E-mail: dclark@deerfield.com

Attn: David J. Clark, Esq.
  

With a copy to (which shall not be deemed to constitute notice):
  

Katten Muchin Rosenman LLP
 575 Madison Avenue

New York NY 10022-2585
 Facsimile: (212) 894-5877
 E-mail: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com

Attn: Mark I. Fisher, Esq.
 Attn: Mark D. Wood, Esq.

			
	 Deerfield International
 Master Fund,
L.P.
	  	 Citibank, N.A. New York
 ABA # 021-000-089
 A/C Morgan Stanley & Co. NY

A/C # 38890774
 Sub A/C Deerfield International Master Fund,
L.P.
 Sub A/C # 038-CDFCZ3
	  	 Deerfield International Master Fund, L.P.
 c/o
Deerfield Management Company, L.P.
 780 Third Avenue, 37th Floor

New York, NY 10017
 Facsimile: 212-599-3075
 E-mail: dclark@deerfield.com

Attn: David J. Clark, Esq.
  

With a copy to (which shall not be deemed to constitute notice):
  

Katten Muchin Rosenman LLP
 575 Madison Avenue

New York NY 10022-2585
 Facsimile: (212) 894-5877
 E-mail: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com

Attn: Mark I. Fisher, Esq.
 Attn: Mark D. Wood, Esq.

					
	 Name of Lender
	  	 Wire Instructions/ Address for

Payments to Lender
	  	 Information for Notices

	 Deerfield Private Design
 Fund III,
L.P.
	  	 Citibank, N.A. New York
 ABA # 021-000-089
 A/C Morgan Stanley & Co. NY

A/C # 38890774
 Sub A/C Deerfield Private Design Fund III,
L.P.
 Sub A/C # 038CDKGC9
	  	 Deerfield Private Design Fund III, L.P.
 c/o
Deerfield Management Company, L.P.
 780 Third Avenue, 37th Floor

New York, NY 10017
 Facsimile: 212-599-3075
 E-mail: dclark@deerfield.com

Attn: David J. Clark, Esq.
  

With a copy to (which shall not be deemed to constitute notice):
  

Katten Muchin Rosenman LLP
 575 Madison Avenue

New York NY 10022-2585
 Facsimile: (212) 894-5877
 E-mail: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com

Attn: Mark I. Fisher, Esq.
 Attn: Mark D. Wood, Esq.

			
	Deerfield Private Design Fund IV, L.P.	  	 Citibank, N.A. New York
 ABA # 021-000-089
 A/C Morgan Stanley & Co. NY

A/C # 38890774
 Sub A/C Deerfield Private Design Fund IV, L.P.

Sub A/C # 038CDNH16
	  	 Deerfield Private Design Fund IV, L.P.
 c/o
Deerfield Management Company, L.P.
 780 Third Avenue, 37th Floor

New York, NY 10017
 Facsimile: 212-599-3075
 E-mail: dclark@deerfield.com

Attn: David J. Clark, Esq.
  

With a copy to (which shall not be deemed to constitute notice):
  

Katten Muchin Rosenman LLP
 575 Madison Avenue

New York NY 10022-2585
 Facsimile: (212) 894-5877
 E-mail: mark.fisher@kattenlaw.com and mark.wood@kattenlaw.com

Attn: Mark I. Fisher, Esq.
 Attn: Mark D. Wood, Esq.

 Schedule 3.1(d) 

Existing Liens 
 None. 

 Schedule 3.1(f) 

Existing Indebtedness 
 None. 

 Schedule 3.1(h) 

Litigation 
 Barry Lucido, etc. v.
TriVascular Technologies, Inc., et al., Superior Court of the State California, County of Sonoma, Case No. SCV 258123. The complaint sought, among other things, rescissory and compensatory damages, and attorneys’ fees and expenses. On
January 25, 2016, the defendants entered into a memorandum of understanding with the plaintiffs providing for the settlement of all claims in both actions. In December 2016, the defendants entered into a stipulation and agreement of compromise,
settlement and release with respect to this matter and the dismissal thereof. The final settlement hearing is scheduled for June 2017. 
 Vicky Nguyen
v. Endologix, Inc., et al. (Filed January 3, 2017 in the United States District Court, Central District of California; Case No. 2:17-cv-00017); and
Kodgi Ahmed v. Endologix, Inc., et al. (Filed January 11, 2017 in the United States District Court, Central District of California; Case No.
8:17-cv-00061). These putative securities class actions are brought against defendants Endologix, Inc., John McDermott, and Vaseem Mahboob. The putative class period is
August 2, 2016 through November 16, 2016. The lawsuits allege that the defendants made misleading statements about the prospects for approval by the FDA of the Nellix medical product in violation of Sections 10(b) and 20(a) of the
Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The lawsuits allege that on November 16, 2016, Endologix announced that the FDA had requested additional data from Endologix to
assess Nellix for approval and that Endologix’s stock fell approximately 20% on this news. The lawsuits seek damages, interest, attorneys’ fees, expert fees, costs, and other relief the Court may deem appropriate. Endologix intends to file
a motion to dismiss the lawsuits after the Court appoints a lead plaintiff and the lead plaintiff files a consolidated complaint. 
 Steven M. Ortiz
v. Endologix, Inc. This wage and hour class action lawsuit was filed by former employee Steven M. Ortiz entitled Steven M. Ortiz. v. Endologix, Inc., Orange County Superior Court Case No. 30-2016-00873893-CU-OE-CXC. The case was filed on September 9, 2016 and involves the following claims that the plaintiff
seeks to certify as a class action: failure to pay all overtime wages owing; failure to provide meal periods and failure to pay meal period premiums; failure to pay all wages owed at time of termination seeking waiting time penalties under Labor
Code section 203; failure to provide accurate wage statements; and violations of Business and Professions Code section 17200. The case also alleges claims for penalties under the Private Attorneys General Act of 2004. Endologix and the plaintiff
held a mediation in March 2017 regarding this matter and are negotiating the terms of a final settlement agreement. 
 Samuels v. TriVascular,
Inc., in the United States District Court for the Northern District of California, Civil Action No.
3:13-cv-02261-EMC. In this action, Dr. Shaun L.W. Samuels filed a complaint asserting patent infringement of United
States Patent No. 6,007,575 (the “’575 patent”) in connection with TriVascular’s Ovation Prime® Abdominal Stent Graft System for the treatment of aortic abdominal
aneurysms. TriVascular filed an answer and counterclaims, asserting various defenses and asserting counterclaims. Dr. Samuels filed a second amended complaint on August 13, 2015, adding individual defendants, Michael A. Chobotov, Ph.D.;
Robert G. Whirley, Ph.D.; and Joseph W. Humphrey, Ph.D. TriVascular filed an answer and counterclaims on August 27, 2015, asserting various defenses and asserting counterclaims that Dr. Samuels’s patent is not infringed and is invalid, as
well as certain breach of contract claims based on previous agreements with Dr. Samuels. On November 3, 2015, the court held a claim construction hearing to construe certain claims of the ‘575 patent, and issued a claim construction
order on November 12, 2015. 

 On December 17, 2015, the court then entered (based on the parties stipulation) an order and final judgment of non-infringement of the ‘575 patent, providing that TriVascular and the individual defendants did not infringe the ‘575 patent and staying TriVascular’s second through fifth counterclaims pending Dr.
Samuels’s appeal of the judgment of non-infringement. On January 12, 2016, Dr. Samuels filed a notice of appeal to the court of appeals for the federal circuit. After briefing, the appeal was argued
before a panel of the federal circuit on November 1, 2016. On November 3, 2016, the federal circuit affirmed the district court’s judgment summarily, without writing an opinion. The federal circuit’s mandate was issued on December 12,
2016. TriVascular filed a motion for attorney fees, which the district court denied on February 22, 2017. The district court also ordered the parties to file a stipulation of dismissal of TriVascular’s counterclaims two through five without
prejudice, as well as a stipulated final judgment disposing of the case, by March 2017. The parties filed the foregoing stipulations and are awaiting a final disposition from the district court. 

 Schedule 3.1(m) 

Real Estate 
 Owned Real Property:

  

			
	 Loan Party or Subsidiary
	  	 Complete street and mailing address, including

zip code

	 N.A.
	  	

 Leased Real Property: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing

address, including zip code
	  	 Landlord name and contact

information

	Endologix, Inc.	  	2 Musick, Irvine, County of Orange, California 92618 U.S.A.	  	The Northwestern Mutual Life Insurance Company
			
	Endologix International Holdings B.V.	  	Burgemeester Burgerslaan 40, 5245 NH Rosmalen, The Netherlands	  	N.A.
			
	TriVascular Technologies, Inc.	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	Sonoma Airport Properties LLC
			
	Endologix Singapore Private Limited	  	50 Ubi Crescent #01-03 Ubi Techpark Singapore 408568	  	Somnotec (S) Pte Ltd., 50 Ubi Crescent #01-03 Ubi Techpark Singapore 408568

 Subleased Real Property: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing

address, including zip code
	  	 Landlord and sublandlord

name and contact information

	N.A.	  		  	

 Other Real Property Operated or Occupied: 
  

					
	 Loan Party or Subsidiary
	  	 Complete street and mailing

address, including zip code
	  	 Nature of use

	N.A.	  		  	

 Schedule 3.1(x) 

Borrower’s Subsidiaries 
  

													
	 Parent
	  	Percentage
ownership	  	 Name of

Subsidiary
	  	 Jurisdiction

of
 Subsidiary
	  	Date of
formation
of
Subsidiary	  	 Federal

employer
 ID no.
of
Subsidiary
	  	 Organizational
identification

no. of

Subsidiary

	Endologix, Inc.	  	100%	  	Nellix, Inc.	  	Delaware	  	03/20/2001	  	94-3398416	  	3359980
							
	Endologix, Inc.	  	100%	  	CVD/RMS Acquisition Corp.	  	Delaware	  	12/13/1998	  	33-0928438	  	2955166
							
	Endologix, Inc.	  	100%	  	RMS/Endologix Sideways Merger Corp.	  	Delaware	  	05/30/2002	  	03-0512974	  	3530477
							
	Endologix, Inc.	  	100%	  	Endologix Singapore Private Limited	  	Singapore	  	01/13/2015	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	ELGX International Holdings GP	  	Cayman Islands	  	07/05/2011	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	Endologix New Zealand Co.	  	New Zealand	  	05/31/2012	  	N.A.	  	N.A.
							
	 Endologix, Inc.
 ELGX International Holdings
GP
	  	99%
 1%
	  	Endologix Bermuda L.P.	  	Bermuda	  	07/24/2012	  	N.A.	  	N.A.
							
	Endologix International Holdings B.V.	  	100%	  	Endologix Poland spolkda z ograniczona odpowiedzialnoscia	  	Poland	  	03/26/2015	  	N.A.	  	N.A.
							
	Endologix Bermuda L.P.	  	100%	  	Endologix International Holdings B.V.	  	The Netherlands	  	08/22/2011	  	N.A.	  	N.A.
							
	Endologix International Holdings B.V.	  	100%	  	Endologix Italia S.r.l.	  	Italy	  	06/04/2012	  	N.A.	  	N.A.
							
	Endologix International holdings B.V.	  	100%	  	Endologix International B.V.	  	The Netherlands	  	08/22/2011	  	N.A.	  	N.A.
							
	Endologix, Inc.	  	100%	  	TriVascular Technologies, Inc.	  	Delaware	  	07/11/2007	  	87-0807313	  	4387054
							
	TriVascular Technologies, Inc.	  	100%	  	TriVascular, Inc.	  	California	  	01/05/1998	  	68-0402620	  	C2065374
							
	TriVascular, Inc.	  	100%	  	TriVascular Sales, LLC	  	Texas	  	08/23/2012	  	46-0859179	  	0801644988
							
	TriVascular, Inc.    	  	100%	  	TriVascular Canada, LLC	  	Delaware	  	11/25/2014	  	N.A.	  	5647226

													
	 Parent
	  	Percentage
ownership	  	 Name of

Subsidiary
	  	 Jurisdiction

of
 Subsidiary
	  	Date of
formation
of
Subsidiary	  	 Federal

employer
 ID no.
of
Subsidiary
	  	 Organizational
identification

no. of

Subsidiary

	TriVascular, Inc.	  	100%	  	TriVascular Germany GmbH	  	Germany	  	05/14/2012	  	N.A.	  	N.A.
							
	TriVascular, Inc.	  	100%	  	TriVascular Switzerland Sarl	  	Switzerland	  	04/30/2010	  	N.A.	  	N.A.
							
	TriVascular, Inc.	  	100%	  	TriVascular Italia S.R.L.	  	Italy	  	04/08/2010	  	N.A.	  	N.A.

 Schedule 3.1(z) 

Borrower’s Outstanding Shares of Stock, Options and Warrants 

 

									
	 Name of Issuer
	  	 Authorized

Securities
	  	 Issued and

Outstanding Securities
	  	 Certificated
(Yes or No)
	  	 Loan

Party/Subsidiary
Owner

	Endologix, Inc.4	  	135,000,000 Shares of Common Stock, $0.001 par value	  	82,925,280 Shares of Common Stock	  	Yes	  	N.A.
	  	5,000,000 Shares of Preferred Stock, $0.001 par value, undesignated	  	Zero Shares of Preferred Stock	  	Yes, when issued	  	N.A.
					
	Nellix, Inc.	  	1,000 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	CVD/RMS Acquisition Corp.	  	100 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	RMS/Endologix Sideways Merger Corp.	  	100 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	TriVascular Technologies, Inc.	  	1,000 Shares of Common Stock, $0.001 par value	  	100 Shares of Common Stock	  	Yes	  	Endologix, Inc.
					
	ELGX International Holdings GP	  	Unspecified Number of Partnership Interests	  	Unspecified Number of Partnership Interests	  	No	  	Endologix, Inc.
					
	Endologix Bermuda, L.P.	  	Unspecified Number of Partnership Interests	  	Unspecified Number of Partnership Interests	  	No	  	Endologix, Inc.
					
	Endologix Singapore Private Limited	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix, Inc.
					
	Endologix New Zealand Co.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix, Inc.
					
	TriVascular, Inc.    	  	100 Shares of Common stock, $0.01 par value	  	100 Shares of Common Stock	  	No	  	TriVascular Technologies, Inc.

  

	4 	As disclosed in the Annual Report on Form 10-K of Endologix, Inc., as filed with the U.S. Securities and Exchange Commission on March 1, 2017, and available on EDGAR.

									
	 Name of Issuer
	  	 Authorized

Securities
	  	 Issued and

Outstanding Securities
	  	 Certificated
(Yes or No)
	  	 Loan

Party/Subsidiary
Owner

	Endologix International Holdings B.V.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix Bermuda, L.P.
					
	Endologix Poland spolkda z ograniczona odpowiedzialnoscia	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	Endologix International B.V.	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	Endologix Italia S.r.l	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	Endologix International Holdings B.V.
					
	TriVascular Sales LLC	  	1,000 Units of Membership Interests	  	1,000 Units of Membership Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Canada, LLC	  	1,000 Units of Membership Interests	  	1,000 Units of Membership Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Italia Sarl	  	Unspecified Number of Company Interests	  	Unspecified Number of Company Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Germany GmbH	  	Unspecified number of Company Interests	  	Unspecified number of Company Interests	  	No	  	TriVascular, Inc.
					
	TriVascular Switzerland Sárl	  	Unspecified number of Company Interests	  	Unspecified number of Company Interests	  	No	  	TriVascular, Inc.

 Options and Equity Incentive/Compensation Plans: 

Equity Awards: The Borrower’s 2015 Stock Incentive Plan (the “2015 Plan”) authorizes the grant of equity awards to
purchase up to 6.8 million shares of Common Stock. As of December 31, 2016, approximately 8.3 million shares were reserved for issuance under outstanding stock options, including stock options granted under equity
compensation plans preceeding the 2015 Plan, and 1.3 million shares were subject to unvested restricted stock awards. The outstanding stock options have exercise prices ranging from $1.64 to $17.60 and a weighted average exercise price of
$9.22. 
 Amended and Restated 2006 Employee Stock Purchase Plan (the “ESPP”): As of December 31, 2016, approximately
4.6 million shares were available for issuance under the ESPP. 
 Non-Plan Inducement
Grants: In connection with its merger with TriVascular Technologies, Inc., the Borrower issued non-plan inducement stock options to purchase 1.3 million shares of Common Stock at an exercise price of
$7.53 per share, and non-plan inducement restricted stock units for 0.3 million shares of Common Stock. 

 Warrants: 

In connection with its merger with TriVascular Technologies, Inc., Borrower assumed 35,094 unexercised out-of-the-money warrants of TriVascular Technologies, Inc., 24,272 of which have an exercise price of $12.58 per share and 10,822 of which have an exercise price of
$28.21 per share. 
 Convertible Notes: 

2.25% Convertible Notes: On December 10, 2013, Borrower issued $86.3 million aggregate principal amount of 2.25% Convertible
Notes. The initial conversion rate of the 2.25% Convertible Notes is 41.6051 shares of Common Stock per $1,000 principal amount of 2.25% Convertible Notes, which represents an initial conversion price of approximately $24.04 per share. The 2.25%
Convertible Notes are not convertible as of the Agreement Date. 
 3.25% Convertible Notes: On November 2, 2015, Borrower issued
$125.0 million aggregate principal amount of 3.25% Convertible Notes. The initial conversion rate of the 3.25% Convertible Notes is 89.4314 shares of Common Stock per $1,000 principal amount of 3.25% Convertible Notes, which represents an
initial conversion price of approximately $11.18 per share. The 3.25% Convertible Notes are not convertible as of the Agreement Date. 
 Other Rights
to Securities of Borrower: 
 In connection with its merger with Nellix, Inc. (“Nellix”), Borrower agreed to issue shares
of Common Stock to the former stockholders of Nellix upon Borrower’s receipt of FDA approval to sell Borrower’s Nellix EVAS System in the United States (the “PMA Milestone”). The number of shares of Common Stock issuable to the
former stockholders of Nellix upon achievement of the PMA Milestone shall equal the quotient obtained by dividing $15.0 million by the average per share closing price of Common Stock on The Nasdaq Global Select Market for each of the 30
consecutive trading days ending with the fifth trading day immediately preceding the date of Borrower’s receipt of FDA approval to sell Borrower’s Nellix EVAS System in the United States, subject to a stock price floor
of $4.50 per share, but not subject to a stock price ceiling. 

 Schedule 3.1(aa) 

Material Contracts 
  

	•	 	Cross License Agreement dated as of October 26, 2011, by and between Endologix, Inc. and Bard Peripheral Vascular, Inc. 

  

	•	 	Settlement Agreement, dated October 16, 2012 by and among Endologix, Inc., Cook Incorporated, Cook Group and Cook Medical, Inc. 

 

	•	 	Standard Industrial/Commercial Multi-Tenant Lease - Net, for 2 Musick, Irvine, California and 35 Hammond, Irvine, dated June 12, 2013, by and between Endologix, Inc. and The Northwestern Mutual Life Insurance
Company. 

 Schedule 3.1(dd) 

Environmental 
 None. 

 Schedule 3.1(ff) 

Labor Relations 
 None. 

 Schedule 3.1(gg) 

Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office 

 

													
	 Loan Party
	 	 Jurisdiction

of

organization
	 	 All other
jurisdictions of

organization
 of
Loan
 Party for 5 years

preceding the

Agreement Date
	 	 Legal name
	 	 All other legal

names of Loan

Party for 5 years
preceding the
Agreement Date
	 	Organizational
identification
no.	 	 Location of chief executive

office or sole place of business

	Endologix, Inc.	 	Delaware	 	N.A.	 	Same as loan party name at left	 	N.A.	 	2338745	 	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	Nellix, Inc.	 	Delaware	 	N.A.	 	Same as loan party name at left	 	N.A.	 	3359980	 	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	CVD/RMS Acquisition Corp.	 	Delaware	 	N.A.	 	Same as loan party name at left	 	N.A.	 	2955166	 	2 Musick, Irvine, County of Orange, California 92618 U.S.A.
							
	TriVascular Technologies, Inc.	 	Delaware	 	N.A.	 	Same as loan party name at left	 	N.A.	 	4387054	 	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A
							
	TriVascular, Inc.	 	California	 	N.A.	 	Same as loan party name at left	 	N.A.	 	C2065374	 	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A
							
	TriVascular Canada, LLC	 	Delaware	 	N.A.	 	Same as loan party name at left	 	N.A.	 	5647226	 	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A

 Schedule 5.1(y) 

Post-Closing Requirements 

The Loan Parties shall satisfy and complete each of the following obligations, or provide Agent each of the items listed below, as applicable,
on or before the date indicated below, all to the satisfaction of Agent in its reasonable discretion: 
 1. Within forty-five (45) days after the
Agreement Date (or such later date as Agent may agree in its sole discretion), ensure that each deposit account and securities account (other than Excluded Accounts and other than the Merrill Lynch Securities Account) maintained by any Loan Party
shall be subject to a Control Agreement, or any other documentation determined by Agent to be reasonably necessary to grant a perfected security interest in the funds or investment property maintained in any such deposit account or securities
account, each of which shall be in form and substance reasonably satisfactory to Agent. 
 2. The Loan Parties shall use commercially reasonable efforts to,
by the date that is sixty (60) days following the Agreement Date (or such later date as Agent may agree in writing in its sole discretion), provide Agent with landlord’s agreement, consignment agreements, landlord waivers, and/or bailee
waivers (as applicable), each of which shall be reasonably satisfactory in form and substance to Agent, for each of the following locations: (a) 3910 Brickway Blvd., Santa Rosa, CA 95403, (b) 5025 Tuggle Road, Memphis, TN 38118 and (c) 2 Musick,
Irvine, CA 92618. 
 3. The Loan Parties shall, by the date that is thirty (30) days after the Agreement Date (or such later date as Agent may agree in
writing in its sole discretion), provide Agent with endorsements to the Loan Parties’ property insurance policies naming Agent as lender loss payee and endorsements to the Loan Parties’ liability insurance policies naming Agent as
additional insured and, in each case, notices of cancellation as set forth in Section 5.1(e). 
 4. The Loan Parties shall, within sixty
(60) days after the Agreement Date (or such later date as Agent may agree in writing in its sole discretion), either (a) provide Agent with evidence reasonably satisfactory to it that Trivascular Sales LLC has been dissolved or
(b) make TriVascular Sales LLC a Guarantor and have TriVascular Sales LLC provide a Lien in its Collateral to Agent for the benefit of the Secured Parties and to execute and deliver all agreements, instruments and documents and take such other
actions reasonably requested by Agent in respect thereof. 
 5. Within forty-five (45) days after the Agreement Date (or such later date as Agent may
agree in writing in its sole discretion), the Loan Parties shall have made all requisite filings to cause their patents currently registered in the name of Radiance Medical Systems (serial numbers 08/877593 (Microcapsules for Site-Specific Delivery)
and 08/965900 (Radiation Delivery Catheter) to be registered in the name of Endologix, Inc. 
 6. The Loan Parties shall, within forty-five (45) days
after the Agreement Date (or such later date as Agent may agree in writing in its sole discretion), make RMS/Endologix Sideways Merger Corp. a Guarantor and have RMS/Endologix Sideways Merger Corp. provide a Lien in its Collateral to Agent for the
benefit of the Secured Parties and to execute and deliver all agreements, instruments and documents and take such other actions reasonably requested by Agent in respect thereof. 

The Loan Parties’ failure to complete and satisfy any of the above obligations on or before the date indicated above (or such later date as Agent may
agree in writing in its sole discretion), or the Loan Parties’ failure to deliver any of the above listed items on or before the date indicated above (or such later date as Agent may agree in writing in its sole discretion), shall constitute an
immediate and automatic Event of Default. 

 Schedule 5.2(iv) 

Contingent Obligations 
  

	•	 	Base Capped Call Confirmation, dated December 4, 2013, between the Borrower and Bank of America, N.A. 

  

	•	 	Additional Capped Call Confirmation, dated December 5, 2013, between the Borrower and Bank of America, N.A. 

The capped call transactions contemplated by the documents listed above relate to the 2.25% Convertible Notes. The capped call transactions are expected to
reduce the potential dilution and/or offset the potential cash payments that the Borrower may be required to make in excess of the principal amount upon conversion of the 2.25% Convertible Notes in the event that the market price per share of the
Borrower’s common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, which initially corresponds to the $24.04 conversion price of the 2.25% Convertible Notes.
The Borrower will not be required to make any cash payments to Bank of America, N.A. upon the exercise of the options that are a part of the capped call transactions, but rather will be entitled to receive from Bank of America, N.A. a number of
shares of the Borrower’s common stock and/or an amount of cash based on the amount by which the market price per share of Common Stock of the Borrower, as measured under the terms of the capped call transactions, is greater than the strike
price of the capped call transactions during the relevant valuation period. 

 Schedule 5.2(vii) 

Transactions with Affiliates 
 Investments
of Inventory pursuant to clause (j) of the definition of Permitted Investments.EX-10.2

 Exhibit 10.2 
  

 
  

CREDIT AND SECURITY AGREEMENT 

dated as of April 3, 2017 

by and among 

ENDOLOGIX, INC., 
 each
of its direct and indirect subsidiaries listed on the signature pages hereto and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, 

and 
 DEERFIELD ELGX
REVOLVER, LLC, 
 as Agent and as a Lender, 

and 
 THE ADDITIONAL
LENDERS 
 FROM TIME TO TIME PARTY HERETO 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	 ARTICLE 1 – DEFINITIONS
	  	 	1	 
			
	 Section 1.1
	  	Certain Defined Terms	  	 	1	 
	 Section 1.2
	  	Accounting Terms and Determinations	  	 	39	 
	 Section 1.3
	  	Other Definitional and Interpretive Provisions	  	 	39	 
	 Section 1.4
	  	Time is of the Essence	  	 	40	 
		
	 ARTICLE 2 - LOANS
	  	 	40	 
			
	 Section 2.1
	  	Loans	  	 	40	 
	 Section 2.2
	  	Interest, Interest Calculations and Certain Fees	  	 	42	 
	 Section 2.3
	  	Notes	  	 	44	 
	 Section 2.4
	  	Reserved	  	 	44	 
	 Section 2.5
	  	Reserved	  	 	44	 
	 Section 2.6
	  	General Provisions Regarding Payment; Loan Account	  	 	44	 
	 Section 2.7
	  	Maximum Interest	  	 	45	 
	 Section 2.8
	  	Taxes; Capital Adequacy	  	 	45	 
	 Section 2.9
	  	Appointment of Borrower Representative	  	 	47	 
	 Section 2.10
	  	Joint and Several Liability; Rights of Contribution; Subordination and Subrogation	  	 	48	 
	 Section 2.11
	  	Collections and Lockbox Account	  	 	50	 
	 Section 2.12
	  	Termination; Restriction on Termination	  	 	52	 
		
	 ARTICLE 3 - REPRESENTATIONS AND WARRANTIES
	  	 	53	 
			
	 Section 3.1
	  	Existence and Power	  	 	53	 
	 Section 3.2
	  	Organization and Governmental Authorization; No Contravention	  	 	53	 
	 Section 3.3
	  	Binding Effect	  	 	53	 
	 Section 3.4
	  	Capitalization	  	 	53	 
	 Section 3.5
	  	Financial Information	  	 	54	 
	 Section 3.6
	  	Litigation	  	 	54	 
	 Section 3.7
	  	Ownership of Property	  	 	54	 
	 Section 3.8
	  	No Default	  	 	54	 
	 Section 3.9
	  	Labor Matters	  	 	54	 
	 Section 3.10
	  	Regulated Entities	  	 	54	 
	 Section 3.11
	  	Margin Regulations	  	 	54	 
	 Section 3.12
	  	Compliance With Laws; Anti-Terrorism Laws	  	 	55	 

  
 i 

							
	 Section 3.13
	  	Taxes	  	 	55	 
	 Section 3.14
	  	Compliance with ERISA	  	 	55	 
	 Section 3.15
	  	Consummation of Operative Documents; Brokers	  	 	56	 
	 Section 3.16
	  	Reserved	  	 	56	 
	 Section 3.17
	  	Material Contracts	  	 	56	 
	 Section 3.18
	  	Compliance with Environmental Requirements; No Hazardous Materials	  	 	56	 
	 Section 3.19
	  	Intellectual Property and License Agreements	  	 	57	 
	 Section 3.20
	  	Solvency	  	 	57	 
	 Section 3.21
	  	Full Disclosure	  	 	57	 
	 Section 3.22
	  	Interest Rate	  	 	57	 
	 Section 3.23
	  	Subsidiaries	  	 	57	 
	 Section 3.24
	  	Reserved	  	 	57	 
	 Section 3.25
	  	Accuracy of Schedules	  	 	57	 
	 Section 3.26
	  	SEC Documents	  	 	58	 
	 Section 3.27
	  	Financial Statements	  	 	58	 
		
	 ARTICLE 4 - AFFIRMATIVE COVENANTS
	  	 	59	 
			
	 Section 4.1
	  	Financial Statements and Other Reports	  	 	59	 
	 Section 4.2
	  	Payment and Performance of Obligations	  	 	60	 
	 Section 4.3
	  	Maintenance of Existence	  	 	61	 
	 Section 4.4
	  	Maintenance of Property; Insurance	  	 	61	 
	 Section 4.5
	  	Compliance with Laws and Material Contracts	  	 	62	 
	 Section 4.6
	  	Inspection of Property, Books and Records	  	 	62	 
	 Section 4.7
	  	Use of Proceeds	  	 	62	 
	 Section 4.8
	  	Reserved	  	 	62	 
	 Section 4.9
	  	Notices of Litigation and Defaults	  	 	62	 
	 Section 4.10
	  	Hazardous Materials; Remediation	  	 	64	 
	 Section 4.11
	  	Further Assurances	  	 	64	 
	 Section 4.12
	  	Reserved	  	 	65	 
	 Section 4.13
	  	Power of Attorney	  	 	65	 
	 Section 4.14
	  	Borrowing Base Collateral Administration	  	 	66	 
	 Section 4.15
	  	Schedule and Perfection Certificate Updates	  	 	67	 
	 Section 4.16
	  	Intellectual Property and Licensing	  	 	67	 
	 Section 4.17
	  	Regulatory Reporting and Covenants	  	 	68	 
	 Section 4.18
	  	Reserved	  	 	68	 

  
 ii 

							
	 Section 4.19
	  	Announcing Form 8-K	  	 	68	 
	 Section 4.20
	  	Regulatory Required Permits	  	 	70	 
	 Section 4.21
	  	Term Debt Documents	  	 	70	 
	 Section 4.22
	  	Post-Closing Items	  	 	70	 
	 Section 4.23
	  	Immaterial Subsidiary	  	 	70	 
		
	 ARTICLE 5 - NEGATIVE COVENANTS
	  	 	71	 
			
	 Section 5.1
	  	Debt; Contingent Obligations	  	 	71	 
	 Section 5.2
	  	Liens	  	 	71	 
	 Section 5.3
	  	Distributions	  	 	71	 
	 Section 5.4
	  	Restrictive Agreements	  	 	71	 
	 Section 5.5
	  	Payments and Modifications of Debt	  	 	71	 
	 Section 5.6
	  	Consolidations, Mergers and Sales of Assets; Change in Control	  	 	72	 
	 Section 5.7
	  	Purchase of Assets, Investments	  	 	73	 
	 Section 5.8
	  	Transactions with Affiliates	  	 	73	 
	 Section 5.9
	  	Modification of Organizational Documents	  	 	74	 
	 Section 5.10
	  	Modification of Certain Agreements	  	 	74	 
	 Section 5.11
	  	Conduct of Business	  	 	74	 
	 Section 5.12
	  	Excluded Foreign Subsidiaries; Joint Ventures	  	 	74	 
	 Section 5.13
	  	Limitation on Sale and Leaseback Transactions	  	 	74	 
	 Section 5.14
	  	Deposit Accounts and Securities Accounts; Payroll and Benefits Accounts	  	 	74	 
	 Section 5.15
	  	Compliance with Anti-Terrorism Laws	  	 	75	 
	 Section 5.16
	  	Change in Accounting	  	 	75	 
	 Section 5.17
	  	Intercreditor Agreement	  	 	76	 
	 Section 5.18
	  	Anti-Layering	  	 	76	 
		
	 ARTICLE 6 - FINANCIAL COVENANTS
	  	 	76	 
			
	 Section 6.1
	  	Additional Defined Terms	  	 	76	 
	 Section 6.2
	  	Minimum Net Revenue	  	 	76	 
	 Section 6.3
	  	Evidence of Compliance	  	 	76	 
		
	 ARTICLE 7 – CONDITIONS
	  	 	77	 
			
	 Section 7.1
	  	Conditions to Closing	  	 	77	 
	 Section 7.2
	  	Conditions to Each Loan	  	 	78	 
	 Section 7.3
	  	Searches	  	 	78	 
		
	 ARTICLE 8 – REGULATORY MATTERS
	  	 	79	 
			
	 Section 8.1
	  	Reserved	  	 	79	 

  
 iii 

							
	 Section 8.2
	  	Representations and Warranties	  	 	79	 
		
	 ARTICLE 9 - SECURITY AGREEMENT
	  	 	81	 
			
	 Section 9.1
	  	Generally	  	 	81	 
	 Section 9.2
	  	Representations and Warranties and Covenants Relating to Collateral	  	 	81	 
		
	 ARTICLE 10 - EVENTS OF DEFAULT
	  	 	85	 
			
	 Section 10.1
	  	Events of Default	  	 	85	 
	 Section 10.2
	  	Acceleration and Suspension or Termination of Revolving Loan Commitment	  	 	88	 
	 Section 10.3
	  	UCC Remedies	  	 	89	 
	 Section 10.4
	  	Reserved	  	 	90	 
	 Section 10.5
	  	Default Rate of Interest	  	 	90	 
	 Section 10.6
	  	Setoff Rights	  	 	91	 
	 Section 10.7
	  	Application of Proceeds	  	 	91	 
	 Section 10.8
	  	Waivers	  	 	92	 
	 Section 10.9
	  	Injunctive Relief	  	 	93	 
	 Section 10.10
	  	Marshalling; Payments Set Aside	  	 	93	 
	 Section 10.11
	  	Credit Bidding	  	 	94	 
		
	 ARTICLE 11 - AGENT
	  	 	94	 
			
	 Section 11.1
	  	Appointment and Authorization	  	 	94	 
	 Section 11.2
	  	Agent and Affiliates	  	 	94	 
	 Section 11.3
	  	Action by Agent	  	 	95	 
	 Section 11.4
	  	Consultation with Experts	  	 	95	 
	 Section 11.5
	  	Liability of Agent	  	 	95	 
	 Section 11.6
	  	Indemnification	  	 	95	 
	 Section 11.7
	  	Right to Request and Act on Instructions	  	 	95	 
	 Section 11.8
	  	Credit Decision	  	 	96	 
	 Section 11.9
	  	Collateral Matters	  	 	96	 
	 Section 11.10
	  	Agency for Perfection	  	 	96	 
	 Section 11.11
	  	Notice of Default	  	 	96	 
	 Section 11.12
	  	Assignment by Agent; Resignation of Agent; Successor Agent	  	 	97	 
	 Section 11.13
	  	Payment and Sharing of Payment	  	 	97	 
	 Section 11.14
	  	Right to Perform, Preserve and Protect	  	 	100	 
	 Section 11.15
	  	Delegation of Duties	  	 	100	 
	 Section 11.16
	  	Amendments and Waivers	  	 	100	 

  
 iv 

							
	 Section 11.17
	  	Assignments and Participations	  	 	101	 
	 Section 11.18
	  	Funding and Settlement Provisions Applicable When Non-Funding Lenders Exist	  	 	104	 
	 Section 11.19
	  	Reserved	  	 	104	 
	 Section 11.20
	  	Definitions	  	 	104	 
		
	 ARTICLE 12 – MISCELLANEOUS
	  	 	105	 
			
	 Section 12.1
	  	Survival	  	 	105	 
	 Section 12.2
	  	No Waivers	  	 	105	 
	 Section 12.3
	  	Notices	  	 	105	 
	 Section 12.4
	  	Severability	  	 	106	 
	 Section 12.5
	  	Headings	  	 	106	 
	 Section 12.6
	  	Confidentiality	  	 	106	 
	 Section 12.7
	  	Waiver of Consequential and Other Damages	  	 	107	 
	 Section 12.8
	  	GOVERNING LAW; SUBMISSION TO JURISDICTION	  	 	107	 
	 Section 12.9
	  	WAIVER OF JURY TRIAL	  	 	108	 
	 Section 12.10
	  	Publication; Advertisement	  	 	108	 
	 Section 12.11
	  	Counterparts; Integration	  	 	109	 
	 Section 12.12
	  	No Strict Construction	  	 	109	 
	 Section 12.13
	  	Lender Approvals	  	 	109	 
	 Section 12.14
	  	Expenses; Indemnity	  	 	109	 
	 Section 12.15
	  	Reserved	  	 	111	 
	 Section 12.16
	  	Reinstatement	  	 	111	 
	 Section 12.17
	  	Successors and Assigns	  	 	111	 
	 Section 12.18
	  	USA PATRIOT Act Notification	  	 	111	 
	 Section 12.19
	  	Intercreditor Agreement	  	 	112	 
	 Section 12.20
	  	Intercreditor Agreements	  	 	112	 

  

  
 v 

 CREDIT AND SECURITY AGREEMENT 

THIS CREDIT AND SECURITY AGREEMENT (as the same may be amended, supplemented, restated or otherwise modified from time to time, the
“Agreement”) is dated as of April 3, 2017 by and among ENDOLOGIX, INC., a Delaware corporation (“Endologix”), each of its direct and indirect Subsidiaries set forth on the signature pages hereto and any
additional borrower that may hereafter be added to this Agreement (individually as a “Borrower”, and collectively with any entities that become party hereto as Borrower and each of their successors and permitted assigns, the
“Borrowers”), DEERFIELD ELGX REVOLVER, LLC, individually as a Lender, and as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender. 

RECITALS 
 Borrowers have
requested that Lenders make available to Borrowers the financing facilities as described herein. Lenders are willing to extend such credit to Borrowers under the terms and conditions herein set forth. 

AGREEMENT 
 NOW,
THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein contained, Borrowers, Lenders and Agent agree as follows: 

ARTICLE 1 - DEFINITIONS 

Section 1.1 Certain Defined Terms. The following terms have the following meanings: 

“2.25% Convertible Notes” means those certain 2.25% senior unsecured notes, governed by the terms of a base indenture, as
supplemented by the first supplemental indenture relating to the 2.25% senior notes (together, the “2.25% Senior Notes Indenture”), between Endologix and Wells Fargo Bank, National Association, as trustee, each of which were entered
into on December 10, 2013. 
 “2.25% Convertible Note Documents” means the 2.25% Convertible Notes, the
2.25% Senior Note Indenture and each other document or agreement from time to entered into in connection with the foregoing. 

“3.25% Convertible Notes” means those certain 3.25% senior unsecured notes, governed by the terms of a base indenture, as
supplemented by the second supplemental indenture relating to the 3.25% senior notes (together, the “3.25% Senior Notes Indenture”), between Endologix and Wells Fargo Bank, National Association, as trustee, each of which were
entered into on November 2, 2015, as the same may be amended, restated, refinanced, supplemented or otherwise modified in connection with a Permitted 3.25% Convertible Note Refinancing. 

“3.25% Convertible Note Documents” means the 3.25% Convertible Notes, the 3.25% Senior Note Indenture and each
other document or agreement from time to entered into in connection with the foregoing, as the same may be amended, restated, refinanced, supplemented or otherwise modified in connection with a Permitted 3.25% Convertible Note Refinancing. 

“10-K” means an annual report on Form 10-K
(or successor form thereto), as required to be filed pursuant to the Exchange Act. 

  
 1 

 “10-Q” means a quarterly report on Form 10-Q (or successor form thereto), as required to be filed pursuant to the Exchange Act. 

“Acceleration Event” means the occurrence of an Event of Default (a) in respect of which Agent has declared all or any
portion of the Obligations to be immediately due and payable pursuant to Section 10.2, (b) pursuant to Section 10.1(a), and in respect of which Agent has suspended or terminated the Revolving Loan Commitment pursuant to Section 10.2,
and/or (c) pursuant to either Section 10.1(e) and/or Section 10.1(f). 
 “Account Debtor” means “account
debtor”, as defined in Article 9 of the UCC, and any other obligor in respect of an Account. 
 “Accounts” means,
collectively, (a) any right to payment of a monetary obligation, whether or not earned by performance, (b) without duplication, any “account” (as defined in the UCC), any accounts receivable (whether in the form of payments for
services rendered or goods sold, rents, license fees or otherwise), any “health-care-insurance receivables” (as defined in the UCC), any “payment intangibles” (as defined in the UCC) and all other rights to payment and/or
reimbursement of every kind and description, whether or not earned by performance, (c) all accounts, “general intangibles” (as defined in the UCC), Intellectual Property, rights, remedies, Guarantees, “supporting
obligations” (as defined in the UCC), “letter-of-credit rights” (as defined in the UCC) and security interests in respect of the foregoing, all rights of
enforcement and collection, all books and records evidencing or related to the foregoing, and all rights under the Financing Documents in respect of the foregoing, (d) all information and data compiled or derived by any Borrower or to which any
Borrower is entitled in respect of or related to the foregoing, and (e) all proceeds of any of the foregoing. 

“Acquisition” means any transaction or series of related transactions for the purpose of or resulting, directly or
indirectly, in (a) the acquisition of all or substantially all of the assets of a Person, or of any business or division of a Person, (b) the acquisition of in excess of fifty percent (50%) of the Stock of any Person or otherwise causing
any Person to become a Subsidiary of a Borrower, (c) a merger or consolidation or any other combination with any other Person or (d) the acquisition (including through licensing) of any Product or Intellectual Property of or from any other
Person if the Acquisition Consideration paid in connection with such acquisition is in excess of $5,000,000 individually or in the aggregate with respect to all such all such acquisitions in any twelve (12) month period. 

“Acquisition Consideration” has the meaning set forth in the definition of Permitted Acquisition. 

“Affiliate” means, with respect to any Person, (a) any Person that directly or indirectly controls such Person,
(b) any Person which is controlled by or is under common control with such controlling Person, and (c) each of such Person’s (other than, with respect to any Lender, any Lender’s) officers or directors (or Persons functioning in
substantially similar roles) and the spouses, parents, descendants and siblings of such officers, directors or other Persons. As used in this definition, the term “control” of a Person means the possession, directly or indirectly, of the
power to vote five percent (5%) or more of any class of voting securities of such Person or to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 “Agent” means Deerfield Revolver, in its capacity as administrative agent for itself and for Lenders hereunder, as such
capacity is established in, and subject to the provisions of, Article 11, and the successors and assigns of Deerfield Revolver in such capacity, and including, when the context may require, during any Third Party Agent Retention Period, any Third
Party Agent. 

  
 2 

 “All-in Yield” means the interest rate
(including margins and floors), original issue discount and fees paid to all lenders (or consenting lenders) of such debt or their Affiliates (based on the remaining life to maturity), but not including any fees not paid to all lenders (such as fees
to initial purchasers (i.e., investment banks in Rule 144A offerings), underwriters or lead agents. 
 “Announcing Form 8-K” has the meaning set forth in Section 4.19. 
 “Anti-Terrorism Laws”
means any Laws relating to terrorism or money laundering, including Executive Order No. 13224 (effective September 24, 2001), the USA PATRIOT Act, the Laws comprising or implementing the Bank Secrecy Act, and the Laws administered by OFAC.

 “Applicable Margin” means four and six tenths percent (4.60%) per annum.  

“Asset Disposition” means any sale, lease, license, transfer, assignment or other consensual disposition by any Credit Party
of any asset. 
 “Bankruptcy Code” means Title 11 of the United States Code entitled “Bankruptcy”, as the same
may be amended, modified or supplemented from time to time, and any successor statute thereto. 
 “Bank of America Cash Collateral
Account” means that certain deposit account #1453234066 of Endologix at Bank of America, N.A. (or such replacement deposit account provided by Bank of America, N.A. or by another commercial bank) established and maintained for the sole
purpose of providing cash collateral in favor of Bank of America, N.A. (or such replacement commercial bank) for obligations of Endologix in respect of certain commercial credit cards (or with respect to a replacement commercial bank, similar
commercial credit cards to those provided by Bank of America, N.A. as of the Closing Date) provided to Endologix by Bank of America, N.A. (or such replacement commercial bank); provided that the aggregate amount on deposit in such
deposit account (or such replacement deposit account) shall not at any time exceed $2,500,000. 
 “Base LIBOR Rate” means,
for each Interest Period, the rate per annum, determined by Agent in accordance with its customary procedures, and utilizing such electronic or other quotation sources as it considers appropriate (rounded upwards, if necessary, to the next 1/100%),
to be the rate at which Dollar deposits (for delivery on the first day of such Interest Period or, if such day is not a Business Day on the preceding Business Day) in the amount of $1,000,000 are offered to major banks in the London interbank market
on or about 11:00 a.m. (London time) two (2) Business Days prior to the commencement of such Interest Period, for a term comparable to such Interest Period, which determination shall be conclusive in the absence of manifest error. 

“Base Rate” means a per annum rate of interest equal to the greater of (a) three and one half percent 3.50%) per annum
and (b) the rate of interest last quoted by The Wall Street Journal as the “Prime Rate” in the United States or, if The Wall Street Journal ceases to quote such rate, the highest per annum interest rate published by the Federal
Reserve Board in Federal Reserve Statistical Release H.15 (519) (Selected Interest Rates) as the “bank prime loan” rate or, if such rate is no longer quoted therein, any similar rate quoted therein (as reasonably determined by the Agent)
or any similar release by the Federal Reserve Board (as reasonably determined by the Agent) . 
 “Blocked Person” means any
Person: (a) listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224, (b) owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to
the provisions of, Executive Order No. 13224, (c) with which any Lender is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law, (d) that commits, threatens or conspires to commit or supports
“terrorism” as defined in Executive Order No. 13224, or (e) that is named a “specially designated national” or “blocked person” on the most current list published by OFAC or other similar list or is named as a
“listed person” or “listed entity” on other lists made under any Anti-Terrorism Law. 

  
 3 

 “Borrower” and “Borrowers” has the meaning set forth in the
introductory paragraph hereto. 
 “Borrower Representative” means Endologix, in its capacity as Borrower Representative
pursuant to the provisions of Section 2.9, or any successor Borrower Representative selected by Borrowers and approved by Agent. 

“Borrowing Base” means: 

(a) the product of (i) eighty-five percent (85%) multiplied by (ii) the aggregate net amount at such time of the Eligible
Accounts; plus 
 (b) fifty percent (50%) multiplied by the value of the Eligible Inventory valued at the lower of first-in-first-out cost or market value, after factoring in all rebates, discounts and other incentives or rewards associated with the
purchase of the applicable Eligible Inventory, provided that the amount in this clause (b) shall not exceed the lesser of (i) thirty-five percent (35%) of the total Borrowing Base at any time and (ii) $10,000,000.00; plus

 (c) fifty percent (50%) of the Net Book Value of Eligible Equipment; minus  

(d) the amount of any reserves and/or adjustments provided for in this Agreement; 

provided, that the Borrowing Base will be automatically adjusted down, if necessary, such that (i) availability from Eligible
Foreign Accounts shall never exceed twenty percent (20%) of the total Borrowing Base and (ii) availability from Eligible Equipment shall never exceed $4,000,000. 

“Borrowing Base Certificate (Agent)” means a certificate, duly executed by a Responsible Officer of Borrower Representative,
appropriately completed and substantially in the form of Exhibit C-1 hereto, which Borrowing Base Certificate (Agent) shall be delivered to Agent in accordance with the terms of this Agreement. 

“Borrowing Base Certificate” means each of the Borrowing Base Certificate (Agent) and Borrowing Base Certificate (Third Party
Agent), as the context may require. 
 “Borrowing Base Certificate (Third Party Agent)” means a certificate, duly executed
by a Responsible Officer of Borrower Representative, appropriately completed and substantially in the form of Exhibit C-2 hereto, which Borrowing Base Certificate (Third Party Agent) shall be delivered
to Third Party Agent during a Third Party Agent Retention Period in accordance with the terms of this Agreement. 
 “Business
Day” means any day except a Saturday, Sunday or other day on which either the New York Stock Exchange is closed, or on which banks in New York, New York are authorized by law to close; provided that when used in connection with a LIBOR Rate
Loan, the term “Business Day” shall also exclude any day on which banks are not open for dealings in Dollar deposits in the London interbank market. 

“Capped Call” means the capped call transactions referenced in Schedule 5.1 in respect of the 2.25% Convertible Notes and any
like transactions that are economically similar to such transactions entered into in connection with any Debt contemplated under clause (j) of the definition of Permitted Debt. 

  
 4 

 “Cash Equivalents” means (a) any readily-marketable securities
(i) issued by, or directly, unconditionally and fully guaranteed or insured by the United States federal government or (ii) issued by any agency of the United States federal government the obligations of which are fully backed by the full
faith and credit of the United States federal government, (b) any readily-marketable direct obligations issued by any other agency of the United States federal government, any state of the United States or any political subdivision of any such
state or any public instrumentality thereof, in each case having a rating of at least “A-1” from S&P or at least “P-1” from Moody’s,
(c) any commercial paper rated at least “A-1” by S&P or “P-1” by Moody’s and issued by any Person organized under the laws of any state
of the United States, (d) any United States dollar-denominated time deposit, insured certificate of deposit, overnight bank deposit or bankers’ acceptance issued or accepted by any commercial bank that is (A) organized under the laws
of the United States, any state thereof or the District of Columbia, (B) “adequately capitalized” (as defined in the regulations of its primary federal banking regulators) and (C) has Tier 1 capital (as defined in such regulations) in
excess of $250,000,000, (e) shares of any United States money market fund that (i) has substantially all of its assets invested continuously in the types of investments referred to in clause (a), (b), (c) or (d) above with maturities as
set forth in the proviso below, (ii) has net assets in excess of $500,000,000 and (iii) has obtained from either S&P or Moody’s the highest rating obtainable for money market funds in the United States; provided, however, that the
maturities of all obligations specified in any of clauses (a), (b), (c) or (d) above shall not exceed one year and (f) investments made in accordance with Endologix’s investment policy in effect as of the Closing Date that was
provided to the Agent’s counsel on March 14, 2017 at 12:15 p.m. New York time, and any amendments thereto that do not, when taken as a whole, materially increase the risk of the investments made by Endologix from time to time from
Endologix’s investment policy in effect as of the Closing Date. 
 “CERCLA” means the Comprehensive Environmental
Response, Compensation and Liability Act of 1980, 42 U.S.C.A. § 9601 et seq., as the same may be amended from time to time. 

“Change in Control” means any of the following events: (a) any Person or two or more Persons acting in concert shall
have acquired beneficial ownership, directly or indirectly, of, or shall have acquired by contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation, will result in its or their acquisition of or control
over, voting Stock of any Borrower (or other securities convertible into such voting Stock) representing more than 50% of the combined voting power of all voting Stock of any Borrower or (b) any Borrower ceases to own, directly or indirectly,
100% of the Stock of any of its Subsidiaries (with the exception of any Subsidiaries permitted to be dissolved or merged to the extent otherwise permitted by this Agreement and other than, solely with respect to Foreign Subsidiaries, directors
qualifying shares as necessary to comply with foreign law); or (c) the occurrence of a “Change of Control”, “Change in Control”, “Fundamental Change” or terms of similar import under the 2.25% Convertible Note
Documents, the 3.25% Convertible Note Documents or the Term Debt Documents. As used herein, “beneficial ownership” shall have the meaning provided in Rule 13d-3 of the SEC under the Exchange Act.

 “Closing Checklist” means the closing checklist attached hereto as Exhibit A. 

“Closing Date” means the date of this Agreement. 

“CMS” means the federal Centers for Medicare and Medicaid Services (formerly the federal Health Care Financing
Administration), and any successor Governmental Authority. 
 “Code” means the Internal Revenue Code of 1986, as amended,
and any Treasury Regulations promulgated thereunder from time to time. 

  
 5 

 “Collateral” means all property, now existing or hereafter acquired, mortgaged
or pledged to, or purported to be subjected to a Lien in favor of, Agent, for the benefit of Agent and Lenders, pursuant to this Agreement and the Security Documents, including all of the property described in Schedule 9.1 hereto. 

“Commitment Annex” means Annex A to this Agreement. 

“Common Stock” means the “Common Stock” of the Borrower, with a $0.001 par value per share. 

“Compliance Certificate” means a certificate, duly executed by a Responsible Officer of Borrower Representative,
appropriately completed and substantially in the form of Exhibit B hereto. 
 “Consolidated Subsidiary” means, at
any date, any Subsidiary the accounts of which would be consolidated with those of “parent” Borrower (or any other Person, as the context may require hereunder) in its consolidated financial statements if such statements were prepared as
of such date. 
 “Contingent Obligation” means, with respect to any Person, any direct or indirect liability of such
Person: (a) with respect to any Debt of another Person (a “Third Party Obligation”) if the purpose or intent of such Person incurring such liability, or the effect thereof, is to provide assurance to the obligee of such Third
Party Obligation that such Third Party Obligation will be paid or discharged, or that any agreement relating thereto will be complied with, or that any holder of such Third Party Obligation will be protected, in whole or in part, against loss with
respect thereto; (b) with respect to any undrawn portion of any letter of credit issued for the account of such Person or as to which such Person is otherwise liable for the reimbursement of any drawing; (c) under any Swap Contract, to the
extent not yet due and payable; (d) to make take-or-pay or similar payments if required regardless of nonperformance by any other party or parties to an agreement;
or (e) for any obligations of another Person pursuant to any Guarantee or pursuant to any agreement to purchase, repurchase or otherwise acquire any obligation or any property constituting security therefor, to provide funds for the payment or
discharge of such obligation or to preserve the solvency, financial condition or level of income of another Person. The amount of any Contingent Obligation shall be equal to the amount of the obligation so Guaranteed or otherwise supported or, if
not a fixed and determinable amount, the maximum amount so Guaranteed or otherwise supported. 
 “Controlled Group” means
all members of any group of corporations and all members of a group of trades or businesses (whether or not incorporated) under common control which, together with any Borrower, are treated as a single employer under Section 414(b), (c), (m) or
(o) of the Code or Section 4001(b) of ERISA. 
 “Convertible Note Documents” means, collectively, the 2.25%
Convertible Note Documents and the 3.25% Convertible Note Documents (which, for the avoidance of doubt, shall include the indenture and each other document or agreement from time to time entered into in connection with any Permitted 3.25%
Convertible Note Refinancing, in each case, to the extent such indenture, documents or agreements are permitted pursuant to the terms of the definition of “Permitted 3.25% Convertible Note Refinancing).” 

“Correction” means repair, modification, adjustment, relabeling, destruction or inspection (including patient monitoring) of
a product without its physical removal to some other location. 
 “Cortland” means Cortland Capital Market Services LLC, a
Delaware limited liability company, and its Affiliates. 
 “Credit Exposure” means, at any time, any portion of the
Revolving Loan Commitment and of any other Obligations that remains outstanding; provided, however, that no Credit Exposure shall be deemed to exist solely due to the existence of contingent indemnification liability, absent the assertion of
a claim, or the known existence of a claim reasonably likely to be asserted, with respect thereto. 

  
 6 

 “Credit Party” means any Guarantor under a Guarantee of the Obligations or any
part thereof, any Borrower and any other Person (other than Agent, a Lender or a participant of a Lender), whether now existing or hereafter acquired or formed, that becomes obligated as a borrower, guarantor, surety, indemnitor, pledgor, assignor
or other obligor under any Financing Document. 
 “DEA” means the Drug Enforcement Administration of the United States of
America, any comparable state or local Governmental Authority, any comparable Governmental Authority in any non-United States jurisdiction, and any successor agency of any of the foregoing. 

“Debt” of a Person means at any date, without duplication, (a) all obligations of such Person for borrowed money,
(b) all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments, (c) all obligations of such Person to pay the deferred purchase price of property or services, except trade accounts payable arising and
paid within 120 days of when due and other than those items covered by clause (h) of this definition, (d) all capital leases of such Person, (e) all non-contingent obligations of such Person to
reimburse any bank or other Person in respect of amounts paid under a letter of credit, banker’s acceptance or similar instrument, (f) all equity securities of such Person subject to repurchase or redemption other than at the sole option
of such Person, (g) all obligations secured by a Lien on any asset of such Person, whether or not such obligation is otherwise an obligation of such Person, (h) “earnouts”, purchase price adjustments, profit sharing arrangements,
deferred purchase money amounts and similar payment obligations or continuing obligations of any nature of such Person arising out of purchase and sale contracts, but only to the extent the same (x) have become due and payable and are recorded
as a liability on the balance sheet of Borrower and (y) are payable in cash, (i) all Debt of others Guaranteed by such Person, (j) off-balance sheet liabilities of such Person, and
(k) obligations arising under non-compete agreements, bonus, deferred compensation, incentive compensation or similar arrangements, other than those arising in the Ordinary Course of Business. Without
duplication of any of the foregoing, Debt of Borrowers shall include any and all Loans. 
 “Deerfield Revolver” means
Deerfield ELGX Revolver, LLC and its successors and assigns. 
 “Default” means any condition or event which with the
giving of notice or lapse of time or both would, unless cured or waived, become an Event of Default. 
 “Defined Period”
has the meaning set forth in Section 6.1. 
 “Deposit Account” means a “deposit account” (as defined in
Article 9 of the UCC), an investment account, or other account in which funds are held or invested for credit to or for the benefit of any Borrower. 

“Deposit Account Control Agreement” means an agreement, in form and substance satisfactory to Agent, among Agent, any
Borrower and each financial institution in which such Borrower maintains a Deposit Account, which agreement provides that (a) such financial institution shall comply with instructions originated by Agent directing disposition of the funds in
such Deposit Account without further consent by the applicable Borrower, and (b) containing such other terms and conditions as Agent may require, including as to any such agreement pertaining to any Lockbox Account, providing that such
financial institution shall wire, or otherwise transfer, in immediately available funds, on a daily basis to the Payment Account (or, prior to the time of the initial borrowing of the Revolving Loans, such Deposit Account of Borrower, as Agent may
direct in its sole discretion) all funds received or deposited into such Lockbox or Lockbox Account. 

  
 7 

 “Disqualified Stock” means any Stock which, by its terms (or by the terms of any
security or other Stock into which it is convertible or for which it is exchangeable), or upon the happening of any event or condition, (a) matures or is mandatorily redeemable (other than solely for Stock that does not constitute Disqualified
Stock), pursuant to a sinking fund obligation or otherwise, or is redeemable (in each case, other than solely for Stock that does not constitute Disqualified Stock) at the option of the holder thereof, in whole or in part, on or prior to the date
that is ninety-one (91) days following the Maturity Date (excluding any provisions requiring redemption upon a “change in control” or similar event, provided that such “change in
control” or similar event results in the occurrence of the payment in full of the Obligations (other than unasserted contingent indemnification obligations)), (b) is convertible into or exchangeable for (i) debt securities or (ii) any
Stock referred to in (a) above, in each case, at any time on or prior to the date that is ninety-one (91) days following the Maturity Date at the time such Stock was issued, or (c) is
entitled to receive scheduled dividends or distributions in cash prior to the date that is ninety-one (91) days following the Maturity Date. 

“Distribution” means as to any Person (a) any dividend or other distribution (whether in cash, securities or other
property) on any equity interest in such Person (except those payable solely in its equity interests of the same class) or (b) any payment by such Person on account of (i) the purchase, redemption, retirement, defeasance, surrender,
cancellation, termination or acquisition of any equity interests in such Person or any claim respecting the purchase or sale of any equity interest in such Person, or (ii) any option, warrant or other right to acquire any equity interests in
such Person. For the avoidance of doubt, the entry into, any payments or deliveries in respect of, and the performance, exercise and/or settlement of Endologix’s 2.25% Convertible Notes, 3.25% Convertible Notes (including, for the avoidance of
doubt, any Permitted 3.25% Convertible Note Refinancing), Capped Calls, Warrants or under the Term Credit Agreement are not Distributions. 

“Dollars” or “$” means the lawful currency of the United States of America. 

“Drug Application” means a new drug application, an abbreviated drug application, or a product license application for any
Product, as appropriate, as those terms are defined in the FDCA. 
 “EDGAR” means the SEC’s Electronic Data Gathering,
Analysis, and Retrieval system, including any successor thereto. 
 “Eligible Accounts” means, collectively, the Eligible
Domestic Accounts and Eligible Foreign Accounts. 
 “Eligible Domestic Account” means, subject to the criteria below, an
account receivable of a Borrower, which was generated in the Ordinary Course of Business, which was generated originally in the name of a Borrower and not acquired via assignment or otherwise. The net amount of an Eligible Domestic Account at any
time shall be (a) the face amount of such Eligible Domestic Account as originally billed minus all cash collections and other proceeds of such Account received from or on behalf of the Account Debtor thereunder as of such date and any
and all returns, rebates, discounts (which may, at Agent’s option, be calculated on shortest terms), credits, allowances or excise taxes of any nature at any time issued, owing, claimed by Account Debtors, granted, outstanding or payable in
connection with such Accounts at such time, and (b) adjusted by applying percentages (known as “liquidity factors”) by payor and/or payor class based upon the applicable Borrower’s actual recent collection history for each
such payor and/or payor class in a manner consistent with Agent’s (including, during any Third Party Agent Retention Period, the Third Party Agent’s) underwriting practices and procedures. Such liquidity factors may be adjusted by Agent
from time to time as warranted by Agent’s underwriting practices and procedures and using Agent’s (including, during any Third Party Agent Retention Period, the Third Party Agent’s) reasonable good faith credit judgment. Without
limiting the generality of the foregoing, no Account shall be an Eligible Domestic Account if: 

  
 8 

 (a) the Account remains unpaid more than ninety (90) days past the claim or invoice date
(but in no event more than one hundred and twenty (120) days after the applicable goods or services have been rendered or delivered); 

(b) the Account is subject to any defense, set-off, recoupment, counterclaim, deduction, discount,
credit, chargeback, freight claim, allowance, or adjustment of any kind (but only to the extent of such defense, set-off, recoupment, counterclaim, deduction, discount, credit, chargeback, freight claim,
allowance, or adjustment), or the applicable Borrower is not able to bring suit or otherwise enforce its remedies against the Account Debtor through judicial process; 

(c) if the Account arises from the sale of goods, any part of any goods the sale of which has given rise to the Account has been returned,
rejected, lost, or damaged (but only to the extent that such goods have been so returned, rejected, lost or damaged); 
 (d) if the Account
arises from the sale of goods, the sale was not an absolute, bona fide sale, or the sale was made on consignment or on approval or on a sale-or-return or bill-and-hold or progress billing basis, or the sale was made subject to any other repurchase or return agreement, or the goods have not been shipped to the Account Debtor or
its designee or the sale was not made in compliance with applicable Laws; 
 (e) if the Account arises from the performance of services, the
services have not actually been performed or the services were undertaken in violation of any law or the Account represents a progress billing for which services have not been fully and completely rendered; 

(f) the Account is subject to a Lien (other than Liens in favor of Agent or Permitted Liens), or Agent does not have a first priority,
perfected Lien on such Account (subject only to the permitted priority of the Permitted Priority Liens); 
 (g) the Account is evidenced by
Chattel Paper or an Instrument (other than checks and other ordinary course payment instruments) of any kind, or has been reduced to judgment, unless such Chattel Paper or Instrument has been delivered to Agent; 

(h) the Account Debtor is an Affiliate or Subsidiary of a Credit Party, or if the Account Debtor holds any Debt of a Credit Party; 

(i) more than fifty percent (50%) of the aggregate balance of all Accounts owing from the Account Debtor obligated on the Account are
ineligible under subclause (a) above (in which case all Accounts from such Account Debtor shall be ineligible); 
 (j) without limiting
the provisions of clause (i) above, fifty percent (50%) or more of the aggregate unpaid Accounts from the Account Debtor obligated on the Account are not deemed Eligible Domestic Accounts under this Agreement for any reason; 

(k) the total unpaid Accounts of the Account Debtor obligated on the Account exceed twenty percent (20%) of the net amount of all Eligible
Domestic Accounts owing from all Account Debtors (but only the amount of the Accounts of such Account Debtor exceeding such twenty percent (20%) limitation shall be considered ineligible); 

  
 9 

 (l) any covenant, representation or warranty contained in the Financing Documents with respect to
such Account has been breached in any material respect; 
 (m) the Account is unbilled or has not been invoiced to the Account Debtor in
accordance with the procedures and requirements of the applicable Account Debtor; 
 (n) the Account is an obligation of an Account Debtor
that is the federal, state or local government or any political subdivision thereof, unless Agent has agreed to the contrary in writing and Agent has received from the Account Debtor the acknowledgement of Agent’s notice of assignment of such
obligation pursuant to this Agreement; 
 (o) the Account is an obligation of an Account Debtor that has suspended business, made a general
assignment for the benefit of creditors, is unable to pay its debts as they become due or as to which a petition has been filed (voluntary or involuntary) under any law relating to bankruptcy, insolvency, reorganization or relief of debtors, or the
Account is an Account as to which any facts, events or occurrences exist which could reasonably be expected to impair the validity, enforceability or collectability of such Account or reduce the amount payable or delay payment thereunder; 

(p) the Account Debtor has its principal place of business or executive office outside the United States; 

(q) the Account is payable in a currency other than United States dollars; 

(r) the Account Debtor is an individual; 

(s) after the Initial Third Party Agent Commencement Date and thereafter so long Section 2.11 is applicable at such time, (i) with
respect to any new or non-continuous Account Debtors, the Borrower owning such Account has not (A) delivered (1) written notice to any such new or
non-continuous Account Debtors directing such new or non-continuous Account Debtors to make payment to the applicable Lockbox Account and (2) to the extent
requested by Agent (or, as applicable, the Third Party Agent), written evidence to Agent (or, as applicable, the Third Party Agent) of such written notice delivered pursuant to clause (i)(A)(1) above, and (B) to the extent requested by
Agent (or, as applicable, the Third Party Agent), signed and delivered to Agent (or, as applicable, the Third Party Agent) notices, in the form requested by Agent (or, as applicable, the Third Party Agent), directing any such new or non-continuous Account Debtors to make payment to the applicable Lockbox Account, and (ii) with respect to any other Account Debtors, upon notice that the current Lockbox Account at such time is not (or is no
longer) acceptable to Agent (or, as applicable, the Third Party Agent), the Borrower owning such Account has not (A) delivered (1) written notice to any such Account Debtors directing such Account Debtors to make payment to a new
Lockbox Account acceptable to Agent (or, as applicable, the Third Party Agent) and (2) to the extent request by Agent (or, as applicable, the Third Party Agent), written evidence to Agent (or, as applicable, the Third Party Agent) of such
written notice delivered pursuant to clause (ii)(A)(1) above, and (B) to the extent requested by Agent (or, as applicable, the Third Party Agent), signed and delivered to Agent (or, as applicable, the Third Party Agent) notices, in the
form requested by Agent (or, as applicable, the Third Party Agent), directing such Account Debtors to make payment to a new Lockbox Account acceptable to Agent (or, as applicable, the Third Party Agent); 

(t) the Account includes late charges or finance charges (but only such portion of the Account shall be ineligible); 

(u) the Account arises out of the sale of any Inventory upon which any other Person holds, claims or asserts a Lien (other than a Permitted
Lien); or 

  
 10 

 (v) the Account or Account Debtor fails to meet such other specifications and requirements which
may from time to time be established by Agent in its reasonable good faith credit judgment and reasonable good faith discretion. 

“Eligible Equipment” means, subject to the criteria below, all Equipment that is: (a) owned by a Borrower free and clear
of all Liens other than Liens in favor of Agent securing the Obligations, (b) installed in a facility (i) owned by a Borrower or (ii) leased by a Credit Party and subject to a landlord’s agreement in favor of Agent that is in
form and substance reasonably satisfactory to Agent, (c) in good operating condition (ordinary wear and tear excepted), and (d) not obsolete or surplus Equipment. In addition, Agent reserves the right, at any time and from time to time
after the Closing Date (including on the basis of any appraisal conducted after the Closing Date), to adjust any of the applicable criteria, to establish new criteria and to adjust advance rates with respect to Eligible Equipment in its reasonable
and good faith credit judgment and discretion, subject to the approval of Required Lenders in the case of adjustments or new criteria or changes in advance rates which have the effect of making more credit available. 

“Eligible Foreign Accounts” means, subject to the criteria below, an Account of any Borrower which (i) was generated in
the Ordinary Course of Business, (ii) was generated originally in the name of such Borrower and not acquired via assignment or otherwise, and (iii) is not a Eligible Domestic Account. Accounts denominated in foreign currencies shall be
converted to US Dollars upon delivery by Borrowers of the current Borrowing Base Certificate in accordance with this Agreement at the then-current rate used by Agent (including, during any Third Party Agent Retention Period, the Third Party Agent)
in accordance with its standard policies. The net amount of an Eligible Foreign Account at any time shall be (a) the face amount of such Account as originally billed minus all cash collections and other proceeds of such Account received
from or on behalf of the Account Debtor thereunder as of such date and any and all returns, rebates, discounts (which may, at Agent’s option, be calculated on shortest terms), credits, allowances or excise taxes of any nature at any time
issued, owing, claimed by Account Debtors, granted, outstanding or payable in connection with such Accounts at such time, and (b) adjusted by applying percentages (known as “Foreign Account liquidity factors”) by payor and/or
payor class based upon the applicable Borrower’s actual recent collection history for each such payor and/or payor class in a manner consistent with Agent’s (including, during any Third Party Agent Retention Period, the Third Party
Agent’s) underwriting practices and procedures. Such Foreign Account liquidity factors may be adjusted by Agent from time to time as warranted by Agent’s (including, during any Third Party Agent Retention Period, the Third Party
Agent’s) underwriting practices and procedures and using Agent’s (including, during any Third Party Agent Retention Period, the Third Party Agent’s) reasonable good faith credit judgment. Without limiting the generality of the
foregoing, no Account shall be an Eligible Foreign Account if: 
 (a) the Account remains unpaid more than ninety (90) days past the
claim or invoice date (but in no event more than one hundred twenty (120) days after the applicable goods or services have been rendered or delivered); 

(b) the Account is subject to any defense, set-off, recoupment, counterclaim, deduction, discount,
credit, chargeback, freight claim, allowance, or adjustment of any kind (but only to the extent of such defense, set-off, recoupment, counterclaim, deduction, discount, credit, chargeback, freight claim,
allowance, or adjustment), or the applicable Borrower is not able to bring suit or otherwise enforce its remedies against the Account Debtor through judicial process; 

(c) if the Account arises from the sale of goods, any part of any goods the sale of which has given rise to the Account has been returned,
rejected, lost, or damaged (but only to the extent that such goods have been so returned, rejected, lost or damaged); 

  
 11 

 (d) if the Account arises from the sale of goods, the sale was not an absolute, bona fide sale,
or the sale was made on consignment or on approval or on a sale-or-return or
bill-and-hold or progress billing basis, or the sale was made subject to any other repurchase or return agreement, or the goods have not been shipped to the Account
Debtor or its designee or the sale was not made in compliance with applicable Laws; 
 (e) if the Account arises from the performance of
services, the services have not actually been performed or the services were undertaken in violation of any Law or the Account represents a progress billing for which services have not been fully and completely rendered; 

(f) the Account is subject to a Lien (other than Liens in favor of the Agent or Permitted Liens), or Agent does not have a first priority,
perfected Lien on such Account; 
 (g) the Account is evidenced by Chattel Paper or an Instrument (other than checks and other ordinary
course payment instruments) of any kind, or has been reduced to judgment, unless such Chattel Paper or Instrument has been delivered to Agent; 

(h) the Account Debtor is an Affiliate or Subsidiary of a Credit Party, or if the Account Debtor holds any Debt of a Credit Party; 

(i) more than fifty percent (50%) of the aggregate balance of all Accounts owing from the Account Debtor obligated on the Account are
ineligible under subclause (a) above (in which case all Accounts from such Account Debtor shall be ineligible); 
 (j) without limiting
the provisions of clause (i) above, fifty percent (50%) or more of the aggregate unpaid Accounts from the Account Debtor obligated on the Account are not deemed Eligible Foreign Accounts under this Agreement for any reason; 

(k) the total unpaid Accounts of the Account Debtor obligated on the Account exceed twenty percent (20%) of the net amount of all Eligible
Foreign Accounts owing from all Account Debtors (but only the amount of the Accounts of such Account Debtor exceeding such twenty percent (20%) limitation shall be considered ineligible); 

(l) any covenant, representation or warranty contained in the Financing Documents with respect to such Account has been breached in any
material respect; 
 (m) the Account is unbilled or has not been invoiced to the Account Debtor in accordance with the procedures and
requirements of the applicable Account Debtor; 
 (n) the Account is an obligation of an Account Debtor that is the federal, state, or local
government or any political subdivision thereof, unless Agent has agreed to the contrary in writing and Agent has received from the Account Debtor the acknowledgement of Agent’s notice of assignment of such obligation pursuant to this
Agreement; 
 (o) the Account is an obligation of an Account Debtor that has suspended business, made a general assignment for the benefit of
creditors, is unable to pay its debts as they become due or as to which a petition has been filed (voluntary or involuntary) under any law relating to bankruptcy, insolvency, reorganization or relief of debtors, or the Account is an Account as to
which any facts, events or occurrences exist which could reasonably be expected to impair the validity, enforceability or collectability of such Account or reduce the amount payable or delay payment thereunder; 

  
 12 

 (p) [reserved]; 

(q) the Account Debtor is an individual; 

(r) after the Initial Third Party Agent Commencement Date and thereafter so long Section 2.11 is applicable at such time, (i) with
respect to any new or non-continuous Account Debtors, the Borrower owning such Account has not (A) delivered (1) written notice to any such new or
non-continuous Account Debtors directing such new or non-continuous Account Debtors to make payment to the applicable Lockbox Account and (2) to the extent
requested by Agent (or, as applicable, the Third Party Agent), written evidence to Agent (or, as applicable, the Third Party Agent) of such written notice delivered pursuant to clause (i)(A)(1) above, and (B) to the extent requested by
Agent (or, as applicable, the Third Party Agent), signed and delivered to Agent (or, as applicable, the Third Party Agent) notices, in the form requested by Agent (or, as applicable, the Third Party Agent), directing any such new or non-continuous Account Debtors to make payment to the applicable Lockbox Account, and (ii) with respect to any other Account Debtors, upon notice that the current Lockbox Account at such time is not (or is no
longer) acceptable to Agent (or, as applicable, the Third Party Agent), the Borrower owning such Account has not (A) delivered (1) written notice to any such Account Debtors directing such Account Debtors to make payment to a new
Lockbox Account acceptable to Agent (or, as applicable, the Third Party Agent) and (2) to the extent request by Agent (or, as applicable, the Third Party Agent), written evidence to Agent (or, as applicable, the Third Party Agent) of such
written notice delivered pursuant to clause (ii)(A)(1) above, and (B) to the extent requested by Agent (or, as applicable, the Third Party Agent), signed and delivered to Agent (or, as applicable, the Third Party Agent) notices, in the
form requested by Agent (or, as applicable, the Third Party Agent), directing such Account Debtors to make payment to a new Lockbox Account acceptable to Agent (or, as applicable, the Third Party Agent); 

(s) the Account includes late charges or finance charges (but only such portion of the Account shall be ineligible); 

(t) the Account arises out of the sale of any Inventory upon which any other Person holds, claims or asserts a Lien (other than Permitted
Liens); or 
 (u) the Account or Account Debtor fails to meet such other specifications and requirements which may from time to time be
established by Agent in its reasonable good faith credit judgment and reasonable good faith discretion. 
 “Eligible
Inventory” means Inventory owned by a Borrower and acquired and dispensed by such Borrower in the Ordinary Course of Business that Agent, in its good faith credit judgment and discretion, deems to be Eligible Inventory. Without limiting the
generality of the foregoing, no Inventory shall be Eligible Inventory if: 
 (a) such Inventory is not owned by a Borrower free and clear of
all Liens and rights of any other Person (other than Agent and other than Permitted Liens) (including the rights of a purchaser that has made progress payments and the rights of a surety that has issued a bond to assure such Borrower’s
performance with respect to that Inventory); 
 (b) such Inventory is covered by a negotiable document of title, unless such document has
been delivered to Agent with all necessary endorsements, free and clear of all Liens except those in favor of Agent; 

  
 13 

 (c) such Inventory is excess, obsolete, unsalable, shopworn, seconds, damaged, unfit for sale,
unfit for further processing, is of substandard quality or is not of good and merchantable quality, free from any defects; 
 (d) such
Inventory consists of marketing materials, display items or packing or shipping materials, manufacturing supplies or Work-In-Process; 

(e) such Inventory is not subject to a first priority Lien in favor of Agent (subject only to the permitted priority of Permitted Priority
Liens); 
 (f) such Inventory consists of goods that can be transported or sold only with licenses that are not readily available or of any
substances defined or designated as hazardous or toxic waste, hazardous or toxic material, hazardous or toxic substance, or similar term, by any environmental law or any Governmental Authority applicable to Borrowers or their business, operations or
assets; 
 (g) such Inventory is not covered by casualty insurance reasonably acceptable to Agent; 

(h) any covenant, representation or warranty contained in the Financing Documents with respect to such Inventory has been breached in any
material respect; 
 (i) such Inventory is located outside of the continental United States; 

(j) after the date that is sixty (60) days following the Closing Date, such Inventory is located on premises with respect to which Agent
has not received a landlord, warehouseman, bailee or mortgagee letter reasonably acceptable in form and substance to Agent; 
 (k) such
Inventory consists of (A) discontinued items, or (B) used items held for resale; 
 (l) such Inventory does not consist of finished
goods; 
 (m) such Inventory does not meet all standards imposed by any Governmental Authority in all material respects, including with
respect to its production, acquisition or importation (as the case may be); 
 (n) such Inventory has an expiration date within the next
three (3) months; 
 (o) such Inventory is held for rental or lease by or on behalf of Borrowers; 

(p) such Inventory is subject to any licensing, patent, royalty, trademark, trade name or copyright agreement with any third parties, which
agreement restricts the ability of Agent or any Lender to sell or otherwise dispose of such Inventory; or 
 (q) such Inventory fails to meet
such other specifications and requirements which may from time to time be established by Agent in its good faith credit judgment. Notwithstanding the foregoing, the valuation of Inventory shall be subject to any legal limitations on sale and
transfer of such Inventory. 
 “Endologix” has the meaning set forth in the introductory paragraph hereto. 

  
 14 

 “Environmental Laws” means any present and future federal, state and local laws,
statutes, ordinances, rules, regulations, standards, policies and other governmental directives or requirements, as well as common law, pertaining to the environment, natural resources, pollution, health (including any environmental clean-up statutes and all regulations adopted by any local, state, federal or other Governmental Authority, and any statute, ordinance, code, order, decree, law rule or regulation all of which pertain to or impose
liability or standards of conduct concerning medical waste or medical products, equipment or supplies), safety or clean-up that apply to any Borrower and relate to Hazardous Materials, including the
Comprehensive Environmental Response, Compensation and Liability Act of 1980 (42 U.S.C. § 9601 et seq.), the Resource Conservation and Recovery Act of 1976 (42 U.S.C. § 6901 et seq.), the Federal Water Pollution Control Act
(33 U.S.C. § 1251 et seq.), the Hazardous Materials Transportation Act (49 U.S.C. § 5101 et seq.), the Clean Air Act (42 U.S.C. § 7401 et seq.), the Federal Insecticide, Fungicide and Rodenticide Act (7 U.S.C.
§ 136 et seq.), the Emergency Planning and Community Right-to-Know Act (42 U.S.C. § 11001 et seq.), the Occupational Safety and Health Act (29
U.S.C. § 651 et seq.), the Residential Lead-Based Paint Hazard Reduction Act (42 U.S.C. § 4851 et seq.), any analogous state or local laws, any amendments thereto, and the regulations promulgated pursuant to said laws,
together with all amendments from time to time to any of the foregoing and judicial interpretations thereof. 
 “Equipment”
means all “equipment,” as such term is defined in the UCC, now owned or hereafter acquired by any Credit Party, wherever located. 

“ERISA” means the Employee Retirement Income Security Act of 1974, as the same may be amended, modified or supplemented from
time to time, and any successor statute thereto, and any and all rules or regulations promulgated from time to time thereunder. 

“ERISA Plan” means any “employee benefit plan”, as such term is defined in Section 3(3) of ERISA (other than a
Multiemployer Plan), which any Borrower maintains, sponsors or contributes to, or, in the case of an employee benefit plan which is subject to Section 412 of the Code or Title IV of ERISA, to which any Borrower or any member of the Controlled
Group may have any liability, including any liability by reason of having been a substantial employer within the meaning of Section 4063 of ERISA at any time during the preceding five (5) years, or by reason of being deemed to be a
contributing sponsor under Section 4069 of ERISA. 
 “Exchange Act” means the Securities Exchange Act of 1934, as
amended, including the rules and regulations promulgated thereunder. 
 “Excluded Accounts” has the meaning set forth in
Section 5.14. 
 “Excluded Domestic Holdco” means a wholly-owned Subsidiary of Borrower substantially all the assets
of which consist of Stock in Foreign Subsidiaries held directly or indirectly by such Subsidiary and who does not engage in any business, operations or activity other than that of a holding company 

“Excluded Property” means, collectively: 

(a) voting shares of any (A) Foreign Subsidiary of Borrower or (B) Excluded Domestic Holdco, in each case, in excess of 65% of all of
the issued and outstanding voting shares of capital stock of such subsidiary; 
 (b) any lease, license, contract, property right or
agreement as to which, if and to the extent that, and only for so long as the grant of a security interest therein shall (1) constitute or result in a breach, termination or default under any such lease, license, contract, property right or
agreement or render it unenforceable, (2) be prohibited by any applicable law or (3) require the consent of any third party (in 

  
 15 

 
each case of clauses (1), (2) and (3), other than to the extent that any such breach, termination, default, prohibition or requirement for consent would be rendered ineffective pursuant to
Sections 9-406, 9-407, 9-408 or 9-409 of the UCC of any relevant jurisdiction or any
other applicable Law); provided that such security interest shall attach immediately to each portion of such lease, license, contract, property rights or agreement that does not result in any of the consequences specified above; 

(c) any “intent to use” trademark applications for which a statement of use has not been filed (but only until such statement is
filed); 
 (d) motor vehicles and other assets, in each instance, in which perfection of a security requires notation on certificates of
title with a value, individually, of less than $250,000; 
 (e) without in any way limiting clause (a) above, equity interests in any
Person (other than wholly owned Subsidiaries) to the extent not permitted by the terms of such Person’s organizational or joint venture documents (so long as such joint venture was not entered into (or such Subsidiary was not formed) in
contravention of the terms of the Financing Documents and such prohibition did not arise in anticipation of the restrictions under the Financing Documents); 

(f) any assets financed by purchase money Debt or capital leases, to the extent such purchase money Debt or capital lease is permitted
hereunder, if the documentation governing such purchase money Debt or capital leases securing such Debt or capital leases prohibits the creation of a security interest or lien thereon or requires the consent of any person or entity as a condition to
the creation of any other security interest or lien on such property or if such contract or other agreement would be breached or give any party the right to terminate it as a result of creation of such security interest or lien; 

(g) those assets as to which Agent determines (in its sole discretion) that the cost of obtaining such a security interest or perfection
thereof are excessive in relation to the benefit to Agent and the Lenders of the security to be afforded thereby; and 
 (h) the Bank of
America Cash Collateral Account; 
 provided, however, notwithstanding anything to the contrary herein or under the other Financing
Documents, “Excluded Property” shall not include (a) any proceeds, products, substitutions, receivables or replacements of Excluded Property (unless such proceeds, products, substitutions, receivables or replacements
would otherwise constitute Excluded Property) or (b) any assets or property provided as security or collateral for the Term Debt or for which a Lien has been granted in favor of Term Agent, any Term Lender or any other Person party to the Term
Debt Documents. 
 “Existing ABL Agent” has the meaning assigned to such term in the definition of “Existing ABL
Credit Facility” herein. 
 “Existing ABL Credit Facility” means that certain Credit and Security Agreement, dated as
of July 29, 2016, by and among the Borrower, the other Persons party thereto from time to time as “Borrowers” (as defined therein), Midcap Financial Trust, a Delaware statutory trust, as Agent (as defined therein, in such capacity,
the “Existing ABL Agent”) and the financial institutions or other entities from time to time parties thereto, each as a Lender (as defined therein) (in such capacity, the “Existing ABL Lenders”), as amended,
restated, supplemented or otherwise modified prior to the Closing Date. 
 “Existing ABL Debt Documents” shall have the
meaning of “Financing Documents” (as defined in the Existing ABL Credit Facility). 

  
 16 

 “Existing ABL Lenders” has the meaning assigned to such term in the definition
of “Existing ABL Credit Facility” herein. 
 “Event of Default” has the meaning set forth in Section 10.1.

 “FATCA” means Sections 1471 through 1474 of the Code and any current or future regulations thereunder or official
interpretations thereof. 
 “FDA” means the Food and Drug Administration of the United States of America, any comparable
state or local Governmental Authority, any comparable Governmental Authority in any non-United States jurisdiction, and any successor agency of any of the foregoing. 

“FDCA” means the Federal Food, Drug and Cosmetic Act, as amended, 21 U.S.C. Section 301 et seq., and all regulations
promulgated thereunder. 
 “Filing of MNPI Option” has the meaning specified in Section 4.19. 

“Financing Documents” means this Agreement, any Notes, the Security Documents, the Intercreditor Agreement, the Perfection
Certificate, any patent security agreement, any trademark security agreement, any copyright security agreement, each subordination or intercreditor agreement pursuant to which any Debt and/or any Liens securing such Debt is subordinated to all or
any portion of the Obligations and all other documents, instruments and agreements related to the Obligations and heretofore executed, executed concurrently herewith or executed at any time and from time to time hereafter, as any or all of the same
may be amended, supplemented, restated or otherwise modified from time to time. For the avoidance of doubt, the Financing Documents shall not include any Warrants, the Registration Rights Agreement, any Stock or any Term Debt Documents (other than
the Intercreditor Agreement). 
 “Foreign Subsidiary” means any Subsidiary of Borrower that is not organized under the laws
of the United States of America, any state thereof or the District of Columbia. 
 “GAAP” means generally accepted
accounting principles set forth from time to time in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting
Standards Board (or agencies with similar functions of comparable stature and authority within the United States accounting profession), which are applicable to the circumstances as of the date of determination. 

“General Intangible” means any “general intangible” as defined in Article 9 of the UCC, and any personal property,
including things in action, other than accounts, chattel paper, commercial tort claims, deposit accounts, documents, goods, instruments, investment property,
letter-of-credit rights, letters of credit, money, and oil, gas or other minerals before extraction, but including payment intangibles and software. 

“Good Manufacturing Practices” means current good manufacturing practices, as set forth in 21 C.F.R. Parts 210 and 211. 

“Governmental Authority” means any nation or government, any state, local or other political subdivision thereof, and any
agency, department or Person exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government and any corporation or other Person owned or controlled (through stock or capital ownership or otherwise)
by any of the foregoing, whether domestic or foreign. 

  
 17 

 “Guarantee” by any Person means any obligation, contingent or otherwise, of such
Person directly or indirectly guaranteeing any Debt or other obligation of any other Person and, without limiting the generality of the foregoing, any obligation, direct or indirect, contingent or otherwise, of such Person (a) to purchase or
pay (or advance or supply funds for the purchase or payment of) such Debt or other obligation (whether arising by virtue of partnership arrangements, by agreement to keep-well, to purchase assets, goods, securities or services, to take-or-pay, or to maintain financial statement conditions or otherwise), or (b) entered into for the purpose of assuring in any other manner the obligee of such Debt or
other obligation of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part), provided, however, that the term Guarantee shall not include endorsements for collection or deposit in the
Ordinary Course of Business. The term “Guarantee” used as a verb has a corresponding meaning. 

“Guarantor” means any Credit Party that has executed or delivered, or shall in the future execute or deliver, any Guarantee
of any portion of the Obligations. 
 “Hazardous Materials” means petroleum and petroleum products and compounds containing
them, including gasoline, diesel fuel and oil; explosives, flammable materials; radioactive materials; polychlorinated biphenyls and compounds containing them; lead and lead-based paint; asbestos or asbestos-containing materials; underground or
above-ground storage tanks, whether empty or containing any substance; any substance the presence of which is prohibited by any Environmental Laws; toxic mold, any substance that requires special handling; and any other material or substance now or
in the future defined as a “hazardous substance,” “hazardous material,” “hazardous waste,” “toxic substance,” “toxic pollutant,” “contaminant,” “pollutant” or other words of
similar import within the meaning of any Environmental Law, including: (a) any “hazardous substance” defined as such in (or for purposes of) CERCLA, or any so-called “superfund” or
“superlien” Law, including the judicial interpretation thereof; (b) any “pollutant or contaminant” as defined in 42 U.S.C.A. § 9601(33); (c) any material now defined as “hazardous waste” pursuant to 40 C.F.R.
Part 260; (d) any petroleum or petroleum by-products, including crude oil or any fraction thereof; (e) natural gas, natural gas liquids, liquefied natural gas, or synthetic gas usable for fuel;
(f) any “hazardous chemical” as defined pursuant to 29 C.F.R. Part 1910; (g) any toxic or harmful substances, wastes, materials, pollutants or contaminants (including asbestos, polychlorinated biphenyls, flammable explosives,
radioactive materials, infectious substances, materials containing lead-based paint or raw materials which include hazardous constituents); and (h) any other toxic substance or contaminant that is subject to any Environmental Laws or other past
or present requirement of any Governmental Authority. 
 “Healthcare Laws” means all applicable Laws relating to the
procurement, development, provision, clinical and non-clinical evaluation or investigation, product approval or clearance, manufacture, production, analysis, distribution, dispensing, importation, exportation,
use, handling, quality, reimbursement, sale, labeling, advertising, promotion, or postmarket requirements of any drug, medical device, clinical laboratory service, food, dietary supplement, or other product (including any ingredient or component of,
or accessory to, the foregoing products) subject to regulation under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. et seq.), Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. §263a et seq) and its implementing regulations (42
C.F.R. Part 493) and similar state or foreign laws, controlled substances laws, pharmacy laws, consumer product safety laws, Medicare, Medicaid, and all laws, policies, procedures, requirements and regulations pursuant to which Regulatory Required
Permits are issued, in each case, as the same may be amended from time to time. 
 “Immaterial Subsidiaries” means, as of
any date of determination, any Subsidiary of Endologix that is not a Credit Party that, when measured as of the most recent fiscal quarter end or fiscal year end for which Endologix has filed its 10-K or 10-Q, when taken together with all other Immaterial Subsidiaries as of such date, (i) did not have assets with a value in excess of 5.0% of the total property and assets of the Credit Parties and their
Subsidiaries on a consolidated basis set forth in the balance sheet included in such 

  
 18 

 
10-K or 10-Q in accordance with GAAP and on a pro forma basis after giving effect to such Subsidiary as an
Immaterial Subsidiary and (ii) did not have revenues representing in excess of 5.0% of total revenues of the Credit Parties and their Subsidiaries on a consolidated basis in accordance with GAAP and on a pro forma basis after giving effect to
such Subsidiary as an Immaterial Subsidiary. 
 “Initial Third Party Agent Commencement Date” means the first date after
the Closing Date on which any Person satisfies the requirements under clause (a) and clause (b) of the definition of “Third Party Agent” to be a Third Party Agent. 

“Instrument” means “instrument”, as defined in Article 9 of the UCC. 

“Intellectual Property” means all copyright rights, copyright applications, copyright registrations and like protections in
each work of authorship and derivative work, whether published or unpublished, any patents, patent applications and like protections, including improvements, divisions, continuations, renewals, reissues, extensions, and continuations-in-part of the same, trademarks, trade names, service marks, mask works, rights of use of any name, domain names, or any other similar rights, any applications
therefor, whether registered or not, know-how, operating manuals, trade secret rights, clinical and non-clinical data, rights to unpatented inventions, and any claims
for damage by way of any past, present, or future infringement of any of the foregoing. 
 “Intercreditor Agreement” means
the Intercreditor Agreement dated as of the Closing Date by and among Agent and the Term Agent and acknowledged and agreed by the Credit Parties, as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms
thereof. 
 “Interest Period” means , with respect to any Loan, the period commencing on the date of such borrowing and
ending on the numerically corresponding day on the calendar month that is three (3) months thereafter; provided that (a) if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to
the next succeeding Business Day unless such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day, and (b) any Interest Period that commences on the
last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period. For
purposes hereof, the date of a borrowing initially shall be the date on which such borrowing is made and thereafter shall be the effective date of the most recent conversion or continuation of such borrowing. 

“Interest Rate” has the meaning set forth in Section 2.1(b)(iv). 

“Inventory” means “inventory” as defined in Article 9 of the UCC. 

“Investment” means, with respect to any Person, directly or indirectly, (a) to purchase or acquire any stock or stock
equivalents, or any obligations or other securities of, or any interest in, any Person, including the establishment or creation of a Subsidiary, (b) to make or commit to make any acquisition (including through licensing) of (i) of all or
substantially all of the assets of another Person, or (ii) any business, Product, business line or product line, division or other unit operation of any Person or (c) make or purchase any advance, loan, extension of credit or capital
contribution to, or any other investment in, any Person. 
 “Investment Company Act” means the Investment Company Act of
1940, as amended, including the rules and regulations promulgated thereunder. 

  
 19 

 “IP Proceeds” means, collectively, all cash, Accounts, license and royalty fees,
claims, products, awards, judgments, insurance claims, and other revenues, proceeds or income, arising out of, derived from or relating to any Intellectual Property of any Borrower, and any claims for damage by way of any past, present or future
infringement of any Intellectual Property of any Borrower (including all cash, royalty fees, other proceeds, Accounts and General Intangibles that consist of rights of payment to or on behalf of a Borrower and the proceeds from the sale, licensing
or other disposition of all or any part of, or rights in, any Intellectual Property by or on behalf of a Credit Party). 
 “Joinder
Requirements” has the meaning set forth in Section 4.11(d). 
 “Latest Balance Sheet Date” has the meaning set
forth in Section 3.27. 
 “Laws” means any and all federal, state, provincial, territorial, local and foreign
statutes, laws, judicial decisions, regulations, ordinances, rules, judgments, orders, decrees, codes, injunctions, permits, governmental agreements and governmental restrictions, whether now or hereafter in effect, which are applicable to any
Credit Party in any particular circumstance. “Laws” includes Healthcare Laws and Environmental Laws. 
 “L/C Cash
Collateral Accounts” means, collectively, each segregated Deposit Account of Borrower from time to time established and maintained with the issuers of letters of credit for the sole purpose of securing Borrower’s obligations under such
letters of credit to the extent such obligations constitute “Permitted Contingent Obligations” for purposes of clause (i) of the definition of thereof; provided, that (a) no such Deposit Account shall hold an aggregate of
cash and Cash Equivalents in excess of 110% of the aggregate value of the letters of credit it is securing and (b) with respect to all such Deposit Accounts, the aggregate amount deposited there in at any time does not exceed $10,000,000. 

“Lender” means each of (a) Deerfield Revolver, in its capacity as a lender hereunder, (b) each other Person party
hereto in its capacity as a lender hereunder, (c) each other Person that becomes a party hereto as Lender pursuant to Section 11.17, and (d) the respective successors of all of the foregoing, and “Lenders” means all
of the foregoing. 
 “LIBOR Rate” means, for each Loan, a per annum rate of interest equal to the greater of (a) one
percent (1.00%) and (b) the rate determined by Agent (rounded upwards, if necessary, to the next 1/100th%) by dividing (i) the Base LIBOR Rate for the Interest Period, by (ii) the sum of one minus the daily
average during such Interest Period of the aggregate maximum reserve requirement (expressed as a decimal) then imposed under Regulation D of the Board of Governors of the Federal Reserve System (or any successor thereto) for “Eurocurrency
Liabilities” (as defined therein). 
 “Lien” means, with respect to any asset, any mortgage, lien, pledge, charge,
security interest or encumbrance of any kind, in respect of such asset. For the purposes of this Agreement and the other Financing Documents, any Borrower or any Subsidiary shall be deemed to own subject to a Lien any asset which it has acquired or
holds subject to the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement relating to such asset. 

“Litigation” means any action, suit or proceeding before any court, mediator, arbitrator or Governmental Authority. 

“Loan Account” has the meaning set forth in Section 2.6(b). 

“Loan(s)” means the Revolving Loans. 

  
 20 

 “Lockbox” has the meaning set forth in Section 2.11. 

“Lockbox Account” means an account or accounts maintained at the Lockbox Bank into which collections of Accounts are paid,
which account or accounts shall be, if requested by Agent (or, during any Third Party Agent Retention Period, the Third Party Agent), opened in the name of Agent or the Third Party Agent (or a nominee of Agent or the Third Party Agent), as
applicable. 
 “Lockbox Bank” has the meaning set forth in Section 2.11. 

“Lockbox Post-Closing Period” means the period beginning on the Closing Date and ending on the earlier of (a) sixty (60)
days after the Closing Date (or such later date as Agent may agree in writing) and (b) the date on which Borrowers shall have delivered to Agent (or, during a Third Party Agent Retention Period, the Third Party Agent) an executed Deposit
Account Control Agreement and such other agreements related to such Lockbox as Agent (or, during a Third Party Agent Retention Period, the Third Party Agent) may require. 

“Market Withdrawal” means a Person’s Removal or Correction of a distributed product which involves a minor violation
that would not be subject to legal action by the FDA or which involves no violation, e.g., normal stock rotation practices, routine equipment adjustments and repairs, etc. 

“Material Adverse Effect” means with respect to any event, act, condition or occurrence of whatever nature (including any
adverse determination in any litigation, arbitration, or governmental investigation or proceeding), whether singly or in conjunction with any other event or events, act or acts, condition or conditions, occurrence or occurrences, whether or not
related, a material adverse change in, or a material adverse effect upon, any of (a) the financial condition, operations, business or properties of the Credit Parties and their Subsidiaries (taken as a whole), (b) the rights and remedies of
Agent or Lenders under any Financing Document, or the ability of any Credit Party to perform any of its Obligations under any Financing Document to which it is a party or (c) the legality, validity or enforceability of any Financing Document.

 “Material Contracts” means (a) the Operative Documents, (b) the Convertible Note Documents, (c) the
agreements listed on Schedule 3.17, and (d) each other agreement or contract to which such Credit Party or its Subsidiaries is a party the termination of which could reasonably be expected to result in a Material Adverse Effect;
provided that Capped Calls shall not be considered Material Contracts. 
 “Material Intangible Assets” means all of
(i) Borrower’s Intellectual Property and (ii) license or sublicense agreements or other agreements with respect to rights in Intellectual Property, in each case that are material to the financial condition, business or operations of
Borrower. 
 “Material Permits and Rights” has the meaning set forth Section 8.2(b). 

“Maturity Date” means March 31, 2020. 

“Maximum Cumulative Rate” means LIBOR Rate plus 6.95% per annum. 

“Maximum Cumulative Rate Provision” has the meaning set forth in Section 2.1(b)(iv). 

“Maximum Lawful Rate” has the meaning set forth in Section 2.7. 

“Medicaid” means the medical assistance programs administered by state agencies and approved by CMS pursuant to the terms of
Title XIX of the Social Security Act, codified at 42 U.S.C. 1396 et seq. 

  
 21 

 “Medicare” means the program of health benefits for the aged and disabled
administered by CMS pursuant to the terms of Title XVIII of the Social Security Act, codified at 42 U.S.C. 1395 et seq. 
 “Merrill
Lynch Securities Account” means that certain securities account maintained in the name of Endologix at Merrill Lynch identified by account number XXXXX2509 that includes only assets that are cash or Cash Equivalents and which will have a
balance of $0 (and will contain no cash, Cash Equivalents or other assets) on and after September 1, 2017. 
 “Minimum
Balance” means, at any time, an amount that equals the lesser of (x) $10,000,000 and (y) the average Borrowing Base (or, if less on any given day, the Revolving Loan Commitment) during the immediately preceding month. 

“Monthly Cash Burn Amount” means, with respect to Borrower, an amount equal to Borrower’s change in cash and Cash
Equivalents, without giving effect to any increase resulting from contributions or proceeds of financings, for either (a) the immediately preceding eighteen (18) month period as determined as of the last day of the month immediately
preceding the proposed consummation of the Permitted Acquisition and based upon the financial statements delivered to Agent in accordance with this Agreement for such period, not including unusual or
non-recurring expenses or (b) the immediately succeeding eighteen (18) month period based upon the Transaction Projections, not including unusual or
non-recurring expenses, using whichever calculation as between clause (a) and clause (b) demonstrates a higher burn rate (or, in other words, more cash used), in either case, divided by eighteen
(18). 
 “Multiemployer Plan” means a multiemployer plan within the meaning of Section 4001(a)(3) of ERISA to which any
Borrower or any other member of the Controlled Group (or any Person who in the last five years was a member of the Controlled Group) is making or accruing an obligation to make contributions or has within the preceding five plan years (as determined
on the applicable date of determination) made contributions. 
 “Net Book Value of Eligible Equipment” means, at any time,
the then-current book value of all Eligible Equipment (giving effect to any adjustments to such book value on or prior to the date of measurement thereof) less all accumulated depreciation and amortization of such Equipment through the date
of measurement, all as determined in accordance with GAAP. 
 “No MNPI Option” has the meaning specified in
Section 4.19. 
 “Non-Third Party Agent Retention Period” means any period of
time that is not during a Third Party Agent Retention Period. 
 “Notes” has the meaning set forth in Section 2.3.

 “Notice of Borrowing” means a written notice of a Responsible Officer of Borrower Representative, appropriately
completed and substantially in the form of Exhibit D hereto. 
 “Obligations” means all obligations, liabilities and
indebtedness (monetary (including the payment of interest and other amounts arising after the commencement of any case with respect to any Credit Party under the Bankruptcy Code or any similar statute which would accrue and become due but for the
commencement of such case, whether or not such amounts are allowed or allowable in whole or in part in such case) or otherwise) of each Credit Party under this Agreement or any other Financing Document, in each case howsoever created, arising or
evidenced, whether direct or indirect (including those acquired by assignment), absolute or contingent, now or hereafter existing, or due or to become due. 

  
 22 

 “OFAC” means the U.S. Department of Treasury Office of Foreign Assets Control.

 “OFAC Lists” means, collectively, the Specially Designated Nationals and Blocked Persons List maintained by OFAC
pursuant to Executive Order No. 13224, 66 Fed. Reg. 49079 (Sept. 25, 2001) and/or any other list of terrorists or other restricted Persons maintained pursuant to any of the rules and regulations of OFAC or pursuant to any other applicable
Executive Orders. 
 “Operative Documents” means the Financing Documents, the Loan Documents (as defined in the Term Credit
Agreement as of the Closing Date) and the Subordinated Debt Documents. 
 “Ordinary Course of Business” means, in respect
of any transaction involving any Credit Party, the ordinary course of business of such Credit Party, as conducted by such Credit Party in accordance with past practices, as applicable. 

“Organizational Documents” means, with respect to any Credit Party or any other Person other than a natural person, the
documents by which such Person was organized (such as a certificate of incorporation, certificate of limited partnership or articles of organization, and including any certificates of designation for preferred stock or other forms of preferred
equity) and which relate to the internal governance of such Person (such as by-laws, a partnership agreement or an operating, limited liability company or members agreement), including any and all shareholder
agreements or voting agreements relating to the capital stock or other equity interests of such Person. 
 “Participant”
has the meaning set forth in Section 11.17(b). 
 “Participant Register” has the meaning set forth in Section
11.17(a)(iii). 
 “Payment Account” means the account specified on Annex B to this Agreement into
which all payments by or on behalf of each Borrower to Agent (or, during a Third Party Agent Retention Period, the Third Party Agent) under the Financing Documents shall be made, or such other account as Agent (or such Third Party Agent) shall from
time to time specify by notice to Borrower Representative. 
 “PBGC” means the Pension Benefit Guaranty Corporation and any
Person succeeding to any or all of its functions under ERISA. 
 “Pension Plan” means any ERISA Plan that is subject to
Section 412 of the Code or Title IV of ERISA. 
 “Perfection Certificate” means the Perfection Certificate delivered
to Agent and Term Agent as of the Closing Date and delivered thereafter from time to time (a) during any Non-Third Party Agent Retention Period, the Agent, and (b) during any Third Party Agent
Retention Period, the Third Party Agent, in each case, together with any amendments or updates thereto required under this Agreement or any other Financing Document or Term Debt Document. 

“Permit” means all licenses, certificates, accreditations, product clearances or approvals, provider numbers or provider
authorizations, supplier numbers, marketing authorizations, drug or device authorizations and approvals, other authorizations, franchises, qualifications, accreditations, registrations, permits, consents and approvals of a Credit Party issued or
required under Laws applicable to the business of Borrower or any of its Subsidiaries or necessary in the manufacturing, importing, exporting, possession, ownership, warehousing, marketing, promoting, sale, labeling, furnishing, distribution or
delivery of goods or services under Laws applicable to the business of Borrower or any of its Subsidiaries. Without limiting the generality of the foregoing, “Permit” includes any Regulatory Required Permit. 

  
 23 

 “Permitted 3.25% Convertible Note Refinancing” has the meaning provided therefor
in the definition of “Permitted Debt.” 
 “Permitted Acquisition” means any Acquisition by a Borrower, in each
case, to the extent that each of the following conditions shall have been satisfied: 
 (a) the Borrower Representative shall have delivered
to (y) during any Non-Third Party Agent Retention Period, subject to Section 4.19, Agent, or (z) during any Third Party Agent Retention Period, the Third Party Agent, in each case, (i) at
least ten (10) Business Days prior to the closing of the proposed Acquisition: (A) a description of the proposed Acquisition; (B) to the extent available, a due diligence package (including, to the extent available, a quality of
earnings report); and (C) the most recent drafts (or, if available, executed counterparts) of the respective agreements, documents or instruments pursuant to which such Acquisition is to be consummated, any available schedules and exhibits to
such agreements, documents or instruments and all other material ancillary agreements, instruments and documents to be executed or delivered in connection therewith, and to the extent required under the related acquisition agreement, all required
regulatory and third party approvals and copies of any environmental assessments and (ii) at the earlier of (A) the time of closing of the proposed Acquisition or (B) as early before the closing of the proposed Acquisition as
available, in each case, final, fully executed copies of the respective agreements, documents or instruments pursuant to which such Acquisition is to be consummated and all schedules and exhibits to such agreements, documents or instruments and all
other material ancillary agreements, instruments and documents executed or delivered in connection therewith; 
 (b) the Credit Parties
(including any new Subsidiary to the extent required by Section 4.11) shall execute and deliver the agreements, instruments and other documents to the extent required by Section 4.11; 

(c) no Event of Default has occurred and is continuing, or would exist after giving pro forma effect to, the proposed Acquisition; 

(d) all transactions in connection with such Acquisition shall be consummated, in all material respects, in accordance with applicable laws;

 (e) the assets acquired in such Acquisition are for use in the same line of business as the Credit Parties are currently engaged or a line
of business reasonably related thereto; 
 (f) such Acquisition shall not be hostile and, if applicable, shall have been approved by the
board of directors (or other similar body) and/or the stockholders or other equity holders of any Person being acquired in such Acquisition; 

(g) no Debt or Liens are assumed or created (other than Permitted Liens and Permitted Debt) in connection with such Acquisition; 

(h) (i) during any Non-Third Party Agent Retention Period, Agent shall have received a certificate
of a Responsible Officer of the Borrower Representative certifying as to compliance, on a pro forma basis after giving to the consummation of such Acquisition, that Borrowers are in compliance with the financial covenants set forth in
Article 6, together with, subject to Section 4.19, any other evidence demonstrating compliance therewith as reasonably requested by Agent, and (ii) during any Third Party Agent Retention Period, the Third Party Agent shall have
received a certificate of a Responsible Officer of the Borrower Representative demonstrating, on a pro forma basis after giving effect to the consummation of such Acquisition, that Borrowers are in compliance with the financial covenants set forth
in Article 6; 

  
 24 

 (i) the total consideration paid or payable (including costs and expenses, deferred
purchase price, seller notes and other liabilities incurred, assumed or to be reflected on a consolidated balance sheet of the Credit Parties and their Subsidiaries after giving effect to such Acquisition but excluding (A) any equity
interests issued as consideration for such Acquisition and (B) the net proceeds of any issuance of equity interests made after the Closing Date that are used for purposes of such Acquisition) (such amounts, collectively, the
“Acquisition Consideration”) shall be in an amount not to exceed $15,000,000 in the aggregate for all such Acquisitions during the term of this Agreement; provided, however, that, in the case of each Acquisition,
(1) during any Non-Third Party Agent Retention Period, subject to Section 4.19, to the extent request by Agent, Agent, and (2) during any Third Party Agent Retention Period, the Third Party
Agent, in each case, has received prior to the consummation of such Acquisition updated financial projections, in form and substance reasonably satisfactory to Agent (or such Third Party Agent), for the immediately succeeding eighteen
(18) months following the proposed consummation of the Acquisition beginning with the month during which the Acquisition is to be consummated (the “Transaction Projections”) and evidence satisfactory to Agent (or such Third
Party Agent) that Borrower has, immediately before and immediately after giving effect to the consummation of such Acquisition, unrestricted cash in one or more Deposit Accounts subject to a Deposit Account Control Agreement in an aggregate amount
equal to or greater than the positive value of the product of (x) eighteen (18) multiplied by (y) the Monthly Cash Burn Amount, as determined as of the last day of the month immediately preceding such Acquisition; and 

(j) all conditions to such Permitted Acquisition (as defined in the Term Credit Agreement) have been satisfied and Agent shall have received
any requested evidence showing satisfaction thereof. 
 Notwithstanding the foregoing, no Accounts, Inventory or Equipment acquired by a
Credit Party in a Permitted Acquisition shall be included as Eligible Accounts, Eligible Equipment or Eligible Inventory until a field examination (and, if required by Agent, an Inventory appraisal or an Equipment appraisal, as applicable) with
respect thereto has been completed to the reasonable satisfaction of Agent, including the establishment of reserves required in Agent’s reasonable discretion; provided that field examinations and appraisals in connection with Permitted
Acquisitions shall not count against the limited number of field examinations or appraisals for which expense reimbursement may be sought. 

“Permitted Asset Dispositions” means the following Asset Dispositions, provided, however, that at the time of such
Asset Disposition (other than an Asset Disposition pursuant to clause (a) or clause (l) below), no Event of Default exists or would result from such Asset Disposition: 

 

	 	(a)	dispositions of Inventory in the Ordinary Course of Business; 

  

	 	(b)	dispositions of furniture, fixtures and equipment (excluding any Collateral included in the Borrowing Base) in the Ordinary Course of Business that the applicable Borrower or Subsidiary determines in good faith is no
longer used or useful in the business of such Borrower and its Subsidiaries, 

  

	 	(c)	to the extent constituting an Asset Disposition, Permitted Investments and Permitted Licenses, 

  

	 	(d)	disposals of obsolete, worn out or surplus tangible personal property, 

  

	 	(e)	without limiting transactions permitted under Section 5.6 hereof, dispositions by any Credit Party to any Borrower so long as each Credit Party (other than, with respect to any transferring Person, an Immaterial
Subsidiary) will remain Solvent after giving effect to the transfer, 

  
 25 

	 	(f)	abandonment of Intellectual Property that does not constitute a Material Intangible Asset, 

  

	 	(g)	the unwinding or terminating of Swap Contracts or any Capped Call permitted by clause (g) of the definition of “Permitted Contingent Obligations” either (i) with respect to a Swap Contract or a
Capped Call, in the Ordinary Course of Business or (ii) with respect to a Capped Call, that were entered into in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing
permitted hereunder or in connection with this Agreement or any of the other Financing Documents; 

  

	 	(h)	dispositions of equipment (excluding any Collateral included in the Borrowing Base) or real property to the extent that (i) such property is exchanged for credit against the purchase price of replacement property
or (ii) the proceeds of such disposition are promptly applied to the purchase price of such replacement property; 

  

	 	(i)	the entering into of any Permitted License; 

  

	 	(j)	Asset Dispositions by any Foreign Subsidiary to any other Foreign Subsidiary or to any Borrower; 

  

	 	(k)	Asset Dispositions approved by Agent in writing; 

  

	 	(l)	to the extent constituting an Asset Disposition, the payment of cash and Cash Equivalents in the Ordinary Course of Business; and 

  

	 	(m)	other Asset Dispositions (excluding dispositions of Intellectual Property) the proceeds of which, when aggregated with the proceeds of all other Asset Dispositions made pursuant to this clause (m) are less than
$2,500,000 during the term of this Agreement; provided that (i) the consideration received for such assets shall be in an amount at least equal to the fair market value thereof (determined in good faith by the board of directors (or
similar governing body) of the Credit Party that owned such assets), (ii) no less than 75% thereof shall be paid in cash; provided that, with respect to any such Asset Disposition under this clause (m) involving Collateral that is
included in the Borrowing Base, Borrower shall have provided (y) during a Non-Third Party Agent Retention Period, Agent with a certificate from a Responsible Officer of the Borrower Representative at
least five (5) Business Days prior to such Asset Disposition certifying that, after giving effect to such Asset Disposition, the Revolving Loan Outstandings do not exceed the Revolving Loan Limit, together with, subject to Section 4.19,
such evidence thereof that is reasonably requested by Agent, and (z) during a Third Party Agent Retention Period, the Third Party Agent with a Borrowing Base Certificate (Third Party Agent) in accordance with this Agreement at least five
(5) Business Days prior to such Asset Disposition evidencing to Agent’s reasonable satisfaction that the Revolving Loan Outstandings shall not exceed the Revolving Loan Limit after giving effect to such Asset Disposition.

 “Permitted Contest” means, with respect to any tax obligation or other obligation or liability allegedly
or potentially owing from any Borrower or its Subsidiary to any governmental tax authority or other third party, a contest maintained in good faith by appropriate proceedings promptly instituted and diligently conducted and with respect to which
such reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made on the books and records and financial statements of the applicable Credit Party(ies); provided, however, that
(a) compliance with the obligation that is the subject of such contest is effectively stayed during such challenge; (b) the Collateral or any part thereof or any interest therein shall not be in any danger of being sold, forfeited or lost
by reason of such contest by Borrowers or its Subsidiaries; and (c) with respect to obligations in excess of $250,000, 

  
 26 

 
Borrowers have given (i) during any Non-Third Party Agent Retention Period, subject to Section 4.19, Agent, and (ii) during any Third Party
Agent Retention Period, the Third Party Agent, in each case, notice of the commencement of such contest and upon request by Agent (or such Third Party Agent, as applicable), from time to time, notice of the status of such contest by Borrowers and/or
confirmation of the continuing satisfaction of this definition. 
 “Permitted Contingent Obligations” means 

(a) Contingent Obligations arising in respect of the Debt under the Financing Documents; 

(b) Contingent Obligations resulting from endorsements for collection or deposit in the Ordinary Course of Business; 

(c) Contingent Obligations outstanding on the date of this Agreement and set forth on Schedule 5.1 (but not including any refinancings,
extensions, increases or amendments to the indebtedness underlying such Contingent Obligations other than extensions of the maturity thereof without any other material change in terms adverse to the Lenders); 

(d) Contingent Obligations incurred in the Ordinary Course of Business with respect to surety and appeal bonds, performance bonds and other
similar obligations not to exceed $2,000,000 in the aggregate at any time outstanding; 
 (e) Contingent Obligations arising under indemnity
agreements with title insurers to cause such title insurers to issue to Agent mortgagee title insurance policies; 
 (f) Contingent
Obligations arising with respect to customary indemnification obligations in favor of purchasers in connection with dispositions of personal property assets permitted under Section 5.6; 

(g) so long as there exists no Event of Default both immediately before and immediately after giving effect to any such transaction, Contingent
Obligations existing or arising under any Swap Contract or Capped Call; provided, however, that such obligations are (or were) entered into by Endologix or an Affiliate thereof for the purpose of directly mitigating risks associated
with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and either (i) with respect to a Swap Contract or a Capped Call, are (or were) entered into in the
Ordinary Course of Business or (ii) with respect to a Capped Call, are (or were) entered into in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes, any refinancings thereof permitted hereunder or in connection with this
Agreement or any of the other Financing Documents; 
 (h) guarantees by (A) one or more Credit Parties of the obligations of Foreign
Subsidiaries up to $1,000,000 in the aggregate at any time outstanding, (B) any Credit Party of the obligations of any other Credit Party (but, for the avoidance of doubt, excluding any Immaterial Subsidiary that may be a Credit Party where,
before and immediately after giving effect to such guarantee (including any rights of contribution set forth in the Loan Documents or otherwise), the Credit Parties cannot represent and warrant that such Immaterial Subsidiary is Solvent on an
individual basis) and (C) any Foreign Subsidiary of the obligations of any other Foreign Subsidiary; 

  
 27 

 (i) Contingent Obligations arising in connection with the issuance of letters of credit in an
aggregate face amount not to exceed $10,000,000 at any one time outstanding secured solely by Liens permitted pursuant to clause (k) of the definition of Permitted Liens; 

(j) Contingent Obligations arising in respect of the Debt under the Loan Documents (as defined in the Term Credit Agreement as of the Closing
Date); and 
 (k) other Contingent Obligations not permitted by clauses (a) through (j) above, not to exceed $2,500,000 in the aggregate
at any time outstanding. 
 “Permitted Debt” means: 

(a) the Credit Parties’ and their Subsidiaries’ Debt to Agent and each Lender under this Agreement and the other Financing Documents;

 (b) Debt incurred as a result of endorsing negotiable instruments received in the Ordinary Course of Business; 

(c) capital leases and purchase money Debt not to exceed $5,000,000 at any time (whether in the form of a loan or a lease) used solely to
acquire equipment used in the Ordinary Course of Business and secured only by such equipment; 
 (d) Debt existing on the Closing Date and
described on Schedule 5.1 (but not including any refinancings, extensions, increases or amendments to such Debt other than Permitted Refinancings); 

(e) so long as there exists no Event of Default both immediately before and immediately after giving effect to any such transaction, Debt
existing or arising under any Swap Contract or Capped Call; provided, however, that such obligations are (or were) entered into by a Credit Party or an Affiliate thereof for the purpose of directly mitigating risks associated with
liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and either (i) with respect to a Swap Contract or a Capped Call, are (or were) entered into in the
Ordinary Course of Business or (ii) with respect to a Capped Call, are (or were) entered into in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or
in connection with this Agreement or any of the other Financing Documents; 
 (f) Debt in the form of insurance premiums financed through the
applicable insurance company; 
 (g) trade accounts payable arising and paid within 120 days of the date when due and in the Ordinary Course
of Business; 
 (h) the Term Debt under the Term Credit Agreement, in accordance with the terms of the Intercreditor Agreement; 

(i) Subordinated Debt; 

  
 28 

 (j) Debt of the Credit Parties incurred under the 3.25% Convertible Notes in an aggregate
principal amount not to exceed the aggregate principal amount outstanding on the Closing Date after giving effect to any repayments or prepayments thereon on the Closing Date, and, so long as no Event of Default has occurred and is continuing, any
refinancing or extension thereof or new issuance in connection with the exchange thereof and/or a new issuance all or any portion of the proceeds of which will be used in connection with the repurchase or other refinancing of all or any portion
thereof therewith that (i) has an aggregate outstanding principal amount not greater than $200,000,000 (when taking into account all such existing, refinanced, extended and newly issued Debt), and does not provide for any amortization payments
or other principal payments of any kind in advance of the first Business Day after the Maturity Date, (ii) has a maturity no shorter than the first Business Day after the Maturity Date (in the case of clause (i) and clause (ii), it being
understood that, in each case, any provision requiring an offer to purchase such Debt as a result of a change in control, fundamental change, delisting, asset sale or similar provision or any exercise or conversion of Stock (other than Disqualified
Stock) shall not violate the foregoing restrictions in clause (i) or clause (ii)), (iii) is unsecured, (iv) does not have one or more obligors that are not obligors under this Agreement and the other Financing Documents, (v) contains
terms that are prevailing market terms at the time of issuing or initial borrowing for the type of financing and for the quality of issuer or borrower, as determined by Endologix and its advisors in their reasonable business judgment, (vi) does
not have an All-in Yield greater than the lesser of (A) 6% per annum and (B) an All-in Yield that would result in more than $10,000,000 per annum being paid in
interest thereunder, (vii) does not cause Endologix either on an individual basis or together with the other Credit Parties and their Subsidiaries (on a consolidated basis), immediately before, at the time of and immediately after giving effect
to such Debt (and after giving effect to the use of the proceeds thereof), to no longer be Solvent (or such Persons are not Solvent immediately prior to giving effect thereto), and (vii) if in existence at such time or on the same date, is
permitted under the Term Debt Documents (collectively, a “Permitted 3.25% Convertible Note Refinancing”); 
 (k) Debt of the
Credit Parties incurred under the 2.25% Convertible Notes in an aggregate principal amount not to exceed the aggregate principal amount outstanding on the Closing Date minus any prepayments, repayments, redemptions or payments thereon made on the
Closing Date or from time to time thereafter; 
 (l) without limiting the provisions of Section 5.7 with respect to any Investment by a
Credit Party, Debt consisting of unsecured intercompany loans and advances (i) incurred by any Borrower owing to one or more other Borrowers, (ii) incurred by any Foreign Subsidiaries owing to any Borrower solely to the extent constituting
a Permitted Investment made by such Borrower, or (iii) incurred by any Foreign Subsidiaries owing to any other Foreign Subsidiary; 

(m) Debt related to commercial credit cards provided by Bank of America, N.A. (or such other commercial bank permitted under the definition of
“Bank of America Cash Collateral Account) that, in the aggregate outstanding at any one time, does not exceed $2,500,000, which Debt may be secured by Liens permitted pursuant to clause (l) of the definition of Permitted Liens; 

(n) to the extent constituting Debt, any Permitted Contingent Obligations; 

(o) Debt incurred in respect of netting services, overdraft protection and other like services, in each case, incurred in the Ordinary Course
of Business; 
 (p) unsecured earn-out obligations and other similar contingent purchase price
obligations incurred in connection with a Permitted Acquisition to the extent earned and payable and permitted pursuant to the definition of Permitted Acquisition and the other terms of this Agreement ; and 

(q) other unsecured Debt not to exceed $2,500,000 outstanding at any one time. 

  
 29 

 “Permitted Distributions” means the following Distributions: (a) dividends
by any direct or indirect Subsidiary of any Credit Party (A) that are not Credit Parties to its parent or parent entities or (B) that are Credit Parties to its parent or parent entities that are Credit Parties; (b) dividends payable
solely in common stock; (c) repurchases of Stock of former employees, directors or consultants pursuant to stock purchase agreements so long as an Event of Default does not exist at the time of such repurchase and would not exist after giving
effect to such repurchase, provided, however, that such repurchase does not exceed $2,500,000 in the aggregate per fiscal year; (d) any distributions made under Subordinated Debt Documents to the extent permitted under the terms of the
applicable Subordination Agreement; and (e) any Distributions required by the Warrants or the Registration Rights Agreement. 

“Permitted Investments” means: 

(a) Investments (i) shown on Schedule 5.7 and existing on the Closing Date and (ii) in Subsidiaries made prior to the Closing Date;

 (b) cash and Cash Equivalents; 

(c) Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the Ordinary
Course of Business; 
 (d) Investments consisting of (i) travel advances and employee relocation loans and other employee loans and
advances in the Ordinary Course of Business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of Borrowers or their Subsidiaries pursuant to employee stock purchase plans or agreements approved by
Borrowers’ Board of Directors (or other governing body), but the aggregate of all such loans outstanding may not exceed $500,000 at any time; 

(e) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in
settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the Ordinary Course of Business; 
 (f)
Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the Ordinary Course of Business, provided, however, that this subpart (f) shall not apply to
Investments of Borrowers in any Subsidiary; 
 (g) Investments consisting of (i) deposit accounts in which Agent has received a Deposit
Account Control Agreement, (ii) deposit accounts that are Excluded Accounts (subject to any caps and applicable restrictions set forth in such definition), and (iii) the Merrill Lynch Securities Account maintained in accordance with, and
subject to the limitations set forth in, Section 5.14; 
 (h) Investments by any Borrower in any Subsidiary now owned or hereafter
created by such Borrower, which Subsidiary is a Borrower or has provided a Guarantee of the Obligations of the Borrowers which Guarantee is secured by a Lien granted by such Subsidiary to Agent in all or substantially all of its property of the type
described in Schedule 9.1 hereto and otherwise made in compliance with Section 4.11(d); 
 (i) Investments by (A) any Borrower
consisting solely of cash and Cash Equivalents in a Foreign Subsidiary; provided that at the time of the making of such Investment and immediately after giving effect thereto (i) no Event of Default has occurred and is continuing and
(ii) the Borrowers have unrestricted (it being understood and agreed that cash and Cash Equivalents shall not be considered “restricted” cash for purposes of this proviso solely due to compliance by the Borrowers with the requirements
set forth in Section 5.14) cash and Cash Equivalents in an aggregate amount of not less than 

  
 30 

 
$10,000,000, which cash and Cash Equivalents (x) are subject to a first priority perfected Lien in favor of Agent for the benefit of itself and the Lenders (subject only to the prior
priority of Permitted Priority Liens) or in the Merrill Lynch Securities Account in accordance with, and subject to the limitations set forth in, Section 5.14), (y) are held in a deposit account that is subject to a Deposit Account Control
Agreement or a securities account subject to a Deposit Account Control Agreement or in the Merrill Lynch Securities Account in accordance with, and subject to the limitations set forth in, Section 5.14 unless the same could not be reasonably
expected to reduce the amounts in such accounts below $10,000,000 at the time of such Investment and immediately after giving effect thereto, do not include any drawn or committed but unpaid drafts, ACH or EFT transactions and (B) a Foreign
Subsidiary in another Foreign Subsidiary; 
 (j) Investments by any Borrower consisting solely of Inventory in Foreign Subsidiaries to the
extent such Investments are made in the Ordinary Course of Business consistent with its customary practices as in effect on and immediately prior to the Closing Date; 

(k) so long as no Default or Event of Default shall have occurred and be continuing at the time thereof or would result therefrom, Investments
consisting solely of cash and Cash Equivalents in joint ventures or similar arrangements in an amount not to exceed $5,000,000 in the aggregate during the term of this Agreement; 

(l) Permitted Acquisitions; 
 (m)
Investments deemed to exist under any Swap Contracts or Capped Calls; provided, however, that such obligations are (or were) entered into by Endologix or an Affiliate of Endologix for the purpose of directly mitigating risks associated
with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Person and not for purposes of speculation and are (or were) entered into either (i) with respect to a Swap Contract or a Capped Call, in the
Ordinary Course of Business or (ii) with respect to a Capped Call, in connection with the 2.25% Convertible Notes, the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing permitted hereunder or in connection with this
Agreement or any of the other Financing Documents; and 
 (n) other Investments in an amount not exceeding $5,000,000 in the aggregate. 

“Permitted License” means (a) any non-exclusive license of patent rights of
Borrower or its Subsidiaries so long as all such Permitted Licenses are granted to third parties in the Ordinary Course of Business, do not result in a legal transfer of title to the licensed property, and have been granted in exchange for fair
consideration, and (b) any exclusive license of patent rights of Borrower or its Subsidiaries so long as such Permitted Licenses do not result in a legal transfer of title to the licensed property, are exclusive solely as to discrete
geographical areas outside of the United States, and have been granted in exchange for fair consideration. 
 “Permitted
Liens” means: 
  

	 	(a)	deposits or pledges of cash to secure obligations under workmen’s compensation, social security or similar laws, or under unemployment insurance (but excluding Liens arising under ERISA or, with respect to any
Pension Plan or Multiemployer Plan, the Code) pertaining to a Borrower’s or its Subsidiary’s employees, if any; 

  

	 	(b)	deposits or pledges of cash to secure bids, tenders, contracts (other than contracts for the payment of money or the deferred purchase price of property or services), leases, statutory obligations, surety and appeal
bonds and other obligations of like nature arising in the Ordinary Course of Business; 

  
 31 

	 	(c)	carrier’s, warehousemen’s, mechanic’s, workmen’s, materialmen’s or other like Liens on Collateral, other than any Collateral which is part of the Borrowing Base, arising in the Ordinary Course
of Business with respect to obligations which are not due, or which are being contested pursuant to a Permitted Contest; 

  

	 	(d)	Liens, other than on Collateral that is part of the Borrowing Base, for taxes or other governmental charges not at the time delinquent or thereafter payable without penalty or the subject of a Permitted Contest;

  

	 	(e)	attachments, appeal bonds, judgments and other similar Liens on Collateral, other than on Collateral that is part of the Borrowing Base, for sums not exceeding $1,000,000 in the aggregate arising in connection with
court proceedings; provided, however, that the execution or other enforcement of such Liens is effectively stayed and the claims secured thereby are the subject of a Permitted Contest; 

 

	 	(f)	with respect to real estate, easements, rights of way, restrictions, minor defects or irregularities of title, none of which, individually or in the aggregate, materially interfere with the benefits of the security
intended to be provided by the Security Documents, materially affect the value or marketability of the Collateral, materially impair the use or operation of the Collateral for the use currently being made thereof or materially impair Borrowers’
ability to pay the Obligations in a timely manner or materially impair the use of the Collateral or the Ordinary Course of Business of any Borrower or any Subsidiary; 

 

	 	(g)	Liens and encumbrances in favor of Agent under the Financing Documents; 

  

	 	(h)	Liens, other than on Collateral that is part of the Borrowing Base, existing on the date hereof and set forth on Schedule 5.2; 

  

	 	(i)	(A) any Lien on any equipment acquired or held by any Credit Party or any Subsidiary of any Credit Party securing Debt incurred or assumed for the purpose of financing (or refinancing)) all or any part of the cost of
acquiring such equipment and permitted under clause (c) of the definition of “Permitted Debt”; provided that (i) such Lien attaches solely to the assets or property so acquired in such transaction and the proceeds thereof
and (ii) the principal amount of the Debt secured thereby does not exceed 100% of the cost of such equipment; and (B) capital leases, in each case of clause (A) and clause (B), Liens securing capital leases or purchase money debt
permitted under clause (c) of the definition of “Permitted Debt”; 

  

	 	(j)	(i) any interest or title of a lessor, sublessor, licensor or sublicensor under any lease or license not prohibited by this Agreement, (ii) non-exclusive licenses and
sublicenses granted by a Borrower or any Subsidiary of a Borrower and leases and subleases (by a Borrower or any Subsidiary of a Borrower as lessor or sublessor) to third parties in the Ordinary Course of Business not materially interfering with the
business of the Borrowers or any of their Subsidiaries or (iii) Permitted Licenses; 

  

	 	(k)	Liens in favor of letter of credit issuers on the L/C Cash Collateral Account to the extent securing obligations of Borrowers permitted pursuant to clause (i) of the definition of Permitted Contingent Obligations;

  

	 	(l)	Liens in favor of Bank of America, N.A. (or such other commercial bank permitted under the definition of “Bank of America Cash Collateral Account”) on the Bank of America Cash Collateral Account;
provided that if Endologix is using credit card services from the Agent or the Lenders under the Financing Documents that are required to be secured by the Financing Documents, Endologix shall promptly use commercially reasonable efforts to
terminate the Liens in respect of the Bank of America Cash Collateral Account; 

  
 32 

	 	(m)	liens on assets of the Borrowers arising in connection with seller notes, earnouts and other similar payment obligations constituting Acquisition Consideration in connection with Permitted Acquisitions so long as such
Liens are subject at all times to a Subordination Agreement; 

  

	 	(n)	Liens granted under the Term Debt Documents, in accordance with the terms of the Intercreditor Agreement (“Permitted Term Debt Liens”); 

 

	 	(o)	Liens in favor of financial institutions arising in connection with Endologix’ or its Subsidiaries’ deposit accounts maintained in the Ordinary Course of Business held at such institutions to secure standard
fees for services charged by, but not financing made available by, such institutions; 

  

	 	(p)	Liens of a collection bank arising under Section 4-210 of the UCC (or equivalent in foreign jurisdictions) on items in the course of collection; 

 

	 	(q)	Liens arising from the filing of precautionary uniform commercial code financing statements with respect to any lease not prohibited by this Agreement; 

 

	 	(r)	Liens arising out of consignment or similar arrangements for the sale of goods entered into by Endologix or any Subsidiary of Endologix in the Ordinary Course of Business; 

 

	 	(s)	Liens in favor of customs and revenue authorities arising as a matter of law which secure payment of customs duties in connection with the importation of goods in the Ordinary Course of Business; and 

 

	 	(t)	Liens on unearned insurance premiums securing the financing thereof to the extent permitted under clause (f) of the definition of “Permitted Debt”. 

“Permitted Modifications” means (a) such amendments or other modifications to a Borrower’s or Subsidiary’s
Organizational Documents as are required under this Agreement or by applicable Law and fully disclosed to Agent within thirty (30) days after such amendments or modifications have become effective, and (b) such amendments or modifications
to a Borrower’s or Subsidiary’s Organizational Documents (other than those involving a change in the name of a Borrower or Subsidiary or involving a reorganization of a Borrower or Subsidiary under the laws of a different jurisdiction)
that would not adversely affect the rights and interests of Agent or Lenders and fully disclosed to Agent within thirty (30) days after such amendments or modifications have become effective. 

“Permitted Priority Liens” means (a) solely with respect to the specific assets or property covered thereby, the Liens
granted pursuant to, and in accordance with, clause (n) of the definition of “Permitted Liens,” (b) Permitted Liens granted over specific property pursuant to clauses (i) (solely with respect to the property permitted to be
secured by such Debt pursuant to such clause (c) of the definition of “Permitted Debt”), (j) (solely with respect to the interest in such applicable lease, sublease, license or sublicense or the assets owned by such lessor, sublessor,
licensor or sublicensor underlying same), (k) (solely with respect to the L/C Cash Collateral Account), (l) (solely with respect to the Bank of America Cash Collateral Account), (m) (solely with respect to the specific assets covered by such lease
that are owned by such lessor) (o) (solely with respect to such applicable deposit accounts), (r) (with respect to the goods permitted to be 

  
 33 

 
consigned thereby) and (t) (solely with respect to such cash held by such insurance agency for such insurance premiums) of the definition of “Permitted Liens”, but, in each case, only
to the extent only such Lien (i) attaches, as applicable, solely to the assets or property so acquired in such transaction and the proceeds thereof and (ii) has prior priority to the Permitted Term Debt Liens, and (c) to the extent
not otherwise covered by clause (b) above, non-consensual Permitted Liens that are solely provided by operation of (and in compliance with) Applicable Law. 

“Permitted Refinancing” means Debt constituting a refinancing or extension of Debt evidenced by the permitted under clause
(d) of the definition of Permitted Debt and that (a) has an aggregate outstanding principal amount not greater than the aggregate principal amount of the Debt being refinanced or extended, (b) has a weighted average maturity (measured
as of the date of such refinancing or extension) and maturity no shorter than that of the Debt being refinanced or extended, (c) is not entered into as part of a sale leaseback transaction, (d) is not secured by a Lien on any assets other
than the collateral securing the Debt being refinanced or extended, (e) the obligors of which are the same as the obligors of the Debt being refinanced or extended and (f) is otherwise on terms no less favorable to Credit Parties and their
Subsidiaries, taken as a whole, than those of the Debt being refinanced or extended. 
 “Permitted Term Debt Liens” has the
meaning set forth in clause (n) of the definition of “Permitted Liens”. 
 “Person” means and includes any
natural person, individual, partnership, joint venture, corporation, trust, limited liability company, limited liability partnership, joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof,
or any other entity. 
 “Principal Market” means the NASDAQ Global Select Market (or any successor to the foregoing). 

“Products” means, from time to time, any products currently manufactured, sold, developed, tested or marketed by any Borrower
or any of its Subsidiaries. 
 “Pro Rata Share” means (a) with respect to a Lender’s obligation to make Revolving
Loans, the Revolving Loan Commitment Percentage of such Lender, (b) with respect to a Lender’s right to receive payments of principal and interest with respect to Revolving Loans, such Lender’s Revolving Loan Exposure with respect
thereto; and (c) for all other purposes (including the indemnification obligations arising under Section 11.6) with respect to any Lender, the percentage obtained by dividing (i) the Revolving Loan Commitment Amount of such
Lender (or, in the event the Revolving Loan Commitment shall have been terminated, such Lender’s then existing Revolving Loan Outstandings), by (ii) the sum of the Revolving Loan Commitment (or, in the event the Revolving Loan
Commitment shall have been terminated, the then existing Revolving Loan Outstanding) of all Lenders. 
 “Recall” means a
Person’s Removal or Correction of a marketed product that the FDA considers to be in violation of the laws it administers and against which the FDA would initiate legal action, e.g., seizure. 

“Register” has the meaning set forth in Section 11.17(a)(iii). 

“Registered Intellectual Property” means any patent, registered trademark or servicemark, registered copyright, registered
mask work, or any pending application for any of the foregoing. 
 “Registration Rights Agreement” has the meaning set
forth in the Term Credit Agreement. 

  
 34 

 “Regulatory Reporting Event” has the meaning set forth in Section 4.17.

 “Regulatory Required Permit” means any and all licenses, approvals and permits issued by the FDA, DEA or any other
applicable Governmental Authority, including Drug Applications, necessary for the testing, manufacture, marketing or sale of any Product by any applicable Borrower(s) and its Subsidiaries as such activities are being conducted by such Borrower and
its Subsidiaries with respect to such Product at such time and any drug listings and drug establishment registrations under 21 U.S.C. Section 510, registrations issued by DEA under 21 U.S.C. Section 823 (if applicable to any Product), and
those issued by State governments for the conduct of Borrower’s or any Subsidiary’s business. 
 “Related
Parties” means, with respect to any Person, such Person’s Affiliates and the partners, directors, officers, employees, agents, subagents, trustees, administrators, managers, attorneys, advisors and representatives of such Person and of
such Person’s Affiliates. For the avoidance of doubt, any Third Party Agent shall be a Related Party of the Agent. 

“Removal” means the physical removal of a product from its point of use to some other location for repair, modification,
adjustment, relabeling, destruction, or inspection. 
 “Reporting Period” has the meaning set forth in Section 4.1.

 “Required Lenders” means at any time Lenders holding (a) fifty-one percent
(51%) or more of the sum of the Revolving Loan Commitment (taken as a whole), or (b) if the Revolving Loan Commitment has been terminated, fifty-one percent (51%) or more of the then aggregate outstanding
principal balance of the Loans. 
 “Responsible Officer” means any of the Chief Executive Officer, Chief Financial
Officer or any other officer of the applicable Borrower acceptable to Agent. 
 “Revolving Lender” means each Lender having
a Revolving Loan Commitment Amount in excess of Zero Dollars ($0) (or, in the event the Revolving Loan Commitment shall have been terminated at any time, each Lender at such time having Revolving Loan Outstandings in excess of Zero Dollars ($0)).

 “Revolving Loan Availability” means, at any time, the Revolving Loan Limit minus the Revolving Loan Outstandings.

 “Revolving Loan Commitment” means, as of any date of determination, the aggregate Revolving Loan Commitment Amounts of
all Lenders as of such date. 
 “Revolving Loan Commitment Amount” means, as to any Lender, the dollar amount set forth
opposite such Lender’s name on the Commitment Annex under the column “Revolving Loan Commitment Amount” (if such Lender’s name is not so set forth thereon, then the dollar amount on the Commitment Annex for the Revolving Loan
Commitment Amount for such Lender shall be deemed to be Zero Dollars ($0)), as such amount may be adjusted from time to time by any amounts assigned (with respect to such Lender’s portion of Revolving Loans outstanding and its commitment to
make Revolving Loans) pursuant to the terms of any and all effective assignment agreements to which such Lender is a party. For the avoidance of doubt, the aggregate Revolving Loan Commitment Amount of all Lenders as of the Closing Date is
$50,000,000. 
 “Revolving Loan Commitment Percentage” means, as to any Lender, (a) on the Closing Date, the
percentage set forth opposite such Lender’s name on the Commitment Annex under the column “Revolving Loan Commitment Percentage” (if such Lender’s name is not so set forth thereon, then, on the

  
 35 

 
Closing Date, such percentage for such Lender shall be deemed to be zero), and (b) on any date following the Closing Date, the percentage equal to the Revolving Loan Commitment Amount of
such Lender on such date divided by the Revolving Loan Commitment on such date. 
 “Revolving Loan Exposure”
means, with respect to any Lender on any date of determination, the percentage equal to the amount of such Lender’s Revolving Loan Outstandings on such date divided by the aggregate Revolving Loan Outstandings of all Lenders on such
date. 
 “Revolving Loan Limit” means, at any time, the lesser of (a) the Revolving Loan Commitment and (b) the
Borrowing Base. 
 “Revolving Loan Outstandings” means, at any time of calculation, (a) the then existing aggregate
outstanding principal amount of Revolving Loans, and (b) when used with reference to any single Lender, the then existing outstanding principal amount of Revolving Loans advanced by such Lender. 

“Revolving Loans” has the meaning set forth in Section 2.1(b). 

“SEC” means the United States Securities and Exchange Commission. 

“SEC Documents” means all reports, schedules, forms, statements and other documents filed by Endologix with the SEC pursuant
to the Securities Act or the Exchange Act since January 1, 2016 (including all financial statements and schedules included therein, all exhibits thereto and all documents incorporated by reference therein). 

“Securities Account” means a “securities account” (as defined in Article 9 of the UCC), an investment account, or
other account in which investment property or securities are held or invested for credit to or for the benefit of any Borrower. 

“Securities Account Control Agreement” means an agreement, in form and substance satisfactory to Agent, among Agent, any
applicable Borrower and each securities intermediary in which such Borrower maintains a Securities Account pursuant to which Agent shall obtain “control” (as defined in Article 9 of the UCC) over such Securities Account. 

“Securities Act” means the Securities Act of 1933, as amended, including the rules and regulations promulgated thereunder.

 “Security Document” means this Agreement and any other agreement, document or instrument executed concurrently herewith
or at any time hereafter pursuant to which one or more Credit Parties or any other Person either (a) Guarantees payment or performance of all or any portion of the Obligations, and/or (b) provides, as security for all or any portion of the
Obligations, a Lien on any of its assets in favor of Agent for its own benefit and the benefit of the Lenders, as any or all of the same may be amended, supplemented, restated or otherwise modified from time to time. 

“Settlement Service” has the meaning set forth in Section 11.17(a)(v). 

“Solvent” means, with respect to any Person, that such Person (a) owns and will own assets the fair saleable value of
which are (i) greater than the total amount of its debts and liabilities (including subordinated and Contingent Obligations), and (ii) greater than the amount that will be required to pay the probable liabilities of its then existing debts
as they become absolute and matured considering all financing alternatives and potential asset sales reasonably available to it; (b) has capital that is not unreasonably small in relation to its business as presently conducted or after giving
effect to any contemplated transaction; and (c) does not intend to incur and does not believe that it will incur debts beyond its ability to pay such debts as they become due. 

  
 36 

 “Stated Rate” has the meaning set forth in Section 2.7. 

“Stock” means a) all shares of capital stock (whether denominated as common stock or preferred stock), equity interests,
beneficial, partnership or membership interests, joint venture interests, participations or other ownership or profit interests in or equivalents (regardless of how designated) of or in a Person (other than an individual), whether voting or non-voting; and (b) all securities convertible into or exchangeable for any other Stock and all warrants, options or other rights (other than the 2.25% Convertible Notes, the 3.25% Convertible Notes, any
Permitted 3.25% Convertible Note Refinancing permitted hereunder, any Capped Call transactions, and the Warrants) to purchase, subscribe for or otherwise acquire any other Stock, whether or not presently convertible, exchangeable or exercisable.

 “Subordinated Debt” means any Debt of Borrowers incurred pursuant to the terms of the Subordinated Debt Documents and
with the prior written consent of Agent, all of which documents must be in form and substance acceptable to Agent in its sole discretion. As of the Closing Date, there is no Subordinated Debt. 

“Subordinated Debt Documents” means any documents evidencing and/or securing Debt governed by a Subordination Agreement, all
of which documents must be in form and substance acceptable to Agent in its sole discretion. As of the Closing Date, there are no Subordinated Debt Documents. 

“Subordination Agreement” means any agreement between Agent and another creditor of Borrowers, as the same may be amended,
supplemented, restated or otherwise modified from time to time in accordance with the terms thereof, pursuant to which the Debt owing from any Borrower(s) and/or the Liens securing such Debt granted by any Borrower(s) to such creditor are
subordinated in any way to the Obligations and the Liens created under the Security Documents, the terms and provisions of such Subordination Agreements to have been agreed to by and be acceptable to Agent in the exercise of its sole discretion.

 “Subsidiary” means, with respect to any Person, (a) any corporation of which an aggregate of more than fifty
percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, capital stock of any other class or classes of such corporation
shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, owned legally or beneficially by such Person or one or more Subsidiaries of such Person, or with respect to which any such
Person has the right to vote or designate the vote of more than fifty percent (50%) of such capital stock whether by proxy, agreement, operation of law or otherwise, and (b) any partnership or limited liability company in which such Person
and/or one or more Subsidiaries of such Person shall have an interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%) or of which any such Person is a general partner or may
exercise the powers of a general partner. Unless the context otherwise requires, each reference to a Subsidiary shall be a reference to a Subsidiary of a Borrower. 

“Swap Contract” means any “swap agreement”, as defined in Section 101 of the Bankruptcy Code, or similar
agreement, not including Capped Calls. 
 “Taxes” has the meaning set forth in Section 2.8. 

“Term Agent” has the meaning ascribed to such term in the definition of “Term Credit Agreement” herein. 

  
 37 

 “Term Credit Agreement” means that certain Facility Agreement, dated as of the
Closing Date, by and among Endologix, the other Persons party thereto from time to time as “Loan Parties” (as defined therein), Deerfield Private Design Fund IV, L.P., in its capacity as Agent (as defined therein, in such capacity, the
“Term Agent”) and the financial institutions or other entities from time to time party thereto, each as a Lender (as defined therein), as amended, restated, supplemented or otherwise modified in accordance and in compliance with the
Intercreditor Agreement. 
 “Term Debt” means the “Facility Obligations” as defined in the Intercreditor
Agreement. 
 “Term Debt Documents” means the “Facility Documents” as defined in the Intercreditor Agreement.

 “Term Lenders” means the lenders under the Term Debt Documents. 

“Termination Date” means the earlier to occur of (a) the Maturity Date, (b) any date on which Agent or the Required
Lenders accelerates the maturity of the Loans pursuant to Section 10.2, or (c) the termination date stated in any notice of termination of this Agreement provided by Borrowers in accordance with Section 2.12. 

“Third Party Agent” means any Person other than Deerfield ELGX Revolver, LLC and its Affiliates that
(a) (i) becomes the Agent under the Financing Documents or (ii) is retained or hired as an agent or a subagent of the Agent to perform certain duties and responsibilities of (or receive certain rights and benefits provided to) the
Agent under the Financing Documents, (b) Borrower Representative has been informed of as being a Third Party Agent, and (c) has not (i) been removed from such role or position of the type set forth in clause (a)(i) or
clause (a)(ii) by Deerfield ELGX Revolver, LLC (or any such succeeding Agent to Deerfield ELGX Revolver, LLC) or (ii) had such role or position be terminated pursuant to the terms of any agreement between the Third Party Agent and Agent
(each of the events in clause (c)(i) and clause (c)(ii) above, a “Third Party Agent Termination Event”). It being understood and agreed that Cortland shall be deemed to be a Third Party Agent upon satisfying both
clause (a) and clause (b) above in this definition so long as a Third Party Agent Termination Event has not occurred. 

“Third Party Agent Retention Period” means any period of time when any Person is acting or performing as a Third Party Agent
pursuant to the definition of “Third Party Agent.” 
 “Third Party Agent Termination Event” has the meaning set
forth in the definition of “Third Party Agent”. 
 “Third Party Payor” means Medicare, Medicaid, TRICARE, and
other state or federal health care program, Blue Cross and/or Blue Shield, private insurers, managed care plans and any other Person or entity which presently or in the future maintains Third Party Payor Programs. 

“Third Party Payor Programs” means all payment and reimbursement programs, sponsored by a Third Party Payor, in which a
Borrower participates. 
 “TRICARE” means the program administered pursuant to 10 U.S.C. Section 1071 et. seq),
Sections 1320a-7 and 1320a-7a of Title 42 of the United States Code and the regulations promulgated pursuant to such statutes. 

“UCC” means the Uniform Commercial Code of the State of New York or of any other state the laws of which are required to be
applied in connection with the perfection of security interests in any Collateral. 

  
 38 

 “United States” means the United States of America. 

“Warrants” has the meaning set forth in the Term Credit Agreement. 

“Work-In-Process” means Inventory that is not
a product that is finished and approved by a Borrower in accordance with applicable Laws and such Borrower’s normal business practices for release and delivery to customers. 

Section 1.2 Accounting Terms and Determinations. Unless otherwise specified herein, all accounting terms used
herein shall be interpreted, all accounting determinations hereunder (including determinations made pursuant to the exhibits hereto) shall be made, and all financial statements required to be delivered hereunder shall be prepared on a consolidated
basis in accordance with GAAP applied on a basis consistent with the most recent audited consolidated financial statements of each Borrower and its Consolidated Subsidiaries delivered to Agent and each of the Lenders on or prior to the Closing Date.
If at any time any change in GAAP would affect the computation of any financial ratio or financial requirement set forth in any Financing Document, and either Borrowers or the Required Lenders shall so request, Agent, the Lenders and Borrowers shall
negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP (subject to the approval of the Required Lenders); provided, however, that until so amended,
(a) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (b) Borrowers shall provide to (i) during any Non-Third Party Agent Retention
Period, subject to Section 4.19, Agent, and (ii) during any Third Party Agent Retention Period, the Third Party Agent, in each case, financial statements and other documents required under this Agreement which include a reconciliation
between calculations of such ratio or requirement made before and after giving effect to such change in GAAP. Notwithstanding any other provision contained herein, (a) all terms of an accounting or financial nature used herein shall be
construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to any election under Statement of Financial Accounting Standards 159 (or any other Financial Accounting Standard having a similar result
or effect) to value any Debt or other liabilities of any Credit Party or any Subsidiary of any Credit Party at “fair value”, as defined therein and (b) leases shall continue to be classified and accounted for on a basis consistent
with Borrower’s financial statements for the year ended December 31, 2015 for all purposes of this Agreement, notwithstanding any change in GAAP relating thereto, unless the parties hereto enter into a mutually acceptable amendment
addressing such changes. 
 Section 1.3 Other Definitional and Interpretive Provisions. References in this
Agreement to “Articles”, “Sections”, “Annexes”, “Exhibits”, or “Schedules” shall be to Articles, Sections, Annexes, Exhibits or Schedules of or to this Agreement unless otherwise specifically
provided. Any term defined herein may be used in the singular or plural. “Include”, “includes” and “including” shall be deemed to be followed by “without limitation”. Except as otherwise specified or limited
herein, references to any Person include the successors and assigns of such Person. References “from” or “through” any date mean, unless otherwise specified, “from and including” or “through and including”,
respectively. Unless otherwise specified herein, the settlement of all payments and fundings hereunder between or among the parties hereto shall be made in lawful money of the United States and in immediately available funds. References to any
statute or act shall include all related current regulations and all amendments and any successor statutes, acts and regulations. All amounts used for purposes of financial calculations required to be made herein shall be without duplication.
References to any statute or act, without additional reference, shall be deemed to refer to federal statutes and acts of the United States. References to any agreement, instrument or document shall include all schedules, exhibits, annexes and other
attachments thereto. As used in this Agreement, the meaning of the term “material” or the phrase “in all material respects” is intended to refer to an act, omission, violation or condition which reflects or could reasonably be
expected to result in a Material Adverse Effect. References to capitalized terms that are not defined herein, but are defined in the UCC, shall have the meanings given them in the UCC. All references herein to times of day shall be references to
daylight or standard time, as applicable. 

  
 39 

 Section 1.4 Time is of the Essence. Time is of the essence in
Borrower’s and each other Credit Party’s performance under this Agreement and all other Financing Documents. 
 ARTICLE 2 -
LOANS 
 Section 2.1 Loans. 

(a) Reserved. 
 (b)
Revolving Loans. 
 (i) Revolving Loans and Borrowings. On the terms and subject to the conditions set forth
herein, each Lender severally agrees to make loans to Borrowers from time to time as set forth herein (each a “Revolving Loan”, and collectively, “Revolving Loans”) equal to such Lender’s Revolving Loan
Commitment Percentage of Revolving Loans requested by Borrowers hereunder, provided, however, that after giving effect thereto, the Revolving Loan Outstandings shall not exceed the Revolving Loan Limit. Borrowers shall deliver to Agent
a Notice of Borrowing with respect to each proposed borrowing of a Revolving Loan, such Notice of Borrowing to be delivered before 1:00 p.m. (Eastern time) two (2) Business Days prior to the date of such proposed borrowing. Each Borrower and
each Revolving Lender hereby authorizes Agent to make Revolving Loans on behalf of Revolving Lenders, at any time in its sole discretion, to pay principal owing in respect of the Loans and interest, fees, expenses and other charges payable by any
Credit Party from time to time arising under this Agreement or any other Financing Document. The Borrowing Base shall be determined by (A) during a Non-Third Party Agent Retention Period, Agent based on
the most recent Borrowing Base Certificate (Agent) delivered to Agent or, (B) during a Third Party Agent Retention Period, the Third Party Agent based on the most recent Borrowing Base Certificate (Third Party Agent) delivered to Third Party
Agent, in each case, in accordance with this Agreement and such other information as may be available to Agent in accordance with this Agreement. Without limiting any other rights and remedies of Agent hereunder or under the other Financing
Documents, the Revolving Loans shall be subject to Agent’s continuing right to withhold from the Borrowing Base reserves, and to increase and decrease such reserves from time to time, if and to the extent that in Agent’s good faith credit
judgment and reasonable discretion, such reserves are necessary. 
 (ii) Mandatory Revolving Loan Repayments and
Prepayments. 
 (A) The Revolving Loan Commitment shall terminate on the Termination Date. On such Termination Date,
there shall become due, and Borrowers shall pay, the entire outstanding principal amount of each Revolving Loan, together with accrued and unpaid Obligations pertaining thereto incurred to, but excluding the Termination Date; provided,
however, that such payment is made not later than 12:00 Noon (Eastern time) on the Termination Date. 
 (B) If at any
time the Revolving Loan Outstandings exceed the Revolving Loan Limit, then, on the next succeeding Business Day, Borrowers shall repay the Revolving Loans, in an aggregate amount equal to such excess. 

  
 40 

 (C) Principal payable on account of Revolving Loans shall be payable by Borrowers
to Agent (I) immediately upon the receipt by any Borrower or Agent of any payments on or proceeds from any of the Accounts, to the extent of such payments or proceeds, as further described in Section 2.11 below, and (II) in full on
the Termination Date. 
 (iii) Optional Prepayments. Borrowers may from time to time, upon at least one
(1) Business Day prior written notice, prepay the Revolving Loans in whole or in part; provided, however, that any such partial prepayment shall be in an amount equal to $100,000 or a higher integral multiple of $25,000. For the
avoidance of doubt, nothing in this clause shall permit termination of the Revolving Loan Commitment by Borrower other than in accordance with Section 2.12(b). 

(iv) LIBOR Rate. 

(A) Except as provided in subsection (C) below, Revolving Loans shall accrue interest at the LIBOR Rate plus the
Applicable Margin; provided that, notwithstanding anything to the contrary in this Agreement, when both (I) there are more than $10,000,000 of Revolving Loans outstanding on average over the applicable month and (II) no Event of
Default has occurred and is continuing, to the extent such interest rate plus the fee set forth in Section 2.2(b) for any month shall exceed the Maximum Cumulative Rate, the Maximum Cumulative Rate shall be paid by the Borrowers for such
month instead of such interest rate and such fee set forth in Section 2.2(b) for such month (the “Maximum Cumulative Rate Provision”). Such applicable interest rate, the “Interest Rate”. 

(B) The LIBOR Rate may be adjusted by Agent with respect to any Lender on a prospective basis to take into account any
additional or increased costs to such Lender of maintaining or obtaining any eurodollar deposits or increased costs, in each case, due to changes in applicable Law occurring subsequent to the commencement of the then applicable Interest Period,
including changes in tax laws (except changes of general applicability in corporate income tax laws) and changes in the reserve requirements imposed by the Board of Governors of the Federal Reserve System (or any successor), which additional or
increased costs would increase the cost of funding loans bearing interest based upon the LIBOR Rate; provided, however, that notwithstanding anything in this Agreement to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer
Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on
Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “change in applicable Law”, regardless of the date
enacted, adopted or issued. In any such event, the affected Lender shall give Borrowers and Agent written notice of such a determination and adjustment and Agent promptly shall transmit the notice to each other Lender and, upon its receipt of the
notice from the affected Lender, Borrowers may, by notice to such affected Lender and Agent (I) require such Lender to furnish to Borrowers a statement setting forth the basis for adjusting such LIBOR Rate and the method for determining the
amount of such adjustment, or (II) repay the Loans bearing interest based upon the LIBOR Rate with respect to which such adjustment is made. 

  
 41 

 (C) In the event that any change in market conditions or any law, regulation,
treaty, or directive, or any change therein or in the interpretation of application thereof, shall at any time after the date hereof, in the reasonable opinion of any Lender, make it unlawful or impractical for such Lender to fund or maintain Loans
bearing interest based upon the LIBOR Rate or to continue such funding or maintaining, or to determine or charge interest rates at the LIBOR Rate, such Lender shall give notice of such changed circumstances to Agent and Borrowers and Agent promptly
shall transmit the notice to each other Lender and (I) in the case of any outstanding Loans of such Lender bearing interest based upon the LIBOR Rate, the date specified in such Lender’s notice shall be deemed to be the last day of the
Interest Period of such Loans, and interest upon such Lender’s Loans thereafter shall accrue interest at Base Rate plus the Applicable Margin, and (II) such Loans shall continue to accrue interest at Base Rate plus the
Applicable Margin until such Lender determines that it would no longer be unlawful or impractical to maintain such Loans at the LIBOR Rate. 

(D) Anything to the contrary contained herein notwithstanding, neither Agent nor any Lender is required actually to acquire
eurodollar deposits to fund or otherwise match fund any Obligation as to which interest accrues based on the LIBOR Rate. 

Section 2.2 Interest, Interest Calculations and Certain Fees. 

(a) Interest. From and following the Closing Date, except as expressly set forth in this Agreement, Loans and the other Obligations
shall bear interest at the Interest Rate. Interest on the Loans shall be paid in arrears for the preceding calendar month on the first Business Day of each month and on the maturity of such Loans, whether by acceleration or otherwise. Interest on
all other Obligations shall be payable upon demand. For purposes of calculating interest, all funds transferred to the Payment Account for application to any Revolving Loans shall be subject to a six (6) Business Day clearance period and all
interest accruing on such funds during such clearance period shall accrue for the benefit of Agent, and not for the benefit of the Lenders.  

(b) Unused Line Fee. In each case subject to the Maximum Cumulative Rate Provision, from and following the initial borrowing of the
Revolving Loans, Borrowers shall pay Agent, for the benefit of all Lenders committed to make Revolving Loans, in accordance with their respective Pro Rata Shares, a fee in an amount equal to (1) if the average daily balance of the sum of the
Revolving Loan Outstandings during the preceding month exceeds the Minimum Balance: (i)(A) the Revolving Loan Limit (with the Borrowing Base being calculated based on the average amount of the Borrowing Base for the preceding month) minus
(B) an amount equal to the average daily balance of the sum of the Revolving Loan Outstandings during the preceding month multiplied by (ii) 1.0% per annum or (2) if the Minimum Balance exceeds the average daily balance of the sum
of the Revolving Loan Outstandings during the preceding month: (i) (A) the Revolving Loan Limit (with the Borrowing Base being calculated based on the average amount of the Borrowing Base for the preceding month) minus (B) the
Minimum Balance, multiplied by (ii) 1.20% per annum. The unused line fee (or, as applicable, the Maximum Cumulative Rate) shall be paid monthly in arrears on the last day of each month and shall be deemed fully earned when due and payable
and, once paid, shall be non-refundable. 
 (c) Reserved. 

(d) Third Party Agent Fee. At any time there is a Third Party Agent, Borrower shall timely pay (or timely reimburse the paying Person
for) such fees, costs and expenses of the Third Party Agent that are charged to (or incurred on behalf of) the Agent, any Lender or any Credit Party (or any of their Related Parties). 

  
 42 

 (e) Reserved. 

(f) Origination Fee. Contemporaneous with Borrowers’ execution of this Agreement, Borrowers shall pay Agent, for the benefit of all
Lenders committed to make Revolving Loans on the Closing Date, in accordance with their respective Pro Rata Shares, a fee in an amount equal to (i) the Revolving Loan Commitment, multiplied by (ii) one half of one percent (0.50%).
All fees payable pursuant to this paragraph shall be due and payable and non-refundable as of the Closing Date. 

(g) Deferred Revolving Loan Origination Fee. If Lenders’ funding obligations in respect of the Revolving Loan Commitment under this
Agreement terminate or are permanently reduced for any reason (whether by voluntary termination by Borrowers, by reason of the occurrence of an Event of Default or otherwise) prior to the Maturity Date, Borrowers shall pay to Agent on the date of
such reduction, for the benefit of all Lenders committed to make Revolving Loans on the Closing Date, a fee as compensation for the costs of such Lenders being prepared to make funds available to Borrowers under this Agreement, equal to an amount
determined by multiplying the Revolving Loan Commitment by the following applicable percentage amount:
two-and-a-half percent (2.5%) for the first year following the Closing Date, one-and-a-half percent (1.5%) for the second year following the Closing Date, and zero percent (0%) thereafter. All fees payable pursuant to this paragraph shall be
deemed fully earned and non-refundable as of the Closing Date. 
 (h) Reserved. 

(i) Reserved. 
 (j)
Reserved. 
 (k) Audit Fees. Subject to Section 4.6, Borrowers shall pay to Agent, for its own account and not for the
benefit of any other Lenders, all reasonable fees and expenses in connection with audits and inspections of Borrowers’ books and records, audits, valuations or appraisals of the Collateral, audits of Borrowers’ compliance with applicable
Laws and such other matters as Agent shall deem appropriate, which shall be due and payable on the first Business Day of the month following the date of issuance by Agent of a written request for payment thereof to Borrowers. 

(l) Wire Fees. Borrowers shall pay to Agent, for its own account and not for the account of any other Lenders, on written demand, fees
for incoming and outgoing wires made for the account of Borrowers, such fees to be based on Agent’s (or, during any Third Party Agent Retention Period, the Third Party Agent’s) then current wire fee schedule (available upon written request
of the Borrowers). 
 (m) Reserved. 

(n) Computation of Interest and Related Fees. All interest and fees under each Financing Document shall be calculated on the basis of a 360-day year for the actual number of days elapsed. The date of funding of a Loan shall be included in the calculation of interest. The date of payment of a Loan shall be excluded from the calculation of interest.
If a Loan is repaid on the same day that it is made, one (1) day’s interest shall be charged. 

  
 43 

 (o) Automated Clearing House Payments. If Agent so elects, monthly payments of principal,
interest, fees, expenses or any other amounts due and owing from Borrower to Agent hereunder shall be paid to Agent by Automated Clearing House debit of immediately available funds from the financial institution account designated by Borrower
Representative in the Automated Clearing House debit authorization executed by Borrowers or Borrower Representative in connection with this Agreement, and shall be effective upon receipt. Borrowers shall execute any and all forms and documentation
necessary from time to time to effectuate such automatic debiting. In no event shall any such payments be refunded to Borrowers. 

Section 2.3 Notes. The portion of the Loans made by each Lender shall be evidenced, if so requested by such
Lender, by one or more promissory notes executed by Borrowers on a joint and several basis (each, a “Note”) in an original principal amount equal to such Lender’s Revolving Loan Commitment Amount. 

Section 2.4 Reserved. 

Section 2.5 Reserved. 

Section 2.6 General Provisions Regarding Payment; Loan Account. 

(a) All payments to be made by each Borrower under any Financing Document, including payments of principal and interest made hereunder and
pursuant to any other Financing Document, and all fees, expenses, indemnities and reimbursements, shall be made without set-off, recoupment or counterclaim. If any payment hereunder becomes due and payable on
a day other than a Business Day, such payment shall be extended to the next succeeding Business Day and, with respect to payments of principal, interest thereon shall be payable at the then applicable rate during such extension (it being understood
and agreed that, solely for purposes of calculating financial covenants and computations contained herein and determining compliance therewith, if payment is made, in full, on any such extended due date, such payment shall be deemed to have been
paid on the original due date without giving effect to any extension thereto). Any payments received in the Payment Account before 12:00 Noon (Eastern time) on any date shall be deemed received by Agent on such date, and any payments received in the
Payment Account at or after 12:00 Noon (Eastern time) on any date shall be deemed received by Agent on the next succeeding Business Day. 

(b) During any Third Party Agent Retention Period, Agent shall maintain a loan account (the “Loan Account”) on its books to
record Loans and other extensions of credit made by the Lenders hereunder or under any other Financing Document, and all payments thereon made by each Borrower. All entries in the Loan Account shall be made in accordance with Agent’s customary
accounting practices as in effect from time to time. The balance in the Loan Account, as recorded in Agent’s books and records at any time shall be conclusive and binding evidence of the amounts due and owing to Agent by each Borrower absent
manifest error; provided, however, that any failure to so record or any error in so recording shall not limit or otherwise affect any Borrower’s duty to pay all amounts owing hereunder or under any other Financing Document. During
any Non-Third Party Agent Retention Period, the Borrower Representative shall maintain such Loan Account and shall make such books, records and Loan Account available to Agent and the Lenders upon request
therefrom. Upon the request of any Third Party Agent upon the commencement of any Third Party Agent Retention Period, the Borrower Representative shall share such books and records of the Borrower Representative and such Loan Account with the Third
Party Agent, and with respect to any discrepancies between the books, records or Loan Account of the Borrower Representative, on the one hand, and the books, records or Loan Account of any Lender, the Agent or the Third Party Agent, on the other
hand, the books, records and Loan Account of such Lender, Agent or Third Party Agent shall govern and control in the absence of manifest error. 

  
 44 

 Section 2.7 Maximum Interest. In no event shall the interest
charged with respect to the Loans or any other Obligations of any Borrower under any Financing Document exceed the maximum amount permitted under the laws of the State of New York or of any other applicable jurisdiction. Notwithstanding anything to
the contrary herein or elsewhere, if at any time the rate of interest payable hereunder or under any Note or other Financing Document (the “Stated Rate”) would exceed the highest rate of interest permitted under any applicable law
to be charged (the “Maximum Lawful Rate”), then for so long as the Maximum Lawful Rate would be so exceeded, the rate of interest payable shall be equal to the Maximum Lawful Rate; provided, however, that if at any
time thereafter the Stated Rate is less than the Maximum Lawful Rate, each Borrower shall, to the extent permitted by law, continue to pay interest at the Maximum Lawful Rate until such time as the total interest received is equal to the total
interest which would have been received had the Stated Rate been (but for the operation of this provision) the interest rate payable. Thereafter, the interest rate payable shall be the Stated Rate unless and until the Stated Rate again would exceed
the Maximum Lawful Rate, in which event this provision shall again apply. In no event shall the total interest received by any Lender exceed the amount which it could lawfully have received had the interest been calculated for the full term hereof
at the Maximum Lawful Rate. If, notwithstanding the prior sentence, any Lender has received interest hereunder in excess of the Maximum Lawful Rate, such excess amount shall be applied to the reduction of the principal balance of the Loans or to
other amounts (other than interest) payable hereunder, and if no such principal or other amounts are then outstanding, such excess or part thereof remaining shall be paid to Borrowers. In computing interest payable with reference to the Maximum
Lawful Rate applicable to any Lender, such interest shall be calculated at a daily rate equal to the Maximum Lawful Rate divided by the number of days in the year in which such calculation is made. 

Section 2.8 Taxes; Capital Adequacy. 

(a) All payments of principal and interest on the Loans and all other amounts payable hereunder shall be made free and clear of and without
deduction for any present or future income, excise, stamp, documentary, payroll, employment, property or franchise taxes and other taxes, fees, duties, levies, assessments, withholdings or other charges of any nature whatsoever (including interest
and penalties thereon) imposed by any taxing authority, excluding (1) taxes imposed on or measured by Agent’s or any Lender’s net income (however denominated), capital or net worth, branch profits taxes, and franchise taxes, in each
case imposed by any jurisdiction (or subdivision thereof) under which Agent or such Lender is organized, conducts business (other than solely as the result of entering into any of the Financing Documents or taking any action thereunder) or, in the
case of any Lender, in which its applicable lending office is located, (2) in the case of any Foreign Lender, any withholding tax that is imposed on amounts payable to such Foreign Lender at the time such Foreign Lender becomes a party to this
Agreement or designates a new lending office (except to the extent that, pursuant to this Section 2.8, amounts with respect to such taxes were payable to such Lender immediately before it changed its lending office), (3) in the case of any
Lender that is not a Foreign Lender, any United States federal backup withholding tax and (4) taxes imposed under FATCA (all such excluded items, “Excluded Taxes”; all non-excluded items
being called “Taxes”). If any withholding or deduction from any payment to be made by any Borrower hereunder is required in respect of any Taxes pursuant to any applicable Law, then Borrowers will: (i) pay directly to the
relevant authority the full amount required to be so withheld or deducted; (ii) promptly forward to Agent an official receipt or other documentation satisfactory to Agent evidencing such payment to such authority; and (iii) pay to Agent
for the account of Agent and Lenders such additional amount or amounts as is necessary to ensure that the net amount actually received by Agent and each Lender will equal the full amount Agent and such Lender would have received had no such
withholding or deduction been required. If any Taxes are directly asserted against Agent or any Lender with respect to any payment received by Agent or such Lender hereunder, Agent or such Lender may pay such Taxes and Borrowers will promptly pay
such additional amounts (including any penalty, interest or expense) as is necessary in order that the net amount received by such Person after the payment of such Taxes (including any Taxes on such additional amount) shall equal the amount such
Person would have received had such Taxes not been asserted so long as such amounts have accrued on or after the day which is two hundred seventy (270) days prior to the date on which Agent or such Lender first made written demand therefor.

  
 45 

 (b) If any Borrower fails to pay any Taxes when due to the appropriate taxing authority or fails
to remit to Agent, for the account of Agent and the respective Lenders, the required receipts or other required documentary evidence, Borrowers shall indemnify Agent and Lenders for any incremental Taxes, interest or penalties that may become
payable by Agent or any Lender as a result of any such failure. 
 (c) Each Lender that is not U.S. person as defined in Section 7701(a)(30)
of the Code and (A) is a party hereto on the Closing Date or (B) purports to become an assignee of an interest as a Lender under this Agreement after the Closing Date (unless such Lender was already a Lender hereunder immediately prior to
such assignment) (each such Lender a “Foreign Lender”) shall execute and deliver to each of Borrowers and Agent one or more (as Borrowers or Agent may reasonably request) United States Internal Revenue Service Forms W-8ECI, W-8BEN, W-8BEN-E, W-8IMY (as applicable) and
other applicable forms, certificates or documents prescribed by the United States Internal Revenue Service or reasonably requested by Agent certifying as to such Lender’s entitlement to a complete exemption from withholding or deduction of
Taxes. Each Lender that is not a Foreign Lender shall (to the extent legally entitled to do so) provide updated forms to Borrower and Agent on or prior to the date any prior form previously provided under this Section 2.8(c) becomes obsolete or
expires, after the occurrence of an event requiring a change in the most recent form or certification previously delivered by it pursuant to this Section 2.8(c) or from time to time if requested by Borrower or Agent. Each such Lender shall deliver
to Agent and Borrower on or prior to the date on which such Lender becomes a party to this Agreement (and from time to time thereafter upon the request of Borrower or Agent) properly completed and executed originals of United States Internal Revenue
Service Form W-9 certifying that such Lender is exempt from backup withholding. Borrowers shall not be required to pay additional amounts to any Lender pursuant to this Section 2.8 with respect to United
States deductions or withholding (or any additions to Tax, penalties or interest with respect thereto) and income Taxes to the extent that the obligation to pay such additional amounts would not have arisen but for the failure of such Lender to
comply with this paragraph other than solely as a result of a change in applicable Tax law. Without limiting the foregoing, each Lender shall timely provide any documentation reasonably requested by Borrower or Agent sufficient for Borrower and
Agent to comply with their obligations under FATCA and to determine whether such Lender has complied with applicable reporting requirements under FATCA. 

(d) If any Lender shall determine in its commercially reasonable judgment that the adoption or taking effect of, or any change in, any
applicable Law regarding capital adequacy, in each instance, after the Closing Date, or any change after the Closing Date in the interpretation, administration or application thereof by any Governmental Authority, central bank or comparable agency
charged with the interpretation, administration or application thereof, or the compliance by any Lender or any Person controlling such Lender with any request, guideline or directive regarding capital adequacy (whether or not having the force of
law) of any such Governmental Authority, central bank or comparable agency adopted or otherwise taking effect after the Closing Date, has or would have the effect of reducing the rate of return on such Lender’s or such controlling Person’s
capital as a consequence of such Lender’s obligations hereunder to a level below that which such Lender or such controlling Person could have achieved but for such adoption, taking effect, change, interpretation, administration, application or
compliance (taking into consideration such Lender’s or such controlling Person’s policies with respect to capital adequacy) then from time to time, upon written demand by such Lender (which demand shall be accompanied by a statement
setting forth the basis for such demand and a calculation of the amount thereof in reasonable detail, a copy of which shall be furnished to Agent), Borrowers shall promptly pay to such Lender such additional amount as will compensate such Lender or
such controlling Person for such reduction, so long as such amounts have accrued on or after the day which is two hundred seventy (270) 

  
 46 

 
days prior to the date on which such Lender first made demand therefor; provided, however, that notwithstanding anything in this Agreement to the contrary, (i) the Dodd-Frank Wall
Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International
Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “change in
applicable Law”, regardless of the date enacted, adopted or issued. 
 (e) If any Lender requires compensation under Section 2.8(d), or
requires any Borrower to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.8(a), then, upon the written request of Borrower Representative, such Lender shall use reasonable
efforts to designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder (subject to the terms of this Agreement) to another of its offices, branches or affiliates, if, in the
judgment of such Lender, such designation or assignment (i) would eliminate or materially reduce amounts payable pursuant to any such subsection, as the case may be, in the future, and (ii) would not subject such Lender to any unreimbursed
cost or expense and would not otherwise be disadvantageous to such Lender (as determined in its sole discretion). Borrowers hereby agree to pay all reasonable costs and expenses incurred by any Lender in connection with any such designation or
assignment. 
 (f) If Agent or a Lender determines in its sole discretion exercised in good faith that it has received a refund of any Taxes
for which it has been indemnified or with respect to which Borrower has paid additional amounts pursuant to Section 2.8(a), it shall pay over such refund to Borrower (but only to the extent of indemnity payments made, or additional amounts paid,
under Section 2.8(a) with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses of the Agent or such Lender and without interest (other
than any interest paid by the relevant Governmental Authority with respect to such refund); provided that Borrower, upon the request of Agent or such Lender, agrees to repay to Agent or such Lender the amount paid over to Borrower in the event Agent
or such Lender is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (f), in no event will the Agent or Lender be required to pay any amount to the Borrower pursuant to this
paragraph (f) the payment of which would place the Agent or Lender in a less favorable net after-tax position than the Agent or Lender would have been in if the tax subject to indemnification and giving
rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such tax had never been paid. This paragraph shall not be construed to require the Agent or Lender to
make available its tax returns (or any other information relating to its taxes that it deems confidential) to the Borrower or any other Person. 

Section 2.9 Appointment of Borrower Representative. 

(a) Each Borrower hereby irrevocably appoints and constitutes Borrower Representative as its agent and attorney-in-fact to request and receive Loans in the name or on behalf of such Borrower and any other Borrowers, deliver Notices of Borrowing, and Borrowing Base Certificates, give instructions with respect
to the disbursement of the proceeds of the Loans, giving and receiving all other notices and consents hereunder or under any of the other Financing Documents and taking all other actions (including in respect of compliance with covenants) in the
name or on behalf of any Borrower or Borrowers pursuant to this Agreement and the other Financing Documents. Agent and Lenders may disburse the Loans to such bank account of Borrower Representative or a Borrower or otherwise make such Loans to a
Borrower, in each case as Borrower Representative may designate or direct, without notice to any other Borrower. Notwithstanding anything to the contrary contained herein, Agent may at any time and from time to time require that Loans to or for the
account of any Borrower be disbursed directly to an operating account of such Borrower. 

  
 47 

 (b) Borrower Representative hereby accepts the appointment by Borrowers to act as the agent and attorney-in-fact of Borrowers pursuant to this Section 2.9. Borrower Representative shall ensure that the disbursement of any Loans that are at any time requested by or
to be remitted to or for the account of a Borrower, shall be remitted or issued to or for the account of such Borrower. 
 (c) Each Borrower
hereby irrevocably appoints and constitutes Borrower Representative as its agent to receive statements on account and all other notices from Agent and/or Lenders with respect to the Obligations or otherwise under or in connection with this Agreement
and the other Financing Documents. 
 (d) Any notice, election, representation, warranty, agreement or undertaking made or delivered by or on
behalf of any Borrower by Borrower Representative shall be deemed for all purposes to have been made or delivered by such Borrower, as the case may be, and shall be binding upon and enforceable against such Borrower to the same extent as if made or
delivered directly by such Borrower. 
 (e) No resignation by or termination of the appointment of Borrower Representative as agent and attorney-in-fact as aforesaid shall be effective, except after ten (10) Business Days’ prior written notice to Agent. If the Borrower Representative resigns under
this Agreement, Borrowers shall be entitled to appoint a successor Borrower Representative (which shall be a Borrower and shall be reasonably acceptable to Agent as such successor). Upon the acceptance of its appointment as successor Borrower
Representative hereunder, such successor Borrower Representative shall succeed to all the rights, powers and duties of the retiring Borrower Representative and the term “Borrower Representative” shall mean such successor Borrower
Representative for all purposes of this Agreement and the other Financing Documents, and the retiring or terminated Borrower Representative’s appointment, powers and duties as Borrower Representative shall be thereupon terminated. 

Section 2.10 Joint and Several Liability; Rights of Contribution; Subordination and Subrogation. 

(a) Borrowers are defined collectively to include all Persons named as one of the Borrowers herein; provided, however, that any
references herein to “any Borrower”, “each Borrower” or similar references, shall be construed as a reference to each individual Person named as one of the Borrowers herein. Each Person so named shall be jointly and severally
liable for all of the obligations of Borrowers under this Agreement. Each Borrower, individually, expressly understands, agrees and acknowledges, that the credit facilities would not be made available on the terms herein in the absence of the
collective credit of all of the Persons named as the Borrowers herein, the joint and several liability of all such Persons, and the cross-collateralization of the collateral of all such Persons. Accordingly, each Borrower individually acknowledges
that the benefit to each of the Persons named as one of the Borrowers as a whole constitutes reasonably equivalent value, regardless of the amount of the credit facilities actually borrowed by, advanced to, or the amount of collateral provided by,
any individual Borrower. In addition, each entity named as one of the Borrowers herein hereby acknowledges and agrees that all of the representations, warranties, covenants, obligations, conditions, agreements and other terms contained in this
Agreement shall be applicable to and shall be binding upon and measured and enforceable individually against each Person named as one of the Borrowers herein as well as all such Persons when taken together. By way of illustration, but without
limiting the generality of the foregoing, the terms of Section 10.1 of this Agreement are to be applied to each individual Person named as one of the Borrowers herein (as well as to all such Persons taken as a whole), such that the occurrence
of any of the events described in Section 10.1 of this Agreement as to any Person named as one of the Borrowers herein shall constitute an Event of Default even if such event has not occurred as to any other Persons named as the Borrowers or as
to all such Persons taken as a whole. 

  
 48 

 (b) Notwithstanding any provisions of this Agreement to the contrary, it is intended that the
joint and several nature of the liability of each Borrower for the Obligations and the Liens granted by Borrowers to secure the Obligations, not constitute a Fraudulent Conveyance (as defined below). Consequently, Agent, Lenders and each Borrower
agree that if the liability of a Borrower for the Obligations, or any Liens granted by such Borrower securing the Obligations would, but for the application of this sentence, constitute a Fraudulent Conveyance, the liability of such Borrower and the
Liens securing such liability shall be valid and enforceable only to the maximum extent that would not cause such liability or such Lien to constitute a Fraudulent Conveyance, and the liability of such Borrower and this Agreement shall automatically
be deemed to have been amended accordingly. For purposes hereof, the term “Fraudulent Conveyance” means a fraudulent conveyance under Section 548 of Chapter 11 of Title II of the Bankruptcy Code or a fraudulent conveyance or
fraudulent transfer under the applicable provisions of any fraudulent conveyance or fraudulent transfer law or similar law of any state, nation or other governmental unit, as in effect from time to time. 

(c) Agent is hereby authorized, without notice or demand (except as otherwise specifically required under this Agreement) and without affecting
the liability of any Borrower hereunder, at any time and from time to time, to (i) renew, extend or otherwise increase the time for payment of the Obligations; (ii) with the written agreement of any Borrower, change the terms relating to
the Obligations or otherwise modify, amend or change the terms of any Note or other agreement, document or instrument now or hereafter executed by any Borrower and delivered to Agent for any Lender; (iii) accept partial payments of the
Obligations; (iv) take and hold any Collateral for the payment of the Obligations or for the payment of any guaranties of the Obligations and exchange, enforce, waive and release any such Collateral; (v) apply any such Collateral and
direct the order or manner of sale thereof as Agent, in its sole discretion, may determine; and (vi) settle, release, compromise, collect or otherwise liquidate the Obligations and any Collateral therefor in any manner, all guarantor and surety
defenses being hereby waived by each Borrower. Without limitations of the foregoing, with respect to the Obligations, each Borrower hereby makes and adopts each of the agreements and waivers set forth in each Guarantee, the same being incorporated
hereby by reference. Except as specifically provided in this Agreement or any of the other Financing Documents, Agent shall have the exclusive right to determine the time and manner of application of any payments or credits, whether received from
any Borrower or any other source, and such determination shall be binding on all Borrowers. All such payments and credits may be applied, reversed and reapplied, in whole or in part, to any of the Obligations that Agent shall determine, in its sole
discretion, without affecting the validity or enforceability of the Obligations of the other Borrower. 
 (d) Each Borrower hereby agrees
that, except as hereinafter provided, its obligations hereunder shall be unconditional, irrespective of (i) the absence of any attempt to collect the Obligations from any obligor or other action to enforce the same; (ii) the waiver or
consent by Agent with respect to any provision of any instrument evidencing the Obligations, or any part thereof, or any other agreement heretofore, now or hereafter executed by a Borrower and delivered to Agent; (iii) failure by Agent to take
any steps to perfect and maintain its security interest in, or to preserve its rights to, any security or collateral for the Obligations; (iv) the institution of any proceeding under the Bankruptcy Code, or any similar proceeding, by or against
a Borrower or Agent’s election in any such proceeding of the application of Section 1111(b)(2) of the Bankruptcy Code; (v) any borrowing or grant of a security interest by a Borrower as debtor-in-possession, under Section 364 of the Bankruptcy Code; (vi) the disallowance, under Section 502 of the Bankruptcy Code, of all or any portion of Agent’s claim(s) for repayment of
any of the Obligations; or (vii) any other circumstance other than payment in full of the Obligations which might otherwise constitute a legal or equitable discharge or defense of a guarantor or surety. 

  
 49 

 (e) Borrowers hereby agree, as between themselves, that to the extent that Agent, on behalf of
Lenders, shall have received from any Borrower any Recovery Amount (as defined below), then the paying Borrower shall have a right of contribution against each other Borrower in an amount equal to such other Borrower’s contributive share of
such Recovery Amount; provided, however, that in the event any Borrower suffers a Deficiency Amount (as defined below), then the Borrower suffering the Deficiency Amount shall be entitled to seek and receive contribution from and against the
other Borrowers in an amount equal to the Deficiency Amount; and provided, further, that in no event shall the aggregate amounts so reimbursed by reason of the contribution of any Borrower equal or exceed an amount that would, if paid,
constitute or result in Fraudulent Conveyance. Until all Obligations have been paid and satisfied in full, no payment made by or for the account of a Borrower including (i) a payment made by such Borrower on behalf of the liabilities of any
other Borrower, or (ii) a payment made by any other Guarantor under any Guarantee, shall entitle such Borrower, by subrogation or otherwise, to any payment from such other Borrower or from or out of such other Borrower’s property. The
right of each Borrower to receive any contribution under this Section 2.10(e) or by subrogation or otherwise from any other Borrower shall be subordinate in right of payment to the Obligations and such Borrower shall not exercise any right or remedy
against such other Borrower or any property of such other Borrower by reason of any performance of such Borrower of its joint and several obligations hereunder, until the Obligations have been indefeasibly paid and satisfied in full, and no Borrower
shall exercise any right or remedy with respect to this Section 2.10(e) until the Obligations have been indefeasibly paid and satisfied in full. As used in this Section 2.10(e), the term “Recovery Amount” means the amount of proceeds
received by or credited to Agent from the exercise of any remedy of the Lenders under this Agreement or the other Financing Documents, including the sale of any Collateral. As used in this Section 2.10(e), the term “Deficiency Amount”
means any amount that is less than the entire amount a Borrower is entitled to receive by way of contribution or subrogation from, but that has not been paid by, the other Borrowers in respect of any Recovery Amount attributable to the Borrower
entitled to contribution, until the Deficiency Amount has been reduced to Zero Dollars ($0) through contributions and reimbursements made under the terms of this Section 2.10(e) or otherwise. 

Section 2.11 Collections and Lockbox Account. Upon and after the Initial Third Party Agent Commencement Date
and at all times thereafter (unless otherwise agreed to in writing by Agent during any Non-Third Party Agent Retention Period): 

(a) Borrowers shall maintain a lockbox (the “Lockbox”) with a United States depository institution designated from time to
time by Agent (the “Lockbox Bank”), subject to the provisions of this Agreement, and prior the end of the Lockbox Post-Closing Period shall execute with the Lockbox Bank a Deposit Account Control Agreement and such other agreements
related to such Lockbox as Agent may require. Borrowers shall have directed each Account Debtor to make payments in respect of the Accounts (and shall use commercially reasonable efforts to ensure that all collections of Accounts are paid directly
from such Account Debtors) (i) into the Lockbox for deposit into the Lockbox Account and/or (ii) directly into the Lockbox Account; provided, however, unless Agent shall otherwise direct by written notice to Borrowers, Borrowers
shall be permitted to cause Account Debtors who are individuals to pay Accounts directly to Borrowers, which Borrowers shall then administer and apply in the manner required below. All funds deposited into a Lockbox Account shall be transferred into
the Payment Account by the close of each Business Day. During the Lockbox Post-Closing Period, Borrower shall ensure that an irrevocable standing wire instruction pursuant to which the Lockbox Bank agrees to transfer all funds from the Lockbox
Account into the Payment Account at the end of each Business Day is in place. 
 (b) Reserved. 

(c) Notwithstanding anything in any lockbox agreement or Deposit Account Control Agreement to the contrary, Borrowers agree that they shall be
liable for any fees and charges in effect from time to time and charged by the Lockbox Bank in connection with the Lockbox, the Lockbox Account, and that Agent shall have no liability therefor. Borrowers hereby indemnify and agree to hold Agent
harmless from any and all liabilities, claims, losses and demands whatsoever, including reasonable attorneys’ fees and expenses, arising from or relating to actions of Agent or the Lockbox Bank pursuant to this Section or any lockbox agreement
or Deposit Account Control Agreement or similar agreement, except to the extent of such losses arising from Agent’s gross negligence or willful misconduct. 

  
 50 

 (d) Agent shall apply, on a daily basis, all funds transferred into the Payment Account pursuant
to this Section 2.11 to reduce the outstanding Revolving Loans in such order of application as Agent shall elect. If as the result of collections of Accounts pursuant to the terms and conditions of this Section, a credit balance exists with
respect to the Loan Account, such credit balance shall not accrue interest in favor of Borrowers, but Agent shall transfer such funds into an account designated by Borrower Representative for so long as no Event of Default exists. 

(e) To the extent that any collections of Accounts or proceeds from the disposition of other Collateral that is included in the Borrowing Base
are not sent directly to the Lockbox or Lockbox Account but are received by any Borrower, such collections shall be held in trust for the benefit of Agent pursuant to an express trust created hereby immediately remitted, in the form received, to
applicable Lockbox or Lockbox Account. No such funds received by any Borrower shall be commingled with other funds of the Borrowers. If any funds received by any Borrower are commingled with other funds of the Borrowers, or are required to be
deposited to a Lockbox or Lockbox Account and are not so deposited within five (5) Business Days, then Borrowers shall pay to Agent, for its own account and not for the account of any other Lenders, a compliance fee equal to $500 for each day
that any such conditions exist. 
 (f) Borrowers acknowledge and agree that compliance with the terms of this Section is essential, and that
Agent and Lenders will suffer immediate and irreparable injury and have no adequate remedy at law, if any Borrower, through acts or omissions, causes or permits Account Debtors to send payments other than to the Lockbox or Lockbox Accounts or if any
Borrower fails to promptly deposit collections of Accounts or proceeds of other Collateral in the Lockbox Account as herein required. Accordingly, in addition to all other rights and remedies of Agent and Lenders hereunder, Agent shall have the
right to seek specific performance of the Borrowers’ obligations under this Section, and any other equitable relief as Agent may deem necessary or appropriate, and Borrowers waive any requirement for the posting of a bond in connection with
such equitable relief. 
 (g) Borrowers shall not, and Borrowers shall not suffer or permit any Credit Party to, (i) withdraw any
amounts from any Lockbox Account, (ii) change the procedures or sweep instructions under the agreements governing any Lockbox Accounts, or (iii) send to or deposit in any Lockbox Account any funds other than payments made with respect to
and proceeds of Accounts or other Collateral. Borrowers shall, and shall cause each Credit Party to, cooperate with Agent in the identification and reconciliation on a daily basis of all amounts received in or required to be deposited into the
Lockbox Accounts. If more than five percent (5%) of the collections of Accounts received by Borrowers during any given fifteen (15) day period is not identified or reconciled to the reasonable satisfaction of Agent within ten (10) Business
Days of receipt, Agent shall not be obligated to make further advances under this Agreement until such amount is identified or is reconciled to the reasonable satisfaction of Agent, as the case may be. In addition, if any such amount cannot be
identified or reconciled to the reasonable satisfaction of Agent, Agent may utilize its own staff or, if it deems necessary (or if Agent has any concerns with obtaining material nonpublic information by utilizing its own staff, engage an outside
auditor, in either case at Borrowers’ expense (which in the case of Agent’s own staff charges shall be in accordance with Agent’s good faith business judgment (plus expenses)), to make such examination and report as may be
necessary to identify and reconcile such amount. 
 (h) If any Borrower breaches its obligation to direct payments of the proceeds of the
Collateral to the Lockbox Account, Agent, as the irrevocably made, constituted and appointed true and lawful attorney for Borrowers, may, by the signature or other act of any of Agent’s authorized representatives (without requiring any of them
to do so), direct any Account Debtor to pay proceeds of the Collateral to Borrowers by directing payment to the Lockbox Account. 

  
 51 

 Section 2.12 Termination; Restriction on Termination. 

(a) Termination by Lenders. In addition to the rights set forth in Section 10.2, Agent may, and at the direction of Required
Lenders shall, terminate this Agreement without notice upon or after the occurrence and during the continuance of an Event of Default. 
 (b)
Termination by Borrowers. Upon at least five (5) Business Days’ prior written notice (or such shorter period to which Agent may agree in its discretion) and pursuant to payoff documentation in form and substance reasonably
satisfactory to Agent and Lenders, Borrowers may, at its option, terminate this Agreement; provided, however, that no such termination shall be effective until Borrowers have paid all fees required pursuant to the terms of Section 2.2 in
immediately available funds. Any notice of termination given by Borrowers shall be irrevocable unless (i) all Lenders otherwise agree in writing and no Lender shall have any obligation to make any Loans on or after the termination date stated
in such notice or (ii) Borrowers indicate to Lender that, in connection with any equity or debt financing or change of control, that such financing or change of control has been delayed, in which case Borrowers shall provide a new date for such
termination. Borrowers may elect to terminate this Agreement in its entirety only. No section of this Agreement or type of Loan available hereunder may be terminated singly. 

(c) Effectiveness of Termination. All of the Obligations (other than inchoate indemnification obligations for which no claim has been
asserted) shall be immediately due and payable upon the Termination Date. All undertakings, agreements, covenants, warranties and representations of Borrowers contained in the Financing Documents shall survive any such termination and Agent shall
retain its Liens in the Collateral and Agent and each Lender shall retain all of its rights and remedies under the Financing Documents notwithstanding such termination until all Obligations (other than inchoate indemnification obligations for which
no claim has been asserted) have been discharged or paid, in full, in immediately available funds, including all Obligations under Section 2.2(g), resulting from such termination; provided that upon such payment in full this Agreement will
automatically terminate and all Collateral shall be automatically released from the security interest created hereunder and under the other Financing Documents without any further action by any party. Notwithstanding the foregoing or the payment in
full of the Obligations, Agent shall not be required to terminate its Liens in the Collateral unless, with respect to any loss or damage Agent may incur as a result of dishonored checks or other items of payment received by Agent from Borrower or
any Account Debtor and applied to the Obligations, Agent shall (i) have received a written agreement satisfactory to Agent, executed by Borrowers and by any Person whose loans or other advances to Borrowers are used in whole or in part to
satisfy the Obligations, indemnifying Agent and each Lender from any such loss or damage or (ii) have retained cash Collateral or other Collateral for such period of time as Agent, in its reasonable discretion, may deem necessary to protect
Agent and each Lender from any such loss or damage. 
 (d) Partial Collateral Release. In respect of Collateral that is disposed of in
a manner permitted hereunder, the security interest in such Collateral (but not in respect of Collateral not so disposed of) shall be automatically terminated upon such disposition without any further action by any party. 

(e) Actions by Agent. Without limiting the foregoing clauses (a)-(d), Agent will, at the sole expense of Borrower, take such actions as
may be reasonably requested by Borrower to evidence any of the foregoing releases set forth in clauses (c) and (d) above (including duly assigning, transferring and delivering to or at the direction of Borrower (without recourse and without any
representation or warranty) such of the Collateral as may then be in the possession of Agent, together with any monies at the time held by Agent hereunder, and executing and delivering to Borrower a proper instrument or instruments, as reasonably
requested, acknowledging the satisfaction and termination of this Agreement (in the case of clause (c) above) and the release of Liens hereunder and under the other Financing Documents. 

  
 52 

 ARTICLE 3 - REPRESENTATIONS AND WARRANTIES 

To induce Agent and Lenders to enter into this Agreement and to make the Loans and other credit accommodations contemplated hereby, each
Borrower hereby represents and warrants to Agent and each Lender that: 
 Section 3.1 Existence and Power.
Each Credit Party (a) is an entity as specified on Schedule 3.1, (b) is duly organized, validly existing and in good standing under the laws of the jurisdiction specified on Schedule 3.1 and no other jurisdiction, (c) has the
same legal name as it appears in such Credit Party’s Organizational Documents and an organizational identification number (if any), in each case as specified on Schedule 3.1, (d) has all powers and all Permits necessary or desirable in
the operation of its business as presently conducted or as proposed to be conducted, except where the failure to have such Permits could not reasonably be expected to have a Material Adverse Effect, and (e) is qualified to do business as a
foreign entity in each jurisdiction in which it is required to be so qualified, which jurisdictions as of the Closing Date are specified on Schedule 3.1, except where the failure to be so qualified could not reasonably be expected to have a
Material Adverse Effect. As of the Closing Date, except as set forth on Schedule 3.1, no Credit Party (x) has had, over the five (5) year period preceding the Closing Date, any name other than its current name, or (y) was
incorporated or organized under the laws of any jurisdiction other than its current jurisdiction of incorporation or organization. 

Section 3.2 Organization and Governmental Authorization; No Contravention. The execution, delivery and
performance by each Credit Party of the Operative Documents to which it is a party (a) are within its powers, (b) have been duly authorized by all necessary action pursuant to its Organizational Documents, (c) require no further
action by or in respect of, or filing with, any Governmental Authority, except for the filings necessary to perfect the Liens created by the Financing Documents and any necessary filings with the SEC, and (d) do not violate, conflict with or
cause a breach or a default under (i) any Law applicable to any Credit Party or any of the Organizational Documents of any Credit Party, or (ii) any agreement or instrument binding upon it, except for such violations, conflicts, breaches
or defaults as could not, with respect to this clause (ii), reasonably be expected to have a Material Adverse Effect. 

Section 3.3 Binding Effect. Each of the Operative Documents to which any Credit Party is a party constitutes
a valid and binding agreement or instrument of such Credit Party, enforceable against such Credit Party in accordance with its respective terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws
relating to the enforcement of creditors’ rights generally and by general equitable principles. 
 Section 3.4
Capitalization. The authorized equity securities of each of the Credit Parties (other than Endologix) as of the Closing Date are as set forth on Schedule 3.4. All issued and outstanding equity securities of each of the Credit
Parties (other than Endologix) are duly authorized and validly issued, fully paid, nonassessable, free and clear of all Liens other than those in favor of Agent for the benefit of Agent and Lenders, and such equity securities were issued in
compliance with all applicable Laws. The identity of the holders of the equity securities of each of the Credit Parties (other than Endologix) and the percentage of their fully-diluted ownership of the equity securities of each of the Credit Parties
(other than Endologix) as of the Closing Date is set forth on Schedule 3.4. No shares of the capital stock or other equity securities of any Credit Party (other than Endologix), other than those described above, are issued and outstanding as
of the Closing Date. Except as set forth on Schedule 3.4, as of the Closing Date there are no preemptive or other outstanding rights, options, warrants, conversion rights or similar agreements or understandings for the purchase or acquisition
from any Credit Party (other than Endologix) of any equity securities of any such entity. 

  
 53 

 Section 3.5 Financial Information. All written information
delivered to Agent and pertaining to the financial condition of any Credit Party fairly presents in all material respects the financial position of the Credit Parties (taken as a whole) as of such date, and with respect to financial statements
delivered after the Closing Date, in conformity with GAAP (and as to unaudited financial statements, subject to normal year-end adjustments and the absence of footnote disclosures). Since December 31,
2016, a Material Adverse Effect has not occurred. 
 Section 3.6 Litigation. Except as set forth on
Schedule 3.6 as of the Closing Date, and except as hereafter disclosed in writing to (a) during any Non-Third Party Agent Retention Period, subject to Section 4.19, Agent, and (b) during
any Third Party Agent Retention Period, the Third Party Agent, in each case, there is no Litigation pending against, or to such Borrower’s knowledge threatened against, any Credit Party and which involves any reasonable likelihood of any
judgment or liability of more than Two Million Dollars ($2,000,000) or that could reasonably be expected to result in a Material Adverse Effect. There is no Litigation pending which could reasonably be expected to have a Material Adverse Effect or
which in any manner draws into question the validity of any of the Financing Documents. 
 Section 3.7
Ownership of Property. Each Borrower and each of its Subsidiaries is the lawful owner of, has good and marketable title to and is in lawful possession of, or has valid leasehold interests in, all properties, accounts and other assets
(real or personal, tangible, intangible or mixed) purported or reported to be owned or leased (as the case may be) by such Person. 

Section 3.8 No Default. No Event of Default, or to such Borrower’s knowledge, Default, has occurred and
is continuing. No Credit Party is in breach or default under or with respect to any contract, agreement, lease or other instrument to which it is a party or by which its property is bound or affected, which breach or default could reasonably be
expected to have a Material Adverse Effect. 
 Section 3.9 Labor Matters. As of the Closing Date, there are
no strikes or other labor disputes pending or, to any Borrower’s knowledge, threatened against any Credit Party. Hours worked and payments made to the employees of the Credit Parties have not been in material violation of the Fair Labor
Standards Act or any other applicable Law dealing with such matters. All payments due from the Credit Parties, or for which any claim may be made against any of them, on account of wages and employee and retiree health and welfare insurance and
other benefits have been paid or accrued as a liability on their books, as the case may be. The consummation of the transactions contemplated by the Financing Documents will not give rise to a right of termination or right of renegotiation on the
part of any union under any collective bargaining agreement to which it is a party or by which it is bound. 

Section 3.10 Regulated Entities. No Credit Party is an “investment company” or a company
“controlled” by an “investment company” or a “subsidiary” of an “investment company,” all within the meaning of the Investment Company Act. 

Section 3.11 Margin Regulations. None of the proceeds from the Loans have been or will be used, directly or
indirectly, for the purpose of purchasing or carrying any “margin stock” (as defined in Regulation U of the Federal Reserve Board), for the purpose of reducing or retiring any indebtedness which was originally incurred to purchase or carry
any “margin stock” or for any other purpose which might cause any of the Loans to be considered a “purpose credit” within the meaning of Regulation T, U or X of the Federal Reserve Board. 

  
 54 

 Section 3.12 Compliance With Laws; Anti-Terrorism Laws. 

(a) Each Credit Party is in compliance with the requirements of all applicable Laws, except for such Laws the noncompliance with which could
not reasonably be expected to have a Material Adverse Effect. 
 (b) None of the Credit Parties and, to the knowledge of the Credit Parties,
none of their Affiliates nor any direct or indirect parent of a joint venture (i) is in violation of any Anti-Terrorism Law, (ii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or
avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law, (iii) is a Blocked Person, or is controlled by a Blocked Person, (iv) is acting or will act for or on behalf of a Blocked Person, (v) is
associated with, or will become associated with, a Blocked Person or (vi) is providing, or will provide, material, financial or technical support or other services to or in support of acts of terrorism of a Blocked Person. No Credit Party nor,
to the knowledge of any Credit Party, any of its Affiliates or agents acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement or any direct or indirect parent of a joint venture, (A) conducts any
business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any Blocked Person, or (B) deals in, or otherwise engages in any transaction relating to, any property or interest in property
blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law. 

Section 3.13 Taxes. All federal and material state, foreign and local tax returns, reports and statements
required to be filed by or on behalf of each Credit Party have been filed with the appropriate Governmental Authorities in all jurisdictions in which such returns, reports and statements are required to be filed and, except to the extent subject to
a Permitted Contest, all Taxes (including real property Taxes) and other charges shown to be due and payable in respect thereof have been timely paid prior to the date on which any fine, penalty, interest, late charge or loss may be added thereto
for nonpayment thereof. Except to the extent subject to a Permitted Contest, all material state and local sales and use Taxes required to be paid by each Credit Party have been paid. All federal and material state Tax returns have been filed by each
Credit Party for all periods for which returns were due with respect to employee income tax withholding, social security and unemployment taxes, and, except to the extent subject to a Permitted Contest, the amounts shown thereon to be due and
payable have been paid in full or adequate provisions therefor have been made. 
 Section 3.14 Compliance with ERISA.

 (a) Each ERISA Plan (and the related trusts and funding agreements) complies in form and in operation with, has been administered in
compliance with, and the terms of each ERISA Plan satisfy, the applicable requirements of ERISA and the Code in all material respects. No Credit Party has incurred liability for any material excise tax under any of Sections 4971 through 5000 of the
Code. 
 (b) Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, each Borrower
and each Subsidiary is in compliance with the applicable provisions of ERISA and the provision of the Code relating to ERISA Plans and the regulations and published interpretations therein. During the
thirty-six (36) month period prior to the Closing Date or the making of any Loan (i) no steps have been taken to terminate any Pension Plan, and (ii) no contribution failure has occurred with
respect to any Pension Plan sufficient to give rise to a Lien under Section 303(k) of ERISA or Section 430(k) of the Code and no event has occurred that would give rise to a Lien under Section 4068 of ERISA. No condition exists or event or
transaction has occurred with respect to any Pension Plan which could result in the incurrence by any Credit Party of any material liability, fine or penalty. No Credit Party has incurred any material liability to the PBGC (other than for current
premiums) 

  
 55 

 
with respect to any employee Pension Plan. Except as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (i) all contributions (if any)
have been made on a timely basis to any Multiemployer Plan that are required to be made by any Credit Party or any other member of the Controlled Group under the terms of the plan or of any collective bargaining agreement or by applicable Law;
(ii) no Credit Party nor any member of the Controlled Group has withdrawn or partially withdrawn from any Multiemployer Plan, incurred any withdrawal liability with respect to any such plan or received notice of any claim or demand for
withdrawal liability or partial withdrawal liability from any such plan; (iii) no condition has occurred which, if continued, could result in a withdrawal or partial withdrawal from any Multiemployer Plan; and (iv) no Credit Party nor any
member of the Controlled Group has received any notice that any Multiemployer Plan is in reorganization, that increased contributions may be required to avoid a reduction in plan benefits or the imposition of any excise tax, that any such plan is or
has been funded at a rate less than that required under Section 412 of the Code, that any such plan is or may be terminated, or that any such plan is or may become insolvent. 

Section 3.15 Consummation of Operative Documents; Brokers. Except for fees payable to Agent and/or Lenders or
as set forth on Schedule 3.15, no broker, finder or other intermediary has brought about the obtaining, making or closing of the transactions contemplated by the Operative Documents, and no Credit Party has or will have any obligation to any
Person in respect of any finder’s or brokerage fees, commissions or other expenses in connection herewith or therewith. 

Section 3.16 Reserved. 

Section 3.17 Material Contracts. Except for the Operative Documents, the Convertible Note Documents, and the
agreements set forth on Schedule 3.17, as of the Closing Date there are no Material Contracts. The consummation of the transactions contemplated by the Financing Documents will not give rise to a right of termination in favor of any party to
any Material Contract (other than any Credit Party), except for such Material Contracts the noncompliance with which would not reasonably be expected to have a Material Adverse Effect. 

Section 3.18 Compliance with Environmental Requirements; No Hazardous Materials. Except in each case as set
forth on Schedule 3.18: 
 (a) no notice, notification, demand, request for information, citation, summons, complaint or order has
been issued, no complaint has been filed, no penalty has been assessed and no investigation or review is pending, or to such Borrower’s knowledge, threatened by any Governmental Authority or other Person with respect to any (i) alleged
violation by any Credit Party of any Environmental Law, (ii) alleged failure by any Credit Party to have any Permits required in connection with the conduct of its business or to comply with the terms and conditions thereof, (iii) any
generation, treatment, storage, recycling, transportation or disposal of any Hazardous Materials, or (iv) release of Hazardous Materials, in any case that could reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect; and 
 (b) no property now owned or leased by any Credit Party and, to the knowledge of each Borrower, no such property
previously owned or leased by any Credit Party, to which any Credit Party has, directly or indirectly, transported or arranged for the transportation of any Hazardous Materials, is listed or, to such Borrower’s knowledge, proposed for listing,
on the National Priorities List promulgated pursuant to CERCLA, or CERCLIS (as defined in CERCLA) or any similar state list or is the subject of federal, state or local enforcement actions or, to the knowledge of such Borrower, other investigations
which may lead to claims against any Credit Party for clean-up costs, remedial work, damage to natural resources or personal injury claims, including claims under CERCLA. 

  
 56 

 For purposes of this Section 3.18, each Credit Party shall be deemed to include any business
or business entity (including a corporation) that is, in whole or in part, a predecessor of such Credit Party. 

Section 3.19 Intellectual Property and License Agreements. A list of all Registered Intellectual Property of
each Credit Party and all material in-bound license or sublicense agreements, exclusive out-bound license or sublicense agreements, or other rights of any Credit Party
to use any Material Intangible Asset (but excluding in-bound licenses of over-the-counter software that is commercially available
to the public), as of the Closing Date and, as updated pursuant to Section 4.17, has been delivered to Agent. Except for Permitted Licenses, each Credit Party is the sole owner of its Intellectual Property free and clear of any Liens. Each
Patent constituting a Material Intangible Asset is valid and enforceable and no part of the Material Intangible Assets has been judged invalid or unenforceable, in whole or in part, and to the best of Borrower’s knowledge, no claim has been
made that any part of the Intellectual Property constituting a Material Intangible Asset violates the rights of any third party. 

Section 3.20 Solvency. After giving effect to the Loan advances and the liabilities and obligations of each
Borrower under the Operative Documents, each Borrower (after giving effect to all rights of such Borrower arising by virtue of Section 2.10(b) and any other rights of contribution or similar rights of such Borrower) is Solvent and the Credit Parties
(taken as a whole) are Solvent; provided, however, that, for the avoidance of doubt, no such representation in this Section 3.20 is made in respect of any Immaterial Subsidiary. 

Section 3.21 Full Disclosure. None of the written information (financial or otherwise) (other than
projections, other forward-looking information and industry information) furnished by or on behalf of any Credit Party to Agent or any Lender in connection with the consummation of the transactions contemplated by the Operative Documents, contains
any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained herein or therein not materially misleading in light of the circumstances under which such statements were made. All financial
projections delivered to Agent and the Lenders by Borrowers (or their agents) have been prepared on the basis of the assumptions stated therein. Such projections represent each Borrower’s reasonable best estimate of such Borrower’s future
financial performance and such assumptions are believed by such Borrower to be fair and reasonable in light of the business conditions at the time such projections were made; provided, however, that Borrowers can give no assurance that
such projections will be attained and the Agent and Lenders are hereby notified that the differences between projected results and actual results may be material. 

Section 3.22 Interest Rate. The rate of interest paid under the Notes and the method and manner of the
calculation thereof do not violate any usury or other law or applicable Laws, any of the Organizational Documents, or any of the Operative Documents. 

Section 3.23 Subsidiaries. Borrowers do not own any stock, partnership interests, limited liability company
interests or other equity securities or Subsidiaries except for Permitted Investments. 
 Section 3.24 Reserved. 

Section 3.25 Accuracy of Schedules. All information set forth in the Schedules to this Agreement is
true, accurate and complete in all material respects as of the Closing Date, the date of delivery of the last Compliance Certificate delivered following the end of a fiscal quarter and any other subsequent date in which Borrower is requested to
update such Schedules. All information set forth in each Perfection Certificate is true, accurate and complete in all material respects as of the Closing Date and any other subsequent date in which Borrower is requested to update such certificate.

  
 57 

 Section 3.26 SEC Documents. Endologix has filed all of the SEC
Documents, within the time frames prescribed by the SEC for the filing of such SEC Documents such that each filing was timely filed with the SEC. Endologix filed and made publicly available on the EDGAR on or prior to the date this representation is
made, true, correct and complete copies of the SEC Documents. As of their respective dates, each of the SEC Documents complied in all material respects with the requirements of the Securities Act and/or the Exchange Act (as applicable) applicable to
the SEC Documents. None of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. Since the filing of the SEC Documents, no event has occurred that would require an amendment or supplement to any of the SEC Documents and as to which such an
amendment or a supplement has not been filed and made publicly available on EDGAR (and true, correct and complete copies of such amendment or supplement, if any, have been delivered to the Agent and the Lenders or their respective representatives)
on or prior to the date this representation is made. Endologix has not received any written comments from the SEC staff that have not been resolved, to the knowledge of Endologix, to the satisfaction of the SEC staff. 

Section 3.27 Financial Statements. As of their respective dates, the consolidated financial statements
of Endologix and its Subsidiaries included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements
have been prepared in accordance with GAAP, consistently applied (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and lack of footnote disclosures), and fairly
present in all material respects the consolidated financial position of Endologix and its Subsidiaries as of the dates thereof and the consolidated results of their operations, cash flows and changes in stockholders equity for the periods then ended
(subject, in the case of unaudited quarterly financial statements, to normal year-end audit adjustments and lack of footnote disclosures). The accounting firm that expressed its opinion with respect to the
consolidated financial statements included in Endologix’s most recently filed annual report on Form 10-K, and reviewed the consolidated financial statements included in Endologix’s most recently
filed quarterly report on Form 10-Q, was independent of Endologix pursuant to the standards set forth in Rule 2-01 of Regulation
S-X promulgated by the SEC and as required by the applicable rules and guidance from the Public Company Accounting Oversight Board (United States), and such firm was otherwise qualified to render such opinion
under applicable Law and the rules and regulations of the SEC. There is no transaction, arrangement or other relationship between Endologix (or any of its Subsidiaries) and an unconsolidated or other
off-balance-sheet Person that is required to be disclosed by Endologix in the SEC Documents that has not been so disclosed in the SEC Documents. Neither Endologix nor any of its Subsidiaries is required to
file or will be required to file any agreement, note, lease, mortgage, deed or other instrument entered into prior to the date this representation is made and to which Endologix or any of its Subsidiaries is a party or by which Endologix or any of
its Subsidiaries is bound that has not been previously filed as an exhibit (including by way of incorporation by reference) to Endologix’s reports filed or made with the SEC under the Exchange Act. Other than (i) the liabilities assumed or
created pursuant to this Agreement and the other Financing Documents and any fees and expenses in connection therewith, (ii) liabilities accrued for in the latest balance sheet included in Endologix’s most recent periodic report (on Form 10-Q or Form 10-K) filed prior to the date this representation is made (the date of such balance sheet, the “Latest Balance Sheet Date”), (iii) liabilities
incurred in the ordinary course of business consistent with past practice since the later of the (A) Closing Date and (B) the Latest Balance Sheet Date, and (iv) liabilities set forth on the Schedules to this Agreement, Endologix and
its Subsidiaries do not have any other material liabilities (whether fixed or unfixed, known or unknown, absolute or contingent, asserted or unasserted, choate or inchoate, liquidated or unliquidated, or secured or unsecured, and regardless of when
any action, claim, suit or proceeding with respect thereto is instituted). Since December 31, 2016, there has been no Material Adverse Effect or any event or circumstance which could reasonably be expected, individually or in the aggregate, to
result in a Material Adverse Effect. All financial performance projections delivered to Agent or any Lender, 

  
 58 

 
including the financial performance projections delivered on or prior to the Closing Date, if any, represent Endologix’s and its Subsidiaries’ good faith estimate of future financial
performance and are based on assumptions believed by Endologix and its Subsidiaries to be fair and reasonable in light of current market conditions, it being acknowledged and agreed by Agent and the Lenders that projections as to future events are
not to be viewed as facts and that the actual results during the period or periods covered by such projections may differ from the projected results and such differences may be material. 

ARTICLE 4 - AFFIRMATIVE COVENANTS 

Each Borrower agrees that, so long as any Credit Exposure exists: 

Section 4.1 Financial Statements and Other Reports. From the Closing Date until the first date on which there
is no more Credit Exposure (the period ending on such latest date, the “Reporting Period”), (i) Endologix shall timely (without giving effect to any extensions pursuant to Rule 12b-25 of the
Exchange Act) file all reports required to be filed with the SEC pursuant to the Exchange Act, and Endologix shall not terminate the registration of the Common Stock under the Exchange Act or otherwise terminate its status as an issuer required to
file reports under the Exchange Act, even if the securities laws would otherwise permit any such termination and (ii) the Borrowers shall deliver to Agent a Compliance Certificate with each of Endologix’s
10-Q and 10-K filings on the date such filing is made with the SEC. Each of such reports in Section 4.1(i) above will comply in all material respects with the applicable
requirements of the Exchange Act and each of such reports in Section 4.1(i) above and such Compliance Certificate will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The consolidated financial statements included in such reports will comply as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC with respect thereto, will be prepared in accordance with GAAP, consistently applied (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and lack of footnote disclosures), and will fairly present in all material respects the consolidated financial position of the Borrowers and their Subsidiaries as of the dates thereof and the
consolidated results of their operations, cash flows and changes in stockholders equity for the periods presented (subject, in the case of unaudited quarterly financial statements, to normal year-end audit
adjustments). The Borrowers hereby agree that, so long as any Credit Exposure exists, the Borrowers shall send to Agent and the Lenders copies of (A) any notices and other information made available or given to the holders of the stock of
Endologix generally, contemporaneously with the Borrowers making available or giving such notices and other information to such holders of Stock (it being understood and agreed that delivery shall be deemed to have occurred if such notices or other
information is posted to EDGAR) and (B) all other documents, reports, financial data and other information not available on EDGAR (y) at all times, with respect to the Agent (other than any Third Party Agent during any Third Party Agent
Retention Period) and the Lenders that does not contain any material nonpublic information of the Borrowers or their Subsidiaries, that Agent or any Lender may reasonably request and (z) with respect to the Third Party Agent during any Third
Party Agent Retention Period, that the Third Party Agent may reasonably request. Each Borrower will deliver (i) during all periods (including any Non-Third Party Agent Retention Period and any Third Party
Agent Retention Period), to Agent on each date that Endologix files a 10-Q or 10-K with the SEC, subject to Section 4.19, a duly completed Borrowing Base
Certificate (Agent), (ii) (A) subject to Section 4.19, during any Non-Third Party Agent Retention Period, upon the request of Agent, to Agent, monthly, within fifteen (15) Business Days
after the end of each such month, a duly completed Borrowing Base Certificate (Agent) and (B) during any Third Party Agent Retention Period, without request, to the Third Party Agent, monthly, within fifteen (15) Business Days after
the end of each such month, a duly completed Borrowing Base Certificate (Third Party Agent), or (iii) upon the occurrence and continuance of an Event of Default, as frequently as requested by (A) during any Non-Third Party Agent Retention Period, subject 

  
 59 

 
to Section 4.19, Agent, deliver to Agent a duly completed Borrowing Base Certificate (Agent), and (B) during any Third Party Agent Retention Period, the Third Party Agent, deliver to
the Third Party Agent, a duly completed Borrowing Base Certificate (Third Party Agent), in each case, together with such other information as required pursuant to this Agreement, signed by a Responsible Officer of the Borrower Representative, with
(y) during any Non-Third Party Agent Retention Period, such listings, summary and other additional information to be limited to information that is not material nonpublic information unless expressly
requested in writing by Agent, and (z) during any Third Party Agent Retention Period, aged listings of accounts receivable and accounts payable (by invoice date) and a summary of Inventory by location and type with a supporting perpetual
Inventory report, in each case, accompanied by such supporting detail and documentation as shall be requested by the Third Party Agent, in its reasonable discretion. In the case of any Borrowing Base Certificate (Agent) delivered on the date of
Endologix’s filing of a 10-Q or 10-K, Endologix shall include in the 10-Q or 10-K,
as the case may be, any material nonpublic information included in such Borrowing Base Certificate (Agent) that would not otherwise be included in such Form 10-Q or
10-K. Upon any Credit Party or any of its Subsidiaries becoming aware that any information in any Borrowing Base Certificate previously delivered to Agent (or any Third Party Agent, as applicable) or any
Lender is inaccurate, incorrect, incomplete or misleading in any material respect, such Credit Parties shall (and shall cause their Subsidiaries to) (y) during any Non-Third Party Agent Retention Period,
notify Agent in writing, and upon one (1) Business Day’s request by Agent thereafter, deliver to Agent an updated Borrowing Base Certificate (Agent) with such accurate, correct, complete and
non-misleading information included therein (and to the extent such prior inaccurate, incorrect, incomplete or misleading information from the Borrowing Base Certificate (Agent) was included or filed with a 10-Q or 10-K, then, at Agent’s request, such information shall be filed by Endologix with the SEC in a Form 8-K) and
(z) during any Third Party Agent Retention Period, deliver to the Third Party Agent an updated Borrowing Base Certificate (Third Party Agent) with such accurate, correct, complete and non-misleading
information included therein (and to the extent such prior inaccurate, incorrect, incomplete or misleading information from the Borrowing Base Certificate (Third Party Agent) was included or filed with a 10-Q
or 10-K, then, at Third Party Agent’s request, such information shall be filed by Endologix with the SEC in a Form 8-K). Upon the reasonable request of Agent or any
Lender, subject to (other than with respect to the Third Party Agent during any Third Party Agent Retention Period) Section 4.19, the Credit Parties and their Subsidiaries shall promptly deliver to Agent or such Lender, as applicable, such
additional business, financial, corporate affairs, perfection certificates, items or documents related to creation, perfection or priority of Agent’s Liens in the Collateral and other information as Agent or any Lender may from time to time
reasonably request. 
 Section 4.2 Payment and Performance of Obligations. Each Borrower (a) will pay
and discharge, and cause each Subsidiary to pay and discharge, on a timely basis as and when due (including prior to the expiration of any applicable grace periods), all of their respective obligations and liabilities, except for such obligations
and/or liabilities (i) that may be the subject of a Permitted Contest, and (ii) the nonpayment or nondischarge of which could not reasonably be expected to have a Material Adverse Effect or result in a Lien against any Collateral, except
for Permitted Liens, (b) without limiting anything contained in the foregoing clause (a) and unless subject to a Permitted Contest, pay all amounts due and owing in respect of Taxes (including payroll and withholdings tax liabilities) on a
timely basis as and when due, and in any case prior to the date on which any fine, penalty, interest, late charge or loss may be added thereto for nonpayment thereof, (c) will maintain, and cause each Subsidiary to maintain, in accordance with
GAAP, appropriate reserves for the accrual of all of their respective obligations and liabilities, and (d) will not breach or permit any Subsidiary to breach, or permit to exist any default under, the terms of any lease, commitment, contract,
instrument or obligation to which it is a party, or by which its properties or assets are bound, except for such breaches or defaults which could not reasonably be expected to have a Material Adverse Effect. 

  
 60 

 Section 4.3 Maintenance of Existence. Subject to Section 5.6(a),
each Borrower will preserve, renew and keep in full force and effect and in good standing, and will cause each Subsidiary to preserve, renew and keep in full force and effect and in good standing, (a) their respective existence and
(b) their respective rights, privileges and franchises necessary or desirable in the normal conduct of business, except, in the case of this clause (b), where a failure to do so could not reasonably be expected to result in a Material Adverse
Effect. 
 Section 4.4 Maintenance of Property; Insurance. 

(a) Each Borrower will keep, and will cause each Subsidiary to keep, all material tangible property useful and necessary in its business in
good working order and condition, ordinary wear and tear and casualty events excepted; and make all necessary repairs and/or restore the affected property in a good and workmanlike manner, regardless of whether Agent agrees to disburse insurance
proceeds or other sums to pay costs of the work of repair or reconstruction, except where the failure to do so could not reasonably be expected to have a Material Adverse Effect. 

(b) Upon completion of any Permitted Contest, Borrowers shall, and will cause each Subsidiary to, promptly pay the amount due, if any, and
deliver to Agent proof of the completion of the contest and payment of the amount due, if any. 
 (c) Each Borrower will maintain
(i) casualty insurance on all real and personal property on an all risks basis (including the perils of flood (if applicable), windstorm and quake), covering the repair and replacement cost of all such property and coverage, business
interruption and rent loss coverages with extended period of indemnity (for the period required by Agent from time to time) and indemnity for extra expense, in each case without application of coinsurance and with agreed amount endorsements,
(ii) general and professional liability insurance (including products/completed operations liability coverage), and (iii) such other insurance coverage, in each case against loss or damage of the kinds customarily insured against by
Persons engaged in the same or similar business, of such types and in such amounts as are customarily carried under similar circumstances by such other Persons. All such insurance shall be provided by insurers having an A.M. Best policyholders
rating reasonably acceptable to Agent. 
 (d) On or prior to the Closing Date, and at all times thereafter, each Borrower will cause Agent to
be named as an additional insured, assignee and lender loss payee (which shall include, as applicable, identification as mortgagee), as applicable, on each insurance policy required to be maintained pursuant to this Section 4.4 pursuant to
endorsements in form and substance acceptable to Agent. Borrowers shall deliver to Agent and the Lenders (i) on the Closing Date, a certificate from Borrowers’ insurance broker dated such date showing the amount of coverage as of a recent
date, and that such policies will include effective waivers (whether under the terms of any such policy or otherwise) by the insurer of all claims for insurance premiums against all loss payees and additional insureds and all rights of subrogation
against all loss payees and additional insureds, and that if all or any part of such policy is canceled, terminated or expires, the insurer will forthwith give notice thereof to each additional insured, assignee and loss payee and that no
cancellation, reduction in amount or material change in coverage thereof shall be effective until at least thirty (30) days after receipt by each additional insured, assignee and loss payee of written notice thereof (or 10 days in the case of
nonpayment of premiums), (ii) upon the request of any Lender through Agent from time to time full information as to the insurance carried, (iii) within five (5) days of receipt of notice from any insurer (or such longer period as Agent may
agree in its reasonable discretion), a copy of any notice of cancellation, nonrenewal or material change in coverage from that existing on the date of this Agreement, (iv) forthwith, notice of any cancellation or nonrenewal of coverage by any
Borrower, and (v) at least five (5) days (or such shorter period as Agent may agree in its reasonable discretion) prior to expiration of any policy of insurance, evidence of renewal of such insurance upon the terms and conditions herein
required. Notwithstanding anything to the contrary in this Section 4.4(d), Borrowers shall not be required to name Agent on any workers compensation or D&O policy. 
  

  
 61 

 (e) In the event any Borrower fails to provide Agent with evidence of the insurance coverage
required by this Agreement within five (5) Business Days of such request (unless an Event of Default has occurred and is continuing, in which case no such waiting period shall apply), Agent may purchase insurance at Borrowers’ expense to
protect Agent’s interests in the Collateral. This insurance may, but need not, protect such Borrower’s interests. The coverage purchased by Agent may not pay any claim made by such Borrower or any claim that is made against such Borrower
in connection with the Collateral. Such Borrower may later cancel any insurance purchased by Agent, but only after providing Agent with evidence that such Borrower has obtained insurance as required by this Agreement. If Agent purchases insurance
for the Collateral, Borrowers will be responsible for the costs of that insurance to the fullest extent provided by law, including interest and other charges imposed by Agent in connection with the placement of the insurance, until the effective
date of the cancellation or expiration of the insurance. The costs of the insurance may be added to the Obligations. The costs of the insurance may be more than the cost of insurance such Borrower is able to obtain on its own. 

Section 4.5 Compliance with Laws and Material Contracts. Each Borrower will comply, and cause each Subsidiary
to comply, with the requirements of all applicable Laws and Material Contracts, except to the extent that failure to so comply could not reasonably be expected to (a) have a Material Adverse Effect, or (b) result in any Lien upon either
(i) a material portion of the assets of any such Person in favor of any Governmental Authority, or (ii) any Collateral which is part of the Borrowing Base. 

Section 4.6 Inspection of Property, Books and Records. Each Borrower will keep, and will cause each
Subsidiary to keep, proper books of record substantially in accordance with GAAP in which full, true and correct entries shall be made of all dealings and transactions in relation to its business and activities; and will permit, and will cause each
Subsidiary to permit, at the sole cost of the applicable Borrower or any applicable Subsidiary, representatives of Agent and of any Lender to visit and inspect any of their respective properties, to examine and make abstracts or copies from any of
their respective books and records, to conduct a collateral audit and analysis of their respective operations and the Collateral, to verify the amount and age of the Accounts, the identity and credit of the respective Account Debtors, to review the
billing practices of Borrowers and to discuss their respective affairs, finances and accounts with their respective officers, employees and independent public accountants; provided that, in the absence of a Default or an Event of Default,
such rights pursuant to this Section 4.6 may be exercised (a) during reasonable business hours, (b) on at least two (2) Business Days advance written notice and (c) not more than twice per calendar year at the
Borrowers’ expense; provided further that the restrictions set forth in clause (a) through (c) shall not apply during the existence and continuance of any Event of Default. Notwithstanding the foregoing, the Borrowers shall comply with
(and coordinate with Agent and the Lenders and their representatives to make sure of compliance with) Section 4.19 in connection with any such inspection, examination, audit or analysis. 

Section 4.7 Use of Proceeds. Borrowers shall use the proceeds of Revolving Loans solely (a) to pay
transaction fees incurred in connection with the Financing Documents and for the payment in full on the Closing Date of certain existing Debt, (b) to refinance the Debt evidenced by the Existing ABL Credit Facility and the Existing ABL Debt
Documents), and (c) general corporate purposes and for the working capital needs of Borrowers and their Subsidiaries. No portion of the proceeds of the Loans will be used for family, personal, agricultural or household use. 

Section 4.8 Reserved. 

Section 4.9 Notices of Litigation and Defaults. 

  
 62 

 (a) Reserved. 

(b) Borrowers will give prompt written notice to (y) during any Non-Third Party Agent Retention
Period, subject to Section 4.19, Agent and (z) during any Third Party Agent Retention Period, the Third Party Agent, in each case of clause (y) and clause (z) above, (i) of any litigation or governmental proceedings pending
or threatened (in writing) against Borrowers or other Credit Party which would reasonably be expected to have a Material Adverse Effect with respect to Borrowers or any other Credit Party or which in any manner calls into question the validity or
enforceability of any Financing Document, (ii) upon any Borrower becoming aware of the existence of any Default or Event of Default, (iii) of any strikes or other labor disputes pending or, to any Borrower’s knowledge, threatened
against any Credit Party, that could reasonably be expected to result in a Material Adverse Effect, (iv) if there is any infringement or written claim of infringement by any other Person with respect to any Intellectual Property rights of any
Credit Party that could reasonably be expected to have a Material Adverse Effect, (v) if there is any written claim by any other Person that any Credit Party in the conduct of its business is infringing on the Intellectual Property rights of
others and an adverse resolution of such claim could reasonably be expected to have a Material Adverse Effect, and (vi) of all returns, recoveries, disputes and claims that involve more than $2,500,000. Borrowers represent and warrant that
Schedule 4.9 sets forth a complete list of all matters existing as of the Closing Date for which notice could be required under this Section and all litigation or governmental proceedings pending or threatened (in writing) against Borrowers
or other Credit Party as of the Closing Date. 
 (c) Borrower shall, and shall cause each Credit Party, to provide such further information
(including copies of such documentation) as (i) at all times, subject to Section 4.19, Agent or any Lender, and (ii) during any Third Party Agent Retention Period, the Third Party Agent, in each case of clause (i) and
clause (ii) above, shall reasonably request with respect to any of the events or notices described in clauses (a) and (b) above. From the date hereof and continuing through the termination of this Agreement, Borrower shall, and shall cause
each Credit Party to, make available to (y) at all times, subject to Section 4.19, Agent and each Lender and (z) during any Third Party Agent Retention Period, the Third Party Agent, in each case of clause (y) and clause (z)
above, without expense to Agent, any Third Party Agent or any Lender, in a commercially reasonable manner and in light of other obligations of such Persons, each Credit Party’s officers, employees and agents and books, to the extent that Agent
or any Lender (or, as applicable, any Third Party Agent) may deem them reasonably necessary to prosecute or defend any third-party suit or proceeding instituted by or against Agent or any Lender (or, as applicable, any Third Party Agent) with
respect to any Collateral or relating to a Credit Party. 

  
 63 

 Section 4.10 Hazardous Materials; Remediation. If any release or disposal of
Hazardous Materials which could reasonably be expected to have a Material Adverse Effect shall occur or shall have occurred on any real property owned or leased by Borrower or any other assets of any Borrower or any other Credit Party, such Borrower
will cause, or direct the applicable Credit Party to cause, the prompt containment and removal of such Hazardous Materials and the remediation of such real property or other assets to the extent such actions are required of Borrower or any Credit
Party under applicable Environmental Laws and then as is necessary to comply with all Environmental Laws and Healthcare Laws and to preserve the value of such real property or other assets. Without limiting the generality of the foregoing, each
Borrower shall, and shall cause each other Credit Party to, comply, in all material respects, with each Environmental Law to the extent such Environmental Law requires Borrower or any Credit Party to perform actions at any real property in response
to the release or threatened release of a Hazardous Material except as could not reasonably be expected to have a Material Adverse Effect 

Section 4.11 Further Assurances. 

(a) Each Borrower will, and will cause each Subsidiary (other than any such Subsidiary that is a Foreign Subsidiary or an Excluded Domestic
Holdco), at its own cost and expense, promptly and duly take, execute, acknowledge and deliver all such further acts, documents and assurances as may from time to time be necessary or as Agent or the Required Lenders may from time to time reasonably
request in order to carry out the intent and purposes of the Financing Documents and the transactions contemplated thereby, including all such actions to (i) establish, create, preserve, protect and perfect a first priority Lien (subject only
to the permitted priority of the Permitted Priority Liens) in favor of Agent for itself and for the benefit of the Lenders on the Collateral (including Collateral acquired after the date hereof), and (ii) unless Agent shall agree otherwise in
writing, cause all Subsidiaries of Borrowers (other than Foreign Subsidiaries and Excluded Domestic Holdcos) to be jointly and severally obligated with the other Borrowers under all covenants and obligations under this Agreement, including the
obligation to repay the Obligations. 
 (b) Upon receipt of an affidavit of an authorized representative of Agent or a Lender as to the loss,
theft, destruction or mutilation of any Note or any other Financing Document which is not of public record and which contains customary indemnifications in favor of Borrowers, and, in the case of any such mutilation, upon surrender and cancellation
of such Note or other applicable Financing Document, Borrowers will issue, in lieu thereof, a replacement Note or other applicable Financing Document, dated the date of such lost, stolen, destroyed or mutilated Note or other Financing Document in
the same principal amount thereof and otherwise of like tenor. 
 (c) Upon the request of Agent, Borrowers (A) shall use commercially
reasonable efforts to obtain a landlord’s agreement or mortgagee agreement, as applicable, from the lessor of each leased property or mortgagee of owned property with respect to any business location where any portion of the Collateral included
in or proposed to be included in the Borrowing Base and (B) shall obtain a landlord’s agreement or mortgagee agreement, as applicable, from the lessor of each leased property or mortgagee of owned property with respect to any business
location where the books and records relating to such Collateral and/or software and equipment relating to such records or Collateral, is stored or located (unless such books and records are also located at another business location that is subject
to landlord’s or mortgagee agreement in favor of Agent), which agreement or letter, in each case of clauses (A) and (B), shall be reasonably satisfactory in form and substance to Agent. Borrowers shall timely and fully pay and perform its
obligations under all leases and other agreements with respect to each leased location where any Collateral, or any records related thereto, is or may be located unless a failure to perform would not give a third party party to such lease a right to
terminate such lease or agreement prior to the expiration thereof. 

  
 64 

 (d) Promptly after the formation (or to the extent permitted under this Agreement, acquisition)
of a new Subsidiary (but in any event (A) within fifteen (15) days thereof for any Subsidiary that is not an Immaterial Subsidiary and (B) within thirty (30) days thereof for any Immaterial Subsidiary), Borrowers shall
(i) pledge, have pledged or cause or have caused to be pledged to Agent pursuant to a pledge agreement in form and substance satisfactory to Agent, all (with respect to a domestic Subsidiary that is not an Excluded Domestic Holdco) or 65% (with
respect to a Foreign Subsidiary of a United States entity (other than an Excluded Domestic Holdco)) of the outstanding shares of equity interests or other equity interests of such new Subsidiary owned directly or indirectly by any Borrower, along
with undated stock or equivalent powers for such certificates, if any, executed in blank; (ii) unless Agent shall agree otherwise in writing, cause the new Subsidiary (other than a Foreign Subsidiary or Excluded Domestic Holdco) to take such
other actions (including entering into or joining any Security Documents) as are necessary or advisable in the reasonable opinion of Agent in order to grant Agent, acting on behalf of the Lenders, a first priority Lien (subject only to the permitted
priority of the Permitted Priority Liens) on all real and personal property of such Subsidiary in existence as of such date and in all after acquired property, which first priority Liens (subject only to the permitted priority of the Permitted
Priority Liens) are required to be granted pursuant to this Agreement; (iii) unless Agent shall agree otherwise in writing, cause such new Subsidiary (other than a Foreign Subsidiary or Excluded Domestic Holdco) to either (at the election of
Agent) become a Borrower hereunder with joint and several liability for all obligations of Borrowers hereunder and under the other Financing Documents pursuant to a joinder agreement or other similar agreement in form and substance satisfactory to
Agent or to become a Guarantor of the obligations of Borrowers hereunder and under the other Financing Documents pursuant to a guaranty and suretyship agreement in form and substance satisfactory to Agent; and (iv) cause the new Subsidiary
(other than a Foreign Subsidiary or Excluded Domestic Holdco) to deliver certified copies of such Subsidiary’s certificate or articles of incorporation, together with good standing certificates, by-laws
(or other operating agreement or governing documents), resolutions of the Board of Directors or other governing body, approving and authorize the execution and delivery of the Security Documents, incumbency certificates and to execute and/or deliver
such other documents and legal opinions or to take such other actions as may be reasonably requested by Agent, in each case, in form and substance reasonably satisfactory to Agent (clauses (i) through (iv), collectively, the “Joinder
Requirements”). 
 Section 4.12 Reserved. 

Section 4.13 Power of Attorney. Each of the authorized representatives of Agent is hereby irrevocably made,
constituted and appointed the true and lawful attorney for Borrowers (without requiring any of them to act as such) with full power of substitution to do the following: (a) endorse the name of Borrowers upon any and all checks, drafts, money
orders, and other instruments for the payment of money that are payable to Borrowers and constitute collections on Borrowers’ Accounts; (b) so long as Agent has provided not less than three (3) Business Days’ prior written notice
to Borrower Representative to perform the same and Borrowers have failed to take such action, execute in the name of Borrowers any schedules, assignments, instruments, documents, and statements that Borrowers are obligated to give Agent under this
Agreement; (c) after the occurrence and during the continuance of an Event of Default, take any action Borrowers are required to take under this Agreement; (d) so long as Agent has provided not less than three (3) Business Days’
prior written notice to Borrower Representative to perform the same and Borrowers have failed to take such action, do such other and further acts and deeds in the name of Borrowers that Agent may deem necessary or desirable to enforce any Account or
other Collateral or perfect Agent’s security interest or Lien in any Collateral; and (e) after the occurrence and during the continuance of an Event of Default, do such other and further acts and deeds in the name of Borrowers that Agent
may deem necessary or desirable to enforce its rights with regard to any Account or other Collateral. This power of attorney shall be irrevocable and coupled with an interest. 

  
 65 

 Section 4.14 Borrowing Base Collateral Administration. 

(a) All data and other information relating to Accounts and other intangible Collateral shall at all times be kept by Borrowers, at their
respective principal offices and shall not be moved from such locations without (i) providing prior written notice to Agent, and (ii) obtaining the prior written consent of Agent, which consent shall not be unreasonably withheld. 

(b) Borrowers shall provide prompt written notice to each Person who either is currently an Account Debtor or becomes an Account Debtor at any
time following the Initial Third Party Agent Commencement Date (and thereafter so long Section 2.11 is applicable at such time) that directs each Account Debtor to make payments into the Lockbox (unless such written notice has previously been
provided and such Lockbox has not since changed from the date of receipt of such notice), and hereby authorizes Agent (or, as applicable, the Third Party Agent), upon Borrowers’ failure to send such notices within thirty (30) days after
the date of this Agreement (or thirty (30) days after the Person becomes an Account Debtor), to send any and all similar notices to such Person. Agent (including any Third Party Agent during any Third Party Agent Retention Period) reserves the
right to notify Account Debtors during the continuance of an Event of Default that Agent has been granted a Lien upon all Accounts. 
 (c) As
of the last day of Endologix’s fiscal year, Borrowers will conduct a physical count of the Inventory at least once per year (or more frequently as Agent may reasonably request during the continuance of any Event of Default), and (i) during
any Non-Third Party Agent Retention Period, in the case of a fiscal year-end count of the Inventory, on the date Endologix files its
10-K for such fiscal year, and in any other case subject to Section 4.19, Borrowers shall provide to Agent or (ii) during any Third Party Agent Retention Period, on the date that is the earlier of
(a) within forty-five (45) Business Days of completing such physical count and (B) the date Endologix files its 10-K for such fiscal year, Borrowers shall provide to the Third Party Agent, in
each case of clause (i) and clause (ii) above, a written accounting of such physical count in form and substance reasonably satisfactory to Agent. Each Borrower will use commercially reasonable efforts to at all times keep its Inventory in
good and marketable condition. In addition to the foregoing, no more than once per calendar year (or more frequently as Agent may reasonably request during the continuance of any Event of Default), Agent may require Borrowers to obtain and
(y) during any Non-Third Party Agent Retention Period, subject to Section 4.19, deliver to Agent, and (z) during any Third Party Agent Retention Period, deliver to the Third Party Agent, in each
case of clause (y) and clause (z) above, appraisal reports in form and substance and from appraisers reasonably satisfactory to Agent (or, as applicable, the Third Party Agent) stating the then current fair market values of all or any
portion of Inventory owned by each Borrower or any Subsidiaries. 
 (d) In addition to the foregoing, from time to time, Agent may require
Borrowers to obtain and (i) during any Non-Third Party Agent Retention Period, subject to Section 4.19, deliver to Agent, or (ii) during any Third Party Agent Retention Period, deliver to
the Third Party Agent, in each case of clause (i) and clause (ii), appraisal reports in form and substance and from appraisers reasonably satisfactory to Agent (or, as applicable, the Third Party Agent) stating the then current fair market
values of all or any portion of the Collateral; provided, however, that, so long as no Event of Default has occurred and is continuing, Borrowers shall not be required deliver more than one (1) appraisal report to Agent (or, as
applicable, the Third Party Agent) per fiscal year. 
 (e) Each Borrower will use commercially reasonable efforts to at all times keep its
furniture, fixtures and equipment in good repair and physical condition. In addition to the foregoing, from time to time, Agent (including, during any Third Party Agent Retention Period, the Third Party Agent) may require Borrowers to obtain and
(i) subject to Section 4.19, deliver to Agent, or (ii) during any Third Party Agent Retention Period, deliver to the Third Party Agent, in each case of clause (i) and clause (ii), appraisal reports in form and substance
and from appraisers reasonably satisfactory to Agent (or, as applicable, the Third Party Agent) stating the then current fair market values of all or any portion of furniture, fixtures and equipment owned by each Borrower or any Subsidiaries. 

  
 66 

 Section 4.15 Schedule and Perfection Certificate Updates.
Subject to Section 4.19 (other than, with respect to the Third Party Agent, during any Third Party Agent Retention Period), Borrower shall, in the event of any information in the Schedules becoming outdated, inaccurate, incomplete or misleading
in any material respect, deliver to Agent, together with the next Compliance Certificate required to be delivered pursuant to Section 4.1 after such event a proposed update to such Schedule correcting all outdated, inaccurate, incomplete or
misleading information; provided, however, (i) with respect to any proposed updates to the Schedules involving Permitted Liens, Permitted Debt or Permitted Investments, Agent will replace the respective Schedule attached hereto with such
proposed update only if such updated information is consistent with the definitions of and limitations herein pertaining to Permitted Liens, Permitted Debt or Permitted Investments and (ii) with respect to any proposed updates to such Schedule
involving other matters, Agent will replace the applicable portion of such Schedule attached hereto with such proposed update upon Agent’s approval thereof. Within five (5) Business Days after Endologix’s filing of its 10-K or 10-Q, as the case may be, the Credit Parties and their Subsidiaries shall deliver to (y) during any Non-Third Party Agent
Retention Period, Agent, or (z) during any Third Party Agent Retention Period, the Third Party Agent, in each case of clause (y) and clause (z) above, an updated Perfection Certificate, as of the date of such filing (provided
that Endologix shall include in the 10-Q or 10-K, as the case may be, any material nonpublic information included in the Perfection Certificate delivered during any Non-Third Party Agent Retention Period (or delivered to Agent (other than the Third Party Agent) or any Lender at any time) that would not otherwise be included in such 10-Q
or 10-K). 
 Section 4.16 Intellectual Property and
Licensing. 
 (a) Within five (5) Business Days after Endologix’s filing of its
10-K and 10-Q, as the case may be, to the extent (A) Borrower acquires and/or develops any new Registered Intellectual Property, or (B) Borrower enters into or
becomes bound by any additional in-bound license or sublicense agreement, any additional exclusive out-bound license or sublicense agreement or other agreement with
respect to rights in Intellectual Property constituting a Material Intangible Asset (other than over-the-counter software that is commercially available to the public),
or (C) there occurs any other change in Borrower’s Registered Intellectual Property, in-bound licenses or sublicenses or exclusive out-bound licenses or
sublicenses from that listed on the Perfection Certificate that could reasonably be expected to result in a Material Adverse Effect, deliver to (i) during a Non-Third Party Agent Retention Period, Agent,
and (ii) during a Third Party Agent Retention Period, the Third Party Agent, in each case of clause (i) and clause (ii) above, an updated Perfection Certificate reflecting such updated information. Upon the request of Agent, within
five Business Days, such Borrower shall execute and deliver, and have recorded, any and all agreements, instruments, documents, and papers as Agent may request to evidence Agent’s security interest in any Intellectual Property owned by such
Borrower, including any copyright, patent or trademark and the goodwill and general intangibles of such Borrower relating thereto or represented thereby. Such Borrower will take all actions that are necessary or reasonably requested by Agent to
maintain and pursue each application (and to obtain the relevant registration or recordation) and to maintain each registration and recordation of all material Intellectual Property owned by it. 

(b) Borrower shall own, or be licensed to use or otherwise have the right to use, all Material Intangible Assets. Borrower shall cause all
Registered Intellectual Property to be duly and properly registered, filed or issued in the appropriate office and jurisdictions for such registrations, filings or issuances, except where the failure to do so would not reasonably be expected to
result in a Material Adverse Effect. Borrower shall at all times conduct its business without infringement of any Intellectual Property rights of others, except where the failure to do so would not reasonably be expected to result in a Material
Adverse Effect. Borrower shall (i) protect, defend and maintain the validity and enforceability of 

  
 67 

 
its Material Intangible Assets (ii) promptly advise Agent in writing of material infringements of its Material Intangible Assets, or of a claim of infringement by Borrower on the
Intellectual Property rights of others which could reasonably be expected to result in a Material Adverse Effect; and (iii) not allow any of Borrower’s Material Intangible Assets to be abandoned, invalidated, forfeited or dedicated to the
public or to become unenforceable. Borrower will notify (A) during any Non-Third Party Agent Retention Period, subject to Section 4.19, Agent, and (B) during any Third Party Agent Retention
Period, the Third Party Agent, in each case of clause (A) and clause (B) above, promptly if it knows, or has reason to know, that any application or registration relating to any Intellectual Property owned by such Borrower may become
unenforceable, invalidated, forfeited, abandoned or dedicated to the public, or of any determination or development (including the institution of, or any such determination or development in, any proceeding in the United States Patent and Trademark
Office, the United States Copyright Office or any court or tribunal in any country) regarding such Borrower’s ownership of, or the validity of, any such material Intellectual Property or such Borrower’s right to register the same or to own
and maintain the same, that could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

Section 4.17 Regulatory Reporting and Covenants. (a) During any
Non-Third Party Agent Retention Period, at any time after the Agent or any Lender has notified Borrower Representative in writing that it desires to receive such information until the Agent or such Lender
notifies Borrower Representative in writing that it again desires not to receive such information, subject to Section 4.19, Borrowers shall notify Agent and each Lender, or (b) during any Third Party Agent Retention Period, at all times,
Borrowers shall notify the Third Party Agent, in each case of clause (a) and clause (b) above, promptly (and in any event within five (5) Business Days) of receiving, becoming aware of or determining that (each, a “Regulatory
Reporting Event” and collectively, the “Regulatory Reporting Events”): (i) any Governmental Authority, specifically including the FDA is conducting or has conducted (A) if applicable, any of Borrower’s or its
Subsidiaries’ manufacturing facilities and processes for any Product, which investigation has disclosed any material deficiencies or violations of Laws and/or the Regulatory Required Permits related to such thereto or (B) an investigation
or review of any Regulatory Required Permit (other than routine reviews in the Ordinary Course of Business associated with the renewal of a Regulatory Required Permit and which could not reasonably be expected to result in a Material Adverse
Effect), (ii) development, testing, and/or manufacturing of any Product or provision of any service that is material to the business of Borrower or its Subsidiaries should cease, (iii) if a Product that is material to the business of the
Borrower or its Subsidiaries has been approved for marketing and sale, any marketing or sales of such Product should cease or such Product should be withdrawn from the marketplace, (iv) any Regulatory Required Permit that is material to the
business of the Borrower or its Subsidiaries has been revoked or withdrawn, (v) adverse clinical test results with respect to any Product which have or could reasonably be expected to result in a Material Adverse Effect, (vi) any Product
recalls or voluntary Product withdrawals from any market (other than discrete batches or lots that are not material in quantity or amount and are not made in conjunction with a larger recall), which have or could reasonably be expected to result in
a Material Adverse Effect or (vii) any significant failures in the manufacturing of any Product such that the amount of such Product successfully manufactured in accordance with all specifications thereof and the required payments to be made to
Borrower therefor in any month shall decrease significantly with respect to the quantities of such Product and payments produced in the prior month, in each case, which could reasonably be expected to result in a Material Adverse Effect. Borrower
shall provide to Agent or any Lender such further information (including copies of such documentation) as Agent or any Lender shall reasonably request with respect to any such Regulatory Reporting Event. 

Section 4.18 Reserved. 

Section 4.19 Announcing Form 8-K. At or prior to 5:30 a.m.
(New York City time) on the fourth (4th) Business Day following the Closing Date, Endologix shall file a Form 8-K with the SEC describing the terms of the
transactions contemplated by the Financing Documents and the Term Credit 

  
 68 

 
Agreement and including as exhibits to such Form 8-K this Agreement (including the schedules and exhibits hereto) and the Term Credit Agreement and the
other agreements and instruments required to be filed pursuant to Section 5.1(q) of the Term Credit Agreement (such Form 8-K, the “Announcing Form
8-K”). Subject to the foregoing, no Borrower or its Subsidiaries shall issue any press releases or any other public statements with respect to the transactions contemplated by any Financing Document
or disclosing the name of Agent or any Lender; provided, however, that Endologix shall be entitled, without the prior approval of Agent or any Lender, to make any press release or other public disclosure with respect to such
transactions (i) in substantial conformity with the Announcing Form 8-K and contemporaneously therewith and (ii) as is required by Applicable Law and regulations (provided that each of the
Agent and Lenders shall be consulted by Endologix in connection with any such press release or other public disclosure prior to its release and shall be provided with a copy thereof other than filings required by the Exchange Act to be made with the
SEC, which Endologix may make without such consultation or notice). From and after Endologix’s filing of the Announcing Form 8-K, neither Agent nor any Lender shall be (or shall be deemed to be) in
possession of any material nonpublic information received from the Borrowers or any of their respective Subsidiaries or Affiliates or any of its or their respective officers, directors, employees, attorneys, representatives or agents, except, with
respect to the Third Party Agent, during any Third Party Agent Retention Period, information (other than any Borrowing Base Certificate (Agent)) provided solely to the Third Party Agent as and to the extent required hereby. Each Borrower shall
not, and shall cause each of its Subsidiaries and Affiliates and its and each of their respective officers, directors, employees, attorneys, representatives and agents (it being understood and agreed that the Third Party Agent is not an agent,
employee, attorney or representative of any Borrower, its Subsidiaries or its Affiliates) to not, provide Agent or any Lender with any material nonpublic information regarding the Borrowers or any of their Subsidiaries or Affiliates from and after
the filing of the Announcing Form 8-K with the SEC without the express prior written consent of Agent or such Lender; provided, however, that a Borrower may provide material nonpublic information to the Third
Party Agent during any Third Party Agent Retention Period as and to the extent required hereby. Each of the parties hereto acknowledges and agrees that no Lender or Agent nor any Affiliate of any Lender or Agent (other than a Third Party Agent,
except with respect to any Borrowing Base Certificate (Agent)) shall be deemed to be in possession of any material nonpublic information provided to any Third Party Agent unless and until such Third Party Agent actually provides such
information (other than any Borrowing Base Certificate (Agent)) to such Lender, Agent or Affiliate thereof (as applicable); and the Borrowers agree not to assert any contrary position. Each Borrower hereby acknowledges and agrees that neither
Agent nor any Lender (nor any of Agent or such Lender’s Affiliates) (other than, except for any Borrowing Base Certificate (Agent), any Third Party Agent or its Affiliates) shall have any duty of trust or confidence with respect to any
material nonpublic information regarding the Borrowers or any of their respective Subsidiaries or Affiliates provided by, or on behalf of, the Borrowers or any of their respective Subsidiaries or Affiliates, or any of its or their respective
officers, directors, employees, attorneys, representatives or agents, in violation of the foregoing covenant or otherwise in violation of this Section 4.19. Notwithstanding anything to the contrary herein or in any other Financing Document,
other than with respect to notices or communications (other than any Borrowing Base Certificate (Agent)) made to the Third Party Agent (but not any other Agent or any Lender) during any Third Party Agent Retention Period, in the event that a
Borrower believes that a notice or communication to any such Agent or any Lender (including any Borrowing Base Certificate (Agent)) contains material nonpublic information relating to the Borrowers or any other Credit Party or any of their
Affiliates or Subsidiaries (other than material nonpublic information being contemporaneously publicly disclosed through the filing with the SEC of a Form 8-K, 10-K or 10-Q or issuance of a broadly disseminated press release, in any such case as identified to the Agent or such Lender, as applicable), such Borrower shall so indicate to the Agent or such Lender contemporaneously
with delivery of such notice or communication (including any Borrowing Base Certificate (Agent)), and such indication shall provide the Agent (other than a Third Party Agent) or such Lender the means to refuse to receive such notice or
communication; and in the absence of any such indication, the Agent or such Lender (as applicable) shall be allowed to presume that all matters relating to such notice or communication (including any Borrowing Base

  
 69 

 
Certificate (Agent)) do not constitute material nonpublic information relating to the Borrowers, any other Credit Party or any of their Affiliates or Subsidiaries, or any of their respective
property or Stock. Upon receipt or delivery by any Credit Party or any of its Subsidiaries of any notice or other communication in accordance with the terms of the Financing Documents, unless the Borrowers have in good faith determined that the
matters relating to such notice do not constitute material, nonpublic information relating to the Borrowers or any Credit Party or any of their Affiliates or Subsidiaries or their respective property or Stock (and other than information (except any
Borrowing Base Certificate (Agent)) delivered to the Third Party Agent during any Third Party Agent Retention Period)), Endologix shall, within one Business Day after any such receipt or delivery publicly disclose the material, nonpublic information
contained in the notice or communication; provided however, that Endologix shall in no event be obligated to make public disclosure of any material nonpublic information contained in any Borrowing Base Certificate (Agent) delivered at the request of
Agent or any Lender in accordance herewith (other than, for the avoidance of doubt, a Borrowing Base Certificate (Agent) delivered in connection with the filing of a 10-Q or
10-K). In the event of a breach of any of the foregoing covenants by any Borrower or any of its Subsidiaries or Affiliates, or any of its or their respective officers, directors (or equivalent persons),
employees, attorneys, representatives or agents (it being understood and agreed that the Third Party Agent is not an agent, employee, attorney or representative of any Borrower, its Subsidiaries or its Affiliates), in addition to any other remedies
provided in the Financing Documents or otherwise available at law or in equity, Agent and the Lenders shall have the right to make a public disclosure in the form of a press release, public advertisement or otherwise, of the applicable material
nonpublic information regarding the Borrowers or its Subsidiaries or Affiliates without the prior approval by any Borrower or its Subsidiaries or Affiliates, or any of its or their respective officers, directors (or equivalent persons), employees,
attorneys, representatives or agents, and neither Agent nor any Lender shall have any liability to any Borrower, any of its Subsidiaries or Affiliates or any of its or their respective officers, directors (or equivalent persons), employees,
equityholders, attorneys, representatives or agents for any such disclosure. 
 Section 4.20 Regulatory
Required Permits. Borrowers shall, and shall cause each Credit Party to, obtain all Regulatory Required Permits necessary for compliance in all material respects with Laws with respect to testing, manufacturing, developing, selling or marketing
of Products and shall, and shall cause each Credit Party to, maintain and comply fully and completely in all respects with all such Regulatory Required Permits, the noncompliance with which could have a Material Adverse Effect. 

Section 4.21 Term Debt Documents. With respect to the Term Debt Documents, to the extent any of the Term
Lenders (or their Affiliates) are not the Agent under this Agreement (but regardless for purpose of the Convertible Note Documents), the Borrowers shall, within two Business Days after delivery by a Credit Party or receipt or knowledge thereof,
provide written notice to Agent of any default or event of default under any of the Term Debt Documents or any of the Convertible Note Documents, and of any amendments, restatements, supplements, waivers or other modifications to (or any consents to
any events or actions under) any of the Term Debt Documents or any of the Convertible Note Documents or any prepayment of any of the Debt thereunder. 

Section 4.22 Post-Closing Items. Each Credit Party shall execute and deliver the documents and complete the
tasks set forth on Schedule 4.22, in each case, within the time limits specified therein (or such longer period agreed to by Agent in its sole discretion). 

Section 4.23 Immaterial Subsidiary. Until the requirements in clause 4 of Schedule 4.22 (and
Section 4.22) are satisfied, such applicable Subsidiary shall at all times remain an Immaterial Subsidiary. 

  
 70 

 ARTICLE 5 - NEGATIVE COVENANTS 

Each Borrower agrees that, so long as any Credit Exposure exists: 

Section 5.1 Debt; Contingent Obligations. No Borrower will, or will permit any Subsidiary to, directly or
indirectly, create, incur, assume, guarantee or otherwise become or remain directly or indirectly liable with respect to, any Debt, except for Permitted Debt. No Borrower will, or will permit any Subsidiary to, directly or indirectly, create,
assume, incur or suffer to exist any Contingent Obligations, except for Permitted Contingent Obligations. 

Section 5.2 Liens. No Borrower will, or will permit any Subsidiary to, directly or indirectly, create, assume
or suffer to exist any Lien on any asset now owned or hereafter acquired by it, except for Permitted Liens. 

Section 5.3 Distributions. No Borrower will, or will permit any Subsidiary to, directly or indirectly,
declare, order, pay, make or set apart any sum for any Distribution, except for Permitted Distributions. 

Section 5.4 Restrictive Agreements. No Borrower will, or will permit any Subsidiary to, directly or
indirectly (a) enter into or assume any agreement prohibiting the creation or assumption of any Lien upon its properties or assets, whether now owned or hereafter acquired, or (b) create or otherwise cause or suffer to exist or become
effective any consensual encumbrance or restriction of any kind on the ability of any Subsidiary to: (i) pay or make Distributions to any Borrower or any Subsidiary; (ii) pay any Debt owed to any Borrower or any Subsidiary; (iii) make
loans or advances to any Borrower or any Subsidiary; or (iv) transfer any of its property or assets to any Borrower or any Subsidiary, other than (1) the Financing Documents and the Term Debt Documents, (2) an encumbrance or
restriction consisting of customary non-assignment provisions in leases or licenses entered into in the Ordinary Course of Business, (3) customary provisions in joint venture agreement and other similar
agreements that restrict the transfer of ownership interests in such joint ventures or provisions limiting the disposition or distribution of assets or property (other than dividends on a pro rata basis based on ownership percentage) of the
applicable joint venture , which limitation is applicable only to the assets that are the subject of such agreements; provided that such agreement was not entered into in contravention of the terms of the Financing Documents, or
(4) limitations set forth in Subordinated Debt (if acceptable to the Agent in its sole discretion). 

Section 5.5 Payments and Modifications of Debt. No Borrower will, or will permit any Subsidiary to, directly
or indirectly: 
 (a) declare, pay, make or set aside any amount for payment in respect of Subordinated Debt, except for payments made in
full compliance with and permitted under the Subordination Agreement, 
 (b) amend or otherwise modify the terms of any Subordinated Debt,
except for amendments or modifications made in full compliance with the Subordination Agreement; 
 (c) declare, pay, make or set aside any
amount for payment in respect of any Debt hereinafter incurred that, by its terms, or by separate agreement, is subordinated to the Obligations, except for payments made in full compliance with and expressly permitted under the subordination
provisions applicable thereto; 
 (d) declare, pay or make any payment in respect of the 3.25% Convertible Notes or the 2.25% Convertible
Notes, except for: (i) regularly scheduled payments of interest and principal as set forth in the applicable Convertible Note Documents (in addition to allowing any cash payments at maturity of the applicable 3.25% Convertible Notes and the
2.25% Convertible Notes, such amounts may also be paid in the applicable Stock of Endologix or through any other conversion feature that does not effectively cause more payments to be made at maturity thereof than the cash principal payments
currently provided 

  
 71 

 
for in the applicable Convertible Note Documents as of the Closing Date), (ii) in connection with any Permitted 3.25% Convertible Note Refinancing, (iii) the issuance of shares of common
stock of Endologix in connection with any conversion of the 3.25% Convertible Notes, the 2.25% Convertible Notes or any convertible notes that are not Disqualified Stock issued in a Permitted 3.25% Convertible Note Refinancing, and any cash solely
in lieu of fractional shares (but no other cash settlement (other than as otherwise permitted by this clause (d)), (iv) payments and conversions (other than for any Disqualified Stock) made in connection with the repurchase (whether for cash, upon
exchange and/or for other consideration), redemption and retirement in respect of the 2.25% Convertible Notes or 3.25% Convertible Notes in a single or series of related transactions; provided that (A) no Event of Default exists at the
time such payments are made or would exist immediately after giving effect thereto and (B) such cash payments are made solely (I) with proceeds received by Endologix from the issuance of its common Stock after the Closing Date for the
purpose of making such payment, (II) regarding the 2.25% Convertible Notes, with the proceeds of the Loans made hereunder or the proceeds of advances made under the Term Credit Agreement and (III) regarding the 3.25% Convertible Notes,
with the proceeds of Debt raised in a Permitted 3.25% Convertible Note Refinancing, with the proceeds of the Loans made hereunder or with the proceeds of advances made under the Term Credit Agreement, and (e) if the foregoing conditions do not
otherwise permit such payment, then, with the express prior written consent of the Agent (which may be withheld in its sole discretion), payments in connection with the retirement, redemption and repurchase of the 2.25% Convertible Notes or the
3.25% Convertible Notes; 
 (e) amend or otherwise modify the terms of any such Debt referred to in clause (d) above (other than with
respect to 3.25% Convertible Notes, in connection with a Permitted 3.25% Convertible Note Refinancing) if the effect of such amendment or modification is to (i) increase the interest rate or fees on, or change the manner or timing of payment
of, such Debt if in any way adverse to the Agent or the Lenders, (ii) accelerate or shorten the dates upon which payments of principal or interest are due on, or the principal amount of, such Debt, (iii) change in a manner adverse to any
Credit Party or Agent any event of default or add or make more restrictive any covenant with respect to such Debt, (iv) change the prepayment provisions of such Debt or any of the defined terms related thereto in a manner adverse to Agent or
the Lenders, or (v) change or amend any other term if such change or amendment would materially increase the obligations of the obligor or confer additional material rights on the holder of such Debt in a manner adverse to Borrowers, any
Subsidiaries, Agent or Lenders; provided, however, that the foregoing shall not restrict any changes expressly required under the terms of the 3.25% Convertible Notes as in effect on the Closing Date, the 2.25% Convertible Notes as in effect as of
the Closing Date or any changes that are expressly permitted to be made hereunder in connection with a Permitted 3.25% Convertible Note Refinancing, or any changes expressly required under any indenture governing any Permitted 3.25% Convertible Note
Refinancing that satisfies the conditions and requirements set forth in the definition of “Permitted 3.25% Convertible Note Refinancing”. Borrowers shall, prior to entering into any such amendment or modification, deliver to Agent
reasonably in advance of the execution thereof, any final or execution form copy thereof; or 
 (f) amend or otherwise modify the terms of
any Term Debt Documents, except as permitted by Section 5.17; 
 Section 5.6
Consolidations, Mergers and Sales of Assets; Change in Control. 
 (a) No Borrower will, or will permit any Subsidiary to,
directly or indirectly consolidate,merge or amalgamate with or into, dissolve or liquidate into or convey, transfer, lease or otherwise dispose of (whether in one transaction or in a series of transactions) all or substantially all of its assets
(whether now owned or hereafter acquired) to or in favor of any Person except (a) a Subsidiary that is not a Credit Party may merge into any Credit Party or any Subsidiary of a Credit Party (provided that, to the extent such Subsidiary that is
not a Credit Party has its equity pledged to Agent, then any Person it 

  
 72 

 
merges with must also have its equity pledged to Agent by at least the same percentage), (2) a Subsidiary that is a Credit Party may merge into any other Credit Party (provided that, (y) to
the extent such Subsidiary being merged has its equity pledged to Agent, then any Person it merges with must also have its equity pledged to Agent by at least the same percentage and (z) to the extent Endologix is part of such transaction,
Endologix must be the surviving Person), (3) any Subsidiary of Endologix (other than, for the avoidance of doubt, Endologix) may liquidate or dissolve if (i) Endologix determines in good faith that such liquidation or dissolution is in the best
interests of Endologix and it is not materially disadvantageous to the Agent or the Lenders and (ii) to the extent such Subsidiary is a Guarantor, any such assets or business held by such subject Subsidiary shall be transferred to, or otherwise
owned or conducted by, a Credit Party after giving effect to such liquidation or dissolution, and (4) Permitted Acquisitions. Endologix shall not permit Endologix to establish or form any Subsidiary, unless such Subsidiary complies with Section
4.11(d)), if applicable, and such Subsidiary (other than any such Subsidiary that is a Foreign Subsidiary or an Excluded Domestic Holdco) executes and/or delivers all other documents, agreements and instruments reasonably requested by Agent or the
Required Lenders to perfect a Lien in favor of Agent (for the benefit of the Agent and the Lenders) on such Subsidiary’s (other than any such Subsidiary that is a Foreign Subsidiary or an Excluded Domestic Holdco) assets and to make such
Subsidiary (other than any such Subsidiary that is a Foreign Subsidiary or an Excluded Domestic Holdco) a Guarantor under the Financing Documents. 

(b) No Borrower will, or will permit any Subsidiary to, directly or indirectly consummate any Asset Dispositions other than Permitted Asset
Dispositions. 
 (c) No Borrower will suffer or permit to occur any Change in Control with respect to itself, any Subsidiary or any
Guarantor. 
 Section 5.7 Purchase of Assets, Investments. No Borrower will, or will permit any Subsidiary to, directly
or indirectly: 
 (a) except as otherwise permitted pursuant to clause (k) of the definition of Permitted Investments, engage or enter
into any agreement to engage in any joint venture or partnership with any other Person; 
 (b) make or enter into any agreement to make an
Acquisition other than Permitted Acquisitions; 
 (c) without limiting the foregoing with respect to Acquisitions, acquire or enter into any
agreement to acquire any other assets other than in the Ordinary Course of Business or as otherwise permitted under the definition of Permitted Investments; or 

(d) acquire or own or enter into any agreement to acquire or own any Investment in any Person other than Permitted Investments. 

Section 5.8 Transactions with Affiliates. Except as otherwise disclosed on Schedule 5.8, and except
for transactions that contain terms that are no less favorable to the applicable Borrower or any Subsidiary, as the case may be, than those which might be obtained from a third party not an Affiliate of any Credit Party, no Borrower will, or will
permit any Subsidiary to, directly or indirectly, enter into or permit to exist any transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of any Borrower that is not itself a
Credit Party. 

  
 73 

 Section 5.9 Modification of Organizational Documents. No
Borrower will, or will permit any Subsidiary to, directly or indirectly, amend or otherwise modify any Organizational Documents of such Person, except for Permitted Modifications. 

Section 5.10 Modification of Certain Agreements. Except as permitted by Section 5.5, no Borrower will,
or will permit any Subsidiary to, directly or indirectly, amend or otherwise modify any Material Contract, which amendment or modification in any case: (a) is contrary to the terms of this Agreement or any other Financing Document;
(b) could reasonably be expected to be materially adverse to the rights, interests or privileges of Agent or the Lenders or their ability to enforce the same; provided however that the foregoing shall not restrict any changes expressly required
under the terms of the 2.25% Convertible Notes as of the Closing Date, the 3.25% Convertible Notes as of the Closing Date, or any indenture governing any Permitted 3.25% Convertible Note Refinancing that satisfies the conditions and requirements set
forth in the definition of “Permitted 3.25% Convertible Note Refinancing”; (c) results in the imposition or expansion in any material respect of any obligation of or restriction or burden on any Borrower or any Subsidiary; or
(d) reduces in any material respect any rights or benefits of any Borrower or any Subsidiaries (it being understood and agreed that any such determination shall be in the discretion of Agent). 

Section 5.11 Conduct of Business. No Borrower will, or will permit any Subsidiary to, directly or indirectly,
engage in any line of business other than those businesses engaged in on the Closing Date and described on Schedule 5.11 and businesses reasonably related thereto. No Borrower will, or will permit any Subsidiary to, other than in the Ordinary
Course of Business, change its normal billing payment and reimbursement policies and procedures with respect to its Accounts (including the amount and timing of finance charges, fees and write-offs). 

Section 5.12 Excluded Foreign Subsidiaries; Joint Ventures. 

(a) No Borrower will, or will permit any Subsidiary (other than a Foreign Subsidiary) to commingle any of its assets (including any bank
accounts, cash or Cash Equivalents) with the assets of any Person other than a Credit Party. 
 (b) No Borrower will, or will permit any
Subsidiary to enter into or own any interest in a joint venture that is not itself a corporation or limited liability company or other legal entity in respect of which the equity holders are not liable for the obligations of such entity as a matter
of law. 
 Section 5.13 Limitation on Sale and Leaseback Transactions. No Borrower will, or will permit any
Subsidiary to, directly or indirectly, enter into any arrangement with any Person whereby, in a substantially contemporaneous transaction, any Borrower or any Subsidiaries sells or transfers all or substantially all of its right, title and interest
in an asset and, in connection therewith, acquires or leases back the right to use such asset. 
 Section 5.14
Deposit Accounts and Securities Accounts; Payroll and Benefits Accounts. Each Credit Party shall enter into, and cause each depository, securities intermediary or commodities intermediary to enter into, Control Agreements with respect to
each deposit, securities, commodity or similar account maintained by such Person (other than (i) deposit accounts exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of the
Borrowers’ employees and identified to Agent by the Borrower Representative as such, (ii) zero balance accounts; provided that such accounts have been identified to Agent by the Borrower Representative as such, (iii) such other petty
cash deposit accounts, amounts on deposit in which do not exceed $100,000 in the aggregate at any one time, (iv) escrow, trust and fiduciary accounts, (v) each account of Excluded Foreign Subsidiaries, (vi) deposit account #XXXXX7912
of TriVascular Canada LLC at Bank of Montreal; 

  
 74 

 
provided the aggregate amount on deposit in such deposit account(s) does not exceed 1,000,000 Canadian dollars at any time, (vii) the Bank of America Cash Collateral Account, and
(viii) the L/C Cash Collateral Accounts (such accounts in clauses (i) through (viii), the “Excluded Accounts”)) as of and after the Closing Date; provided that (x) the Credit Parties shall have until the date
that is forty-five (45) days following the Closing Date or the closing date of any Permitted Acquisition, as applicable (or such later date as may be agreed to by Agent in its sole reasonable discretion) to comply with the provisions of this
Section 5.14 with regard to such accounts (other than Excluded Accounts) of the Credit Parties existing on the Closing Date or acquired in connection with such Permitted Acquisition, as applicable, (y) until the earlier of the date of
(A) the date that any Person (other than the Merrill Lynch branch where the Merrill Lynch Securities Account is maintained) has a Lien on or “control (as defined in the UCC) (including by way of a Deposit Account Control Agreement or a
Securities Account Control Agreement) of the Merrill Lynch Securities Account and (B) on or after September 1, 2017, the date that the Merrill Lynch Securities Account has any cash, Cash Equivalents or other assets with a value in excess
of $0, the Credit Parties shall not be required to enter into a Deposit Account Control Agreement or a Securities Account Control Agreement in respect of the Merrill Lynch Securities Account as long as the Borrowers do not deposit any additional
funds, amounts or other assets of any kind into such Merrill Lynch Securities Account after the Closing Date and as long as promptly upon the maturity of each tranche of the securities and Cash Equivalents in such Merrill Lynch Securities Account,
the Borrowers shall transfer the applicable amount of cash invested in such matured tranche of securities or Cash Equivalents to a deposit account or securities account over which the Agent has “control” for UCC purposes under a Deposit
Account Control Agreement or a Securities Account Control Agreement in favor of the Agent covering such deposit account or securities account and (z) for deposit accounts, securities accounts and commodities accounts opened after the Closing
Date, the Credit Parties shall have until the date that is thirty (30) days following the opening of any such new account (or such later date as may be agreed to by Agent in its sole reasonable discretion) to comply with this Section 5.14.
As of the end of the last Business Day of each calendar month, the Borrowers shall have at least $10,000,000 of cash and Cash Equivalents maintained in the deposit accounts or securities accounts of the Borrowers subject to Deposit Account Control
Agreements or Securities Account Control Agreement, respectively, in each case, reasonably satisfactory to Agent (or, to the extent in compliance, and in accordance, with the provisions in this Section 5.14, in the Merrill Lynch Securities
Account) in compliance with the foregoing provisions of this Section 5.14, and, upon written request by the Agent, the Borrowers shall provide Agent with written evidence reasonably satisfactory to the Agent as of such Business Day or the next
Business Day showing compliance therewith. 
 Section 5.15 Compliance with Anti-Terrorism Laws. Agent
hereby notifies Borrowers that pursuant to the requirements of Anti-Terrorism Laws, and Agent’s policies and practices, Agent is required to obtain, verify and record certain information and documentation that identifies Borrowers and its
principals, which information includes the name and address of each Borrower and its principals and such other information that will allow Agent to identify such party in accordance with Anti-Terrorism Laws. No Borrower will, or will permit any
Subsidiary to, directly or indirectly, knowingly enter into any Material Contracts with any Blocked Person or any Person listed on the OFAC Lists. No Borrower will, or will permit any Subsidiary to, directly or indirectly, (i) conduct any
business or engage in any transaction or dealing with any Blocked Person, including the making or receiving of any contribution of funds, goods or services to or for the benefit of any Blocked Person, (ii) deal in, or otherwise engage in any
transaction relating to, any property or interests in property blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law, or (iii) engage in or conspire to engage in any transaction that evades
or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in Executive Order No. 13224 or other Anti-Terrorism Law. 

Section 5.16 Change in Accounting. No Borrower shall, and no Borrower shall suffer or permit any of its
Subsidiaries to, (i) make any significant change in accounting treatment or reporting practices, except as required by GAAP or (ii) change the fiscal year or method for determining fiscal quarters of any Credit Party or of any consolidated
Subsidiary of any Credit Party. 

  
 75 

 Section 5.17 Intercreditor Agreement. No Credit Party shall, and
no Credit Party shall permit any of its Subsidiaries to, (A) make any payment, or take any action, with respect to the Term Debt that is in violation or breach of the Intercreditor Agreement, if applicable; (B) make any amendment,
restatement, supplement or modification of any Term Debt Document in violation or breach of the Intercreditor Agreement, if applicable; or (C) join any Subsidiary or any Affiliate of any Credit Party as a borrower, guarantor or obligor, or have
such Person pledge or grant a Lien on any of its property or assets, under the Term Debt Documents, unless, in each case, the same Person becomes a Credit Party in the same capacity (and/or pledges and grants Liens on the same property or assets
(and with no Person having priority in between the Liens granted under the Term Debt Documents and the Liens granted under the Financing Documents in connection with this Section 5.17)) under the Financing Documents and
such Person executes and delivers such agreements, instruments and documents reasonably requested by Agent to effectuate any of the foregoing. 

Section 5.18 Anti-Layering. Notwithstanding anything to the contrary in this Agreement or in any other
Financing Documents, no Credit Party shall, and no Credit Party shall permit any of its Subsidiaries to, create, incur or suffer to exist any Debt which is subordinated or junior (either in respect of Lien priority or in right of payment or any
combination thereof) to any of the Term Debt unless such Debt is expressly subordinated or junior to the Obligations (both in terms of Lien priority and in right of payment) on terms and conditions acceptable to Agent and the Lenders; it being
understood and agreed that the foregoing shall in no way limit the incurrence of unsecured Debt otherwise permitted hereunder that is not payment subordinated to the Term Debt when not also payment subordinated to the same extent to the Obligations.

 ARTICLE 6 - FINANCIAL COVENANTS 

Section 6.1 Additional Defined Terms. The following additional definitions are hereby appended to
Section 1.1 of this Agreement: 
 “Defined Period” means, for purposes of calculating the minimum Net Revenue for each
fiscal quarter of Endologix, beginning with the fiscal quarter ending June 30, 2017, the preceding twelve (12) month period ending on the last day of such fiscal quarter. 

“Net Revenue” means, for any period, (a) Borrowers’ gross revenues during such period, less (b)(i) trade, quantity
and cash discounts allowed by Borrowers, (ii) discounts, refunds, rebates, charge backs, retroactive price adjustments and any other allowances which effectively reduce net selling price, (iii) product returns and allowances,
(iv) allowances for shipping or other distribution expenses, (v) set-offs and counterclaims, and (vi) any other similar and customary deductions used by Borrower in determining net revenues,
all, in respect of (a) and (b), as determined in accordance with GAAP and in the Ordinary Course of Business. 

Section 6.2 Minimum Net Revenue. Borrowers shall not permit their consolidated Net Revenue for any applicable
Defined Period, as tested quarterly, to be less than the minimum amount set forth on Schedule 6.2 for such Defined Period. 

Section 6.3 Evidence of Compliance. Borrowers shall furnish to Agent (or, as applicable, the Third Party
Agent) a Compliance Certificate in accordance with Section 4.1 as evidence, among other things, of Borrowers’ compliance with the covenants in this Article 6 and evidence that no Event of Default specified in this Article 6 has
occurred. Subject to (other than, with respect to the Third 

  
 76 

 
Party Agent, during any Third Party Agent Retention Period) Section 4.19, upon Agent’s request, the Compliance Certificate shall include (a) a statement and report, on a form
approved by Agent, detailing Borrowers’ calculations, (b) bank statements, and (c) back-up documentation (including invoices, receipts and other evidence of costs incurred during such month as
Agent shall reasonably require) evidencing the propriety of the calculations. 
 ARTICLE 7 - CONDITIONS 

Section 7.1 Conditions to Closing. The obligation of each Lender to make the initial Loans on the Closing
Date shall be subject to the receipt by Agent of each agreement, document and instrument set forth on the Closing Checklist prepared by Agent or its counsel, each in form and substance satisfactory to Agent, and such other closing deliverables
reasonably requested by Agent and Lenders, and to the satisfaction of the following conditions precedent, each to the satisfaction of Agent and Lenders and their respective counsel in their sole discretion: 

(a) [reserved]; 
 (b) the payment
of all fees, expenses and other amounts due and payable under each Financing Document; 
 (c) since December 31, 2016, the absence of
any Material Adverse Effect; 
 (d) the fact that the representations and warranties of each Credit Party contained in the Financing
Documents shall be true, correct and complete in all material respects (without duplication of any materiality qualifier contained therein) on and as of the Closing Date, except to the extent that any such representation or warranty relates to a
specific date in which case such representation or warranty shall be true and correct in all material respects (without duplication of any materiality qualifier contained therein) as of such earlier date; 

(e) the (i) executed payoff letter evidencing the payoff of all Debt under the Existing ABL Credit Facility and all other Existing ABL
Debt Documents and all other Debt owed to MidCap Financial Trust or its Affiliates by any Credit Party or any of its Subsidiaries, the termination of all revolving commitments and lines of credit and other products and services provided thereunder
and the termination and release of all Liens granted thereunder or thereto, and (B) release and termination documents evidencing such termination of all such Liens (including UCC-3 termination statements)
and (ii) Existing ABL Agent and Existing ABL Lenders shall have taken all actions and made all recordings and filings to effectuate the foregoing, or shall have given Borrowers and/or Agent the authority to do so, as requested by Agent and the
Lenders; and 
 (f) Agent shall have received the Term Debt Documents, which shall be in form and substance reasonably satisfactory to the
Agent and the Lenders and the Agent and the Lenders shall have received evidence reasonably satisfactory to them that all conditions set forth in the Term Debt Documents to make such documents effective and closed and to fund loans thereunder have
been satisfied in all respects. 
 Each Lender, by delivering its signature page to this Agreement, shall be deemed to have acknowledged
receipt of, and consented to and approved, each Financing Document, each additional Operative Document and each other document, agreement and/or instrument required to be approved by Agent, Required Lenders or Lenders, as applicable, on the Closing
Date. 

  
 77 

 Section 7.2 Conditions to Each Loan. The obligation of the
Lenders to make a Loan or an advance in respect of any Loan, is subject to the satisfaction of the following additional conditions: 
 (a)
receipt by Agent of (i) a Notice of Borrowing (or telephonic notice if permitted by this Agreement) and (ii) (A) prior to the Initial Third Party Agent Commencement Date in connection with the Notice of Borrowing for the first Loan
borrowing hereunder, a Borrowing Base Certificate (Agent) using the most recent available amounts that are not material nonpublic information, (B) during a Non-Third Party Agent Retention Period (other
than the circumstance covered in Section 7.2(a)(i)(A) directly above), if requested by Agent within one Business Day of receipt of the Notice of Borrowing, an updated Borrowing Base Certificate (Agent), and (C) during a Third Party Agent
Retention Period, an updated Borrowing Base Certificate (Third Party Agent); 
 (b) (i) the fact that, immediately after such borrowing
and after application of the proceeds thereof or after such issuance, the Revolving Loan Outstandings will not exceed the Revolving Loan Limit and (ii) a representation providing the same shall be included in the Notice of Borrowing for such
borrowing; 
 (c) in the case of the initial borrowing of the Revolving Loans, subject to Section 4.22, receipt by Agent of Deposit
Account Control Agreements for all Deposit Accounts and Securities Account Control Agreements for all Securities Accounts (in each case, other than Excluded Accounts and the Merrill Lynch Securities Account in accordance with, and subject to the
limitations set forth in, Section 5.14) and, on and after the Initial Third Party Agent Commencement Date, evidence reasonably satisfactory to Agent (or, as applicable, the Third Party Agent) that the Borrowers are in compliance with all
requirements of Section 2.11; 
 (d) the fact that, immediately before and after such advance or issuance, no Default or Event of
Default shall have occurred and be continuing; 
 (e) for Loans made after the Closing Date, the fact that the representations and warranties
of each Credit Party contained in the Financing Documents shall be true, correct and complete in all material respects on and as of the date of such borrowing or issuance, except to the extent that any such representation or warranty relates to a
specific date in which case such representation or warranty shall be true and correct in all material respects as of such earlier date; provided, however, in each case, such materiality qualifier shall not be applicable to any representations and
warranties that already are qualified or modified by materiality in the text thereof; and 
 (f) the fact that no Material Adverse Effect
shall have occurred and be continuing since the date of this Agreement. 
 Each giving of a Notice of Borrowing hereunder and each
acceptance by any Borrower of the proceeds of any Loan made hereunder shall be deemed to be (y) a representation and warranty by each Borrower on the date of such notice or acceptance as to the facts specified in this Section, and (z) a
restatement by each Borrower that each and every one of the representations made by it in any of the Financing Documents is true and correct in all material respects (without duplication of any materiality qualifier in the text of such
representation or warranty) as of such date (except to the extent that such representations and warranties expressly relate solely to an earlier date). 

Section 7.3 Searches. Before the Closing Date, and thereafter (as and when determined by Agent in its
discretion), Agent shall have the right to perform, all at Borrowers’ expense, the searches described in clauses (a), (b), and (c) below against Borrowers and any other Credit Party, the results of which are to be consistent with
Borrowers’ representations and warranties under this Agreement and the 

  
 78 

 
satisfactory results of which shall be a condition precedent to all advances of Loan proceeds: (a) UCC searches with the Secretary of State of the jurisdiction in which the applicable Credit
Party is organized; (b) judgment, pending litigation, federal tax lien, personal property tax lien, and corporate and partnership tax lien searches, in each jurisdiction searched under clause (a) above; and (c) searches of applicable
corporate, limited liability company, partnership and related records to confirm the continued existence, organization and good standing of the applicable Person and the exact legal name under which such Credit Party is organized. 

ARTICLE 8 – REGULATORY MATTERS 

Section 8.1 Reserved. 

Section 8.2 Representations and Warranties. To induce Agent and Lenders to enter into this Agreement
and to make credit accommodations contemplated hereby, Borrowers hereby represent and warrant that, except as disclosed in Schedule 8.2(b), the following statements are true, complete and correct in all material respects (without giving
effect to any double materiality) as of the date hereof, and Borrowers hereby covenant and, subject to (other than, with respect to the Third Party Agent, during any Third Party Agent Retention Period) Section 4.19, agree to notify Agent (or,
during any Third Party Agent Retention Period, the Third Party Agent) each quarter in connection with the Compliance Certificate required to be delivered pursuant to Section 4.1 and upon each submittal of a Notice of Borrowing of the occurrence
of any facts, events or circumstances known to a Borrower, whether threatened in writing, existing or pending, that would make any of the following representations and warranties untrue, incomplete or incorrect in any material respect (without
giving effect to any double materiality) (together with such supporting data and information as shall be necessary to fully explain to Agent (or, if applicable, the Third Party Agent) the scope and nature of the fact, event or circumstance), and,
subject to (other than, with respect to the Third Party Agent, during the Third Party Agent Retention Period) Section 4.19, shall provide to Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) within five
(5) Business Days of Agent’s (or, if applicable, the Third Party Agent) request, such additional information as Agent (or, if applicable, the Third Party Agent) shall request regarding such disclosure: 

(a) Reserved. 
 (b)
Permits. Borrowers have (i) each Permit and other rights from, and have made all declarations and filings with, all applicable Governmental Authorities, all self-regulatory authorities and all courts and other tribunals necessary to
engage in the ownership, management and operation of the business or the assets of any Borrower, except where the failure to do so could not reasonably be expected to result in a Material Adverse Effect (“Material Permits and
Rights”) and (ii) no knowledge that any Governmental Authority is considering limiting, suspending or revoking any such Material Permit and Right. Subject to (other than, with respect to the Third Party Agent, during any Third Party
Agent Retention Period) Section 4.19, Borrower has delivered to Agent (or, during any Third Party Agent Retention Period, the Third Party Agent) a copy of all Permits requested by Agent (or, if applicable, the Third Party Agent) as of the date
hereof or to the extent requested by Agent (or, if applicable, the Third Party Agent) pursuant to Section 4.15. All such Material Permits and Rights are valid and in full force and effect and Borrowers are in compliance with the terms and
conditions of all such Material Permits and Rights, except where failure to be in such compliance or for a Material Permit and Right to be valid and in full force and effect could not be reasonably expected to have a Material Adverse Effect. 

(c) Regulatory Required Permits. With respect to any Product, (i) Borrower and its Subsidiaries have received, and such Product is
the subject of, all Regulatory Required Permits needed in connection with the testing, manufacture, marketing or sale of such Product as currently being conducted by or on behalf of Borrower, except where the failure to have such Regulatory Required
Permits would not 

  
 79 

 
have a Material Adverse Effect, and have provided, subject to (other than, with respect to the Third Party Agent, during any Third Party Agent Retention Period) Section 4.19, Agent and each
Lender with all notices and other information required by Section 4.15, and (ii) such Product is being tested, manufactured, marketed or sold, as the case may be, in compliance in all material respects with all applicable Laws and Material
Permits and Rights. 
 (d) Healthcare and Regulatory Events. 

(i) None of the Borrowers are in violation of any Healthcare Laws, except where any such violation would not have a Material
Adverse Effect. 
 (ii) As of the Closing Date, there have been no Regulatory Reporting Events which could reasonably be
expected to result in a Material Adverse Effect. 
 (iii) No Borrower is participating in any Third Party Payor Program. 

(iv) To the knowledge of any of Borrower’s Responsible Officers, none of the Borrower’s officers, directors,
employees, shareholders, their agents or affiliates has made an untrue statement of material fact or fraudulent statement to the FDA or failed to disclose a material fact required to be disclosed to the FDA, committed an act, made a statement, or
failed to make a statement that could reasonably be expected to provide a basis for the FDA to invoke its policy respecting “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,” set forth in 56 Fed. Regulation
46191 (September 10, 1991). 
 (v) Borrower has not received any written notice that any Governmental Authority, including
the FDA, the Office of the Inspector General of HHS or the United States Department of Justice has commenced or threatened to initiate any action against a Credit Party, any action to enjoin a Credit Party, their officers, directors, employees,
shareholders or their agents and Affiliates, from conducting their businesses at any facility owned or used by them or for any civil penalty, injunction, seizure or criminal action, in each case, which could reasonably be expected to result in a
Material Adverse Effect. 
 (vi) Borrower has not received from the FDA, a Warning Letter, Form FDA-483, “Untitled Letter,” other correspondence or notice setting forth allegedly objectionable observations or alleged violations of laws and regulations enforced by the FDA, or any comparable
correspondence from any state or local authority responsible for regulating drug products and establishments, or any comparable correspondence from any foreign counterpart of the FDA, or any comparable correspondence from any foreign counterpart of
any state or local authority with regard to any Product or the manufacture, processing, packing, or holding thereof, in each case, which could reasonably be expected to result in a Material Adverse Effect. 

(vii) Borrower has not engaged in any Recalls, Market Withdrawals, or other forms of product retrieval from the marketplace of
any Products which could reasonably be expected to result in a Material Adverse Effect. 
 (viii) Each Product (a) is
not adulterated or misbranded within the meaning of the FDCA; (b) is not an article prohibited from introduction into interstate commerce under the provisions of Sections 404, 505 or 512 of the FDCA; (c) each Product has been and/or shall
be manufactured, imported, possessed, owned, warehoused, marketed, promoted, sold, labeled, furnished, distributed and marketed and each service has been conducted in accordance in all material respects with all applicable Permits and Laws; and
(d) each Product has been and/or shall be manufactured in accordance with Good Manufacturing Practices, in each case, except where the failure to do so would not have a Material Adverse Effect. 

  
 80 

 (e) Proceedings. No Borrower is subject to any proceeding, suit or, to Borrowers’
knowledge, investigation by any federal, state or local government or quasi-governmental body, agency, board or authority or any other administrative or investigative body (including the Office of the Inspector General of the United States
Department of Health and Human Services) which would have a Material Adverse Effect on any Borrower; 
 (f) Ancillary Laws. Borrowers
have received no notice, and are not aware, of any violation of applicable antitrust laws, employment or landlord-tenant laws of any federal, state or local government or quasi-governmental body, agency, board or other authority with respect to the
Borrowers that could reasonably be expected to result in a Material Adverse Effect. 
 ARTICLE 9 - SECURITY AGREEMENT 

Section 9.1 Generally. As security for the payment and performance of the Obligations, and without limiting
any other grant of a Lien and security interest in any Security Document, Borrowers hereby collaterally assign and grant to Agent, for the benefit of itself and Lenders, and a continuing first priority (subject only to the permitted priority of the
Permitted Priority Liens) Lien on and security interest in, upon, and to the personal property set forth on Schedule 9.1 attached hereto and made a part hereof; provided, however, anything in this Agreement to the contrary
notwithstanding, “Collateral” shall not include the Excluded Property. 
 Section 9.2 Representations and
Warranties and Covenants Relating to Collateral. 
 (a) The security interest granted pursuant to this Agreement constitutes a valid and,
to the extent such security interest is required to be perfected by this Agreement and any other Financing Document, continuing perfected security interest in favor of Agent in all Collateral subject, for the following Collateral, to the occurrence
of the following: (i) in the case of all Collateral in which a security interest may be perfected by filing a financing statement under the UCC, the filing of such a financing statement in the jurisdiction of organization of the applicable
Credit Party, (ii) with respect to any Deposit Account, the execution of Deposit Account Control Agreements by all parties required to be party thereto, (iii) in the case of
letter-of-credit rights that are not supporting obligations of Collateral, the execution of a contractual obligation granting control to Agent over such letter-of-credit rights, (iv) in the case of electronic chattel paper, the completion of all steps necessary to grant control to Agent over such electronic chattel paper,
(v) in the case of all certificated stock, debt instruments and investment property, the actions taken under clause (i) above and/or the delivery thereof to Agent of such certificated stock, debt instruments and investment property
consisting of instruments and certificates, in each case properly endorsed for transfer to Agent or in blank, (vi) in the case of all investment property not in certificated form, the actions taken under clause (i) above and/or the
execution of control agreements with respect to such investment property, (vii) in the case of all other instruments and tangible chattel paper that are not certificated stock, debt instructions or investment property, the delivery thereof to
Agent of such instruments and tangible chattel paper, and (viii) in the case of all copyrights, trademarks and patents for which UCC filings are insufficient, all appropriate filings having been made with the applicable Intellectual Property
registries, including but not limited to the United States Copyright Office or the United States Patent and Trademark Office, as applicable. Such security interest shall be prior to all other Liens on the Collateral except for Permitted Liens.
Except to the extent not required pursuant to the terms of this Agreement, all actions by each Credit Party reasonably requested by Agent to protect and perfect the Lien granted hereunder on the Collateral have been duly taken. 

  
 81 

 (b) Schedule 9.2 sets forth (i) each chief executive office and principal place of
business of each Borrower and each of their respective Subsidiaries, and (ii) all of the addresses (including all warehouses) at which any of the Collateral is located (it being understood and agreed that from time to time Credit Parties may
(1) sell assets in accordance with the terms of this Agreement, (2) maintain de minimis amounts of Inventory with its sales personnel and at medical facilities, and (3) send items of Collateral out for repair and that from time to
time certain items of Collateral will be in transit and that no such locations need be disclosed on Schedule 9.2) and/or books and records of Borrowers regarding any Collateral or any of Borrower’s assets, liabilities, business
operations or financial condition are kept, which such Schedule 9.2 indicates in each case which Borrower(s) have Collateral and/or books located at such address, and, in the case of any such address not owned by one or more of the
Borrowers(s), indicates the nature of such location (e.g., leased business location operated by Borrower(s), third party warehouse, consignment location, processor location, etc.) and the name and address of the third party owning and/or operating
such location. 
 (c) Without limiting the generality of Section 3.2, except with respect to any rights of any Borrower as a licensee
under any license of Intellectual Property owned by another Person, and except for the filing of financing statements under the UCC, no authorization, approval or other action by, and no notice to or filing with, any Governmental Authority or
consent of any other Person is required for (i) the grant by each Borrower to Agent of the security interests and Liens in the Collateral provided for under this Agreement and the other Security Documents (if any), or (ii) the exercise by
Agent of its rights and remedies with respect to the Collateral provided for under this Agreement and the other Security Documents or under any applicable Law, including the UCC and neither any such grant of Liens in favor of Agent or exercise of
rights by Agent shall violate or cause a default under any agreement between any Borrower and any other Person relating to any such collateral, including any license to which a Borrower is a party, whether as licensor or licensee, with respect to
any Intellectual Property, whether owned by such Borrower or any other Person. 
 (d) As of the Closing Date, no Borrower has any ownership
interest in any Chattel Paper (as defined in Article 9 of the UCC), letter of credit rights, commercial tort claims, Instruments (other than (i) checks and other ordinary course payment instruments, in each case in the ordinary course of
business and (ii) Instruments not in excess of $250,000 in the aggregate at any one time), documents or investment property (other than equity interests in any Subsidiaries of such Borrower disclosed on Schedule 3.4 or subsequently
created hereunder and advised to Agent) and Borrowers shall give notice to Agent promptly (but in any event not later than the delivery by Borrowers of the next Compliance Certificate required pursuant to Section 4.1 above following the end of
a fiscal quarter) upon the acquisition by any Borrower of any such Chattel Paper, letter of credit rights, commercial tort claims, Instruments (subject to the exceptions noted above), documents and investment property (other than equity interests in
any Subsidiaries of such Borrower disclosed on Schedule 3.4 or subsequently created hereunder and advised to Agent). No Person other than Agent or (if applicable) any Lender has “control” (as defined in Article 9 of the UCC) over
any Deposit Account, investment property (including Securities Accounts and commodities account), letter of credit rights or electronic chattel paper in which any Borrower has any interest (except for such control arising by operation of law in
favor of any bank or securities intermediary or commodities intermediary with whom any Deposit Account, Securities Account or commodities account of Borrowers is maintained), other than the Term Agent, subject to the terms of the Intercreditor
Agreement, if applicable. 
 (e) Borrowers shall not, and shall not permit any Credit Party to, take any of the following actions or make any
of the following changes unless, subject to (other than, with respect to the Third Party Agent, during any Third Party Agent Retention Period) Section 4.19, Borrowers have given at least ten (10) Business Days’ prior written notice
(or such later period to which Agent may in its discretion agree) to Agent of Borrowers’ intention to take any such action (which such written notice shall include an 

  
 82 

 
updated version of any Schedule impacted by such change) and have executed any and all documents, instruments and agreements and taken any other actions which Agent may request after receiving
such written notice in order to protect and preserve the Liens, rights and remedies of Agent with respect to the Collateral: (i) change the legal name or organizational identification number of any Borrower as it appears in official filings in
the jurisdiction of its organization, (ii) change the jurisdiction of incorporation or formation of any Borrower or Credit Party or allow any Borrower or Credit Party to designate any jurisdiction as an additional jurisdiction of incorporation
for such Borrower or Credit Party, or change the type of entity that it is, (iii) change its chief executive office or principal place of business, or (iv) change the location of its books and records or move any Collateral to or place any
Collateral on any location that is not then listed on the Schedules (it being understood and agreed that from time to time Credit Parties may (1) sell assets in accordance with the terms of this Agreement, (2) maintain de minimis amounts
of Inventory with its sales personnel and at medical facilities, and (3) send items of Collateral out for repair and that from time to time certain items of Collateral will be in transit and that no such locations need be disclosed on
Schedule 9.2 or any notification need be made to Agent in respect of the foregoing) and/or establish any business location at any location that is not then listed on the Schedules. 

(f) Borrowers shall not adjust, settle or compromise the amount or payment of any Account, or release wholly or partly any Account Debtor, or
allow any credit or discount thereon (other than adjustments, settlements, compromises, credits and discounts in the Ordinary Course of Business, made while no Event of Default exists) without the prior written consent of Agent. Without limiting the
generality of this Agreement or any other provisions of any of the Financing Documents relating to the rights of Agent after the occurrence and during the continuance of an Event of Default, Agent shall have the right at any time after the
occurrence and during the continuance of an Event of Default to: (i) exercise the rights of Borrowers with respect to the obligation of any Account Debtor to make payment or otherwise render performance to Borrowers and with respect to any
property that secures the obligations of any Account Debtor or any other Person obligated on the Collateral, and (ii) adjust, settle or compromise the amount or payment of such Accounts. 

(g) Without limiting the generality of Sections 9.2(c) and 9.2(e): 

(i) Borrowers shall deliver to Agent all tangible Chattel Paper and all Instruments (other than (i) checks and other
ordinary course payment instruments, in each case in the ordinary course of business and (ii) Instruments not in excess of $250,000 in the aggregate at any one time) and documents owned by any Borrower and constituting part of the Collateral
duly endorsed and accompanied by duly executed instruments of transfer or assignment, all in form and substance reasonably satisfactory to Agent. Borrowers shall provide Agent with “control” (as defined in Article 9 of the UCC) of all
electronic Chattel Paper, if any, owned by any Borrower and constituting part of the Collateral by having Agent identified as the assignee on the records pertaining to the single authoritative copy thereof and otherwise complying with the applicable
elements of control set forth in the UCC. Borrowers also shall deliver to Agent all security agreements securing any such Chattel Paper, if any, and securing any such Instruments. Borrowers will mark conspicuously all such Chattel Paper and all such
Instruments and documents with a legend, in form and substance satisfactory to Agent, indicating that such Chattel Paper and such instruments and documents are subject to the security interests and Liens in favor of Agent created pursuant to this
Agreement and the Security Documents. Borrowers shall comply with all the provisions of Section 5.14 with respect to the Deposit Accounts and Securities Accounts of Borrowers. 

(ii) Borrowers shall deliver to Agent all letters of credit on which any Borrower is the beneficiary and which give rise to
letter of credit rights owned by such Borrower which constitute part of the Collateral in each case duly endorsed and accompanied by duly 

  
 83 

 
executed instruments of transfer or assignment, all in form and substance reasonably satisfactory to Agent. Borrowers shall take any and all actions as may be necessary or desirable, or that
Agent may request, from time to time, to cause Agent to obtain exclusive “control” (as defined in Article 9 of the UCC) of any such letter of credit rights in a manner reasonably acceptable to Agent. 

(iii) Borrowers shall promptly advise, subject to (other than, with respect to the Third Party Agent, during any Third Party
Agent Retention Period) Section 4.19, Agent upon any Borrower becoming aware that it has any interests in any commercial tort claim that constitutes part of the Collateral, which such notice shall include descriptions of the events and
circumstances giving rise to such commercial tort claim and the dates such events and circumstances occurred, the potential defendants with respect such commercial tort claim and any court proceedings that have been instituted with respect to such
commercial tort claims, and Borrowers shall, with respect to any such commercial tort claim, execute and deliver to Agent such documents as Agent shall request to perfect, preserve or protect the Liens, rights and remedies of Agent with respect to
any such commercial tort claim. 
 (iv) Except for Accounts and Inventory in an aggregate amount of $500,000, no Accounts or
Inventory or other Collateral and no books and records and/or software and equipment of the Borrowers regarding any of the Collateral or any of the Borrower’s assets, liabilities, business operations or financial condition shall at any time be
located at any leased location or in the possession or control of any warehouse, consignee, bailee or any of Borrowers’ agents or processors, without prior written notice to Agent and the receipt by Agent, of warehouse receipts, consignment
agreements, landlord waivers, or bailee waivers (as applicable) satisfactory to Agent prior to the commencement of such lease or of such possession or control (as applicable) (it being understood and agreed that from time to time Credit Parties may
(1) sell assets in accordance with the terms of this Agreement, (2) maintain de minimis amounts of Inventory with its sales personnel and at medical facilities, and (3) send items of Collateral out for repair and that from time to
time certain items of Collateral will be in transit). Borrower has notified Agent that Collateral and books and records are currently located at the locations set forth on Schedule 9.2. Borrowers shall, upon the request of Agent, notify any such
landlord, warehouse, consignee, bailee, agent or processor of the security interests and Liens in favor of Agent created pursuant to this Agreement and the Security Documents, instruct such Person to hold all such Collateral for Agent’s account
subject to Agent’s instructions and shall obtain an acknowledgement from such Person that such Person holds the Collateral for Agent’s benefit. 

(v) Borrowers shall cause all equipment and other tangible personal property other than Inventory to be maintained and
preserved in the same condition, repair and in working order as when new, ordinary wear and tear excepted, and shall promptly make or cause to be made all repairs, replacements and other improvements in connection therewith that are necessary or
desirable to such end, unless failure to so comply with the foregoing could not reasonably be expected to result in a Material Adverse Effect. Upon request of Agent, Borrowers shall promptly deliver to Agent any and all certificates of title,
applications for title or similar evidence of ownership of all such tangible Personal Property with a value greater than $250,000 and shall cause Agent to be named as lienholder on any such certificate of title or other evidence of ownership.
Borrowers shall not permit any tangible Personal Property included in the Borrowing Base to become fixtures to real estate unless such real estate is subject to a Lien in favor of Agent. 

(vi) Each Borrower hereby authorizes Agent and its representatives, agents, subagents and attorneys and any Third Party Agent
to file without the signature of such Borrower one or more UCC financing statements relating to liens on personal property relating to all or any part of the Collateral, which financing statements may list Agent as the “secured party” and
such 

  
 84 

 
Borrower as the “debtor” and which describe and indicate the collateral covered thereby as all or any part of the Collateral under the Financing Documents (including an indication of
the collateral covered by any such financing statement as “all assets” (or similar language) of such Borrower now owned or hereafter acquired), in such jurisdictions as Agent from time to time determines are appropriate, and to file
without the signature of such Borrower any continuations of or corrective amendments to any such financing statements, in any such case in order for Agent to perfect, preserve or protect the Liens, rights and remedies of Agent with respect to the
Collateral. Each Borrower also ratifies its authorization for Agent and its representatives, agents, subagents and attorneys and any Third Party Agent to have filed in any jurisdiction any initial financing statements or amendments thereto if filed
prior to the date hereof. 
 (vii) As of the Closing Date, except as set forth on Schedule 9.2(vii), no Borrower
holds, and after the Closing Date Borrowers shall update such schedule on a quarterly basis in respect of, any Collateral which constitutes a claim against any Governmental Authority (other than in respect of the Account Debtors listed on
Schedule 9.2(vii)), including the federal government of the United States or any instrumentality or agency thereof, the assignment of which claim is restricted by any applicable Law, including the federal Assignment of Claims Act and any
other comparable Law. Upon the reasonable request of Agent, Borrowers shall use commercially reasonable efforts to take the actions reasonably requested by Agent to comply with any such applicable Law. 

(viii) Subject to (other than, with respect to the Third Party Agent, during any Third Party Agent Retention Period)
Section 4.19, Borrowers shall furnish to Agent from time to time any statements and schedules further identifying or describing the Collateral and any other information, reports or evidence concerning the Collateral as Agent may reasonably
request from time to time. 
 (h) Solely for the purpose of enabling Agent (for the benefit of the Agent and the Lenders) to exercise rights
and remedies upon an Event of Default (including in order to take possession of, collect, receive, assemble, process, appropriate, remove, realize upon, sell, assign, convey, transfer or grant options to purchase any Collateral), each Borrower
hereby grants to Agent, for the benefit of the Agent and the Lenders, (i) an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to such Borrower) including in such license the right to use, practice,
license or sublicense any Intellectual Property now owned or hereafter acquired by such Borrower, and wherever the same may be located, and including in such license access to all media in which any of the licensed items may be recorded or stored
and to all computer software and programs used for the compilation or printout thereof, and (ii) an irrevocable license (without payment of rent or other compensation to such Borrower) to use, operate and occupy all real estate owned, operated,
leased, subleased or otherwise occupied by such Borrower; provided, in each case, that no such licenses shall be granted with respect to any Excluded Property. 

ARTICLE 10 - EVENTS OF DEFAULT 

Section 10.1 Events of Default. For purposes of the Financing Documents, the occurrence of any of the
following conditions and/or events, whether voluntary or involuntary, by operation of law or otherwise, shall constitute an “Event of Default”: 

(a) (i) any Credit Party shall fail to pay when due any principal, interest, premium or fee under any Financing Document or any other
amount payable under any Financing Document, or (ii) there shall occur any default in the performance of or compliance with any of the following sections of this Agreement: Section 2.11, Section 4.1, Section 4.2(b), Section 4.4(c),
Section 4.7, Section 4.11, Section 4.14, Section 4.15, Section 4.17, Section 4.19, Section 4.20, Section 4.21, Section 4.22, Section 4.23, Article 5, Article 6, Article 8 and Section 9.2(e) (other
than clause (iv) thereof); 

  
 85 

 (b) any Credit Party defaults in the performance of or compliance with any term contained in this
Agreement or in any other Financing Document (other than occurrences described in other provisions of this Section 10.1 for which a different grace or cure period is specified or for which no grace or cure period is specified and thereby
constitute immediate Events of Default) and such default is not remedied by the Credit Party or waived by Agent within thirty (30) days (other than Section 9.1(g)(iv) of this Agreement, in which case, within ten (10) days) after the
earlier of (i) receipt by Borrower Representative of notice from Agent or Required Lenders of such default, or (ii) actual knowledge of any Borrower or any other Credit Party of such default; 

(c) any representation, warranty, certification or statement made by any Credit Party or any other Person in any Financing Document or in any
certificate, financial statement or other document delivered pursuant to any Financing Document is incorrect in any respect (or in any material respect if such representation, warranty, certification or statement is not by its terms already
qualified as to materiality) when made (or deemed made) (subject in the case of projections, other forward-looking information and industry information to the limitations set forth in Section 3.21 hereof); 

(d) (i) failure of any Credit Party to pay when due or within any applicable grace period any principal, interest or other amount on Debt
(other than the Loans), or the occurrence of any breach, default, condition or event with respect to any Debt (other than the Loans), if the effect of such failure or occurrence is to cause or to permit the holder or holders of any such Debt, or to
cause, Debt or other liabilities having an individual principal amount in excess of $3,000,000 or having an aggregate principal amount in excess of $8,000,000 to become or be declared due prior to its stated maturity, (ii) the occurrence of any
breach or default under any terms or provisions of any Convertible Note Document or any Subordinated Debt Document or the occurrence of any event requiring the prepayment or mandatory redemption of any 3.25% Convertible Note (or any Permitted 3.25%
Convertible Note Refinancing thereof), any 2.25% Convertible Note or of any Subordinated Debt; provided, however that, notwithstanding the foregoing, any event or condition that occurs that permits holders of convertible Debt permitted hereunder to
convert such Debt into Stock (other than Disqualified Stock) pursuant to the terms of the applicable indenture shall not constitute a Default or Event of Default hereunder on such basis alone; or (iii) (A) the failure of any Credit Party or its
Subsidiaries to make any payment when due (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of the Term Debt, or (B) fails to observe or perform any other agreement or condition relating to the
Term Debt or the Term Debt Documents or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event occurs, the effect of which default or other event is to cause, or to permit the holder or holders of such
Term Debt or the beneficiary or beneficiaries of any Guarantee related thereto (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, such Term Debt to be demanded or to become due or to be repurchased,
prepaid, defeased or redeemed (automatically or otherwise), or an offer to repurchase, prepay, defease or redeem such Term Debt to be made, prior to its stated maturity, or such Guarantee to become payable; 

(e) any Credit Party or any Subsidiary of a Borrower shall commence a voluntary case or other proceeding seeking liquidation, reorganization or
other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it or any
substantial part of its property, or shall consent to any such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against it, or shall make a general assignment for the
benefit of creditors, or shall fail generally to pay its debts as they become due, or shall take any corporate action to authorize any of the foregoing; 

  
 86 

 (f) an involuntary case or other proceeding shall be commenced against any Credit Party or any
Subsidiary of a Borrower (other than any Immaterial Subsidiary) seeking liquidation, reorganization or other relief with respect to it or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the
appointment of a trustee, receiver, liquidator, custodian or other similar official of it or any substantial part of its property, and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of sixty
(60) days; or an order for relief shall be entered against any Credit Party or any Subsidiary of a Borrower (other than any Immaterial Subsidiary) under applicable federal bankruptcy, insolvency or other similar law in respect of
(i) bankruptcy, liquidation, winding-up, dissolution or suspension of general operations, (ii) composition, rescheduling, reorganization, arrangement or readjustment of, or other relief from, or stay
of proceedings to enforce, some or all of the debts or obligations, or (iii) possession, foreclosure, seizure or retention, sale or other disposition of, or other proceedings to enforce security over, all or any substantial part of the assets
of such Credit Party or Subsidiary (other than assets that are not Collateral of any Immaterial Subsidiary); 
 (g) (i) institution of
any steps by any Person to terminate a Pension Plan if as a result of such termination any Credit Party or any member of the Controlled Group could be required to make a contribution to such Pension Plan, or could incur a liability or obligation to
such Pension Plan, in excess of $1,000,000, (ii) a contribution failure occurs with respect to any Pension Plan sufficient to give rise to a Lien under Section 303(k) of ERISA or Section 430(k) of the Code or an event occurs that could reasonably be
expected to give rise to a Lien under Section 4068 of ERISA, or (iii) there shall occur any withdrawal or partial withdrawal from a Multiemployer Plan and the withdrawal liability (without unaccrued interest) to Multiemployer Plans as a
result of such withdrawal (including any outstanding withdrawal liability that any Credit Party or any member of the Controlled Group have incurred on the date of such withdrawal) exceeds $1,000,000; 

(h) one or more judgments or orders for the payment of money (to the extent not paid or covered by insurance maintained in accordance with the
requirements of this Agreement and as to which the relevant insurance company has acknowledged coverage) aggregating in excess of $1,000,000 (above any amounts so covered by insurance) shall be rendered against any or all Credit Parties and either
(i) enforcement proceedings shall have been commenced by any creditor upon any such judgments or orders, or (ii) there shall be any period of twenty (20) consecutive days during which a stay of enforcement of any such judgments or
orders, by reason of a pending appeal, bond or otherwise, shall not be in effect; 
 (i) any material provision of any Financing Document
shall for any reason cease to be valid and binding on or enforceable against any Credit Party or any Subsidiary of any Credit Party party thereto or any Credit Party or any Subsidiary of any Credit Party shall so state in writing or bring an action
to limit its obligations or liabilities thereunder or otherwise contest the validity, binding effect or enforceability of the Financing Documents; or any Financing Document shall for any reason (other than pursuant to the terms thereof) cease to
create a valid security interest in any of the Collateral in excess of such Collateral that has a fair market value of $50,000 as determined by the Agent in its sole reasonable discretion (to the extent that such perfection or priority is required
hereby) purported to be covered thereby or such security interest shall for any reason cease to be a perfected and first priority security interest (subject only to the prior priority of the Permitted Priority Liens); 

(j) the institution by any Governmental Authority of criminal proceedings against any Credit Party; 

(k) an event of default occurs under any Guarantee of any portion of the Obligations; 

  
 87 

 (l) any Borrower makes any payment on account of any Debt that has been subordinated to any of
the Obligations, other than payments specifically permitted by the terms of such subordination; 
 (m) if any Borrower is or becomes an
entity whose equity is registered with the SEC, and/or is publicly traded on and/or registered with a public securities exchange, such Borrower’s equity fails to remain registered with the SEC in good standing, and/or such equity fails to
remain publicly traded on and registered with a public securities exchange; 
 (k) [reserved]; 

(l) the voluntary withdrawal or institution of any action or proceeding by the FDA or similar Governmental Authority to order the withdrawal of
any Product or Product category from the market or to enjoin Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries from manufacturing, marketing, selling or distributing any Product or Product category that has or could
reasonably be expected to have a Material Adverse Effect, (ii) the institution of any action or proceeding by the DEA, the FDA, or any other Governmental Authority to revoke, suspend, reject, withdraw, limit, or restrict any Regulatory Required
Permit held by Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries, which, in each case, has or could reasonably be expected to result in a Material Adverse Effect, (iii) the commencement of any enforcement action
against Borrower, its Subsidiaries or any representative of Borrower or its Subsidiaries (with respect to the business of Borrower or its Subsidiaries) by the DEA, the FDA, or any other Governmental Authority which has or could reasonably be
expected to result in a Material Adverse Effect, or (iv) the occurrence of adverse test results in connection with a Product which could reasonably be expected to result in a Material Adverse Effect; 

(m) any Credit Party defaults under or breaches any Material Contract (after any applicable grace period contained therein), or a Material
Contract shall be terminated by a third party or parties party thereto prior to the expiration thereof (other than in accordance with its terms) (other than the Warrant, the 3.25% Convertible Notes, any Permitted 3.25% Convertible Note Refinancing
or the 2.25% Convertible Notes, any Term Debt or any Loan Documents (as defined in the Term Credit Agreement)), or there is a loss of a material right of a Credit Party under any Material Contract to which it is a party, in each case which could
reasonably be expected to result in a Material Adverse Effect; 
 (n) any provisions of the Intercreditor Agreement shall for any reason be
revoked or invalidated, or otherwise cease to be in full force and effect other than in accordance with the terms of the Intercreditor Agreement, or any Credit Party or its Affiliates shall contest in any manner the validity or enforceability
thereof or deny that it has any further liability or obligation thereunder; or 
 (o) the Common Stock shall cease to be registered under the
Exchange Act or to be listed on the Principal Market. 
 All cure periods provided for in this Section 10.1 shall run concurrently with
any cure period provided for in any applicable Financing Documents under which the default occurred. 
 Section 10.2
Acceleration and Suspension or Termination of Revolving Loan Commitment. Upon the occurrence and during the continuance of an Event of Default, Agent may, and shall if requested by Required Lenders, (a) by notice to Borrower
Representative suspend or terminate the Revolving Loan Commitment and the obligations of Agent and the Lenders with respect thereto, in whole or in part (and, if in part, each Lender’s Revolving Loan Commitment shall be reduced in
accordance with its Pro Rata Share), and/or (b) by notice to Borrower Representative declare all or any portion of the Obligations to be, and the Obligations shall thereupon become, immediately due and payable, with accrued

  
 88 

 
interest thereon, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Borrower and Borrowers will pay the same; provided,
however, that in the case of any of the Events of Default specified in Section 10.1(e) or 10.1(f) above, without any notice to any Borrower or any other act by Agent or the Lenders, the Revolving Loan Commitment and the obligations of
Agent and the Lenders with respect thereto shall thereupon immediately and automatically terminate and all of the Obligations shall become immediately and automatically due and payable without presentment, demand, protest or other notice of any
kind, all of which are hereby waived by each Borrower and Borrowers will pay the same. 
 Section 10.3 UCC Remedies. 

(a) Upon the occurrence of and during the continuance of an Event of Default under this Agreement or the other Financing Documents, Agent, in
addition to all other rights, options, and remedies granted to Agent under this Agreement or at law or in equity, may exercise, either directly or through one or more assignees or designees, all rights and remedies granted to it under all Financing
Documents and under the UCC in effect in the applicable jurisdiction(s) and under any other applicable law; including: 
 (i)
the right to take possession of, send notices regarding, and collect directly the Collateral, with or without judicial process; 

(ii) the right to (by its own means or with judicial assistance) enter any of Borrowers’ premises and take possession of
the Collateral, or render it unusable, or to render it usable or saleable, or dispose of the Collateral on such premises in compliance with subsection (iii) below and to take possession of Borrowers’ original books and records, to obtain
access to Borrowers’ data processing equipment, computer hardware and software relating to the Collateral and to use all of the foregoing and the information contained therein in any manner Agent deems appropriate, without any liability for
rent, storage, utilities, or other sums, and Borrowers shall not resist or interfere with such action (if Borrowers’ books and records are prepared or maintained by an accounting service, contractor or other third party agent, Borrowers hereby
irrevocably authorize such service, contractor or other agent, upon notice by Agent to such Person that an Event of Default has occurred and is continuing, to deliver to Agent or its designees such books and records, and to follow Agent’s
instructions with respect to further services to be rendered); 
 (iii) the right to require Borrowers at Borrowers’
expense to assemble all or any part of the Collateral and make it available to Agent at any place designated by Lender; 

(iv) the right to notify postal authorities to change the address for delivery of Borrowers’ mail to an address designated
by Agent and to receive, open and dispose of all mail addressed to any Borrower; and/or 
 (v) the right to enforce
Borrowers’ rights against Account Debtors and other obligors, including (i) the right to collect Accounts directly in Agent’s own name (as agent for Lenders) and to charge the collection costs and expenses, including attorneys’
fees, to Borrowers, and (ii) the right, in the name of Agent or any designee of Agent or Borrowers, to verify the validity, amount or any other matter relating to any Accounts by mail, telephone, telegraph or otherwise, including verification
of Borrowers’ compliance with applicable Laws. Borrowers shall cooperate fully with Agent in an effort to facilitate and promptly conclude such verification process. Such verification may include contacts between Agent and applicable federal,
state and local regulatory authorities having jurisdiction over the Borrowers’ affairs, all of which contacts Borrowers hereby irrevocably authorize. 

  
 89 

 (b) Each Borrower agrees that a notice received by it at least ten (10) days before the time
of any intended public sale, or the time after which any private sale or other disposition of the Collateral is to be made, shall be deemed to be reasonable notice of such sale or other disposition. If permitted by applicable law, any perishable
Collateral which threatens to speedily decline in value or which is sold on a recognized market may be sold immediately by Agent without prior notice to Borrowers. At any sale or disposition of Collateral, Agent may (to the extent permitted by
applicable law) purchase all or any part of the Collateral, free from any right of redemption by Borrowers, which right is hereby waived and released. Each Borrower covenants and agrees not to interfere with or impose any obstacle to Agent’s
exercise of its rights and remedies with respect to the Collateral. Agent shall have no obligation to clean-up or otherwise prepare the Collateral for sale. Agent may comply with any applicable state or
federal law requirements in connection with a disposition of the Collateral and compliance will not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. Agent may sell the Collateral without giving any
warranties as to the Collateral. Agent may specifically disclaim any warranties of title or the like. This procedure will not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. If Agent sells any of the
Collateral upon credit, Borrowers will be credited only with payments actually made by the purchaser, received by Agent and applied to the indebtedness of the purchaser. In the event the purchaser fails to pay for the Collateral, Agent may resell
the Collateral and Borrowers shall be credited with the proceeds of the sale. Borrowers shall remain liable for any deficiency if the proceeds of any sale or disposition of the Collateral are insufficient to pay all Obligations. 

(c) Without restricting the generality of the foregoing and for the purposes aforesaid, each Borrower hereby appoints and constitutes Agent its
lawful attorney-in-fact with full power of substitution in the Collateral, upon the occurrence and during the continuance of an Event of Default, to (i) use
unadvanced funds remaining under this Agreement or which may be reserved, escrowed or set aside for any purposes hereunder at any time, or to advance funds in excess of the face amount of the Notes, (ii) pay, settle or compromise all existing
bills and claims, which may be Liens or security interests, or to avoid such bills and claims becoming Liens against the Collateral, (iii) execute all applications and certificates in the name of such Borrower and to prosecute and defend all
actions or proceedings in connection with the Collateral, and (iv) do any and every act which such Borrower might do in its own behalf; it being understood and agreed that this power of attorney in this subsection (c) shall be a power
coupled with an interest and cannot be revoked. 
 (d) Solely for the purpose of enabling Agent (for the benefit of Agent and the Lenders) to
exercise remedies upon an Event of Default (including in order to take possession of, collect, receive, assemble, process, appropriate, remove, realize upon, sell, assign, convey, transfer or grant options to purchase any Collateral), Agent and each
Lender is hereby granted a non-exclusive, royalty-free license or other right to use, without charge, Borrowers’ labels, mask works, rights of use of any name, any other Intellectual Property and
advertising matter, and any similar property as it pertains to the Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Agent’s exercise of its rights under this Article,
Borrowers’ rights under all licenses (whether as licensor or licensee) (unless constituting Excluded Property) and all franchise agreements inure to Agent’s and each Lender’s benefit. 

Section 10.4 Reserved.  

Section 10.5 Default Rate of Interest. At the election of Agent or Required Lenders, after the occurrence of
an Event of Default and for so long as it continues, the Loans and other Obligations shall bear interest at rates that are two percent (2.0%) per annum in excess of the rates otherwise payable under this Agreement; provided, however, that in
the case of any Event of Default specified in Section 10.1(e) or 10.1(f) above, such default rates shall apply immediately and automatically without the need for any election or action of any kind on the part of Agent or any Lender. For the
avoidance of doubt and notwithstanding anything to the contrary in this Agreement or any other Financing Agreement, the Maximum Cumulative Rate Provision is not applicable to this Section 10.5 (or any rate set forth herein). 

  
 90 

 Section 10.6 Setoff Rights. During the continuance of any Event
of Default, each Lender is hereby authorized by each Borrower at any time or from time to time, with reasonably prompt subsequent notice to such Borrower (any prior or contemporaneous notice being hereby expressly waived) to set off and to
appropriate and to apply any and all (a) balances held by such Lender or any of such Lender’s Affiliates at any of its offices for the account of such Borrower or any of its Subsidiaries (regardless of whether such balances are then due to
such Borrower or its Subsidiaries), and (b) other property at any time held or owing by such Lender to or for the credit or for the account of such Borrower or any of its Subsidiaries, against and on account of any of the Obligations; except
that no Lender shall exercise any such right without the prior written consent of Agent. Any Lender exercising a right to set off shall purchase for cash (and the other Lenders shall sell) interests in each of such other Lender’s Pro Rata Share
of the Obligations as would be necessary to cause all Lenders to share the amount so set off with each other Lender in accordance with their respective Pro Rata Share of the Obligations. Each Borrower agrees, to the fullest extent permitted by law,
that any Lender and any of such Lender’s Affiliates may exercise its right to set off with respect to the Obligations as provided in this Section 10.6. 

Section 10.7 Application of Proceeds. 

(a) Notwithstanding anything to the contrary contained in this Agreement, upon the occurrence and during the continuance of an Event of
Default, each Borrower irrevocably waives the right to direct the application of any and all payments at any time or times thereafter received by Agent from or on behalf of such Borrower or any Guarantor of all or any part of the Obligations, and,
as between Borrowers on the one hand and Agent and Lenders on the other, Agent shall have the continuing and exclusive right to apply and to reapply any and all payments received against the Obligations in such manner as Agent may deem advisable
notwithstanding any previous application by Agent. 
 (b) Following the occurrence and continuance of an Event of Default, but absent the
occurrence and continuance of an Acceleration Event, Agent shall apply any and all payments received by Agent in respect of the Obligations, and any and all proceeds of Collateral received by Agent, in such order as Agent may from time to time
elect. 
 (c) Notwithstanding anything to the contrary contained in this Agreement, if an Acceleration Event shall have occurred, and so long
as it continues, Agent shall apply any and all payments received by Agent in respect of the Obligations, and any and all proceeds of Collateral received by Agent, in the following order: first, to all fees, costs, indemnities, liabilities,
obligations and expenses incurred by or owing to Agent with respect to this Agreement, the other Financing Documents or the Collateral; second, to all fees, costs, indemnities, liabilities, obligations and expenses incurred by or owing to any
Lender with respect to this Agreement, the other Financing Documents or the Collateral; third, to accrued and unpaid interest on the Obligations (including any interest which, but for the provisions of the Bankruptcy Code, would have accrued
on such amounts); fourth, to the principal amount of the Obligations outstanding; and fifth to any other indebtedness or obligations of Borrowers owing to Agent or any Lender under the Financing Documents. Any balance remaining shall
be delivered to Borrowers or to whomever may be lawfully entitled to receive such balance or as a court of competent jurisdiction may direct. In carrying out the foregoing, (y) amounts received shall be applied in the numerical order provided
until exhausted prior to the application to the next succeeding category, and (z) each of the Persons entitled to receive a payment in any particular category shall receive an amount equal to its Pro Rata Share of amounts available to be
applied pursuant thereto for such category. 

  
 91 

 Section 10.8 Waivers. 

(a) Except as otherwise provided for in this Agreement and to the fullest extent permitted by applicable law, each Borrower waives:
(i) presentment, demand and protest, and notice of presentment, dishonor, intent to accelerate, acceleration, protest, default, nonpayment, maturity, release, compromise, settlement, extension or renewal of any or all Financing Documents, the
Notes or any other notes, commercial paper, accounts, contracts, documents, Instruments, Chattel Paper and Guarantees at any time held by Lenders on which any Borrower may in any way be liable, and hereby ratifies and confirms whatever Lenders may
do in this regard; (ii) all rights to notice and a hearing prior to Agent’s or any Lender’s taking possession or control of, or to Agent’s or any Lender’s replevy, attachment or levy upon, any Collateral or any bond or
security which might be required by any court prior to allowing Agent or any Lender to exercise any of its remedies; and (iii) the benefit of all valuation, appraisal and exemption Laws. Each Borrower acknowledges that it has been advised by
counsel of its choices and decisions with respect to this Agreement, the other Financing Documents and the transactions evidenced hereby and thereby. 

(b) Each Borrower for itself and all its successors and assigns, (i) agrees that its liability shall not be in any manner affected by any
indulgence, extension of time, renewal, waiver, or modification granted or consented to by Lender; (ii) consents to any indulgences and all extensions of time, renewals, waivers, or modifications that may be granted by Agent or any Lender with
respect to the payment or other provisions of the Financing Documents, and to any substitution, exchange or release of the Collateral, or any part thereof, with or without substitution, and agrees to the addition or release of any Borrower,
endorsers, guarantors, or sureties, or whether primarily or secondarily liable, without notice to any other Borrower and without affecting its liability hereunder; (iii) agrees that its liability shall be unconditional and without regard to the
liability of any other Borrower, Agent or any Lender for any tax on the indebtedness; and (iv) to the fullest extent permitted by law, expressly waives the benefit of any statute or rule of law or equity now provided, or which may hereafter be
provided, which would produce a result contrary to or in conflict with the foregoing. 
 (c) To the extent that Agent or any Lender may have
acquiesced in any noncompliance with any requirements or conditions precedent to the closing of the Loans or to any subsequent disbursement of Loan proceeds, such acquiescence shall not be deemed to constitute a waiver by Agent or any Lender of such
requirements with respect to any future disbursements of Loan proceeds and Agent may at any time after such acquiescence require Borrowers to comply with all such requirements. Any forbearance by Agent or Lender in exercising any right or remedy
under any of the Financing Documents, or otherwise afforded by applicable law, including any failure to accelerate the maturity date of the Loans, shall not be a waiver of or preclude the exercise of any right or remedy nor shall it serve as a
novation of the Notes or as a reinstatement of the Loans or a waiver of such right of acceleration or the right to insist upon strict compliance of the terms of the Financing Documents. Agent’s or any Lender’s acceptance of payment of any
sum secured by any of the Financing Documents after the due date of such payment shall not be a waiver of Agent’s and such Lender’s right to either require prompt payment when due of all other sums so secured or to declare a default for
failure to make prompt payment. The procurement of insurance or the payment of taxes or other Liens or charges by Agent as the result of an Event of Default shall not be a waiver of Agent’s right to accelerate the maturity of the Loans, nor
shall Agent’s receipt of any condemnation awards, insurance proceeds, or damages under this Agreement operate to cure or waive any Credit Party’s default in payment of sums secured by any of the Financing Documents. 

  
 92 

 (d) Without limiting the generality of anything contained in this Agreement or the other
Financing Documents, each Borrower agrees that if an Event of Default is continuing (i) to the extent permitted by applicable law, Agent and Lenders shall not be subject to any “one action” or “election of remedies” law or
rule, and (ii) all Liens and other rights, remedies or privileges provided to Agent or Lenders shall remain in full force and effect until Agent or Lenders have exhausted all remedies against the Collateral and any other properties owned by
Borrowers and the Financing Documents and other security instruments or agreements securing the Loans have been foreclosed, sold and/or otherwise realized upon in satisfaction of Borrowers’ obligations under the Financing Documents or until
indefeasible payment in full of the Obligations (other than contingent indemnification Obligations for which no claim has been asserted). 

(e) Nothing contained herein or in any other Financing Document shall be construed as requiring Agent or any Lender to resort to any part of
the Collateral for the satisfaction of any of Borrowers’ obligations under the Financing Documents in preference or priority to any other Collateral, and Agent may seek satisfaction out of all of the Collateral or any part thereof, in its
absolute discretion in respect of Borrowers’ obligations under the Financing Documents. In addition, Agent shall have the right from time to time to partially foreclose upon any Collateral in any manner and for any amounts secured by the
Financing Documents then due and payable as determined by Agent in its sole discretion if an Event of Default has occurred and is continuing, including the following circumstances: (i) in the event any Borrower defaults beyond any applicable
grace period in the payment of one or more scheduled payments of principal and/or interest, Agent may foreclose upon all or any part of the Collateral to recover such delinquent payments, or (ii) in the event Agent elects to accelerate less
than the entire outstanding principal balance of the Loans, Agent may foreclose all or any part of the Collateral to recover so much of the principal balance of the Loans as Lender may accelerate and such other sums secured by one or more of the
Financing Documents as Agent may elect. Notwithstanding one or more partial foreclosures, any unforeclosed Collateral shall remain subject to the Financing Documents to secure payment of sums secured by the Financing Documents and not previously
recovered. 
 (f) To the fullest extent permitted by law, each Borrower, for itself and its successors and assigns, waives in the event of
foreclosure of any or all of the Collateral any equitable right otherwise available to any Credit Party which would require the separate sale of any of the Collateral or require Agent or Lenders to exhaust their remedies against any part of the
Collateral before proceeding against any other part of the Collateral; and further in the event of such foreclosure each Borrower does hereby expressly consent to and authorize, at the option of Agent, the foreclosure and sale either separately or
together of each part of the Collateral. 
 Section 10.9 Injunctive Relief. The parties acknowledge and
agree that, in the event of a breach or threatened breach of any Credit Party’s obligations under any Financing Documents, Agent and Lenders may have no adequate remedy in money damages and, accordingly, shall be entitled to an injunction
(including a temporary restraining order, preliminary injunction, writ of attachment, or order compelling an audit) against such breach or threatened breach, including maintaining any cash management and collection procedure described herein.
However, no specification in this Agreement of a specific legal or equitable remedy shall be construed as a waiver or prohibition against any other legal or equitable remedies in the event of a breach or threatened breach of any provision of this
Agreement. Each Credit Party waives, to the fullest extent permitted by law, the requirement of the posting of any bond in connection with such injunctive relief. By joining in the Financing Documents as a Credit Party, each Credit Party
specifically joins in this Section as if this Section were a part of each Financing Document executed by such Credit Party. 

Section 10.10 Marshalling; Payments Set Aside. Neither Agent nor any Lender shall be under any obligation to
marshal any assets in payment of any or all of the Obligations. To the extent that Borrower makes any payment or Agent enforces its Liens or Agent or any Lender exercises its right of set-off, and such payment
or the proceeds of such enforcement or set-off is subsequently invalidated, declared to be fraudulent or preferential, set aside, or required to be repaid by anyone, then to the extent of such recovery, the
Obligations or part thereof originally intended to be satisfied, and all Liens, rights and remedies therefor, shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or set-off had not occurred. 
  

  
 93 

 Section 10.11 Credit Bidding. The Credit Parties and the
Lenders hereby irrevocably authorize Agent based upon the written instruction of the Lenders, to (a) credit bid and in such manner purchase (either directly or through one or more acquisition vehicles) all or any portion of the Collateral at
any sale thereof conducted under the provisions of the Bankruptcy Code, including under Section 363 of the Bankruptcy Code or any similar laws in any other jurisdictions to which a Credit Party is subject, or (b) credit bid and in such
manner purchase (either directly or through one or more acquisition vehicles) all or any portion of the Collateral at any other sale or foreclosure conducted by (or with the consent or at the direction of) Agent (whether by judicial action or
otherwise) in accordance with applicable Law. In connection with any such credit bid and purchase, the Obligations owed to any Lender shall be entitled to be, and shall be, credit bid on a ratable basis (with Obligations with respect to contingent
or unliquidated claims being estimated for such purpose if the fixing or liquidation thereof would not unduly delay the ability of Agent to credit bid and purchase at such sale or other disposition of the Collateral and, if such claims cannot be
estimated without unduly delaying the ability of Agent to credit bid, then such claims shall be disregarded, not credit bid, and not entitled to any interest in the asset or assets purchased by means of such credit bid) and the Lenders whose
Obligations are credit bid shall be entitled to receive interests (ratably based upon the proportion of their Obligations credit bid in relation to the aggregate amount of Obligations so credit bid) in the asset or assets so purchased (or in the
Stock of the acquisition vehicle or vehicles that are used to consummate such purchase). Except as provided above and otherwise expressly provided for herein or in the other Financing Documents, Agent will not execute nor deliver a release of any
Lien on any Collateral. Upon request by Agent or the Borrower Representative at any time, the Lenders will confirm in writing Agent’s authority to release any such Liens on particular types or items of Collateral pursuant to this
Section 10.11. 
 ARTICLE 11 - AGENT 

Section 11.1 Appointment and Authorization. Each Lender hereby irrevocably appoints and authorizes Agent
(including any Third Party Agent) to enter into each of the Financing Documents to which it is a party (other than this Agreement) on its behalf and to take such actions as Agent (or such Third Party Agent) on its behalf and to exercise such powers
under the Financing Documents as are delegated to Agent (or such Third Party Agent) by the terms thereof, together with all such powers as are reasonably incidental thereto. Subject to the terms of Section 11.16 and to the terms of the other
Financing Documents, Agent is authorized and empowered to amend, modify, or waive any provisions of this Agreement or the other Financing Documents on behalf of Lenders. The provisions of this Article 11 are solely for the benefit of Agent
(including any Third Party Agent) and Lenders and neither any Borrower nor any other Credit Party shall have any rights as a third party beneficiary of any of the provisions hereof. In performing its functions and duties under this Agreement, Agent
(and any Third Party Agent) shall act solely as agent of Lenders and does not assume and shall not be deemed to have assumed any obligation toward or relationship of agency or trust with or for any Borrower or any other Credit Party. Agent may
perform any of its duties hereunder, or under the Financing Documents, by or through its agents, subagents, servicers, trustees, investment managers or employees or any Third Party Agent. 

Section 11.2 Agent and Affiliates. Agent shall have the same rights and powers under the Financing Documents
as any other Lender and may exercise or refrain from exercising the same as though it were not Agent, and Agent and its Affiliates may lend money to, invest in and generally engage in any kind of business with each Credit Party or Affiliate of any
Credit Party as if it were not Agent hereunder. 

  
 94 

 Section 11.3 Action by Agent. The duties of Agent shall be
mechanical and administrative in nature. Agent shall not have by reason of this Agreement a fiduciary relationship in respect of any Lender. Nothing in this Agreement or any of the Financing Documents is intended to or shall be construed to impose
upon Agent any obligations in respect of this Agreement or any of the Financing Documents except as expressly set forth herein or therein. 

Section 11.4 Consultation with Experts. Agent may consult with legal counsel, independent public accountants
and other experts selected by it and shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the advice of such counsel, accountants or experts. 

Section 11.5 Liability of Agent. Neither Agent nor any of its directors, officers, agents, subagents,
trustees, investment managers, servicers or employees shall be liable to any Lender for any action taken or not taken by it in connection with the Financing Documents, except that Agent shall be liable with respect to its specific duties set forth
hereunder but only to the extent of its own gross negligence or willful misconduct in the discharge thereof as determined by a final non-appealable judgment of a court of competent jurisdiction. Neither Agent
nor any of its directors, officers, agents, subagents, trustees, investment managers, servicers or employees shall be responsible for or have any duty to ascertain, inquire into or verify (a) any statement, warranty or representation made in
connection with any Financing Document or any borrowing hereunder; (b) the performance or observance of any of the covenants or agreements specified in any Financing Document; (c) the satisfaction of any condition specified in any
Financing Document; (d) the validity, effectiveness, sufficiency or genuineness of any Financing Document, any Lien purported to be created or perfected thereby or any other instrument or writing furnished in connection therewith; (e) the
existence or non-existence of any Default or Event of Default; or (f) the financial condition of any Credit Party. Agent shall not incur any liability by acting in reliance upon any notice, consent,
certificate, statement, or other writing (which may be a bank wire, facsimile or electronic transmission or similar writing) believed by it to be genuine or to be signed by the proper party or parties. Agent shall not be liable for any apportionment
or distribution of payments made by it in good faith and if any such apportionment or distribution is subsequently determined to have been made in error the sole recourse of any Lender to whom payment was due but not made, shall be to recover from
other Lenders any payment in excess of the amount to which they are determined to be entitled (and such other Lenders hereby agree to return to such Lender any such erroneous payments received by them). 

Section 11.6 Indemnification. Each Lender shall, in accordance with its Pro Rata Share, indemnify Agent (to
the extent not reimbursed by Borrowers) upon demand against any cost, expense (including counsel fees and disbursements), claim, demand, action, loss or liability (except such as result from Agent’s gross negligence or willful misconduct as
determined by a final non-appealable judgment of a court of competent jurisdiction) that Agent may suffer or incur in connection with the Financing Documents or any action taken or omitted by Agent hereunder
or thereunder. If any indemnity furnished to Agent for any purpose shall, in the opinion of Agent, be insufficient or become impaired, Agent may call for additional indemnity and cease, or not commence, to do the acts indemnified against even if so
directed by Required Lenders until such additional indemnity is furnished. 
 Section 11.7 Right to Request and
Act on Instructions. Agent may at any time request instructions from Lenders with respect to any actions or approvals which by the terms of this Agreement or of any of the Financing Documents Agent is permitted or desires to take or to grant,
and if such instructions are promptly requested, Agent shall be absolutely entitled to refrain from taking any action or to withhold any approval and shall not be under any liability whatsoever to any Person for refraining from any action or
withholding any approval under any of the Financing Documents until it shall have received such instructions from Required Lenders or all or such other portion of the Lenders as shall be prescribed by this Agreement. Without limiting the foregoing,
no Lender shall have any right of action whatsoever against 

  
 95 

 
Agent as a result of Agent acting or refraining from acting under this Agreement or any of the other Financing Documents in accordance with the instructions of Required Lenders (or all or such
other portion of the Lenders as shall be prescribed by this Agreement) and, notwithstanding the instructions of Required Lenders (or such other applicable portion of the Lenders), Agent shall have no obligation to take any action if it believes, in
good faith, that such action would violate applicable Law or exposes Agent to any liability for which it has not received satisfactory indemnification in accordance with the provisions of Section 11.6. 

Section 11.8 Credit Decision. Each Lender acknowledges that it has, independently and without reliance upon
Agent or any other Lender, and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without
reliance upon Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking any action under the Financing Documents. 

Section 11.9 Collateral Matters. Lenders irrevocably authorize Agent, at its option and in its discretion, to
(a) release any Lien granted to or held by Agent under any Security Document (i) upon termination of the Revolving Loan Commitment and payment in full of all Obligations; or (ii) constituting property sold or disposed of as part of or
in connection with any disposition permitted under any Financing Document (it being understood and agreed that Agent may conclusively rely without further inquiry on a certificate of a Responsible Officer as to the sale or other disposition of
property being made in full compliance with the provisions of the Financing Documents); and (b) subordinate any Lien granted to or held by Agent under any Security Document to a Permitted Lien that is allowed to have priority over the Liens
granted to or held by Agent pursuant to the definition of “Permitted Liens”. Upon request by Agent at any time, Lenders will confirm Agent’s authority to release and/or subordinate particular types or items of Collateral pursuant to
this Section 11.9. 
 Section 11.10 Agency for Perfection. Agent and each Lender hereby appoint each
other Lender and any Third Party Agent as agent for the purpose of perfecting Agent’s security interest in assets which, in accordance with the Uniform Commercial Code in any applicable jurisdiction, can be perfected by possession or control.
Should any Lender (other than Agent) obtain possession or control of any such assets, such Lender shall notify Agent thereof, and, promptly upon Agent’s request therefor, shall deliver such assets to Agent or in accordance with Agent’s
instructions or transfer control to Agent in accordance with Agent’s instructions. Each Lender agrees that it will not have any right individually to enforce or seek to enforce any Security Document or to realize upon any Collateral for the
Loan unless instructed to do so by Agent (or consented to by Agent), it being understood and agreed that such rights and remedies may be exercised only by Agent. 

Section 11.11 Notice of Default. Agent shall not be deemed to have knowledge or notice of the occurrence of
any Default or Event of Default except with respect to defaults in the payment of principal, interest and fees required to be paid to Agent for the account of Lenders, unless Agent shall have received written notice from a Lender or a Borrower
referring to this Agreement, describing such Default or Event of Default and stating that such notice is a “notice of default”. Agent will notify each Lender of its receipt of any such notice. Agent shall take such action with respect to
such Default or Event of Default as may be requested by Required Lenders (or all or such other portion of the Lenders as shall be prescribed by this Agreement) in accordance with the terms hereof. Unless and until Agent has received any such
request, Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable or in the best interests of Lenders. 

  
 96 

 Section 11.12 Assignment by Agent; Resignation of Agent; Successor Agent. 

(a) Agent may resign as Agent upon thirty (30) days’ notice to the Lenders (or such lesser period agreed to by the Required Lenders).
If Agent resigns under this Agreement, Agent may appoint, with the consent of the Required Lenders, a successor Agent. If no successor Agent is appointed prior to the effective date of the resignation of Agent, the Required Lenders may appoint a
successor Agent from among the Lenders or may appoint another Person as a successor Agent. Upon the acceptance of its appointment as successor Agent hereunder, such successor Agent shall succeed to all the rights, powers and duties of the retiring
Agent and the term “Agent” shall mean such successor Agent, and the retiring Agent’s appointment, powers and duties as Agent shall be terminated. If no successor Agent has accepted appointment as Agent by the date which is 30 days (or
such lesser period agreed to by the Required Lenders) following a retiring Agent’s notice of resignation, the retiring Agent’s resignation shall nevertheless thereupon become effective and the Required Lenders shall perform all of the
duties of Agent hereunder (and all payments, communications and determinations provided to be made by, to or through Agent shall instead be made by or to each Lender directly) until such time, if any, as the Required Lenders appoint a successor
Agent as provided for above. 
 (b) Upon (i) an assignment permitted by subsection (a) above, or (ii) the acceptance of a
successor’s appointment as Agent pursuant to subsection (a) above, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Agent, and the retiring Agent shall be
discharged from all of its duties and obligations hereunder and under the other Financing Documents (if not already discharged therefrom as provided above in this Section 11.12). The fees payable by Borrowers to a successor Agent shall be the
same as those payable to its predecessor unless otherwise agreed between Borrowers and such successor. After the retiring Agent’s resignation hereunder and under the other Financing Documents, the provisions of this Article and
Section 11.12 shall continue in effect for the benefit of such retiring Agent and its agents and subagents and its Third Party Agents in respect of any actions taken or omitted to be taken by any of them while the retiring Agent was acting or
was continuing to act as Agent. 
 (c) Notwithstanding anything to the contrary in any of the Financing Documents, any Third Party Agent that
becomes the Agent and any delegation, assignment or other transfer of duties, responsibilities or rights of Agent to any Third Party Agent, in each case, does not require the consent of any Person (other than Agent) and shall be permitted at all
times under the Financing Documents. 
 Section 11.13 Payment and Sharing of Payment. 

(a) Revolving Loan Advances, Payments and Settlements; Interest and Fee Payments. 

(i) Agent shall have the right (but not an obligation), on behalf of Revolving Lenders, to disburse funds to Borrowers for all
Revolving Loans requested or deemed requested by Borrowers pursuant to the terms of this Agreement. Agent shall be conclusively entitled to assume, for purposes of the preceding sentence, that each Revolving Lender, other than any Non-Funding Lenders, will fund its Pro Rata Share of all Revolving Loans requested by Borrowers. Each Revolving Lender shall reimburse Agent on demand, in accordance with the provisions of the immediately following
paragraph, for all funds disbursed on its behalf by Agent pursuant to the first sentence of this clause (i), or if Agent so requests, each Revolving Lender will remit to Agent its Pro Rata Share of any Revolving Loan before Agent disburses the same
to a Borrower. If Agent elects to require that each Revolving Lender make funds available to Agent, prior to a disbursement by Agent to a Borrower, Agent shall advise each Revolving Lender by telephone, facsimile or
e-mail of the amount of such Revolving Lender’s Pro Rata Share of the Revolving Loan requested 

  
 97 

 
by such Borrower no later than noon (Eastern time) on the date of funding of such Revolving Loan, and each such Revolving Lender shall pay Agent on such date such Revolving Lender’s Pro Rata
Share of such requested Revolving Loan, in same day funds, by wire transfer to the Payment Account, or such other account as may be identified by Agent to Revolving Lenders from time to time. If any Lender fails to pay the amount of its Pro Rata
Share of any funds advanced by Agent pursuant to the first sentence of this clause (i) within one (1) Business Day after Agent’s demand, Agent shall promptly notify Borrower Representative, and Borrowers shall immediately repay such
amount to Agent. Any repayment required by Borrowers pursuant to this Section 11.13 shall be accompanied by accrued interest thereon from and including the date such amount is made available to a Borrower to but excluding the date of payment at
the rate of interest then applicable to Revolving Loans. Nothing in this Section 11.13 or elsewhere in this Agreement or the other Financing Documents shall be deemed to require Agent to advance funds on behalf of any Lender or to relieve any
Lender from its obligation to fulfill its commitments hereunder or to prejudice any rights that Agent or any Borrower may have against any Lender as a result of any default by such Lender hereunder. 

(ii) On a Business Day of each week as selected from time to time by Agent, or more frequently (including daily), if Agent so
elects (each such day being a “Settlement Date”), Agent will advise each Revolving Lender by telephone, facsimile or e-mail of the amount of each such Revolving Lender’s percentage
interest of the Revolving Loan balance as of the close of business of the Business Day immediately preceding the Settlement Date. In the event that payments are necessary to adjust the amount of such Revolving Lender’s actual percentage
interest of the Revolving Loans to such Lender’s required percentage interest of the Revolving Loan balance as of any Settlement Date, the Revolving Lender from which such payment is due shall pay Agent, without setoff or discount, to the
Payment Account before 1:00 p.m. (Eastern time) on the Business Day following the Settlement Date the full amount necessary to make such adjustment. Any obligation arising pursuant to the immediately preceding sentence shall be absolute and
unconditional and shall not be affected by any circumstance whatsoever. In the event settlement shall not have occurred by the date and time specified in the second preceding sentence, interest shall accrue on the unsettled amount at the rate of
interest then applicable to Revolving Loans. 
 (iii) On each Settlement Date, Agent shall advise each Revolving Lender by
telephone, facsimile or e-mail of the amount of such Revolving Lender’s percentage interest of principal, interest and fees paid for the benefit of Revolving Lenders with respect to each applicable
Revolving Loan, to the extent of such Revolving Lender’s Revolving Loan Exposure with respect thereto, and shall make payment to such Revolving Lender before 1:00 p.m. (Eastern time) on the Business Day following the Settlement Date of such
amounts in accordance with wire instructions delivered by such Revolving Lender to Agent, as the same may be modified from time to time by written notice to Agent; provided, however, that, in the case such Revolving Lender is a Defaulted
Lender, Agent shall be entitled to set off the funding short-fall against that Defaulted Lender’s respective share of all payments received from any Borrower. 

(iv) On the Closing Date, Agent, on behalf of Lenders, may elect to advance to Borrowers the full amount of the initial Loans
to be made on the Closing Date prior to receiving funds from Lenders, in reliance upon each Lender’s commitment to make its Pro Rata Share of such Loans to Borrowers in a timely manner on such date. If Agent elects to advance the initial Loans
to Borrower in such manner, Agent shall be entitled to receive all interest that accrues on the Closing Date on each Lender’s Pro Rata Share of such Loans unless Agent receives such Lender’s Pro Rata Share of such Loans before 3:00 p.m.
(Eastern time) on the Closing Date. 

  
 98 

 (v) It is understood that for purposes of advances to Borrowers made pursuant to
this Section 11.13, Agent will be using the funds of Agent, and pending settlement, (A) all funds transferred from the Payment Account to the outstanding Revolving Loans shall be applied first to advances made by Agent to Borrowers
pursuant to this Section 11.13, and (B) all interest accruing on such advances shall be payable to Agent. 
 (vi)
The provisions of this Section 11.13(a) shall be deemed to be binding upon Agent and Lenders notwithstanding the occurrence of any Default or Event of Default, or any insolvency or bankruptcy proceeding pertaining to any Borrower or any other Credit
Party. 
 (b) Reserved. 

(c) Return of Payments. 

(i) If Agent pays an amount to a Lender under this Agreement in the belief or expectation that a related payment has been or
will be received by Agent from a Borrower and such related payment is not received by Agent, then Agent will be entitled to recover such amount from such Lender on demand without setoff, counterclaim or deduction of any kind, together with interest
accruing on a daily basis at the Federal Funds Rate. 
 (ii) If Agent determines at any time that any amount received by
Agent under this Agreement must be returned to any Borrower or paid to any other Person pursuant to any insolvency law or otherwise, then, notwithstanding any other term or condition of this Agreement or any other Financing Document, Agent will not
be required to distribute any portion thereof to any Lender. In addition, each Lender will repay to Agent on demand any portion of such amount that Agent has distributed to such Lender, together with interest at such rate, if any, as Agent is
required to pay to any Borrower or such other Person, without setoff, counterclaim or deduction of any kind. 
 (d) Defaulted Lenders.
The failure of any Defaulted Lender to make any payment required by it hereunder shall not relieve any other Lender of its obligations to make payment, but neither any other Lender nor Agent shall be responsible for the failure of any Defaulted
Lender to make any payment required hereunder. Notwithstanding anything set forth herein to the contrary, a Defaulted Lender shall not have any voting or consent rights under or with respect to any Financing Document or constitute a
“Lender” (or be included in the calculation of “Required Lenders” hereunder) for any voting or consent rights under or with respect to any Financing Document. 

(e) Sharing of Payments. If any Lender shall obtain any payment or other recovery (whether voluntary, involuntary, by application of
setoff or otherwise) on account of any Loan (other than pursuant to the terms of Section 2.8(d)) in excess of its Pro Rata Share of payments entitled pursuant to the other provisions of this Section 11.13, such Lender shall purchase from the
other Lenders such participations in extensions of credit made by such other Lenders (without recourse, representation or warranty) as shall be necessary to cause such purchasing Lender to share the excess payment or other recovery ratably with each
of them; provided, however, that if all or any portion of the excess payment or other recovery is thereafter required to be returned or otherwise recovered from such purchasing Lender, such portion of such purchase shall be rescinded and each
Lender which has sold a participation to the purchasing Lender shall repay to the purchasing Lender the purchase price to the ratable extent of such return or recovery, without interest. Each Borrower agrees that any Lender so purchasing a
participation from another Lender pursuant to this clause (e) may, to the fullest extent permitted by law, exercise all its rights of payment (including pursuant to Section 10.6) with respect to such participation as fully as if such
Lender were the direct creditor of Borrowers in the amount of such participation). If under any applicable 

  
 99 

 
bankruptcy, insolvency or other similar law, any Lender receives a secured claim in lieu of a setoff to which this clause (e) applies, such Lender shall, to the extent practicable, exercise
its rights in respect of such secured claim in a manner consistent with the rights of the Lenders entitled under this clause (e) to share in the benefits of any recovery on such secured claim. 

Section 11.14 Right to Perform, Preserve and Protect. If any Credit Party fails to perform any obligation
hereunder or under any other Financing Document, Agent itself may, but shall not be obligated to, cause such obligation to be performed at Borrowers’ expense. Agent is further authorized by Borrowers and the Lenders to make expenditures from
time to time which Agent, in its reasonable business judgment, deems necessary or desirable to (a) preserve or protect the business conducted by Borrowers, the Collateral, or any portion thereof, and/or (b) enhance the likelihood of, or
maximize the amount of, repayment of the Loan and other Obligations. Each Borrower hereby agrees to reimburse Agent on demand for any and all costs, liabilities and obligations incurred by Agent pursuant to this Section 11.14. Each Lender
hereby agrees to indemnify Agent upon demand for any and all costs, liabilities and obligations incurred by Agent pursuant to this Section 11.14, in accordance with the provisions of Section 11.6. 

Section 11.15 Delegation of Duties. The Agent may perform any and all of its duties and exercise its rights and powers
hereunder or under any other Financing Document by or through any one or more sub-agents appointed by the Agent. The Agent and any such sub-agent may perform any and all
of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Article shall apply to any such sub-agent and to the Related Parties of the
Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as the Agent. 

Section 11.16 Amendments and Waivers. 

(a) No provision of this Agreement or any other Financing Document may be amended, waived or otherwise modified unless such amendment, waiver
or other modification is in writing and is signed or otherwise approved by Borrowers, the Agent, and the Required Lenders and any other Lender to the extent required under Section 11.16(b). 

(b) In addition to the required signatures under Section 11.16(a), no provision of this Agreement or any other Financing Document may be
amended, waived or otherwise modified unless such amendment, waiver or other modification is in writing and is signed or otherwise approved by the following Persons: 

(i) if any amendment, waiver or other modification would increase a Lender’s funding obligations in respect of any Loan,
by such Lender (other than solely by reason of a waiver of a Default or Event of Default by the Required Lenders in accordance with the terms of this Agreement); and/or 

(ii) if the rights or duties of Agent are affected thereby, by Agent; 

provided, however, that, in each of (i) and (ii) above, no such amendment, waiver or other modification shall, unless signed or otherwise approved
in writing by all the Lenders directly affected thereby, (A) reduce the principal of, rate of interest on or any fees with respect to any Loan or forgive any principal, interest (other than default interest) or fees (other than late charges)
with respect to any Loan; (B) postpone the date fixed for, or waive, any payment (other than any mandatory prepayment pursuant to Section 2.1(b)(ii)) of principal of any Loan, or of interest on any Loan (other than default interest) or any fees
provided for hereunder (other than late charges) or postpone the date of termination of any commitment of any Lender hereunder; (C) change the definition of the term Required Lenders or the percentage of Lenders

  
 100 

 
which shall be required for Lenders to take any action hereunder; (D) release all or substantially all of the Collateral, authorize any Borrower to sell or otherwise dispose of all or
substantially all of the Collateral, release any Guarantor of all or any portion of the Obligations or its Guarantee obligations with respect thereto, except, in each case with respect to this clause (D), as otherwise may be provided in this
Agreement or the other Financing Documents (including in connection with any disposition permitted hereunder); (E) amend, waive or otherwise modify this Section 11.16(b) or the definitions of the terms used in this Section 11.16(b) insofar as the
definitions affect the substance of this Section 11.16(b); (F) consent to the assignment, delegation or other transfer by any Credit Party of any of its rights and obligations under any Financing Document or release any Borrower of its payment
obligations under any Financing Document, except, in each case with respect to this clause (F), pursuant to a merger or consolidation permitted pursuant to this Agreement; or (G) amend any of the provisions of Section 10.7 or amend any of
the definitions Pro Rata Share, Revolving Loan Commitment, Revolving Loan Commitment Amount, or Revolving Loan Commitment Percentage or that provide for the Lenders to receive their Pro Rata Shares of any fees, payments, setoffs or proceeds
of Collateral hereunder. It is hereby understood and agreed that all Lenders shall be deemed directly affected by an amendment, waiver or other modification of the type described in the preceding clauses (C), (D), (E), (F) and (G) of the
preceding sentence. 
 Section 11.17 Assignments and Participations. 

(a) Assignments. 

(i) Any Lender may at any time assign to one or more Eligible Assignees all or any portion of such Lender’s Loan together
with all related obligations of such Lender hereunder. Except as Agent may otherwise agree, the amount of any such assignment (determined as of the date of the applicable Assignment Agreement shall be in a minimum aggregate amount equal to
$1,000,000 or, if less, the assignor’s entire interests in the outstanding Loan; provided, however, that, in connection with simultaneous assignments to two or more related Approved Funds, such Approved Funds shall be treated as one
assignee for purposes of determining compliance with the minimum assignment size referred to above. Notwithstanding anything to the contrary in any Financing Documents, the Credit Parties shall not (and the Credit Parties agree not to have their
Affiliates or Related Parties agree to), solely in connection with a refinancing of this Agreement whereby the Borrowers are not entering into a new credit facility that refinances or replaces this Agreement (and the Loans and the Revolving Loan
Commitments hereunder) but rather is seeking a financial institution (or other Person) and its Affiliates that are not Deerfield ELGX Revolver, LLC or its Affiliates to replace Deerfield ELGX Revolver, LLC and its Affiliates as Agent and as the
Lenders hereunder pursuant to an assignment of the agency of Agent and the Loans and Revolving Loan Commitments hereunder, and whereby the assignment documentation for the agency of Agent and the Loans and Revolving Loan Commitments hereunder
requires the written consent of Endologix (even if the terms hereof do not otherwise require such consent), request from any Lender that any Person be assigned, delegated or transferred any of the Revolving Loan Commitments unless Endologix advises
Deerfield ELGX Revolver, LLC on or prior to the written consent of Endologix of the terms of Section 5.4(s)(i) of the Term Credit Agreement, and any such assignment, delegation or transfer in the scenario described in this sentence that does not
meet the foregoing terms shall be absolutely void ab initio.    Borrowers and Agent shall be entitled to continue to deal solely and directly with such Lender in connection with the interests so assigned to an Eligible
Assignee until Agent shall have received and accepted an effective Assignment Agreement executed, delivered and fully completed by the applicable parties thereto, a processing fee of $3,500 to be paid by the assigning Lender, and, if the Assignee is
not already a Lender, all documentation and other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including, without limitation, the USA PATRIOT Act;
provided, however, no processing fee shall be due for assignments between 

  
 101 

 
Lenders or between a Lender and its Affiliate or Approved Fund. AGENT AND/OR ANY LENDER CONSIDERING ASSIGNING ANY REVOLVING LOAN COMMITMENTS, LOANS OR OBLIGATIONS UNDER THIS AGREEMENT OR THE
OTHER FINANCING DOCUMENTS IS ADVISED AND ENCOURAGED TO REVIEW WITH COUNSEL SECTION 5.4(s) (PARTICULARLY CLAUSE (i) OF THE PROVISO THEREOF) OF THE TERM CREDIT AGREEMENT AND UNDERSTAND ANY IMPLICATIONS OF ANY SUCH ASSIGNMENT IF AGENT AND/OR
ANY LENDER HOLDS ANY INTEREST IN ANY LOANS OR OTHER OBLIGATIONS UNDER THE TERM DEBT DOCUMENTS AT SUCH TIME. 
 (ii) From
and after the date on which the conditions described above have been met, (A) such Eligible Assignee shall be deemed automatically to have become a party hereto and, to the extent of the interests assigned to such Eligible Assignee pursuant to
such Assignment Agreement, shall have the rights and obligations of a Lender hereunder, and (B) the assigning Lender, to the extent that rights and obligations hereunder have been assigned by it pursuant to such Assignment Agreement, shall be
released from its rights and obligations hereunder (other than those that survive termination pursuant to Section 12.1). Upon the request of the Eligible Assignee (and, as applicable, the assigning Lender) pursuant to an effective Assignment
Agreement, each Borrower shall execute and deliver to Agent for delivery to the Eligible Assignee (and, as applicable, the assigning Lender) Notes in the aggregate principal amount of the Eligible Assignee’s Loan (and, as applicable, Notes in
the principal amount of that portion of the principal amount of the Loan retained by the assigning Lender). Upon receipt by the assigning Lender of such Note, upon written request of Borrower Representative, the assigning Lender shall return to
Borrower Representative any prior Note held by it. 
 (iii) During any Third Party Agent Retention Period, Agent, acting
solely for this purpose as an agent of Borrower, shall maintain at one of its office a copy of each Assignment Agreement delivered to it and a register for the recordation of the names and addresses of each Lender, and the commitments of, and
principal amount of the Loan owing to, such Lender pursuant to the terms hereof (the “Register”). The entries in such Register shall be conclusive, absent manifest effort, and Borrowers, Agent and Lenders may treat each Person whose
name is recorded therein pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. Such Register shall be available for inspection by Borrowers and any Lender, at any reasonable
time upon reasonable prior notice to Agent. During any Non-Third Party Agent Retention Period, the Borrower Representative shall maintain such Register and shall make such Register available to Agent and the
Lenders at any reasonable time upon reasonable prior notice to the Borrower Representative. Upon the request of any Third Party Agent upon the commencement of any Third Party Agent Retention Period, the Borrower Representative shall share such
Register with the Third Party Agent, and with respect to any discrepancies between the records or Register of the Borrower Representative, on the one hand, and the records or Register of any Lender, the Agent or the Third Party Agent, on the other
hand, the records and Register of such Lender, Agent or Third Party Agent shall govern and control absent manifest error. Each Lender that sells a participation shall, acting solely for this purpose as an agent of Borrower maintain a register on
which it enters the name and address of each participant and the principal amounts (and stated interest) of each participant’s interest in the Obligations (each, a “Participant Register”). The entries in the Participant
Registers shall be conclusive, absent manifest error. Each Participant Register shall be available for inspection by Borrower and Agent at any reasonable time upon reasonable prior notice to the applicable Lender; provided, that no Lender shall have
any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant’s interest in any commitments, loans, letters of credit or its other obligations
under any Financing Document) to 

  
 102 

 
any Person (including Borrower) except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under
Section 5f.103-1(c) of the United States Treasury Regulations. For the avoidance of doubt, Agent (in its capacity as Agent) shall have no responsibility for maintaining a participant register. 

(iv) Notwithstanding the foregoing provisions of this Section 11.17(a) or any other provision of this Agreement, any Lender may
at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank; provided,
however, that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto. 

(v) Notwithstanding the foregoing provisions of this Section 11.17(a) or any other provision of this Agreement, Agent has the
right, but not the obligation, to effectuate assignments of Loans via an electronic settlement system acceptable to Agent as designated in writing from time to time to the Lenders by Agent (the “Settlement Service”). At any time
when Agent elects, in its sole discretion, to implement such Settlement Service, each such assignment shall be effected by the assigning Lender and proposed assignee pursuant to the procedures then in effect under the Settlement Service, which
procedures shall be consistent with the other provisions of this Section 11.17(a). Each assigning Lender and proposed Eligible Assignee shall comply with the requirements of the Settlement Service in connection with effecting any assignment of Loans
pursuant to the Settlement Service. With the prior written approval of Agent, Agent’s approval of such Eligible Assignee shall be deemed to have been automatically granted with respect to any transfer effected through the Settlement Service.
Assignments and assumptions of the Loan shall be effected by the provisions otherwise set forth herein until Agent notifies Lenders of the Settlement Service as set forth herein. 

(b) Participations. Any Lender may at any time, without the consent of, or notice to, any Borrower or Agent, sell to one
or more Persons (other than any Borrower or any Borrower’s Affiliates) participating interests in its Loan, commitments or other interests hereunder (any such Person, a “Participant”). In the event of a sale by a Lender of a
participating interest to a Participant, (i) such Lender’s obligations hereunder shall remain unchanged for all purposes, (ii) Borrowers and Agent shall continue to deal solely and directly with such Lender in connection with such
Lender’s rights and obligations hereunder, and (iii) all amounts payable by each Borrower shall be determined as if such Lender had not sold such participation and shall be paid directly to such Lender. Each Borrower agrees that if amounts
outstanding under this Agreement are due and payable (as a result of acceleration or otherwise), each Participant shall be deemed to have the right of set-off in respect of its participating interest in
amounts owing under this Agreement to the same extent as if the amount of its participating interest were owing directly to it as a Lender under this Agreement; provided, however, that such right of
set-off shall be subject to the obligation of each Participant to share with Lenders, and Lenders agree to share with each Participant, as provided in Section 11.5. 

(c) Reserved. 

(d) Credit Party Assignments. No Credit Party may assign, delegate or otherwise transfer any of its rights or other
obligations hereunder or under any other Financing Document, and any attempted assignment thereby shall be absolutely void ab initio. 

  
 103 

 Section 11.18 Funding and Settlement Provisions Applicable When Non-Funding Lenders Exist. So long as Agent has not waived the conditions to the funding of Loans set forth in Section 7.2 or Section 2.1, any Lender may deliver a notice to Agent stating that such
Lender shall cease making Revolving Loans due to the non-satisfaction of one or more conditions to funding Loans set forth in Section 7.2 or Section 2.1, and specifying any such non-satisfied conditions. Any Lender delivering any such notice shall become a non-funding Lender (a “Non-Funding
Lender”) for purposes of this Agreement commencing on the Business Day following receipt by Agent of such notice, and shall cease to be a Non-Funding Lender on the date on which such Lender has either
revoked the effectiveness of such notice or acknowledged in writing to each of Agent the satisfaction of the condition(s) specified in such notice, or Required Lenders waive the conditions to the funding of such Loans giving rise to such notice by Non-Funding Lender. Each Non-Funding Lender shall remain a Lender for purposes of this Agreement to the extent that such Non-Funding
Lender has Revolving Loan Outstanding in excess of Zero Dollars ($0); provided, however, that during any period of time that any Non-Funding Lender exists, and notwithstanding any provision to the
contrary set forth herein, the following provisions shall apply: 
 (a) For purposes of determining the Pro Rata Share of each Revolving
Lender under clause (c) of the definition of such term, each Non-Funding Lender shall be deemed to have a Revolving Loan Commitment Amount as in effect immediately before such Lender became a Non-Funding Lender. 
 (b) Except as provided in clause (a) above, the Revolving Loan Commitment
Amount of each Non-Funding Lender shall be deemed to be Zero Dollars ($0). 
 (c) The Revolving Loan
Commitment at any date of determination during such period shall be deemed to be equal to the sum of (i) the aggregate Revolving Loan Commitment Amounts of all Lenders, other than the Non-Funding Lenders
as of such date plus (ii) the aggregate Revolving Loan Outstandings of all Non-Funding Lenders as of such date. 

(d) Agent shall have no right to make or disburse Revolving Loans for the account of any Non-Funding
Lender pursuant to Section 2.1(b)(i) to pay interest, fees, expenses and other charges of any Credit Party. 
 (e) To the extent that Agent
applies proceeds of Collateral or other payments received by Agent to repayment of Revolving Loans pursuant to Section 10.7, such payments and proceeds shall be applied first in respect of Revolving Loans made at the time any Non-Funding Lenders exist, and second in respect of all other outstanding Revolving Loans. 

Section 11.19 Reserved. 

Section 11.20 Definitions. As used in this Article 11, the following terms have the following meanings: 

“Approved Fund” means any (a) investment company, fund, trust, securitization vehicle or conduit that is (or will be)
engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the Ordinary Course of Business, or (b) any Person (other than a natural person) which temporarily warehouses loans for any
Lender or any entity described in the preceding clause (a) and that, with respect to each of the preceding clauses (a) and (b), is administered or managed by (i) a Lender, (ii) an Affiliate of a Lender, or (iii) a Person
(other than a natural person) or an Affiliate of a Person (other than a natural person) that administers or manages a Lender. 

“Assignment Agreement” means an assignment agreement in form and substance acceptable to Agent. 

  
 104 

 “Defaulted Lender” means, so long as such failure shall remain in existence and
uncured, any Lender which shall have failed to make any Loan or other credit accommodation, disbursement, settlement or reimbursement required pursuant to the terms of any Financing Document. 

“Eligible Assignee” means (a) a Lender, (b) an Affiliate of a Lender, (c) an Approved Fund, and (d) any
other Person (other than a natural person) approved by Agent; provided, however, that with respect to clause (d) above, no such Person shall include (i) Borrowers or any of Borrowers’ Affiliates or (ii) unless an Event of
Default has occurred and is continuing, (A) any direct competitor of Credit Parties, in each case, as determined by Agent in its reasonable discretion, (B) any investor or fund that has publicly announced in writing its intention to obtain
control of Endologix publicly or otherwise to the knowledge of the assigning Lender, or (D) any Person listed in the email delivered by counsel to Endologix to counsel to the Agent on March 16, 2017 at 5: 00 p.m. (Pacific time) and any
Affiliates or Approved Funds of any such Person actually known to the assigning Lender and to the Agent to be Affiliates or Approved Funds of any such Person. 

“Federal Funds Rate” means, for any day, the rate of interest per annum (rounded upwards, if necessary, to the nearest whole
multiple of 1/100 of 1%) equal to the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System as published by the Federal Reserve Bank of New York on the Business Day next succeeding such day,
provided, however, that (a) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding Business Day, and (b) if no such rate is so published on such next
preceding Business Day, the Federal Funds Rate for such day shall be the average rate quoted to Agent on such day from three U.S. banks on such transactions as determined by Agent. 

ARTICLE 12 - MISCELLANEOUS 

Section 12.1 Survival. All agreements, representations and warranties made herein and in every other
Financing Document shall survive the execution and delivery of this Agreement and the other Financing Documents and the other Operative Documents. The provisions of Section 2.10 and Articles 11 and 12 shall survive the payment of the
Obligations (both with respect to any Lender and all Lenders collectively) and any termination of this Agreement and any judgment with respect to any Obligations, including any final foreclosure judgment with respect to any Security Document, and no
unpaid or unperformed, current or future, Obligations will merge into any such judgment. 
 Section 12.2 No
Waivers. No failure or delay by Agent or any Lender in exercising any right, power or privilege under any Financing Document shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further
exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein and therein provided shall be cumulative and not exclusive of any rights or remedies provided by law. Any reference in any Financing Document to
the “continuing” nature of any Event of Default shall not be construed as establishing or otherwise indicating that any Borrower or any other Credit Party has the independent right to cure any such Event of Default, but is rather presented
merely for convenience should such Event of Default be waived in accordance with the terms of the applicable Financing Documents. 

Section 12.3 Notices. 

(a) All notices, requests and other communications to any party hereunder shall be in writing (including prepaid overnight courier, facsimile
transmission or similar writing) and shall be given to such party at its address, facsimile number or e-mail address set forth on the signature pages hereof (or, in the case of any such Lender who becomes a
Lender after the date hereof, in an assignment agreement or in a notice delivered to Borrower Representative and Agent by the assignee Lender forthwith upon such 

  
 105 

 
assignment) (or, in the case of any Third Party Agent, in the notice delivered to Borrower Representative pursuant to clause (b) of the definition of “Third Party Agent” herein) or
at such other address, facsimile number or e-mail address as such party may hereafter specify for the purpose by notice to Agent and Borrower Representative; provided, however, that notices,
requests or other communications shall be permitted by electronic means only in accordance with the provisions of Section 12.3(b) and (c). Each such notice, request or other communication shall be effective (i) if given by facsimile, when such
notice is transmitted to the facsimile number specified by this Section and the sender receives a confirmation of transmission from the sending facsimile machine, or (ii) if given by mail, prepaid overnight courier or any other means, when
received or when receipt is refused at the applicable address specified by this Section 12.3(a). 
 (b) Notices and other communications to
the parties hereto may be delivered or furnished by electronic communication (including e-mail and Internet or intranet websites) pursuant to procedures approved from time to time by Agent, provided,
however, that the foregoing shall not apply to notices sent directly to any Lender if such Lender has notified Agent that it is incapable of receiving notices by electronic communication. Agent or Borrower Representative may, in their
discretion, agree to accept notices and other communications to them hereunder by electronic communications pursuant to procedures approved by it, provided, however, that approval of such procedures may be limited to particular notices
or communications. 
 (c) Unless Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender’s receipt of an acknowledgment from the intended recipient (such as by the “return receipt requested” function, as available, return e-mail or other written acknowledgment), and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause (i) of notification that such notice or communication is available and identifying the website address therefor, provided, however, that if any
such notice or other communication is not sent or posted during normal business hours, such notice or communication shall be deemed to have been sent at the opening of business on the next Business Day. 

Section 12.4 Severability. In case any provision of or obligation under this Agreement or any other Financing
Document shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be
affected or impaired thereby. 
 Section 12.5 Headings. Headings and captions used in the Financing
Documents (including the Exhibits, Schedules and Annexes hereto and thereto) are included for convenience of reference only and shall not be given any substantive effect. 

Section 12.6 Confidentiality. 

(a) Each of the Agent and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may
be disclosed (a) to its Affiliates and to its Related Parties (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information
confidential), (b) to the extent required or requested by any regulatory authority purporting to have jurisdiction over such Person or its Related Parties (including any self-regulatory authority), (c) to the extent required by applicable Laws or
regulations or by any subpoena or similar legal process, (d) to any Secured Party or any other party hereto, (e) in connection with the exercise of any remedies hereunder or under any other Financing Document or any action or proceeding
relating to this Agreement or any other Financing Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement containing provisions 

  
 106 

 
substantially the same as those of this Section, to (i) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights and obligations under this
Agreement or the other Financing Documents or (ii) any actual or prospective party (or its Related Parties) to any transaction under which payments are to be made by reference to the Credit Parties and their obligations, this Agreement, the
other Financing Documents or payments hereunder or thereunder, (g) on a confidential basis to (i) any rating agency in connection with rating any Credit Party or its Subsidiaries or the credit facilities provided hereunder or (ii) the
CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers or other market identifiers with respect to the credit facilities provided hereunder, (h) with the consent of any Credit Party or any of
its Affiliates, (i) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section 12.6(a) or (y) becomes available to any Secured Party or any of its Affiliates on a nonconfidential
basis from a source other than Endologix, or (j) as provided in Section 4.19. In addition, Agent and the Lenders may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service
providers to the lending industry and service providers to Agent and the Lenders in connection with the administration of the Loans and this Agreement and the other Financing Documents. 

(b) For purposes of this Section, “Information” means all information received from a Credit Party relating to the Credit Parties or
any Subsidiary or any of their respective businesses, other than any such information that is available to the Agent or any Lender on a nonconfidential basis prior to disclosure by such Credit Party or any Subsidiary; provided that, notwithstanding
anything to the contrary in the Financing Documents, in the case of information received from the Borrowers or any of their Subsidiaries after the date hereof, such Information is both (y) clearly identified at the time of delivery as
confidential and (z) provided to Agent and the Lenders at a time when Agent and such Lenders have requested in writing to receive material nonpublic information. Any Person required to maintain the confidentiality of Information as provided in
this Section 12.6 shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential
information. 
 Section 12.7 Waiver of Consequential and Other Damages. To the fullest extent permitted by
applicable law, no Credit Party shall assert, and each Credit Party hereby waives, any claim against any Indemnitee (as defined below), on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or
actual damages) arising out of, in connection with, or as a result of this Agreement, any other Financing Document or any agreement or instrument contemplated hereby or thereby, the transactions contemplated hereby or thereby, any Loan or the use of
the proceeds thereof. No Indemnitee shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission
systems in connection with this Agreement or the other Financing Documents or the transactions contemplated hereby or thereby. 

Section 12.8 GOVERNING LAW; SUBMISSION TO JURISDICTION. 

(a) THIS AGREEMENT, EACH NOTE AND EACH OTHER FINANCING DOCUMENT, AND ALL DISPUTES AND OTHER MATTERS RELATING HERETO OR THERETO OR ARISING
THEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES (OTHER THAN SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW). 

  
 107 

 (b) EACH CREDIT PARTY HEREBY CONSENTS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED
IN THE STATE OF NEW YORK IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, AND IRREVOCABLY AGREES THAT, SUBJECT TO AGENT’S ELECTION, ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OTHER FINANCING DOCUMENTS SHALL BE
LITIGATED IN SUCH COURTS. EACH CREDIT PARTY EXPRESSLY SUBMITS AND CONSENTS TO THE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS. EACH CREDIT PARTY HEREBY WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS AND AGREES
THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE UPON SUCH CREDIT PARTY BY CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED, ADDRESSED TO SUCH CREDIT PARTY AT THE ADDRESS SET FORTH IN THIS AGREEMENT AND SERVICE SO MADE SHALL BE COMPLETE TEN
(10) DAYS AFTER THE SAME HAS BEEN POSTED. 
 Section 12.9 WAIVER OF JURY TRIAL.    (a) EACH CREDIT
PARTY, AGENT AND THE LENDERS HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THE FINANCING DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY AND AGREES THAT ANY SUCH
ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. EACH BORROWER, AGENT AND EACH LENDER ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS RELIED ON THE WAIVER IN
ENTERING INTO THIS AGREEMENT AND THE OTHER FINANCING DOCUMENTS, AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN THEIR RELATED FUTURE DEALINGS. EACH CREDIT PARTY, AGENT AND EACH LENDER WARRANTS AND REPRESENTS THAT IT HAS HAD THE OPPORTUNITY OF
REVIEWING THIS JURY WAIVER WITH LEGAL COUNSEL, AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS. 
 (b) In the event
any such action or proceeding is brought or filed in any United States federal court sitting in the State of California or in any state court of the State of California, and the waiver of jury trial set forth in Section 12.9(a) hereof is determined
or held to be ineffective or unenforceable, the parties agree that all actions or proceedings shall be resolved by reference to a private judge sitting without a jury, pursuant to California Code of Civil Procedure Section 638, before a
mutually acceptable referee or, if the parties cannot agree, a referee selected by the Presiding Judge of the Los Angeles County, California. Such proceeding shall be conducted in Los Angeles County, California, with California rules of evidence and
discovery applicable to such proceeding.    In the event any actions or proceedings are to be resolved by judicial reference, any party may seek from any court having jurisdiction thereover any prejudgment order, writ or other
relief and have such prejudgment order, writ or other relief enforced to the fullest extent permitted by Law notwithstanding that all actions or proceedings are otherwise subject to resolution by judicial reference. 

Section 12.10 Publication; Advertisement. 

(a) Publication. No Credit Party will directly or indirectly publish, disclose or otherwise use in any public disclosure, advertising
material, promotional material, press release or interview, any reference to the name, logo or any trademark of Deerfield Revolver or any of its Affiliates or any reference to this Agreement or the financing evidenced hereby, in any case except
(i) as required by Law, subpoena or judicial or similar order, in which case the applicable Credit Party shall give Agent prior written notice of such publication or other disclosure (other than filings made with the SEC, which a Credit Party
may make without such notice) or (ii) with Deerfield Revolver’s prior written consent. 

  
 108 

 (b) Advertisement. With the prior written consent of the Borrower (not to be unreasonably
withheld), Deerfield Revolver may publish the name of each Lender and Credit Party, the existence of the financing arrangements referenced under this Agreement, the primary purpose and/or structure of those arrangements, the amount of credit
extended under each facility, the title and role of each party to this Agreement, and the total amount of the financing evidenced hereby in any “tombstone”, comparable advertisement or press release which Deerfield Revolver elects to
submit for publication. In addition, with the prior written consent of the Borrower (not to be unreasonably withheld), Deerfield Revolver may provide lending industry trade organizations with information necessary and customary for inclusion in
league table measurements after the Closing Date. 
 Section 12.11 Counterparts; Integration. This
Agreement and the other Financing Documents may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Signatures by facsimile or by
electronic mail delivery of an electronic version of any executed signature page shall bind the parties hereto. This Agreement and the other Financing Documents constitute the entire agreement and understanding among the parties hereto and supersede
any and all prior agreements and understandings, oral or written, relating to the subject matter hereof. 

Section 12.12 No Strict Construction. The parties hereto have participated jointly in the negotiation and
drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of the authorship of any provisions of this Agreement. 
 Section 12.13 Lender
Approvals. Unless expressly provided herein to the contrary, any approval, consent, waiver or satisfaction of Agent or Lenders with respect to any matter that is the subject of this Agreement, the other Financing Documents may be granted or
withheld by Agent and Lenders in their sole and absolute discretion and credit judgment. 
 Section 12.14 Expenses;
Indemnity 
 (a) Borrowers agree to pay on or prior to the Closing Date and, within ten (10) Business Days (or such later date as
Agent may agree in its sole discretion) after delivery of an invoice therefor after the Closing Date, (a) all reasonable fees, reasonable costs and reasonable,
out-of-pocket expenses of Agent and the Lenders and of legal counsel to Agent and the Lenders of negotiation, documentation, preparation, execution, delivery and
closing, of the Financing Documents and in connection with the consummation of the transactions contemplated hereby and thereby, (b) any consents, amendments, waivers or other modifications to the Financing Documents or otherwise in connection
with the consummation of the transactions contemplated hereby and thereby, (c) all fees, costs and expenses of creating and perfecting Liens in favor of Agent pursuant to any Financing Document, including filing and recording fees, expenses and
Taxes, search fees, title insurance premiums, and fees, costs, expenses and disbursements of counsel to Agent and the Lenders and of counsel providing any opinions that Agent or the Lenders may request in respect of any Financing Documents or the
Liens created pursuant to the Financing Documents, (d) all costs and expenses incurred by Agent or any Lender in connection with the custody or preservation of any of the Collateral, (e) all costs and expenses, including the reasonable out-of-pocket documented fees, costs and expenses of legal counsel to Agent and the Lenders and reasonable,
out-of-pocket documented fees, costs and expenses of accountants, advisors and consultants, incurred by Agent, any Lender and its counsel relating to efforts to protect,
evaluate, assess or dispose of any of the Collateral, (f) all costs and expenses, including fees, costs and expenses of legal counsel to Agent and the Lenders and all fees, costs and expenses of accountants, advisors and consultants and costs
of settlement, incurred by the Agent and the Lenders in enforcing any of the Financing Documents or any 

  
 109 

 
Obligations of, or in collecting any payments due from, any Credit Party hereunder or under the other Financing Documents (including in connection with the sale of, collection from, or other
realization upon any of the Collateral or the enforcement of the Financing Documents) or in connection with any refinancing or restructuring of the credit arrangements provided under this Agreement in the nature of a
“work-out” or pursuant to any proceeding or event of the type set forth in Section 10.1(f), (g) the cost of purchasing insurance that the Credit Parties fail to obtain as required by the Financing
Documents, (h) providing any notices under the Financing Documents that are required or recommended by applicable Laws (i) providing any new Notes or amended and restated Notes and (j) any other actions taken after the Closing Date
related to the Obligations or the Financing Documents. Without limiting any of the foregoing provisions of this Section 12.14(a), any action taken by any Credit Party under or with respect to any Financing Document, even if required under any
Financing Document or at the request of the Agent or any Lender, shall be at the sole expense of such Credit Party, and neither Agent nor any Lender shall be required under any Financing Document to reimburse any Credit Party or any Subsidiary of
any Credit Party therefor. Notwithstanding anything to the contrary contained in this Section 12.14(a), the Credit Parties shall only be obligated to pay the items listed under clause (a) of this Section 12.14(a) that are incurred solely prior
to the Closing Date (but not thereafter) up to a maximum of the Pre-Closing Attorney’s Fees Cap ((as defined in the Term Credit Agreement) which, for the avoidance of doubt, is inclusive of the
attorneys’ fees of Term Agent incurred prior to the date hereof (but not thereafter) pursuant to Section 6.3(a) of the Term Credit Agreement in connection with negotiating and closing the Term Credit Agreement). 

(b) Each Borrower hereby agrees to indemnify, pay and hold harmless Agent (including any Third Party Agent) and Lenders and the officers,
directors, employees, trustees, agents, subagents, investment advisors and investment managers, collateral managers, servicers, and counsel of Agent and Lenders and their other Related Parties (collectively called the “Indemnitees”)
from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, claims, costs, expenses and disbursements of any kind or nature whatsoever (including the fees and disbursements of counsel for such
Indemnitee) in connection with any investigative, response, remedial, administrative or judicial matter or proceeding, whether or not such Indemnitee shall be designated a party thereto and including any such proceeding initiated by or on behalf of
a Credit Party, and the reasonable expenses of investigation by engineers, environmental consultants and similar technical personnel and any commission, fee or compensation claimed by any broker (other than any broker retained by Agent or Lenders)
asserting any right to payment for the transactions contemplated hereby, which may be imposed on, incurred by or asserted against such Indemnitee as a result of or in connection with the transactions contemplated hereby or by the other Operative
Documents (including (i)(A) as a direct or indirect result of the presence on or under, or escape, seepage, leakage, spillage, discharge, emission or release from, any property now or previously owned, leased or operated by Borrower, any Subsidiary
or any other Person of any Hazardous Materials, (B) arising out of or relating to the offsite disposal of any materials generated or present on any such property, or (C) arising out of or resulting from the environmental condition of any
such property or the applicability of any governmental requirements relating to Hazardous Materials, whether or not occasioned wholly or in part by any condition, accident or event caused by any act or omission of Borrower or any Subsidiary, and
(ii) proposed and actual extensions of credit under this Agreement) and the use or intended use of the proceeds of the Loans, except that Borrower shall have no obligation hereunder to an Indemnitee with respect to (x) any liability
resulting from the gross negligence, bad faith or willful misconduct of such Indemnitee or a material breach of this Agreement by such Indemnitee, in each case, as determined by a final non-appealable judgment
of a court of competent jurisdiction or (y) disputes solely among any Indemnitees (other than any claims against an Indemnitee in its capacity or in fulfilling its role as Agent, arranger or any similar role hereunder) to the extent such
disputes do not arise from any act or omission of any Credit Party or of any of any Credit Party’s Affiliates, unless such claims arise from the gross negligence, willful misconduct or bad faith of any such person. To the extent that the
undertaking set forth in the immediately preceding sentence may be unenforceable, Borrower shall contribute the maximum portion which it is permitted to pay and satisfy under applicable Law to the payment and satisfaction of all such indemnified
liabilities incurred by the Indemnitees or any of them. 

  
 110 

 (c) Notwithstanding any contrary provision in this Agreement, the obligations of Borrowers under
this Section 12.14 shall survive the payment in full of the Obligations and the termination of this Agreement. NO INDEMNITEE SHALL BE RESPONSIBLE OR LIABLE TO THE BORROWERS OR TO ANY OTHER PARTY TO ANY FINANCING DOCUMENT, ANY SUCCESSOR,
ASSIGNEE OR THIRD PARTY BENEFICIARY OR ANY OTHER PERSON ASSERTING CLAIMS DERIVATIVELY THROUGH SUCH PARTY, FOR INDIRECT, PUNITIVE, EXEMPLARY OR CONSEQUENTIAL DAMAGES WHICH MAY BE ALLEGED AS A RESULT OF CREDIT HAVING BEEN EXTENDED, SUSPENDED OR
TERMINATED UNDER THIS AGREEMENT OR ANY OTHER FINANCING DOCUMENT OR AS A RESULT OF ANY OTHER TRANSACTION CONTEMPLATED HEREUNDER OR THEREUNDER. 

(d) To the extent permitted by applicable law, each Borrower for itself and all endorsers, guarantors and sureties and their heirs, legal
representatives, successors and assigns, hereby further specifically waives any rights that it may have under Section 1542 of the California Civil Code (to the extent applicable), which provides as follows: “A GENERAL RELEASE DOES NOT
EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR,” and further
waives any similar rights under applicable Laws; provided that, notwithstanding the foregoing, this Section 12.14(d) shall not itself constitute a release or waiver of any claims.

 Section 12.15 Reserved.  

Section 12.16 Reinstatement. This Agreement shall remain in full force and effect and continue to be
effective should any petition or other proceeding be filed by or against any Credit Party for liquidation or reorganization, should any Credit Party become insolvent or make an assignment for the benefit of any creditor or creditors or should an
interim receiver, receiver, receiver and manager or trustee be appointed for all or any significant part of any Credit Party’s assets, and shall continue to be effective or to be reinstated, as the case may be, if at any time payment and
performance of the Obligations, or any part thereof, is, pursuant to applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Obligations, whether as a fraudulent preference reviewable
transaction or otherwise, all as though such payment or performance had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the Obligations shall be reinstated and deemed reduced only by
such amount paid and not so rescinded, reduced, restored or returned. 
 Section 12.17 Successors and
Assigns. This Agreement shall be binding upon and inure to the benefit of Borrowers and Agent and each Lender and their respective successors and permitted assigns. 

Section 12.18 USA PATRIOT Act Notification. Agent (for itself and not on behalf of any Lender) and each
Lender hereby notifies Borrowers that pursuant to the requirements of the USA PATRIOT Act, it is required to obtain, verify and record certain information and documentation that identifies Borrowers, which information includes the name and address
of Borrower and such other information that will allow Agent or such Lender, as applicable, to identify Borrowers in accordance with the USA PATRIOT Act. 

  
 111 

 Section 12.19 Intercreditor Agreement. Notwithstanding anything
to the contrary in this Agreement or in any other Financing Document: (a) the Liens granted to the Agent in favor of Agent and the Lenders pursuant to the Financing Documents and the exercise of any right related to any Collateral shall be
subject, in each case, to the terms of the Intercreditor Agreement, (b) in the event of any conflict between the express terms and provisions of this Agreement or any other Financing Document, on the one hand, and of the Intercreditor
Agreement, on the other hand, the terms and provisions of the Intercreditor Agreement, shall control, (c) any Collateral held by (or in the possession or control of) the Term Agent (or its agents or bailees) shall be held as agent and bailee
for security, Lien perfection and control purposes in favor of Agent (for the benefit of Agent and the Lenders) in accordance with the terms of the Intercreditor Agreement and the Financing Documents, and (d) each Lender hereunder authorizes
and instructs Agent to execute the Intercreditor Agreement on behalf of such Lender, and such Lender agrees to be bound by the terms thereof. 

Section 12.20 Intercreditor Agreements. Each Lender hereunder authorizes and instructs the Agent, as
Agent and on behalf of such Lender, to enter into one or more intercreditor agreements (including any Intercreditor Agreement) from time to time pursuant to, or as contemplated by, the terms of this Agreement and agrees that it will be bound by the
terms and provisions thereof and will take no actions contrary to the terms and provisions thereof. 
 [SIGNATURES APPEAR ON FOLLOWING
PAGE(S)] 

  
 112 

 IN WITNESS WHEREOF, intending to be legally bound, and intending that this Agreement
constitute an agreement executed under seal, each of the parties have caused this Agreement to be executed under seal the day and year first above mentioned. 
  

			
	BORROWERS:	  	ENDOLOGIX, INC.
		
		  	By:     /s/ Vaseem
Mahboob                                        
                
		  	Name: Vaseem Mahboob
		  	Title:   Chief Financial Officer
		
		  	Address:
		  	2 Musick
		  	Irvine, CA 92618
		  	E-mail:    vmahboob@endologix.com
		  	E-mail: jtejedor@endologix.com
		  	Attn: Vaseem Mahboob, CFO
		  	Attn: James Tejedor, Treasury Manager
		
		  	With a copy to (which shall not be deemed to constitute notice):
		
		  	Stradling Yocca Carlson & Rauth, P.C.
		  	660 Newport Center Dr # 1600
		  	Newport Beach, CA 92660
		  	E-mail: mlawhead@sycr.com
		  	Attn: Mike Lawhead
		
		  	Stradling Yocca Carlson & Rauth, P.C.
		  	100 Wilshire Blvd., Fourth Floor
		  	Santa Monica, CA 90401
		  	E-mail: drosen@sycr.com
		  	Attn: Dayan Rosen
		
		  	CVD/RMS ACQUISITION CORP.
		
		  	By:     /s/ Vaseem
Mahboob                                        
                
		  	Name: Vaseem Mahboob
		  	Title:   Chief Financial Officer
		
		  	NELLIX, INC.
		
		  	By:     /s/ Vaseem
Mahboob                                        
                
		  	Name: Vaseem Mahboob
		  	Title:   Chief Financial Officer

 
			
	TRIVASCULAR TECHNOLOGIES, INC.
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer
	
	TRIVASCULAR, INC.
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer
	
	TRIVASCULAR CANADA, LLC
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer

			
	AGENT:	  	DEERFIELD ELGX REVOLVER, LLC
		
		  	 By: Deerfield Management Company, L.P. (Series C),

Manager

		
		  	By: Flynn Management LLC, General Partner
		
		  	By: /s/ David
J. Clark                                       
                             
		  	Name: David J. Clark
		  	Title: Authorized Signatory
		
		  	Address:
		
		  	 c/o Deerfield Management Company, L.P.

		  	 780 Third Avenue, 37th Floor

		  	 New York, NY 10017

		  	 Facsimile: 212-599-3075

		  	 E-mail: dclark@deerfield.com

		  	 Attn: David J. Clark, Esq.

		
		  	With a copy to (which shall not be deemed to constitute notice):
		
		  	 Katten Muchin Rosenman LLP

		  	 575 Madison Avenue

		  	 New York NY 10022-2585

		  	 Facsimile: (212) 894-5877

		  	 E-mail: mark.fisher@kattenlaw.com and

		  	 mark.wood@kattenlaw.com

		  	 Attn: Mark I. Fisher, Esq.

		  	 Attn: Mark D. Wood, Esq.

			
	LENDER:	  	DEERFIELD ELGX REVOLVER, LLC
		
		  	By: Deerfield Management Company, L.P. (Series C), Manager
		
		  	By: Flynn Management LLC, General Partner
		
		  	By: /s/ David
J. Clark                                       
                             
		  	Name: David J. Clark
		  	Title: Authorized Signatory
		
		  	Address:
		
		  	 c/o Deerfield Management Company, L.P.

		  	 780 Third Avenue, 37th Floor

		  	 New York, NY 10017

		  	 Facsimile: 212-599-3075

		  	 E-mail: dclark@deerfield.com

		  	 Attn: David J. Clark, Esq.

		
		  	With a copy to (which shall not be deemed to constitute notice):
		
		  	 Katten Muchin Rosenman LLP

		  	 575 Madison Avenue

		  	 New York NY 10022-2585

		  	 Facsimile: (212) 894-5877

		  	 E-mail: mark.fisher@kattenlaw.com and

		  	 mark.wood@kattenlaw.com

		  	 Attn: Mark I. Fisher, Esq.

		  	 Attn: Mark D. Wood, Esq.

 ANNEXES, EXHIBITS AND SCHEDULES 

 

			
	ANNEXES	  	
		
	Annex A	  	Commitment Annex
	Annex B	  	Payment Account
		
	EXHIBITS 	  	
		
	Exhibit A	  	Closing Checklist
	Exhibit B	  	Form of Compliance Certificate
	Exhibit C-1	  	Borrowing Base Certificate (Agent)
	Exhibit C-2	  	Borrowing Base Certificate (Third Party Agent)
	Exhibit D	  	Form of Notice of Borrowing
		
	SCHEDULES	  	
		
	Schedule 3.1	  	Existence, Organizational ID Numbers, Foreign Qualification, Prior Names
	Schedule 3.4	  	Capitalization
	Schedule 3.6	  	Litigation
	Schedule 3.15	  	Broker’s Fees
	Schedule 3.17	  	Material Contracts
	Schedule 3.18	  	Environmental Compliance
		
	Schedule 5.1	  	Debt; Contingent Obligations
	Schedule 5.2	  	Liens
	Schedule 5.7	  	Permitted Investments
	Schedule 5.8	  	Affiliate Transactions
	Schedule 5.11	  	Business Description
	Schedule 6.2	  	Minimum Net Revenue
	Schedule 7.4	  	Post-Closing Obligations
	Schedule 8.2(b)	  	Exceptions to Healthcare Representations and Warranties
	Schedule 9.1	  	Collateral
	Schedule 9.2	  	Location of Collateral
	 Schedule 9.2(vii)        
	  	 Governmental Authority Account Debtors

 Annex A to Credit Agreement (Commitment Annex) 

 

									
	 Lender
	 	Revolving Loan Commitment Amount	 	 	Revolving Loan Commitment Percentage	 
	 DEERFIELD ELGX REVOLVER, LLC
	 	$	50,000,000	 	 	 	100	% 
	 TOTALS
	 	$	50,000,000	 	 	 	100	% 

 Annex B (Payment Account) 

After the Closing Date until and including the Initial Third Party Agent Commencement Date: 

Beneficiary Bank: The Northern Trust International Banking Corporation, New Jersey 

SWIFT: CNORUS33 
 Fedwire ABA:
026001122 
 CHIPS ABA: 0112 

Beneficiary Name: Deerfield ELGX Revolver LLC 

Beneficiary account:143057-20010 
 After the
Initial Third Party Agent Commencement Date to the extent the Third Party Agent is Cortland and until Cortland is no longer the Third Party Agent during a Third Party Agent Retention Period, such payment information from time to time provided by
Cortland. 

 EXHIBIT A 

DEERFIELD / ENDOLOGIX 

CLOSING CHECKLIST 

Facility Agreement Parties: 
  

			
	Term Borrower	  	Endologix, Inc., a Delaware corporation
		
	Term Guarantors (collectively with the Term Borrower, the “Loan Parties”)	  	See attached Schedule A 
		
	Term Lenders	  	Deerfield Private Design Fund IV, L.P.; Deerfield International Master Fund, L.P.; Deerfield Partners, L.P.; and Deerfield Private Design Fund III, L.P.
		
	Term Agent	  	Deerfield Private Design Fund IV, L.P.
		
	Katten	  	Katten Muchin Rosenman LLP, Counsel to Term Agent
		
	SYCR	  	Stradling Yocca Carlson & Rauth, P.C., Counsel to the Loan Parties

 ABL Agreement Parties: 
  

			
	ABL Borrowers (also referred to as the “Credit Parties”)	  	Endologix, Inc., a Delaware corporation, and as listed on attached Schedule A 
		
	ABL Lender	  	Deerfield ELGX Revolver, LLC
		
	ABL Agent	  	Deerfield ELGX Revolver, LLC
		
	Katten	  	Katten Muchin Rosenman LLP, Counsel to ABL Agent
		
	SYCR	  	Stradling Yocca Carlson & Rauth, P.C., Counsel to the Credit Parties

 FACILITY AGREEMENT DOCUMENTS AND DELIVERABLES: 

 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	A.	  	DEBT DOCUMENTS – AGREEMENTS
					
	1.	  	Facility Agreement	  	Katten	  	 ☐ Term Borrower

☐ Term Guarantors
 ☐ Term Agent

☐ Term Lenders
	  	Final and Executed
					
	2.	  	Annexes to Facility Agreement	  		  		  	
					
	3.	  	Disbursement Amount and Warrants	  	Katten	  	N/A	  	In final form
					
	4.	  	Schedules to Facility Agreement	  		  		  	
					
	5.	  	Schedule P-1—Existing Investments	  	Loan Parties/SYCR	  	N/A	  	In final form
					
	6.	  	Schedule 2.4—List of Agreement Date Lenders and Such Lenders’ Wire Instructions and Information for Notices	  	Katten/Agent	  	N/A	  	In final form

  
 120 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	7.	  	Schedule 3.1(d)—Existing Liens	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	8.	  	Schedule 3.1(f)—Existing Indebtedness	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	9.	  	Schedule 3.1(h)—Litigation	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	10.	  	Schedule 3.1(m)—Real Estate	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	11.	  	Schedule 3.1(x)—Borrower’s Subsidiaries	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	12.	  	Schedule 3.1(z)—Borrower’s Outstanding Shares of Stock, Options and Warrants	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	13.	  	Schedule 3.1(aa)—Material Contracts	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	14.	  	Schedule 3.1(dd)—Environmental	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	15.	  	Schedule 3.1(ff)—Labor Relations	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	16.	  	Schedule 3.1(gg)—Jurisdiction of Organization, Legal Name, Organizational Identification Number and Chief Executive Office	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	17.	  	Schedule 5.1(y)—Post-Closing Requirements	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	18.	  	Schedule 5.2(iv)—Contingent Obligations	  	Loan Parties/SYCR	  	N/A	  	In final form
					
	19.	  	Schedule 5.2(vii)—Transactions with Affiliates	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	20.	  	Exhibits to Facility Agreement	  		  		  	
					
	21.	  	Exhibit A—Form of Loan Note	  	Katten	  	N/A	  	In final form
					
	22.	  	Exhibit B—Form of Perfection Certificate	  	Katten	  	N/A	  	In final form
					
	23.	  	Exhibit C—Form of Warrant	  	Katten	  	N/A	  	In final form
					
	24.	  	Exhibit D—Closing Checklist	  	Katten	  	N/A	  	
					
	25.	  	Exhibit E—Form of Registration Rights Agreement	  	Katten	  	N/A	  	In final form
					
	26.	  	Exhibit F—Form of Compliance Certificate	  	Katten	  	N/A	  	In final form
					
	27.	  	Original Notes in favor of each Term Lender	  	Katten	  	☐ Term Borrower	  	Final and Executed
					
	28.	  	Guaranty and Security Agreement	  	Katten	  	 ☐ Term Borrower

☐ Term Guarantors
 ☐ Term Agent
	  	Final and Executed
					
	29.	  	Schedules to Guaranty and Security Agreement	  	SYCR	  		  	

  
 121 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	30.	  	Schedule 1–Pledged Equity and Pledged Debt Instruments	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	31.	  	Schedule 1A—Pledged Investmetn Property	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	32.	  	Schedule 2—Filings and Perfection	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	33.	  	Schedule 3—Grantor Information	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	34.	  	Schedule 4—Places of Business/Location of Collateral	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	35.	  	Schedule 5—Commercial Tort Claims	  	 Loan
 Parties/SYCR
	  	N/A	  	In final form
					
	36.	  	Perfection Certificate	  	 Katten
 (form)/Loan Parties/SYCR
(substance)
	  	 ☐ Term Borrower

☐ Term Guarantors
	  	Final and Executed
					
	37.	  	Original Warrants in favor of each Term Lender	  	Katten	  	☐ Term Borrower	  	Final and Executed
					
	38.	  	Registration Rights Agreement	  	Katten	  	 ☐ Term Borrower
 ☐ Term
Lenders
	  	Final and Executed
					
	39.	  	UCC-1 Financing Statements for each Loan Party	  	Katten	  	N/A	  	In final form
					
	40.	  	Patent Security Agreement(s)	  	Katten	  	 ☐ Applicable Term Borrower(s)

☐ Term Agent
	  	Final and Executed
					
	41.	  	Schedule to Patent Security Agreement(s)	  	SYCR	  		  	In final form
					
	42.	  	Trademark Security Agreement(s)	  	Katten	  	 ☐ Applicable Term Borrower(s)
 ☐
Term Agent
	  	Final and Executed
					
	43.	  	Schedule to Trademark Security Agreement(s)	  	SYCR	  		  	In final form
					
	44.	  	Receipt by ABL Agent of original Certificates for certificated Equity Interests and Equity Interests Powers and Language in Intercreditor Agreement that ABL Agent is holding such Collateral also on behalf of Term Agent for the
benefit of Term Agent and Term Lenders	  	Katten/SYCR	  		  	Process confirmed
					
	45.	  	Executed Insurance Certificates of the Loan Parties and their Subsidiaries evidencing liability and casualty insurance, naming Term Agent on behalf of the Secured Parties as additional insured (liability insurance) or lender’s
loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	SYCR	  	☐ Insurance Broker (for insurance certificates)	  	In final form

  
 122 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	46.	  	Intercreditor Agreement	  	Katten	  	 ☐ Term Borrower

☐ ABL Borrowers
 ☐ Term Agent

☐ Term Lenders
 ☐ ABL Agent

☐ ABL Lender
	  	Final and Executed
					
	47.	  	Written notice requesting the Disbursement of the proposed date of funding and satisfying the conditions in Section 2.2(a) of the Facility Agreement	  	Loan Parties/SYCR	  	☐ Term Borrower	  	Final and Executed
					
	48.	  	 A.     Funds Flow
	  	 Loan
 Parties/SYCR
	  		  	
					
	49.	  	Irrevocable Proxies	  	Katten	  		  	Final and Executed
					
	B.	  	CERTIFICATES AND MISCELLANEOUS	  		  		  	
					
	50.	  	Lien Searches and IP Searches for Loan Parties	  	SYCR	  	N/A	  	Complete
					
	51.	  	Secretary’s Certificate of each Loan Party, attaching Organization Documents, resolutions, incumbency and good standings	  	SYCR	  	See attached Schedule A 	  	In final form
					
		  	 A.     Certificate of Incorporation or Formation
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 B.     Bylaws or Operating Agreement
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 C.     Resolutions
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 D.     Incumbency
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 E.     Good Standings
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
	52.	  	 Agreement Date Officer’s Certificate from an Authorized Officer of Endologix, Inc. certifying to each of the following:

a)     The conditions set forth in Section 2.2(a) have been satisfied and the terms set forth in
Section 2.2(a) have been completely complied with
 b)     No Default or Event of Default shall
have occurred or would result from the Disbursement or the use of the proceeds therefrom

c)     All of the representations and warranties in the Loan Documents are true and correct

d)    All conditions set forth in Section 4.1 of the Facility Agreement have been
satisfied
	  	SYCR	  	☐ Endologix, Inc.	  	Final and Executed

  
 123 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	53.	  	Solvency Certificate	  	SYCR	  	☐ Term Borrower	  	Final and Executed
					
	54.	  	Legal Opinion of the Loan Parties	  	SYCR	  	☐ SYCR	  	Final and Executed
					
	55.	  	Receipt by the Term Agent and the Term Lenders of any fees required to be paid on or before the Agreement Date	  	Loan Parties	  	N/A	  	
					
	56.	  	Payment by Loan Parties of all costs and expenses required to be paid on the Agreement Date (including pursuant to Sections 2.7(a) and 6.3 of the Facility Agreement) to the Term Agent	  	Loan Parties	  	N/A	  	
					
	57.	  	Receipt by Term Agent and Term Lenders at least 3 Business Days prior to the Agreement Date all KYC and anti-money laundering rules and regulations	  	Loan Parties	  	☐ Loan Parties	  	
					
	58.	  	Transfer Agent Letter as to shares outstanding	  	Loan Parties	  	☐ Transfer Agent	  	Final and Executed
					
	59.	  	Payoff of MidCap	  		  		  	
					
		  	 A.     Payoff Letter
	  	Loan Parties	  	 ☐ MidCap
 ☐ Loan Parties
	  	Final and Executed
					
		  	 B.     UCC-3s
	  	 Loan
 Parties/MidCap
	  	N/A	  	In final form
					
		  	 C.     DACA Terminations
	  	Loan Parties	  		  	
					
		  	 a.      SVB
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 b.      BoA
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 c.      Wells Fargo
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 D.     Landlord Waiver Terminations
	  	Loan Parties	  		  	
					
		  	 a.      Sonoma
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 b.      Northwestern
	  	Loan Parties	  	☐ MidCap	  	Final and Executed
					
		  	 c.      FedEx (bailee)
	  	Loan Parties	  	☐ MidCap	  	Final and Executed

  
 124 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	C.	  	POST-CLOSING ITEMS	  		  		  	
					
	60.	  	 Landlord/Bailee Waivers

•    2 Musick, Irvine, County of Orange, CA 92618 U.S.A.

•    3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.

•    5025 Tuggle Road, Memphis, TN 38118

•    [Foreign Locations]
	  	 Loan
 Parties/SYCR
	  	 ☐ Applicable Loan Parties
 ☐
Applicable Landlord
 ☐ Term Agent
 ☐ ABL
Agent
	  	
					
	61.	  	 Account Control Agreements

•    Wells Fargo

•    Bank of America

•    Silicon Valley Bank

•    [Foreign Accounts]
	  	 Loan
 Parties/SYCR
	  	 ☐ Applicable Loan Parties
 ☐
Applicable Bank
 ☐ Term Agent
 ☐ ABL Agent
	  	
					
	62.	  	Executed Insurance Endorsements of the Loan Parties and their Subsidiaries evidencing liability and casualty insurance, naming Term Agent on behalf of the Secured Parties as additional insured (liability insurance) or lender’s
loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	SYCR	  	 ☐ Insurance Carriers
 (for insurance
endorsements)
	  	Final and Executed

 ABL AGREEMENT DOCUMENTS AND DELIVERABLES 

 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	A.	  	DEBT DOCUMENTS – AGREEMENTS	  		  		  	
					
	1.	  	Credit and Security Agreement	  	Katten	  	 ☐ ABL Borrowers
 ☐ ABL Agent

☐ ABL Lender
	  	Final and Executed
					
	2.	  	Annexes to Facility Agreement	  		  		  	
					
	3.	  	Annex A –Commitment Annex	  	Katten	  	N/A	  	In final form
					
	4.	  	Schedules to Facility Agreement	  		  		  	
					
	5.	  	Schedule 3.1—Existence, Organizational ID Numbers, Foreign Qualification, Prior Names	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	6.	  	Schedule 3.4—Capitalization	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	7.	  	Schedule 3.6—Litigation	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	8.	  	Schedule 3.15—Broker’s Fees	  	Credit Parties/SYCR	  	N/A	  	In final form

  
 125 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

					
	9.	  	Schedule 3.17—Material Contracts	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	10.	  	Schedule 3.18—Environmental Compliance	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	11.	  	Schedule 4.9—Notice of Litigation and Defaults	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	12.	  	Schedule 4.22—Post-Closing Items	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	13.	  	Schedule 5.1—Debt; Contingent Obligations	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	14.	  	Schedule 5.2—Liens	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	15.	  	Schedule 5.7—Permitted Investments	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	16.	  	Schedule 5.8—Affiliate Transactions	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	17.	  	Schedule 5.11—Business Description	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	18.	  	Schedule 5.14—Deposit Accounts and Securities Accounts	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	19.	  	Schedule 6.2—Minimum Net Revenue	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	20.	  	Schedule 8.2(b)—Exceptions to Healthcare Representations and Warranties	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	21.	  	Schedule 9.1—Collateral	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	22.	  	Schedule 9.2—Location of Collateral	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	23.	  	Schedule 9.2(vii)—Governmental Authority Account Debtors	  	Credit Parties/SYCR	  	N/A	  	In final form
					
	24.	  	Exhibits to Credit Agreement	  		  		  	
					
	25.	  	Exhibit A—Closing Checklist	  	Katten	  	N/A	  	
					
	26.	  	Exhibit B—Form of Compliance Certificate	  	Katten	  	N/A	  	In final form
					
	27.	  	Exhibit C—Borrowing Base Certificate	  	Katten	  	N/A	  	In final form
					
	28.	  	Exhibit D—Form of Notice of Borrowing	  	Katten	  	N/A	  	In final form
					
	29.	  	Original Notes in favor of each ABL Lender	  	Katten	  	☐ ABL Borrower	  	Final and Executed
					
	30.	  	Pledge Agreement	  	Katten	  	 ☐ ABL Borrowers
 ☐ Pledgees

☐ ABL Agent
	  	Final and Executed
					
	31.	  	Schedules to Pledge Agreement	  	SYCR	  		  	In final form

  
 126 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	32.	  	Perfection Certificate	  	Katten (form)/Credit Parties/SYCR (substance)	  	See above	  	See above
					
	33.	  	UCC-1 Financing Statements for each Credit Party	  	Katten	  	N/A	  	
					
	34.	  	Delivery of original Certificates for certificated Equity Interests and Equity Interests Powers	  	Katten	  		  	See above
					
	35.	  	Executed Insurance Certificates of the Credit Parties and their Subsidiaries evidencing liability and casualty insurance, naming the ABL Agent on behalf of the Secured Parties as additional insured (liability insurance) or
lender’s loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	SYCR	  	☐ Insurance Broker	  	In final form
					
	36.	  	Intercreditor Agreement	  	Katten	  	See above	  	See above
					
	37.	  	Patent Security Agreement(s)	  	Katten	  	 ☐ Applicable ABL Borrower(s)
 ☐ ABL
Agent
	  	Final and Executed
					
	38.	  	Schedule to Patent Security Agreement(s)	  	SYCR	  		  	In final form
					
	39.	  	Trademark Security Agreement(s)	  	Katten	  	 ☐ Applicable ABL Borrower(s)
 ☐ ABL
Agent
	  	Final and Executed
					
	40.	  	Schedule to Trademark Security Agreement(s)	  	SYCR	  		  	In final form
					
	B.	  	CERTIFICATES AND MISCELLANEOUS	  		  		  	
					
	41.	  	Lien Searches and IP Searches for Credit Parties	  	SYCR	  	N/A	  	See above
					
	42.	  	Secretary’s Certificate of each Credit Party, attaching Organization Documents, resolutions, incumbency and good standings	  	SYCR	  	See attached Schedule A 	  	In final form
					
		  	 A.     Certificate of Incorporation or Formation
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 B.     Bylaws or Operating Agreement
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 C.     Resolutions
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
		  	 D.     Incumbency
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 

  
 127 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

		  	 E.     Good Standings
	  	SYCR	  	See attached Schedule A 	  	See attached Schedule A 
					
	43.	  	 Agreement Date Officer’s Certificate from an Authorized Officer of Endologix, Inc. certifying to each of the following:

a)     Since December 31, 2016, the absence of any MAE

b)     The representations and warranties of each Credit Party contained in the Financing
Documents are true, correct and complete on and as of the Closing Date, except to the extent that any such representation or warranty relates to a specific date in which case such representation or warranty is true and correct as of such earlier
date
 c)     All conditions set forth in Section 7.1 of the Facility Agreement have been
satisfied
 d)     Immediately after such borrowing and after application of the proceeds
thereof or after such issuance, the Revolving Loan Outstandings will not exceed the Revolving Loan Limit

e)     Immediately before and after such advance or issuance, no Default or Event of Default shall
have occurred and be continuing
	  	SYCR	  	☐ Endologix, Inc.	  	See above
					
	44.	  	Solvency Certificate	  	SYCR	  	☐ ABL Borrower	  	Final and Executed
					
	45.	  	Borrowing Base Certificate	  	SYCR	  	☐ [ABL Borrower]	  	
					
	46.	  	Legal Opinion of the Credit Parties	  	SYCR	  	☐ SYCR	  	Final and Executed
					
	47.	  	Receipt by the ABL Agent and the ABL Lender of any fees, costs and expenses required to be paid on or before the Closing Date	  	Credit Parties	  	N/A	  	
					
	48.	  	Receipt by ABL Agent and ABL Lender at least 3 Business Days prior to the Agreement Date all KYC and anti-money laundering rules and regulations	  	Credit Parties	  	☐ Credit Parties	  	

  
 128 

									
	 	  	 Document
	  	 Responsible

Party
	  	 Signatures
	  	 Status

	49.	  	Payoff of MidCap	  	See above	  	See above	  	See above
					
	C.	  	POST-CLOSING ITEMS	  		  		  	
					
	50.	  	Landlord/Bailee Waivers	  	Credit Parties/SYCR	  	See above	  	See above
					
	51.	  	Account Control Agreements	  	Credit Parties/SYCR	  	See above	  	See above
					
	52.	  	Cortland Documentation (including KYC items)	  	Cortland	  	TBD	  	
					
	53.	  	Setting up of Cash Dominion Mechanics	  	ABL Agent	  	N/A	  	
					
	54.	  	Executed Insurance Endorsements of the Credit Parties and their Subsidiaries evidencing liability and casualty insurance, naming the ABL Agent on behalf of the Secured Parties as additional insured (liability insurance) or
lender’s loss payee (casualty insurance) and providing for 30 days’ prior written notice before any such policy may be modified or cancelled (or 10 days’ prior written notice in the case of failure to pay any premiums thereunder)	  	SYCR	  	☐ Insurance Carriers	  	In final form

  
 129 

 Schedule A 

Secretary’s Certificates 
  

															
	 Borrower/Guarantor
	  	 Loan

Party/Credit Party
	  	 Certificate of
Formation /
Articles
of
Organization
	  	 Operating
Agreement
/ Bylaws
	  	 Resolutions
	  	 Incumbency
	  	 Good
Standings

	 Facility

Agreement
	  	 ABL

Agreement
	  	  	  	  	  	  
	Borrower	  	Borrower	  	Endologix, Inc., a Delaware corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	CVD/RMS Acquisition Corp., a Delaware corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	Nellix, Inc., a Delaware corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	TriVascular Technologies, Inc., a Delaware corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	TriVascular, Inc., a California corporation	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received
								
	Guarantor	  	Borrower	  	Trivascular Canada, LLC, a Delaware limited liability company	  	Received	  	Received	  	Final and Executed	  	In final form	  	Received

 EXHIBIT B 

FORM OF COMPLIANCE CERTIFICATE 

This Compliance Certificate is given by _____________________, a Responsible Officer of Endologix, Inc., a Delaware corporation (the
“Borrower Representative”), pursuant to that certain Credit and Security Agreement dated as of April 3, 2017, by and among the Borrower Representative, the other Borrowers signatory thereto and any additional Borrower that may
hereafter be added thereto, collectively, “Borrowers”), Deerfield ELGX Revolver, LLC, individually as a Lender and as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender (as
such agreement may have been amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein without definition shall have the meanings set forth in the Credit
Agreement. 
 The undersigned Responsible Officer hereby certifies to Agent and Lenders that: 

(a) the financial statements delivered with this certificate in accordance with Section 4.1 of the Credit Agreement
fairly present in all material respects the results of operations and financial condition of Borrowers and their Consolidated Subsidiaries as of the dates and the accounting period covered by such financial statements; 

(b) I have reviewed the terms of the Credit Agreement and have made, or caused to be made under my supervision, a review in reasonable detail
of the transactions and conditions of Borrowers and their Consolidated Subsidiaries during the accounting period covered by such financial statements, and such review has not disclosed the existence during or at the end of such accounting period,
and I have no knowledge of the existence as of the date hereof, of any condition or event that constitutes a Default or an Event of Default, except as set forth in Schedule 1 hereto, which includes a description of the nature
and period of existence of such Default or an Event of Default and what action Borrowers have taken, are undertaking and propose to take with respect thereto; 

(c) except as noted on Schedule 2 attached hereto, Schedule 9.2 to the Credit Agreement contains a complete and accurate
list of all business locations of Borrowers and Guarantors and all names under which Borrowers and Guarantors currently conduct business; Schedule 2 specifically notes any changes in the names under which any Borrower or Guarantors conduct
business; 
 (d) except as noted on Schedule 3 attached hereto, the undersigned has no knowledge of (i) any federal
or state tax liens having been filed against any Borrower, Guarantor or any Collateral, or (ii) any failure of any Borrower or any Guarantors to make required payments of withholding or other tax obligations of any Borrower or any Guarantors
during the accounting period to which the attached statements pertain or any subsequent period; 
 (e) [reserved]; 

(f) except as noted on Schedule 4 attached hereto, Schedule 3.6 to the Credit Agreement is true and correct in all
material respects; 
 (g) [reserved]; 

(h) except as noted on Schedule 6 attached hereto, no Borrower or Guarantor has acquired, by purchase or otherwise, any
Chattel Paper, Letter of Credit Rights, Instruments in excess of $250,000 in the aggregate, Documents or Investment Property (other than in the equity interests of Subsidiaries of the Borrowers) that has not previously been reported to Agent on any
Schedule 6 to any previous Compliance Certificate delivered by Borrower Representative to Agent; 

 (i) except as noted on Schedule 7 attached hereto, no Borrower or Guarantor is
aware of any commercial tort claim that has not previously been reported to Agent on any Schedule 7 to any previous Compliance Certificate delivered by Borrower Representative to Agent; and 

(j) Borrowers and Guarantor are in compliance with the covenants contained in Article 6 of the Credit Agreement, and in any Guarantee
constituting a part of the Financing Documents, as demonstrated by the calculation of such covenants below, except as set forth below; in determining such compliance, the following calculations have been made: 

[insert calculations, as applicable] 

Such calculations and the certifications contained therein are true, correct and complete. 

The foregoing certifications and computations are made as of ________________, 20___ (end of month) and as of _____________, 20___. 

 

	
	Sincerely,
	
	ENDOLOGIX, INC.
	
	By:                                     
                                         
                  
	Name:                                     
                                         
            
	Title:                                     
                                         
              

 Exhibit C-1 

Agent 
 Borrowing Base
Certificate 
 BBR
Date:                              

Name: Endologix 
 Borrowing Base

 As of: 
  

																	
	 	  	 	  	 	  	 	 	  	 	  	 	  	CAP	  	 
	(a)	  	Eligible Accounts	  	Gross Accounts Receivable Allowance for doubtful accounts Net Accounts Receivable	  	 	                    	 	  	85%	  		  		  	-
								
		  		  		  	 	US Domestic	 	  		  		  		  	
								
	(b)	  	Net Eligible Inventory	  	Finished Goods	  				  	50%	  	-     OR	  	10,000,000	  	-
								
		  		  		  	 	Gross	 	  		  		  		  	
								
	(c)
	  	Net Book Value of Eligible Equipments	  	Product Equipments, Molds, Office Furnitures Computer Hardware and Software Leasehold Improvements CIP	  	 	                    	 	  		  		  		  	
								
		  		  	TOTAL	  	 	-	 	  		  		  		  	
								
		  		  	Less; Accumulated Depreciation	  	 	                    	 	  		  		  		  	
								
		  		  	NET PPE	  				  	50%	  	-     OR	  	4,000,000	  	

 NET ELIGIBLE
BORROWING                           

Pursuant to, and in accordance with, the terms and provisions of that certain Credit and Security Agreement, dated as of April 3, 2017, by and among
Endologix, Inc. (“Borrower”), the other Persons party thereto from time to time as “Borrowers” (as defined therein) or guarantors therein, Deerfield ELGX Revolver, LLC, in its capacity as Agent (as defined therein, in such
capacity, “Secured Party”) and the financial institutions or other entities from time to time parties thereto, each as a “Lender” (as defined therein) (as amended, restated, supplemented, or otherwise modified in accordance and
in compliance with the Intercreditor Agreement, the “Credit Agreement”; capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Credit Agreement), Borrower is executing and delivering
to Secured Party this Borrowing Base Report accompanied by supporting data (collectively referred to as “Report”). Borrower warrants and represents to Secured Party, that this Report is true and correct in all material respects and based
on information contained in Borrower’s own financial accounting records. 
 Borrower, by the execution of this report: 

(a) Hereby ratifies, confirms, and affirms all of the terms, and further certifies that the Borrower is in compliance with the Financing Documents as of
                     (b) Hereby certifies that the Borrower has paid all State and Federal payroll withholding taxes immediately due and
payable through                      (c) Hereby certifies that the Revolving Loan Outstandings do not exceed the Revolving Loan Limit. 

(Responsible Officer’s Signature) 
  

                          
                           

Name: Vaseem Mahboob 
 Title: CFO 

 EXHIBIT C-2 

Third Party Agent 

Borrowing Base Report 
  

			
	BBR
Date:                                        
	 	                        
		
	Name: Endologix	 	                        

  

																	
	A/R Category	  	Domestic	 	  	Foreign Eligible	 	  	Foreign Ineligible	 	  	TOTAL	 
	 1.      Summary AR Aging 
	  				  				  				  			
	 0 - 30 Days
	  				  				  				  			
	 31 - 60 Days
	  				  				  				  			
	 61 - 90 Days
	  				  				  				  			
	 91 - 120 Days
	  				  				  				  			
	 121 - 150 Days
	  				  				  				  			
	 151 - 180 Days
	  				  				  				  			
	 > 180 Days
	  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total A/R
	  	 	—  	 	  	 	—  	 	  	 	—  	 	  	 	—  	 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 2.      (Less): Ineligibles AR 
	  				  				  				  			
	 Over 120 Days
	  				  				  				  			
	 Foreign under 121 days
	  				  				  				  			
	 Crossage
	  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total Ineligible AR
	  				  				  				  			
	 3.      Eligible Accounts 
	  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 4.      Liquidity Factor 
	  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 5.      Net Eligible Accounts
	  				  				  				  			
	 6.      Reserves
	  				  				  				  			
	 Credits > 120 days
	  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total Reserves
	  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 7.      Net Eligible
	  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 

  

					
	 Computation of Availability
	  	$	—  	 
	 8. Total Eligible Accounts:
	  			
	 9a. (Less): Cash Posted Since Last Aging
	  			
	 9b. Add: Revenues since last aging
	  			
	 9c. Plus/(Minus): Adjustments
	  	$	—  	 
		  	  
	  
	 
	 9d. Net Eligible Accounts
	  	$	—  	 
	 10. Advance Rate
	  	 	85.00	% 
	 11. A/R Availability before Reserves
	  	$	—  	 
	 12. (Less): Cross Age
	  			
	 13. (Less): Third Party Liability

14. (Less): Foreign A/R Reserve
	  			
		  	  
	  
	 
	 15. Net A/R Availability
	  	$	—  	 
		  	  
	  
	 
	 16. Net Inventory Availability
	  			
	 17. Net PP&E Availability
	  			
		  	  
	  
	 
	 18. Total Availability 
	  			
		  	  
	  
	 
	 Computation of Loan
	  			
	 19. Facility Limit
	  	$
 	50,000,000
	 
 
	 20. Available to Borrow (not to exceed limit)
	  			
	 21. Loan Balance on Prior Borrowing Base Certificate
	  			
	 22. (Less): Cash Collections since last Borrowing Base Certificate
	  			
	 23. Increase/(Decrease): Adjustments
	  			

					
	 24. Loan Advances
	  			
		  	  
	  
	 
	 25. Ending Loan Balance
	  	$	—  	 
		  	  
	  
	 
	 26. Letter of Credit Outstandings
	  			
	 27. Overall Reserve
	  	$	—  	 
		  	  
	  
	 
	 28. Remaining Availability (Lines
17-22-23-24)
	  			
		  	  
	  
	 

  

	
	 Pursuant to, and in accordance with, the terms and provisions of that certain Credit and Security Agreement, dated as
of April 3, 2017, by and among Endologix, Inc. (“Borrower”), the other Persons party thereto from time to time as “Borrowers” (as defined therein) or guarantors therein, Deerfield ELGX Revolver, LLC, in its capacity as Agent
(as defined therein, in such capacity, “Secured Party”) and the financial institutions or other entities from time to time parties thereto, each as a “Lender” (as defined therein) (as amended, restated, supplemented, or otherwise
modified in accordance and in compliance with the Intercreditor Agreement, the “Credit Agreement”; capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Credit Agreement), Borrower is
executing and delivering to Third Party Agent this Borrowing Base Report accompanied by supporting data (collectively referred to as “Report”). Borrower warrants and represents to Third Party Agent and Secured Party, that this Report is
true and correct in all material respects and based on information contained in Borrower’s own financial accounting records.

	
	 Borrower, by the execution of this Report:

	
	 (a) Hereby ratifies, confirms, and affirms all of the terms, and further certifies that the Borrower is in compliance
with the Financing Documents as of _______________ (b) Hereby certifies that the Borrower has paid all State and Federal payroll withholding taxes immediately due and payable through _______________ (c) Hereby certifies that the Revolving Loan
Outstandings do not exceed the Revolving Loan Limit.

	
	 (Responsible Officer’s Signature)

	
	
                      
                                         
             

	 Name: Vaseem Mahboob

	 Title: CFO

 EXHIBIT D 

FORM OF NOTICE OF BORROWING 

This Notice of Borrowing is given by _____________________, a Responsible Officer of Endologix, Inc. (the “Borrower
Representative”), pursuant to that certain Credit and Security Agreement dated as of April 3, 2017, by and among the Borrower Representative, the other Borrowers signatory thereto and any additional Borrower that may hereafter be added
thereto (collectively, “Borrowers”), Deerfield ELGX Revolver, LLC, individually as a Lender and as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender (as such agreement may
have been amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein without definition shall have the meanings set forth in the Credit Agreement. 

The undersigned Responsible Officer hereby gives notice to Agent of Borrower Representative’s request to borrow $____________________ of
Revolving Loans on _______________, 20___. [Attached is a Borrowing Base Certificate complying in all respects with the Credit Agreement and confirming that, after giving effect to the requested advance, the Revolving Loan Outstandings will not
exceed the Revolving Loan Limit.]1 
 The undersigned officer hereby certifies that,
both before and after giving effect to the request above (a) each of the conditions precedent set forth in [Section 7.1 and]2 Section 7.2 has been satisfied, (b) all of the
representations and warranties contained in the Credit Agreement and the other Financing Documents are true, correct and complete in all material respects as of the date hereof, except to the extent such representation or warranty relates to a
specific date, in which case such representation or warranty is true, correct and complete as of such earlier date; provided, however, in each case, such materiality qualifier shall not be applicable to any representations and warranties that
already are qualified or modified by materiality in the text thereof, (c) no Default or Event of Default has occurred and is continuing on the date hereof, (d) immediately upon the making of such requested Revolving Loan and after
application of the proceeds thereof or after such issuance, the Revolving Loan Outstandings will not exceed the Revolving Loan Limit, and (e) no Material Adverse Effect shall have occurred and be continuing since the Closing Date. 

IN WITNESS WHEREOF, the undersigned officer has executed and delivered this Notice of Borrowing this ____ day of ___________, 20___.

  

	
	Sincerely,
	
	ENDOLOGIX, INC. 
	
	By: ________________________________
	Name: ______________________________
	Title: ______________________________

  
  

	1 	Include bracketed language and attach Borrowing Base Certificate only to the extent set forth in Section 7.2(a) of the Credit Agreement. 

	2 	Include bracketed language only for any Revolving Loan requested to be made on the Closing Date. 

 Schedule 3.1 – Existence, Organizational ID Numbers, Foreign Qualification, Prior Names

  

													
	 Borrower
	  	 Prior
Names
	  	 Type of
Entity / State
of
Formation
	  	 States Qualified
	  	 State Org. ID Number
	  	 Federal

Tax ID
Number
	  	 Location of Borrower (address)

	Endologix, Inc.	  	N.A.	  	Delaware corporation	  	***	  	2338745	  	68-0328265	  	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.
							
	Nellix, Inc.	  	N.A.	  	Delaware corporation	  	N.A.	  	3359980	  	94-3398416	  	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.
							
	CVD/RMS Acquisition Corp.	  	N.A.	  	Delaware corporation	  	N.A.	  	2955166	  	33-0928438	  	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.
							
	TriVascular Technologies, Inc.	  	N.A.	  	Delaware corporation	  	California	  	4387054	  	87-0807313	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.
							
	TriVascular, Inc.	  	N.A.	  	California corporation	  	N.A.	  	C2065374	  	68-0402620	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.
							
	TriVascular Canada, LLC	  	N.A.	  	Delaware limited liability company	  	California	  	5647226	  	N.A.	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.

  

	***	Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, llinois, Indiana, Iowa, Kansas, Kentucky, Louisiana [does business as Endologix, Inc. of Delaware], Maine, Maryland, Massachusetts,
Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Texas, Utah, Virginia, Washington, West Virginia and Wyoming. 

 Schedule 3.4 – Capitalization 

 

							
	 Name of Issuer
	 	 Authorized

Securities
	 	 Issued and

Outstanding Securities
	 	 Holder; Precentage

Ownership

	Nellix, Inc.	 	1,000 Shares of Common Stock, Par Value $0.001 Per Share	 	100 Shares of Common Stock	 	 Endologix, Inc.;
 100% ownership

				
	CVD/RMS Acquisition Corp.	 	100 Shares of Common Stock, Par Value $0.001 Per Share	 	100 Shares of Common Stock	 	 Endologix, Inc.;
 100% ownership

				
	TriVascular Technologies, Inc.	 	1,000 Shares of Common Stock, Par Value $0.001 Per Share	 	100 Shares of Common Stock	 	 Endologix, Inc.;
 100% ownership

				
	TriVascular, Inc.	 	100 Shares of Common stock, Par Value $0.01 Per Share	 	100 Shares of Common Stock	 	 TriVascular
 Technologies, Inc.;

100% ownership

				
	TriVascular Canada, LLC	 	1,000 Units of Membership Interests	 	1,000 Units of Membership Interests	 	 TriVascular, Inc.;
 100% ownership

 Options and Equity Incentive/Compensation Plans: 

Equity Awards: Endologix’s 2015 Stock Incentive Plan (the “2015 Plan”) authorizes the grant of equity awards to purchase
up to 6.8 million shares of Common Stock. As of December 31, 2016, approximately 8.3 million shares were reserved for issuance under outstanding stock options, including stock options granted under equity compensation plans
preceeding the 2015 Plan, and 1.3 million shares were subject to unvested restricted stock awards. The outstanding stock options have exercise prices ranging from $1.64 to $17.60 and a weighted average exercise price of $9.22. 

Amended and Restated 2006 Employee Stock Purchase Plan (the “ESPP”): As of December 31, 2016, approximately
4.6 million shares of Common Stock were available for issuance under the ESPP. 
 Non-Plan
Inducement Grants: In connection with its merger with TriVascular Technologies, Inc., Endologix issued non-plan inducement stock options to purchase 1.3 million shares of Common Stock at an exercise
price of $7.53 per share, and non-plan inducement restricted stock units for 0.3 million shares of Common Stock. 

Warrants: 
 In connection with its
merger with TriVascular Technologies, Inc., Endologix assumed 35,094 unexercised out-of-the-money warrants of TriVascular
Technologies, Inc., 24,272 of which have an exercise price of $12.58 per share and 10,822 of which have an exercise price of $28.21 per share. 

 Convertible Notes: 

2.25% Convertible Notes: On December 10, 2013, Endologix issued $86.3 million aggregate principal amount of 2.25% Convertible
Notes. The initial conversion rate of the 2.25% Convertible Notes is 41.6051 shares of Common Stock per $1,000 principal amount of 2.25% Convertible Notes, which represents an initial conversion price of approximately $24.04 per share. The 2.25%
Convertible Notes are not convertible as of the Agreement Date. 
 3.25% Convertible Notes: On November 2, 2015, Endologix issued
$125.0 million aggregate principal amount of 3.25% Convertible Notes. The initial conversion rate of the 3.25% Convertible Notes is 89.4314 shares of Common Stock per $1,000 principal amount of 3.25% Convertible Notes, which represents an
initial conversion price of approximately $11.18 per share. The 3.25% Convertible Notes are not convertible as of the Agreement Date. 
 Other Rights
to Securities of Borrower: 
 In connection with its merger with Nellix, Inc. (“Nellix”), Endologix agreed to issue shares of Common Stock
to the former stockholders of Nellix upon Endologix’s receipt of FDA approval to sell Endologix’s Nellix EVAS System in the United States (the “PMA Milestone”). The number of shares of Common Stock issuable to the former
stockholders of Nellix upon achievement of the PMA Milestone shall equal the quotient obtained by dividing $15.0 million by the average per share closing price of Common Stock on The Nasdaq Global Select Market for each of the 30 consecutive
trading days ending with the fifth trading day immediately preceding the date of Endologix’s receipt of FDA approval to sell Endologix’s Nellix EVAS System in the United States, subject to a stock price floor of $4.50 per share,
but not subject to a stock price ceiling. 

 Schedule 3.6 – Litigation 

Barry Lucido, etc. v. TriVascular Technologies, Inc., et al., Superior Court of the State California, County of Sonoma, Case No. SCV 258123. The
complaint sought, among other things, rescissory and compensatory damages, and attorneys’ fees and expenses. On January 25, 2016, the defendants entered into a memorandum of understanding with the plaintiffs providing for the settlement of
all claims in both actions. In December 2016, the defendants entered into a stipulation and agreement of compromise, settlement and release with respect to this matter and the dismissal thereof. The final settlement hearing is scheduled for June
2017. 
 Vicky Nguyen v. Endologix, Inc., et al. (Filed January 3, 2017 in the United States District Court, Central District of
California; Case No. 2:17-cv-00017); and Kodgi Ahmed v. Endologix, Inc., et al. (Filed January 11, 2017 in the United States District Court, Central
District of California; Case No. 8:17-cv-00061). These putative securities class actions are brought against defendants Endologix, Inc., John McDermott, and Vaseem
Mahboob. The putative class period is August 2, 2016 through November 16, 2016. The lawsuits allege that the defendants made misleading statements about the prospects for approval by the FDA of the Nellix medical product in violation of
Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The lawsuits allege that on November 16, 2016, Endologix announced that the FDA had requested
additional data from Endologix to assess Nellix for approval and that Endologix’s stock fell approximately 20% on this news. The lawsuits seek damages, interest, attorneys’ fees, expert fees, costs, and other relief the Court may deem
appropriate. Endologix intends to file a motion to dismiss the lawsuits after the Court appoints a lead plaintiff and the lead plaintiff files a consolidated complaint. 

Steven M. Ortiz v. Endologix, Inc. This wage and hour class action lawsuit was filed by former employee Steven M. Ortiz entitled Steven M.
Ortiz. v. Endologix, Inc., Orange County Superior Court Case No.
30-2016-00873893-CU-OE-CXC. The case was filed on September 9, 2016 and involves the
following claims that the plaintiff seeks to certify as a class action: failure to pay all overtime wages owing; failure to provide meal periods and failure to pay meal period premiums; failure to pay all wages owed at time of termination seeking
waiting time penalties under Labor Code section 203; failure to provide accurate wage statements; and violations of Business and Professions Code section 17200. The case also alleges claims for penalties under the Private Attorneys General Act of
2004. Endologix and the plaintiff held a mediation in March 2017 regarding this matter and are negotiating the terms of a final settlement agreement. 

Samuels v. TriVascular, Inc., in the United States District Court for the Northern District of California, Civil Action No. 3:13-cv-02261-EMC. In this action, Dr. Shaun L.W. Samuels filed a complaint asserting patent infringement of United States
Patent No. 6,007,575 (the “’575 patent”) in connection with TriVascular’s Ovation Prime® Abdominal Stent Graft System for the treatment of aortic abdominal aneurysms.
TriVascular filed an answer and counterclaims, asserting various defenses and asserting counterclaims. Dr. Samuels filed a second amended complaint on August 13, 2015, adding individual defendants, Michael A. Chobotov, Ph.D.; Robert G.
Whirley, Ph.D.; and Joseph W. Humphrey, Ph.D. TriVascular filed an answer and counterclaims on August 27, 2015, asserting various defenses and asserting counterclaims that Dr. Samuels’s patent is not infringed and is invalid, as well as
certain breach of contract claims based on previous agreements with Dr. Samuels. On November 3, 2015, the court held a claim construction hearing to construe certain claims of the ‘575 patent, and issued a claim construction order on
November 12, 2015. 
 On December 17, 2015, the court then entered (based on the parties stipulation) an order and final judgment of non-infringement of the ‘575 patent, providing that TriVascular and the individual defendants did not infringe the ‘575 patent and staying TriVascular’s second through fifth counterclaims pending
Dr. Samuels’s appeal of the judgment of non-infringement. On January 12, 2016, Dr. Samuels filed a notice 

 
of appeal to the court of appeals for the federal circuit. After briefing, the appeal was argued before a panel of the federal circuit on November 1, 2016. On November 3, 2016, the federal
circuit affirmed the district court’s judgment summarily, without writing an opinion. The federal circuit’s mandate was issued on December 12, 2016. TriVascular filed a motion for attorney fees, which the district court denied on February
22, 2017. The district court also ordered the parties to file a stipulation of dismissal of TriVascular’s counterclaims two through five without prejudice, as well as a stipulated final judgment disposing of the case, by March 2017. The parties
filed the foregoing stipulations and are awaiting a final disposition from the district court. 

 Schedule 3.15 – Broker’s Fees 

Pursuant to the terms of an Engagement Letter Agreement between Endologix and Perella Weinberg Partners LP (“PWP”), Endologix is obligated to
pay PWP an amount equal to 2.5% of the aggregate gross amount of funds made available for borrowing (whether or not drawn) from each Lender under the Agreement and the Term Credit Agreement. Endologix is not required to pay any fees to J. Wood
Capital Advisors LLC in connection with the transactions contemplated by the Agreement and the Term Credit Agreement.  

 Schedule 3.17 – Material Contracts 

 

	 	•	 	Cross License Agreement dated as of October 26, 2011, by and between Endologix, Inc. and Bard Peripheral Vascular, Inc. 

  

	 	•	 	Settlement Agreement, dated October 16, 2012 by and among Endologix, Inc., Cook Incorporated, Cook Group and Cook Medical, Inc. 

 

	 	•	 	Standard Industrial/Commercial Multi-Tenant Lease—Net, for 2 Musick, Irvine, California and 35 Hammond, Irvine, dated June 12, 2013, by and between Endologix, Inc. and The Northwestern Mutual Life Insurance
Company. 

 Schedule 3.18 – Environmental Compliance 

None. 

 Schedule 4.9 – Notices of Litigation and Defaults 

Barry Lucido, etc. v. TriVascular Technologies, Inc., et al., Superior Court of the State California, County of Sonoma, Case No. SCV 258123. The
complaint sought, among other things, rescissory and compensatory damages, and attorneys’ fees and expenses. On January 25, 2016, the defendants entered into a memorandum of understanding with the plaintiffs providing for the settlement of
all claims in both actions. In December 2016, the defendants entered into a stipulation and agreement of compromise, settlement and release with respect to this matter and the dismissal thereof. The final settlement hearing is scheduled for June
2017. 
 Vicky Nguyen v. Endologix, Inc., et al. (Filed January 3, 2017 in the United States District Court, Central District of
California; Case No. 2:17-cv-00017); and Kodgi Ahmed v. Endologix, Inc., et al. (Filed January 11, 2017 in the United States District Court, Central
District of California; Case No. 8:17-cv-00061). These putative securities class actions are brought against defendants Endologix, Inc., John McDermott, and Vaseem
Mahboob. The putative class period is August 2, 2016 through November 16, 2016. The lawsuits allege that the defendants made misleading statements about the prospects for approval by the FDA of the Nellix medical product in violation of
Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The lawsuits allege that on November 16, 2016, Endologix announced that the FDA had requested
additional data from Endologix to assess Nellix for approval and that Endologix’s stock fell approximately 20% on this news. The lawsuits seek damages, interest, attorneys’ fees, expert fees, costs, and other relief the Court may deem
appropriate. Endologix intends to file a motion to dismiss the lawsuits after the Court appoints a lead plaintiff and the lead plaintiff files a consolidated complaint. 

Steven M. Ortiz v. Endologix, Inc. This wage and hour class action lawsuit was filed by former employee Steven M. Ortiz entitled Steven M.
Ortiz. v. Endologix, Inc., Orange County Superior Court Case No.
30-2016-00873893-CU-OE-CXC. The case was filed on September 9, 2016 and involves the
following claims that the plaintiff seeks to certify as a class action: failure to pay all overtime wages owing; failure to provide meal periods and failure to pay meal period premiums; failure to pay all wages owed at time of termination seeking
waiting time penalties under Labor Code section 203; failure to provide accurate wage statements; and violations of Business and Professions Code section 17200. The case also alleges claims for penalties under the Private Attorneys General Act of
2004. Endologix and the plaintiff held a mediation in March 2017 regarding this matter and are negotiating the terms of a final settlement agreement. 

Samuels v. TriVascular, Inc., in the United States District Court for the Northern District of California, Civil Action No. 3:13-cv-02261-EMC. In this action, Dr. Shaun L.W. Samuels filed a complaint asserting patent infringement of United States
Patent No. 6,007,575 (the “’575 patent”) in connection with TriVascular’s Ovation Prime® Abdominal Stent Graft System for the treatment of aortic abdominal aneurysms.
TriVascular filed an answer and counterclaims, asserting various defenses and asserting counterclaims. Dr. Samuels filed a second amended complaint on August 13, 2015, adding individual defendants, Michael A. Chobotov, Ph.D.; Robert G.
Whirley, Ph.D.; and Joseph W. Humphrey, Ph.D. TriVascular filed an answer and counterclaims on August 27, 2015, asserting various defenses and asserting counterclaims that Dr. Samuels’s patent is not infringed and is invalid, as well as
certain breach of contract claims based on previous agreements with Dr. Samuels. On November 3, 2015, the court held a claim construction hearing to construe certain claims of the ‘575 patent, and issued a claim construction order on
November 12, 2015. 
 On December 17, 2015, the court then entered (based on the parties stipulation) an order and final judgment of non-infringement of the ‘575 patent, providing that TriVascular and the individual defendants did not infringe the ‘575 patent and staying TriVascular’s second through fifth counterclaims pending
Dr. Samuels’s appeal of the judgment of non-infringement. On January 12, 2016, Dr. Samuels filed a notice 

 
of appeal to the court of appeals for the federal circuit. After briefing, the appeal was argued before a panel of the federal circuit on November 1, 2016. On November 3, 2016, the federal
circuit affirmed the district court’s judgment summarily, without writing an opinion. The federal circuit’s mandate was issued on December 12, 2016. TriVascular filed a motion for attorney fees, which the district court denied on February
22, 2017. The district court also ordered the parties to file a stipulation of dismissal of TriVascular’s counterclaims two through five without prejudice, as well as a stipulated final judgment disposing of the case, by March 2017. The parties
filed the foregoing stipulations and are awaiting a final disposition from the district court. 

 Schedule 4.22 – Post Closing Requirements 

Borrowers shall satisfy and complete each of the following obligations, or provide Agent each of the items listed below, as applicable, on or
before the date indicated below, all to the satisfaction of Agent in its reasonable discretion: 
 1. Within forty-five (45) days after the Closing Date
(or such later date as Agent may agree in writing in its sole discretion), ensure that each Deposit Account and Securities Account (other than Excluded Accounts and other than, subject to compliance with and the terms of Section 5.14, the
Merrill Lynch Securities Account) maintained by Borrowers shall be subject to a Deposit Account Control Agreement or a Securities Account Control Agreement, as applicable, or any other documentation determined by Agent to be reasonably necessary to
grant a perfected security interest in the funds or investment property maintained in any such Deposit Account or Securities Account, each of which shall be in form and substance reasonably satisfactory to Agent. 

2. Borrowers shall use commercially reasonable efforts to, by the date that is sixty (60) days following the Closing Date (or such later date as Agent may
agree in writing in its sole discretion), provide Agent with landlord’s agreement, consignment agreements, landlord waivers, and/or bailee waivers (as applicable), each of which shall be reasonably satisfactory in form and substance to Agent,
for each of the following locations: (a) 3910 Brickway Blvd., Santa Rosa, CA 95403, (b) 5025 Tuggle Road, Memphis, TN 38118 and (c) 2 Musick, Irvine, CA 92618. 

3. Borrowers shall, by the date that is thirty (30) days after the Closing Date (or such later date as Agent may agree in writing in its sole discretion),
provide Agent with endorsements to Borrowers’ property insurance policies naming Agent as lender loss payee and endorsements to Borrowers’ liability insurance policies naming Agent as additional insured and, in each case, notices of
cancellation as set forth in Section 4.4(d). 
 4. Borrowers shall, within sixty (60) days after the Closing Date (or such later date as Agent
may agree in writing), either (a) provide Agent with evidence reasonably satisfactory to it that TriVascular Sales LLC has been dissolved or (b) make TriVascular Sales LLC a Borrower and have TriVascular Sales LLC provide a Lien in its
Collateral to Agent for the benefit of the Secured Parties and to execute and deliver all agreements, instruments and documents reasonably requested by Agent in respect thereof. 

5. Within forty-five (45) days after the Closing Date (or such later date as Agent may agree in writing), Borrowers shall have made all requisite filings
to cause their patents currently registered in the name of Radiance Medical Systems (serial numbers 08/877593 (Microcapsules for Site-Specific Delivery) and 08/965900 (Radiation Delivery Catheter) to be registered in the name of Endologix, Inc. 

6. Within forty-five (45) days after the Closing Date (or such later date as Agent may agree in writing), Borrower shall make RMS/Endologix Sideways
Merger Corp. a Borrower and have RMS/Endologix Sideways Merger Corp. provide a Lien in its Collateral to Agent for the benefit of the Secured Parties and to execute and deliver all agreements, instruments and documents reasonably requested by Agent
in respect thereof. 
 Borrower’s failure to complete and satisfy any of the above obligations on or before the date indicated above,
or Borrower’s failure to deliver any of the above listed items on or before the date indicated above, shall constitute an immediate an automatic Event of Default. 

 Schedule 5.1 – Debt; Contingent Obligations 

1. Base Capped Call Confirmation, dated December 4, 2013, between the Borrower and Bank of America, N.A. 

2. Additional Capped Call Confirmation, dated December 5, 2013, between the Borrower and Bank of America, N.A. 

The capped call transactions contemplated by the documents listed above relate to the 2.25% Convertible Notes. The capped call transactions are expected to
reduce the potential dilution and/or offset the potential cash payments that the Borrower may be required to make in excess of the principal amount upon conversion of the 2.25% Convertible Notes in the event that the market price per share of the
Borrower’s common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, which initially corresponds to the $24.04 conversion price of the 2.25% Convertible Notes.
The Borrower will not be required to make any cash payments to Bank of America, N.A. upon the exercise of the options that are a part of the capped call transactions, but rather will be entitled to receive from Bank of America, N.A. a number of
shares of the Borrower’s common stock and/or an amount of cash based on the amount by which the market price per share of Common Stock of the Borrower, as measured under the terms of the capped call transactions, is greater than the strike
price of the capped call transactions during the relevant valuation period. 

 Schedule 5.2 – Liens 

None. 

 Schedule 5.7 – Permitted Investments 

None. 

 Schedule 5.8 – Affiliate Transactions 

Investments of Inventory pursuant to clause (j) of the definition of Permitted Investments. 

 Schedule 5.11 – Business Description 

The Borrowers engage in the business of developing, manufacturing, marketing and selling innovative medical devices for the treatment of aortic disorders,
including but not limited to the minimally invasive endovascular treatment of abdominal aortic aneurysms. 

 Schedule 6.2 – Minimum Net Revenue 

 

					
	 Defined Period Ending
	  	Minimum Net Revenue Amount*	 
	 June 30, 2017
	  	$	184,000,000	 
	 September 30, 2017
	  	$	184,000,000	 
	 December 31, 2017
	  	$	184,000,000	 
	 March 31, 2018
	  	$	191,000,000	 
	 June 30, 2018
	  	$	191,000,000	 
	 September 30, 2018
	  	$	191,000,000	 
	 December 31, 2018
	  	$	191,000,000	 
	 March 31, 2019
	  	$	199,000,000	 
	 June 30, 2019
	  	$	199,000,000	 
	 September 30, 2019
	  	$	199,000,000	 
	 December 31, 2019
	  	$	199,000,000	 
	 March 31, 2020
	  	$	207,000,000	 

 * Trailing 12 months 

 Schedule 8.2(b) – Exceptions to Healthcare Representations and Warranties 

None. 

 Schedule 9.1 – Collateral 

The Collateral consists of all of Borrower’s assets (other than Excluded Property), including without limitation, all of Borrower’s
right, title and interest in and to the following, whether now owned or hereafter created, acquired or arising: 
  

	 	(a)	all goods, Accounts (including health-care insurance receivables), Equipment, Inventory, contract rights or rights to payment of money, leases, license agreements, franchise agreements, General Intangibles, commercial
tort claims, documents, instruments (including any promissory notes) (and any distribution of property made on, in respect of or in exchange for such instruments from time to time), chattel paper (whether tangible or electronic), cash, Cash
Equivalents, deposit accounts, securities accounts, commodities accounts, investment accounts, Intellectual Property, fixtures, letter of credit rights (whether or not the letter of credit is evidenced by a writing), securities, and all other
investment property (including any distribution of property made on, in respect of or in exchange for such investment property from time to time), supporting obligations, and financial assets, whether now owned or hereafter acquired, wherever
located; 

  

	 	(b)	all of Borrowers’ books and records relating to any of the foregoing; 

  

	 	(c)	all property of any Borrower held by Agent or any Lender, including all property of every description, in the custody of or in transit to Agent or such Lender for any purpose, including safekeeping, collection or
pledge, for the account of such Borrower or as to which such Borrower may have any right or power, including cash; and 

  

	 	(d)	any and all claims, rights and interests in any of the above and all substitutions for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and insurance proceeds of
any or all of the foregoing. 

 Schedule 9.2 – Location of Collateral 

 

	(i)	The following list sets forth each chief executive office and principal place of business of each Borrower and each of their respective Subsidiaries: 

 

			
	 Complete Street and Mailing Address, including County and Zip
Code
	  	 Borrower/Subsidiary

	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.	  	 Endologix, Inc.
 Nellix,
Inc.    
 CVD/RMS Acquisition Corp.

RMS/Endologix Sideways Merger Corp.
 TriVascular Sales,
LLC

		
	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	 TriVascular Technologies, Inc.
  

TriVascular, Inc.
  

TriVascular Canada, LLC

		
	Somnotec (S) Pte Ltd., 50 Ubi Crescent #01-03 Ubi Techpark Singapore 408568	  	Endologix Singapore Private Limited
		
	PO BOX 309, Ugland House, Grand Cayman, Cayman Islands, KY1-1104	  	ELGX International Holdings GP
		
	Level 27, 88 Shortland Street, Auckland, New Zealand	  	Endologix New Zealand Co.
		
	Clarendon House 2 Church Street, Hamilton HM11, Bermuda	  	Endologix Bermuda L.P.
		
	ul. Hrubieszowska 2, 01-209 Warsaw, REGON: 147323048,	  	Endologix Poland spolkda z ograniczona odpowiedzialnoscia
		
	Burgemeester Burgerslaan 40, 5245 NH Rosmalen, The Netherlands	  	 Endologix International Holdings B.V.
 Endologix
International B.V.

		
	Via Boezio n. 4/C, 00193 Roma, Italy	  	Endologix Italia S.r.l.
		
	World Trade Center, Freiberger Str. 39, D-01067 Dresden Germany	  	TriVascular Germany GmbH
		
	Route De Crassier 7, 1262 Eysins, Switzerland	  	TriVascular Switzerland Sárl
		
	Piazzale Biancamano, 8, 20121 Milano – Italia, Italy	  	TriVascular Italia S.r.l.

	(ii)	The following list sets forth all of the addresses (including all warehouses) at which any of the Collateral is located and/or books and records of Borrowers regarding any Collateral or any of Borrower’s assets,
liabilities, business operations or financial condition are kept. 

  

									
	 Borrower
	  	 Location
	  	
Specify
Whether
Location
Has
(i) Inventory
and/or
Equipment,
(ii) Books
and
Records,
or
(iii) Both
	  	 Interest
	  	 Owner or Operator

	Endologix, Inc.	  	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.	  	Both	  	Lease	  	 The Northwestern Mutual Life Insurance Company, att:
William A. Budge, 19

Hammond, Suite 501, Irvine,
 California 92618

					
	Endologix, Inc.	  	 FedEx Supply Chain, 5025 Tuggle Road
 Memphis,
TN 38118
	  	Inventory	  	Third Party Warehouse	  	 FedEx Supply Chain, 5025
 Tuggle Road

Memphis, TN 38118

					
	Endologix, Inc.	  	50 Ubi Crescent #01-03 Ubi Techpark Singapore 408568	  	Inventory	  	Lease	  	 Somnotec (S) Pte Ltd., 50 Ubi
 Crescent #01-03 Ubi Techpark
 Singapore 408568

					
	Endologix, Inc.	  	Inventory held by Sales Representatives (“Trunk Stock”)	  	Inventory	  	The Trunk Stock inventory is not held at a specific location or locations. Endologix, Inc. sales representatives hold Trunk Stock inventory in their possession for sales calls and procedures.	  	N.A.

									
	 Borrower
	  	 Location
	  	
Specify
Whether
Location
Has
(i) Inventory
and/or
Equipment,
(ii) Books
and
Records,
or
(iii) Both
	  	 Interest
	  	 Owner or Operator

	CVD/RMS Acquisition Corp.	  	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.	  	Both	  	Lease	  	 The Northwestern Mutual Life Insurance Company, attn:
William A. Budge, 19

Hammond, Suite 501, Irvine,
 California 92618

					
	Nellix, Inc.	  	2 Musick, Irvine, County of Orange, CA 92618 U.S.A.	  	Both	  	Lease	  	 The Northwestern Mutual Life Insurance Company, attn:
William A. Budge, 19

Hammond, Suite 501, Irvine,
 California 92618

					
	TriVascular Technologies, Inc.	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	Both	  	Lease	  	Sonoma Airport Properties LLC
					
	TriVascular, Inc.	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	Both	  	Lease	  	Sonoma Airport Properties LLC
					
	TriVascular Canada, LLC	  	3910 Brickway Blvd., Santa Rosa, County of Sonoma, CA 95403 U.S.A.	  	Both	  	Lease	  	Sonoma Airport Properties LLC

 Schedule 9.2(vii) – Governmental Authority Account Debtors 

None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]